Final Program WOC See you. World Ophthalmology Congress 2010 ICC, Berlin, Germany

Size: px
Start display at page:

Download "Final Program WOC See you. World Ophthalmology Congress 2010 ICC, Berlin, Germany"

Transcription

1 World Ophthalmology Congress 2010 ICC, Berlin, Germany XXXII International Congress of Ophthalmology 108 th DOG Congress 5-9 June 2010 AAD Congress June 2010 WOC 2010 See you Final Program

2 WOC 2010 Map ICC Hall Level Hall 1 Rooms Room 56 Hall 2 Salon 11/12 Salon 13/14 Lobby Level Salon 15/16 Salon 17/18 Salon 19 Salon 20 Salon 21 Salon 22 Roof Garden Hall 10 Hall 9 Hall 8 Media Check Hall 7 Hall 6 Hall 4/5 Entrance Level Hall 3 Rooms ICC Lounge Rooms Press Office (Rooms 31-33) Kids Club (Room 35) WOC 2010 PCO Counter BVA Registration Registration Terminals Registration Terminals Main Lobby Main Entrance

3 Lobby Level VIP Lounge 1 VIP Lounge 2 Rooms Madrid, Sydney, Hong Kong, Istanbul Hall 11 Poster Exhibition Hall 12 Industrial Exhibition Abu Dhabi Hall 13 Industrial Exhibition Oslo Hall 14 Industrial Exhibition Radio Tower Lounge 1, Lounge 2 Sao Paulo Hall 17 Congress Bags Stockholm Hall 15 Industrial Exhibition Hall 17 Industrial Exhibition Hall 16 Industrial Exhibition

4 When monotherapy is not enough Control under pressure GANFORT (bimatoprost 0.03%/timolol 0.5%). Abbreviated Prescribing Information. Presentation: Eye drop solution, one ml contains 0.3mg bimatoprost and 5mg timolol (as maleate). Indications: Reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues. Dosage and Administration: Please refer to the Summary of Product Characteristics before prescribing. Recommended dose is one drop in the affected eye(s) once daily, administered in the morning (evening dosing may be considered). If more than one topical ophthalmic product is to be used, each should be instilled at least 5 minutes apart. Not recommended in children or adolescents (under the age of 18). Use with caution in renal or hepatic impairment. Contraindications: Hypersensitivity to active substances or to any of the excipients. Reactive airway disease including bronchial asthma or a history of bronchial asthma, severe chronic obstructive pulmonary disease. Sinus bradycardia, second or third degree atrioventricular block, overt cardiac failure, cardiogenic shock. Warnings/Precautions: Ganfort may be absorbed systemically. The same types of cardiovascular and pulmonary adverse reactions as seen with systemic beta-blockers may occur. Cardiac failure should be adequately controlled before beginning therapy. Patients with a history of severe cardiac disease should be watched for signs of cardiac failure and have their pulse rates checked. Cardiac and respiratory reactions, including death due to bronchospasm in patients with asthma, and, rarely, death in association with cardiac failures have been reported following administration of timolol maleate. Beta-blockers may also mask the signs of hyperthyroidism and cause worsening of Prinzmetal angina, severe peripheral and central circulatory disorders and hypotension. Betaadrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) as beta-blockers may mask the signs and symptoms of acute hypoglycemia. While taking beta-blockers, patients with a history of atopy or a history of severe anaphylactic reaction to a variety of allergens may be unresponsive to the usual dose of adrenaline used to treat anaphylactic reactions. In patients with a history of mild liver disease or abnormal alanine amino transferase (ALT), aspartate amino transferase (AST) and/or bilirubin at baseline, bimatoprost had no adverse reactions on liver function over 24 months. There are no known adverse reactions of ocular timolol on liver function. Before treatment is initiated, patients should be informed of the possibility of eyelash growth, darkening of the eyelid skin and increased iris pigmentation since these have been observed during treatment with bimatoprost and Ganfort. Some of these changes may be permanent, and may lead to differences in appearance between the eyes if only one eye is treated. After discontinuation of Ganfort, pigmentation of iris may be permanent. After 12 months treatment with Ganfort, the incidence of iris pigmentation was 0.2%. After 12 months treatment with bimatoprost eye drops alone, the incidence was 1.5% and did not increase following 3 years treatment. Cystoid macular oedema has been reported with Ganfort. Therefore, Ganfort should be used with caution in patients with known risk factors for macular oedema (e.g. aphakic patients, pseudophakic patients with a torn posterior lens capsule). The preservative in Ganfort, benzalkonium chloride, may cause eye irritation. Contact lenses must be removed prior to application, with at least a 15-minute wait before reinsertion. Benzalkonium chloride is known to discolour soft contact lenses; avoid contact. Benzalkonium chloride has been reported to cause punctate keratopathy and/or toxic ulcerative keratopathy. Therefore monitoring is required with frequent or prolonged use of Ganfort in dry eye patients or where the cornea is compromised. Ganfort has not been studied in patients with inflammatory ocular conditions, neovascular, inflammatory, angle-closure glaucoma, congenital glaucoma or narrow-angle glaucoma. Potential for additive effects resulting in hypotension, and/or marked bradycardia when eye drops containing timolol are administered concomitantly with oral calcium channel blockers, guanethidine, or betablocking agents, anti-arrhythmics, digitalis glycosides or para - sympathomimetics. The hypertensive reaction to sudden withdrawal of clonidine can be potentiated when taking beta-blockers. There are no adequate data from the use of Ganfort in pregnant women. Do not use during pregnancy unless clearly necessary. Ganfort should not be used by breast-feeding women. Ganfort has negligible influence on ability to drive and use machines. Adverse Effects: No adverse drug reactions (ADRs) specific for Ganfort have been observed in clinical studies. The ADRs have been limited to those earlier reported for bimatoprost and timolol and the majority were ocular, mild in severity and none were serious. Based on 12-month clinical data, the most commonly reported ADR was conjunctival hyperaemia (mostly trace to mild and thought to be of a noninflammatory nature) in approximately 26% of patients and led to discontinuation in 1.5% of patients. The following ADRs were reported during clinical trials with Ganfort. Eye disorders: Very common ( 1/10): conjunctival hyperaemia, growth of eyelashes. Common ( 1/100 to <1/10): superficial punctuate keratitis, corneal erosion, burning sensation, eye pruritus, stinging sensation in the eye, foreign body sensation, eye dryness, eyelid erythema, eye pain, photophobia, eye discharge, visual disturbance, eyelid pruritus. Skin and subcutaneous tissue disorders: Common: blepharal pigmentation. Additional adverse events that have been seen with one of the components and may potentially occur also with Ganfort. Please refer to Summary of Product Characteristics for full information on side effects. Basic NHS Price: per 3ml bottle for 3x3ml bottle. Marketing Authori sation Number: EU/1/06/340/ Marketing Authorisation Holder: Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, Co. Mayo, Ireland. Legal Category: POM. Date of Preparation: March Further information is available from: Allergan Ltd, Marlow International, The Parkway, Marlow, Bucks, SL7 1YL. Adverse events should be reported to your local regulatory authority and Allergan office. Allergan Ltd, Marlow International, The Parkway, Marlow, Bucks, SL7 1YL Tel: +44 (0) Fax: +44 (0) EU/0201/2010 Date of preparation: April 2010.

5 World Ophthalmology Congress 2010 ICC, Berlin, Germany XXXII International Congress of Ophthalmology 108 th DOG Congress 5-9 June 2010 AAD Congress June 2010 Final Program WOC 2010 See you President WOC 2010 Professor Gerhard K. Lang Congress Venue ICC - Internationales Congress Centrum Berlin Messedamm 22, Berlin, Germany

6 Sharing Your Commitment to Eye Care for 65 Years The global leader in eye care, Alcon is dedicated to discovering and developing breakthrough products that advance the treatment of eye disease Alcon, Inc. 3/10 MIX10501JA

7 WOC Table of contents Page Welcome Addresses Awards Sponsors Committees Supporting Organizations WOC History Program Social Program Information Organizing Societies Welcome Address from the WOC 2010 Honorary President Welcome Address from the WOC 2010 Congress President Welcome Address from the WOC 2010 Scientific Program Committee Chair Welcome Address from the WOC 2010 Scientific Program Committee Co-Chair Welcome Address from the Federal Minister of Education and Research Welcome Address from Berlin's Governing Mayor Awards DOG Promotions and Awards Acknowledgement to main Sponsors WOC 2010 Executive Committee Professional Congress Organizer WOC 2010 Scientific Program Committee WOC 2010 Scientific Program Coordinators WOC 2010 Submitted Program Reviewing Committee ICO Roster 2010 ICO Advisory Committee ICO Foundation Council Board of Directors DOG Executive Committee AAD Executive Committee WOC 2010 Supporting Organizations Past and future WOCs Highlights How to Read the Scientific Program Subspecialty Days Scientific Program Saturday, 5 June 2010 Sunday, 6 June 2010 Monday, 7 June 2010 Tuesday, 8 June 2010 Wednesday, 9 June 2010 Courses and Wetlabs (incl. AAD-Courses Joint Program) Posters Administrative Meetings Company Symposia Other Symposia Official Social Program Program for Accompanying Persons Information for authors Travel and accommodation grants France 2010 European Sponsors and Exhibitors Complete ICC, Exhibition Halls Information from A to Z Press Office WOC 2010 Adverts Author Index Imprint

8 4 WOC 2010 Organizing Societies Sponsor International Council of Ophthalmology (ICO) Host Deutsche Ophthalmologische Gesellschaft e. V. (DOG, German Society of Ophthalmology) Co-Host Augenärztliche Akademie Deutschland (AAD, German Academy of Ophthalmology)

9 WOC Welcome Address from the President of the International Council of Ophthalmology Dear Colleagues, On behalf of the International Council of Ophthalmology, the sponsor of the World Ophthalmology Congress 2010 (WOC 2010), I am most pleased to welcome you to the exciting international city of Berlin, to the superb scientific program, organized under the leadership of Stephen Ryan and Gabriele Lang, and the extraordinary overall program and social events organized under Congress President Gerhard Lang. Welcome Address We are thrilled to return the World Ophthalmology Congress 2010 to Europe this year, following previous successful gatherings in Brussels in 1958, Munich in 1966, Paris in 1974, Rome in 1986, and Amsterdam in As the world comes closer together, it is particularly so in ophthalmology. We held our first international meeting in 1857 in Brussels and this meeting, 153 years later, is our 32nd World Congress. As the first true specialty in medicine, ophthalmology continues to be a leader in diagnostics, surgical innovation, education, certification and certainly congeniality. This World Congress is a chance for generalists in ophthalmology and subspecialists in every field to learn from one another and to maintain a central commitment to ophthalmology as a specialty. We come together with the mutual goal of preventing and alleviating vision loss, and to face the challenge of 314 million people visually impaired. On behalf of the International Council and the world s ophthalmologists, I welcome you and wish for you a most successful Congress personally and professionally. Bruce E. Spivey, M.D., M.S., M.Ed. President, International Council of Ophthalmology

10 Lotemax 0.5% Eye Drops, Suspension Abbreviated Prescribing Information UK (Please refer to full Summary of Product Characteristics when Prescribing). Presentation: The suspension contains 0.5% loteprednol etabonate (5 mg/ml). Each drop contains 0.19 mg loteprednol etabonate. Uses: Treatment of post-operative inflammation following ocular surgery. Dosage and administration: Ocular: Adults and elderly One to two drops four times daily beginning 24 hours after surgery and continuing throughout the post-operative period. The duration of treatment should not exceed 2 weeks. Children and adolescents: Lotemax should not be used in the paediatric age group until further data become available. Contraindications: most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures; untreated purulent acute infections, red eye with unknown diagnosis and infection caused by amoeba. Hypersensitivity to the active substance, to any of the excipients, and to other corticosteroids. Warnings and Precautions: Prolonged use of corticosteroids may result in ocular hypertension or glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision, and in posterior subcapsular cataract formation. Steroids should be used with caution in the presence of glaucoma. Prolonged use of corticosteroids may suppress the host response and may increase the possibility of secondary ocular infections. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids. In acute purulent conditions of the eye, steroids may mask infection or enhance existing infection. The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation. Long term treating with corticosteroids can cause fungal disease. Fungal disease should be considered in the differential diagnosis when a corneal ulcer persists. Contains benzalkonium chloride which may cause eye irritation. In general patients should not wear contact lenses after cataract surgery, unless contact lens wearing is medically indicated. Contact with soft contact lenses should be avoided. Known to discolour soft contact lenses. If signs and symptoms fail to improve after two days, the patient should be reevaluated. If this product is used for 10 days or longer, intraocular pressure should be monitored. Interactions: the low potential of ocular loteprednol etabonate eye drops to increase the intraocular pressure may be adversely affected by systemically administered medicinal products with anticholinergic activity. In patients receiving concomitant ocular hypotensive therapy, the addition of loteprednol etabonate may increase intraocular pressure and decrease the apparent ocular hypotensive effect of these medicinal products. Concurrent administration of cycloplegics may increase the risk of raised intraocular pressure. Undesirable effects: reactions associated with ophthalmic steroids include elevated intraocular pressure in steroid responsive patients, which may be associated with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera. The most common side-effects (>1/100, <1/10) during clinical trials with loteprednol included the following: corneal defect, eye discharge, ocular discomfort, dry eye, epiphora, foreign body sensation in eyes, conjunctival hyperaemia and ocular itching. Instillation site burning, headache, rise in IOP (see SPC for full details of adverse events). Use in pregnancy and lactation: contraindicated. Overdosage: Acute overdosage is unlikely to occur via the ophthalmic route. Basic NHS price: 5.50 Legal Category: POM Product Licence number: PL17947/0001. Product Licence Holder: Bausch & Lomb GmbH, Brunsbütteler Damm , Berlin, Germany. Date of last revision: September Further Information is available from: Bausch& Lomb UK Ltd London Road, Kingston- Upon-Thames, KT2 6QJ. Tel: Trademark statement: Lotemax is a registered trademark of Bausch& Lomb Incorporated. Adverse events should be reported. Reporting forms and Information can be found at Adverse events should also be reported to Bausch & Lomb UK Ltd on * In a summation of controlled, randomized studies of individuals treated for 28 days or longer with LOTEMAX, LOTEMAX provided a lower incidence of IOP elevations 10 mm Hg vs prednisolone acetate 1% (2.1%, 14/664 for LOTEMAX; 6.7%, 11/164 for prednisolone acetate 1%). References: 1. Lotemax, German SPC, Dec Stewart R, Horwitz B, Howes J, Novack GD, Hart K, and the Loteprednol Etabonate Post-operative Inflammation Study Group 1. Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. J Cataract Refract Surg. 1998;24: Beehler C, Bodner B, Bowman B, et al, for the Loteprednol Etabonate Postoperative Inflammation Study Group 2. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. Ophthalmology. 1998;105: Novack GD, Howes J, Crockett RS, Sherwood MB. Change in intraocular pressure during long-term use of loteprednol etabonate. J Glaucoma. 1998;7: LOTEMAX is a registered trademark of Bausch + Lomb incorporated Bausch + Lomb Incorporated Lotemax

11 WOC Welcome Address from the WOC 2010 Congress President Dear colleagues and friends, It is my pleasure and honor to welcome you to the World Congress of Ophthalmology WOC 2010, the 108 th DOG Congress and the AAD Congress 2010 in Berlin. For the third time the DOG will be host of this outstanding international congress. Following Heidelberg in 1888 and Munich in 1966 this year ophthalmologists from all over the world will be meeting in Berlin. 20 years after the German Reunification, Berlin, the cultural and political center of Germany, has become a unique symbol of the overcoming of global frontiers. It is thus predestined to host the World Congress WOC 2010: The necessity of international cooperation as well as responsibility-and problem-orientated action are essential responsibilities of international ophthalmology especially with regard to the discrepancy in quality in the treatment of eye diseases between industrialized and third world countries. The WOC 2010 will also focus on this aspect. In an outstanding scientific program with numerous lectures, presentations, courses, posters, videos in over sessions leading experts of all subspecialties will present the latest scientific knowledge in research and state of the art ophthalmology. Subspecialty Days will prioritize retina, glaucoma, pediatric ophthalmology as well as cataract and refractive surgery. In addition to the scientific discourse, the social program offers various possibilities for a personal and cultural exchange: The opening ceremony will commemorate Albrecht von Graefe, co-founder of the German Society of Ophthalmology and the ICO. You can look forward to a stunning presentation! On Monday evening we will invite you to a typical Bavarian-like WOCtoberfest. A further highlight will be WOC in Concert on Sunday evening in the French Church of Friedrichstadt, where ophthalmologists will be perform for ophthalmologists. It is a special pleasure for me that numerous colleagues will be visiting the WOC 2010 with their families and I extent a cordial welcome to all of them. For those participants travelling with children, I would like to point out to the day care for children offered free of charge in Room 35. It is my deep desire to thank everybody involved in the preparation of the congress and the scientific program. All in all 82 program coordinators, 55 societies and organizations, more than speakers contribute to the success of this congress. My special thanks go to the coordinators of the scientific program, Prof. Steve Ryan and Prof. Gabriele Lang. Special thank also go to the sponsors and exhibitors for their various support. Without their contributions this congress would not have been possible. Last but not least I would like to thank our friends of the ICO Council for their active and long-standing support and I express my thanks to the members of the organizing committee for more than eight years of active support and help in the planning and preparation of this congress. Let me again welcome you to Berlin also on behalf of the ICO. Let s look forward to an interesting congress, a manifold collegial exchange, to meeting with old friends and making new friends with ophthalmologists from all over the world. Welcome Address Prof. Dr. Gerhard K. Lang Congress President WOC 2010

12 8 WOC 2010 Welcome Address Welcome Address from the WOC 2010 Scientific Program Committee Chair It is with great pleasure that I add my words of welcome to the World Ophthalmology Congress 2010 (WOC 2010) in Berlin. We are all indebted to the leading ophthalmologists from around the world who have contributed their time and organizational abilities as coordinators, chairs, moderators, and speakers. Their scientific contributions and active participation guarantee the success of the scientific program in the 32nd International Congress of Ophthalmology. Our colleagues have expanded our core programs including the latest in scientific practice with the newest cutting edge treatments, ophthalmic drugs and devices. The leaders of industry from around the world join the leaders of ophthalmology in the outstanding Congress. The WOC 2010 provides a unique opportunity for scientific communication and exchange between the worlds s leading specialists in the various fields of ophthalmology. The cosmopolitan city of Berlin, Germany s capital, invites you not only for its science but to show you the dynamics and development of the 20 years following reunification making it an ideal setting for our prestigious world congress. We take pride that ophthalmology has the longest history of any regular international medical meeting. At the time of the first international meeting in Brussels in 1857, Berlin was the location for the remarkable contributions of von Helmholtz, von Graefe, and others who provided the scientific basis for our specialty, ophthalmology. We are fortunate to pursue the heritage they established in international ophthalmology. More than 3,000 international experts will make their presentations in more than 600 sessions. 81 coordinators have organized the chairs, moderators, and speakers in 31 specialties and separate areas in the scientific program. 58 separate ophthalmic organizations from around the world actively participate in the scientific program. The quality of scientific program is even more impressive to me than these numbers. The scientific program makes the WOC 2010 professionally rewarding as well as enjoyable. Our colleagues of the German Society of Ophthalmology and the German Academy of Ophthalmology have been delightful colleagues with whom to work. We welcome you and look forward to an exciting scientific program in this stimulating environment so that we may exchange the newest cutting edge ideas, and build stronger and better practices for our patients for the future. I am delighted to join in welcoming you to Berlin. Stephen J. Ryan, MD Scientific Program Committee Chair

13 WOC Welcome Address from the President of the BVA Dear Colleagues, 2010 marks a momentous year in the field of ophthalmology. For the first time in 44 years, the World Ophthalmology Congress 2010 (WOC 2010) will once again take place in Germany. The WOC 2010 organizers have put together a comprehensive and informative program. Top-class speakers will update delegates on the most up-to-date practices and procedures in ophthalmology, guaranteed to offer stimulated discussions. The annual conference of the German Academy of Ophthalmology (AAD), the leading German-speaking conference in training and continuing education in the field of ophthalmology, will take place at the same time. This is being hosted by the German Society of Ophthalmology (DOG) and the Professional Organisation of German Ophthalmologists (BVA). Welcome Address The German ophthalmic community is delighted that their international colleagues are coming to Berlin, Germany s capital, to exchange ideas and share new perspectives. German and international visitors alike - we cordially welcome you all at WOC 2010 and AAD! Prof. Dr. Bernd Bertram President Professional Association of German Ophthalmologists (BVA)

14 10 WOC 2010 Welcome Address Welcome Address from the Federal Minister of Education and Research The field of ophthalmology is facing major challenges as a result of current demographic developments. We urgently need improved methods for the diagnosis and treatment of degenerative diseases in particular. Recent estimates have revealed that about ten million Europeans are at risk of losing their eyesight as a result of age-related degeneration of the macula. Such degeneration may lead to blindness, as do cataracts, glaucoma and retinopathy in patients with a history of diabetes. The growing number of people suffering from diabetes in old age will exacerbate this negative trend. Innovative technological solutions are being used in ophthalmology to improve patients' quality of life. It is not yet possible for blind patients to regain their eyesight, but impressive progress has already been made in the development of electronic retinal prostheses. The enormous progress made in basic biomedical research needs to be transferred to routine treatment more quickly so that patients can receive even better care in the future. Smooth cooperation between all players in science, industry and health care requires the establishment of forums for the exchange of information and experience forums where researchers and practitioners can meet, discuss their challenges and visions and work together to find solutions. The World Ophthalmology Congress 2010 is such a forum. It does not only provide an excellent opportunity to learn about innovative techniques and new methods for use in clinical practice; it is also a platform for the generation of promising project ideas and the creation of new cooperation networks. I wish the participants in this congress stimulating discussions and a productive exchange of ideas. Prof. Dr. Annette Schavan, MdB Federal Minister of Education and Research

15 WOC Welcome Address from Berlin s Governing Mayor We are delighted to welcome the participants in the World Ophthalmology Congress to Berlin. As both a conference venue and a science capital, our city is honored to be hosting this major international congress and its discussions of the current state of research, study outcomes, and the prospects for ophthalmology. A good 20 years after the peaceful revolution and the fall of the Wall, Germany s capital shows the impact of unprecedented change. Not only have the two halves of the city been visibly reunited, leaving behind the long era of division, but Berlin has discovered new strengths in many different areas. A magnet especially for talented and creative people from all over the world, it owes its national and international appeal in large part to its many cultural institutions and its renowned scientific landscape. Welcome Address One of Berlin s special strengths lies in medicine and the health care sector. Tradition and modern medical research are intertwined here. For instance, Berlin is the birthplace of your discipline, ophthalmology. The festivities surrounding the Berlin Science Year in 2010 give us an especially vivid impression of the long history of the sciences in our city. The Charité, for instance, Europe s largest university hospital, is celebrating its 300 th anniversary this year. However, we are not just looking back. The spotlight is also on our excellent universities and renowned scientific institutes, many of which do worldclass research and offer the next generation of scholars and scientists a bright future. In other words, the World Ophthalmology Congress is taking place in an exciting environment. In this spirit, I would again like to say Welcome! and to wish you not only many new insights and productive professional exchange, but also the opportunity to round off your stay in Berlin with a cultural or culinary experience you will long remember. Klaus Wowereit Governing Mayor of Berlin

16

17 WOC The Gonin Medal The Gonin Medal has been instituted in 1937 and is the oldest but also the most prestigious medal in ophthalmology. It is placed every year at the disposition of the Board of the International Council of Ophthalmology by the University of Lausanne and the Swiss Ophthalmological Society. Awards Honoree: Alan Charles Bird (London/UK) Laudatio: Bruce E. Spivey (ICO President) Alan Bird started his ophthalmology residency at St Bartholomew s Hospital in London His first interest was neuro-ophthalmology and he worked for one year as Senior House Officer at Guy s/maudsley Neurosurgical Unit. In 1965 he joined the staff of Moorfields Eye Hospital. In he completed a clinical fellowship at the Bascom Palmer Eye Institute, Miami. He became a close friend of Donald Gass who had a major influence on him. In August 1969 Alan returned to Moorfields Eye Hospital where he became an undisputed world leader in medical retina. In 1976 he became Professor of Clinical Ophthalmology and is since October 2006 Emeritus Professor. He is still a Honorary Consultant at Moorfields Eye Hospital. Dr. Bird s main interests are age-related macular degeneration and retinal dystrophies. Together with John Marshall and Daniel Pauleikhoff he studied aging changes in Bruch s membrane. With A. Hoskins he was the first to recognize tears of the retinal pigment epithelium. His group described a number of genotypephenotype correlations and identified new gene mutations in various retinal dystrophies. With Fitzke and Holz he introduced fundus auto-fluorescence as a diagnostic tool in retinal diseases. Professor Bird also worked on Sickle Cell disease in Jamaica and on Onchocercosis in Africa. His scientific production is amazing with over 400 papers in peer-reviewed journals and over 80 contributions in books. He sits on the Editorial Board of Investigative Ophthalmology and Vision Science and of a number of other journals. He is a foreign advisor to INSERM, member of the scientific committee on AMD of the Deutsche Forschungsgemeinschaft and an Ad Hoc member of the Board of Scientific Counsellors of the NEI in Bethesda. Alan Bird has delivered more than 60 named lectures, including the Duke-Elder Lecture, the Doyne Lecture, the Jackson Memorial Lecture, the Donders Lecture, the Bowman Lecture, the Jules François Lecture to name only some of the most prestigious ones. He is a Honorary Fellow of the Royal Society of Medicine, of the Royal College of Ophthalmology, of the American College of Surgeons, of the South African College of Ophthalmologists. He was the 2008 Laureate of the American Academy of Ophthalmology and obtained the 2003 ICO Golden Apple Award for teaching. He is a gifted speaker and a superb teacher who trained numerous young ophthalmologists from all over the world. The list of speakers at his career celebration in London in 2005 reads as a Who s Who in world ophthalmology.

18 14 WOC 2010 Awards Jules François Golden Medal The Jules François Golden Medal is awarded every four years by the Board of the International Council of Ophthalmology for ophthalmic work of high scientific quality. Honoree: Gisèle Soubrane (Paris-Créteil/F) Laudatio: Bruce E. Spivey (ICO President) Professor Soubrane obtained her MD degree in 1969 in Paris where she also did her residency under Professor Brégeat and Professor Coscas, followed by a fellowship in medical retina in Créteil. In 1992 she presented her Ph.D. thesis: "Ocular angiogenesis in normal and pathologic eyes. Implication of basic fibroblast growth factor" at the Faculté des Sciences Pierre et Marie Curie, Paris V. In 1987 she became Associate Professor and in 1993 Professor of Ophthalmology at the Eye University Clinic of Paris XII Créteil. She succeeded Professor Coscas as chair of the department in Professor Soubrane is a world expert on age-related macular degeneration. Her scientific production is impressive with 243 papers in international journals, 85 articles in national ophthalmological journals, and more than 50 chapters in books. She co-authored 6 books or reports of the French Ophthalmological Societies and was the chief editor of the 2007 report on Age-related Macular Degeneration. She was instrumental in one of the first randomized study on laser photocoagulation of subretinal neovascular membranes, studied the natural history of occult new vessels and was the first to describe reticular pseudodrusen. She delivered multiple lectures on her favourite topic all over he world. She serves on the editorial board of Graefes Archives of Ophthalmology, the European Journal of Ophthalmology, the Journal Français d'ophtalmologie, the British Journal of Ophthalmology and Investigative Ophthalmology and Vision Science. She is past president of the European Board of Ophthalmology and of EVER, she served as Board member of the Gonin Club and as secretary-general of the French Ophthalmological Society of which she is still a Board member. She is member of 17 ophthalmological societies. Professor Soubrane was made Professor Honoris Causa of the University of Ulm in 2000 and delivered 11 named lectures. Professor Soubrane is still active in clinical research improving the diagnosis of age-related macular degeneration and looking for new therapeutic approaches.

19 WOC International Duke Elder Medal Lady Phyllis Duke Elder established a gold medal in honor of her late husband, Sir Stewart Duke Elder. This medal, which is called the International Duke Elder Medal is awarded every four years by the Board of the International Council of Ophthalmology to an ophthalmologist who by his/her distinction, leadership and teaching has contributed most to the development of international relations and friendship between ophthalmologists, and who has advanced the field by his/her contributions in writing and organization in ophthalmology. Awards Honoree: Mohammad Daud Khan (Peshawar/PK) Laudatio: Bruce E. Spivey (ICO President) Professor Daud Khan graduated in 1969 at the Khyber Medical College, Peshawar (Pakistan). He obtained his Diploma in Ophthalmology, University of London in 1971, became a fellow of the Royal College of Surgeons Edinburgh in 1976, of the: Royal College of Ophthalmologists, London, in 1989, of the College of Physicians and Surgeons Pakistan in 1994, of the Pakistan Academy of Medical Sciences in1990, of the National Academy of Medical Sciences, Pakistan in 1996 and of the Bangladesh College of Physician & Surgeons in He was Professor of Ophthalmology Post Graduate Medical Institute/Lady Reading Hospital, Peshawar ( ), Chairman of the National Steering Committee for Prevention of Blindness ( ), Chief Executive, Hayat Abad Medical complex, Dean Post Graduate Medical Institute Peshawar, and is the Founder Vice Chancellor, Khyber Medical University, Peshawar. He is currently the chairman of CHEF International an NGO which aims at providing high quality health care and educational opportunities to the needy population in Pakistan and other developing countries and. Vice President of the College of Physicians and Surgeons of Pakistan. Professor Kahn served as President of the Asia- Pacific Academy of Ophthalmology, of the SAARC Academy of Ophthalmology, of the Ophthalmological Society of Pakistan, of the Eye Bank Society, Peshawar, of the glaucoma interest group of Pakistan, was a Board member for 6 years of the ICO and is still Vice Chairman of the International Agency for Prevention of Blindness (IAPB), East Mediterranean Region, Advisor to the WHO and Councilor, College of Physician & Surgeon of Pakistan (CPSP). He made huge contributions to teaching. He is credited with training over two hundred ophthalmologists and ophthalmic medical assistants. With the help of the WHO and a consortium of INDGOs, he established the Pakistan Institute of Community Ophthalmology (PICO) as a major regional resource centre in Community Eye Health, Research and HRD and started Masters Course in community eye health. Professor Kahn published over 80 scientific papers and gave over 280 lectures in Pakistan and abroad. He served on the editorial board of 8 national and international journals. He played a key role in initiating a major partnership between the government of North West Frontier Province (NWFP) and a consortium of highly committed INGOs to start district comprehensive eye care program in Pakistan. The program started as a ten district initiative and is now covering over 80 districts. Professor Kahn continues to serve on the Board of trustees of Layton Rahmatullah Benevolent Trust (LRBT) since 1984, one of the largest and the finest eye NGO in Pakistan and assisted LRBT to establish two eye hospitals in NGO sector in NWFP. Among the many awards received we should mention the President of Pakistan Award for outstanding position in MBBS, the President of Pakistan Pride of Performance Award, the Prevention of Blindness Award APAO, the Prevention of Blindness Award Saudi Ophthalmological Society, the APAO Jose Rizal Gold medal, the SARC ophthalmology Life time Achievement Award, the Pakistan Institute of Community Ophthalmology Life time Achievement Award.

20 16 WOC 2010 Awards International Council of Ophthalmology Ophthalmic Pathology Award The Gottfried and Liselotte Naumann Foundation was established in 1997 in Erlangen (Germany) as a non-profit organization to support Ophthalmic Pathology including Clinico-Pathologic Correlations. The Foundation has provided an amount at the disposition of the Board of the International Council of Ophthalmology. An International Committee of experts in Ophthalmic Pathology, selects three candidates from which the ICO Board elects every four years a laureate. The first laureate TP Drija MD, received his award in 2006 at the Opening Ceremony of the WOC in Sao Paulo. Honoree: Ursula Schlötzer-Schrehardt Laudatio: Bruce E. Spivey (ICO President) Ursula Schlötzer-Schrehardt is Associate Professor and Senior Scientist at the Department of Ophthalmology, University Erlangen-Nürnberg (Erlangen/D) She received a PhD ( summa cum laude ) in Biology (thesis Ultrastructural investigations on reproduction, development and structural organization of Pygospio elegans (Polychaeta, Spionidae)) from the University of Erlangen-Nürnberg in 1992 and joined the Department of Ophthalmology, where she graduated 1998 in Experimental Ophthal-mology and became a member of the Faculty of Medicine. Her thesis on the subject of Pseudoexfoliation syndrome: histopathology and pathogenesis of a newly described systemic process of the extracellular matrix was awarded as the best thesis of the Medical Faculty of this year. Since 2008, she also serves as a representative for equal opportunities for the Faculty of Medicine. By means of full integration into the clinical environment, Ursula Schlötzer-Schrehardt was, as a basic researcher, in a position to contribute greatly to the common and clinically relevant disorder of pseudoexfoliation (PEX) syndrome and to add a growing body of knowledge to this formerly rather obscure entity. Comprehensive clinical-histopathological correlations helped to explain the causative mechanisms of the frequent ocular complications including phacodonesis and lens subluxation, pigment dispersion, poor mydriasis, blood-aqueous barrier dysfunction, and development of secondary glaucomas. The combination of clinical and her histopathological observations led to the original description of a specific PEX-associated keratopathy. These clinical-pathological correlations not only increased our under-standing of this entity and allowed diagnosis of early stages, but also helped to prevent complications and to improve clinical management by close follow-up. One of her most outstanding contributions is the documentation of PEX syndrome as a new systemic process affecting the heart, lungs, liver, kidney, cerebral meninges and blood vessel walls, which appears to be associated with increased cardio-vascular and cerebrovascular morbidity. Lately, her pioneering analytic studies have provided new insights into the underlying molecular pathophysiology and resulted in the commonly accepted pathogenetic concept of PEX syndrome as a stress-induced elastosis. This concept was recently substantiated by the identification of the LOXL1 (lysyl oxidase-like 1) gene, coding for a key enzyme in elastogenesis, as a principal genetic risk factor for both PEX syndrome and PEX glaucoma. Functional alterations of the LOXL1 risk variant, detected by her group, open new approaches for specific treatment strategies in the future. Apart from being dedicated to pseudoexfoliation, her research interests also include corneal biology/pathology and corneal stem cells, glaucoma basic science, extracellular matrix as well as general ophthalmic pathology and ultrastructural research. She also established an improved culture technique supporting the preferential expansion and preservation of limbal stem cells for future therapeutic applications in patients with limbal stem cell deficiency. Her research projects have been continuously supported by the German Research Foundation since From 1997 until 2009 she was principal investigator and scientific secretary of a Collaborative Research Center Glaucomas including Pseudoexfoliation Syndrome (SFB 539). She is Editorial Board Member of the journal Experimental Eye Research and Scientific Advisory Board Member of The Glaucoma Foundation, New York. She has published over 175 scientific articles in peer-reviewed journals, including many describing the histopatho-logic features of ocular diseases, and 20 book chapters. She also received several awards including poster prizes. All in all, her work received broad recognition worldwide and substantiated her international position as the leading basic researcher in the field of pseudoexfoliation syndrome. Moreover, her personality is gifted to allow exemplarily smooth cooperation so essential for the combination of basic and clinical research. In her spare time, she enjoys literature and the arts as well as scuba diving. These awards will be conferred on Saturday, 5 June 2010 from 18:30-19:00 during the Opening Ceremony in Hall 1, ICC.

21 WOC Bernardo Streiff Gold Medal In 1997, on behalf of friends and disciples, Professor Jean-François Cuendet was commissioned by the Academia Ophthalmologica Internationalis to create the "Bernardo Streiff Gold Medal." honoring the memory of Professor Bernardo Streiff ( ), Head of the University Eye Clinic, Lausanne, Switzerland, and AOI member. The Bernardo Streiff Gold Medal is awarded by election of the Academia every four years to an ophthalmologist who has contributed most, through history, ethics and education, to the advance of ophthalmology. Awards Honoree: Gullapalli N. Rao Laudatio: Peter G. Watson (AOI President) Gullapalli Rao was educated at the Guntur Medical College, India; All India Institute of Medical Sciences, New Delhi; and at the Tufts Medical School; University of Connecticut; University of Rochester, U.S.A. He is a Diplomat of the American Board, FACS, FRCS, FNAMS, D.Sc. He is the Founder Director and Distinguished Chair of Eye Health, L V Prasad Eye Institute of the L. V. Prasad Eye Institute, Hyderabad, India which is a complex of a modern eye hospital with advanced training programs for ophthalmologists and paramedical personnel, an eye research centre, and also provides a rehabilitation program. The L. V. Prasad Eye Institute has developed high quality eye care models for underserved areas and regularly trains not only ophthalmologists but also hospital administrators and allied health personnel from developing countries. Professor Rao is also Adjunct Professor, University of New South Wales, Australia (1993 -), Adjunct Professor of Ophthalmology, University of Rochester, USA (2002 -), formerly Associate Clinical Professor of Ophthalmology, and Director, Cornea Research Laboratory, University of Rochester, Rochester, New York and Medical Director, Rochester Eye Bank. His main scientific interests are corneal diseases and community eye health. He authored over 240 published papers in journals all over the world, 18 chapters and one book. He sits on the editorial board of the American Journal of Ophthalmology, Cornea, The Ocular Surgery, CLAO Journal, Ophthalmic Surgery and Lasers and a number of other journals. He is the former Editor-in-Chief of the Indian Journal of Ophthalmology. Professor Rao has been a visiting professor at several Universities in the U.S., Japan, Europe, Hong Kong, South Korea, Australia, China, South Africa, Africa, South East Asia, South America and India. He gave lectures at many international ophthalmology research and public health meetings. He was the Academic and Clinical Supervisor for 20 fellows in Cornea at the University of Rochester and over 200 past and present fellows in Hyderabad, India, from all over the world. Professor Rao had and still has a wide number of national and international responsibilities: Medical Advisory Board, Eye Bank Association of America ( & ); Castroviejo International Corneal Society (Board of Directors, & 2009-); Hyderabad Eye Institute (Chairman, 1986-); Indo-American Eye Care, Inc. (Chairman, ); President, Eye Bank Association of India ( ). From 2004 till 2004 he was the Chairman of the Board of Trustees and President of the International Agency for the Prevention of Blindness ( ). He received grants from many national and international governmental agencies and corporations and non-governmental organizations as well as several honours and awards from many international organisations including All India Ophthalmological Society (1982, 1984, 1986); Ranbaxy Research Award for excellence in Clinical Research (1995); Senior Honour Award, American Academy of Ophthalmology (1998); Member, Academia Ophthalmologica Internationalis (1998-), Doctor of Science honoris causa of the University of New South Wales, Australia (2001), Padma Shri from the Government of India (Republic Day Honours given by the President of India), Fellow qua Surgeon ad eundem of the Royal College of Physicians and Surgeons of Glasgow (2003); HRH Prince Abdulaziz bin Ahmed bin Abdulaziz Al-Saud for the Prevention of Blindness Award (2004), First "G. B. Bietti International Award for Prevention of Blindness" by the Italian Society for Prevention of Blindness (2005), International Blindness Prevention Award by the American Academy of Ophthalmology (2006), Pisart Vision Award by Lighthouse International (2007), Honorary Doctorate of Science from University of Melbourne, Australia (2007), AAO-Essilor Award for Outstanding International Contributions to global eye care by the American Academy of Optometry (2009).

22 18 WOC 2010 Promotions and Awards European Vision Award Lecture 2010 DOG Promotions and Awards Monday, 7 June 2010, 17:45-18:15, Room Stockholm A systemic view on retinal ciliopathies: inherited retinal degeneration revisited. Speaker: Dr. Ronald Roepman (Nijmegen/NL) Welcome & Laudatio: Prof. E. Zrenner, Chairman European Vision Institute Keynote Lecture Dr. Ronald Roepman Promotions Research Funding for Innovative Scientific Projects in Ophthalmology donated by the DOG Funding for Research in Tropical Ophthalmology donated by the DOG The Award will be conferred on Sunday, 6 June 2010 from 16:00 17:30 at Hall 9, ICC. Awards Glaucoma Research Award donated by Pharm Allergan GmbH (Ettlingen/D) Julius Springer Award for Ophthalmology donated by Springer Medizin Verlag (Heidelberg/D) Kröner Research Award donated by the Kröner-Stiftung Leonhard-Klein-Award donated by the Leonhard-Klein-Stiftung Poster Award 3 posters a day will be awarded, donated by the DOG Promotional Award "Innovative developments and therapeutic attempts with age-related macular degeneration (AMD)" donated by Novartis Pharma GmbH (Nuremberg/D) Research Award Bausch & Lomb donated by Bausch & Lomb GmbH (Berlin/D) Senator-Hermann-Wacker-Award donated by Hermann Wacker Fonds Three best German participants in the EBO exam Tropical Ophthalmology Award donated by the German Committee for the Prevention of Blindness, URSAPHARM Arzneimittel GmbH & Co. KG (Saarbrücken/D), Novartis Pharma GmbH (Nuremberg/D), 1StQ Deutschland GmbH & Co. KG (Mannheim/D) and WaveLight AG (Erlangen /D) The Award will be conferred on Sunday, 6 June 2010 from 16:00 17:30 at Hall 9, ICC. Uveitis Award 2010 donated by LUX Bioscience, Inc. (Jersey City/USA) Allergan Inc. (Irvine/USA) The Award will be conferred on Monday, 7 June 2010 from 14:30 15:30 at Salon 21 (Lilienthal). Video Award donated by Carl Zeiss Meditec AG (Munich/D) The award will be conferred on Sunday, 6 June 2010 from 10:30 12:00 at Radio Tower Lounge. Von Graefe Award donated by the DOG Short-term Lectures Short-term lectureships donated by the DOG The Awards will be conferred on Sunday, 6 June 2010 from 16:00 17:00 at Hall 9 The DOG Promotions and Awards will be conferred on Wednesday, 9 June 2010 from 11:30-13:00 during the session Award Ceremony and Handover of DOG Presidency" in the Hall Roof Garden, ICC (if not stated differently).

23 WOC Acknowledgement to Package Sponsors We cordially thank the following sponsors for their generous support of the WOC 2010: Sponsor City Country Sponsors Diamond Sponsor Carl Zeiss Meditec AG Jena D Gold Sponsors Alcon Laboratories, Inc. Fort Worth, Texas USA Bausch & Lomb Zug CH Pharmaceuticals Chibret Pharmazeutische GmbH Haar D Merck, Sharp & Dohme Whitehouse Station, New Jersey USA Pfizer Ophthalmics New York New York USA Santen Pharmaceutical Co, Ltd Osaka J Silver Sponsors ALLERGAN AG Nordics UK Novartis Pharma GmbH Basel CH Bronze Sponsors AMO Abbott Santa Ana USA Heidelberg Engineering GmbH Heidelberg D Sponsors Aeon Astron Europe Leiden NL Abbott GmbH & Co. KG Wiesbaden D Bayer Schering Pharma AG Berlin D GEUDER AG Heidelberg D Oculentis GmbH Berlin D OCULUS Optikgeräte GmbH Wetzlar D Sanofi Pasteur MSD Lyon F Sixt Pullach D Ziemer Group Port CH

24 IN OCULAR HYPERTENSION AND GLAUCOMA Protect what s precious Start with powerful IOP control for lasting patient success. 1 4 FIND OUT HOW WE CAN HELP YOU PROTECT JOIN OUR SYMPOSIUM: FUNCTION, FUNCTIONING & QUALITY OF LIFE DATE: SATURDAY 05 JUNE TIME: 13:10 14:00 LOCATION: THE ICC (HALL SAO PAULO) Xalatan 0.005% w/v eye drops solution Prescribing Information Please refer to the SmPC before prescribing Xalatan 0.005% w/v eye drops solution (latanoprost) Presentation Plastic bottle containing 2.5ml eye drops. Each 1ml contains latanoprost 50 micrograms (0.005%) and benzalkonium chloride. Indication Reduction of elevated intraocular pressure in patients with OAG and ocular hypertension. Dosage and Administration Adults including the Elderly: One eye drop into the affected eye(s) once daily in the evening. Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes (see Precautions). Children: Not recommended. Contra-indications Known hypersensitivity to any component. Precautions Xalatan may increase brown pigment within the iris leading to a gradual change in eye colour usually within the fi rst 8 months of treatment, rarely during the second or third year, and has not been seen after the fourth year of treatment. The rate of progression of iris pigmentation decreases with time and is stable for fi ve years. The effect of increased pigmentation beyond fi ve years has not been evaluated. In an open 5-year latanoprost safety study, 33% of patients developed iris pigmentation. This has predominantly been seen in patients with mixed coloured irides and may be permanent. Patients should be examined regularly and treatment discontinued if appropriate. Unilateral treatment can result in permanent heterochromia. Exercise caution in patients with asthma, infl ammatory ocular conditions and other types of glaucoma, including chronic angle closure, OAG of pseudophakic patients and in pigmentary glaucoma. Also caution is recommended in aphakic patients, pseudophakic patients with torn posterior lens capsule or anterior chamber lenses or patients with known risk factors for cystoid macular oedema. Latanoprost may gradually change eyelashes and vellus hair in the treated eye and surrounding areas; these changes include increased length, thickness, pigmentation, number of lashes or hairs and misdirected growth of eyelashes. Eyelash changes are reversible upon discontinuation of treatment. Xalatan contains the preservative benzalkonium chloride which has been reported to cause punctate keratopathy and/or toxic ulcerative keratopathy, may cause eye irritation and is known to discolour soft contact lenses. Close monitoring required with frequent or prolonged use of Xalatan in dry eye patients/ conditions where the cornea is compromised. Contact lenses may absorb benzalkonium chloride. These should be removed before applying Xalatan but may be reinserted after 15 minutes (see Dosage and Administration). Pregnancy Do not use. Lactation Do not use or stop breast feeding. Interactions Defi nitive data are not available. There have been reports of paradoxical elevations in intraocular pressure following the concomitant ophthalmic administration of two prostaglandin analogues. Therefore, the use of two or more prostaglandins, prostaglandin analogues or prostaglandin derivatives is not recommended. Any other eye drops should be administered fi ve minutes apart. Side Effects Ocular side effects - Very common ( 1/10): Increased iris pigmentation, mild to moderate conjunctival hyperaemia, eye irritation (burning, grittiness, itching, stinging and foreign body sensation), eyelash and vellus hair changes (increased length, thickness, pigmentation and number); Common ( 1/100 and <1/10): transient punctate epithelial erosions (mostly without symptoms), blepharitis, eye pain. Please refer to SmPC for other ocular side-effects. Non-ocular side-effects Uncommon ( 1/1000 and <1/100): Skin rash; Rare ( 1/10,000 and <1/1000): Asthma, asthma exacerbation, dyspnoea, localised skin reaction on the eyelids, darkening of the palpebral skin of the eyelids; Very rare (<1/10,000): Aggravation of angina in patients with pre-existing disease, chest pain. There have been additional post-marketing spontaneous reports of: headache, dizziness, palpitations, myalgia and arthralgia Driving Instillation of eye drops may cause transient blurring of vision. Overdosage Symptomatic treatment. Pharmaceutical Precautions Store at 2 C - 8 C. Protect from light. Once opened, store at room temperature ( 25 C) and discard after 1 month. Legal category POM. Packaging Quantities and Basic NHS price 2.5 ml PL number PL 00032/0220. PL Holder Pharmacia Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK. Date of preparation of PI January Further information is available on request from: Pfi zer Limited, Walton Oaks, Dorking Road, Tadworth, Surrey, KT20 7NS, UK. Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Pfizer Medical Information on REFERENCES: 1. European Glaucoma Prevention Study (EGPS) Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 2007;114: Gordon MO, et al. The Ocular Hypertension Treatment Study. Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120: Heijl A, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol Oct;120(10): Advanced Glaucoma Intervention Study (AGIS) Investigators. AGIS: 7. The relationship between control of intraocular pressure and visual fi eld deterioration. Am J Ophthalmol. 2000;130: * Registration in the UK 16/12/1996. Date of preparation: March XLUO1042A

25 WOC WOC 2010 Congress President Gerhard K. Lang, MD DOG President Ulm, Germany WOC 2010 Honorary President Bruce E. Spivey, MD ICO President San Francisco, USA Committees WOC 2010 Executive Committee President Gerhard K. Lang, MD Ulm, Germany WOC 2010 Scientific Program Committee Chair Stephen J. Ryan, MD Los Angeles, USA Secretary General Anselm Kampik, MD Munich, Germany Co-Chair Bernd Bertram, MD Aachen, Germany Treasurer Jochen Kammann, MD Davos, Switzerland Co-Chair Gabriele E. Lang, MD Ulm, Germany Program Director Gabriele E. Lang, MD Ulm, Germany Executive Director of the DOG Philip Gass, PhD German Society of Ophthalmology Munich, Germany Professional Congress Organizer (PCO) Monika Porstmann Porstmann Kongresse GmbH Berlin, Germany

26 22 WOC 2010 Committees WOC 2010 Scientific Program Coordinators Subspecialty Area Cataract Contact Lens and Refraction Coordinators Dennis Lam (Kowloon, Hong Kong/CN) Amar Agarwal (Chennai/IND) Joseph Colin (Bordeaux/F) Abhay R. Vasavada (Ahmenabad/IND) Thomas F. Neuhann (Munich/D) Albert Franceschetti (Meyrin/CH) Gudrun Bischoff (Hamburg/D) Evidence Based Ophthalmology Richard L. Abbott (San Francisco/USA) Klaus Dieter Lemmen (Düsseldorf/D) External Eye Disease, Cornea, EyeBank Abdulaziz AlRajhi (Riyadh/SA) Zbigniew Zagorski (Lublin/PL) Thomas Reinhard (Freiburg/D) Eye Trauma and Emergencies Ferenc Kuhn (Birmingham/USA) Wolfgang F. Schrader (Nuremberg/D) Glaucoma Robert Ritch (New York/USA) Clive Migdal (London/UK) Jian Ge (CN) Norbert Pfeiffer (Mainz/D) Immunology, Molecular Biology, Microbiology Robert Nussenblatt (Bethesda/USA) Arnd Heiligenhaus (Münster/D) Low Vision August Colenbrander (Novato/USA) Susanne Trauzettel-Klosinski (Tübingen/D) Neuro-Ophthalmology Christian Luco (Santiago/RCA) Klara Landau (Zurich/CH) Eberhart Zrenner (Tübingen/D) NewTechnology: Bioengineering, Nanotechnology Shigeru Kinoshita (Kyoto/J) Friedrich E. Kruse (Erlangen/D) Oculoplasty, Lacrimal System,Orbit John Richard O. Collin (London/UK) Artur Klett (Tallinn/EST) Christoph Hintschich (Munich/D) Rudolf F. Guthoff (Rostock/D) Oncology Jerry Shields (Philadelphia/USA) Tero Kivelä (Helsinki/FIN) Norbert Bornfeld (Essen/D) Ophthalmic Epidemiology Jialiang Zhao (Beijing/CN) Paul Mitchell (Sydney/AUS) Norbert Pfeiffer (Mainz/D) Pathology Tatsuro Ishibashi (Kyushu/J) Miguel N. Burnier Jr. (Montréal/CDN) Hans E. Grossniklaus (Atlanta/USA) Karin U. Löffler (Bonn/D) Pediatric Ophthalmology, Genetics Marilyn Miller (Chicago/USA) Günther Rudolph (Munich/D) Pharmacology, Ocular Drug Delivery Mark Blumenkranz (Stanford/USA) Karl Ulrich Bartz-Schmidt (Tübingen/D)

27 WOC WOC 2010 Scientific Program Coordinators Subspecialty Area Refractive Surgery Retina, Vitreous Coordinators Peter McDonnell (Baltimore/USA) Theo Seiler (Zurich/CH) Gernot I. W. Duncker (Halle/D) Xiao Xin Li (Beijing/CN) Zdenek J. Gregor (London/UK) Peter Wiedemann (Leipzig/D) Committees Strabismus Kanxing Zhao (Tianjin/CN) Eugene Helveston (Indianapolis/USA) Joachim Esser (Essen/D) Teleophthalmology and Computers Jorge Valdez (Nuevo Leon/MEX) Georg Michelson (Erlangen/D) Uveitis, Intraocular Inflammation Rubens Belfort Jr. (São Paulo/BR) Shigeaki Ohno (Sapporo/J) Manfred Zierhut (Tübingen/D) Vision 2020 (Prevention of Blindness) Nathan Congdon (Baltimore/USA) Hugh R. Taylor (Melbourne/AUS) Volker Klauss (Munich/D) Cataract and Refractive Surgery Subspecialty Day Douglas D. Koch (Houston/USA) Jorge L. Alió (Alicante/E) Thomas Kohnen (Frankfurt/Main/D) Glaucoma Subspecialty Day Clement C. Y. Tham (Hong Kong/CN) Harry Quigley (Baltimore/USA) Franz Grehn (Würzburg/D) Pediatric Ophthalmology Subspecialty Day Birgit Lorenz (Giessen/D) Retina Subspecialty Day Michael T. Trese (Rochester/USA) Alain Gaudric (Paris/F) William Aylward (London/UK) Anselm Kampik (Munich/D) World Ophthalmic Educational Colloquium Marko Hawlina (Ljubljana/SLO) Pinar Aydin (Ankara/TR) Mark Tso (Baltimore/USA) Klaus Peter Steuhl (Essen/D) World Forum of Journal Editors World Forum of Prevention of Blindness Andrew P. Schachat (Baltimore/USA) Alexander J. Brucker (Gladwyne/USA) Bernd Kirchhof (Cologne/D) Hilel Lewis (New York/USA) Volker Klauss (Munich/D) Bruce Spivey (San Francisco/USA)

28 24 WOC 2010 Committees WOC 2010 Submitted Program Reviewing Committee Winfried M. Amoaku (Nottingham/GB) Rimvydas Asoklis (Vilnius/LT) Leonid I. Balashevich (St. Petersburg/RUS) Kristine Baumane (Riga/LV) Wolfgang Behrens-Baumann (Magdeburg/D) Amarildo Belshi (AL) Gudrun Bischoff (Hamburg/D) Nadija F. Bobrova (Odessa/UA) Norbert Bornfeld (Essen/D) Andrej Cernák (Bratislava/SK) Stefan Cornel (Bukarest/RO) H. Burkhard Dick (Bochum/D) Vjekoslav Dorn (Zagreb/HR) Brigita Drnovšek-Olup (Ljubljana/SI) Gernot I. W. Duncker (Halle/Saale/D) Carl Erb (Berlin/D) Christoph Faschinger (Graz/A) Michael Gräf (Giessen/D) Rolf Grewe (Münster/D) Steffen Heegaard (Copenhagen/DK) Frank G. Holz (Bonn/D) Raimond Hoxha (AL) Tatsiana Imshenetskaya (Minsk/BY) Antonia M. Joussen (Düsseldorf/D) Jozef Kaluzny (Bydgoszcz/PL) Jochen Kammann (Davos/CH) Volker Klauss (Munich/D) Gerold H. Kolling (Heidelberg/D) Lajos Kolozsvári (Szeged/H) Günther K. Krieglstein (Cologne/D) Friedrich E. Kruse (Erlangen/D) Morten La Cour (Glostrup/DK) Guna Laganovską (Riga/LV) Klara Landau (Zurich/CH) Klaus-Dieter Lemmen (Düsseldorf/D) Wolfgang E. Lieb (Karlsruhe/D) Karin U. Löffler (Bonn/D) Birgit Lorenz (Giessen/D) Dmitry J. Maitchuk (Moscow/RUS) Hans-Werner Meyer-Rüsenberg (Hagen/D) Georg Michelson (Erlangen/D) Christian Ohrloff (Francfort/Main/D) Dušica Pahor (Maribor/SI) Daniel Pauleikhoff (Münster/D) Iva Petkova (Sofia/BG) Norbert Pfeiffer (Mainz/D) Duy-Thoai Pham (Berlin/D) Maria Manuela Pires Carmona (Lisboa/P) Susanne Pitz (Mainz/D) Uwe Pleyer (Berlin/D) Thomas Reinhard (Freiburg/D) Gisbert Richard (Hamburg/D) Johann Roider (Kiel/D) Günther Rudolph (Munich/D) Ahmet Sarici (Cerrahpas a/tr) Reinier O. Schlingemann (Amsterdam/NL) Ursula Schmidt-Erfurth (Vienna/A) Berthold Seitz (Homburg/Saar/D) Daniela F. Selaru (Bucharest/RO) Eric Sellem (Lyon/F) Halina Sitnik (Minsk/BY) Nelly Sivkova (Plovdiv/BG) Heimo Steffen (Würzburg/D) Josef Stoiber (Salzburg/A) Peter Strmeň (Bratislava/SK) Jerzy Szaflik (Warszawa/PL) Nevbahar Tamcelik (Cerrahpas a/tr) Susanne Trauzettel-Klosinski (Tübingen/D) António Casa Nova Travassos (Coimbra/P) Zoran Vatavuk (Zagreb/HR) Catherine Vignal-Clermont (Paris/F) Christian K. Vorwerk (Magdeburg/D) Carroll A. B. Webers (Maastricht/NL) Helmut Wilhelm (Tübingen/D) Sebastian Wolf (Bern/CH) Aleksandra Zborovskaya (Odessa/UA) Eberhart Zrenner (Tübingen/D) Biro Zsolt (Pécs/H)

29 WOC International Council of Ophthalmology Members of the Board of Trustees Roster 2010 President Vice President Secretary General Treasurer Executive Director Immediate Past President Honorary Life President Honorary Life Member Bruce E. Spivey, MD (San Francisco/USA) Akef El-Maghraby, MD (Jeddah/SA) Jean-Jacques de Laey, MD (Ghent/B) Hugh R. Taylor, AC, MD (Carlton/AUS) William Felch, BA (Stinson Beach/USA) Gottfried O. H. Naumann, MD, ML (Erlangen/D) Akira Nakajima, MD (Tokyo/J) Benjamin F. Boyd, MD (Panama/PA) Balder P. Gloor, MD (Zurich/CH) Bradley R. Straatsma, MD, JD (Los Angeles/USA) Committees Members Richard L. Abbott, MD (San Francisco/USA) Jean-Paul Adenis, MD (Limoges /F) Selwa A. F. Al Hazzaa, MD (Riyadh/SA) Abdulaziz AlRajhi, MD (Riyadh/SA) Rubens Belfort Jr., MD, PhD (São Paulo/BR) Susanne Binder, MD (Vienna/A) Daniel Etya'ale, MD (Genève/CH) Veit-Peter Gabel, MD (Regensburg/D) Enrique L. Graue Wiechers, MD (Mexico City/MEX) Adekunle Olubola Hassan, MD (Lagos/NGA) Tero Kivelä, MD (Helsinki/FIN) Volker Klauss, MD (Munich/D) Dennis S. C. Lam, MBBS (Kowloon/Hong Kong/CN) Gerhard K. Lang, MD (Ulm/D) Hilel Lewis, MD (New York/USA) Frank J. Martin, MBBS (Sydney/AUS) David W. Parke II, MD (San Francisco/USA) Jacob Pe'er, MD (Jerusalem/IL) Mohammed Babar Qureshi, BMBCh, MSc (Peshawar/(PK) Serge Resnikoff, MD, PhD (Clermont-Ferrand/F) Robert Ritch, MD (New York/USA) José A. Roca, MD (Lima/PE) Stephen J. Ryan, MD (Los Angeles/USA) Alfred Sommer, MD (Baltimore/USA) David Taylor, MB, ChB, DSc (Med) (London/UK) Mark O. M. Tso, MD, DSc (Baltimore/USA) Gabriel van Rij, MD, PhD (Rotterdam/NL) Abhay R. Vasavada, MD, MS (Ahmenabad/IND) Peter G. Watson, MB, BChir (Cambridge/UK) Zbigniew Zagórski, MD (Lublin/PL) Jialiang Zhao, MD (Beijing/CN) Members of the Advisory Committee to the Board of Trustees ICO Advisory Committee Committee Chair Members Robert Ritch, MD (New York/USA) Pinar Aydin, MD, PhD (Kavaklidere/Ankara/TR) Emilio Carlo Campos, MD (Bologna/I) August Colenbrander, MD (Novato/USA) Joseph Colin, MD (Bordeaux/F) John Richard O. Collin, MD (London/UK) Mohamed Alaa, El-Danasoury, MD (Jeddah/SA) Neeru Gupta, MD PhD (Toronto/CDN) Marko Hawlina, MD, PhD (Ljubljana/SLO) Ana Luisa Hofling-Lima, MD, PhD (Sao Paulo/BR) Tatsuro Ishibashi, MD (Fukuoka/J) Martine J. Jager, MD, PhD (Leiden/NL) Ivo Kocur, MD (Geneva/CH) Anthony Murray, MD (Cape Town/ZA) Amel Meddeb Ouertani, MD (Tunis/TN) Ramachandra Pararajasegaram, MD (Geneva/CH) N. Venkatesh Prajna, MBBS (Tamilnadu/IND) Stefan Seregard, MD, PhD (Stockholm/S) Peter Wiedemann, MD (Leipzig/D)

30 26 WOC 2010 Committees International Council of Ophthalmology Foundation Board of Directors and ICO Members President Vice President Secretary Treasurer Members Bradley R. Straatsma, MD, JD (Los Angeles/USA) Alfred Sommer, MD, MHS (Baltimore/USA) Bruce E. Spivey, MD (San Francisco/USA) H. R. H. Prince Abdulaziz Ahmed Abdulaziz Al Saud (Riyadh/SA) Rubens Belfort Jr., MD PhD (São Paulo/BR) Kevin J. Buehler (Fort Worth/USA) Jean-Jacques de Laey, MD, PhD (Ghent/B) Akef El-Maghraby, MD (Jeddah/SA) Michael Kaschke, PhD (Oberkochen/D) Hilel Lewis, MD (New York/USA) Paul R. Lichter, MD (Ann Arbor/USA) James V. Mazzo (Santa Ana/USA) Alice R. McPherson, MD (Houston/USA) Takakazu Morita (Osaka/J) David E. I. Pyott (Irvine/USA) Stephan J. Ryan, MD (Los Angeles/USA) Timothy R. G. Sear (Fort Worth/USA) Paul A. Sieving, MD, PhD (Bethesda/USA) Hugh R. Taylor, AC, MD (Melbourne/AUS)

31 WOC DOG Executive Committee President First Vice President Professor Gerhard K. Lang (Ulm/D) Professor Thomas Reinhard (Freiburg/D) Committees Second Vice President Professor Peter Wiedemann (Leipzig/D) Secretary General Professor Anselm Kampik (Munich/D) Secretary Professor Franz Grehn (Würzburg/D) Treasurer Professor Jochen Kammann (Davos/CH) Executive Director Dr. Philip Gass (Munich/D) DOG Office Platenstr. 1, Munich T F E geschaeftsstelle@dog.org For information about DOG membership please visit the DOG booth located in the main foyer (1 st floor) of the ICC or go to and click on membership.

32 28 WOC 2010 Committees AAD Executive Committee President of the BVA (Berufsverband der Augenärzte) Vice President of the BVA Professor Bernd Bertram (Aachen/D) Dr. Klaus Heckmann (Wiesbaden/D) Secretary General of the DOG Professor Anselm Kampik (Munich/D) Secretary of the DOG Professor Franz Grehn (Würzburg/D) Scientific Board Member of the BVA Professor Norbert Pfeiffer (Mainz/D) Delegate of Strabismology and Neuroophthalmology Professor Joachim Esser (Essen/D) Manager of the BVA Christian Gante (Düsseldorf/D) Assistant of the BVA Manager Claudia Werner (Düsseldorf/D) For information about BVA membership please visit the BVA booth located in the entrance foyer of the ICC or please go to (This site is only in German).

33 WOC WOC 2010 Supporting Organizations Academia Ophthalmologica Internationalis (AOI) American Association for Pediatric Ophthalmology and Strabismus (AAPOS) American Society of Ophthalmic Plastic & Reconstructive Surgery (ASOPRS) American Academy of Ophthalmology (AAO) American Society of Retina Specialists (ASRS) Asian Oceanic Glaucoma Society (AOGS) Asia Pacific Academy of Ophthalmology (APAO) Asia Pacific Society of Ophthalmic Plastic & Reconstructive Surgery (APSOPRS) Asia Pacific Intraocular Inflammation Study Group (APIISG) Association for Research in Vision and Ophthalmology (ARVO) Barraquer Foundation Bielschowsky Society Black Sea Ophthalmological Society (BSOS) Club Jules Gonin Contact Lens Association of Ophthalmologists (CLAO) European Academy of Ophthalmology (EAO) European Association for Vision and Eye Research (EVER) European Board of Ophthalmology (EBO) European Contact Lens Society of Ophthalmologists (ECLSO) European Glaucoma Society (EGS) European Ophthalmic Oncology Group (EOOG) European Paediatric Ophthalmological Society (EPOS) European Society of Cataract and Refractive Surgery (ESCRS) European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS) European Society of Ophthalmology (SOE) European Society of Retina Specialists (EURETINA) European Strabismological Association (ESA) European VitreoRetinal Society (EVRS) Federation of European Ophthalmology (FEOph) German Ophthalmic Surgeons (DOC) German Society of Intraocular Lens Implantation, Interventional and Refractive Surgery (DGII) Glaucoma Research Society (GRS) International Medical Contact Lens Council International Ocular Inflammation Society (IOIS) International Organization Against Trachoma (IOAT) International Society for Clinical Electrophysiology of Vision (ISCEV) International Society of Geographical and Epidemiological Ophthalmology (ISGEO) International Society of Low Vision Research and Rehabilitation (ISLRR) International Society of Ocular Oncology (ISOO) International Society of Ocular Trauma (ISOT) International Society for Ophthalmic Pathology International Society of Refractive Surgery of the American Academy of Ophthalmology (ISRS/AAO) International Strabismological Association (ISA) International Uveitis Study Group (IUSG) Julius Hirschberg Society Latin American Society of Cataract and Refractive Surgery (ALACCSA-R) Lindberg Society Middle East Africa Council of Ophthalmology (MEACO) Pan American Oculoplastic Society Pan American Association of Ophthalmology (PAAO) Retinological Society Sociedad Panamericana de Retina y Vítreo (SPRV) South East Asia Glaucoma Interest Group (SEAGIG) South East European Ophthalmological Society (SEEOS) Tear Film & Ocular Surface Society (TFOS) The Macula Society The Retina Society von Graefe Society World Glaucoma Association (WGA) Supporting Organizations

34

35 WOC WOC History WOC 2002 XXIX International Congress of Ophthalmology April 2002, Sydney (AUS) President: Peter Hardy Smith, MD WOC 2006 XXX International Congress of Ophthalmology February 2006, São Paulo (BR) President: Rubens Belfort, Jr., M.D., Ph.D. WOC 2008 XXXI International Congress of Ophthalmology 28 June - 2 July 2008, Hong Kong (CN) President: Dennis S.C. Lam, MD, FRCOphth WOC 2010 XXXII International Congress of Ophthalmology 5-9 June 2010, Berlin (D) President: Gerhard K. Lang, MD WOC 2012 XXXIII International Congress of Ophthalmology February 2012, Abu Dhabi (UAE) President: Abdulaziz AlRahji, MD WOC 2014 XXXIV International Congress of Ophthalmology 2-6 April 2014, Tokyo (J) President: Tetsuro Oshika, MD

36 32 DOG Deutsche Ophthalmologische Gesellschaft e.v. Die wissenschaftliche Gesellschaft der Augenärzte Ankündigung Announcement Herausforderungen in der Augenheilkunde 109. DOG-Kongress Estrel Hotel Berlin Challenges in Ophthalmology 109 th DOG Congress 29 September - 2 October 2011 Estrel Hotel Berlin Präsident President Prof. Dr. Thomas Reinhard Direktor der Universitäts-Augenklinik Freiburg

37 33 Invitation to the DOG Congress 2011 Einladung zum DOG-Kongress 2011 Dear Colleagues, It is a special honour and pleasure for me to invite you to the 109 th Congress of the German Society of Ophthalmology in Berlin, September 29 th to October 2 nd Our theme is Challenges in Ophthalmology and we will be highlighting diagnostic and therapeutic aspects in depth. We will address what constitutes the cutting edge in clinical and scientific-research terms, and economic and educational topics will also be presented. Various symposia will form the backbone of the congress. This applies in particular to the Subspeciality Day, during which the latest topics regarding each ophthalmological section may be presented and discussed critically. Poster sessions will be given particularly close attention. Two Keynote Lectures and the von Graefe Lecture are further highlights. The congress offers a perfect forum for ophthalmologists, scientists, residents and the industry to exchange knowledge. Our congress has traditionally had an international flair, which is why we express an especially warm welcome to guests and ophthalmological societies from all over the world. The congress is taking place in the Hotel Estrel in Berlin for the third time. This location offers a large number of conference rooms, an excellent infrastructure as well as more than 2,000 beds. Together with the board of the German Society of Ophthalmology, I would be very pleased to welcome you in Berlin at the 109 th congress. Sehr geehrte, liebe Kolleginnen und Kollegen, verehrte Gäste, sehr geehrte Damen und Herren, zum 109. Kongress der Deutschen Ophthalmologischen Gesellschaft vom 29. September bis zum 2. Oktober 2011 möchte ich Sie sehr herzlich nach Berlin einladen. Unter dem Thema des Kongresses Herausforderungen in der Augenheilkunde sollen diagnostische und therapeutische Aspekte unseres Faches umfassend beleuchtet werden. Dies wird die Cutting Edges in der Klinik und in der Forschung, aber auch gesundheitsökonomische Herausforderungen sowie Bereiche der Aus-, Weiter- und Fortbildung betreffen. Das Rückgrat des Kongresses stellen die zahlreichen Symposien dar. Dies gilt ganz besonders für den geplanten Subspeciality Day. Hier sollen aktuelle Themen des jeweiligen ophthalmologischen Schwerpunkts von allen Seiten dargestellt und kritisch hinterfragt werden. Daneben wird den aufgewerteten Postersitzungen besonderes Augenmerk gewidmet. Besondere Highlights stellen wiederum zwei Keynote Lectures sowie die von Graefe-Vorlesung dar. Der Kongress bietet Klinikärzten, niedergelassenen Augenärzten, Wissenschaftlern, dem Nachwuchs und der Industrie eine hervorragende Gelegenheit zum Wissensaustausch. Der Tradition folgend ist der Kongress auch international ausgerichtet. So sind europäische und außereuropäische Referenten und Gäste, aber auch Fach - gesellschaften ganz besonders willkommen. Der Kongress findet zum dritten Mal im Estrel in Berlin statt. Diese Lokalität hat sich als Veranstaltungsort mit einer großen Zahl an Tagungs- und Ausstellungsräumen, mehr als Hotelbetten, sowie einer exzellenten Infrastruktur sehr gut bewährt. Gemeinsam mit dem Geschäftsführenden Präsidium der Deutschen Ophthalmolo - gischen Gesellschaft würde ich mich sehr freuen, Sie in Berlin zum 109. Kongress begrüßen zu dürfen. Prof. Dr. Thomas Reinhard First Vice President of the DOG Erster Vizepräsident der DOG

38 34 WOC 2010 The impressive memorial of the founder of the DOG, the German Society of Ophthalmology, Albrecht von Graefe (May 22 nd th July 1870 in Berlin) is situated in front of the Charité at the corner Luisen-/ Schumannstr. in Berlin-Mitte. On the initiative of the Medical Society of Berlin, the memorial was built by the sculptor Rudolf Leopold Siemering. It was originally positioned in the Charité s garden which was von Graefe s main place of work. Later the memorial was reestablished at its current location. As a founder of the German Society of Ophthalmology Albrecht von Graefe proved visionary farsightedness. The German Society of Ophthalmology is the first and oldest scientific medical society of the world. The DOG wishes to thank all sponsors for the generous contribution to the restoration of the memorial: *Acri.Tec AG Bausch & Lomb GmbH Chibret Pharmazeutische GmbH HOYA Medical Europe GmbH sowie Alcon Pharma GmbH, AMO Germany GmbH, Anteis GmbH, DOMILENS GmbH, GEUDER AG, Pharm-Allergan GmbH, Rayner Surgical GmbH, Santen GmbH, TECHNOMED GmbH

39 WOC

40 36 World Ophthalmology Congress 2010 ICC, Berlin, Germany XXXII International Congress of Ophthalmology 108 th DOG Congress 5-9 June 2010 AAD Congress June 2010 WOC 2010 Berlin

41 37 3 Congresses under one roof! XXXII International Congress of Ophthalmology 108 th DOG Congress AAD Congress 2010 Scientific Program Highlights sessions and courses - 1,204 invited speakers - 1,123 papers from the coordinators program - 1,120 posters free papers Subspecialty Days The subspecialty days on 6 and 7 June, 2010 provide the opportunity to discuss in depth new research approaches in the areas of cataract, retina, glaucoma, refractive surgery and pediatric ophthalmology. Symposia sponsored by Supporting Organizations 55 supporting organizations offer 70 Symposia covering various fields of modern ophthalmology. From the Academia Ophthalmologica Internationalis (AOI) to the World Glaucoma Association (WGA) all leading ophthalmic associations will be represented at the WOC Submitted Scientific Program 559 free paper presentations 1120 poster presentations 33 video presentations E-Posters More than 1,120 posters can be viewed during the entire congress at e-workstations located within the exhibition area in Hall 17. E-Videos Videos are available for viewing at the e-poster and video terminals in Hall 17. Headphones will be provided. E-Papers Available online immediately after their presentation at the congress at the e-workstations in Hall 17.

42 TM At MSD Ophthalmics, innovative science is in our DNA. Today s MSD is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching programs that donate and deliver our products to the people who need them. For over 50 years, MSD has been committed to ophthalmic research. And this commitment continues into our future of ophthalmic research. Heritage. Commitment. Vision. (dorzolamide HCI-timolol maleate ophthalmic solution, MSD) Before prescribing SAFLUTAN and COSOPT, please read the Prescribing Information available from your local MSD representative. Visit us at MSD exhibit booth #14/06 or on the Worldwide Web at SAFLUTAN and COSOPT are trademarks of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA. Copyright 2010 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved CST-2010-W J SAFLUTAN is manufactured by Santen Oy, Finland.

43 WOC Opening Ceremony Saturday, 5 June :30-20:00 ICC, Hall 1 Followed by the WOC Reception 20:00-22:00 ICC, Hall 2 Highlights Do not miss the WOC 2010 Opening Ceremony, Saturday 5 June 2010 at 6.30pm Follow us and discover past, present and future during the Opening Ceremony: Pay tribute to our ancestor Albrecht von Graefe Explore the iconic Berlin, the vibrant capital of Germany and its Queen Look into the future with WOC 2012 to be held in Abu Dhabi, United Arab Emirates. Join us in welcoming the Who is Who of ophthalmology marching in and coming from across the world and be part of the promotion of scientific excellence reflected throughout the International Award Ceremony. Featured in HD sequences, the beauty of the Eye will be omnipresent during the Opening Ceremony and strives to represent the vision and mission of our fascinating profession. Admire the breathtaking pictures of Eyeland Design. Enjoy phantastic music and entertainment. The WOC Reception is the perfect get-together for the international ophthalmologist community and allied specialties to meet old friends and make new ones in a friendly atmosphere. On behalf of the International Council of Ophthalmology, the German Society of Ophthalmology, the German Academy of Ophthalmology and both, the WOC 2010 Executive Committee and Scientific Programme Committee, we take pleasure in welcoming you to this key event. Prof. Dr. Gerhard K. Lang President of the DOG President WOC 2010 Bruce E. Spivey, MD, MS, Med International Council of Ophthalmology President

44 The future of eye-diagnostics starts now! OCULUS High tech devices emphasizing your competence Reliable - Instruments you can trust on during your daily tasks Innovative Our philosophy for more than 115 years Customer-oriented We consult, train and care all over the world This is OCULUS A family-owned enterprise with outlook Look for us at the WOC 2010, booth #15A/10 Oculus Optikgeräte GmbH Wetzlar GERMANY Tel Fax

45 WOC WOC in Concert Sunday, 6 June :00 21:30 French Church of Friedrichstadt (French Cathedral, Französische Friedrichstadtkirche) directly at the Gendarmenmarkt Highlights Ophthalmologists play for Ophthalmologists The musicians present masterpieces from Carl Philipp Emmanuel Bach Léon Boëllmann Leopold Mozart Wolfgang Amadeus Mozart Johann Joachim Quantz Robert Schumann Louis Vierne Ludwig van Beethoven Organizers: Georg Fischer Varvitsiotis (Conductor) and Franz Grehn Entrance open from 19:30 Admission free. Concert attendees are kindly requested to support the work of Stiftung Auge (the Eye Foundation) with a donation.

46 YOU VE ONLY JUST ARRIVED & ALREADY WE RE THINKING OF YOUR NEXT TRIP As the official airline network for World Ophthalmology Congress 2010, we d like to thank you for choosing the Star Alliance network and hope that all goes really well for you here today. Whilst you concentrate on the day s events, we hope you ll consider us the next time you need to attend a conference. With over 19,700 flights a day to 1,077 airports across 175 countries, our 26 member airlines will extend a wide choice of flights to any future conference you re planning to attend. And no matter which of those airline s frequent flyer programmes you belong to, you can earn and redeem miles across all of them. So the next time you want to concentrate all your energies on your conference, we hope you ll decide to leave the travel arrangements to us. Information correct as at 01/2010

47 WOC 2010 WOC toberfest Monday, 7 June :30-24:00 Hangar II at Tempelhof Airport WOC toberfest will be a typical Bavarian-like Oktoberfest with beer, German food and entertainment. You should not miss this special social highlight! We cordially invite you to come and join us for a Bavarian-style Oktoberfest at the WOC toberfest. With traditional Oktoberfest brass band music, beer and Bavarian specialties, we plan to enjoy a lively, intercultural evening. Of course, there will also be non-alcoholic drinks and vegetarian food. We are offering some other attractions for adults and children so as to celebrate this WOC toberfest as a family party. All participants are also most welcome to wear their own national dress at this event, as wearing different and colorful national dresses conveys a sense of friendly solidarity. Our motto for the evening is: meet old friends and make new friends in a relaxed and friendly atmosphere. c 80 WOC toberfest Children from 7 to 14 years c 25 (free up to 6 years) Highlights 43

48 ARVO Summer Eye Reseach Conference Diabetic Retinopathy: Neurovascular Dysfunction & Protection August 11 14, 2010 Reykjavik, Iceland Photo courtesy of freefoto.com Discover the Future of Ophthalmology ARVO Annual Meeting May 1 5, 2011 Fort Lauderdale, Florida

49 WOC Academia Ophthalmologica Internationalis (AOI) Lecture Sunday, 6 June 2010, 17:30-18:15 Hall Oslo Highlights Galileo s Blindness Chair: Paul R. Lichter (Ann Arbor/USA) Introduction of the AOI Lecturer: Juan Verdaguer T. (Santiago/RCH) Lecturer: Peter Watson (Cambridge/UK) He was educated in medicine at the University of Cambridge and University College London. After posts in general medicine, neurosurgery and plastic surgery, he trained in Ophthalmology at Moorfields Eye Hospital. He later became Senior lecturer at Moorfields Eye Hospital and London University. He was Consultant Ophthalmologist at Addenbrooke's University Hospital and Moorfields Eye Hospital until He was Boerhaave Professor of Ophthalmology University of Leiden The Netherlands from 1999 to His specialty interests are in glaucoma transplantation and inflammatory eye disease, especially scleritis. These interests have led to the development of Trabeculectomy in 1976 with John Cairns and the unravelling of the types of Scleral Disease together with the developmentof effective treatments for these conditions. The third edition of the "Sclera and Systemic Disorders" is currently in preparation. He has also initiatited of the Cambridge now in its 40th year. This 2 day symposium on a specific, sometimes minor topic, brings together basic scientists and clinicians. It has been published as a separate issue of EYE since it started. He was responsible for the initiation and development of the International Council Assessments for Ophthalmologists. Over 2000 candidates a year from 70 countries now take this exam. Whilst Boerhaave Professor he was able to pursue his interest in Transplantation which led to the successful transplantation of Ciliary Body in the rabbit. His interest in portraiture has led him to investigate Galileo's blindness.

50 46 Stiftung Auge weil Sehen wichtig ist Auction Art From above: Peter Halley Laurence Weiner Rosemarie Trockel From above: Matt Mullican Marc Francis

51 47 WOC 2010 Art Auction Benefit Art Auction in aid of Stiftung Auge (the Eye Foundation) as part of the WOC June 2010 Main foyer, ICC Berlin Join the bidding for some eye-catching pieces of art work! Exclusive to WOC 2010 you have the opportunity to purchase modern works centered on the theme of Art in the Art of Healing. In the works of art donated by Georg Thieme Verlag, renowned contemporary artists have dealt with the fascination of the human body, and also its fragility and limitations. This has resulted in the creation of impressive works of art, which are available for purchase as hand-signed, numbered serigraphs (limited edition of 250). Highlights Art is Seeing Seeing is Art Founded in 2008 by the German Society of Ophthalmology (DOG), Stiftung Auge is dedicated to fighting avoidable blindness and serious visual impairment. Its commitment is to raising awareness, training and the promotion of research to preserve vision. If you would like to support the work of Stiftung Auge, join the bidding and see what delights your eye. Stiftung Auge. Because sight is important. The artists Peter Halley, New York Rosemarie Trockel, Cologne Marc Francis, London Laurence Weiner, New York Matt Mullican, New York Would you like to bid? It s easy: At WOC 2010, you have the opportunity to see the expression and power of these works of art for yourself. They will be on exhibition in the main foyer of the ICC next to the Stiftung Auge stand. The value of each work is estimated at at least 1,300 Euro. Join in by making an opening bid of 300 Euro. Should you wish to bid in the auction, you can have your name entered on a list of bidders at the Stiftung Auge stand. Here, we will have some information on the works of art to be auctioned, the current bidding situation and the foundation itself. Curious? Then come along during WOC and join the bidding.

52 48 WOC 2010

53 WOC The Eye Run Because sight is important Five-kilometer run in aid of Stiftung Auge (the Eye Foundation) as part of the World Ophthalmology Congress. Highlights Start: Sunday, 6 June 2010, 7.00 a.m. at Mommsenstadion, near the ICC Berlin Waldschulallee 34, Berlin, Germany Open your eyes to a beautiful route and a good cause! Make a sporty start to Sunday morning together with some fellow runners and help to preserve the sense of sight at the same time: this is the goal of the Eye Run on the occasion of WOC This breakfast-time run follows a flat course leading through city and forest. The start and finish are located at Mommsenstadion, 10 minutes walk from the Messe Berlin exhibition grounds and the ICC Berlin. An award ceremony will take place following the run. Refreshments are provided and changing rooms and sanitary facilities are available. Support Stiftung Auge! Founded in 2008 by the German Society of Ophthalmology (DOG), Stiftung Auge is dedicated to fighting avoidable blindness and serious visual impairment. Its commitment is to raising awareness, training and the promotion of research to preserve vision. If you would like to support the work of Stiftung Auge, run with us on June 6, 2010 in the Eye Run! You d like to join in? It s easy: All congress attendees and running enthusiasts are most welcome to take part in the Eye Run. Pay a 15 Euro donation fee and you re off! Registrations can be made at the Stiftung Auge stand in the main foyer of the ICC Berlin during WOC Would you like to do something for your health and support the work of Stiftung Auge? Then pack your running shoes and join in on June 6, 2010 when the cry goes up: On your marks, get set, go!

54 50 WOC 2010 How to Read the Scientific Program

55 WOC Scientific Program Subspecialty Days

56 Zwei-Jahres-Abo: 22 Ausgaben für 166 Euro*. (inkl. jährl. aktualisiertem Ophthalmo-Index) Jahres-Abo: 11 Ausgaben für 83 Euro*. (inkl. jährl. aktualisiertem Ophthalmo-Index) Test-Abo: 3 Ausgaben für 20 Euro**. Das Abonnement verlängert sich nur dann um ein Jahr, wenn nach Erhalt der 2. Ausgabe keine schriftliche Kündigung vorliegt. Ermäßigtes Abo: 11 Ausgaben für 47 Euro, für Assistenzärzte und Studenten. Nachweis beilegen. *zzgl. Versand 16 Euro (inkl. MwSt.); **inkl. Versand und MwSt. Bestell-Service: Augenspiegel Leserservice PressUp GmbH, Postfach Hamburg, Fax: Telefon: mediawelt@pressup.de

57 WOC Sunday, 6 June 2010 Stockholm 08:30-09:15 SU-01 Present and Future Imaging Subspecialty Day Glaucoma Glaucoma Care: A Look into the Future Section 1: Structure and Function in Glaucoma Care Ted Garway-Heath (London/UK) Ester M. Hoffmann (Mainz/D) 08:30 IL SU What is most useful present imaging (HRT, OCT, GDx) Ester M. Hoffmann (Mainz/D) 08:40 IL SU Measuring progressive change with imaging: which stage, which strategy, which consequences Ted Garway-Heath (London/UK) 08:50 IL SU Ganglion cell visualization: animals and humans M. Francesca Cordeiro (London/UK) 09:25 IL SU What is weak in present conventional perimetry and what can we do about it Ulrich Schiefer (Tübingen/D) 09:35 IL SU Alternatives presently available (Flicker tests [FDT, Matrix, etc.], electrophysiology) Michael Bach (Freiburg/D) 09:45 IL SU What we need - the ideal new functional test Balwantray C. Chauhan (Halifax/CDN) 09:55 Stockholm 10:30-11:15 SU-03 Decisions for Treatment and Change in Treatment Subspecialty Day Glaucoma Glaucoma Care: A Look into the Future Section 2: Present and Future Approaches to Glaucoma Care Sunday, 6 June Subspecialty Days 09:00 IL SU Perspectives in retinal imaging: adaptive optics, en face OCT and full-field doppler Michel Paques (Paris/F) 09:10 Norbert Pfeiffer (Mainz/D) Augusto Azuara-Blanco (Aberdeen/UK) 10:30 IL SU Risk assessment and risk calculation Steven L. Mansberger (Portland/USA) Stockholm 09:15-10:00 SU-02 10:40 IL SU The impact of risk calculation on physician decisions Michael Boland (Baltimore/USA) Present and Future of Functional Diagnostics Subspecialty Day Glaucoma Glaucoma Care: A Look into the Future Section 1: Structure and Function in Glaucoma Care 10:50 IL SU Cost/benefit, Cost effectiveness Augusto Azuara-Blanco (Aberdeen/UK) 11:00 IL SU Practice patterns, too much or too little Norbert Pfeiffer (Mainz/D) Anders Heijl (Malmö/S) Ulrich Schiefer (Tübingen/D) 11:10 09:15 IL SU Useful strategies in present perimetry Anders Heijl (Malmö/S)

58 54 WOC 2010 Subspecialty Days Sunday, 6 June Sunday, 6 June 2010 Stockholm 11:15-12:00 SU-04 New Approaches to Gathering Information About Glaucoma Subspecialty Day Glaucoma Glaucoma Care: A Look into the Future Section 2: Present and Future Approaches to Glaucoma Care Alfred Sommer (Baltimore/USA) Richard Wormald (London/UK) 14:10 IL SU Barriers to adherence Jenny Lacey (Norwich/UK) 14:20 IL SU How does physician communication affect adherence? Michael Boland (Baltimore/USA) 14:30 IL SU How much would be gained if we increased adherence? James C Tsai (/USA) 14:40 11:15 IL SU The challenge: conduct large-scale research with many centers Don Budenz (Miami/USA) Stockholm 14:45-15:40 SU-06 11:25 IL SU Insurance database studies: strengths and weaknesses Joshua D. Stein (Ann Arbor/USA) 11:35 IL SU Mining our hard drives (Lessons from Cochrane approach) Richard Wormald (London/UK) 11:45 IL SU How to do research cheaper and better Alfred Sommer (Baltimore/USA) Present and Future of Glaucoma Surgery Surgical Challenges Subspecialty Day Glaucoma Glaucoma Care: A Look into the Future Section 3: Outlooks to Medical and Surgical Therapy Peng T. Khaw (London/UK) Tarek M. Shaarawy (Geneva/CH) George Baerveldt (Irvine/USA) 12:05 14:45 IL SU Developments making trabeculectomy safer Peng T. Khaw (London/UK) Stockholm 14:00-14:45 SU-05 Adherence with Medical Therapy, the Dirty Secret Subspecialty Day Glaucoma Glaucoma Care: A Look into the Future Section 3: Outlooks to Medical and Surgical Therapy Günther K. Krieglstein (Cologne/D) Jenny Lacey (Norwich/UK) 14:00 IL SU How bad is adherence now? Günther K. Krieglstein (Cologne/D) 14:55 IL SU Bleb classification and management of complications related to blebs Franz Grehn (Würzburg/D) 15:05 IL SU Non-penetrating glaucoma surgery techniques has their time come or gone? Tarek M. Shaarawy (Geneva/CH) 15:15 IL SU Tubes: When, why, how Keith Barton (London/UK) 15:25 IL SU Angle surgery: status report on newer methods George Baerveldt (Irvine/USA) 15:35 IL SU Standardized reporting on surgical studies Mark Sherwood (Gainesville/USA)

59 WOC Sunday, 6 June 2010 Stockholm 16:10-16:50 SU-07 Childhood Glaucoma Care: the Patient who Lives up to 2100 Subspecialty Day Glaucoma Glaucoma Care: A Look into the Future Section 4: Neglected Areas: Where Can We Improve Jan Eric Jakobsen (Oslo/N) Franz Grehn (Würzburg/D) Jugnoo S. Rahi (London/UK) 16:10 IL SU Present and future surgical techniques: Innovation at the horizon? Jan Eric Jakobsen (Oslo/N) 16:20 IL SU Spontaneous resolution of congenital glaucoma a natural help for surgery Franz Grehn (Würzburg/D) 16:25 IL SU Developing vision: Amblyopia is a major challenge Thomas Klink (Würzburg/D) 16:55 IL SU What is done now for OAG in the developing world Kuldev Singh (Stanford/USA) 17:00 IL SU What is done now for ACG in the developing world Clement C. Y. Tham (Hong Kong/CN) What should be done right now: 3 viewpoints 17:05 IL SU We should apply the developed country model Tarek M. Shaarawy (Geneva/CH) 17:10 IL SU We should use different programs for different regions Tin Aung (Singapore/SGP) 17:15 IL SU We should use the center of excellence pyramid model Garudadri Chandra Sekhar (Hyderabad/IND) 17:25 IL SU Where will we make the biggest short-term gains in reducing impairment Mingguang He (Guangzhou/CN) 17:25 Sunday, 6 June Subspecialty Days 16:35 IL SU New aspects of secondary glaucoma after congenital cataract surgery Jugnoo S. Rahi (London/UK) Abu Dhabi 08:30-10:00 SU-13 16:45 Correcting Presbyopia with IOLs Subspecialty Day Cataract Stockholm 16:50-17:30 SU-08 Glaucoma Care in Developing Countries Subspecialty Day Glaucoma Glaucoma Care: A Look into the Future Jorge L. Alió (Alicante/E) Charles Claoué (Brentwood/UK) Thomas F. Neuhann (Munich/D) 08:30 IL SU Monovision Thomas F. Neuhann (Munich/D) Section 4: Neglected Areas: Where Can We Improve Paul Foster (London/UK) Clement C. Y. Tham (Hong Kong/CN) 16:50 IL SU The scope of the problem Paul Foster (London/UK) 08:40 IL SU Multifocal, refractive Charles Claoué (Brentwood/UK) 08:50 IL SU Mulitfocal, diffractive José F. Alfonso (Miami/USA) 09:00 IL SU Accommodating, monooptic Milind Pande (North Ferriby/UK)

60 56 WOC 2010 Subspecialty Days Sunday, 6 June Sunday, 6 June :10 IL SU Accommodating, dualoptic Ivan L. Ossma-Gomez (Bucaramanga/CO) 09:20 IL SU Managing astigmatism and residual ametropia Michael C. Knorz (Mannheim/D) 09:30 Abu Dhabi 10:30-12:00 SU-14 Managing Complex Cases Subspecialty Day Cataract Boris Malyugin (Moscow/RUS) Hiroko Bissen-Miyajima (Tokyo/J) Duy-Thoai Pham (Berlin/D) Abu Dhabi 14:00-15:30 SU-15 New Monofocal IOL Designs Subspecialty Day Cataract Rudy Nuijts (Maastricht/NL) Liliana Werner (Berlin/D) Thomas Kohnen (Frankfurt am Main/D) 14:00 IL SU Aspheric Thomas Kohnen (Frankfurt am Main/D) 14:10 IL SU Toric overview Rudy Nuijts (Maastricht/NL) 14:20 IL SU Surgical pearls for toric IOLs David Spalton (London/UK) 10:30 IL SU Incisional issues Amar Agarwal (Chennai/IND) 14:30 IL SU Extreme cases Gerd U. Auffarth (Heidelberg/D) 10:40 IL SU Dense nuclei Duy-Thoai Pham (Berlin/D) 14:40 IL SU Light-adjustable Fritz Hengerer (Bochum/D) 10:50 IL SU Small pupils Boris Malyugin (Moscow/RUS) 14:50 IL SU New IOL biomaterials Liliana Werner (Berlin/D) 11:00 IL SU Ruptured posterior capsule Hiroko Bissen-Miyajima (Tokyo/J) 15:00 11:10 IL SU Iris defects (aniridia, coloboma, traumatic) Stephan Kohnen (Aachen/D) Abu Dhabi 16:00-17:30 SU-16 11:20 IL SU Dislocated iols TBA Emerging Technology in Cataract Surgery Subspecialty Day Cataract 11:30 Mats Lundström (Karlskrona/S) Douglas D. Koch (Houston/USA) Oliver Findl (Vienna/A) 16:00 IL SU Advances in techniques for patient assessment Oliver Findl (Vienna/A) 16:10 IL SU IOL calculations, technology?, formulas - Haigis, IOL calculations after refractive surgery - DDK Jaime Aramberri Agesta (Vitoria-Gasteiz/E)

61 WOC Sunday, 6 June :20 IL SU Phaco technology Barry S. Seibel (Los Angeles/USA) 16:30 IL SU Prevention of PCO Manfred Tetz (Berlin/D) 16:40 IL SU Prevention of endophthalmitis Mats Lundström (Karlskrona/S) 16:50 IL SU Small-incision ECCE" to "Modern Manual Cataract Srinivas K. Rao (Chennai/IND) 9:30 IL SU Trauma and vitreoretinal surgery timing and management Masahito Ohji (Otsu/J) 09:40 IL SU Intraocular tamponade what s new? David Wong (Pok Fu Lam/HK) 09:50 IL SU Hot topic (last minute announcement) TBA 10:00 Sunday, 6 June Subspecialty Days 17:00 Hall 3 Hall 3 08:30-10:00 SU-48 10:30-12:00 SU-49 Vitreoretinal Interface Epiretinal Macular Surgery Retinal Detachment and PVR Subspecialty Day Retina Subspecialty Day Retina George William Aylward (London/UK) Alain Gaudric (Paris/F) 08:30 IL SU Surgical instrumentation for RD and PVR repair (20, 23, 25 g etc.) Constantin J. Pournaras (Geneva/CH) 08:40 IL SU Which new drugs can treat PVR? Louisa Wickham (London/UK) 08:50 IL SU Is there still place for scleral buckling in primary surgery for RD? Heinrich Heimann (Liverpool/UK) 09:00 IL SU Management after failure of primary RD-repair Periklis Brazitikos (Athens/GR) 09:10 IL SU Prevention of RD: are there cases in which it is worthwhile? Fred Hendrikse (Maastricht/NL) 09:20 IL SU Management of second eye in vitreoretinal dystrophies Antonio Capone (Oakland/USA) Alain Gaudric (Paris/F) Michael T. Trese (Royal Oak/USA) 10:30 IL SU Pathology of the vitreoretinal interface: Implications for surgery Arnd Gandorfer (Munich/D) 10:40 IL SU Pharmacologic vitreolysis and vitreodynamics Matthew Benz (Houston/USA) 10:50 IL SU Progress in epiretinal surgery: vital stains Christos Haritoglou (Munich/D) 11:00 IL SU Macular hole surgery: is face -down positioning still necessary? D. Alistair H. Laidlaw (London/UK) 11:10 IL SU Macular hole surgery: is ILM peeling always useful? Ramin Tadayoni (Paris/F) 11:20 IL SU ERM and VMTS surgery: cases which fail Thomas J. Wolfensberger (Lausanne/CH) 11:30 IL SU Vitreoretinal interface in AMD Susanne Binder (Vienna/A)

62 58 WOC 2010 Subspecialty Days Sunday, 6 June Sunday, 6 June :40 IL SU Vitreoretinal Interface in children therapeutic implications Michael T. Trese (Royal Oak/USA) 11:50 IL SU Hot topic (last minute announcement) TBA 12:00 Hall 3 16:00-17:30 SU-51 AMD Subspecialty Day Retina Anselm Kampik (Munich/D) George William Aylward (London/UK) Hall 3 14:00-15:30 SU-50 Retinal Vascular Diseases: Diabetic Retinopathy / Vein Occlusions Subspecialty Day Retina Michael T. Trese (Royal Oak/USA) Anselm Kampik (Munich/D) 16:00 IL SU When to stop anti VEGF therapy? Adnan Tufail (London/UK) 16:10 IL SU Update on Clinical Trials of Intravitreal Drugs for Neovascular AMD Alexander J. Brucker (Philadelphia/USA) 16:20 IL SU Geographic atrophy: Imaging Metrics and Progression Determinants Frank G. Holz (Bonn/D) 14:00 IL SU Retinal oximetry in diabetic retinopathy and retinal vein occlusions Einar Stefánsson (Reykjavik/IS) 14:10 IL SU Steroids vs laser in DME Pascale Massin (Paris/F) 14:20 IL SU Anti VEGFs vs Steroids in DME Julia A. Haller (Philadelphia/USA) 14:30 IL SU Slow release steroids in DME Frank G. Holz (Bonn/D) 14:40 IL SU Combination of pharmacology and VR surgery in DR J. Fernando Arevalo (Caracas/Y) 16:30 IL SU Future drugs for treatment of dry AMD Salvatore Grisanti (Lübeck/D) 16:40 IL SU Genetics and prevention of AMD Hendrik Peter Nicolas Scholl (Bonn/D) 16:50 IL SU Is there a place for surgery in AMD? Jan van Meurs (Rotterdam/NL) 17:00 IL SU Cell therapy for AMD TBA 17:10 IL SU How to prevent endophthalmitis in intravitreal therapy? Thierry C. Verstraeten (Pittsburgh/USA) 14:50 IL SU Does early intravitreal drug therapy change the course of BRVO and CVRO Francesco Bandello (Milano/I) 17:10 IL SU Hot topic (last minute announcement) TBA 15:00 IL SU Is surgery useful in BRVO and CRVO? José García Arumí (Barcelona/E) 15:10 IL SU Hot topic (last minute announcement) TBA 15:20 IL SU Hot topic (last minute announcement) TBA

63 WOC Monday, 7 June 2010 Sao Paulo 08:30-10:00 MO-04 Update on Retinopathy of Prematurity: New Approaches for Research, Diagnosis and Treatment Subspecialty Day Pediatric Ophthalmology Andrea Zin (Rio de Janeiro/BR) Anand Vinekar (Bangalore/IND) Birgit Lorenz (Giessen/D) 10:30 IL MO Best choice surgery in pediatric cataract Marie-José Tassignon (Antwerb/B) 10:45 IL MO Alternatives to penetrating keratoplasty in pediatric corneal disease Ken K. Nischal (London/UK) 11:00 IL MO Pediatric Corneal Transplantation: Experiences from a large tertiary referral center in India Pravin V. Krishna (Hyderabad/IND) Monday, 7 June Subspecialty Days 08:30 IL MO New research areas in ROP diagnosis and management Ann Hellstrom (Gothenburg/S) 11:15 IL MO The choice and effectiveness of surgery in different clinical forms of congenital glaucoma Anton Gerinec (Bratislava/SK) 08:40 IL MO Organizing national screening programs for ROP Andrea Zin (Rio de Janeiro/BR) 08:50 IL MO ROP Screening in Vietnam Nguyen Xuan Tinh (Hanoi/VN) 11:30 IL MO Pediatric perforating injuries of the globe: timing of surgical steps Robert Stegmann (Pretoria/ZA) 11:45 09:00 IL MO Telemedicine as an option for screening: The expert s view on WFDI in ROP Michael Chiang (New York/USA) Sao Paulo 14:00-15:30 MO-06 09:10 IL MO Telemedicine in ROP: The Indian Experience Anand Vinekar (Bangalore/IND) 09:20 IL MO WFDI in ROP. Opportunity for automated image analysis Alistair Fielder (London/UK) 09:30 IL MO Anti-VEGF and ROP Helen A. Mintz-Hittner (Houston/USA) 09:40 Sao Paulo 10:30-12:00 MO-05 Surgical Challenges in Pediatric Anterior Segment Diseases Subspecialty Day Pediatric Ophthalmology Birgit Lorenz (Giessen/D) Marie-José Tassignon (Antwerp/B) Ken K. Nischal (London/UK) Update on Infantile Nystagmus: Clinics, Genetics, and Treatment Subspecialty Day Pediatric Ophthalmology Irene Gottlob (Leicester/UK) Christina Zeitz (Paris/F) Birgit Lorenz (Giessen/D) 14:00 IL MO Modern work-up in infantile nystagmus Birgit Lorenz (Giessen/D) 14:15 IL MO Genetics of X-linked idiopathic nystagmus Irene Gottlob (Leicester/UK) 14:30 IL MO Genetics of cone dysfunction disorders Susanne Kohl (Tübingen/D) 14:45 IL MO Genetic and clinical hetereogeneity of congenital forms of night blindness Christina Zeitz (Paris/F) 15:00 IL MO Medical and surgical treatment options Anil Kumar (Leicester/UK)

64 60 WOC 2010 Subspecialty Days Monday, 7 June Monday, 7 June :15 IL MO Gene therapy provides cure for achromatopsia Knut Stieger (Giessen/D) Sao Paulo 16:00-17:30 MO-07 EPOS : Vision 2020 in Pediatric Ophthalmology. Dreams and Realities in Eliminating Avoidable Childhood Blindness Hall 3 08:30-10:00 MO-37 Corneal Approaches for Addressing Presbyopia Subspecialty Day Refractive Surgery Douglas D. Koch (Houston/USA) Emanuel S. Rosen (Manchester/UK) Thomas F. Neuhann (Munich/D) Subspecialty Day Pediatric Ophthalmology Birgit Lorenz (Giessen/D) Clare Gilbert (London/UK) David Taylor (London/UK) 16:00 IL MO VISION 2020 and children: achievements and challenges Clare Gilbert (London/UK) 08:30 IL MO Corneal Techniques (Monovision) Thomas F. Neuhann (Munich/D) 08:45 IL MO Corneal Pseudoaccommodation Douglas D. Koch (Houston/USA) 09:00 IL MO Presby-Lasik Damián Gatinel (Paris/F) 16:15 IL MO Pediatric cataract: can we improve on what we have achieved? Michael O Keefe (Dublin/IRL) 16:30 IL MO Pediatric glaucoma. Holes, tubes and more Peng T. Khaw (London/UK) 16:45 IL MO Pediatric infectious eye diseases: Prevention and treatment Perumalsamy Vijayalakshmi (Madurai/IND) 09:15 IL MO Intracorneal Lenses Emanuel S. Rosen (Manchester/UK) 09:30 IL MO Small Aperture Devices George Waring (Atlanta/USA) 09:45 Hall 3 17:00 IL MO Predictions of genotype and phenotype in pediatric hereditary diseases: present achievements and future challenges Josseline Kaplan (Paris/F) 10:30-12:00 MO-38 Corneal Laser Refractive Surgery Subspecialty Day Refractive Surgery 17:15 IL MO Retinal dystrophies: hopes for cure Birgit Lorenz (Giessen/D) Günther Grabner (Salzburg/A) J. Bradley Randleman (Atlanta/USA) Michael C. Knorz (Mannheim/D) 10:30 IL MO Femtosecond Laser Technology Günther Grabner (Salzburg/A) 10:40 IL MO Excimer Laser Technology Theo Seiler (Zurich/CH) 10:50 IL MO Other New Technologies for Ablation and Flap Creation Holger Lubatschowski (Hannover/D)

65 WOC Monday, 7 June :00 IL MO Eye-Tracking Michael Mrochen (Zurich/CH) 11:10 IL MO LASIK Techniques and Complications Michael C. Knorz (Mannheim/D) 11:20 IL MO Surface Techniques and Complications Marguerite McDonald (New Orleans/USA) 11:30 IL MO Ectasia J. Bradley Randleman (Atlanta/USA) 11:40 Hall 3 14:00-15:30 MO-39 Corneal Physiology and Biomechanics Subspecialty Day Refractive Surgery Jorge L. Alió (Alicante/E) William J. Dupps Jr. (Cleveland/USA) Theo Seiler (Zurich/CH) Hall 3 16:00-17:30 MO-40 Managing High Refractive Errors Subspecialty Day Refractive Surgery Joseph Colin (Bordeaux/F) Roberto Zaldivar (Buenos Aires/RA) Thomas Kohnen (Frankfurt am Main/D) 16:00 IL MO Phakic iols vs corneal refractive surgery José L. Güell (Barcelona/E) 16:10 IL MO Angle-supported Thomas Kohnen (Frankfurt am Main/D) 16:20 IL MO Iris-fixated Camille Budo (Melveren/B) 16:30 IL MO Sulcus-fixated Roberto Zaldivar (Buenos Aires/RA) 16:40 IL MO Phakic IOLs: complications Joseph Colin (Bordeaux/F) Monday, 7 June Subspecialty Days 14:00 IL MO Biomechanics William J. Dupps Jr. (Cleveland/USA) 16:50 IL MO Refractive lens exchange Antonio A. P. Marinho (Porto/P) 14:10 IL MO Accommodation and presbyopia Adrian Glasser (Houston/USA) 17:00 IL MO IOL selection for refractive lens exchange Roberto Bellucci (Verona/I) 14:20 IL MO Normal wavefront error as function of age, pupil size and anatomy Jorge L. Alió (Alicante/E) 17:10 14:30 IL MO Retinal image quality in refractive surgery Jack T. Holladay (Bellaire/USA) 14:40 IL MO Laser tissue interaction Ronald R. Krueger (Cleveland/USA) 14:50 IL MO New advances in corneal imaging Mitchell P. Weikert (Houston/USA) 15:00

66 European Association for Vision and Eye Research EVER 2010 Crete Oct Science for Sight Pre-congress Courses COS - Optical coherence tomography applications in anterior segment eye diseases Edward WYLEGALA - Corneal infectious disease - Jean-Jacques GICQUEL, Harminder S DUA - Facial nerve palsy: anatomy, etiology, evaluation, and management Ioannis MAVRIKAKIS IM - EBO Review Course 1: Intraocular infl ammation and infection - Bahram BODAGHI, Carl P HERBORT - EBO Review Course 2: Intraocular infl ammation and infection - Bahram BODAGHI, Carl P HERBORT LC - Anaesthesia in ocular surgery - Kati GOMBOS NSPH - Common neuro-ophthalmic pitfalls: casebased studies - Valerie PURVIN, Aki KAWASAKI PO - Diagnostic of ophthalmic tumors - Laurence DEJARDINS, Bertil DAMATO - Proper use of words and numbers in scientifi c writing - Bertil DAMATO, Tero KIVELÄ - Simple and effective alternatives to textbook surgical procedures for treatment of trichiasis, removal of orbital tumors and evisceration - Mordechai ROSNER, Nachum ROSEN RV - Retinal detachment: how to improve our success rate? - Caherine CREUZOT, Constantin POURNARAS - Retinal imaging: fi rst to describe and then to analyse - Caherine CREUZOT, Gisèle SOUBRANE Special Interest Symposia/workshops in the following scienti c sections: Anatomy / Cell Biology - ACB Cornea / Ocular Surface - COS Glaucoma - G Immunology / Microbiology - IM Lens and Cataract - LC Molecular Biology / Genetics / Epidemiology - MBGE Neuro-ophthalmology / Strabismology/ Paediatric Ophthalmology / History of Ophthalmology - NSPH Pathology / Oncology - PO Physiology/Biochemistry/Pharmacology - PBP Retina / Vitreous - RV Vision Sciences / Electrophysiology / Physiol. Optic - VEP Keynote - Plenary Lectures Keynote Lectures - David TAYLOR, UK - Alan BIRD, UK - Stefan SEREGARD, Sweden EVER - Acta Lecture - Wolfgang DREXLER, Austria EVER Lecture - Charles RIVA, Switzerland European Ophthalmic Heritage Lecture Ophthalmic Research Lecture EVI Prize and Lecture Dates to remember Abstract submission deadline: June 14, 2010 Final programme online: July 15, 2010 Early registration deadline: September 1, 2010 Join EVER Largest annual european eye research meeting Keynote lectures Special interest symposia Free paper sessions and posters Workshops and courses Commercial Interest Symposia New attractive location every three years Become an active member Reduced fee for annual meeting Organizing Special Interest Symposia (SIS) during the annual meeting Voting rights for the election of Board Members Free access to Acta Ophthalmologica Travel grants Quarterly E-Newsletter 21 CME CREDITS EVER 2010 Hosts: ARVO - ESCRS - EURETINA - FRO - ISCEV - MEACO - OOG - SOIE 23/03/2010

67 WOC Scientific Program Scientific Program Schedule Saturday, 5 June 2010 Saturday, 5 June

68 DOCH-Meeting ICC Hall 1 Hall 2 Hall 6 Hall 7 Hall 8 Hall 9 Hall 10 Roof Garden Salon 11/12 Salon 13/14 Salon 15/16 Room 34 Room 44 Room 56 Hall 3 Highlight Free Paper WOC Course Industry Meetings Breakfast Ziemer Breakfast AeonAstron SA-33 Brucker, Soubrane, Holz Update on Management of AMD SA-37 Kollmann, Ilako, Nkumbe Africa: Can we succeed in the greatest chall. SA-40 Rosenbaum, Mackensen, Gul Genetics and Uveitis WOC-C-13 Emmerich The Aging Lid Functional Effects and their Treatment SA-05 Menapace, Fishkind, Artal Advances in Cataract and IOL Technology WOC-AAD-C-09 Völcker Corneal Degeneration / Dystrophy SA-34 Li, Bandello, Schmidt- Erfurth Update in Diabetic Retinopathy SA-38 Landau, Zrenner, Lee, Luco Panel: Neuro-Ophthalmological Problems SA-41 Arevalo, Wilkinson, Roca PAAO : Retinal and Choroidal Manifest. WOC-C-10 Wormald, Virgili Evidence-Based Ophthalmology WOC-C-14 Geerling, Grehn, Müller Management of Complex Glaucoma SA-06 O'Brien, Barry, Bartz- Schmidt Endophthalmitis ICO Ophthalmologic Society Advocates Lunch Lunch Alcon Lunch Allergan Ophthalmology Lunch Bausch&Lomb Lunch Zeiss Mitgliedervers. Bielschowsky- Gesellschaft Sitzung der Sektion DOG-Glaukom WOC-AAD-C-17 Zierhut Episcleritis and Scleritis WOC-AAD-C-18 Kirchhof Diagnosis and Treatment of Peripheral Retinal Degener. Lunch MSD Ophthalmics Saturday, 5 June SA-15 Franceschetti, Khoo, Kuhn Panel: Contact Lenses and Children SA-16 Kinoshita, Fiol-Silva, Guthoff Corneal Imaging: New Versus Useful ICO World Ophthalmology Roundtable on Leadership Development (WORLD) and ICO General Assembly WOC-AAD-C-11 Cursiefen Crosslinking of the Cornea: When, How and Why? WOC-C-15 Schmidt-Erfurth Modern OCT imaging: Clinical value and perspectives SA-07 Agarwal, Kohnen Phaco Nightmares and Worst Case Scenarios Arbeitsgruppe Internet und medizinische Informationsverarbeitung WOC-C-12 Chakrabarti Advanced Biaxial Microphaco and Coaxial Phaco WOC-AAD-C-16 Kohnen KRC Advanced Course for the Refractive Surgery SA-08 Wakefield, Pavesio, Thurau Unmet Needs in Diagnosis of Uveitis Sitzung der Sektion DOG-Gewebetransplantation und Biotechnologie WOC-AAD-C-19 Behrens- Baumann Diagnosis and Treatment of Keratomycoses WOC-AAD-C-20 Grehn Glaucoma Surgery Follow-up Care SA-00 Opening Ceremony Oculus User Meeting 19:00-20:00 Vorstandssitzung DGII

69 Poster exhibition of Poster P-SA-001 to P-SA-282 Messe Stockholm Sao Paulo Abu Dhabi Oslo Room Madrid Room Sydney Room Hong Kong Room Istanbul VIP Lounge 1 VIP Lounge 2 Radio Tower Lounge 1 Radio Tower Lounge 2 Hall SA-01 Holladay Hot Topics in Refractive Surgery WOC-AAD-C-01 Lang Differential Diagnosis of Macular Diseases SA-25 Mieler, Murray, Roider Retina: Diagnostics 1 SA-09 Desjardins, Silva, Lohmann Ocular Tumors in Childhood Develop. Eye Dis. SA-13 Kohlhaas, Kanpolat, Neuhann Basic Research, Upd. on Treatm. and Opt. Cor. SA-17 Tseng, Meller Amniotic Membrane Transplantation SA-21 Wormald, Krieglstein, Ritch Evidence-based Management of Glaucoma WOC-C-05 Kohnen WetLab Refractive Surgery 1 SA-29 Michelson, Chiang, Olson, Tost Clinical Aspects: Screening, Diagnosing, SA-02 Krueger, Sekundo 2010 WOC Femtosecond Laser Review WOC-AAD-C-02 Dietlein Glaucoma without high Pressure Normal-tension Glauc. SA-26 Knorz, El Danasoury, Neuhann Refractive surgery/refraction 1 SA-10 Dutton, Fazzi, Lorenz Cerebral Visual Impairment SA-14 Bischoff, Key, Bialasiewicz Clinical Manag. of Contact Lens Complica. SA-18 Lisch, Munier Corneal Dystrophies SA-22 Kuppermann, Spaide, Ziemssen Panel: Challenges and Persp. of Intravit. Drugs WOC-C-06 Duncker Wetlab Refractive Surgery 2 SA-30 Goldberg, Rojanapongpun, Fang SEAGIG Symp.: Angle-Closure Glaucoma Lunch Geuder AG Lunch Pfizer Mitgliederversammlung der Sektion DOG-Kornea SA-03 Zarbin, MacLaren, Binder SOE Symp: Cell Derived Therapies WOC-AAD-C-03 Kampik Diabetic Retinopathy SA-35 Mieler, Jager, Foerster Retinal Showcase SA-11 Krieglstein, Gandolfi, Fantes Trabeculectomy: Problems and Solutions SA-42 Collin, Hintschich, Klett Congenital and Acquired Lid Mal Positions SA-19 Reinhard, Seitz, AlRajhi Laser-assisted Keratoplasty SA-23 Pfeiffer, Friedman, Zhao Epidemiological Research in Eye Disease WOC-C-07 Richard, Corcostegui, Wong Wetlab: Endotamponades in Vitreor. SA-27 Bretthauer, Beiko, Tabin Cataract/biometry 1 SA-31 Aung, Chiselita, Jansonius Glaucoma: Diagnostics SA-04 Reinstein, Rabinovitz, Preußner Safety of Refr. Surgery using New Diagn. Techn. WOC-AAD-C-04 Schroeter Optic disc elevation Differential Diagnosis and Work Up SA-36 D'Amico, van Meurs, Wiedemann What's New on Management of Reti. Disease SA-12 Ritch, Jonas, Flammer Pressure-independent Factors in Glaucoma SA-43 Ishibashi, Grossniklaus, Dithmar Retinal Diseases and Degenerations SA-20 Knop, Knop, Bron Meibomian Gland Anatomy, Physiology and Disease SA-24 Pfeiffer, Friedman, Perulasamy New Challenges to Vision 2020 WOC-C-08 Struck, Schrage, Kiraly Wetlab Surgical Measurement in the Early Phase SA-28 Spiegel, Krieglstein, Reitsamer Glaucoma: Basics 1 SA-32 Binder, Framme, Lipshitz Retina: AMD 1 AOI Meeting and Luncheon (AOI Oration) SA-44 APSORPS SA-45 Engle,, Neugebauer Congenital Cranial Dysinnervation Disorders (CCDD) SA-46 Pe'er, Prause, Guthoff Orbital, Adnexal and Conjunctival Tumors SA-47 Repka, Thouvenin, Ehrt Amblyopia: early detection and screening programs SA-48 Thulasiraj, Gilbert, Etya'ale Changing Realities in Eye Care Highlight Free Paper WOC Course Industry Meetings Saturday, 5 June

70 Subscribe FREE * to the following products from Ophthalmology Times Europe Magazine Digital Digest E-news Web seminars Interested? Ophthalmology Times Europe is a comprehensive publication covering all of the latest developments within the ophthalmic industry with a broad focus on cataract, corneal and refractive surgery, glaucoma and vitreoretinal conditions. To subscribe for FREE* visit *Free to qualifying readers in Europe

71 WOC Saturday, 5 June 2010 Stockholm 08:30-10:00 SA-01 Hot Topics in Refractive Surgery Refractive Surgery Chair: Jack T. Holladay (Bellaire/USA) 08:30 IL SA Patient Satisfaction With Laser Vision Correction as Performed by a Large Corporate Provider Steven C. Schallhorn (San Diego/USA) 08:40 IL SA Wavefront Analysis: When Do We Need It? Jack T. Holladay (Bellaire/USA) 08:50 IL SA Optics and Causes of Rainbow Glare Ronald R. Krueger (Cleveland/USA) 09:00 IL SA Managing the Not Quite Emmetropic Postcorneal Laser Patient Julian D. Stevens (London/UK) 09:10 IL SA Six-Month Results of All-in-One Femtosecond Laser Refractive Surgery Rupal S. Shah (Vadodara/IND) Stockholm 10:30-12:00 SA WOC Femtosecond Laser Review Refractive Surgery Ronald R. Krueger (Cleveland/USA) Walter Sekundo (Marburg/D) 10:30 IL SA Personal Experience with several fs laser platforms and review of current status of all fs lasers for corneal surgery Günther Grabner (Salzburg/A) 10:40 IL SA Use of FS lasers for cataract surgery Ramon Naranjo-Tackman (Vadodara/IND) 10:50 IL SA FS laser surgery for presbyopia Mike P. Holzer (Heidelberg/D) 11:00 IL SA FLEX Surgical Results Rupal S. Shah (Vadodara/IND) 11:10 IL SA FS Lasers for Corneal Transplantation Yaron Rabinovitz (Los Angeles/USA) Scientific Program Schedule Saturday, 5 June 09:20 IL SA Corneal Biomechanics, Refraction, and Corneal Aberrometry in Keratoconus: An Integrated Diagnostic Study Jorge L. Alió (Alicante/E) 11:20 Stockholm 09:30 IL SA Outcome of Refractive Surgery in Keratoconus Suspect Eyes Damián Gatinel, Alain Saad (Paris/F) 14:00-15:30 SA-03 SOE : Cell Derived Therapies for Retinal Degeneration 09:40 IL SA Femtolaser Deep Anterior Keratoplasty with Baring of Descemet Membrane in Keratoconus and Post-LASIK Ectasia Mohamed Alaa El Danasoury (Jeddah/SA) 09:50 Retina Marco Zarbin (Roseland/USA) Robert E. MacLaren (London/UK) Susanne Binder (Vienna/A) 14:00 IL SA Cell based therapy for AMD Marco Zarbin (Roseland/USA) 14:10 IL SA Current status of Human RPE transplantation Susanne Binder (Vienna/A)

72 68 WOC 2010 Saturday, 5 June Scientific Program Schedule Saturday, 5 June :20 IL SA Rejuvenation of retinal pigment epithelial cells Kerstin Steindl (Vienna/A) 14:30 IL SA Novel aspects of cell-based non viral gene therapy Gabriele Thumann (Aachen/D) 14:40 IL SA Tissue engineering and cellular replacement strategies of the RPE Boris V. Stanzel (Bonn/D) 14:50 IL SA How close are we in stem cell therapy in retinal disorder? Taraprasad P. Das (Hyderabad/IND) 15:00 Stockholm 16:00-17:30 SA-04 Abu Dhabi 08:30-10:00 SA-25 Retina: Diagnostics 1 Free Paper Retina William F. Mieler (Chicago/USA) Timothy G. Murray (Miami/USA) Johann Roider (Kiel/D) 08:30 FP SA Pathological Changes of Cerebral and Ocular Hemodynamics in Optic Nerve Atrophy Ekaterina Kravchuk, Tatyana Kiseleva (Moscow/RUS) 08:37 FP SA Analysis of indocyanine green angiography in myopic choroidal neovascularization Hyoung Jun Koh, Jong Uk Yoon, Yong Min Kim, Yeo Jue Byun (Seoul/ROK) Safety of Refractive Surgery Using New Diagnostic Technologies Refractive Surgery 08:44 FP SA A preliminary study on the value of autofluorescence photography in observing inherited fundus diseases Kai Ma, Feng Zhang, Ning Pu Liu (Beijing/CN) Dan Z. Reinstein (London/UK) Paul-Rolf Preußner (Mainz/D) 16:00 IL SA Phakic-IOL sizing and monitoring technology Carlo F. Lovisolo (Milan/I) 16:15 IL SA Keratoconus screening is the back surface of benefit? Renato Ambrósio Jr. (Rio de Janeiro/BR) 08:51 FP SA High-speed, high-penetration, swept-source optical coherence tomography at 1 micrometer wavelength band for posterior eye diseases. Yasushi Ikuno, Yoshiaki Yasuno, Miki Sawa, Motokazu Tsujikawa, Fumi Gomi (Suita/J) 08:58 FP SA Spectral-domain Optical Coherence Tomography for gas-filled eyes Makoto Inoue, Kimihiko Sano, Shutaro Taniuchi, Akito Hirakata (Tokyo/J) 16:30 IL SA Epithelial thickness profiles in sub-surface keratoconus screening Timothy C. Archer (London/UK) 16:45 IL SA Surface and sub-surface corneal diagnostic technology in refractive surgery complications Dan Z. Reinstein (London/UK) 17:00 IL SA Everything you ever wanted to know about dry eye evaluation technology and LASIK Ilpo Tuisku (Hus/FIN) 09:05 FP SA Analysis of retinal layers in patients with symptomatic central serous chorioretinopathy (CSC) by high resolution spectral domain OCT (SD-OCT) Mark Saeger, Carsten Klatt, Felix Treumer, Anne Wissen, Johann Roider (Kiel/D) 09:12 FP SA Simultaneous Infrared cslo and Spectral Domain- OCT Imaging of RPE Tears Hans-Martin Helb, Sandeep Saxena, Frank G. Holz, Carsten H. Meyer (Bonn/D) 17:15

73 WOC Saturday, 5 June :19 FP SA Macular volume is decreased in Multiple Sclerosis depending on the disease stage an OCT study Andrea Hassenstein, Maria-Katharina Wölbert, Armin Julius Wulff, Benedikt Große Darrelmann, Jana Pöttgen, Rüdiger Schwartz, Sven Schippling (Hamburg/D) 09:26 FP SA Diffuse diabetic macular edema using Spectral-Domain Optical Coherence Tomography Avinoam Ophir, Michael R. Martinez, Paola Mosqueda, Aaron Trevino (Hadera/IL) 09:33 FP SA Evaluating retinal and vitreoretinal pathology with en-face optical coherence tomography Desislava Koleva-Georgieva, Nelly Sivkova (Plovdiv/BG) 09:40 Abu Dhabi 11:07 FP SA Reading performance after implantation of the AcuFocus Corneal Inlay (ACI) for the surgical correction of presbyopia a two year follow-up Alois Dexl, Orang Seyeddain, Wolfgang Riha, Melchior Hohensinn, Gerhard Nix, Günther Grabner (Salzburg/A) 11:14 FP SA Our results with Epilasik in Thin Corneas Chitra Ramamurthy (Coimbatore/IND) 11:21 FP SA Thin corneas: how safe in laser refractive surgery? Hassan Al Arrayed (Manama/BRN) 11:28 FP SA Advanced surface ablation at DR. Yap Eye Hospital Yogyakarta three years experience Siti Sundari, Suhardjo Suhardjo, Nurfifi Arliani (Yogyakarta/RI) 11:35 Scientific Program Schedule Saturday, 5 June 10:30-12:00 SA-26 Abu Dhabi Refractive Surgery/Refraction 1 14:00-15:30 SA-35 Free Paper Refractive Surgery Michael C. Knorz (Mannheim/D) Mohamed Alaa El Danasoury (Jeddah/SA) Thomas F. Neuhann (Munich/D) 10:30 FP SA Objective Assessment of Quality of vision and Lens Stability after Toric Posterior Chamber Phakic IOL Implantation Alaa El Danasoury (Jeddah/SA) Retinal Showcase Retina William F. Mieler (Chicago/USA) Martine J. Jager (Leiden/NL) Michael H. Foerster (Berlin/D) 14:00 IL SA Macrophages and angiogenesis Rajendra Apte (Rotterdam/NL) 10:37 FP SA Refractive Outcomes with Toric ICL Implants Dandapani Ramamurthy (Coimbatore/IND) 14:10 IL SA Angiogenesis in uveal melanoma Nikolaos E. Bechrakis (Innsbruck/A) 10:44 FP SA All-In-One Femtosecond Laser (Flex and Smile) for the correction of myopia and astigmatism Osama Ibrahim (Alexandria/ET) 10:51 FP SA Changes of higher order aberrations after surface ablation of highly aberrated corneas Stefan Pieh, Gerald Schmidinger, Christian Skorpik (Vienna/A) 10:58 SL SA Clinical evaluation of the IntraCOR intrastromal femtosecond laser procedure to correct presbyopia Michael C. Knorz (Mannheim/D) 14:20 IL SA Macrophages and aging Martine J. Jager (Leiden/NL) 14:30 IL SA Angiogenesis in retinoblastoma Timothy G. Murray (Miami/USA) 14:40 IL SA Von Hippel Lindau disease: why does it develop? Klaus-Martin Kreusel (Berlin/D)

74 70 WOC 2010 Saturday, 5 June Scientific Program Schedule Saturday, 5 June :50 IL SA Therapy of choroidal and retinal hemangiomas Michael H. Foerster (Berlin/D) 15:00 Abu Dhabi 16:00-17:30 SA-36 What's New on Management of Retinal Disease Retina Donald J. D'Amico (New York/USA) Jan van Meurs (Rotterdam/NL) Peter Wiedemann (Leipzig/D) 16:00 IL SA Comparison of AMD Treatment Trial: Lucentis verus Avastin Current Status (CATT) TBA Oslo 08:30-10:00 SA-09 Ocular Tumors in Childhood Developmental Eye Diseases Pediatric Ophthalmology, Genetics Laurence Desjardins (Paris/F) Eduardo Silva (Coimbra/P) Dietmar Lohmann (Essen/D) 08:30 IL SA Genetic of retinoblastoma Dietmar Lohmann (Essen/D) 08:40 IL SA Treatment of retinoblastoma Francis Munier (Lausanne/CH) 08:50 IL SA Orbital tumors of childhood Jerry Shields (Philadelphia/USA) 16:10 IL SA Direct Ophthalmic Artery Delivery of Chemotherapy for Retinoblastoma 4 Year Results David H. Abramson (NY/USA) 16:20 IL SA Pharmacologic Agents in the Management of Radition Retinopathy Carol L. Shields (Philadelphia/USA) 16:30 IL SA The Case For and Against Complement in the Pathogenesis of AMD Anthony P. Adamis (Boston/USA) 16:40 IL SA Modulation of the Subretinal Fluid in Retinal Detachment Patients Marc A. Veckeneer (Rotterdam/NL) 16:50 IL SA New Surgical Treatments for AMD Robert E. MacLaren (London/UK) 17:00 IL SA Liquid Expansile Vetreous Endotamponades: an Avenue To Pursue? Bernd Kirchhof (Cologne/D) 17:10 09:00 IL SA Medulloepitheloma in childhood Laurence Desjardins (Paris/F) 09:10 IL SA Conjunctival and lid tumors Christine Levy (Paris/F) 09:20 IL SA Cytogenetic and molecular findings in developmental eye diseases. A complex puzzle Eduardo Silva (Coimbra/P) 09:30 Oslo 10:30-12:00 SA-10 Cerebral Visual Impairment Low Vision Gordon Dutton (Glasgow/UK) Elisa Fazzi (Brescia/I) Birgit Lorenz (Giessen/D) 10:30 IL SA Cerebral Visual Impairment a Common Cause of Visual Impairment in Childhood Gordon Dutton (Glasgow/UK)

75 WOC Saturday, 5 June :45 IL SA Visual routes to knowledge and action Mel Goodale (Ontario/CDN) 11:00 IL SA Spectrum of visual disorders with cerebral visual impairment Elisa Fazzi (Pavia/I) 11:15 IL SA Cerebral Visual Impairment (CVI) Schools need clear information on clinical findings for assessment of visual processing problems Lea Hyvärinen (Helsinki/FIN) 11:30 IL SA Visual field defects and compensating mechanisms associated with pre-and perinatal brain damage Lena Jacobson (Stockholm/S) Oslo 16:00-17:30 SA-12 Graefe Society Symposion Pressure-independent Factors in Glaucoma Glaucoma Robert Ritch (New York/USA) Jost B. Jonas (Mannheim/D) Josef Flammer (Basel/CH) 16:00 IL SA Genetics and epidemiology of normal-tension glaucoma Paul Mitchell (Sydney/AUS) Scientific Program Schedule Saturday, 5 June 11:45 Oslo 14:00-15:30 SA-11 Trabeculectomy: Problems and Solutions Glaucoma 16:10 IL SA Significance of optic disc hemorrhages Gustavo de Moraes (New York/USA) 16:20 IL SA Peripapillary atrophy and its importance Jost B. Jonas (Mannheim/D) 16:30 IL SA Vacular risk factors in normal-tension glaucoma Josef Flammer (Basel/CH) Günther K. Krieglstein (Cologne/D) Stefano Gandolfi (Parma/I) Francisco Fantes (Miami/USA) 16:40 IL SA Circadian fluctuation of IOP in normal-tension glaucoma Yaniv Barkana (Zerifin/IL) 14:00 IL SA Patients' selection: which patients, which risks Stefano Gandolfi (Parma/I) 14:10 IL SA Intra-operative complications Francisco Fantes (Miami/USA) 14:20 IL SA Short-term post-operative complications Carlo E. Traverso (Genova/I) 14:30 IL SA Long-term post-operative complications Roberto Carassa (Milano/I) 16:50 IL SA The role of neuroimaging in normal-tension glaucoma Y. L. Dexter Leung (Hong Kong/CN) 17:00 IL SA Summary: basic workup of NTG. What to do when and why Theodore Krupin (Chicago/USA) 17:10 14:40 IL SA Why and how do blebs fail in the long-term? Franz Grehn (Würzburg/D) 14:50 IL SA Trabeculectomy: still a worthwhile surgery Günther K. Krieglstein (Cologne/D) 15:00

76 72 WOC 2010 Saturday, 5 June Scientific Program Schedule Saturday, 5 June 2010 Room Madrid 08:30-10:00 SA-13 Basic Research, Update on Treatment and Optical Correction of Keratoconus Contact Lens and Refraction Markus Kohlhaas (Dortmund/D) Ayfer Kanpolat (Ankara/TR) Thomas F. Neuhann (Munich/D) 08:30 IL SA Surgical treatment of keratoconus Markus Kohlhaas (Dortmund/D) 10:50 IL SA Complications regarding Contact Lens hygiene, handling and equipment Elena Rybakova (Mokau/RUS) 11:00 IL SA Contact lens related inflammation recent insights Christina Grupcheva (Varna/BG) 11:10 IL SA Global change of pathogens infectiousness: how does it affect contact lens wearing? Alexander A. Bialasiewicz (Doha/QAT) 11:20 IL SA Contact lens induced infectious keratitis Review of recent data René Mély (Saarlouis/D) 08:45 IL SA Causes end etiology of keratoconus TBA 09:00 IL SA Biomechanics and keratoconus problems and solutions of contact lens Eberhard Spörl (Dresden/D) 11:30 IL SA Microsporidia Keratitis in Contact Lens Wearers in Singapore an Emerging Trend Cordelia M. L. Chan (Singapore/SGP) 11:40 09:15 IL SA Fitting for keratoconus Gudrun Bischoff (Hamburg/D) Room Madrid 14:00-15:30 SA-42 09:30 IL SA Keratoconus which examination is the best Jens Bühren (Frankfurt/D) 09:45 Room Madrid Congenital and Acquired Lid Mal Positions Oculoplasty, Lacrimal System, Orbit John Richard O. Collin (London/UK) Christoph Hintschich (Munich/D) Artur Klett (Tallinn/EST) 10:30-12:00 SA-14 Clinical Management of Contact Lens Complications Contact Lens and Refraction 14:00 IL SA Entropion Artur Klett (Tallinn/EST) 14:15 IL SA Ectropion Angelo Tsirbas (Los Angeles/USA) Gudrun Bischoff (Hamburg/D) James E. Key (Houston/USA) Alexander A. Bialasiewicz (Doha/QAT) 10:30 IL SA The Peter Halberg Lecture: efficacy of disinfecting solutions against acanthamoeba James E. Key (Houston/USA) 10:40 IL SA Why do complications happen? Newton Kara-José (Sao Paulo/BR) 14:30 IL SA Ptosis Francesco Quaranta-Leoni (Rome/I) 14:45 IL SA Retraction Christoph Hintschich (Munich/D) 15:00 IL SA Coloboma John Richard O. Collin (London/UK) 15:15

77 WOC Saturday, 5 June 2010 Room Madrid 16:00-17:30 SA-43 Retinal Diseases and Degenerations Retina Tatsuro Ishibashi (Fukuoka/J) Hans E. Grossniklaus (Atlanta/USA) Stefan Dithmar (Heidelberg/D) 16:00 IL SA Macular holes Toshio Hisatomi (Fukuoka/J) 08:40 IL SA Amniotic Membrane Transplantation to Augment the Success of Conjunctival Autograft for Pterygium Viktor L. Perez (Miami/USA) 08:50 IL SA Biochemical Purification and Characterization of HC-HA Complex as the Active Component from Amniotic Membrane Scheffer C. G. Tseng (Miami/USA) 09:00 IL SA Clinical Efficacy of Amniotic Membrane Transplantation for Acute Stevens Johnson Syndrome/Toxic Epidermal Necrolysis Darren G. Gregory (Denver/USA) Scientific Program Schedule Saturday, 5 June 16:15 IL SA Age-related macular degeneration Hans E. Grossniklaus (Atlanta/USA) 16:30 IL SA Retinal Imaging Today: FA, ICG and OCT Stefan Dithmar (Heidelberg/D) 16:45 IL SA Fundus autofluorescence Frank G. Holz (Bonn/D) 17:00 IL SA Diabetic retinopathy Gabriele E. Lang (Ulm/D) 17:15 IL SA Lebers optic neuropathy Cornelia M. Mooy (Dordecht/NL) 09:10 IL SA Impact of Different Preservation Methods on Clinical Important Features of Amniotic Membrane Henning Thomasen (Essen/D) 09:20 IL SA Amniotic Membrane Transplantation in Acute Burns Henrike Westekemper (Essen) 09:30 IL SA Anti-angiogenic Factors in Amniotic Membrane Mikk Pauklin (Essen/D) 09:40 Room Sydney 17:30 10:30-12:00 SA-18 Corneal Dystrophies Room Sydney 08:30-10:00 SA-17 Amniotic Membrane Transplantation External Eye Disease, Cornea Scheffer C. G. Tseng (Miami/USA) Daniel Meller (Essen/D) 08:30 IL SA Sutureless Amniotic Membrane Transplantation via ProKera for High-risk Penetrating Keratoplasty Samuel C. Yiu (Los Angeles/USA) External Eye Disease, Cornea Walter Lisch (Hanau/D) Francis Munier (Lausanne/CH) 10:30 IL SA IC3D classification of corneal dystrophies(cd) a new guide for the ophthalmologist Francis Munier (Lausanne/CH) 10:40 IL SA The molecular pathomechanism of CD where we are staying? Daniel Schorderet (Sion/CH) 10:50 IL SA Gene therapy for diseases of the cornea Keryn A. Williams (Bredford Park/AUS)

78 74 WOC 2010 Saturday, 5 June Scientific Program Schedule Saturday, 5 June :00 IL SA Indications and results of electrolysis in TGFBI related CD Akira Kobayashi (Kanazawa/J) 11:10 IL SA Surgical and laser-mediated therapies in CD Berthold Seitz (Homburg/D) 11:20 IL SA Light-, electronmicroscopical and immunohistochemical findings of Franceschetti corneal dystrophy Claudia Auw-Hädrich (Freiburg/D) 11:30 Room Sydney 16:00-17:30 SA-20 Meibomian Gland Anatomy, Physiology and Disease External Eye Disease, Cornea Erich Knop (Berlin/D) Nadja Knop (Hannover/D) Anthony Bron (Oxford/UK) 16:00 IL SA Anatomy and Embryology of the Meibomian gland Erich Knop (Berlin/D) Room Sydney 14:00-15:30 SA-19 Laser-assisted Keratoplasty ( of the Section Cornea of the German Ophthalmological Society) External Eye Disease, Cornea Thomas Reinhard (Freiburg/D) Berthold Seitz (Homburg(Saar)/D) Abdulaziz AlRajhi (Riyadh/SA) 14:00 IL SA Basics of Laser Keratoplasty Achim Langenbucher (Erlangen/D) 16:10 IL SA Meibomian gland physiology: factors influencing ocular surface integrity Anthony Bron (Oxford/UK) 16:20 IL SA Keratinization of the Meibomian gland as a major cause for obstructive MGD Nadja Knop (Hannover/D) 16:30 IL SA Regulation of the Meibomian gland in health and disease David Sullivan (La Jolla/USA) 16:40 IL SA New insight into Meibomian gland function from gene expression experiments Frank Schirra (Homburg/D) 14:10 IL SA Femtosecond Laser Keratoplasty The Freiburg Experience Thomas Reinhard (Freiburg/D) 14:20 IL SA Femtosecond Laser Keratoplasty The Munich Experience Thomas F. Neuhann (Munich/D) 16:50 IL SA New treatments for Meibomian gland diseases Stefano Barabino (Genova/I) 17:00 Room Hong Kong 14:30 IL SA Femtosecond Laser Keratoplasty The Bochum Experience H. Burkhard Dick, Astrid Willert (Bochum/D) 14:40 IL SA Advantages of Excimer Laser Keratoplasty Berthold Seitz (Homburg/D) 14:50 08:30-10:00 SA-21 Evidence-based Management of Glaucoma Evidence Based Ophthalmology Richard Wormald (London/UK) Günther K. Krieglstein (Cologne/D) Robert Ritch (New York/USA)

79 WOC Saturday, 5 June :30 IL SA Is there current evidence for effective neuroprotection in glaucoma? Robert N. Weinreb (La Jolla/USA) 08:40 IL SA The role of the ocular and systemic circulation in glaucoma progression Josef Flammer (Basel/CH) 08:50 IL SA Tubes versus trabeculectomy Stephen Gedde (Miami/USA) 09:00 IL SA The treatment of acute and chronic angle-closure Clement C. Y. Tham (Hong Kong/CN) 09:10 IL SA Antimetabolites for glaucoma surgery revisited Jonathan C. K. Clarke (London/UK) 09:20 IL SA Feasibility of a randomised trial of glaucoma screening Jennifer Burr (Aberdeen/UK) Room Hong Kong 14:00-15:30 SA-23 Epidemiological Research in Eye Disease Ophthalmic Epidemiology Norbert Pfeiffer (Mainz/D) David Friedman (Baltimore/USA) Jialiang Zhao (Beijing/CN) 14:00 IL SA Epidemiology: Basic Principles to Solve Problems in Ophthalmology Alfred Sommer (Baltimore/USA) 14:15 IL SA Epidemiological research in glaucoma David Friedman (Baltimore/USA) 14:30 IL SA Problems in the design of epidemiological studies Richard Wormald (London/UK) Scientific Program Schedule Saturday, 5 June 09:30 IL SA Evidence of selective laser trabeculoplasty Detlev Spiegel (Augsburg/D) 09:40 14:45 IL SA The survey of blindness and visual impairment in China Jialiang Zhao (Beijing/CN) 15:00 Room Hong Kong 10:30-12:00 SA-22 Panel: Challenges and Perspectives of Intravitreal Drugs Differences in Biological and Functional Effects Room Hong Kong 16:00-17:30 SA-24 New Challenges to Vision 2020: Glaucoma and Diabetic Retinopathy Panel Pharmacology, Ocular Drug Delivery Vision 2020 Prevention of Blindness Panel list: Baruch D. Kuppermann (Irvine/USA) Richard F. Spaide (New York/USA) Focke Ziemssen (Tübingen/D) Peter K. Kaiser (Cleveland) Combination therapy: what and when to combine? Fixed regimen vs. adjusted dosing as needed? Disease parameter: what to consider being relevant? Risk profile and cardiovascular health: reasonable care or unjustified hysteria? Norbert Pfeiffer (Mainz/D) David Friedman (Baltimore/USA) Nam Perulasamy (Madurai/IND) 16:00 IL SA How does glaucoma fit into Vision 2020 and how should it fit in? TBA 16:15 IL SA Is Vision 2020 Ready for Glaucoma? James E. Standefer (White Bear Lake/USA)

80 76 WOC 2010 Saturday, June 5 Scientific Program Schedule Saturday, 5 June :30 IL SA The Aravind telemedicine system for detecting and treating DR Nam Perulasamy (Madurai/IND) 16:45 IL SA Innovations in technology to improve screening efficiency for DR Michael Abramoff (Iowa/USA) 17:00 IL SA Launching two new DR screening projects in Indonesia and Bangladesh: challenges and successes David Friedman (Baltimore/USA) 17:15 VIP Lounge 1 14:37 SL SA New concepts of multifocal IOLs design Khristo Takhchidi (Moscow/RUS) 14:46 FP SA Diffractive add-on IOL as a secondary implant in pseudophakic eyes: first results Georg Gerten, Omid Kermani, Karl Schmiedt, Elham Farvili, Uwe Oberheide (Köln/D) 14:53 FP SA The implantation of bifocal prismatic IOL in patients with age-related macular degeneration Almazbek Botbaev, A. Eshmambetov (Bishkek/KIS) 15:00 FP SA Visual Quality and Ocular Aberrations with Aspheric Single Piece and Spherical Multi-Piece IOL; Contralateral comparative study Ahmed Assaf (Cairo/ET) 14:00-15:30 SA-27 Cataract/Biometry 1 Free Paper Cataract Georg Bretthauer (Karlsruhe/D) George Beiko (St. Catharines/CDN) Huck Holz (Santa Clara/USA) 14:00 SL SA Restoring human accommodation the role of mechatronics and microtechnology Georg Bretthauer (Karlsruhe/D) 15:07 FP SA Femtosecond Laser-Assisted Cataract Surgery (FLACS): A new paradigm for refractive cataract surgery? Jonathan H. Talamo (Waltham/USA) 15:14 FP SA Optical analysis, reading performance and quality of life evaluation after implantation of the Acri.Lisa 366D multifocal intraocular lens Ana Belen Plaza, David Pablo Piñero Llorens, Ramon Jimenez, Francisco Amparo, Jose Luis Rodriguez Prats (Alicante/E) 15:21 14:09 FP SA Protein Profiling of Human Aqueous Humour by Mass Spectrometry A Comparative and Quantitative Study Marion Funk, Keiryn Bennett, Melanie Planyavsky, Ceereena Ubaida Mohien, Andreas Pollreisz, Stefan Sacu, Michael Georgopoulos, André Müller, Zlatko Trajanoski, Jacques Colinge, Giulio Superti-Furga, Ursula Schmidt-Erfurth (Vienna/A) VIP Lounge 1 16:00-17:30 SA-28 Glaucoma: Basics 1 Free Paper Glaucoma 14:16 FP SA Synchrony dual optic accommodating IOL: 4 year results Ricardo Alarcon, Victor Bohorquez (Bogota/CO) Detlev Spiegel (Augsburg/D) Günther K. Krieglstein (Cologne/D) Herbert Reitsamer (Salzburg/A) 14:23 FP SA Comparison of vision with accommodating IOLs versus minimonovison with a standard IOL George Beiko (St. Catharines/CDN) 16:00 SL SA Different aspects on the significance of ocular blood flow for glaucoma Herbert Reitsamer (Salzburg/A) 14:30 FP SA Binovision A New Approach to Presbiopia Correction with the Calhoun LAL Sylvia Paulig (Cottbus/D) 16:09 FP SA Assessment of Intraocular Pressure in response to isokinetic exercise Camila Netto, Marcelo Conte, Marinho Scarpi (Rio de Janeiro/BR, São Paulo/BR)

81 WOC Saturday, 5 June :16 FP SA Corneal Hysteresis and Corneal Resistance Factor are not associated with occurrence of Disc Haemorrhage in Patients with Normal Tension Glaucoma Nafees B. Baig, Dexter Yu-lung Leung, Douglas Lam (Hong Kong/HK) 16:23 FP SA Immunoproteomics of tears as a diagnostic tool in glaucoma Franz Grus, Nils Boehm, Sabine Beck, Markus Schlich, Ulrike Lossbrandt, Ulrike Lossbrandt, Norbert Pfeiffer (Mainz/D) 16:30 FP SA Oxidative Stress Markers in Patients with Primary Open-angle Glaucoma Asaad Ghanem, Lamiaa Arafa, Ayman El-Baz (Mansoura/ET) VIP Lounge 2 08:30-10:00 SA-29 Clinical Aspects: Screening, Diagnosing, Treatment and Medical Workflow, Medical Education Teleophthalmology and Computers Georg Michelson (Erlangen/D) Michael Chiang (New York/USA) John Olson (Aberdeen/UK) Frank H. W. Tost (Greifswald/D) 08:30 IL SA Worldwide Access to online Education-Atlas of Ophthalmology Ludwig Maximilian Heindl (Erlangen/D) Scientific Program Schedule Saturday, 5 June 16:37 FP SA Immunization with optic nerve antigens causes loss of retinal ganglion cells and elevated antibody reactivity against ocular tissues Panagiotis Laspas, Stephanie C. Joachim, Oliver W. Gramlich, Philip F. Gottschling, Clemens Cuny, Norbert Pfeiffer, Franz H. Grus (Halandri/GR, Mainz/D) 16:44 FP SA Serum endothelin-1 levels in patients with glaucoma Daria Nefedova, Yury Astakhov, Irina Birulya, Margarita Kadinskaya (St. Petersburg/RUS) 08:45 IL SA How computers educate glaucoma patients Catherina Goltz, Stefan Clemens, Frank H. W. Tost (Greifswald/D) 09:00 IL SA Telemedical glaucoma home monitoring: blessing or curse? Clemens Jürgens (Greifswald/D) 09:15 IL SA Automated evaluation of the optic nerve head in respect to glaucoma in colour images Rüdiger Bock (Erlangen/D) 16:51 FP SA Genomic (epigenetic) DNA methylation in patients with open-angle glaucoma Anselm G. M. Jünemann, Bernd Lenz, Ursula Schlötzer-Schrehardt, Robert Rejdak, Johannes Kornhuber, Friedrich Kruse, Stefan Bleich (Erlangen/D, Lublin/PL) 09:30 IL SA A regional Tele-ophthalmological Network evaluating retinal vessels and the optic nerve head Georg Michelson (Erlangen/D) 09:45 16:58 FP SA CYP1B1 mutations In South Korean Patients With Primary Congenital Glaucoma: Genotype Phenotype Correlations Wool Suh, Sung Chul Park, Michael S. Kook, Yong Yeon Kim, Chan Yun Kim, Chang Sik Kim, Ki Ho Park, Chan Kee Park, Hee Jung Kim, Chang Seok Ki, Changwon Kee (Seoul/ROK) 17:05 FP SA Global Gene Expression and Protein Profiling of Young and Elderly Retinas Exposed to Elevated Intraocular Pressures Molly Walsh (Durham/USA) 17:12

82 78 WOC 2010 Saturday, 5 June Scientific Program Schedule Saturday, 5 June 2010 VIP Lounge 2 10:30-12:00 SA-30 SEAGIG : Angle-Closure Glaucoma Glaucoma Ivan Goldberg (Sydney/AUS) Prin Rojanapongpun (Bangkok/T) Seng Kheong Fang (Sydney/AUS) 10:30 IL SA Definitions, classifications, epidemiology Ramanjit Sihota (New Delhi/IND) VIP Lounge 2 14:00-15:30 SA-31 Glaucoma: Diagnostics Free Paper Glaucoma Tin Aung (Singapore/SGP) Dorin Chiselita (Iasi/RO) Nomdo M. Jansonius (Groningen/NL) 14:00 SL SA Glaucoma progression Dorin Chiselita (Iasi/RO) 10:38 IL SA Angle assessment Paul Chew (Singapore/SGP) 10:46 IL SA Mechanisms of angle closure Prin Rojanapongpun (Bangkok/T) 10:54 IL SA Initial Management of PACG Ki Ho Park (Seoul/ROK) 11:09 IL SA Surgical management of PACG Clement C. Y. Tham (Hong Kong/CN) 11:24 IL SA Management of acute PAC Paul Healey (Sydney/AUS) 14:09 SL SA On the accuracy of measuring rates of visual field change in glaucoma Nomdo Jansonius (Groningen/NL) 14:18 FP SA RNFL thickness analysis with fourier domain OCT compared to time domain OCT Anna Nowinska, Edward Wylegala, Janiszewska Dominika, Dariusz Dobrowolski (Katowice/PL) 14:25 FP SA Comparison of slitlamp adapted 1310nm OCT and high-frequency ultrasound in the evaluation of Schlemm s Canal and suture traction after Canaloplasty Joshua Torrent Despouy, Anne Bruggemann, Swaantje Peters, Salvatore Grisanti, Maya Müller (Lübeck/D) 11:32 IL SA Secondary ACG Seng Kheong Fang (Sydney/AUS) 11:40 IL SA Newly designed provocative test for detecting angle closure Ning-li Wang (Beijing/CN) 11:48 14:32 FP SA A new darkroom provocative test using anterior segment optical coherence tomography (AS-OCT) Li Dejiao (Beijing/CN) 14:39 FP SA Retrobulber imaging in glaucoma with diffusion tensor MRI / optic tractography and fmri: structural and functional analysis Kaya N Engin, Bülent Yemis ci, Nurten Turan, Sibel Bayramoğ lu, Onur Özyurt, Esin Karahan, Cengizhan Öztürk (Istanbul/TR) 14:46 FP SA Progression of glaucomatous visual field loss in primary angle closure glaucoma with intraocular pressure which has decreased to normal range Noriko Toyokawa, Shinichiro Kuroda, Hideya Kimura, Atsuko Fukumoto, Makoto Nagata (Nara/J) 14:53 FP SA Frequency of the origin of open-angle glaucoma in patients with hypothyroidism Pavel Bezdetko, Alla Saveleva, Julia Babak (Kharkov/UA)

83 WOC Saturday, 5 June :00 FP SA Angle closure in Caucasians a pilot, clinic-based study Yaniv Barkana, Inbal Dekel (Shoham/IL) 15:07 SL SA The diurnal variation of intraocular pressure the most important symptom for early detection and follow-up of the glaucomas Jörg Albert Draeger (Hamburg/D) 15:16 VIP Lounge 2 16:00-17:30 SA-32 Retina: AMD 1 Free Paper Retina Susanne Binder (Vienna/A) Carsten Framme (Bern/CH) Isaac Lipshitz (Tel Aviv/IL) 16:00 SL SA Posterior hyaloid behavior in age-related macular degeneration Susanne Binder (Winn/A) 16:09 FP SA Interobserver variability for re-treatment indications after Ranibizumab upload in neovascular age-related macular degeneration Carsten Framme, Georgios Panagakis, Andreas Walter, Aandrea Gamulescu, Wolfgang Herrmann, Horst Helbig (Bern/CH, Regensburg/D) 16:16 FP SA Intravitreal injection of Bevacizumab for treatment of CNV associated with AMD in Chinese Lei Gao, Wenjie Liu, Changxia Dong, Huajun Yu (Yantai/CN) 16:37 FP SA Prevalence and Significance of Subretinal Drusenoid Deposits (Reticular Pseudodrusen) in Age-Related Macular Degeneration Sandrine Anne Zweifel, Yutaka Imamura, Theodore C Spaide, Takamitsu Fujiwara, Richard F Spaide (New York/USA) 16:44 FP SA Anti Oxidant Therapy in Dry Age Related Macular Degeneration: A Hope for Vision Swati Tomar (Jaipur/IND) 16:51 FP SA LMI Intra Ocular Mirror Telescopic Projector for AMD Isaac Lipshitz, Amar Agarwal (Hertzlia/IL) 16:58 FP SA Retinal Sensitivity in age related macular degeneration using Scanning Laser Ophthalmoscope imaging stabilized Microperimetry Kathrin Hartmann, Jae Suk Kim, Helaina Klein, Sylvia Hsueh, Laura Gomez, Paym Amini, Lingyun Cheng, Dirk-Uwe Bartsch, William R. Freeman (San Diego/USA) 17:05 FP SA Vitreomacular interface and posterior vitreomacular adhesion in exsudative age-related macular degeneration (AMD): A Spectralis-OCT-Study Mathias Maier, Sarah Pfrommer, Sophie Burzer, Nikolaus Feucht, Christoph Winkler von Mohrenfels, Chris Lohmann (Munich/D) 17:12 Hall 2 08:30-10:00 SA-33 Update on Management of AMD Retina Scientific Program Schedule Saturday, 5 June 16:23 FP SA Three Major Loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy Luiz H Lima, Carl Schubert, Daniela Ferrara, Joanna Merriam, Yutaka Imamura, K. Bailey Freund, Richard F. Spaide, Lawrence Yannuzzi, Rando Allikmets (New York/USA) 16:30 FP SA Small Hard Macular Drusen and Peripheral Drusen: Associations with AMD Genotypes in the Inter99 Eye Study Inger Christine Munch (Glostrup/DK) Alexander J. Brucker (Philadelphia/USA) Gisèle Soubrane (Créteil/F) Frank G. Holz (Bonn/D) 08:30 IL SA Recent clinical trial results on management of neovascular AMD Gisèle Soubrane (Créteil/F) 08:40 IL SA Role of diagnostic tools for assessing patients response Daniel Pauleikhoff (Münster/D)

84 80 WOC 2010 Saturday, 5 June Scientific Program Schedule Saturday, 5 June :50 IL SA Combined treatment approaches to wet AMD? Anat Loewenstein (Tel Aviv/IL) 09:00 IL SA Predictors of disease: current treatment guidelines Paolo Lanzetta (Udine/I) 09:10 IL SA Management of pigment epithelial detachments and PCV in the era of anti-vegf-therapy Richard F. Spaide (New York/USA) 09:20 IL SA Imaging progression and treatment approaches for geographic atrophy Frank G. Holz (Bonn/D) 09:30 Hall 2 11:30 IL SA Carotid endarterectomy for treatmend of ischemic diabetic retinopathy Xiaoxin Li (Beijing/CN) 11:40 Hall 6 08:30-10:00 SA-37 Africa: Can We Succeed in the Greatest Challenge to Blindness Prevention? Vision 2020 Prevention of Blindness K. H. Martin Kollmann (Nairobi/EAK) Dunera Rahel Ilako (Nairobi/EAK) Henry Nkumbe (Antananarivo/RM) 10:30-12:00 SA-34 Update in Diabetic Retinopathy Retina Xiaoxin Li (Beijing/CN) Francesco Bandello (Milano/I) Ursula Schmidt-Erfurth (Vienna/A) 10:30 IL SA Information technology in diabetic eye screening Einar Stefánsson (Reykjavik/IS) 10:40 IL SA Inflammatory processes in diabetic retinopathy Timothy Kern (Cleveland/USA) 10:50 IL SA Intravitreal steroids in diabetic macular disease Albert J. Augustin (Karlsruhe/D) 11:00 IL SA Antiangiogenic strategies in diabetic macular and retinal disease Ursula Schmidt-Erfurth (Vienna/A) 11:10 IL SA The presence and future of laser therapy in diabetes Francesco Bandello (Milano/I) 08:30 IL SA Introduction a) Why is Africa the "greatest challenge"? b) What is success in this context? c) How do we succeed in blindness prevention? K. H. Martin Kollmann, Henry Nkumbe (Nairobi/EAK, Antananarivo/RM) 08:40 IL SA Co-Ordinated Planning (Global, Regional and National) K. H. Martin Kollmann, Kovin Naidoo, Hannah Faal, Daniel Etya'ale (Nairobi/EAK, Durban/ZA, Accra/GH, Geneva/CH) 08:50 IL SA Advocacy & Resource Mobilisation Dunera Rahel Ilako, Doulaye Sacko, Adekunle Olubola Hassan, Amir Bedri, Gullapali N. Rao (Nairobi/EAK, Lagos/WAN, Addis Abeba/ETH, Hyderabad/IND) 09:00 IL SA Control of Avoidable Blindness: The Evidence Henry Nkumbe, Wanjiku Mathenge, Susan Lewallen, Asiwome Seneadza (Antananarivo/RM, Moshi/EAT) 09:10 IL SA Human Resource Development (Incld. Management) K. H. Martin Kollmann, Kayode, Volker Klauss, Adekunle Olubola Hassan (Nairobi/EAK, Munich/D, Lagos/WAN) 11:20 IL SA Modern surgery in diabetic disease David S. H. Wong (Hong Kong/HK)

85 WOC Saturday, 5 June :20 IL SA Infrastructure and Appropriate Technology Dunera Rahel Ilako, Kolawole Ogundimu, Ingrid Mason, Adekunle Olubola Hassan, Wanjiku Mathenge (Nairobi/EAK, Accra/GH, Lagos/WAN) 09:30 IL SA Community Participation Henry Nkumbe, Ngoy Janvier Kilangalanga, Paul Courtright, Asiwome Seneadza (Antananarivo/RM, Kinshasa/ZRE, Moshi/EAT) 09:40 IL SA Conclusions / Wrap-Up K. H. Martin Kollmann (Nairobi/EAK) Hall 6 10:30-12:00 SA-38 Panel: Neuro-Ophthalmological Problems (Handling of NNO, AION, and Benign Tumors; Neuro-Ophthalmology in Children) Hall 6 14:00-15:30 SA-15 Panel: Contact Lenses and Children Indications, Fitting Rules and Benefits Panel Contact Lens and Refraction Albert Franceschetti (Meyrin (Geneva)/CH) Chong Yew Khoo (Singapore/SGP) Dorothea Kuhn (Riedlingen/D) 14:00 IL SA The Jonathan Kersley Lecture: Children have a right to contact lenses Albert Franceschetti (Meyrin/CH) 14:20 IL SA Success with RGP-lensfitting in children. First result of the BVA Juneor Project Dorothea Kuhn (Riedlingen/D) Scientific Program Schedule Saturday, 5 June Panel Neuro-Ophthalmology Klara Landau (Zurich/CH) Eberhart Zrenner (Tübingen/D) Andrew G. Lee (Houston/USA) Christian Luco (Santiago/RCH) Panel List: Klara Landau (Zurich/CH) Eberhart Zrenner (Tübingen/D) Christian Luco (Santiago/RCH) Andrew G. Lee (Houston/USA) Emely Karam (Caracas/Y) Michael Gräf (Giessen/D) Gordon Plant (London/UK) Helmut Wilhelm (Tübingen/D) Caroline Tilikete (Lyon/F) Michael Bach (Freiburg/D) Thomas R. Hedges (Boston/USA) Pinar Aydin (Kavaklidere/Ankara/TR) Carlos Mendoza (Ciudad de la Habana/C) 14:30 IL SA Contact lense in Pediatrics (CLIP) Study in Singapore Li Lim (Singapore/SGP) 14:40 IL SA RGPs for Children with High Myopia and High Astigmatism Jenny Deva (Selangor/MAL) 14:50 IL SA Effect of ON-K RGP lenses on the Cornea Curvatures ans Axial Length of Myopic Children a cross-over study Chong Yew Khoo (Singapore/SGP)

86 82 WOC 2010 Saturday, 5 June Scientific Program Schedule Saturday, 5 June 2010 Hall 6 16:00-17:30 SA-16 Corneal Imaging: New Versus Useful Contact Lens and Refraction Shigeru Kinoshita (Kyoto/J) Zoraida Fiol-Silva (Philadelphia/USA) Rudolf F. Guthoff (Rostock/D) 16:00 IL SA IMCLC Special Lecture: Medical Use of Contact Lens: An Effective Tool for Ocular Surface Surgery Shigeru Kinoshita (Kyoto/J) 08:50 IL SA Blau Syndrome James T. Rosenbaum (Portland/USA) 09:00 IL SA KIR genes and uveitis Ralph D. Levinson (Los Angeles/USA) 09:10 IL SA TINU-Syndrome Friederike Mackensen (Heidelberg/D) 09:20 IL SA Genetic of Behcet s Disease Ahmet Gul (Istanbul/TR) 09:30 16:10 IL SA Diagnostic and Imaging of the Ocular Surface in Contact Lens Jacek P. Szaflik (Warsaw/PL) Hall 7 10:30-12:00 SA-41 16:20 IL SA HRT 2 Confocal Image In Corneal Epithelium Christina Jacobi (Erlangen/D) 16:30 IL SA Is It Keratoconus or CL Warpage? Stephen D. Klyce (New Orleans/USA) 16:40 IL SA Tear Film Disrupted or Protected By Contact Lenses; How To Cope Marek Habela (Piaseczno/PL) Hall 7 08:30-10:00 SA-40 Genetics and Uveitis Uveitis, Intraocular Inflammation PAAO : Retinal and Choroidal Manifestations of Selected Systemic Diseases 2010 Retina J. Fernando Arevalo (Caracas/Y) Charles P. Wilkinson (San Fransisco/USA) José Roca (Lima/PE) 10:30 IL SA Introduction J. Fernando Arevalo (Caracas/Y) 10:40 IL SA AIDS Update Rubens Belfort, Jr. (São Paulo/BR) 10:50 IL SA Phacomatosis Carol L. Shields (Philadelphia/USA) James T. Rosenbaum (Portland/USA) Friederike Mackensen (Heidelberg/D) Ahmet Gul (Istanbul/TR) 08:30 IL SA Overview on genome wide scanning Jürgen Braun (Herne/D) 08:40 IL SA HLA-B27 associated Uveitis Tammy Martin (Portland/USA) 11:00 IL SA Retinal and Choroidal Manifestations of SLE Careen Y. Lowder (Cleveland/USA) 11:10 IL SA Diffuse Unilateral Subacute Neuroretinitis (DUSN) J. Fernando Arevalo (Caracas/Y) 11:20 IL SA Intraocular Lymphoma Lihteh Wu (West Chester/USA) 11:30 IL SA Choroidal and Retinal Metastasis Jerry Shields (Philadelphia/USA)

87 WOC Saturday, 5 June :40 IL SA Retinal-Choroidal Toxicity of Systemic Drugs William F. Mieler (Chicago/USA) 11:50 IL SA Final considerations Charles P. Wilkinson (San Fransisco/USA) Roof Garden 08:30-10:00 SA-05 Advances in Cataract and IOL Technology Cataract Rupert Menapace (Vienna/A) William J. Fishkind (Tucson/USA) Pablo Artal (Murcia/E) 08:30 IL SA Aspheres Pablo Artal (Murcia/E) 08:40 IL SA Light Adjustable Lens José L. Güell (Barcelona/E) 08:50 IL SA Telescope Lenses Isaac Lipshitz (Tel Aviv/IL) Roof Garden 10:30-12:00 SA-06 Endophthalmitis Cataract Terrence O'Brien (Palm Beach/USA) Peter Barry (Dublin/IRL) Karl Ulrich Bartz-Schmidt (Tübingen/D) 10:30 IL SA Why we do not use intracameral cefuroxime at the end of cataract surgery? Terrence O'Brien (Palm Beach/USA) 10:50 IL SA The clinical implications of the ESCRS Endophthalmitis study Peter Barry (Dublin/IRL) 11:10 IL SA Why we do use intracameral cefuroxime at the end of cataract surgery? Jean-François Korobelnik (Bordeaux/F) 11:30 Roof Garden Scientific Program Schedule Saturday, 5 June 09:00 IL SA MICS: gimmick or progress Rupert Menapace (Vienna/A) 09:10 IL SA non-us phaco Peter Rieck (Berlin/D) 14:00-15:30 SA-07 Phaco Nightmares and Worst Case Scenarios: A Video-based Cataract 09:20 IL SA US-phaco: Technical state of the art William J. Fishkind (Tucson/USA) 09:30 Various complications can occur in phaco surgery but the worst case scenarios are dropped lenses and nuclei. In this course presentation of various cases will be shown of crazy cases and their management. The usage of diamond tipped forceps in the removal of dropped IOL s will also be shown. Difficult cases like subluxated lenses, posterior polar cataracts, colobomas and complications will also be shown on videos. Management of IFIS, Implantation of the glued IOL will also be taught with endoacapsular rings and capsule retractors. Chairmen: Amar Agarwal, Thomas Kohnen Faculty: Thomas Kohnen Amar Agarwal Athiya Agarwal

88 84 WOC 2010 Saturday, 5 June Scientific Program Schedule Saturday, 5 June 2010 Roof Garden 16:00-17:30 SA-08 Unmet Needs in Diagnosis of Uveitis Uveitis, Intraocular Inflammation Denis Wakefield (Sydney/AUS) Carlos Pavesio (London/UK) Stephan Thurau (Munich/D) 16:00 IL SA HLA B27 AU what we know and what we don t know Denis Wakefield (Sydney/AUS) 16:10 IL SA Treatment of CME in uveitis other options than steroids and acetazolamide Carlos Pavesio (London/UK) Radio Tower Lounge 1 16:00-17:30 SA-44 APSOPRS : Oculoplastic and Orbital Surgery Oculoplasty, Lacrimal System, Orbit XianQun Fan (Shanghai/CN) Yip Chee Chew (Singapore/SGP) Ashok Kumar Grover (New Delhi/IND) 16:00 IL SA The new concepts of diagnosis and treatment on orbital diseases Sun Fengyuan (Tianjin/CN) 16:10 IL SA Eyelid anatomy: An update Hirohiko Kakizaki (Aichi-ken/J) 16:20 IL SA Topical antiinflammatory medication beyond steroids how to avoid medication-induced glaucoma and cataract Manfred Zierhut (Tübingen/D) 16:40 IL SA New perspectives for treatment of human uveitis from animal models Gerhild Wildner (Munich/D) 16:50 IL SA How to optimize the diagnostic use of intraocular specimens Bahram Bodaghi (Paris/F) 17:00 IL SA The problem of retinal vasculitis Elisabetta Miserocchi (Milano/I) 17:10 16:20 IL SA Thyroid Myopathy, morbidity and treatment Seah Lay Leng (Singapore/SGP) 16:30 IL SA Rejuvenation of the peri-orbital region Yip Chee Chew (Singapore/SGP) 16:40 IL SA Management of jaw winking ptosis no longer a problem! Ashok Kumar Grover (New Delhi/IND) 16:50 IL SA Microendoscopy of the lacrimal pathways Reynaldo M. Javate (Manila/RP) 17:00 IL SA Lower lid horizontal laxity correction Chai Teck Choo (Singapore/SGP) 17:10 IL SA Clinical therapy on congenital anophthalmia and microphthalmia Xian Qun Fan (Shanghai/CN) 17:20

89 WOC Saturday, 5 June 2010 Radio Tower Lounge 2 08:30-10:00 SA-45 Congenital Cranial Dysinnervation Disorders (CCDD) Strabismus Elizabeth Engle (Boston/USA) Antje Neugebauer (Cologne/D) 08:30 IL SA Genetics in strabismology Birgit Lorenz (Giessen/D) 08:50 IL SA CCDDs the development of a developmental concept Elizabeth Engle (Boston/USA) 09:20 IL SA Surgical management of CCDDs David G. Hunter (Boston/USA) 11:00 IL SA Systemic association of eyelid and conjunctival tumors Arun D. Singh (Cleveland/USA) 11:10 IL SA Phantom eye syndrome Marie Louise Roed Rasmussen (Copenhagen/DK) 11:20 IL SA Optic Nerve tumors Jan Ulrik Prause (Copenhagen/DK) 11:30 IL SA Lacrimal gland tumors Geoffrey Rose (London/UK) 11:40 IL SA Fusion oncogenes in lacrimal gland adenoid cystic carcinoma Sarah Linea von Holstein (Copenhagen/DK) 11:50 IL SA The anophthalmic socket: prevention and treatment of the post enucleation socket syndrome Rudolf F. Guthoff (Rostock/D) Scientific Program Schedule Saturday, 5 June 09:40 IL SA CCDDs - perspectives Antje Neugebauer (Cologne/D) Radio Tower Lounge 2 14:00-15:30 SA-47 Radio Tower Lounge 2 10:30-12:00 SA-46 Orbital, Adnexal and Conjunctival Tumors Amblyopia: Early Detection and Screening Programs Strabismus Oncology Jacob Pe'er (Jerusalem/IL) Jan Ulrik Prause (Copenhagen/DK) Rudolf F. Guthoff (Rostock/D) 10:30 IL SA Treatment of epithelial and melanocytic conjunctival tumors Jacob Pe'er (Jerusalem/IL) 10:40 IL SA Epithelial Eyelid Tumors Mordechai Rosner (Tel-Hashomer/IL) 10:50 IL SA Eyelid stromal tumors Geeta Vemuganti (Hyderabad/IND) Michael X. Repka (Baltimore/USA) Dominique Thouvenin (Toulouse/F) Oliver Ehrt (Munich/D) 14:00 IL SA Effectiveness of Screening Preschool Children for Amblyopia Wolf A. Lagrèze (Freiburg/D) 14:10 IL SA Impact of Amblyopia on Quality of Life Jill Carlton (Sheffield/UK) 14:20 IL SA Cost-effectiveness of Screening Programmes for Amblyopia Jill Carlton (Sheffield/UK) 14:30 IL SA Brückner test: scope and limits Michael Gräf (Giessen/D)

90 86 WOC 2010 Saturday, 5 June Scientific Program Schedule Saturday, 5 June :40 IL SA Detection of Refractive Errors, Strabismus and Cataract with the Plusoptix S04 Oliver Ehrt (Munich/D) 14:50 IL SA Screening Based on Visual Acuity Testing Michael X. Repka (Baltimore/USA) Radio Tower Lounge 2 16:00-17:30 SA-48 Changing Realities in Eye Care: What is Needed Most to Prevent Blindness in Developing Countries Vision 2020 Prevention of Blindness R. D. Thulasiraj (Madurai/IND) Clare Gilbert (London/UK) Daniel Etya'ale (Genève/CH) 16:00 IL SA Tertiary vs. Primary care ophthalmology equal or unequal emphasis? Daniel Etya'ale (Genève/CH) 16:15 IL SA Are we making any progress in combating cataract in the developing world? Should we be training Ophthalmologists or PEC workers and non MD- Cataract Surgeons? Alfred Sommer (Baltimore/USA) 16:30 IL SA Vertical vs. Integrated approach? Satellite eye clinics in rural areas vs. Integrating eye care into primary health care. What about urban areas? Susan Lewallen (Moshi/EAT) 16:45 IL SA The challenges of strengthening health systems to deliver eye care Hannah Faal (Accra/GH) 17:00 IL SA Integrating Ophthalmology and Optometry Kovin Naidoo (Durban/ZA) 17:15

91 WOC Scientific Program Scientific Program Schedule Sunday, 6 June 2010 Sunday, 6 June

92 ICC Hall 2 Hall 3 Hall 6 Hall 7 Hall 8 Hall 9 Hall 10 Roof Garden Salon 19 Salon 20 Salon 22 Room 44 Room 45 Room 46 Hall 4/5 Highlight Free Paper WOC Course Industry Meetings Breakfast Oculus Optikgeräte GmbH Breakfast Zeiss SU-57 Burnier, Rao, Holbach Uveitis SU-48 Aylward, Gaudric Retinal Detachment and PVR SU-52 Repka,Del Monte,Jaafar AAPOS : Emerging Concepts SU-34 Bechrakis, Kivelä, Heegaard Oncology 1 WOC-AAD-C-23 Pleyer Immunology of the Eye: Intraocular Inflammations SU-62 Michelson, Schrage Teleophthalmology WOC-AAD-C-26 Schaudig Complic. in Plastic-Reconstr. and Aesthetic Surgery SU-73 Pfeiffer, Zhao, Wolfram Epidemiological Studies SU-58 Colin, Koller Rehabilitation in Primary Keratectasia SU-49 Gaudric, Trese Vitreoretinal Interface Epiretinal Macular Surgery SU-53Schachat, Lang, Stefánsson Jour. Public. SU-53Schachat, Lang, Stefánsson Reviewers SU-35 Barabino, Lohmann, Dua Cornea/External Disease: Surgical therapy 1 SU-61 Rudolph, Zeitz, Zin Strabismus SU-63 Sullivan, Bron, Foulks TFOS Symp.: A Report from the Intern. Workshop SU-67 Pe'er, Coupland, Vemuganti ISOO : Ocular Lymphoma SU-74 Klauß, Finger Vision 2020 Prevention of Blindness 1 12 SU-70 Barraquer, Barraquer, Barraquer Highlights of Anterior Segment Surgery & Refractive Surgery WOC-AAD-C-27 Pitz The Interdiscipl. Context of Mult. Sclerosis and Myasth Gravis Lunch Alcon Lunch Santen Meeting BVA-Leitlinienkomission Sitzung der Sektion DOG-Internationale Ophthalmologie Studientreffen zur FANCY-Studie Sitzung der Makulakommission ICO Committee: Education Committee SU-59 Randleman, El Danasoury, Hafezi Post-LASIK corneal ectasia SU-50 Trese, Kampik Retinal Vascular Diseases: Diabetic Retinopathy / Vein Occlu. SU-78 Price, Cursiefen, Reinhard Posterior Lamellar Keratoplasty SU-36 Colin, Cochener, Slade Refractive surgery/refraction 2 WOC-AAD-C-24 Messmer Corneal Ulcers and Conjunctival Scarring. What to do? SU-64 Belfort, Vassileva, Finger Beyond Vertical Programs: Chal. and Success in Building SU-68 Shetta, Hunter, Seitz Egyptian German Symp: Combined Surgeries in Ophthalm. SU-71 Emmerich, Javate, Oestreicher New Diagn.and Therap. Aspects of Lacri. Dis. WOC-AAD-C-28 Klauss Ophthalmic Conditions in Third World countries SU-75 Berta, Seregard, Sitnik Cornea/External Disease: Surgical therapy Sunday, 6 June SU-60McRae,Cheng,Mrochen Is a Custom. Abl. Prof. the Best for Stand. Refr. Corrections SU-51 Kampik, Aylward AMD SU-56 Naumann, Lang, Völcker Anatomy/pathology SU-37 Holopainen, Németh, Zagórski External Disease, Dry Eye WOC-AAD-C-25 Schiefer Visual Agnosia and other Central Visual Impairments SU-65 Taylor, Klauß, Kocur Vision 2020: 10 Years on, 10 Years to go SU-69 Thanos, Gatzioufas, Seitz Greek German Symp: From Glaucoma to Neuropr. SU-72 Lagrèze, Mojon, Besch Strat. in Surgical Treatment of Eye Diseases in Childhood WOC-AAD-C-29 Gerding Retinop. of Prematurity Clinic. Diagn. and Treatment SU-47 Grabner, Duncker, Gatinel Refractive surgery/refraction Evening Merck Evening Zeiss SEAGIG Board Meeting Lunch Bausch&Lomb

93 Messe Stockholm Sao Paulo Abu Dhabi Oslo Hall Room Madrid Room Sydney Room Hong Kong Room Istanbul VIP Lounge 1 VIP Lounge 2 Radio Tower Lounge 1 Radio Tower Lounge 2 Hall Breakfast Santen SU-01 Zangwill, Garway-Heath, Hoffmann SU-02 Heijl, Schiefer Functional Diagn. SU-09 Koffler, Asbell, Berzas Next Generations of Silicone Hydrogel Contact Lenses SU-13 Alió, Claoué, Neuhann Correcting Presbyopia with IOLs SU-17 Cernák, Kruse Cornea/External Disease: Basics SU-22 Kikkawa, Baldeschi, Eckstein Graves' Disease SU-77 Kruse, Güell New Technologies for Keratoplasty SU-30 Yogesan, Lamminen, Paulus Panel: Future Aspects Advanced Inf., Way-forward WOC-C-21 Duncker Wetlab Basic Course on Penetrating Corneal Grafting Techniques SU-44 Plant, Wilhelm, Wie Neuro-Ophthalmology SU-38 Bornfeld, Zeschnigk, Desjardins Workshop: Uveal Melanoma Genetic Testing SU-40 Belfort, Jr., Golnik, Kashii Miscellaneous 1 SU-79 Helbig, Wagner Video Session 1: Cataract Highlight Free Paper WOC Course Industry Meetings 11 SU-03 Pfeiffer, Azuara-Blanco Dec. for Treat SU-04 Sommer, Wormald New Approa. SU-10 Alió, Auffarth AAO : Excellence in Cataract Surgery SU-14 Malyugin, Bissen- Miyajima, Pham Managing Complex Cases SU-18 Luco, Gräf, Plant Ocular Motor Problems SU-23 Gottlob, Mojon, Pieh Panel: Case presentations SU-27 Heiligenhaus, Bodaghi, Becker Uveitis/intraoc. inflam., microb./immunology 1 SU-31 Nussenblatt, Forrester, Wildner Current Opinion in Immunology of Uveitis WOC-C-22 Duncker Wetlab for the Advanced: Lamellar Grafting Techniques SU-41 Gerinec, Lorenz, Yetik Pediatric Ophthalmology & Genetics 1 SU-80 Schrader, Holzer Video Session 2: Miscellaneous Lunch Heidelberg Engineering Lunch Novartis Pharma AG Lunch Bayer SU-05 Krieglstein, Lacey Adherence 15 SU-06 Khaw, Shaarawy, Baerveldt SU-11 Hawlina, Holder, Bach SOE/ISCEV Symp: Use of Electrophysiological Methods SU-15 Nuijts, Werner, Kohnen New Monofocal IOL Designs SU-19 Armitage, Böhringer, Duquesnoy Matching in Penetrating Keratoplasty SU-24 Rao, Garweg, Pleyer Infectious Uveitis SU-28 Behrens-Baumann, Dart, Németh Corneal Infections SU-32 Hopkins, Guthoff, Foster Onchocerciasis: Moving to elimination WOC-C-36 Koch, Bornfeld, Krüger Modern Pars plana Vitrectomy DryLab (Basics) SU-46 Franceschetti, Jokl, Krogmann Julius Hirschberg Society SU-55 Bobrova, Gottlob, Miller Pediatric Ophthalmology & Genetics 2 SU-42 Belshi, Meyer-Rüsenberg Oculoplasty/orbita/ lids/lacrimal system 1 SU-45 Roider, Dick, Klink Video Session 3 and Presentation of Video Awards SU-07 Jakobsen, Grehn, Rahi Childh. 17 SU-08 Foster, Tham Glaucoma Care SU-12 Löffler, Klintworth, Saornil Eyelid, Ocular Adnexal and Conjunct. Tumors SU-16 Lundström, Koch, Findl Emerging Technology in Cataract Surgery SU-20 Watson, Verdaguer, Lichter AOI Symp: Dealing with Complic. of Anterior SU-25 Stout, Sahel, Zrenner Recent Development in Inherited Retinal Diseases SU-29 Wilhelm, Kashii, Lee Neuro-ophthalmic Emergencies SU-33 Pleyer, Bodaghi EVER Symp: Therapy in noninf. ocular inflammation WOC-C-37 Koch, Koss Modern Pars plana Vitrectomy DryLab (Advanced) SU-76 Abbott, Beaconsfield, Lemmen Incorp. Evidencebased Clin. Practice Guidel. SU-39 Kinoshita, Guthoff, Andrews Nanotechnology 1 SU-43 Singh PAAO Symp: Challenging Cases Clinico- Pathologic Correlation SU-81 Steuhl Video Session 4; Miscellaneous 2 Poster exhibition of Poster P-SU-001 to P-SU SU-21 AOI Lecture Sunday, 6 June Evening Pfizer

94 Vorankündigung Kongress Deutschsprachigen Gesellschaft für Intraokularlinsen-Implantation, interventionelle und refraktive Chirurgie Frankfurt/Main März mit Wet-Lab s, Kursveranstaltungen Programm für das Pflegepersonal Kongressleitung: Prof. Dr. med. Michael Amon Krankenhaus Barmherzige Brüder Abteilung für Augenheilkunde Johannes-von-Gott-Platz 1 A 1020 Wien Telefon: (+43) Telefax: (+43) Organisation: Congress-Organisation Gerling GmbH Werftstraße 23, D Düsseldorf Telefon: (+49) Telefax: (+49) info@congresse.de Internet: PIA Stadt Frankfurt am Main Foto: Tanja Schäfer

95 WOC Sunday, 6 June 2010 Stockholm 08:30-09:15 SU-01 Present and Future Imaging Subspecialty Day Glaucoma Section 1: Structure and Function in Glaucoma Care Ted Garway-Heath (London/UK) Esther M. Hoffmann (Mainz/D) 08:30 IL SU What is most useful present imaging (HRT, OCT, GDx) Esther M. Hoffmann (Mainz/D) 09:45 IL SU What we need the ideal new functional test Balwantray C. Chauhan (Halifax/CDN) 09:55 Stockholm 10:30-11:15 SU-03 Decisions for Treatment and Change in Treatment Subspecialty Day Glaucoma Section 2: Present and Future Approaches to Glaucoma Care Scientific Program Schedule Sunday, 6 June 08:40 IL SU Measuring progressive change with imaging: which stage, which strategy, which consequences Ted Garway-Heath (London/UK) 08:50 IL SU Ganglion cell visualization: animals and humans M. Francesca Cordeiro (London/UK) 09:00 IL SU Perspectives in retinal imaging: adaptive optics, en face OCT and full-field doppler Michel Paques (Paris/F) 09:10 Norbert Pfeiffer (Mainz/D) Augusto Azuara-Blanco (Aberdeen/UK) 10:30 IL SU Risk assessment and risk calculation Steven L. Mansberger (Portland/USA) 10:40 IL SU The impact of risk calculation on physician decisions Michael Boland (Baltimore/USA) 10:50 IL SU Cost/benefit, Cost effectiveness Augusto Azuara-Blanco (Aberdeen/UK) Stockholm 09:15-10:00 SU-02 Present and Future of Functional Diagnostics 11:00 IL SU Practice patterns, too much or too little Norbert Pfeiffer (Mainz/D) 11:10 Subspecialty Day Glaucoma Section 1: Structure and Function in Glaucoma Care Stockholm Anders Heijl (Malmö/S) Ulrich Schiefer (Tübingen/D) 09:15 IL SU Useful strategies in present perimetry Anders Heijl (Malmö/S) 09:25 IL SU What is weak in present conventional perimetry and what can we do about it Ulrich Schiefer (Tübingen/D) 11:15-12:00 SU-04 New Approaches to Gathering Information about Glaucoma Subspecialty Day Glaucoma Section 2: Present and Future Approaches to Glaucoma Care Alfred Sommer (Baltimore/USA) Richard Wormald (London/UK) 09:35 IL SU Alternatives presently available (Flicker tests [FDT, Matrix, etc.], electrophysiology) Michael Bach (Freiburg/D) 11:15 IL SU The challenge: conduct large-scale research with many centers Don Budenz (Miami/USA)

96 92 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :25 IL SU Insurance database studies: strengths and weaknesses Joshua D. Stein (Ann Arbor/USA) 11:35 IL SU Mining our hard drives (Lessons from Cochrane approach) Richard Wormald (London/UK) 11:45 IL SU How to do research cheaper and better Alfred Sommer (Baltimore/USA) 11:55 Stockholm Stockholm 14:45-15:40 SU-06 Present and Future of Glaucoma Surgery Surgical Challenges Subspecialty Day Glaucoma Section 3: Outlooks to Medical and Surgical Therapy Peng T. Khaw (London/UK) Tarek M. Shaarawy (Geneva/CH) George Baerveldt (Irvine/USA) 14:45 IL SU Developments making trabeculectomy safer Peng T. Khaw (London/UK) 14:00-14:45 SU-05 Adherence with Medical Therapy, the Dirty Secret Subspecialty Day Glaucoma Section 3: Outlooks to Medical and Surgical Therapy Günther K. Krieglstein (Cologne/D) Jenny Lacey (Norwich/UK) 14:00 IL SU How bad is adherence now? Günther K. Krieglstein (Cologne/D) 14:10 IL SU Barriers to adherence Jenny Lacey (Norwich/UK) 14:20 IL SU How does physician communication affect adherence? David Friedman (Baltimore/USA) 14:55 IL SU Bleb classification and management of complications related to blebs Franz Grehn (Würzburg/D) 15:05 IL SU Non-penetrating glaucoma surgery techniques has their time come or gone? Tarek M. Shaarawy (Geneva/CH) 15:15 IL SU Tubes: When, why, how Keith Barton (London/UK) 15:25 IL SU Angle surgery: status report on newer methods George Baerveldt (Irvine/USA) 15:35 IL SU Standardized reporting on surgical studies Mark Sherwood (Gainesville/USA) Stockholm 14:30 IL SU How much would be gained if we increased adherence? James C Tsai (New Haven/USA) 16:10-16:50 SU-07 Childhood Glaucoma Care: the Patient Who Lives Up to :40 Subspecialty Day Glaucoma Section 4: Neglected Areas: Where Can We Improve Jan Eric Jakobsen (Oslo/N) Franz Grehn (Würzburg/D) Jugnoo S. Rahi (London/UK) 16:10 IL SU Present and future surgical techniques: Innovation at the horizon? Jan Eric Jakobsen (Oslo/N)

97 WOC Sunday, 6 June :20 IL SU Spontaneous resolution of congenital glaucoma a natural help for surgery Franz Grehn (Würzburg/D) 16:25 IL SU Developing vision: Amblyopia is a major challenge Thomas Klink (Würzburg/D) 16:35 IL SU New aspects of secondary glaucoma after congenital cataract surgery Jugnoo S. Rahi (London/UK) 16:45 Stockholm 16:50-17:30 SU-08 Glaucoma Care in Developing Countries Subspecialty Day Glaucoma Section 4: Neglected Areas: Where Can We Improve 17:20 IL SU Where will we make the biggest short-term gains in reducing impairment Mingguang He (Guangzhou/CN) 17:25 Sao Paulo 08:30-10:00 SU-09 Next Generations of Silicone Hydrogel Contact Lenses Contact Lens and Refraction Bruce H. Koffler (Lexington/USA) Cornelius Berzas (Offenbach/D) 08:30 IL SU The Oliver Dabezies Lecture; Oliver Dabezies Jr. M.D.: A True Gentleman Jane Sparholt (Rønne/DK) Scientific Program Schedule Sunday, 6 June Paul Foster (London/UK) Clement C. Y. Tham (Hong Kong/CN) 16:50 IL SU The scope of the problem Paul Foster (London/UK) 16:55 IL SU What is done now for OAG in the developing world Kuldev Singh (Stanford/USA) 17:00 IL SU What is done now for ACG in the developing world Clement C. Y. Tham (Hong Kong/CN) What should be done right now: 3 viewpoints 17:05 IL SU We should apply the developed country model Tarek M. Shaarawy (Geneva/CH) 17:10 IL SU We should use different programs for different regions Tin Aung (Singapore/SGP) 17:15 IL SU We should use the center of excellence - pyramid model Paul Foster (London/UK) 08:40 IL SU Is it safe to wear extended and continuous wear lenses? Mihály Végh (Szeged/H) 08:50 IL SU Silicone hydrogel multifocal lenses for the presbyope Ebru Toker (Istanbul/TR) 09:00 IL SU Ophthalmic Drug Delivery by contact lenses Anuj Chauhan (Florida/USA) 09:10 IL SU Silicone hydrogel for ectatic (& irregular) corneas Ursula Vogt (London/UK) 09:20 IL SU Next generations of silicone-hydrogels Bruce H. Koffler (Lexington/USA) 09:30 IL SU Treatment and Management of Contact Lens infectious complications; Pseudonomas infection and melting and acanthamoeba ceratities Andrena McElvanney (London/UK) 09:40 IL SU Therapeutic uses of Silicone Hydrogels in Ocular Surface Disease Antonio Elizondo (San Pedro/MEX) 09:50

98 94 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June 2010 Sao Paulo 10:30-12:00 SU-10 AAO : Excellence in Cataract Surgery: What We Should Demand in 2010? Cataract Jorge L. Alió (Alicante/E) Gerd U. Auffarth (Heidelberg/D) 10:30 IL SU Excellence in Incision Jorge L. Alió (Alicante/E) 10:40 IL SU Excellence in Outcomes TBA 14:15 IL SU What can we learn from electrophysiology in AMD patients Thomas Meigen (Würzburg/D) 14:30 IL SU The differentiation between optic nerve and macular dysfunction Marko Hawlina (Ljubljana/SI) 14:45 IL SU Electrophysiology in glaucoma Michael Bach (Freiburg/D 15:00 IL SU Electrophysiology in inflammatory and autoimmune diseases Graham E. Holder (London/UK) 15:15 10:50 IL SU Excellence in Restoring Near Vision Function TBA 11:00 IL SU Excellence in Restoring Visual Optics Douglas D. Koch (Houston/USA) 11:10 IL SU Excellence in Astigmatic Correction during Cataract Surgery Gerd U. Auffarth (Heidelberg/D) 11:20 IL SU Excellence in Phaco Engineering Michael Colvard (Los Angeles/USA) 11:30 Sao Paulo 16:00-17:30 SU-12 Eyelid, Ocular Adnexal and Conjunctival Tumors Pathology Karin U. Löffler (Bonn/D) Gordon Klintworth (Morrisville/USA) Maria Antonia Saornil (Valladolid/E) 16:00 IL SU Eyelid malignancies: conventional and new therapeutic modalities Gonzalo Blanco-Mateos (Valladolid/E) Sao Paulo 14:00-15:30 SU-11 SOE/ISCEV : Use of Electrophysiological Methods in Acquired Retinal and Optic Nerve Diseases 16:10 IL SU Sebaceous carcinoma Tom Cummings (Durham/USA) 16:20 IL SU In vivo confocal microscopy of conjunctival lesions with histopathologic correlation Elisabeth M. Messmer (Munich/D) Electrophysiology Marko Hawlina (Ljubljana/SLO) Graham E. Holder (London/UK) Michael Bach (Freiburg/D) 14:00 IL SU Electrophysiology and imaging in retinal diseases Ulrich Kellner (Siegburg/D) 16:30 IL SU Conjunctival intraepithelial neoplasia: risk factors, prophylaxis and treatment Claudia Auw-Hädrich (Freiburg/D) 16:40 IL SU New classification of primary acquired melanosis (PAM) Sarah E. Coupland (Liverpool/UK)

99 WOC Sunday, 6 June :50 IL SU What is this caruncular tumor? Steffen Heegaard (Copenhagen/DK) 17:00 IL SU Case presentations Jerry Shields (Philadelphia/USA) 17:10 Abu Dhabi 08:30-10:00 SU-13 Correcting Presbyopia with IOLs Subspecialty Day Cataract Jorge L. Alió (Alicante/E) Charles Claoué (Brentwood/UK) Thomas F. Neuhann (Munich/D) Abu Dhabi 10:30-12:00 SU-14 Managing Complex Cases Subspecialty Day Cataract Boris Malyugin (Moscow/RUS) Hiroko Bissen-Miyajima (Tokyo/J) Duy-Thoai Pham (Berlin/D) 10:30 IL SU Incisional issues Amar Agarwal (Chennai/IND) 10:40 IL SU Dense nuclei Duy-Thoai Pham (Berlin/D) 10:50 IL SU Small pupils Boris Malyugin (Moscow/RUS) Scientific Program Schedule Sunday, 6 June 08:30 IL SU Monovision Thomas F. Neuhann (Munich/D) 11:00 IL SU Ruptured posterior capsule Hiroko Bissen-Miyajima (Tokyo/J) 08:40 IL SU Multifocal, refractive Charles Claoué (Brentwood/UK) 11:10 IL SU Iris defects (aniridia, coloboma, traumatic) Stephan Kohnen (Aachen/D) 08:50 IL SU Mulitfocal, diffractive José F. Alfonso (Oviedo/E) 11:20 IL SU Dislocated IOLs TBA 09:00 IL SU Accommodating, monooptic Milind Pande (North Ferriby/UK) 11:30 09:10 IL SU Accommodating, dualoptic Ivan L. Ossma-Gomez (Bucaramanga/CO) Abu Dhabi 14:00-15:30 SU-15 09:20 IL SU Managing astigmatism and residual ametropia Michael C. Knorz (Mannheim/D) New Monofocal IOL Designs Subspecialty Day Cataract 09:30 Rudy Nuijts (Maastricht/NL) Liliana Werner (Berlin/D) Thomas Kohnen (Frankfurt/D) 14:00 IL SU Aspheric Thomas Kohnen (Frankfurt/D) 14:10 IL SU Toric overview Rudy Nuijts (Maastricht/NL)

100 96 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :20 IL SU Surgical pearls for toric IOLs David Spalton (London/UK) 14:30 IL SU Extreme cases Gerd U. Auffarth (Heidelberg/D) 14:40 IL SU Light-adjustable Fritz Hengerer (Bochum/D) 14:50 IL SU New IOL biomaterials Liliana Werner (Berlin/D) 15:00 Oslo 08:30-10:00 SU-17 Cornea/External Disease: Basics Free Paper Cornea, External Disease Andrej Cernák (Bratislava/SK) Rupert Strauß (Linz/A) 08:30 FP SU Donor corneal tissue characteristics and graft survival Tatyana Hergeldzhieva-Fileva, Petja Ivanova Vassileva, Nickolai Surchev, Yordanka Kirilova (Sofia/BG) Abu Dhabi 16:00-17:30 SU-16 Emerging Technology in Cataract Surgery Subspecialty Day Cataract Mats Lundström (Karlskrona/S) Douglas D. Koch (Houston/USA) Oliver Findl (Vienna/A) 08:37 FP SU The effect of human and rabbit serum on the recovery of the wounded corneal surface in the Ex vivo Eye Irritation test B. Kranz-Opgen-Rhein, Norbert Schrage, M. Frentz (Aachen/D, Köln/D) 08:44 FP SU Immunocytochemical analysis after treatment with osmoprotective lubricant in patients with dysfunctional tear syndrome Rossen M. Hazarbassanov (Sao Paulo/BR) 16:00 IL SU Advances in techniques for patient assessment Oliver Findl (Vienna/A) 16:10 IL SU IOL calculations, technology? formulas Haigis, IOL calculations after refractive surgery DDK Jaime Aramberri Agesta (Vitoria-Gasteiz/E) 16:20 IL SU Phaco technology Barry S. Seibel (Los Angeles/USA) 16:30 IL SU Prevention of PCO Manfred Tetz (Berlin/D) 16:40 IL SU Prevention of endophthalmitis Mats Lundström (Karlskrona/S) 16:50 IL SU Small-incision ECCE" to "Modern Manual Cataract TBA 17:00 08:51 FP SU Osmoprotectants can protect corneal epithelial cells from death after exposure to hyper-osmolar solutions Mark Willcox, Qian Garrett, Sharon Shih, Joseph Vehige, Peter Simmons (Sydney/AUS, Irvine/USA) 08:58 FP SU Keratoconus experimentally induced in mice using collagenase Mahsa Hadipour Jahromy, Farhad Adhami-moghadam, Simin Fazelipour, Shahrzad Khakpour, Mohammadsadegh Younesian (Tehran/IR) 09:05 FP SU Differentiation of human bone mesenchymal stem cells into keratocytes in vitro Dong Shi, Yuji Tanaka, Akira Kubota, Kohji Nishida (Sendai/J) 09:12 FP SU Atomic Force Microscopy of the corneal ultrastructure before and after corneal crosslinking Rupert Strauß, David Diesenberger, Martin Dirisamer, Manfred Dichtl, Andreas Wedrich, Kurt Schilcher, Siegfried G. Priglinger (Linz/A)

101 WOC Sunday, 6 June :19 FP SU Monitoring osmotic stress within a new in vitro dry eye model Felix Spöler, Markus Frentz, Heinrich Kurz, Norbert Schrage (Aachen/D, Köln/D) 09:26 FP SU Bone Marrow-Derived Endothelial Progenitor Cells: a Promising Therapeutic Alternative for Corneal Endothelial Dysfunction Chunyi Shao, Yao Fu, Wenjuan Lu, Xianqun Fan (Shanghai/CN) 09:33 FP SU Expression of Tim-3 in high risk murine model of corneal graft rejection Wei Kun Hu, Nan Xiang, Rong Liu, Jing Yuan (Wuhan/CN) 09:40 SL SU Tomographic normal values for elevation and pachymetry in a hyperopic population Michael W. Belin, Michael Cortese (Marana/USA, Albany/USA) 09:49 Oslo 11:20 IL SU Paroxysmal diplopia Gordon Plant (London/UK) 11:30 Oslo 14:00-15:30 SU-19 Matching in Penetrating Keratoplasty External Eye Disease, Cornea John Armitage (Bristol/UK) Daniel Böhringer (Freiburg/D) René J. Duquesnoy (Pittsburgh/USA) 14:00 IL SU HLA matching in keratoplasty: The Bristol experience John Armitage (Bristol/UK) 14:15 IL SU HLA matching in keratoplasty: The Freiburg experience Daniel Böhringer (Freiburg/) Scientific Program Schedule Sunday, 6 June 10:30-12:00 SU-18 Ocular Motor Problems Neuro-Ophthalmology Christian Luco (Santiago/RCH) Michael Gräf (Giessen/D) Gordon Plant (London/UK) 10:30 IL SU Localizing value of nystagmus Christian Luco (Santiago/RCH) 14:30 IL SU HLA matching at the epitope level: a new approach to select transplant donors René J. Duquesnoy (Pittsburgh/USA) 14:45 IL SU Minor transplantation antigens Eric Spierings (Utrecht/NL) 15:00 IL SU Pathophysiology of corneal graft rejection John V. Forrester (Aberdeen/UK) 15:15 10:40 IL SU Cryptic Ocular motor Palsies Emely Karam (Caracas/Y) 10:50 IL SU Congenital and acquired paretic strabismus Michael Gräf (Giessen/D) 11:00 IL SU Differential diagnosis of diplopia Oliver Ehrt (Munich/D) 11:10 IL SU Localising value of disorders of saccades Caroline Tilikete (Lyon/F)

102 98 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June 2010 Oslo 16:00-17:30 SU-20 AOI : Dealing with Complications of Anterior Segment Surgery Cataract Peter G. Watson (Cambridge/UK) Juan Verdaguer (Santiago/RCH) Paul R. Lichter (Ann Arbor/USA) 16:00 IL SU Dealing with infections after LASIK Richard L. Abbott (San Francisco/USA) 16:10 IL SU Management of post-lasik corneal ectasia Jorge L. Alió (Alicante/E) 16:20 IL SU Dealing with zonular dialysis during phacoemulsification Marie-José Tassignon (Antwerb/B) Oslo 17:30-18:15 SU-21 Academia Ophthalmologica Internationalis Lecture Highlights Paul R. Lichter (Ann Arbor/USA) Juan Verdaguer (Santiago/RCH) 17:30 IL SU Introduction Juan Verdaguer (Santiago/RCH) 17:35 IL SU Galileo's Blindness Peter G. Watson (Cambridge/UK) Room Madrid 08:30-10:00 SU-22 Graves' Disease 16:30 IL SU Dealing with non filtering, flat or encapsulated blebs Paul R. Lichter (Ann Arbor/USA) 16:40 IL SU Intraocular lens implantation in the absence of capsular support Enrique Malbrán (Buenos Aires/RA) 16:50 IL SU Dealing with early-onset endophthalmitis after cataract surgery Pran Nath Nagpal (Ahmedabad/IND) 17:00 IL SU Late-onset endophthalmitis after cataract surgery Rubens Belfort, Jr. (São Paulo/BR) 17:10 IL SU Cystoid macular edema in early pseudophakia Kenasaku Miyake (Nagoya/J) 17:20 IL SU Management of suprachoroidal hemorrhage after anterior segment surgery William F. Mieler (Chicago/USA) Strabismus Don O. Kikkawa (La Jolla/USA) Lelio Baldeschi (Amsterdam/NL) Anja K. Eckstein (Essen/D) 08:30 IL SU Pathogenesis of GO Marian Ludgate (Cardiff/UK) 08:40 IL SU Symptoms and assessment of GO Alison J. Dickenson (New Castle/UK) 08:50 IL SU EUGOGO Management Plan of GO Anja K. Eckstein (Essen/D) 09:00 IL SU Orbital surgery Lelio Baldeschi (Amsterdam/NL) 09:10 IL SU Eye muscle surgery Joachim Esser (Essen/D) 09:20 IL SU Lid surgery Don O. Kikkawa (La Jolla/USA) 09:30

103 WOC Sunday, 6 June 2010 Room Madrid 10:30-12:00 SU-23 Panel: Case Presentations Strabismus Irene Gottlob (Leicester/UK) Daniel Mojon (St. Gallen/CH) Christina Pieh (Freiburg/D) 10:30 IL SU Elevation of one eye during tooth brushing Irene Gottlob (Leicester/UK) 10:40 IL SU Complications of botulinum toxin injection in an infant: remaining mydriasis Claude Speeg-Schatz (Strasbourg/F) 10:50 IL SU Vertical angle "kappa" Klara Landau (Zurich/CH) 11:00 IL SU Unilateral exophthalmos surprise, surprise Andrea Langmann (Graz/A) 11:10 IL SU "I don t like to ride my bike anymore!" Bettina K. Wabbels (Bonn/D) 11:20 IL SU "I wish I hadn t done this!" Heimo Steffen (Würzburg/D) 11:30 IL SU Synergistic adduction in a 5-year-old girl Christina Pieh (Freiburg/D) 14:00 IL SU Pathophysiology and Diagnostics for Toxoplasmosis Michael E. Grigg (Bethesda/USA) 14:10 IL SU Challenges in the Diagnosis and Management of Ocular Toxoplasmosis Justus G. Garweg (Bern/CH) 14:20 IL SU Pathophysiology and Diagnostics for Lyme s Disease Volker Fingerle (Oberschleißheim/D) 14:30 IL SU Challenges in the Diagnosis and Management of Ocular Lyme s Disease Uwe Pleyer (Berlin/D) 14:40 IL SU Pathophysiology and Diagnostics for Tuberculosis Daniel Vítor Vasconcelos Santos (Belo Horizonte/ BR) 14:50 IL SU Challenges in the Diagnosis and Management of Ocular Tuberculosis Narsing A. Rao (Los Angeles/USA) 15:00 Room Madrid 16:00-17:30 SU-25 Recent Development in Inherited Retinal Diseases Retina, Vitreous Scientific Program Schedule Sunday, 6 June 11:40 Room Madrid 14:00-15:30 SU-24 Infectious Uveitis Tim Stout (Portland/USA) José-Alain Sahel (Paris/F) Eberhart Zrenner (Tübingen/D) 16:00 IL SU Gene Replacement Therapy for Inherited Retinal Disease James W. B. Bainbridge (London/UK) Uveitis, Intraocular Inflammation Narsing A. Rao (Los Angeles/USA) Justus G. Garweg (Bern/CH) Uwe Pleyer (Berlin/D) 16:10 IL SU Stem Cell Therapy Peter J. Francis (Portland/USA) 16:20 IL SU The Future of High-Throughput Ophthalmic DNA Diagnostics Bernhard H. F. Weber (Regensburg/D)

104 100 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :30 IL SU Rod derived Cone Viability José-Alain Sahel (Paris/F) 16:40 IL SU Control of VEGF Gene Expression Tim Stout (Portland/USA) 16:50 IL SU Outer retina a role for channels and connections in degenerative diseases Mathias Seeliger (Tübingen/D) 17:00 Room Sydney 08:30-10:00 SU-77 New Technologies for Keratoplasty New Technology, Bioengineering Friedrich E. Kruse (Erlangen/D) José L. Güell (Barcelona/E) Room Sydney 10:30-12:00 SU-27 Uveitis/Intraocular Inflammation, Microbiology/Immunology 1 Uveitis, Intraocular Inflammation Arnd Heiligenhaus (Münster/D) Bahram Bodaghi (Paris/F) Matthias D. Becker (Zurich/CH) 10:30 FP SU Rationale and Study Design of a Phase III Clinical Trial Evaluating IL-17A Inhibition with AIN457 in Patients with Posterior Segment Uveitis Secondary to Behçet s Disease Yonca Akova (Ankara/TR) 10:37 FP SU Experience with Adalimumab for the treatment of non-infectious uveitis Bianca Dobner, Regina Max, Matthias D. Becker, Carsten Heinz, Talin Barisani-Asenbauer, Arnd Heiligenhaus, Friederike Mackensen (Heidelberg/D, Vienna/A, Zurich/CH, Münster/D) 08:30 IL SU A New Collagen Implant to Treat Corneal Defects Björn Bachmann (Erlangen/D) 08:40 IL SU New Developments in DALK Donald T. H. Tan (Singapore/SGP) 08:50 IL SU Mushroom Keratoplasty for High, Irregular Astigmatism After Penetrating Keratoplasty Gabriel van Rij (Rotterdam/NL) 09:00 IL SU Long-term Results of DSAEK in 1000 Eyes Francis W. Price (Indianapolis/USA) 09:10 IL SU Visual Rehabilitation after DASEK and DMEK Friedrich E. Kruse (Erlangen/D) 10:44 FP SU An Open-Label Trial to Assess the Efficacy of AIN457, a Monoclonal Antibody Against IL-17A, in Noninfectious Uveitis C. Stephen Foster, Rosa Kim, C. Michael Samson, Naomi Falk, David Chu, David Callahan, Quan Dong Nguyen, Thaddeus P. Dryja (Cambridge/USA) 10:51 FP SU Safety Profile of LX211 (Luveniq /voclosporin oral capsule) in Sight-Threatening Noninfectious Uveitis as reported in the LUMINATE Studies Christoph Deuter, on behalf of the LUMINATE Study Group (Tübingen/D) 10:58 FP SU Uveitis refractive to cyclosporine A improves with additional everolimus: a pilot study Arnd Heiligenhaus (Münster/D) 09:20 IL SU DELK, DASEK, DMEK, the Thinner the Better Gerrit R. J. Melles (Rotterdam/NL) 09:30 IL SU Future Options for Endothelial Transplantation Shigeru Kinoshita (Kyoto/J) 09:40 11:05 FP SU Acute retinal necrosis a national survey in Germany Sibylle Winterhalter, Antonia M Joussen, Uwe Pleyer, Arnd Heiligenhaus, Friederike Mackensen, Manfred Zierhut, Anna-Karina Maier, Thomas Ness (Berlin/D, Münster/D, Heidelberg/D, Freiburg/D, Tübingen/D)

105 WOC Sunday, 6 June :12 FP SU Twenty five gauge pars plana vitrectomy for vitreous opacities secondary to ocular toxoplasmosis Claudio Garcia, Tiago Arantes, Fabio Barreto, Cristina Muccioli (Sao Paulo/BR) 11:19 FP SU Long-term follow-up of patients with Behcet s disease: Apropos one case Mirsad Ibisevic (Sarajevo/BIH) 11:26 FP SU Severe cases of occlusive retinal vasculitis Anne Wissen, Mark Saeger, Johann Roider, Bernhard Nölle (Kiel/D) 11:33 Room Sydney Room Sydney 16:00-17:30 SU-29 Neuro-Ophthalmic Emergencies Neuro-Ophthalmology Helmut Wilhelm (Tübingen/D) Satoshi Kashii (Osaka/J) Andrew G. Lee (Houston/USA) 16:00 IL SU Acute eye pain Satoshi Kashii (Osaka/J) 16:15 IL SU Perilous pupils Helmut Wilhelm (Tübingen/D) Scientific Program Schedule Sunday, 6 June 14:00-15:30 SU-28 Corneal Infections External Eye Disease, Cornea Wolfgang Behrens-Baumann (Magdeburg/D) John K. G. Dart (London/UK) Janos Németh (Budapest/H) 14:00 IL SU Problem solving for progressive microbial keratitis John K. G. Dart (London/UK) 14:15 IL SU Current aspects of keratomycosis Wolfgang Behrens-Baumann (Magdeburg/D) 16:30 IL SU Traumatic Optic Neuropathy: Is there an evidence based recommendation for management? Andrew G. Lee (Houston/USA) 16:45 IL SU Giant cell Arteriitis Aki Kawasaki (Lausanne/CH) 17:00 IL SU Abnormal eye movements that should not be missed Francois Borruat (Lausanne/CH) 17:15 Room Hong Kong 14:30 IL SU The Challenge of Acanthamoeba Keratitis Elmer Tu (Chicago/USA) 14:45 IL SU Mycobacterial keratitis Prashant Garg (Hyderabad/IND) 08:30-10:00 SU-30 Panel: Future Aspects Advanced Information, Way-forward Teleophthalmology and Computers 15:00 IL SU Herpetic keratitis Lies Remeijer (Rotterdam/NL) 15:15 Kanagasingam Yogesan (Nedlands/AUS) Heikki Lamminen (Tampere/FIN) Dietrich Paulus (Koblenz/D) 08:30 IL SU Round table discussion Kanagasingam Yogesan (Nedlands/AUS) 08:50 IL SU Current status and way forward Sajeesh Kumar (Pittsburgh/USA)

106 102 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :10 IL SU Round table discussion Heikki Lamminen (Tampere/FIN) 09:30 IL SU Round table discussion Dietrich Paulus, Kanagasingam Yogesan, Heikki Lamminen (Koblenz/D, Nedlands/AUS, Pittsburgh/USA, Tampere/FIN) Room Hong Kong 10:30-12:00 SU-31 Current Opinion in Immunology of Uveitis Immunology, Molecular Biology, Microbiology Robert Nussenblatt (Bethesda/USA) John V. Forrester (Aberdeen/UK) Gerhild Wildner (Munich/D) 10:30 IL SU Recent developments of experimental uveitis in mice Rachel R. Caspi (Bethesda/USA) 10:40 IL SU Recent developments of experimental uveitis in rats Gerhild Wildner (Munich/D) 10:50 IL SU Intraocular immune response in human uveitis S. John Curnow (Birmingham/UK) Room Hong Kong 14:00-15:30 SU-32 Onchocerciasis: Moving to Elimination Prevention of Blindness Adrian Dennis Hopkins (Decatur/USA) Rudolf F. Guthoff (Rostock/D) Allen Foster (London/UK) 14:00 IL SU Onchocerciasis Eye pathology and current understanding Tony Ukety (Geneva/CH) 14:10 IL SU Elimination of Onchocerciasis in the Americas on course for 2012 Mauricio Sauerbrey (San Salvador/ES) 14:20 IL SU A paradigm shift from Control to Elimination in Africa Adenike Abiose (Ibadan/WAN) 14:30 IL SU Community Directed Interventions; Onchocerciasis control leads the way in Public Health Uche Amazigo (Ouagadougou/HV) 14:40 IL SU Current research: What do we need to know to eliminate the disease? Frank Richards (Atlanta/USA) 11:00 IL SU Leukocyte migration in uveitis Isabel J. Crane (Aberdeen/UK) 11:10 IL SU How is uveitis initiated? John V. Forrester (Aberdeen/UK) 14:50 IL SU Neglected Tropical Diseases and Onchocerciasis: can widening the vision lose focus? Adrian Dennis Hopkins (Decatur/USA) 15:00 11:20 IL SU "Immunologicals" as therapy for uveitis Robert Nussenblatt (Bethesda/USA) 11:30 Room Hong Kong 16:00-17:30 SU-33 EVER : Therapy in Noninfectious Ocular Inflammation: Recent Developements Uveitis, Intraocular Inflammation Uwe Pleyer (Berlin/D) Bahram Bodaghi (Paris/F)

107 WOC Sunday, 6 June :00 IL SU Principles and new targets in immunemodulation TBA 16:15 IL SU Biologicals: Beyond anti-tnf treatment Marc D. de Smet (Antwerpen/B) 16:30 IL SU Immunosuppression in children (JIA) Bahram Bodaghi (Paris/F) 16:45 IL SU Corticosteroids: old agents new options Uwe Pleyer (Berlin/D) 17:15 VIP Lounge 1 08:30-10:00 SU-44 09:00 FP SU Saccade dynamics in peripheral vs central fourth nerve palsies Tao Fu, Alan Blakeman, Manokaraananthan Chandrakumar, Herbert Goltz, Agnes M. F. Wong (Beijing/CN) 09:07 FP SU Restoration of vision: non-invasive current stimulation enhances brain synchronization after optic nerve damage a retrospective, observational study with 446 patients Anton Fedorov, Sandra Jobke, Alexandra N. Chibisova, Julia M. Chibisova, Carolin Gall, Bernhard Sabel (Magdeburg/D, St. Petersburg/RUS) 09:14 FP SU Neuroplasticity in acute optic neuritis: an Functional magnetic resonance imaging (fmri) study Anoop Kishore Gupta, Senthil kumaran, Rohit Saxena, Vimla Menon, Pradeep Sharma, Pradeep Sharma (Dehli/IND) Scientific Program Schedule Sunday, 6 June Neuro-Ophthalmology 1 Free Paper Neuro-Ophthalmology Gordon Plant (London/UK) Helmut Wilhelm (Tübingen/D) Shihui Wei (Beijing/CN) 08:30 SL SU Relaticity analysis of rhinogenous ocular manifestations Shihui Wei (Beijing/CN) 09:21 FP SU Restoration of vision: Non-invasive current stimulation for the treatment of visual field defects in optic neuropathy as single-center prospective trial Bernhard A. Sabel, Anton B. Fedorov, Christoph Herrmann, Carolin Gall (Magdeburg/D) 09:28 FP SU Automated morphometry of the visual pathway in primary open-angle glaucoma Aditya Hernowo, Christine Boucard, Nomdo Jansonius, Johanna Hooymans, Frans Cornelissen (Groningen/NL) 08:39 FP SU Neuroprotective effect on retinal ganglion cells by transpupillary laser irradiation of the optic nerve head Libin Jiang (Beijing/CN) 09:35 FP SU Dissemination of glioblastoma multiforme masquerading multiple sclerosis Nikolai Holak, Heinrich Holak, S. Pfeifenbring, S. Baumgarten (Salzgitter/D) 08:46 FP SU Clinical analysis of 52 cases with ophthalmologic signs in vertebral-basilar insufficiency Shihui Wei (Beijing/CN) 09:42 08:53 FP SU Are we neglecting visual neglect? Shu Jeng Ting, Alex Pollock, Fergus Doubal, Gordon Dutton, Shu Wei Ting, Bal Dhillon, Thompson Michelle (Glasgow/UK)

108 104 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June 2010 VIP Lounge 1 14:00-15:30 SU-46 Julius Hirschberg Society: Symposion Contribution to Hundred and Fifty Years of Ophthalmology International Ophthalmology Albert Franceschetti (Meyrin/CH) Danny Hirsch-Kauffmann Jokl (New York/USA) Frank Krogmann (Thüngersheim/D) 14:00 IL SU An ophthalmologist's trip to India Gregor Wollensak (Halle/D) 14:10 IL SU Swiss contribution to International Ophthalmology Balder P. Gloor (Zurich/CH) VIP Lounge 1 16:00-17:30 SU-76 Incorporating Evidence-based Clinical Practice Guidelines into the Care of our Patients Evidence-based Ophthalmology Richard L. Abbott (San Francisco/USA) Michèle Beaconsfield (London/UK) Klaus-Dieter Lemmen (Düsseldorf/D) 16:00 IL SU Incorporating evidence based clinical practice guidelines into patient care Richard Wormald (London/UK) 16:15 IL SU Guideline development in the absence of evidence Michèle Beaconsfield (London/UK) 14:20 IL SU The first female medical students Albert Franceschetti (Meyrin/CH) 16:30 IL SU Evidence Based Clinical Guidelines in Strabismus Emilio Carlo Campos (Bologna/I) 14:30 IL SU Albrecht von Graefe- previously unrecognized contributions to modern Ophthalmology Danny Hirsch-Kauffmann Jokl (New York/USA) 16:45 IL SU Diabetic Retinopathy: an international problem with national clinical practice guidelines Klaus-Dieter Lemmen (Düsseldorf/D) 14:40 IL SU Vienna and its significance in worldwide ophthalmology Frank Krogmann (Thüngersheim/D) 14:50 IL SU Glaucoma und migraine a historical review Carl Erb (Berlin/D) 17:00 IL SU Promoting and Implementing Clinical Practice Guidelines in Developing Countries: What We have learned from the China Experience Richard L. Abbott (San Francisco/USA) 17:15 15:00 IL SU Ludwik Zamenhof One of the most famous ophthalmologists in the world s Culture Andrzej Grzybowski (Poznan/PL) 15:10

109 WOC Sunday, 6 June 2010 VIP Lounge 2 08:30-12:00 SU-39 Workshop: Uveal Melanoma Genetic Testing Workshop Oncology Session 1: Uveal Melanoma Prognostic Testing Norbert Bornfeld (Essen/D) Jacob Pe'er (Jerusalem/IL) 08:30 IL SU Introduction Norbert Bornfeld (Essen/D) 08:45 IL SU Prognosis Assessment by Genome Wide Profiling in Uveal Melanoma Jerome Couturier (Paris/F) 09:00 IL SU MSA and MLPA for Genetic Testing of Uveal Melanoma Michael Zeschnigk (Essen/D) 11:15 IL SU Techniques for Harvesting Fresh Tumor Tissue for Genetic Studies Jerry Shields (Philadelphia/USA) 11:30 IL SU Fine Needle Aspiration Biopsy for Genetic Testing of Uveal Melanoma in 500 Cases Carol L. Shields (Philadelphia/USA) VIP Lounge 2 14:00-15:30 SU-55 Pediatric Ophthalmology & Genetics 2 Free Paper Pediatric Ophthalmology, Genetics Nadija F. Bobrova (Odessa/UA) Irene Gottlob (Leicester/UK) Marilyn Miller (Chicago/USA) 14:00 SL SU Pediatrics Ophthalmology New Approaches Nadiya Bobrova (Odessa/UA) Scientific Program Schedule Sunday, 6 June 09:15 IL SU Follow-Up Study of 347 Patients with Uveal Melanoma Tested by Microsatellite Analysis Stefanie Thomas (Essen/D) 09:30 IL SU Genetic Changes and Expression Profiling in Uveal Melanoma: Markers of Patient Survival Hanneke Mensink (Rotterdam/NL) 09:45 IL SU High PTP4A3 Phosphatase Expression Correlates with Uveal Melanoma Metastasis Simon Saule (Paris/F) Session 2: Taking Biopsy Michael Zeschnigk (Essen/D) Laurence Desjardins (Paris/F) 10:30 IL SU Serum Markers Jacob Pe'er (Jerusalem/IL) 10:45 IL SU To Biopsy or Not to Biopsy Stefan Seregard (Stockholm/S) 14:09 FP SU Incidence of retinopathy of prematurity in Bahrain, Ebtisam K. Al Alawi, Mohamed Shaker Omran (Isa Town/BRN) 14:16 FP SU Effect of Two Months Oral CDP-Choline on Visual Function in Amblyopic Patients: Long-Term Results Emilio Carlo Campos, Michela Fresina (Bologna/I) 14:23 FP SU Infants implantation surgery specific features Nadiya Bobrova, Oleksii Zhekov, Anna Dembovetskaya (Odessa/UA) 14:30 FP SU Systemic Exposure and Safety of Latanoprost 0.005% in Infants with Glaucoma Susan Raber, Tomoko Maeda-Chubachi, Rachel Courtney, Brad Simons, Sharon Freedman, Barbara Wirostko (San Diego/USA) 14:37 FP SU Demyelinating optic neuritis in Asian children: clinical features and risk of multiple sclerosis Yoon Jeon Kim, Joo Hyun Choi, Hyun Taek Lim (Seoul/ROK) 11:00 IL SU Clinical Application of Genetic Studies on Choroidal Melanoma Bertil D. Damato (Liverpool/UK) 14:44 FP SU OCT charecteristics of the macula and optic disc in high myopic children Michal Szuminski, Alina Bakunowicz-Lazarczyk (Bialystok/PL)

110 106 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :51 FP SU Earlier visual rehabilitation in pediatric cataracts Role of cataract surgery with primary posterior capsulotomy with anterior vitrectomy primary IOL implantation Seema Deshmukh, Vikas Mahatme (Nagpur/IND) 14:58 FP SU Prevention of oxygen induced retinopathy by high doses of vitamin A in the newborn rat Xanthi Couroucli, Yan-hong Wei, Weiwu Jiang, Bhagavatula Moorthy (Houston/USA) 15:05 FP SU Neonatal Dacryostenosis as a Risk Factor for Anisometropia Brian Mohney, Joshua Piotrowski (Rochester/USA) 15:12 16:21 FP SU Assessing the functionality and biocompatibility of a wireless contact lens sensor for 24 hourintraocular pressure monitoring in volunteers: preliminary results. Stefan De Smedt, Sylvain Roy, André Mermoud, Joseph Geinoz, Philippe Seira, Jeanette Lindell, Corinne Schnyder (Lausanne/CH) 16:28 FP SU Pupillometer-Based Objective Chromatic Perimetry Preliminary Evaluation Ygal Rotenstreich, Andrew Kolker, Shlomo Melamed, Michael Belkin, Alon Skaat (Kfar Bilu/IL, Tel Hashomer/IL) 16:35 FP SU Gene Therapy to Modulate Apoptosis and Prevent Loss of Corneal Endothelial Cells Thomas Fuchsluger, Ula Jurkunas, Andrius Kazlauskas, Reza Dana (Essen/D, Boston/USA) VIP Lounge 2 16:00-17:30 SU-38 New technology, Bioengineering, Nanotechnology 1 16:42 FP SU Photography of meibomian glands with scanning laser ophthalmoscope Takashi Sone, Kazufumi Kaneda, Atsushi Hirota, Hiroshi Nakamoto, Ryotaro Toda, Kaori Ideguchi, Yoshiaki Kiuchi (Hiroshima/J, Yamaguchi/J) Free Paper New Technology, Bioengineering Shigeru Kinoshita (Kyoto/J) Rudolf F. Guthoff (Rostock/D) Russell Andrews (Los Gatos/USA) 16:00 FP SU Image Quality of a Novel Navigated Retina Laser (NAVILAS ) Aljoscha Neubauer, Marcus Kernt, Christos Haritoglou, Michael Ulbig, Anselm Kampik, Igor Kozak, Stephen Oster, Katrin Hartmann, Jae Suk Kim, William R Freeman (Munich/D, San Diego/USA, La Jolla/USA) 16:07 FP SU Benefit of NAVILAS Retina Navigation in Challenging Retinal Pathologies Alexandra Hoeh, Thomas Ach, Mira Ruppenstein, Giovanni Staurenghi, Stefan Dithmar (Heidelberg/D, Milano/I) 16:49 FP SU Surgical Media Centre, a scientific tool in Phaco training programme Navneet Toshniwal (Solapur/IND) 16:56 FP SU A new computer assisted technique to correct the post-enucleation socket syndrome Martin Rücker, Harald Essig, Isabella Rücker, Horst Kokemueller, Frank Tavassol, Nils-Claudius Gellrich (Hannover/D) 17:03 FP SU Reconstruction of conjunctival epithelium by trans-differentiated human amniotic epithelial cells Jian Chen (Guangzhou/CN) 17:10 16:14 FP SU Different ways to treat Presbiopia, including the new PresbV (Vejarano Method) L. Felipe Vejarano (Popayán/CO)

111 WOC Sunday, 6 June 2010 Hall 2 08:30-10:00 SU-57 Uveitis Pathology Miguel Noel Burnier (Montreal/CDN) Narsing A. Rao (Los Angeles/USA) Leonard M. Holbach (Erlangen/D) 08:30 IL SU Role of pathology in diagnosis and management of uveitis Rubens Belfort Neto (São Paulo/BR) 08:40 IL SU Role of vitreous biopsy specimen in intraocular inflammation Miguel Noel Burnier (Montreal/CDN) 10:30 IL SU Differentiation and Diagnostics in Different Forms of Keratectasia Joseph Colin (Bordeaux/F) 10:45 IL SU Intrastromal Rings Jonathan H. Talamo (Waltham/USA) 11:00 IL SU Corneal Crosslinking (CLX) Paolo Vinciguerra (Milano/I) 11:15 IL SU Lamellar Keratoplasty Rudy Nuijts (Maastricht/NL) 11:30 IL SU Decision Tree for Management of Keratectasia Theo Seiler (Zurich/CH) 11:45 Scientific Program Schedule Sunday, 6 June 08:50 IL SU Role of extraocular tissue biopsy in uveitis Kalpana Babu (Bangalore/IND) 09:00 IL SU Retina and choroidal biopsy in the diagnosis of recalcitrant uveitis Hans E. Grossniklaus (Atlanta/USA) 09:10 IL SU Role of aqueous humor microscopic examination in uveitis Hiroshi Goto (Shinjuku-ku/J) 09:20 IL SU Iris biopsy in management of uveitis Anita S. Yee Chan (Los Angeles/USA) 09:30 Hall 2 Hall 2 14:00-15:30 SU-59 Post-LASIK Corneal Ectasia: Understanding and Treating Refractive Surgery J. Bradley Randleman (Atlanta/USA) Mohamed Alaa El Danasoury (Jeddah/SA) Farhad Hafezi (Fribourg/CH) 14:00 IL SU Ectasia: Biomechanics William J. Dupps Jr. (Cleveland/USA) 14:10 IL SU Ectasia: Diagnosis & Screening J. Bradley Randleman (Atlanta/USA) 10:30-12:00 SU-58 Rehabilitation in Primary Keratectasia (Keratoconus, Pellucid Marginal Degeneration) Refractive Surgery Joseph Colin (Bordeaux/F) Tobias Koller (Dietikon/CH) 14:20 IL SU Advanced topographic/diagnostic indices Renato Ambrósio Jr. (Rio de Janeiro/BR) 14:30 IL SU Ectasia treatment: CXL: CXL in iatrogenic keratectasia: long-term results Farhad Hafezi (Fribourg/CH) 14:40 IL SU Ectasia treatment: ICRS Jorge L. Alió (Alicante/E)

112 108 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :50 IL SU Ectasia Treatment: Corneal Transplantation: Intralase Enabled DALK with Big Bubble "idalk" is the best for advanced ectasia; 1 year results Mohamed Alaa El Danasoury (Jeddah/SA) 15:00 Hall 2 16:00-17:30 SU-60 Is a Customized Ablation Profile the Best for Standard Refractive Correction? Refractive Surgery Scott McRae (Rochester/USA) Arthur C. Cheng (Hong Kong/CN) Michael Mrochen (Zurich/CH) 16:00 IL SU Clinical advantages and limitations of wavefront sensing Ronald R. Krueger (Cleveland/USA) Radio Tower Lounge 1 08:30-10:00 SU-40 Miscellaneous 1 Free Paper Miscellaneous Rubens Belfort (São Paulo/BR) Karl Golnik (Cincinatti/USA) Satoshi Kashii (Osaka/J) 08:30 FP SU New trainees in ophthalmology their experiences and perspectives from the UK Nishant Kumar, Robert Cheeseman (London/UK) 08:37 FP SU The Training of Para-ophthalmic Personnel A Caribbean Experience Marilyn Watkins (Bridgetown/BDS) 08:44 FP SU Aspects of Educational Inclusion in Brazilian public schools: Students Experience with Special Need Colleagues M. Cristina de O. Regina (Campinas/BR) 16:10 IL SU Optical aberrations and vision, which aberrations matter? Pablo Artal (Murcia/E) 16:20 IL SU Clinical outcomes with "standard/wavefront optimized" refractive treatments Karl G. Stonecipher (Greensboro/USA) 16:30 IL SU Topography based treatments indications and limitations Theo Seiler (Zurich/CH) 16:40 IL SU Clinical outcomes wavefront guided treatments with different platforms Stephen G. Slade (Houston/USA) 16:50 IL SU Ray tracing, the missing link between wavefront and topography guided treatment Michael Mrochen (Zurich/CH) 08:51 FP SU Perioperative Anaesthetic Management in Ophthalmologic Surgery Current changes in guidelines and clinical practice Jan-Peer Rogmann, Michael Goerig, Alwin E. Goetz (Hamburg/D) 08:58 FP SU Study the functional statement of the visual analyzer in patients with chronic vertebral-basilar insufficiency Ramazanova Lyia (Moscow/RUS) 09:05 F SU First Demonstration of Fermentation and Putrefaction by Ambient Bacteria (Theodor Schwann 1837) Dieter Schmidt (Freiburg/D) 09:12 17:00

113 WOC Sunday, 6 June 2010 Radio Tower Lounge 1 10:30-12:00 SU-41 Pediatric Ophthalmology & Genetics 1 Free Paper Pediatric Ophthalmology, Genetics Anton Gerinec (Bratislava/SK) Birgit Lorenz (Giessen/D) Huseyin Yetik (Istanbul/TR) 10:30 SL SU Retinopathy of prematurity (ROP): What we know and what we should know about? Huseyin Yetik (Istanbul/TR) 11:28 FP SU Photoleukocoria Study: Encouraging the Early Detection of Retinoblastoma and Childhood Blindness Ashwin Mallipatna, Helen Dimaras, Cynthia VandenHoven, Lindsay Hampejsková, Maria Pezzente, Brenda Gallie (Bangalore/IND, Toronto/CDN) 11:35 Radio Tower Lounge 1 14:00-15:30 SU-42 Oculoplasty/Orbita/Lids/Lacrimal System 1 Scientific Program Schedule Sunday, 6 June 10:39 FP SU Computer quantitative assessment of retinal vessel measures in predicting the outcome of retinopathy of prematurity Wai Ching Lam, Crystal Cheung, Ziad Nasser, Nasrin Tehrani (Toronto/CDN) 10:46 FP SU Predictive Value of Pre-plus Disease in Retinopathy of Prematurity David Wallace, Sharon Freedman, Mary Elizabeth Hartnett, Graham Quinn (Durham/USA) 10:53 FP SU Mutational Screening of the RB1 gene in Chinese Patients with Retinoblastoma Bin Li (Beijing/CN) 11:00 FP SU Tumor necrosis factor alpha blockers in the therapy of uveitis in childhood L. A. Katargina, Ekaterina Denisova, A. V. Starikova, N. V. Lubimova (Moscow/RUS) Free Paper Oculoplasty, Orbita, Lids Amarildo Belshi (Tirana/AL) Luigi Colangelo (Chieti/I) Hans-Werner Meyer-Rüsenberg (Hagen/D) 14:00 SL SU Palpebral Reconstructive Surgery Amarildo Belshi (Tirana/AL) 14:09 FP SU Combined Endoscopic and Transconjunctival Approach to the Orbital Apex Gonzalo Blanco-Mateos, Jaime Santos-Pérez, Eduardo J. Duarte Silva, Marta Alonso Mesonero (Valladolid/E) 14:16 FP SU Divided nevus of the eyelids a 10 year experience with 73 Chinese cases Renbing Jia (Shanghai/CN) 11:07 FP SU To know the awareness amongst the children & their parents regarding the conditions causing childhood blindness between age-group 0-18 years. Vikas Mahatme (Nagpur/IND) 14:23 FP SU Eye'dentifying correctable impaired visual acuity and visual field loss in patients undergoing elective lower limb arthroplasty surgery Jaswant Sandhu, Kwok Yin Chan, Philip Roberts (Wolverhampton/UK) 11:14 FP SU Results of late onset amblyopia therapy in excentric fixation Gabriele Gusek-Schneider (Erlangen/D) 11:21 FP SU When good is not good enough visual acuity, refractive error and visual quality in school children Alicja Krawczyk, Jacek P. Szaflik, Urszula Malinowska, Jerzy Szaflik (Warsaw/PL) 14:30 FP SU Eyelid Malposition in Patients with Isolated Congenital and Childhood Acquired Facial Palsy Adel Alsuhaibani, Yasser Elfakey, Robert Goldberg (Riyadh/SA) 14:37 FP SU Dual delivery of VEGF and BMP2 enhances angiogenesis and bone regeneration in critical-size orbital wall defects Caiwen Xiao, Xianqun Fan (Shanghai/CN)

114 110 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :44 FP SU Evaluation of an Integrated Orbital Tissue Expander in Congenital Anophthalmos: Report of Preliminary Clinical Experience David Tse, Mohammad Hafez, Marcia Orozco, Len Pinchuk (Miami/USA) 14:51 FP SU Endonasal dacryocystorhinostomy in children less than 2 years of age Angelo Tsirbas (Bondi Junction/AUS) 14:58 FP SU Nitrogen-containing bisphosphonates: an attractive alternative to surgery in periobital fibrous dysplasia R. J. W. de Keizer (Leiden/NL) 15:05 FP SU Palpebral lipogranuloma caused by transcanalicular ointment injection after laser canaliculoplasty Xianqun Fan, Yefei Wang, Xiaoping Bi (Shanghai/CN) 15:12 16:40 IL SU Choroidal MCT David Pelayes (Buenos Aires/RA) 16:48 IL SU BDUMP Ernest Rand Simpson (Toronto/CDN) 16:56 IL SU Ciliary body mass Arun D. Singh (Cleveland/USA) 17:04 IL SU Cytogenetic analysis of choroidal melanoma after radiotherapy Werner Wackernagel (Graz/A) 17:12 Radio Tower Lounge 2 08:30-10:00 SU-79 Video Session 1: Cataract Radio Tower Lounge 1 16:00-17:30 SU-43 PAAO : Challenging Cases Clinico- Pathologic Correlation Pathology Arun D. Singh (Cleveland/USA) 16:00 IL SU Angiogenesis in Uveal Melnoma Nikolaos E. Bechrakis (Innsbruck/A) 16:08 IL SU Choroidal mass Norbert Bornfeld (Essen/D) 16:16 IL SU Choroidal Osteoma Michael H. Foerster (Berlin/D) Free Paper Horst Helbig (Regensburg/D) Peter Wagner (Ulm/D) 08:30 VF SU Automated Foot-controlled Lens Insertion John Smiles (Canberra/AUS) 08:40 VF SU Complicated IOL insertions: just when you thought your surgery went smoothly... Naira Pereyra-Munoz, Jaun Manuel Paulin-Huerta, Jaime Zapata, Eduardo Chavez-Mondragon (Mexico City/MEX) 08:50 VF SU Implantation technique for the Toric Artiflex Camille Budo (Sint-Truiden/B) 09:00 VF SU In-Situ Phaco a newer concept is a preferred choice in difficult situations Navneet Toshniwal (Solapur/IND) 16:24 IL SU Corneal tumor Hans E. Grossniklaus (Atlanta/USA) 09:10 VF SU Rock 'n Roll phacoemulsification Detlef Uthoff (Kiel/D) 16:32 IL SU The course of a metastasizing conjunctival melanom followed over a period of 15 years Peter Karl Lommatzsch (Leipzig/D)

115 WOC Sunday, 6 June :20 VF SU The MultiKeratome for Cataract Surgery Curved with Multiple Points Engineered to Seal Better and to Minimize the Induced Astigmatism Tom Schossau, Matthew Giegengack, Shree K. Kurup, Gerald W. Zaidman (Scarsdale/USA) 09:30 VF SU Cataract surgery 30 years after excision of a melanotic iris tumor Peter Wagner, Ingo Conzelmann, Gerhard K. Lang (Ulm/D) Radio Tower Lounge 2 10:30-12:00 SU-80 Video Session 2: Miscellaneous 1 Free Paper Wolfgang F. Schrader (Nürnberg/D) Mike P. Holzer (Heidelberg/D) Radio Tower Lounge 2 14:00-15:30 SU-45 Video Session 3: Presentation of Video Awards Free Paper Johann Roider (Kiel/D) H. Burkhard Dick (Bochum/D) Thomas Klink (Würzburg/D) 14:00 VF SU Blind Date: Reencountering Ophthalmology Excellance Victor Cvintal, Jose Ricardo C. L. Rehder, Paulo C. Sampaio (Sao Paulo/BR) 14:10 VF SU Adjuvant use of a novel releasable suture Technique in 20-G Trocar vitrectomy for prevention of imcompetent wound closure Byung Ro Lee, Yumi Song, Young Hee Yoon (Seoul/ROK) Scientific Program Schedule Sunday, 6 June 10:30 VF SU Outcome of hole and chop technique phacoemulcification on hard cataracts Keembiyage Dayawansa (Kandy/CL) 10:40 VF SU Orientation of toric IOL (TIOL) The evolution from Screen Transparencies (STACY) to standardized limbal and axis tracking (Z-ALIGN) Detlev Breyer (Düsseldorf/D) 14:20 VF SU Ipsilateral autologous rotating lamellar keratoplasty with femtosecondlaser Hans-Jürgen Buchwald, Sebastian Kupferschmid, Gerhard K. Lang (Ulm/D) 14:30 VF SU Microincisional surgery of subluxed lenses with the modified capsular tension ring Boris Malyugin (Moscow/RUS) 10:50 VF SU Corneoplastique: ART of Vision Surgery Arun Gulani (Jacksonville/USA) 11:00 VF SU Microendoscopic lacrimal duct surgery Stefan Clemens, Frank Tost, Martin Küstner (Greifswald/D) 11:10 VF SU CO2 Laser Surgery for Ophthalmology Nobuyuki Miyata, Eiichi Okada (Yokohama/J) 11:20 VF SU Overcoming pediatric challenges Manish Mahendra (Kanpur/IND) 11:30 VF SU Hynrid Technique using conventional illuminated Infusion Cannula in any Gauge Trocar Vitrectomy Byung Ro Lee, Yumi Song, Yong Woon Shin (Seoul/ROK) 14:40 VF SU Pediatric Cataract Surprises Tanja M. Rabsilber, Mike P. Holzer, Maria J. Sanchez, Dragana Vucic, Gerd U. Auffarth (Heidelberg/D, Knjazevac/SRB) 14:50 VF SU Treatment of complex ocular trauma with 25/23 gauge systems Cesare Forlini, Paolo Rossini (Ravenna/I) 15:00 VF SU Glued IOL Reloaded Amar Agarwal (Chennai/IND) 15:10 Video Award of the DOG, donated by Carl Zeiss Meditec AG (Munich/D)

116 112 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June 2010 Radio Tower Lounge 2 16:00-17:30 SU-81 Video Session 4: Miscellaneous 2 Free Paper Hans-Jürgen Buchwald (Ulm/D) Klaus-Peter Steuhl (Essen/D) 16:00 VF SU Parachute Keratoplasty Wesley Herman, Oren N. Fass (Dallas/USA) 16:10 VF SU Ahmed Glaucoma Valve-Prime,Implant and Reprime Dipanjan Pal, Alokesh Ganguly (Kolkata/IND) Hall 3 08:30-10:00 SU-48 Retinal Detachment and PVR Subspecialty Day Retina George William Aylward (London/UK) Alain Gaudric (Paris/F) 08:30 IL SU Surgical instrumentation for RD and PVR repair (20, 23, 25 g etc.) Constantin J. Pournaras (Geneva/CH) 08:40 IL SU Which new drugs can treat PVR? Louisa Wickham (London/UK) 16:20 VF SU Superficial Lateral Canthopexy to Correct Lateral Canthal Tendon Disinsertion Erin Shriver, David Tse (Palm Beach Gardens/USA, Miami/USA) 16:30 VF SU Surgical approach in acute retinal necrosis Ilian Shandurkov, Petja Vassileva, Tatyana Hergeldzhieva, Daniela Paskaleva (Sofia/BG) 16:40 VF SU Diagnostic image-guide for indentification of early acute retinal necrosis Byung Ro Lee, Yong Woon Shin (Seoul/ROK) 16:50 VF SU Half day for eye screening cures blindness in many Rekha Khandelwal, Shashank Bidaye, D. Kose, Mohana Majumdar, Shivani Bidaye (Nagpur/IND) 17:00 VF SU Jesus and the Eye: New Testament Miracles of Vision Ahmad Mansour, Ahmad Nasri, Rami Santini, Majd Akar (Beirut/RL) 08:50 IL SU Is there still place for scleral buckling in primary surgery for RD? Heinrich Heimann (Liverpool/UK) 09:00 IL SU Management after failure of primary RD-repair Periklis Brazitikos (Athens/GR) 09:10 IL SU Prevention of RD: are there cases in which it is worthwhile Fred Hendrikse (Maastricht/NL) 09:20 IL SU Management of second eye in vitreoretinal dystrophies Antonio Capone (Oakland/USA) 09:30 IL SU Trauma and vitreoretinal surgery timing and management Masahito Ohji (Otsu/J) 09:40 IL SU Intraocular tamponade what s new David Wong (Pok Fu Lam/HK) 09:50 IL SU Hot topic (last minute announcement) TBA

117 WOC Sunday, 6 June 2010 Hall 3 10:30-12:00 SU-49 Vitreoretinal Interface Epiretinal Macular Surgery Subspecialty Day Retina Alain Gaudric (Paris/F) Michael T. Trese (Royal Oak/USA) 10:30 IL SU Pathology of the vitreoretinal interface: Implications for surgery Arnd Gandorfer (Munich/D) Hall 3 14:00-15:30 SU-50 Retinal Vascular Diseases: Diabetic Retinopathy / Vein Occlusions Subspecialty Day Retina Michael T. Trese (Royal Oak/USA) Anselm Kampik (Munich/D) 14:00 IL SU Retinal oximetry in diabetic retinopathy and retinal vein occlusions Einar Stefánsson (Reykjavik/IS) Scientific Program Schedule Sunday, 6 June 10:40 IL SU Microplasmin to treat vitreomacular traction: results of a phase III clinical trial (MIVI-006) Matthew S. Benz (Houston/USA) 10:50 IL SU Progress in epiretinal surgery: vital stains Christos Haritoglou (Munich) 11:00 IL SU Macular hole surgery: is face -down positioning still necessary? D. Alistair H. Laidlaw (London/UK) 11:10 IL SU Macular hole surgery: is ILM peeling always useful? Ramin Tadayoni (Paris/F) 11:20 IL SU ERM and VMTS surgery: cases which fail Thomas J. Wolfensberger (Lausanne/CH) 11:30 IL SU Vitreoretinal interface in AMD Susanne Binder (Vienna/A) 11:40 IL SU Vitreoretinal Interface in children therapeutic implications Michael T. Trese (Royal Oak/USA) 11:50 IL SU Hot topic (last minute announcement) TBA 14:10 IL SU Steroids vs laser in DME Pascale Massin (Paris/F) 14:20 IL SU Anti VEGFs vs Steroids in DME Julia A. Haller (Philadelphia/USA) 14:30 IL SU Slow release steroids in DME Frank G. Holz (Bonn/D) 14:40 IL SU Combination of pharmacology and VR surgery in DR J. Fernando Arevalo (Caracas/Y) 14:50 IL SU Does early intravitreal drug therapy change the course of BRVO and CVRO Francesco Bandello (Milano/I) 15:00 IL SU Is surgery useful in BRVO and CRVO José García Arumí (Barcelona/E) 15:10 IL SU Hot topic (last minute announcement) TBA 15:20 IL SU Hot topic (last minute announcement) TBA

118 114 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June 2010 Hall 3 16:00-17:30 SU-51 AMD Subspecialty Day Retina Anselm Kampik (Munich/D) George William Aylward (London/UK) 16:00 IL SU When to stop anti VEGF therapy? Adnan Tufail (London/UK) 16:10 IL SU Update on Clinical Trials of Intravitreal Drugs for Neovascular AMD Alexander J. Brucker (Philadelphia/USA) 16:20 IL SU Geographic atrophy: Imaging Metrics and Progression Determinants Frank G. Holz (Bonn/D) 16:30 IL SU Future drugs for treatment of dry AMD Salvatore Grisanti (Lübeck/D) 16:40 IL SU Genetics and prevention of AMD Hendrik Peter Nicolas Scholl (Bonn/D) 16:50 IL SU Is there a place for surgery in AMD? Jan van Meurs (Rotterdam/NL) 17:00 IL SU Cell therapy for AMD TBA 17:10 IL SU How to prevent endophthalmitis in intravitreal therapy? Thierry C. Verstraeten (Pittsburgh/USA) 17:20 IL SU Hot topic (last minute announcement) TBA Hall 6 08:30-10:00 SU-52 AAPOS : Emerging Concepts in Amblyopia and Strabismus 2010: Recognizing Gunter K. von Noorden, MD Strabismus Michael X. Repka (Baltimore/USA) Monte A. Del Monte (Ann Arbor/USA) Mohamad Jaafar (Washington/USA) 08:30 IL SU Treatment of bilateral superior oblique palsy Derek Sprunger (Indianapolis/USA) 08:40 IL SU Brown Syndrome: When and How to Intervene Mohamad Jaafar (Washington/USA) 08:50 IL SU The Goal of Treatment in "Organic Amblyopia" Robert LaRoche (Halifax/CDN) 09:00 IL SU Lessons Learned in Strabismus Diagnosis from Telemedicine Eugene Helvestone (Indianapolis/USA) 09:10 IL SU Atropine Treatment for Severe Amblyopia Michael X. Repka (Baltimore/USA) 09:20 IL SU TBD Jan-Tjeerd de Faber (Rotterdam/NL) 09:30 IL SU Strabismus in patients with posterior fossa tumors Jane C. Edmond (Houston/USA) 09:40

119 WOC Sunday, 6 June 2010 Hall 6 10:30-11:15 SU-53 Journal Publications, As a Mean to Evaluate Scientists: He/She Publishes in Good Journals World Forum of Journal Editors Martine J. Jager (Leiden/NL) Gerhard K. Lang (Ulm/D) 10:30 IL SU Journal independent evaluation of scientists and faculties by citation counts Holger Schwechheimer (Bielefeld/D) 10:40 IL SU The Better Way to Evaluate Researchers Martine J. Jager (Leiden/NL) 10:50 IL SU Is there a future to Non-English scientific journals? Gerhard K. Lang (Ulm/D) 11:00 Hall 6 Hall 6 14:00-15:30 SU-78 Posterior Lamellar Keratoplasty External Eye Disease, Cornea Francis W. Price (Indianapolis/USA) Claus Cursiefen (Erlangen/D) Thomas Reinhard (Freiburg/D) 14:00 IL SU Long-term results of DSEK/DSAEK in over 1300 cases: endothelial cell counts, incidence of rejection, visual acuity, glaucoma Francis W. Price (Indianapolis/USA) 14:10 IL SU DSAEK in Asian Eyes: The Singapore Perspective Donald T. H. Tan (Singapore/SGP) 14:20 IL SU Femtosecond laser-assisted DSAEK Philip Maier (Freiburg/D) 14:30 IL SU Is DMEK the preferred method of PLK? How can corneal surgeons begin doing this? Gerrit R. J. Melles (Rotterdam/NL) Scientific Program Schedule Sunday, 6 June 11:15-12:00 SU-54 Reviewers, Contents Language 14:40 IL SU Advances in EK techniques Massimo Busin (Forli/I) World Forum of Journal Editors Martine J. Jager (Leiden/NL) Einar Stefánsson (Reykjavik/IS) Gerhard K. Lang (Ulm/D) 14:50 IL SU Results of his hybrid DSEK/DMEK technique Pavel Studeny (Sokolov/CZ) 15:00 IL SU The German DMEK Experience Friedrich E. Kruse (Erlangen/D) 11:15 IL SU How to find suitable reviewers Martijn J. Schuemie (Rotterdam/NL) 15:10 IL SU Scuba Technique for DMEK: Results and Pearls Art Giebel (Chehalis/USA) 11:25 IL SU Is the presentation of a theory sufficient to justify publication? Einar Stefánsson (Reykjavik/IS) 15:20 IL SU Cultivated Endothelial Cell Transplantation: The Future? Shigeru Kinoshita (Kyoto/J) 11:35 IL SU Current situation and prospects of Chinese ophthalmological journals internationalization Xiu-Wen Hu (Xi an/cn) 11:45

120 116 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June 2010 Hall 6 16:00-17:30 SU-56 Anatomy/Pathology Free Paper Anatomy/Pathology Gottfried O. H. Naumann (Erlangen/D) Gerhard K. Lang (Ulm/D) Hans Eberhard Völcker (Heidelberg/D) 16:00 FP SU Diagnosis and differential diagnosis of orbital spindle cell tumours Yongping Li (Guangzhou/CN) 16:07 FP SU Applied anatomy of endoscopic transnasal lacrimal duct reconstruction with grafting of autogenous tissue Hai Tao (Beijing/CN) 16:14 FP SU Analysis of p53 mutations and the expression of p53 and p21waf1/cip1 protein in sebaceous carcinoma of the eyelid Kunihiro Kiyosaki, Chisato Nakada, Masamoto Imaizumi, Masatsugu Moriyama, Toshiaki Kubota (Yufu/J) 16:21 FP SU Alterations of the cornea and retina in a mouse model of Niemann-Pick disease type C1 Marine Hovakimyan, Oliver Stachs, Mariya Reichard, Arndt Rolfs, Jan Lukas, Moriz Frech, Rudolf Guthoff, Martin Witt, Andreas Wree (Rostock/D) 16:28 FP SU Clinical and pathologic studies on nanophthalmos complicated with uveal effusion Jing Tao, Naiqing Weng, Ningli Wang, Bowen Zhao, Qian Liu (Beijing/CN) 16:35 SL SU Value of ocular pathology in clinical practice Gerhard K. Lang (Ulm/D) 16:44 FP SU Introduction Gottfried Naumann (Erlangen/D) 16:49 FP SU Ophthalmic Pathology Award Ursula Schlötzer-Schrehardt (Erlangen/D) Hall 7 08:30-10:00 SU-34 Oncology 1 Free Paper Oncology Nikolaos E. Bechrakis (Innsbruck /A) Tero Kivelä (Helsinki/FIN) Steffen Heegaard (Copenhagen/DK) 08:30 SL SU Ophthalmic Oncology and Pathology Steffen Heegaard (Copenhagen/DK) 08:39 SL SU Hemodynamic modifications of the choroid and the retina in ocular oncology Leonidas Zografos, A. Schalenbourg, L. Chamot (Lausanne/CH) 08:48 FP SU The role of transpupillary thermotherapy in treatment of residual and recurrent choroidal melanomas Svetlana V. Saakyan, Vladimir V. Valsky, Ekaterina A. Semenova (Moscow/RUS) 08:55 FP SU SD OCT and Auto-Fluorescence Features of Indeterminate Choroidal Melanocytic Lesions Arun Singh, Rubens Belfort, Kaori Sayanagi, Peter Kaiser (Cleveland/USA, São Paulo/BR) 09:02 FP SU Changing concepts regarding management of orbital extension of uveal melanoma Jerry Shields, Carol Shields, Ralph C. Eagle (Philadelphia/USA) 09:09 FP SU Receiver Operating Characteristic (ROC) Curve for the Marker Melanoma inhibitory activity (MIA) in Patients with Metastatic Uveal Melanoma Annemarie Klingenstein, Ingrid Haritoglou, Markus Schaumberger, Martin Nentwich, Hein Rüdiger, Ulrich Christoph Schaller (Munich/D) 09:16 FP SU Choroidal Melanocytic Clusters: A Distinct Clinical Entity? James J. Augsburger, Zelia M. Corrêa, Camila C. Simões (Cincinnati/USA) 09:23 FP SU Imaging of anterior segment tumours Lubna Razzaq, Marina Marinkovic, G. Luyten, J. C. Bleeker, R. J. W. de Keizer (Leiden/NL)

121 WOC Sunday, 6 June :30 FP SU Metastasis of iris, ciliary body, and choroidal melanoma in 8033 patients Carol Shields, Minoru Furuta, Archana Thangappan, Saya Nagori, Rishita Nutheti, Arman Mashayekhi, Jerry Shields (Philadelphia/USA) 09:37 FP SU Role of episcleral brachytherapy as adjuvant therapy in conjunctival tumors Alejandro Portero-Benito, Carmen Valverde-Collar, Ester Carreño, Maria Antonia Saornil, Ciro Garcia-Alvarez, Jesus M. Frutos, Patricia Diez- Andino, Francisco J Lopez-Lara (Valladolid/E) 09:44 FP SU Clinical profile of epithelial conjunctival tumors at an ocular oncology unit Ester Carreño, Alejandro Portero-Benito, Fernando Sánchez-Mannarelli, María Antonia Saornil, María Fe Muñoz, Ciro García-Álvarez (Valladolid/E) 10:58 FP SU Descemet s Membrane Endothelial Keratoplasty (DMEK): safety and outcomes Aruna Dharmasena (Manchster/UK) 11:05 FP SU New method of destructive corneal diseases treatment by using cellular technology Daria Danilova, Ekaterina Chentsova, Irina Saburina, Irina Maklakova (Moscow/RUS) 11:12 FP SU Corneal aberrometric and refractive performance of 2 intrastromal corneal ring segment models in early and moderate ectatic disease David Pablo Piñero Llorens, Jorge Alió (Alicante/E) 11:19 FP SU Corneal Intrastromal Implantation Surgery (CISIS) vs. Keratoplasty for the treatment of Keratokonus Albert Daxer (Ybbs/A) Scientific Program Schedule Sunday, 6 June 09:51 Hall 7 11:26 FP SU Effectiveness of Triple Procedure in Severe Bacterial Keratitis Shamurad Amansakhatov, Maya Zhutdieva (Seyidi/TUR) 10:30-12:00 SU-35 Cornea/External Disease: Surgical therapy 1 Free Paper Cornea, External Disease Stefano Barabino (Genova/I) Chris Patrick Lohmann (Munich/D) 11:33 FP SU Cultured oral epithelium in treatment of limbal stem cell deficiency in aniridia Dariusz Dobrowolski, Edward Wylegala (Sosnowiec/PL, Katowice/PL) 11:40 FP SU Quadruple-procedure for Correction of Congenital Aniridia with Cataract and Corneal Scarring Alexey Dashevsky, Konstantin Kotliar (Munich/D) 10:30 FP SU Crosslinking and Topography-guided Surface Ablation for Keratoconus-121 Eyes Tassos Georgiou, Pavlos Greveniotis, Soula Michael, Panayiotis Neophytou (Nicosia/CY) 11:47 Hall 7 10:37 FP SU Effect of an irregular anterior surface on a lamellar femtosecond laser cut Robert Fintelmann, Michele Bloomer, Bennie Jeng (San Francisco/USA) 10:44 FP SU Cross-Linking for Progressive Keratoconus in Pediatrics Aldo Caporossi, Cosimo Mazzotta, Stefano Baiocchi, Rosario Denaro (Siena/I) 14:00-15:30 SU-36 Refractive Surgery/Refraction 2 Free Paper Refractive Surgery Joseph Colin (Bordeaux/F) Béatrice Cochener (Brest/F) Stephen G. Slade (Houston/USA) 10:51 FP SU Keratoprosthesis. 40-year experience of study and application in the Filatov Institute (analysis of 1000 operations) Stanislav Iakymenko (Odessa/UA) 14:00 SL SU Keys for Successful phakic IOLs implantation Béatrice Cochener, Pierre Marie Josselin, Mathieu Lamard (Brest/F)

122 118 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :09 FP SU Corneal stromal ablation by femtosecond UV pulses: in vivo study Egle Danieliene, Romualdas Danielius, Egle Gabryte, Osvaldas Ruksenas, Agne Vaiceliunaite, Mikas Vengris (Vilnius/LT) 14:16 FP SU Results of All-in-One Femtosecond Laser Surgery for correction of myopia and myopic astigmatism Rupal Shah (Vadodara/IND) 14:23 FP SU The functional results of the Sub-Bowmen Femto-keratomileusis (SBFK) & Tissue Saving Ablation (TSA) Alexander Doga, Galina Kachalina, Nataliya Maychuk (Moscow/RUS) 14:30 FP SU Comparison of postoperative pain, reepithelialization speed and early visual and refractive outcomes between PRK with mechanical epithelial removal and integrated transepithelial custom ablation in treatment of low to moderate myopia Xiangjun Chen (Oslo/N) 14:37 FP SU Tunnel Keratoplasty with Different Intracorneal Implants in Myopia and Myopic Astigmatism Correction, 20-Year-Old Experience Yuriy Shusterov (Karaganda/KZ) 14:44 FP SU Theoretical relationship between surgical parameters and refractive correction of conductive keratoplasty Xiaobing Wang (Beijing/CN) 14:51 FP SU Use of an Image-Guided Femtosecond Laser in Cataract Surgery with Accommodating or Multi-Focal IOL Stephen Slade (Houston/USA) 14:58 FP SU Position-depending pseudo-accommodation of retropupillary fixed iris claw lenses Kilian Schöpfer, Alexandra Berger, Bernhard M. Stoffelns, Walter Sekundo (Mainz/D, Marburg/D) 15:05 FP SU Effects of Pterygium on Ocular Aberrations Siamak Zarei-Ghanavati, Mohammad Zare, Mohammad-Reza Ansari-Astaneh, Alireza Baradaran-Rafiee, Bahram Einolahi (Mashhad/IR) 15:12 Hall 7 16:00-17:30 SU-37 External Disease, Dry Eye Free Paper Cornea, External Disease Juha M. Holopainen (Helsinki/FIN) Janos Németh (Budapest/H) Zbigniew Zagórski (Lublin/PL) 16:00 SL SU Molecular pathogenesis of dry eye Juha Holopainen (Helsinki/FIN) 16:09 SL SU New diagnostic methods in dry eye Janos Németh (Budapest/H) 16:18 FP SU Results of phase 1 tolerability study of LX214 (0.2% Voclosporin topical solution) in healthy volunteers and subjects with Keratoconjunctivitis Sicca (KCS) Thomas Reinhard, Daniel Böhringer, Sid Weiss, Eddy Anglade (Freiburg/D, Jersey City/USA) 16:25 FP SU Biomarkers for Dry Eye Tested in Two Patient Populations Roger Beuerman, Choi Mun Chan, Lei Zhou, Louis Tong, Michael Stern, Xiaor Li, Shao Zhao (Singapore/SGP) 16:32 FP SU Assessment of Dry Eye Treatment Effectiveness Using the TearLab Osmolarity System Timothy Albert, Marco Nardi, Chiara Posarelli, Umberto Benelli (Pisa/I) 16:39 FP SU Immune Response in Conjunctival Epithelium of Dry Eye Patients Stefano Barabino (San Remo/I) 16:46 FP SU Permanent punctal occlusion for severe dry eye syndrome a new approach Chedly Bouzouaya, Peter Raus (Tunis/TN, Mol/B) 16:53 FP SU Liposomes spray versus non preserved tears substitutes in patients with meibomian gland dysfunction Maria Elena Langman, Nathalie Amouroux-Gicquel, Jean-Jacques Gicquel (Poitiers/F)

123 WOC Sunday, 6 June :00 FP SU Role of Ultrasound Bio-Microscopy (UBM) in the diagnosis of subconjunctival cysticercosis Bipasha Mukherjee (Chennai/IND) 17:07 Hall 8 10:30-12:00 SU-61 Strabismus Free Paper Strabismus Günther Rudolph (Munich/D) Oliver Zeitz (Berlin/D) Andrea Zin (Rio de Janeiro/BR) 11:12 FP SU Superior Oblique Palsy A Review of 817 Cases Ze Wang (Nanjing/CN) 11:19 FP SU Treatment of potentially amblyopia inducing early childhood eyelid hemangioma with systemic propanolol Rike Michels, Kathrin Schaeffer, Veit Sturm, Marcel Menke, Klara Landau, Clemens Schiestl (Zurich/CH) 11:26 FP SU Diplopia after orbital floor fracture: Look for the causative muscle away from the floor in some cases Akmal Rizk (Cairo/ET) 11:33 FP SU Triamcinolone acetonide loaded PLGA nanoparticles pharmacokinetics characterization and application in actue extraocular muscle injury Hong Yan, Lihua Sun (Xi'an/CN) Scientific Program Schedule Sunday, 6 June 10:30 FP SU Multifocal VEP, Bifoveal Fusion and Stereopsis in Children with Esotropia Wei Zhang (Tianjin/CN) 10:37 FP SU Comparisons of cryo therapy and laser therapy with simple follow-up in globe perforation meanwhile strabismus surgery in an animal model Abbas Bagheri (Teheran/IR) 10:44 FP SU CFEOM Congenital fibrosis of the extraocular muscles. Clinical phenotypes and molecular mechanisms. Günther Rudolph, Alfons Meindl, Michael Nentwich, Heide Hellebrand (Munich/D) 10:51 FP SU Analysis of patients with congenital fibrosis of the extraocular muscles: clinical, tomographic and genetic findings. Naira Pereyra-Munoz, Claudia Murillo-Correa, Sanjuanita Flores-Limas, Juan Carlos Zenteno Ruiz (Mexico City/MEX) 10:58 FP SU Ultrarapid School Vision Screening Using the Brückner test Mihir Kothari (Mumbai/IND) 11:05 FP SU Inverse occlusion a therapy option bei eccentric fixation 20 years follow-up Samad Abri, E. Windischbauer, E. Kramar, T. K. Keindl, B. Neudorfer, Siegfried Priglinger (Salzburg/A, Linz/A) 11:40 Hall 9 08:30-10:00 SU-62 Teleophthalmology Free Paper Teleophthalmology Georg Michelson (Erlangen/D) Norbert Franz Schrage (Cologne/D) 08:30 FP SU Automated Estimation of Image-Level Vessel Tortuosity in Retinal Images Alfredo Ruggeri, Giovanni Ughi, Enrico Grisan, Tunde Peto (Padua/I, London/UK) 08:37 FP SU Telemedicine diabetic retinopathy assessment in the US: Impediments to wide-scale adoption Ingrid E. Zimmer-Galler, Ran Zeimer (Frederick/USA) 08:44 FP SU Tele-ophthalmology as a screening tool for Diabetic retinopathy in a rural population Rodney John Morris, Narendran Venkatapathy (Coimbatore/IND, Tamilnadu/IND)

124 120 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :51 FP SU Automated Image Analysis and Disease Stratification in RISANet: a Web-Based Telemedicine Network in the Southern United States Thomas Karnowski, Kenneth Tobin, Luca Giancardo, Yaqin Li, Seema Garg, Michael Abramoff, Matthew Tennant, Karen Fox, Edward Chaum (Oak Ridge/USA) 08:58 FP SU Comparing the accuracy of a RETCAM Trained Technician versus a Pediatric Ophthalmologist-intraining in diagnosing Retinopathy of Prematurity (ROP) using wide-field digital imaging Mayuri Bhargava, Anand Vinekar, Ravindra Battu, P. Devika, Bhujang Shetty, Siva Kumar (Bangalore/IND) 10:50 IL SU Definition and Classification of MGD Gary Foulks (Louisville/USA) 11:00 IL SU Epidemiology of, and Associated Risk Factors for, MGD David Sullivan (Boston/USA) 11:10 IL SU Evaluation, Diagnosis and Grading of Severity of MGD Anthony Bron (Oxford/UK) 11:20 IL SU Design and Conduct of Clinical Trials Kerstin Wickstrom (Uppsala/S) 09:05 SL SU First clinical application of the ACTO online visual evaluation Norbert Schrage, B. Seeliger, F. Simsonsen (Köln/D) 09:14 FP SU Telemedicine in ophthalmic practice our experience with Cyber-Sight Nikolay Surchev, Petja Vassileva, Tatyana Hergeldzhieva-Fileva, Yordanka Kirilova, Ilian Shandurkov (Sofia/BG) 11:30 IL SU Management and Therapy of MGD Gerd Geerling (Würzburg/D) 11:40 Hall 9 14:00-15:30 SU-64 09:21 Beyond Vertical Programs: Challenges and Success in Building in Comprehensive Eye Care Within a Health Care System Hall 9 10:30-12:00 SU-63 Tear Film & Ocular Surface Society : A Report from the International Workshop on Meibomian Gland Dysfunction Vision 2020 Prevention of Blindness Rubens Belfort, Jr. (São Paulo/BR) Petja Ivanova Vassileva (Sofia/BG) Robert P. Finger (Bonn/D) External Eye Disease, Cornea David Sullivan (Boston/USA) Anthony Bron (Oxford/UK) Gary Foulks (Louisville/USA) 10:30 IL SU Anatomy, Physiology and Pathophysiology of the Meibomian Gland Erich Knop (Berlin/D) 10:40 IL SU Tear Film Lipids, and Lipid-Protein Interactions, in Health and Disease Friedrich Paulsen (Halle/D) 14:00 IL SU Eye care services in the Republic of Kosovo Gazmend Kaçaniku (Prishtina/KS) 14:10 IL SU WetLab educational system for ophthalmic microsurgery the Russian experience Boris Malyugin (Moscow/RUS) 14:20 IL SU Providing comprehensive eye care within underfinanced health care system Tatyana G. Hergeldzhieva-Fileva (Sofia/BG) 14:30 IL SU TBA Paulo Henrique Morales (São Paulo/BR) 14:40 IL SU The Cuban Eye Care Program as innovative public model of health system Marcelino Rio Torres (Ciudad Habana/C)

125 WOC Sunday, 6 June :50 IL SU Comprehensive eye care at the Sankara Eye Foundation R. V. Ramani (Coimbatore/IND) 15:00 IL SU Vision 2020 in Latin America Rainaldo Duerksen (Asunción/PY) 15:10 Hall 9 16:00-17:30 SU-65 Vision 2020: 10 Years on, 10 Years to go Vision 2020 Prevention of Blindness Hall 10 10:30-12:00 SU-67 ISOO : Ocular Lymphoma Oncology Jacob Pe'er (Jerusalem/IL) Sarah E. Coupland (Liverpool/UK) Geeta Vemuganti (Hyderabad/IND) 10:30 IL SU Overview on ocular adnexal lymphoma Lene Dissing Sjo (Copenhagen/DK) 10:40 IL SU Update on ocular adnexal MALT lymphoma Estelle Chanudet (Cambridge/UK) Scientific Program Schedule Sunday, 6 June Hugh R. Taylor (Carlton/AUS) Volker Klauss (Munich/D) Ivo Kocur (Geneva/CH) 16:00 IL SU Why VISION 2020 was Initiated Allen Foster (London/UK) 16:10 IL SU How VISION 2020 Developed Gullapali N. Rao (Hyderabad/IND) 16:20 IL SU VISION 2020 in Africa the Challenge in Developing Countries Daniel Etya'ale (Geneva/CH) 16:30 IL SU VISION 2020 in Latin America the Challenge in Mid Level Countries Rainaldo Duerksen (Asunción/PY) 16:40 IL SU VISION 2020 in Australia the Challenge in Developed Countries Hugh R. Taylor (Carlton/AUS) 16:50 IL SU The Role of Advocacy and Political Leadership Abdulaziz AlRajhi (Riyadh/SA) 10:50 IL SU Unusual Ocular Andexal Lymphomas Geeta Vemuganti (Hyderabad/IND) 11:00 IL SU TNM staging of ocular adnexal lymphoma Sarah E. Coupland (Liverpool/UK) 11:10 IL SU Treatment of ocular adnexal lymphoma Bita Esmaeli (Houston/USA) 11:20 IL SU Overview of intraocular lymphoma Justine R. Smith (Portland/USA) 11:30 IL SU Clinical presentations of intraocular lymphoma Nathalie Cassoux (Paris/F) 11:40 IL SU Treatment of vitreoretinal lymphoma with methotrexate Jacob Pe'er (Jerusalem/IL) 11:50 IL SU Treatment of Vitreoretinal lymphoma with rituximab Jose S. Pulido (Rochester/USA) 17:00 IL SU Lessons Learnt and the Way Forward Ivo Kocur (Geneva/CH) 17:10

126 122 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June 2010 Hall 10 14:00-15:30 SU-68 Egyptian German : Combined Surgeries in Ophthalmology International Ophthalmology Sherif Shetta (Cairo/ET) Mostafa Hunter (Bonn/D) Berthold Seitz (Homburg/D) 14:00 IL SU International Public Private Partnership in Eye Healthcare, a Success Story between Egypt and Germany Mostafa Hunter (Bonn/D) 14:10 IL SU Sustainable Relationships between Egyptian and German Pediatric and Rehabilitative Ophthalmology Barbara Käsmann-Kellner (Homburg/D) 14:20 IL SU Combined Scleral Buckling and Pars Plana Vitrectomy in the Management of Primary Retinal Detachment Sherif Shetta (Cairo/ET) 14:30 IL SU Temporary Keratoprosthesis in the Management of Posterior Segment Problems in Eyes with Opaque Corneas Hassan Mortada (Cairo/ET) Hall 10 16:00-17:30 SU-69 Greek German : From Γλαυχοµα to Neuroprotection a Long Journey in Understanding Glaucoma Glaucoma Solon Thanos (Münster/D) Zisis Gatzioufas (Homburg/D) Berthold Seitz (Homburg/D) 16:00 IL SU Congenital glaucoma today Nikolaos Kozeis (Thessaloniki/GR) 16:10 IL SU The spectrum of pediatric glaucoma beyond buphthalmia Barbara Käsmann-Kellner (Homburg/D) 16:20 IL SU Sclerotrabeculectomy for better IOP control Vassilios Kozobolis (Alexandroupoli/GR) 16:30 IL SU Glaucoma management before and after keratoplasty Christian-Paul Jonescu-Cuypers (Homburg/D) 16:40 IL SU Present and future role of fixed combinations in glaucoma therapy Anastasios Konstas (Thessaloniki/GR) 14:40 IL SU Combined Procedures in Diabetic Vitrectomy Mahmoud Soliman (Cairo/ET) 14:50 IL SU Simultaneous Glaucoma and Cataract Surgery Christian-Paul Jonescu-Cuypers (Homburg/D) 16:50 IL SU Neuroprotection in glaucoma: reality soon or dream? Solon Thanos (Münster/D) 17:00 15:00 IL SU Combined Corneal Transplantation and Cataract Surgery ( The Triple Procedure ) Berthold Seitz (Homburg/D) 15:10

127 WOC Sunday, 6 June 2010 Roof Garden 10:30-12:30 SU-70 Highlights of Anterior Segment Surgery & Refractive Surgery Cataract, Refractive Surgery Joaquin Barraquer (Barcelona/E) Rafael Barraquer (Barcelona/E) Maria-Elena Barraquer (Barcelona/E) This 120-minutes multi-authored is divided in five different sections: 1. Cataract Surgery; 2. Corneal Surgery; 3. Refractive Surgery (Cornea and Lens); 4. Surgical Management of Glaucoma; and 5. Management of Ocular Injuries. Each section comprises several rapid fire contributions of different members of the team from Barcelona, illustrated with didactic material and challenging casuistics. Cataract surgery is reviewed from the suction cup procedure for intracapsular extraction, called Phacoerysis, invented in 1917, inclusion of intraocular anterior chamber lenses to correct aphakia (1954) and enzymatic zonulolysis to overcome zonular resistence prior to the extraction (1958), to modern techniques such as sonophaco and injectable lenses with due consideration to management of certain complications, such as secondary cataract and intraoperative small pupil. In the Section on Corneal Surgery the techniques of anterior and posterior lamellar procedures are presented. The topics discussed in the Section on Refractive surgery (Cornea and Lens) include molding of the cornea (crosslinking), photokeratomileusis for astigmatismus, tectonic and refractive large diameter penetrating keratoplasties, clear lens extraction and multifocal IOL. In Glaucoma Surgery, besides advances in goniotomy and iridotomy, the procedure of non-perforating deep sclerecotomy with intrascleral T-Flux implantation is highlighted. The Section of Management of Ocular Injuries includes modern approach of severe physical (explosion) and chemical trauma. Cataract Surgery 10:37 IL SU Strampelli s anterior chamber IOL Joaquin Barraquer (Barcelona/E) 10:38 IL SU Sonophaco & injectable lenses Maria-Elena Barraquer (Barcelona/E) 10:42 IL SU YAG Laser capsulotomy for secondary cataract Isabel Canut (Barcelona/E) 10:43 IL SU Management of intraoperative small pupil Rafael Barraquer (Barcelona/E) 10:49 Corneal Surgery 10:58 IL SU Lamellar anterior keratoplasty Rafael Barraquer (Barcelona/E) 11:03 IL SU Lamellar posterior keratoplasty J. P. Alvarez de Toledo (Barcelona/E) 11:08 Refractive Surgery 11:13 IL SU Molding of the cornea from intracorneal segments to collagen crosslinking Rafael Barraquer (Barcelona/E) 11:22 IL SU Photokeratomileusis in astigmatismus induced by keratoplasty J. P. Alvarez de Toledo (Barcelona/E) 11:25 IL SU Large diameter penetrating keratoplasties (Tectonic and refractive) Joaquin Barraquer, Mercé Uxó (Barcelona/E) Scientific Program Schedule Sunday, 6 June 10:30 IL SU Introduction Joaquin Barraquer (Barcelona/E) 11:37 IL SU Clear lens extraction and multifocal IOL Maria-Elena Barraquer (Barcelona/E) 10:31 IL SU Phacoeresis of Professor Ignacio Barraquer Maria-Elena Barraquer (Barcelona/E) 11:42 10:33 IL SU Enzymatic Zonulolysis Joaquin Barraquer (Barcelona/E)

128 124 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June 2010 Surgical Management of Glaucoma 11:47 IL SU Goniotomy Ignacio García-Barberán, Joaquin Barraquer (Barcelona/E) 11:49 IL SU Peripheral Iridotomy Muhsen Samaan (Barcelona/E) 11:50 IL SU Non-perforating deep sclerectomy with intrascleral implantation of T-Flux Isabel Canut, Joaquin Barraquer (Barcelona/E) 11:55 14:20 IL SU Management of Lacrimal Trauma Hunter K. L. Yuen (Kowloon/HK) 14:30 IL SU Current Techniques in DCR Yannis Ntountas (GR) 14:40 IL SU Microendoscopy of the Lacrimal Outflow System Efficacy of Endoscopic Lacrimal Duct Recanalization using Microendoscope Reynaldo M. Javate (Manila/RP) 14:50 IL SU Influence of Microendoscopic Techniques to Lacrimal Surgery Karl-Heinz Emmerich (Darmstadt/D) Management of Ocular Injuries 15:00 12:00 IL SU Bomb explosion affecting both eyes Joaquin Barraquer, Mercé Uxó (Barcelona/E) 12:14 IL SU Alkali burn with extensive ocular surface alterations Juan P. Alvarez de Toledo, Mª de la Paz (Barcelona/E) 12:21 IL SU Keratoprosthesis Joaquin Barraquer, José Temprano (Barcelona/E) 12:25 Roof Garden 16:00-17:30 SU-72 Strategies in Surgical Treatment of Eye Diseases in Childhood Pediatric Ophthalmology Wolf A. Lagrèze (Freiburg/D) Daniel Mojon (St. Gallen/CH) Herbert Jägle (Regensburg/D) Roof Garden 14:00-15:30 SU-71 New Diagnostic and Therapeutic Aspects of Lacrimal Diseases 16:00 IL SU Minimally invasive strabismus surgery Daniel Mojon (St. Gallen/CH) 16:15 IL SU Advances in the treatment of pediatric glaucoma Peng T. Khaw (London/UK) Oculoplasty, Lacrimal System, Orbit Karl-Heinz Emmerich (Darmstadt/D) Reynaldo M. Javate (Manila/RP) James Oestreicher (Toronto/CDN) 16:30 IL SU Current management of pediatric cataract Wolf A. Lagrèze (Freiburg/D) 16:45 IL SU Current management of capillary hemangioma Herbert Jägle (Regensburg/D) 14:00 IL SU Clinical and Imaging Evaluation of the Tearing Patient James Oestreicher (Toronto/CDN) 14:10 IL SU Congenital Lacrimal Disorders Franz Josef Steinkogler (Vienna/A) 17:00 IL SU Anti VEGF for ROP Michael T. Trese (Royal Oak/USA) 17:15

129 WOC Sunday, 6 June 2010 Room 44 08:30-10:00 SU-73 Epidemiological Studies Free Paper Epidemiological Studies Norbert Pfeiffer (Mainz/D) Jialiang Zhao (Beijing/CN) Christian Wolfram (Mainz/D) 08:30 FP SU Adenoviral Eye Infections at the Main Tertiary Eye Center in Kuwait Maya Pandova (Kuwait/KWT) 08:37 FP SU Retinopathy in Persons without Diabetes: The Handan Eye Study Fenghua Wang (Beijing/CN) 08:44 FP SU Alcohol Consumption and the Long-term Incidence of Cataract and Cataract Surgery The Blue Mountains Eye Study Gowri Kanthan, Paul Mitchell, George Burlutsky, Jie Jin Wang (Strathfield/AUS) 08:51 FP SU Choroidal nevi prevalence in a Portuguese population series of patients Esmeralda Costa, Luís Miguel Cristóvão, Rui Proença (Coimbra/P) 08:58 FP SU Longitudinal study of visual acuity changes in cone and cone-rod dystrophies Elena Prokofyeva, Eric Tröger, Robert Wilke, Eberhart Zrenner (Tübingen/D) 09:05 FP SU The 5 year incidence of visual impairment in adult Chinese. The Beijing Eye Study Qisheng You, Liang Xu, Jost B. Jonas (Beijing/CN, Mannheim/D) 09:26 FP SU Rapid Assessment of Avoidable Blindness in Tribal Areas of Andhra Pradesh State in India Srinivasa Pallerla (Hyderabad/IND) 09:33 Room 44 10:30-12:00 SU-74 Vision 2020 Prevention of Blindness 1 Free Paper Vision 2020 Prevention of Blindness Volker Klauss (Munich/D) Robert P. Finger (Bonn/D) 10:30 FP SU Trachoma in Brazil a nationwide school survey Maria de Fatima Lopes, Karen Brock, Helen Freitas, Norma Helen Medina, Expedito Luna, Ligia Caligaris, Maria Regina Alves, Inês Koizumi, Neusa Bernardes (Brasilia/BR, Nova Lima/BR, São Paulo/BR, Palmas Tocantins/BR) 10:37 FP SU Using Digital Cameras to Elicit Red-Reflexes for the Detection of Childhood Blindness Alefia Merchant, Brenda Gallie, Helen Dimaras, Maria Pezzente, Robert Downie, Cynthia Vanden- Hoven, Lindsay Hampejsková, K. Vasudha, Kaushik Hegde, Nasrin Najm-Tehrani, Pradeep Banandur, Ashwin Mallipatna (Bangalore/IND, Toronto/CDN) 10:44 FP SU Reaching rural Africans with eye care services: Findings from primary eye care approaches in Rwanda Andreas Mueller, Janvier Murenzi, Wanjiku Mathenge, Joseph Munana, Paul Courtright (South Melbourne/AUS, Gisenyi/RWA, Nairobi/EAK, Kigali/RWA, Moshi/EAT) Scientific Program Schedule Sunday, 6 June 09:12 FP SU Improving the detection and early management of blindness in childhood: findings from the British Childhood Vision Impairment Study Phillippa Cumberland, Catherine Peckham, Jugnoo S. Rahi (London/UK) 09:19 FP SU Blindness in the state of Northrhine now and in 2030 Robert P. Finger, Rolf Fimmers, Hendrik P. N. Scholl, Frank G. Holz (Bonn/D) 10:51 FP SU Utilisation of Eye Care Services in a Rural Adult Population of South-Western Nigeria Bolutife Olusanya, A. O. Ashaye, B. G. K. Ajayi, E. Owoaje (Ibadan/WAN) 10:58 FP SU Factors Affecting Uptake of Cataract Surgical Services at University College Hospital Ibadan, Nigeria by Patients Screened in Outreach Camps Charles Bekibele, G. V. S. Murthy (Ibadan/WAN)

130 126 WOC 2010 Sunday, 6 June Scientific Program Schedule Sunday, 6 June :05 FP SU Profile of Patients with Retinopathy of Prematurity at a Pediatric Low Vision Service in Brazil Galton Carvalho Vasconcelos, Cristina Helena Toledo de Paula, Clovis Correa de Carvalho, Jose Herculano De Carvalho, Luciene Chaves Fernandes (Belo Horizonte/BR) 11:12 FP SU Analysis of Correlation Factors Concerning Early Visual Acuity of High Volume Cataract Surgery in China Kai Wang, Yong Zhen Bao, Xian Ru Hou, Xiao Xin Li (Beijing/CN) 11:19 FP SU Eye Care Development as a Tool for Stimulating General Health Care Development Kolawole Ogundimu, Suleiman Buhari (Accra/GH) 11:26 FP SU Expression and Biological Activity Identification of Human Pigment Epithelium-derived Factor Yi Dai, Wenjing Shi, Yuxiong Wang, Chao Chen, Min Yu (Shanghai/CN) 11:33 FP SU Ophthalmologic short-term operations in the Black Continent Namibia and Mali: What makes sense? Andreas Künster, Thomas Schwarz (Traben-Trarbach/D) 14:14 FP SU Combining treatments to control advanced keratoconic aberropia Sergio Kandelman (Rio de Janeiro/BR) 14:21 FP SU Post-DALK corneal endothelial assessment by confocal microscopy and manual morphometry Sven Jonuscheit, Michael J. Doughty, Kanna Ramaesh (Glasgow/UK) 14:28 FP SU Anterior lamellar keratectomy using the Gebauer mikrokeratom Toam Katz, Gisbert Richard, Stephan Linke (Hamburg/D) 14:35 SL SU Proteolytic enzymes in corneal wound healing Andras Berta (Debrecen/H) 14:44 FP SU Pre Cut Tissue: Organ culture preservation of OCT guided femtosecond laser lamellar dissected corneas Lutz Blomberg, Konstantinos Zinelis, Frank Will, Holger Lubatschowski, Rolf Winter (Hannover/D) 14:51 SL SU Combined surgical treatment of severe corneal ulcers and perforations Halina Sitnik (Minsk/BY) 11:40 Room 44 14:00-15:30 SU-75 Cornea/External Disease: Surgical Therapy 2 Free Paper Cornea, External Disease András Berta (Debrecen/H) Stefan Seregard (Stockholm/S) Halina Sitnik (Minsk/BY) 15:00 FP SU Corneal patch grafts as a primary treatment for corneal perforations Robin Rios (Guayaquil/EC) 15:07 FP SU Epidermal Growth Factor Variations in Culture Ready Amniotic Membranes Jean-Jacques Gicquel, A. Brodie, A. Hopkinson, I. Mohammed, H. Suleman, E. Lazutina, D. K. James, Harminder S. Dua (Poitiers/F, Nottingham/UK) 15:14 14:00 FP SU Phototherapeutic keratectomy in the treatment of corneal dystrophies and degenerations own results Ewa Mrukwa-Kominek (Katowice/PL) 14:07 FP SU DMEK-S surgery in patients with posterior polymorphous corneal dystrophy Katerina Liehneova, Deli Sivekova, Andrej Farkas, Michal Hyndrak, Pavel Studeny (Prague/CZ)

131 WOC Sunday, 6 June 2010 Room 44 16:00-17:30 SU-47 Refractive Surgery/Refraction 3 Free Paper Refractive Surgery Günther Grabner (Salzburg/A) Gernot I. W. Duncker (Halle/D) Damián Gatinel (Paris/F) 16:00 FP SU The evaluation of the magnitude of cyclotorsion using the Advanced Control Eyetracking (ACE) technology in the Technolas Excimer Workstation 217P Eon-hee Bae, Keon-uk Park, Jong-ook Kim, Chul-min Woo (Daegu/ROK) 16:56 FP SU Binocular interaction in visual evoked responses: a presbyopic treatment study Kimiya Shimizu, Misae Ito (Sagamihara/J) 17:03 FP SU Results of Conventional, OATz, and OPDCAT LASIK for the treatment of high astigmatism with the cross cylinder technique. Tamer Gamaly (Muscat/MAO) 17:10 Scientific Program Schedule Sunday, 6 June 16:07 FP SU Comparison of hyperopic lasik using Femto laser and mechanical microkeratome Maja Bohac, Nikica Gabric, Iva Dekaris (Zagreb/HR) 16:14 FP SU LASIK for moderate and high myopia. A comparison of eyes operated using a Moria M2 microkeratome and a Visumax femto-second laser Jesper Hjortdal, Anders Ivarsen, Sven Asp, Mikkel Lyngholm (Aarhus/DK) 16:21 FP SU Influence of wavefront aberrations on visual performance after conventional LASIK and wavefront-guided LASIK with iris-registration Jing Zhang, Yue-hua Zhou, Rui Li, Lei Tian (Beijing/CN) 16:28 FP SU Optical performance of multifocal lenses with combined capsular tension ring implantation Tobias Neuhann (Munich/D) 16:35 FP SU Comparison of different types of multifocal intraocular lenses after clear lens extraction Nikica Gabric, Iva Dekaris, Maja Bohac, Ante Barisic (Zagreb/HR) 16:42 FP SU ICL vault assessment in patients with high myopia Khristo Takhchidi (Moscow/RUS) 16:49 FP SU Correction of Presbyopia in Hyperopic and Myopic Patients with Biaspheric Multifocal Ablation Mounir Khalifa, Tarek A. Wahab (Alexandria/ET)

132 Novartis-sponsored symposium at the 32nd World Ophthalmology Congress (WOC), Berlin, Germany, 5 9 June 2010 Improving vision for patients with DME: Compelling New Evidence Abu Dhabi Room, International Congress Centrum 6 June 2010, 12:30 13:30 INVITATION Scientific Programme Chair: Gabriele Lang (Germany) Epidemiology & current evidence for treatment of diabetic macular edema patients in the Phase II RESOLVE study Gabriele Lang (Germany) 12:40 Improving vision in patients with visual impairment due to diabetic macular edema in the Phase III RESTORE study Paul Mitchell (Australia) 13:05 Further clinical trial evidence of treating patients with diabetic macular edema Neil M Bressler (USA) 13:30 Close

133 WOC Scientific Program Scientific Program Schedule Monday, 7 June 2010 Monday, 7 June

134 ICC Hall 3 Hall 4/5 Hall 6 Hall 7 Hall 8 Hall 9 Hall 10 ICC Lounge Roof Garden Salon 11/12 Salon 19 Salon 20 Salon 21 Salon 22 Room 37 Highlight Free Paper WOC Course Industry Meetings Breakfast Allergan Ophthalmology Breakfast OD-OS MO-37 Koch, Rosen, Neuhann Corneal Approaches for Addressing Presbyopia MO-49 Heiligenhaus, Kinoshita Cicatrizing Conjunctivitis MO-53 Khaw, Michelson ARVO Symp: Transl. Research Develop. Innov. New Treatm. MO-57 de Freitas, Abbott PAAO Symp: A close look into the future MO-41 Golnik, Aydin, Steuhl Worldwide Program of Teaching Directors of Ophth. MO-65 Tsai, Barton, Thieme AAO Symp: Glaucoma implants: now and the future MO-45 Holz, Cunha-Vaz, Chakravarthy Editorial Management MO-69 Sprunger, Martin, de Faber, Schiavi ISA Symp: Clinical Challenges in Strabismus Treffen der Woche des Sehens MO-38 Grabner, Randleman, Knorz Corneal Laser Refractive Surgery MO-50 Belfort, Jr., Loewenstein, Neß Intra-Ocular Therapy MO-54 Migdal, Goñi Foncillas, Thygesen EGS Symp: Glaucoma Management MO-58 Valdez, Tuulonen, Jan, Oberacher-Velten Organisational Aspects MO-42 Lee, Hawlina, Gabel The New Frontier of Changing Parameters of Residency MO-66 Mojon, Alió Minimally Invasive Ophthalmic Surgery MO-46 Nussenblatt, Forrester, Zierhut IUSG Symp: Update of new Developments MO-70Taryam,Shetta,Kirchhof MEACO Symp: Management of Retina and Macular General Assembly of the DOG Lunch Santen Lunch Zeiss ICO Fellowships Alumni Reception MO-39 Alió, Dupps, Seiler Corneal Physiology and Biomechanics MO-63 Gragoudas Macula Society Symp: Nonsurgical Treatment MO-51 Congdon, Ehrt, Gilbert Combating Childhood Blindness MO-55 Hawlina, Aclimandos, Tassignon EBO Symp From Nat. towards Europ. training MO-59 Astle, Bischoff JCAHPO : Teaching allied Health Personnel MO-43 Tso, Edward, Löffler Innovative Technologies for Teaching Ophthalmology MO-67 Meyer, Soubrane, Wolfensberger Retina: Vascular Disease 1 MO-47 MO-71 Wiggs, Ritch, Zarbin Hunter Nanotechnology ARVO : Genetics of Eye Disease MO-81 Luco Disaster Response: Ophthalmology s Organizational Role Treffen der Vision 2020 Initiativgruppe Mitgliederversammlung der Sektion DOG-Uveitis Herausgebersitzung Der Ophthalmologe 2010 Kommissionssitzung Refraktive Chirurgie MO-26 Pahor, Takhchidi, Lanzl Miscellaneous 2 Uveitis Award 2010 EVICR.net Meeting EVI Steering Committee Monday, 7 June MO-40 Colin, Zaldivar, Kohnen Managing High Refractive Errors MO-64 Tan, Geerling, AlRajhi Pterygium Surgery MO-52 Lee, Keeffe The Economics of Blindness: What Does Lost Vision Cost MO-56 Constable, Lai, Li APAO Symp: Age-related Macular Degeneration MO-60 Schlötzer-Schrehardt, Irkec, Holló Lindberg Society Symp: Exfoliation Syndrome MO-44 Mayorga Argañaraz, Tso, Löffler Emerging Techn. for Ophth.TeachingandLearn. MO-82 Perros, Hintschich, Dickinson, Ludgate EUGOGO MO-48 Korwitz, Schachat, Kirchhof Google's Approach, Open Access Publishing MO-72 Wu, Augustin AAO : Retinal Pharmacotherapy EBO Executive Board EVI General Assembly

135 Room 42 Room 43 Room 44 Room 45 Messe Stockholm Sao Paulo Abu Dhabi Oslo Hall Room Madrid Room Sydney Room Hong Kong Room Istanbul VIP Lounge 1 VIP Lounge 2 Radio Tower Lounge 1 Radio Tower Lounge 2 Hall MO-73 Ahmed, Gerinec, Pillunat Glaucoma: Basics 2 WOC-C-38 Mark Update on Tonometry MO-74 Garweg, Gul, Biswas Uveitis/intrao. inflammation, microb./immunology 2 WOC-C-39 Daxer, Mahmood A Flexible Ring in a Corneal Pocket for the Treatment CEVG International Advisory Group MO-77 Bornfeld, Gallie, Romanowska-Dixon Oncology 2 Breakfast Santen Breakfast Pfizer MO-01 Nguyen, Ogura, Joussen Retina and Angiogenesis MO-04 Zin, Vinekar, Lorenz Update on Retinopathy of Prematurity MO-08 Grehn, Quigley, Tham Glaucoma Research Society MO-12 Krupin, Hommer, Jünemann Medical and Laser Tre. of Open-Angle Glaucoma MO-16 Augustin, Rizzo, Mieler Vitreo-Retinal Considerations in Cataract Surgery WOC-C-30 Hattenbach Sutureless = Happiness? MO-20 Tassignon, van Rij SOE : Slips, Tricks and Fall MO-02 Leys, Lang, Gregor Retinal Cases with MO-05 Lorenz, Tassignon, Nischal Surgical Challenges in Paediatric Anterior Segm. Dis. MO-09 Özkan, Lee, Schiavi ESA : Hot Topics in Strabismus and Amblyopia MO-13 Liebmann, Cohn, Hoffmann Panel: Predicting and Determ. Rates of Glauc. Pro. MO-17 Dua, Kruse, Pellegrini Ocular Surface Reconstruction WOC-C-31 Burk, Chauhan, Burgoyne HRT and Spectral OCT in Glaucoma MO-21 Liesegang, Verjans, Heiligenhaus DNA Viruses and the Eye MO-25 Laganovska, Mandic, Stark Cataract/biometry 2 MO-29 D'Amico, Wolfensberger, Wiedemann Club Jules Gonin MO-33 Grossniklaus, Burnier, Auw-Hädrich Intraocular Tumors MO-24 Foerster, Imshenetskaya, Ohno-Matsui Retina: Surgical therapy 1 MO-62 Trimmel, Kibata, Buehler NGO/Private Sector Partnerships: WIN/WIN MO-30 Birnbaum, Wylegala, AlRajhi Surgical Therapy of Keratoconus MO-34 Rose, Guthoff, Katowitz New Diagn. and Therapeutic Aspects of Orbital Diseases Highlight Free Paper WOC Course Industry Meetings MO-75 Bartz-Schmidt, Sahel, Schmidt-Erfurth Retina: Miscellaneous 1 WOC-C-40 Barraquer, Barraquer, Nadal Modern Surg.of the Posterior Segm. of the Eye MO-78 Drnovšek-Olup, Emmerich, Tse Oculopl./ orbita/lids/lacrimal system 2 ICO Advisory Group on Sub-Saharan Africa MO-76 Chan, Decaudin, Zierhut Uveitis/intrao. inflammation, microbiol./immunology 3 WOC-C-41 Wong, Sullivan, Bartz-Schmidt Complications in Vitreoretinal Surgery MO-79 van Rij, Xiao, Zarbin New technology, Bioengineering, Nanotechnology 2 MO-03 Belfort, Graham, Dithmar Retinal and Choroidal Manifestations MO-06 Gottlob, Zeitz, Lorenz Update on Infantile Nystagmus MO-10 van Rens, Rubin ISLRR Symp: Vision on Low Vision Research MO-14 Heijl, Garway-Heath, Schiefer Perimetry: Now and Future MO-18 Coupland, Holbach, Seregard Tumors of the Ocular Surface WOC-C-32 Lang Laser Treatment of Retinal Diseases MO-22 Araie, Grus, Medeiros AOGS : Normaltension Glaucoma WOC-C-34 Pfeiffer Wetlab Glaucoma Surgery for Beginners MO-61 Richard, Cunha-Vaz, Drexler Euretina MO-07 Lorenz, Gilbert, Taylor EPOS Symp: Vision 2020 in paediatric ophthalmology MO-11 Kampik, Beaconsfield FEOph : Uveitis MO-15 Suarez, Ossma-Gomez, Alió, Alfonso ALACCSA-R MO-19 Rosen, Dick Astigmatism Management in Cataract Surgery WOC-C-33 Riedel Blepharoplasty of the Upper and Lower Eye Lids MO-23 Colenbrander, Rohrschneider, van Rens Panel: Vision Rehabilitation WOC-C-35 Pfeiffer Wetlab Glaucoma Surgery for the Advanced MO-32 Belfort, Loewenstein Retina: Medical therapy 1 European Vision Award MO-27 Kirchhof, Walter, Scholl Retina: Diagnostics 2 MO-31 Barton, Stein, +Flammer Glaucoma: Surgical therapy 1 MO-35 Dart, Seitz, Spierings Cornea/External Disease: Diagnostics MO-28 Schrader, Sivkova Trauma MO-68 Holz, Radecka, Sulzbacher Retina: AMD 2 MO-36 Szurman, Roider, Spitzer Ocular Pharmacology Poster exhibition of Poster P-MO-001 to P-MO-298 Monday, 7 June

136 7-10 May 2011 Paris 117th Congress of the French Society of Ophthalmology Official languages: French - English Welcome to Paris

137 WOC Monday, 7 June 2010 Stockholm 08:30-10:00 MO-01 Retina and Angiogenesis Retina Quan Dong Nguyen (Baltimore/USA) Yuichiro Ogura (Nagoya/J) Antonia M. Joussen (Berlin/D) 08:30 IL MO The role of cathepsin L from bone marrow-derived cells in retinal angiogenesis Kyoko Ohno-Matsui (Tokyo/J) 08:40 IL MO How to promote regeneration of functional capillaries in the ischemic retina Akiyoshi Uemura (Kobe/J) 10:30 IL MO Radiation retinopathy: what to do? Zdenek J. Gregor (London/UK) 10:40 IL MO Light chain deposition disease Anita Leys (Leuven/B) 10:50 IL MO A man with recurrent macular hermorrhage Timothy Lai (Hong Kong/CN) 11:00 IL MO Mystery case William F. Mieler (Chicago/USA) 11:10 IL MO Brain melanoma: How did it get there? Jerry Shields (Philadelphia/USA) 11:20 IL MO Mystery Case J. Fernando Arevalo (Caracas/Y) Scientific Program Schedule Monday, 7 June 08:50 IL MO Modulation of Retinal Angiogenesis by Retinal Ganglion Cells: Implications for Proliferative Retinopathies Mike Sapieha (Montreal(CDN) 09:00 IL MO Can VEGF Blockade Result in Regression of Choroidal Neovascularization? Diana Do (Baltimore/USA) 09:10 IL MO Advanced glycation endproducts in vascular disease Alan Stitt (Belfast/UK) 09:20 IL MO Inflammation in Angiogenesis John V. Forrester (Aberdeen/UK) 11:30 IL MO Mystery Case Andries Stulting (Bloemfontein/ZA) 11:40 IL MO Mysterious macular disease Gabriele E. Lang (Ulm/D) 11:50 IL MO Mystery case Peter Wiedemann (Leipzig/D) Stockholm 14:00-15:30 MO-03 Retinal and Choroidal Manifestations of Systemic Diseases 09:30 Retina Stockholm 10:30-12:00 MO-02 Rubens Belfort, Jr. (São Paulo/BR) Elisabeth Graham (London/UK) Stefan Dithmar (Heidelberg/D) Retinal Cases with Retina Anita Leys (Leuven/B) Gabriele E. Lang (Ulm/D) Zdenek J. Gregor (London/UK) 14:00 IL MO Metabolic diseases: Diabetes Paul Mitchell (Sydney/AUS) 14:10 IL MO Metabolic diseases: non diabetic diseases Elisabeth Graham (London/UK)

138 134 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June :20 IL MO Retinochoroiditis Rubens Belfort, Jr. (São Paulo/BR) 14:30 IL MO Vasculitis Quan Dong Nguyen (Baltimore/USA) 14:40 IL MO Neurological diseases Alfredo Sadun (Los Angeles/USA) 14:50 IL MO Oncological entities Nikolaos E. Bechrakis (Innsbruck/A) 15:00 Stockholm 16:00-17:30 MO-61 Euretina : Retinal Imaging with Optical Coherence Tomography / Future of Imaging Retina Gisbert Richard (Hamburg/D) José Cunha-Vaz (Coimbra/P) Wolfgang Drexler (Cardiff/UK) 16:00 IL MO OCT in Macula Pathologies Gisbert Richard (Hamburg/D) 16:10 IL MO Multimodal Macula Mapping José Cunha-Vaz (Coimbra/P) 16:20 IL MO Cellular Resolution Retinal Imaging and Optophysiology Wolfgang Drexler (Cardiff/UK) 16:30 IL MO Polarization Sensitive Retinal OCT Christoph Hitzenberger (Vienna/A) 16:40 IL MO Ultrahigh speed retinal OCT James G. Fujimoto (Cambridge/USA) 16:50 IL MO Retinal OCT at 1060nm Yoshiaki Yasuno (Ibaraki/J) Stockholm 17:45-18:15 MO-83 European Vision Award 2010 Lecture see also p. 18 Sao Paulo 08:30-10:00 MO-04 Update on Retinopathy of Prematurity: New Approaches for Research, Diagnosis and Treatment Subspecialty Day Pediatric Ophthalmology Andrea Zin (Rio de Janeiro/BR) Anand Vinekar (Bangalore/IND) Birgit Lorenz (Giessen/D) 08:30 IL MO New research areas in ROP diagnosis and management Ann Hellstrom (Gothenburg/S) 08:40 IL MO Organizing national screening programs for ROP Andrea Zin (Rio de Janeiro/BR) 08:50 IL MO ROP Screening in Vietnam Nguyen Xuan Tinh (Hanoi/VN) 09:00 IL MO Telemedicine as an option for screening: The expert s view on WFDI in ROP Michael Chiang (New York/USA) 09:10 IL MO Telemedicine in ROP: The Indian Experience Anand Vinekar (Bangalore/IND) 09:20 IL MO WFDI in ROP: Opportunity for automated image analysis Alistair Fielder (London/UK) 09:30 IL MO Anti-VEGF and ROP Helen A. Mintz-Hittner (Houston/USA) 09:40 17:00

139 WOC Monday, 7 June 2010 Sao Paulo 10:30-12:00 MO-05 Surgical Challenges in Pediatric Anterior Segment Diseases Subspecialty Day Pediatric Ophthalmology Birgit Lorenz (Giessen/D) Marie-José Tassignon (Antwerp/B) Ken K. Nischal (London/UK) 10:30 IL MO Best choice surgery in pediatric cataract Marie-José Tassignon (Antwerp/B) 14:30 IL MO Genetics of cone dysfunction disorders Susanne Kohl (Tübingen/D) 14:45 IL MO Genetic and clinical hetereogeneity of congenital forms of night blindness Christina Zeitz (Paris/F) 15:00 IL MO Medical and surgical treatment options Anil Kumar (Leicester/UK) 15:15 IL MO Gene therapy provides cure for achromatopsia Knut Stieger (Giessen/D) Scientific Program Schedule Monday, 7 June 10:450 IL MO Alternatives to penetrating keratoplasty in pediatric corneal disease Ken K. Nischal (London/UK) 11:00 IL MO Pediatric Corneal Transplantation: Experiences from a large tertiary referral center in India. Pravin V. Krishna (Hyderabad/IND) Sao Paulo 16:00-17:30 MO-07 EPOS : Vision 2020 in Pediatric Ophthalmology. Dreams and Realities in Eliminating Avoidable Childhood Blindness Subspecialty Day Pediatric Ophthalmology 11:15 IL MO The choice and effectiveness of surgery in different clinical forms of congenital glaucoma Anton Gerinec (Bratislava/SK) Birgit Lorenz (Giessen/D) Clare Gilbert (London/UK) David Taylor (London/UK) 11:30 IL MO Pediatric perforating injuries of the globe: timing of surgical steps Robert Stegmann (Pretoria/ZA) 16:00 IL MO VISION 2020 and children: achievements and challenges Clare Gilbert (London/UK) 11:45 Sao Paulo 14:00-15:30 MO-06 Update on Infantile Nystagmus: Clinics, Genetics, and Treatment Subspecialty Day Pediatric Ophthalmology Irene Gottlob (Leicester/UK) Christina Zeitz (Paris/F) Birgit Lorenz (Giessen/D) 14:00 IL MO Modern work-up in infantile nystagmus Birgit Lorenz (Giessen/D) 14:15 IL MO Genetics of X-linked idiopathic nystagmus Irene Gottlob (Leicester/UK) 16:15 IL MO Pediatric cataract: can we improve on what we have achieved? Michael O Keefe (Dublin/IRL) 16:30 IL MO Pediatric glaucoma. Holes, tubes and more. Peng T. Khaw (London/UK) 16:45 IL MO Pediatric infectious eye diseases: Prevention and treatment Perumalsamy Vijayalakshmi (Madurai/IND) 17:00 IL MO Predictions of genotype and phenotype in pediatric hereditary diseases: present achievements and future challenges Josseline Kaplan (Paris/F) 17:15 IL MO Retinal dystrophies: hopes for cure Birgit Lorenz (Giessen/D)

140 136 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 Abu Dhabi 08:30-10:00 MO-08 Glaucoma Research Society : The Impact of Glaucoma on Real Life Glaucoma Franz Grehn (Würzburg/D) Clement C. Y. Tham (Hong Kong/CN) 08:30 IL MO Functional impairment in glaucoma Pradeep Ramulu (Baltimore/USA) 08:40 IL MO Psychology of glaucoma and blindness Robert Dolgoff (Berkeley/USA) 10:30 IL MO Accommodation and strabismus Emilio Carlo Campos (Bologna/I) 10:40 IL MO Amblyopia beyond acuity John Sloper (London/UK) 10:50 IL MO How do the extraocular muscles function do we know all? Costantino Schiavi (Bologna/I) 11:00 IL MO Surgical strategies for incomitance John P. Lee (London/UK) 11:10 IL MO Lateral rectus orbital wall fixation where and how to use? Seyhan B. Özkan (Aydin/TR) 08:50 IL MO Assessing Quality of Life in Glaucoma Patients Ivan Goldberg (Sydney/AUS) 09:00 IL MO Patient Presentation Living with Glaucoma Joseph Cohen (New York/USA) 11:20 IL MO Botulinum toxin versus surgery in treatment of infantile esotropia Rosario Gomez de Liano (Madrid/E) 12:30 09:10 IL MO Patient Presentation Living with Glaucoma Jeffrey Kassel (USA) 09:20 IL MO Patient presentation living with glaucoma Maria Gorby (Waterford/USA) 09:30 IL MO How to start a glaucoma support group Beverly Lindsell (Crows Nest/AUS) 09:40 Abu Dhabi 14:00-15:30 MO-10 ISLRR : Vision on Low Vision Research Low Vision Ger van Rens (Amsterdam/NL) Gary S. Rubin (London/UK) Veera Ramani (Coimbatore/IND) Abu Dhabi 10:30-12:00 MO-09 ESA : Hot Topics in Strabismus and Amblyopia 14:00 IL MO Rehabilitation and quality of life Ruth M. A. van Nispen (Amsterdam/NL) 14:10 IL MO Effects of CCTV training Marloes C. Burggraaff (Amsterdam/NL) Strabismus Seyhan B. Özkan (Aydin/TR) John P. Lee (London/UK) Costantino Schiavi (Bologna/I) 14:20 IL MO CCTV and vision related quality of life Ger van Rens (Amsterdam/NL) 14:30 IL MO Low vision related research in the UK Gary S. Rubin (London/UK)

141 WOC Monday, 7 June :40 IL MO Development and use of the preferred retinal locus Michael D. Crossland (London/UK) 14:50 IL MO DAI, outcome of a pilot study Janna Bruijning (Amsterdam /NL) 15:00 Abu Dhabi 16:00-17:30 MO-11 17:10 IL MO Differential Diagnosis of Anterior Uveitis Philip I. Murray (Birmingham/UK) 17:20 IL MO Adalimumab Therapy for Refractory Uveitis A Multicenter Study Manuel Díaz-Llopis (Valencia/E) Oslo 08:30-10:00 MO-12 Medical and Laser Treatment of Open-Angle Glaucoma Scientific Program Schedule Monday, 7 June FEOph : Uveitis Uveitis, Intraocular Inflammation Anselm Kampik (Munich/D) Michèle Beaconsfield (London/UK) 16:00 IL MO HLA A29 and B27: Hypotheses and Links to Disease Mechanism in Uveitis Dominique Monnet (Paris/F) 16:10 IL MO Th17 in the Pathogenesis of Uveitis Rafael Grajewski (Gänheim/D) 16:20 IL MO Aqueous Humor Neutrophil Gelatinase-associated Lipocalin Levels in Patients with Acute Anterior Uveitis David Salom (Valencia/E) 16:30 IL MO Aqueous Humor Analysis for the Differential Diagnosis of Uveitis Uwe Pleyer (Berlin/D) Glaucoma Theodore Krupin (Chicago/USA) Anton Bernhard Hommer (Vienna/A) Anselm G. M. Jünemann (Erlangen/D) 08:30 IL MO Who needs treatment, who needs observation only Anselm G. M. Jünemann (Erlangen/D) 08:40 IL MO Medication is the first step in glaucoma treatment Anton Bernhard Hommer (Vienna/A) 08:50 IL MO The different methods of Laser trabeculoplasty Herbert Reitsamer (Salzburg/A) 09:00 IL MO Don't forget iridoplasty in your therapeutic considerations Christoph Faschinger (Graz/A) 09:10 IL MO Pressure independent treatment Theodore Krupin (Chicago/USA) 16:40 IL MO Occurence and Long-term Surgical Outcome in Secondary Glaucoma in Juvenile Idiopathic Arthritisassociated Uveitis Carsten Heinz (Münster/D) 16:50 IL MO Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-associated Uveitis Arnd Heiligenhaus (Münster/D) 09:20 IL MO Combination therapy Anastasios Konstas (Thessaloniki/GR) 09:30 17:00 IL MO Birdshot Chorioretinopathy: A Model for the Long-term Follow-up of Patients with Posterior Uveitis Antoine Brezin (Paris/F)

142 138 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 Oslo 10:30-12:00 MO-13 Panel: Predicting and Determining Rates of Glaucoma Progression Panel Glaucoma Jeffrey M. Liebmann (New York/USA) Howard C. Cohn (Paris/F) Esther M. Hoffmann (Mainz/D) 10:30 IL MO Optic disc and Nerve fiber layer features that predict future progression Christopher A. Girkin (Birmingham/USA) 10:40 IL MO Detection of retinal nerve fiber layer progression Sek Tien Hoh (Singapore/SGP) Oslo 14:00-15:30 MO-14 Perimetry: Now and Future Glaucoma Anders Heijl (Malmö/S) Ted Garway-Heath (London/UK) Ulrich Schiefer (Tübingen/D) 14:00 IL MO Do new psychophysical tests have any advantages of SAP? John G. Flanagan (Toronto/CDN) 14:10 IL MO Visual field progression in glaucoma - definition and assessment Boel Bengtsson (Malmö/S) 10:50 IL MO Detection of optic disc progression Remo Susanna, Jr (São Paulo/BR) 11:00 IL MO Detection of visual field progression Boel Bengtsson (Malmö/S) 11:10 IL MO Optic disc hemorrhage: Progression endpoint or predictor? Gustavo de Moraes (New York/USA) 11:20 IL MO What constitutes clinically significant structural progression? Robert Fechtner (Newark/USA) 11:30 IL MO What constitutes clinically significant functional progression? Norbert Pfeiffer (Mainz/D) 14:20 IL MO The importance of signal-to-noise ratio in measuring progression Paul Artes (Halifax/CDN) 14:30 IL MO The relation of visual field loss to quality of life and disability David P. Crabb (London/UK) 14:40 IL MO STAT3 and retinal ganglion cell protection Samuel Shao-Min Zhang (New Haven/USA) 14:50 IL MO What can structure add to function in identifying early glaucoma and progresssion? Ted Garway-Heath (London/UK) 15:00 IL MO Visual field assessment in advanced glaucoma Ulrich Schiefer (Tübingen/D) 11:40 IL MO Using structure and funciton information in clinical practice Robert N. Weinreb (La Jolla/USA) 15:10 11:50

143 WOC Monday, 7 June 2010 Oslo 16:00-17:30 MO-15 ALACCSA-R : Presbyopia Correcting IOLS: The Best Option Cataract Enrique Suarez (Caracas/Y) Ivan L. Ossma-Gomez (Bucaramanga/CO) Jorge L. Alió (Alicante/E) José F. Alfonso (Oviedo/E) 16:00 IL MO A New concept in Multifocal IOLs: The M Plus Oculentis Jorge L. Alió (Alicante/E) 16:10 IL MO Presbyopia correction with Pseudoaccommodative IOL Enrique Suarez (Caracas/Y) 16:20 IL MO Lens based reversal of presbyopia Ivan L. Ossma-Gomez (Bucaramanga/CO) 16:30 IL MO Comparative study of quality of vision with OKAS in Multifocal IOLs vs Accommodative IOLs Carlos Palomino (Madrid/E) Room Madrid 08:30-10:00 MO-16 Vitreo-Retinal Considerations in Cataract Surgery Cataract Albert J. Augustin (Karlsruhe/D) Stanislao Rizzo (Pisa/I) William F. Mieler (Chicago/USA) 08:30 IL MO Bifocal lenses and the vitreoretinal surgeon Stanislao Rizzo (Pisa/I) 08:40 IL MO DR and CE: How to prepare the eye with diabetic retinopathy for CE William F. Mieler (Chicago/USA) 08:50 IL MO AMD and CE: Progression/prevention Albert J. Augustin (Karlsruhe/D) 09:00 IL MO Pucker and phaco: combined or sequential Bernd Kirchhof (Cologne/D) 09:10 IL MO CME after CE Anat Loewenstein (Tel Aviv/IL) Scientific Program Schedule Monday, 7 June 16:40 IL MO TEK-CLEAR Clinical Results Jose M. Vargas (Valencia/Y) 09:20 IL MO RD in high myopes after phaco Irmingard Neuhann (Tübingen/D) 16:50 IL MO Restor and Lasik Angel Pineda Fernandez (Caracas/Y) 09:30 17:00 IL MO Results with New Difractives Multifocal IOLs: Restor +3 vs Tecnis Luis Izquierdo (Lima/PE) 17:10 IL MO Monocular Restor Juan Manuel Paulin Huerta (Mexico City/MEX) Room Madrid 10:30-12:00 MO-17 Ocular Surface Reconstruction External Eye Disease, Cornea 17:20 IL MO Cataract Surgery: Challenging cases Jorge Villar Kuri (Mexico City/MEX) Harminder S. Dua (Nottingham/UK) Friedrich E. Kruse (Erlangen/D) Graziella Pellegrini (Modena/I) 10:30 IL MO Oral mucosa cells for ocular surface reconstruction Shigeru Kinoshita (Kyoto/J)

144 140 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June :40 IL MO Decision making for ocular surface reconstruction Björn Bachmann (Erlangen/D) 10:50 IL MO The role of amniotic membrane in ocular surface reconstruction Harminder S. Dua (Nottingham/UK) 11:00 IL MO Principles and perspectives of cell based ocular surface reconstruction Friedrich E. Kruse (Erlangen/D) 11:10 IL MO Ex vivo expanded limbal stem cells for ocular surface reconstruction Paolo Rama (Venice/I) 11:20 IL MO Bridging anterior and posterior ocular surfaces Iqbal Ahmad (New Haven/USA) 11:30 14:50 IL MO Ocular surface reconstruction Friedrich E. Kruse (Erlangen/D) 15:00 Room Madrid 16:00-17:30 MO-19 Astigmatism Management in Cataract Surgery Cataract Emanuel S. Rosen (Manchester/UK) H. Burkhard Dick (Bochum/D) 16:00 IL MO Current options of astigmatism correction in cataract surgery: a critical overview Emanuel S. Rosen (Manchester/UK) Room Madrid 14:00-15:30 MO-18 16:20 IL MO On-axis versus temporal clear corneal incisions Which to choose? Edmund Borasio (London/UK) Tumors of the Ocular Surface External Eye Disease, Cornea Sarah E. Coupland (Liverpool/UK) Leonard M. Holbach (Erlangen/D) Stefan Seregard (Stockholm/S) 14:00 IL MO Epidemiology of conjunctival melanoma Stefan Seregard (Stockholm/S) 14:10 IL MO Management of conjunctival melanoma Bertil D. Damato (Liverpool/UK) 14:20 IL MO Management of conjunctival carcinoma Leonard M. Holbach (Erlangen/D) 14:30 IL MO Why I prefer 5-FU for topical chemotherapy Edoardo Midena (Padova/I) 14:40 IL MO Why I prefer mitomycin for topical chemotherapy Jacob Pe'er (Jerusalem/IL) 16:40 IL MO Toric IOLs: a wide variety of options H. Burkhard Dick (Bochum/D) 17:00 IL MO Changes in astigmatism after congenital cataract surgery and IOL implantation Abraham Spierer (Tel-Hashomer/IL) 17:20 Room Hong Kong 08:30-10:00 MO-20 SOE : Slips, Tricks and Falls in Cataract Surgery Cataract Marie-José Tassignon (Antwerp/B) Gabriel van Rij (Rotterdam/NL) 08:30 IL MO Basic phacoemulsification David Allen (Newcastle on Tyne/UK)

145 WOC Monday, 7 June :50 IL MO IOL calculation after refractive surgery Wolfgang Haigis (Würzburg/D) 09:10 IL MO Basic phacoemulsification Khiun F. Tjia (Zwolle/NL) 09:30 IL MO Calibration, sizing and centration of the anterior capsulorhexis Marie-José Tassignon (Antwerp/B) 09:50 Room Hong Kong 10:30-12:00 MO-21 DNA Viruses and the Eye Room Hong Kong 14:00-15:30 MO-22 AOGS : Normal-tension Glaucoma Glaucoma Makoto Araie (Tokyo/J) Franz H. Grus (Mainz/D) Felipe A. Medeiros (La Jolla/USA) 14:00 IL MO Ocular blood flow in normal tension glaucoma Leopold Schmetterer (Vienna/A) 14:10 IL MO Managing Glaucoma in Patients with Keratoprostheses Joshua D. Stein (Ann Arbor/USA) Scientific Program Schedule Monday, 7 June Immunology, Molecular Biology, Microbiology Thomas J. Liesegang (Jacksonville/USA) G. M. G. M. Verjans (Rotterdam/NL) Arnd Heiligenhaus (Münster/D) 10:30 IL MO CMV retinitis, clinical Gary N. Holland (Los Angeles/USA) 10:40 IL MO Adenoviruses of the Cornea; Virology and Treatment Eric G. Romanowski (Pittsburgh/USA) 10:50 IL MO Fundamentals of herpetic keratitis G. M. G. M. Verjans (Rotterdam/NL) 11:00 IL MO Diagnosis and treatment of herpetic keratitis, acyclivir resistance Lies Remeijer (Rotterdam/NL) 14:20 IL MO Genetic aspect of normal tension glaucoma Kenji Kashiwagi (Yamanashi/J) 14:30 IL MO Central corneal thickness in NTG: Measurement error or risk factor? Michael Kook (Seoul/ROK) 14:40 IL MO Autoimmune phenomena in glaucoma Franz H. Grus (Mainz/D) 14:50 IL MO IOP dynamics in NTG: Water loading and postural change Makoto Araie (Tokyo/J) 15:00 IL MO Treatment of normal-tension glaucoma IOP Jian Ge (Guangzhou/CN) 15:10 IL MO Treatment of normal tension glaucoma Non IOP Catherine Liu (Taipei/TJ) 11:10 IL MO Herpes zoster Ophthalmicus and Complications Arnd Heiligenhaus (Münster/D) 15:20 11:20 IL MO Herpes Zoster: Epidemiology, risk factors and prevention through vaccination Thomas J. Liesegang (Jacksonville/USA) 11:30

146 142 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 Room Hong Kong 16:00-17:30 MO-23 Panel: Vision Rehabilitation Demands and Challenges in the 21st Century Panel Low Vision August Colenbrander (Novato/USA) Klaus Rohrschneider (Heidelberg/D) Ger van Rens (Amsterdam/NL) 16:00 IL MO Comprehensive Vision Rehabilitation August Colenbrander (Novato/USA) 16:10 IL MO Rehabilitation Guidelines for General Ophthalmologists; Development and Follow-up Ger van Rens (Amsterdam/NL) 16:20 IL MO Comprehensive Low Vision Rehabilitation in Germany Now and in the Future Klaus Rohrschneider (Heidelberg/D) 16:30 IL MO Low Vision Rehabilitation Model at the L V Prasad Eye Institute, India Vijaya Kumari Gothwal (Hyderabad/IND) 16:40 IL MO Bridging gaps in Low Vision Care in the Philippines Sheila Santos-Jimenez (Quezon City/RP) 16:50 IL MO Successes in the Development Low Vision Services in Latin America Rosario Espinoza (Lima/PE) VIP Lounge 1 10:30-12:00 MO-24 Retina: Surgical Therapy 1 Free Paper Retina Michael H. Foerster (Berlin/D) Tatsiana Imshenetskaya (Minsk/BY) Kyoko Ohno-Matsui (Tokyo/J) 10:30 FP MO Pars-plana vitrectomy alone versus vitrectomy with scleral buckling for primary rhegmatogenous pseudophakic retinal detachment Khalifa Al Sawidi (Triploi/LAR) 10:37 FP MO The clinical outcomes of short-term heavy silicon oil (Densiron-68) intraocular tamponade. Li-bo Ma, Tie-hong Chen, Zhi Zhng, Jian-dong Zhang, Ju Wen (Shenyang/CN) 10:44 FP MO Surgical outcomes in vitrectomy for myopic foveoschisis Michael Engelbert, D. Kar, S. Chang (New York/USA) 10:51 SL MO Rhegmatogenous retinal detachment: philosophy of surgical delicacy Tatsiana Imshenetskaya, Volha Yarmak (Minsk/BY) 10:58 FP MO Postoperative results of vitrectomy with ICG assisted ILM-peeling from idiopathic macular holes stage 4 and with baseline visual acuity 0,2 Mete Gök, Harun Akgül, Michael Freistühler, Theodora Gkika, Norbert Bornfeld (Essen/D) 17:00 IL MO Expanding Low Vision benefits in Turkey Kardircan Keskinbora (Tekirdag/TR) 17:10 IL MO Multidisciplinary Rehabilitation and Resident Education Mary Lou Jackson (Boston/USA) 17:20 11:05 FP MO Staining properties, anatomical and functional outcome in Brilliant Blue G Chromovitrectomy Paul Bernhard Henrich (Basel/CH) 11:12 FP MO Surgical Management of Coats disease presentation of a modified technique Sabine Aisenbrey, Daniela Suesskind, K. Ulrich Bartz-Schmidt (Tübingen/D) 11:19 FP MO Randomized Trial of Transpupillary Thermotherapy Versus Sham Treatment for Central Serous Chorioretinopathy (TTT4CSC): Long-term results Harvey Uy (Makati City/RP)

147 WOC Monday, 7 June :26 FP MO Combined Cataract Extraction, PCIOL, Pars Plana Vitrectomy, Retisert Implant, and Pars Plana Tube in Chronic Advanced Non-Infectious Uveitis with Cataract and Glaucoma. The CPR-PT Procedure Tamer Mahmoud (Troy/USA) 11:33 FP MO "Re-flow" surgical strategy with one pars plana port for the treatment of epiretinal disesases: sutdy of the endothelial cells loss Cesare Forlini, Paolo Rossini, Matteo Forlini (Ravenna/I) 11:40 VIP Lounge 1 16:00-17:30 MO-32 Retina: Medical Therapy 1 Free Paper Retina Rubens Belfort, Jr. (São Paulo/BR) Anat Loewenstein (Tel Aviv/IL) 16:00 FP MO Benefits of Early Treatment with Dexamethasone Intravitreal Implant in Patients with Macular Edema due to BRVO or CRVO over 12 Months Rubens Belfort, Jeffrey Heier, Julia A. Haller, Mark S. Blumenkranz, Francesco Bandello, Anat Loewentstein, Young-Hee Yoon, Jenny Jiao, Xiao-Yan Li, Scott M. Whitcup (Sao Paulo/BR, Stanford/USA, Milano/I, Philadelphia/USA, Tel Aviv/IL, Boston/USA, Irvine/USA, Seoul/ROK) 16:07 FP MO month Evaluation of Dexamethasone Intravitreal Implant in Patients with Macular Edema due to Branch Retinal Vein Occlusion Anat Loewenstein, Julia A. Haller, Mark S. Blumenkranz, Francesco Bandello, Rubens Belfort, Jr., Mark Gillies, Jeffrey Heier, Young-Hee Yoon, Jenny Jiao, Xiao-Yan (Joanne) Li, Scott M. Whitcup (Tel-Aviv/IL, Stanford/USA, Milano/I, Sao Paulo/BR, Vienna/A, Philadelphia/USA, Sydney/AUS, Boston/USA, Seoul/ROK, Irvine/USA) 16:21 FP MO Verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy for symptomatic macular polypoidal choroidal vasculopathy (PCV): Anatomical outcomes of the EVEREST study Tock Han Lim, on behalf of the EVEREST study group (Singapore/SGP) 16:28 FP MO Peribulbar Triamcinolone for Diabetic Macular Edema: Efficacy and Effects on Glycemic Control Jelliti Bechir, Attia Sonia, Kahloun Rym, Ammari Wafa, Messaoud Riadh, Moncef Khairallah (Monastir/TN) 16:35 FP MO A randomized clinical trial to compare the efficacy and safety of isolated or combined intravitreal injection of Triamcinolone Acetonide and Bevacizumab for diabetic macular edema Hermelino Oliveira Neto, Rafael Ernane Andrade, Cristina Muccioli, Antonio Marcelo Casella, Mario Junqueira Nobrega, Michel Eid Farah, Rubens Belfort (Feira de Santana-Bahia/BR) 16:42 FP MO Comparison of intravitreally applied Bevacizumab and Triamcinolone on diabetic macular edema Sonja G. Prager, Katharina Kriechbaum, Georgios Mylonas, Georg Rainer, Ursula Schmidt- Erfurth (Vienna/A) 16:49 FP MO Does the Prevention of Dark adaptation affect the course of Diabetic Macular Oedema? Sobha Sivaprasad, Sreedhar Jyothi, Geoffrey Arden (London/UK) 16:56 FP MO Syringes, needles, and techniques for intravitreal injections in retinal pharmacotherapy Eduardo Rodrigues, Octaviano Magalhaes, Eduardo Dib, Fernando M. Penha, Carsten H. Meyer, Quan D. Nguyen, Mauricio Maia, Michel Eid Farah (Florianopolis/BR, São Paulo/BR, Bonn/D, Baltimore/USA) 17:03 FP MO Intravitreal Growth Factors in AMD, DME and RVO Michael Koss, Marcel Pfister, Florian Rothweiler, Jindrich Cinatl, Martin Michaelis, Frank Koch (Frankfurt/D) Scientific Program Schedule Monday, 7 June 16:14 FP MO Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion Richard Spaide, Louis Chang, James Klancnik, Lawrence Yannuzzi, John Sorenson, Jason Slakter (New York/USA) 17:10

148 144 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 VIP Lounge 2 08:30-10:00 MO-25 Cataract/Biometry 2 Free paper Cataract Guna Laganovska (Riga/LV) Zdravko Mandic (Zagreb/HR) Walter Stark (Baltimore/USA) 08:30 SL MO Surgical technique for suture fixation of an acrylic intraocular lens in the absence of capsule support Walter Stark (Baltimore/USA) 08:39 FP MO Correction of medium-to-high myopia and myopic astigmatism with AcrySof Cachet phakic intraocular lens and limbal relaxing incisions Thomas Kohnen, Oliver Klaproth (Frankfurt/D) 08:46 SL MO Treatment of lens dislocation Guna Laganovska (Riga/LV) 08:55 FP MO Comparative study of corneal endothelial protection characteristics between dispersive and adaptive OVDs Randall Olson (Salt Lake City/USA) 09:02 FP MO Vitrectomy and Retropupillar Artisan IOLs in the Management of Aphakia and Luxated Cataract with Insufficient Zonular Support Justus G. Garweg, Markus Halberstadt (Bern/CH) 09:09 SL MO Contemporary aproach to the combined glaucoma and cataract procedure Zdravko Mandic (Zagreb/HR) 09:18 FP MO Comparison of torsional mode and conventional ultrasound mode phacoemulisification for cataract surgery Jing Ji, Min Luo, Xianqun Fan, Yilei Pan, Jianfeng Lu (Shanghai/CN) 09:41 FP MO B Guided Versus Contact A-mode Biometry for Accurate Measurement of Axial Length and I.O.L Power Calculation in Siliconized Eyes Mervat H Shalaby, Khaled G. Abu El Einen, Hoda Elshiwy Elshiwy (Cairo/ET) 09:48 VIP Lounge 2 10:30-12:00 MO-62 NGO/Private Sector Partnerships: WIN/WIN or Conflicting Agendas? Prevention of Blindness Johannes Trimmel (Vienna/A) Amos Kibata (Uheal/EAK) Kevin J. Buehler (Fort Worth/USA) 10:30 IL MO Introduction to the Session Kevin J. Buehler (Fort Worth/USA) 10:35 IL MO Introduction to the Speakers Johannes Trimmel (Vienna/A) 10:40 IL MO Corporate Social Responsibility-an opportunity for NGO/Private Sector partnerships Roy Acosta (Fort Worth/USA) 10:50 IL MO How Do You Bridge Competing Interests? Joanna Conlon (London/UK) 11:00 IL MO How Private Ophthalmologist Engage with NGO the Kikuyu Eye Unit Model Amos Kibata (Uheal/EAK) 11:10 IL MO How NGOs Participate in Developing Ophthalmic Markets John M. Barrows (Kensington/USA) 09:25 SL MO Coaxial MICS an important step in phacoemulsification development Wojciech Omulecki (L ódź/pl) 11:20 IL MO Key Successes and Never Dos in NGO/Private Sector Partnerships Peter Ackland (London/UK) 09:34 FP MO outcome of hole and chop technique phaco on hard cataracts Keembiyage Dayawansa (Kandy/CL) 11:30 IL MO Question / Answer Session Amos Kibata (Uheal/EAK)

149 WOC Monday, 7 June 2010 VIP Lounge 2 14:00-15:30 MO-27 Retina: Diagnostics 2 Free Paper Retina Bernd Kirchhof (Cologne/D) Peter Walter (Aachen/D) Hendrik P. N. Scholl (Baltimore/USA) 14:00 FP MO Detection of Drusen using Polarization-sensitive Optical Coherence Tomography Ferdinand Georg Schlanitz, Bernhard Baumann, Christian Ahlers, Sabine Schriefl, Tobias Spalek, Isabelle Golbaz, Michael Pircher, Erich Götzinger, Christoph Hitzenberger, Ursula Schmidt-Erfurth (Vienna/A) 14:07 FP MO Automated detection and quantification of hard exudates in diabetic macular edema using polarization sensitive optical coherence tomography Jan Lammer, Matthias Bolz, Bernhard Baumann, Michael Pircher, Barbara Wetzel, Christoph Hitzenberger, Ursula Schmidt-Erfurth (Vienna/A) 14:14 FP MO Retinal Cellular Imaging using a New Clinical Ultra High Resolution Confocal Microscope with Ultra High Speed Spectral Domain OCT Richard Rosen, Patricia Garcia, Gennady Landa, Mark Hathaway, John Rogers, Rishard Weitz, Thomas Muldoon, Ronald Gentile, Alfonso Ponce, Joseph Walsh (New York/USA) 14:21 FP MO Spectral domain OCT in central serous chorioretinopathy description of retinal changes Veronique Valet, Mathias Maier, Chris Patrick Lohmann (Munich/D) 14:28 FP MO Spectral OCT observations of non full thickness defects of the fovea Janusz Michalewski, Zofia Michalewska, Dominik Odrobina, Slawomir Cisiecki, Krzysztof Dziegielewski, Zbigniew Pikulski, Jerzy Nawrocki (L ódź/pl) 14:35 FP MO Structure-Function Correlation of the Human Central Retina Hendrik P. N. Scholl, Peter Charbel Issa, Eric Tröger, Robert P. Finger, Frank G. Holz, Robert Wilke (Baltimore/USA, Bonn/D) 14:42 FP MO Comparison of microperimetry and conventional computer perimetry in patients with macular hole Alexander Shpak, Galina Kachalina, Elena Pedanova (Moscow/RUS) 14:49 FP MO Optical coherence tomography findings in shaken adult syndrome Volha Yarmak, Tatsiana Imshenetskaya, Galina Vashkevich, Vladimir Rubis (Zaslavl/BY, Minsk/BY) 14:56 FP MO Maculopathy After Long-Term Chloroquine Treatment A Microperimetry and MF-ERG-Study Christina Springer, Petra Weimer, Dorothea Thiemeyer, Regina Max, Klaus Rohrschneider, Friederike Mackensen (Zurich/CH, Heidelberg/D) 15:03 FP MO Visual prognosis of Purtscher s-retinopathy-like central retinal artery occlusion Hiroyuki Iijima (Yamanashi/J) 15:10 VIP Lounge 2 16:00-17:30 MO-28 Trauma Free Paper Trauma Wolfgang F. Schrader (Nürnberg/D) Nelly Sivkova (Plovdiv/BG) 16:00 FP MO The influence of alcohol abuse on the etiology and severity of open globe injuries Florian Rüfer, Andrea Peters, Alexa Klettner, Felix Treumer, Johann Roider (Kiel/D) 16:07 SL MO War and Eye Trauma in West Darfur (Sudan) Mohamed Siddig (Elafuon/SUD) 16:16 FP MO Intraocular metal foreign body: personal experience Nelly Sivkova (Plovdiv/BG) 16:23 FP MO Is There Ocular Primary Blast Injury? Richard Blanch, Robert A. H. Scott, David R. J. Snead (Birmingham/UK) Scientific Program Schedule Monday, 7 June

150 146 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June :30 FP MO A comparitive study of visual outcome, ocular survival and complications of open globe injuries in age groups of <18 yr and >18 year old individuals Lavanya Rao, Krishna Rao, Manali Hazarika, Sulatha Bhandary (Manipal/IND) 16:37 FP MO Location of the canalicular laceration and the clinical outcome after surgical repair Shi Wodong (Shanghai/CN) 16:44 FP MO Phakoanaphylactic Endophthalmitis 67 years after trauma Fabian Höhn, Alireza Mirshahi, Lars-Olof Hattenbach (Mannheim/D, Ludwigshafen/D, Mainz/D) 08:40 IL MO Anti-VEGF therapy and surgery for ROP Antonio Capone (Oakland/USA) 08:50 IL MO Intraoperative use of Plasmin for vitreoretinal surgery Michael T. Trese (Royal Oak/USA) 09:00 IL MO Perioperative use of steroids and lasers in vitreoretinal surgery Mark S. Blumenkranz (Stanford/USA) 09:10 IL MO Pharmacological adjuvants in retinal detachment surgery George William Aylward (London/UK) 16:51 FP MO Multi-local exposure within the Ex Vivo Eye Irritation Test (EVEIT) Norbert Schrage, M. Frentz, F. Spöler (Köln/D) 16:58 FP MO Long-term results after endonasal microsurgical decompression of the optic nerve Hartmut Möbius, Lothar Bauer, Hans-Jürgen Welkoborsky, Burkhard Wiechens (Hannover/D) 09:20 IL MO Role of t-pa in vitreoretinal surgery José García Arumí (Barcelona/E) 09:30 IL MO State of the Art management of endophthalmitis Thomas J. Wolfensberger (Lausanne/CH) 09:40 17:05 FP MO Vitreous metastasis in cutaneous malignant melanoma Isabella Rücker, Fariba Mohammadi Rad, Christine Förster, Ludwig Wilkens, Burkhard Wiechens (Hannover/D) Radio Tower Lounge 1 10:30-12:00 MO-30 Surgical Therapy of Keratoconus 17:12 SL MO Post-traumatic eyelid repair Brigita Drnovšek-Olup (Ljubljana/SI) 17:21 External Eye Disease, Cornea Florian Birnbaum (Freiburg/D) Edward Wylegala (Katowice/PL) Abdulaziz AlRajhi (Riyadh/SA) Radio Tower Lounge 1 08:30-10:00 MO-29 Club Jules Gonin : Surgical Management of Macular Diseases Retina 10:30 IL MO Crosslinking treatment to stopp keratoconus progression Philip Maier (Freiburg) 10:40 IL MO Excimer laser assisted penetrating keratoplasty in advanced keratoconus Berthold Seitz (Homburg/D) Donald J. D'Amico (New York/USA) Thomas J. Wolfensberger (Lausanne/CH) Peter Wiedemann (Leipzig/D) 10:50 IL MO Deep anterior lamellar keratoplaty vs. penetrating keratoplasty in advanced keratoconus Edward Wylegala (Katowice/PL) 08:30 IL MO Anti-VEGF therapy and surgery for PDR Pascale Massin (Paris/F)

151 WOC Monday, 7 June :00 IL MO Femtosecondlaser assisted penetrating keratoplasty in keratoconus Florian Birnbaum (Freiburg/D) 11:10 IL MO Intracorneal ring segments in keratoconus patients Efekan Coskunseven (Istanbul/TR)) 11:20 IL MO Treatment of keratoconus recurrence TBA 11:30 Radio Tower Lounge 1 14:35 FP MO Conventinal Trabeculectomy versus ExPress Shunt(R) Filtering surgery both with 5-FU: a prospective clinical ramdomized trial Gangolf Sauder (Stuttgart/D) 14:42 FP MO Does the size of the subconjunctival preparation influence the outcome of trabeculectomy with mitomycin C? Joanna Wasielica-Poslednik, Daniel Herzog, Esther Hoffmann, Shakhsanam Aliyeva, Norbert Pfeiffer (Mainz/D) 14:49 FP MO Outcome of Repeat Trabeculectomies Carpi Olali, Alan Rotchord, Anthony J. King (Boston/UK) Scientific Program Schedule Monday, 7 June 14:00-15:30 MO-31 Glaucoma: Surgical Therapy 1 Free Paper Glaucoma 14:56 FP MO Vitrectomy does not influence the incidence of ocular hypertension or open-angle glaucoma a 5-year follow-up Alice Yu, Wolfgang Brummeisl, Anselm Kampik, Ulrich Welge-Lüßen (Munich/D, Erlangen/D) Keith Barton (London/UK) Joshua D. Stein (Ann Arbor/USA) Josef Flammer (Basel/CH) 14:00 FP MO Investigation of the Efficacy of Selective Laser Trabeculoplasty (= SLT ) particularly its healtheconomic Aspects. Presentation of 12 Month Postoperative Results Juergen Reese, Mark Tomalla (Duisburg/D) 15:03 FP MO Optimizing the detection of visual field change using automated pointwise linear regression analysis: the truncated trend-event based approach Gustavo V. De Moraes, C. Tello, Robert Ritch, J. M. Liebmann (New York/USA) 15:10 14:07 FP MO Selective Laser Trabeculoplasty (SLT) in Patients with inadequate Reduction of Intraocular Pressure under maximum tolerated Drug Therapy.Results 12-month postoperative Cornelia Hirn, Sandrine Zweifel, Annette Hediger, Marc Töteberg-Harms, Jens Funk (Zurich/CH) 14:14 FP MO Comparision of Trabeculectomy With and Without Amniotic Membrane A Pilot Study Dipanjan Pal, Alokesh Ganguly (Kolkata/IND) 14:21 FP MO The outcome of combined endoscopic cyclophotocoagulation and phacoemulsification in treatment of medically controlled primary open angle glaucoma patients Hon Seng Wong, Ropilah Abdul Rahman (Kuala Lumpur/MAL) 14:28 FP MO How does viscocanaloplasty work? In vivo anterior segment ultrasound to explain the mechanism. Jan Olivier, Robert Stegmann (Pretoria/ZA) Radio Tower Lounge 1 16:00-17:30 MO-68 Retina: AMD 2 Free Paper Retina Frank G. Holz (Bonn/D) Liga Radecka (Riga/LV) Florian Sulzbacher (Vienna/A) 16:00 SL MO ARMD and Cataract Surgery Liga Radecka (Riga/LV) 16:09 FP MO Safety profiles of diabetic versus non-diabetic AMD patients in randomized controlled clinical studies with ranibizumab Frank G. Holz, Gabriela Burian, Andreas Weichselberger, Yehia Hashad (Bonn/D, Basel/D)

152 148 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June :16 FP MO SDOCT-morphology and the corresponding retinal function in neovascular age-related macular degeneration (namd) Florian Sulzbacher, Christopher Kiss, Marion Munk, Stefan Eisenkoelbl, Stefan Sacu, Ursula Schmidt- Erfurth (Vienna/A) 16:23 FP MO Safety and efficacy of OZURDEX (Dexamethasone Intravitreal Implant) as adjunctive therapy to Lucentis in patients with Choroidal Neovascularization (CNV) secondary to Age-Related Macular Degeneration (AMD) Baruch Kuppermann, Michael Singer, Dov Weinberger, Anat Loewenstein, Ching-chi Liu, Jean Lou, Xiao-Yan (Joanne) Li, Scott M. Whitcup (Irvine/USA, Tel-Aviv/IL) 17:05 FP MO One-Year s Treatment Result of Chinese with Neovascular Age-related Macular Degeneration with Intra-vitreal Ranibizumab in Clinical Setting Thomas Tai Ka Fat (Hong Kong/HK) 17:12 Radio Tower Lounge 2 08:30-10:00 MO-33 Intraocular Tumors Pathology 16:30 FP MO Targeting the alternative pathway of complement in AMD with a factor D selective antibody Menno van Lookeren Campagne, Kenneth J. Katschke, Ping Wu, Christian Wiesmann, Robert F. Kelley, Kelly Loyet, Laura DeForge, Philip E. Hass, Peter Haughney, Lisa A. Damico (San Francisco/USA) Hans E. Grossniklaus (Atlanta/USA) Miguel Noel Burnier (Montreal/CDN) Claudia Auw-Hädrich (Freiburg/D) 08:30 IL MO Melanoma Miguel Noel Burnier (Montreal/CDN) 16:37 FP MO Microperimetry as a method for monitoring macular function in patients with dry age-related macular degeneration Yuri Astakhov, Alla Lisochkina, Pavel Nechiporenko (Saint-Petersburg/RUS) 16:44 FP MO Activity Loss Predicts Cognitive Decline in Age-Related Macular Degeneration (AMD) William Tasman, Barry Rovner, Robin Castin (Wyndmoor/USA, Philadelphia/USA) 16:51 FP MO Senile Local Eye Amyloidosis Risk Factor for Age-related Macular Degeneration Victor Ermilov (Volgograd/RUS) 16:58 FP MO A prospective study on different methods of treatment for choroidal neovascularization. The efficacy of verteporfin photodynamic therapy (PDT), intravitreal bevacizumab and transpupillary thermo therapy (TTT) in patients with neovascular AMD Michal Nowak, Piotr Jurowski, Roman Gos, Miroslaw Pastuszka, Andrzej Kapica, Janusz Smigielski (L ódź/pl) 08:40 IL MO Ciliary body tumors Claudia Auw-Hädrich (Freiburg/D) 08:50 IL MO Primary intraocular lymphoma Sarah E. Coupland (Liverpool/UK) 09:00 IL MO Retinoblastoma Ralph C. Eagle (Philadelphia /USA) 09:10 IL MO Mimickers of intraocular tumors Tero Kivelä (Helsinki/FIN) 09:20 IL MO Metastatic intraocular tumors Rubens Belfort Neto (São Paulo/BR) 09:30 IL MO Mystery intraocular tumors Jerry Shields (Philadelphia/USA) 09:40

153 WOC Monday, 7 June 2010 Radio Tower Lounge 2 10:30-12:00 MO-34 New Diagnostic and Therapeutic Aspects of Orbital Diseases Oculoplasty, Lacrimal System, Orbit Geoffrey Rose (London/UK) Rudolf F. Guthoff (Rostock/D) James A. Katowitz (Philadelphia/USA) 10:30 IL MO Ab-externo lateral wall decompression for thyroid eye disease Geoffrey Rose (London/UK) 10:40 IL MO The significance of Orbit Imaging particulary with regard to differential diagnosis and therapy planing of orbital diseases Volker Hingst (Rostock/D) 10:50 IL MO Compressive neuropathy in thyroid eye disease diagnostic features and therapeutic strategies Nicole Fichter (Olten/CH) 11:00 IL MO Orbital space occupying lesions decision orientated strategies Rudolf F. Guthoff (Rostock/D) 11:10 IL MO Innovative uses for dermis fat grafting in orbital reconstruction James A. Katowitz (Philadelphia/USA) 11:20 IL MO Angiodysplasia of the Orbit or Complications of Orbital Surgery How to Avoid Serge Morax (Neuilly-sur-Seine/F) 11:30 Radio Tower Lounge 2 14:00-15:30 MO-35 Cornea/External Disease: Diagnostics Free Paper Cornea, External Disease John K. G. Dart (London/UK) Berthold Seitz (Homburg/D) Eric Spierings (Utrecht/NL) 14:00 FP MO Multicenter Study of the Herpes Simplex Virus Immunochromatography Kit for the Diagnosis of Herpetic Epithelilal Keratitis Yoshitsugu Inoue, Yoshikazu Shimomura, Masahiko Fukuda, HSV kit study group (Yonago/J, Osaka-Sayama/J) 14:07 FP MO Impact of voriconazole in fungal keratitis in Eastern India Suman Saha, Jayangshu Sengupta, Debdulal Banerjee, Archana Khetan (Kolkata/IND) 14:14 FP MO Intraocular pressure survey in patients who underwent lamellar keratoplasty Janiszewska Dominika, Edward Wylegala, Anna Nowinska, Dariusz Dobrowolski (Katowice/PL) 14:21 FP MO Distribution of antigen presenting cells in human corneas with different pathologic entities correlation of confocal in vivo microscopy and immunofluorescence histochemistry Marc Mackert, Nicole Kranebitter, Elisabeth Messmer, Martin Grüterich, Daniel Kook, Armin Wolf, Anselm Kampik, Eveline Irschick, Wolfgang Mayer (Munich/D) 14:28 FP MO Confocal microscopic evaluation of corneal changes after riboflavin-uva corneal collagen cross-linking for keratoconus Laurence Lim, Roger Beuerman, Li Lim, Donald Tan (Singapore/SGP) Scientific Program Schedule Monday, 7 June 14:35 FP MO Repeatability of corneal wavefront measurements with the Orbscan IIz topographer in normal and keratoconus eyes Yasemin Tanyildizi (Frankfurt/D) 14:42 FP MO Detection of subclinical keratconus using conventional and corneal wavefront-based metrics Jens Bühren, Daniel Kook, Thomas Kohnen (Frankfurt/D)

154 150 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June :49 FP MO Peculiarities of corneal changes of patients with diabetes mellitus depending on the compensation of diabetes Olesya Zavoloka, Pavlo Bezditko, Maryna Shchadnykh, Darya Zubkova (Kharkiv/UA) 14:56 FP MO Clinical and ultrasound biomicroscopy (UBM) features predictive of growth in iris melanocytic lesions Gian Paolo Giuliari, Hatem Krema, E. Rand Simpson, Charles J. Pavlin (Toronto/CDN) 15:03 SL MO Experience of corneal collagen cross-linking with riboflavin and ultraviolet-a light for progressive keratoconus: one year follow-up in Pakistani population Wajid Khan (Rawalpindi/PK) 16:50 IL MO In-vivo veritas animal models for ocular drug testing Peter Heiduschka (Tübingen/D) 17:00 IL MO Optic nerve crush testing Evaluation of neuroprotective drugs Frank Schüttauf (Tübingen/D) 17:10 Hall 3 08:30-10:00 MO-37 Corneal Approaches for Addressing Presbyopia 15:10 Radio Tower Lounge 2 16:00-17:30 MO-36 Ocular Pharmacology: Preclinical Safety and Efficacy Testing Subspecialty Day Refractive Surgery Douglas D. Koch (Houston/USA) Emanuel S. Rosen (Manchester/UK) Thomas F. Neuhann (Munich/D) 08:30 IL MO Corneal Techniques (Monovision) Thomas F. Neuhann (Munich/D) Pharmacology, Ocular Drug Delivery Peter Szurman (Tübingen/D) Johann Roider (Kiel/D) Martin S. Spitzer (Tübingen/D) 08:45 IL MO Corneal Pseudoaccommodation Douglas D. Koch (Houston/USA) 09:00 IL MO Presby-Lasik Damián Gatinel (Paris/F) 16:00 IL MO Preclinical drug evaluation more than a simple biocompatibility testing? Peter Szurman (Tübingen/D) 16:10 IL MO Ocular cell culture the cheap and easy way to test preclinical safety and efficacy Martin S. Spitzer (Tübingen/D) 16:20 IL MO VEGF Inhibitor efficacy can cell culture experiments tell us which of them is the best? Johann Roider (Kiel/D) 09:15 IL MO Intracorneal Lenses Emanuel S. Rosen (Manchester/UK) 09:30 IL MO Small Aperture Devices George Waring (Atlanta/USA) 09:45 16:30 IL MO Penetration and distribution of VEGF-Inhibitors after intravitreal injection Swaantje Peters (Lübeck/D) 16:40 IL MO Superfused isolated bovine retina testing intravitreal drugs in-vivo without sacrificing animals Matthias Lüke (Lübeck/D)

155 WOC Monday, 7 June 2010 Hall 3 10:30-12:00 MO-38 Corneal Laser Refractive Surgery Subspecialty Day Refractive Surgery Günther Grabner (Salzburg/A) J. Bradley Randleman (Atlanta/USA) Michael C. Knorz (Mannheim/D) 10:30 IL MO Femtosecond Laser Technology Günther Grabner (Salzburg/A) 14:00 IL MO Biomechanics William J. Dupps Jr. (Cleveland/USA) 14:10 IL MO Accommodation and presbyopia Adrian Glasser (Houston/USA) 14:20 IL MO Normal wavefront error as function of age, pupil size and anatomy Jorge L. Alió (Alicante/E) 14:30 IL MO Retinal image quality in refractive surgery Jack T. Holladay (Bellaire/USA) Scientific Program Schedule Monday, 7 June 10:40 IL MO Excimer Laser Technology Theo Seiler (Zurich/CH) 14:40 IL MO Laser tissue interaction Ronald R. Krueger (Cleveland/USA) 10:50 IL MO Femtosecond Laser: More Than a Flap Maker Holger Lubatschowski (Hannover/D) 14:50 IL MO New advances in corneal imaging Mitchell P. Weikert (Houston/USA) 11:00 IL MO Eye-tracking Michael Mrochen (Zurich/CH) 15:00 11:10 IL MO LASIK Techniques and Complications Michael C. Knorz (Mannheim/D) Hall 3 16:00-17:30 MO-40 11:20 IL MO Surface Techniques and Complications Marguerite McDonald (New Orleans/USA) Managing High Refractive Errors Subspecialty Day Refractive Surgery 11:30 IL MO Ectasia J. Bradley Randleman (Atlanta/USA) 11:40 Hall 3 14:00-15:30 MO-39 Corneal Physiology and Biomechanics Subspecialty Day Refractive Surgery Jorge L. Alió (Alicante/E) William J. Dupps Jr. (Cleveland/USA) Theo Seiler (Zurich/CH) Joseph Colin (Bordeaux/F) Roberto Zaldivar (Buenos Aires/RA) Thomas Kohnen (Frankfurt/D) 16:00 IL MO Phakic IOLs vs Corneal Refractive Surgery José L. Güell (Barcelona/E) 16:10 IL MO Angle-supported Thomas Kohnen (Frankfurt/D) 16:20 IL MO Iris-fixated Camille Budo (Sint-Truiden/B) 16:30 IL MO Sulcus-fixated Roberto Zaldivar (Buenos Aires/RA) 16:40 IL MO Phakic IOLs: Complications Joseph Colin (Bordeaux/F)

156 152 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June :50 IL MO Refractive Lens Exchange Antonio A. P. Marinho (Porto/P) 17:00 IL MO IOL Selection for Refractive Lens Exchange Roberto Bellucci (Verona/I) 17:10 Hall 4/5 14:00-15:30 MO-63 Macula Society : Nonsurgical Treatment of Macular Diseases Retina Hall 4/5 16:00-17:30 MO-64 Pterygium Surgery External Eye Disease, Cornea Donald T. H. Tan (Singapore/SGP) Gerd Geerling (Würzburg/D) Abdulaziz AlRajhi (Riyadh/SA) 16:00 IL MO Epidemiology and Etiology Hugh R. Taylor (Carlton/AUS) 16:16 IL MO Current Understanding of Pterygium Pathogenesis Nick Di Girolamo (Sydney/AUS) Evangelos S. Gragoudas (Boston/USA) 14:00 IL MO New developments in pharmacotherapy for AMD Anthony P. Adamis (Chicago/USA) 14:10 IL MO Treatment of diabetic macular dedma Lloyd Paul Aiello (Boston/USA) 14:20 IL MO Management of macula edema in branch an central retinal vein occlusion Thomas Friberg (Pittsburgh/USA) 14:30 IL MO Management of dry AMD Ivana Kim (Boston/USA) 14:40 IL MO Treatment of geographic atrophy Michael L. Klein (Portland/USA) 14:50 IL MO Treatment of macular telangiectasia type 2 Joan Miller (Boston/USA) 16:32 IL MO Mind the Gap Surgical Pearls for Primary and Recurrent Pterygia Scheffer C. G. Tseng (Miami/USA) 16:48 IL MO EBM Review of Surgical Trials in Pterygia Cordelia M. L. Chan (Singapore/SGP) 17:04 IL MO Anti-angiogenic Treatment Modalities Gerd Geerling (Würzburg/D) 17:14 IL MO Management of Complications of Pterygium Surgery Donald T. H. Tan (Singapore/SGP) Hall 6 08:30-10:00 MO-49 Cicatrizing Conjunctivitis External Eye Disease, Cornea 15:00 Arnd Heiligenhaus (Münster/D) Shigeru Kinoshita (Kyoto/J) 08:30 IL MO Stevens Johnson syndrome and toxic epidermal necrolysis; management in the acute phase with immunosuppression, steroids, and AMT Shigeru Kinoshita (Kyoto/J) 08:40 IL MO Pathogenesis, autoantigens, diagnostics of mucous membrane pemphigoid Detlef Zillikens (Lübeck/D)

157 WOC Monday, 7 June :50 IL MO Immunosuppression and immunoglobulins in cicatrizing conjunctivitis Manfred Zierhut (Tübingen/D) 09:00 IL MO Stem cell deficiency and fornix reconstruction in cicatrizing conjunctivitis Daniel Meller (Essen/D) 09:10 IL MO Clinic and management of other cicatrizing conjunctivitis Thanh Hoang-Xuan (Paris/F) 09:20 IL MO Mucous membrane pemphigoid: making the diagnosis John K. G. Dart (London/UK) 09:30 11:30 IL MO Intraocular antibiotic therapy Denise Freitas (Sao Paulo/BR) 11:40 Hall 6 14:00-15:30 MO-51 Combating Childhood Blindness: Strategies of Prevention, Detection and Treatment Vision 2020 Prevention of Blindness Nathan G. Congdon (Baltimore/USA) Oliver Ehrt (Munich/D) Clare Gilbert (London/UK) Scientific Program Schedule Monday, 7 June Hall 6 10:30-12:00 MO-50 14:00 IL MO Combating Childhood Blindness: Overview of the avoidable causes of blindness in children Clare Gilbert (London/UK) Intra-Ocular Therapy Uveitis, Intraocular Inflammation 14:10 IL MO Prevention: Strategies for preventing retinopathy of prematurity Luz Gordillo (Lima/PE) Rubens Belfort, Jr. (São Paulo/BR) Anat Loewenstein (Tel Aviv/IL) Thomas Ness (Freiburg/D) 14:20 IL MO Early detection: Neonatal screening: experiences from Brazil Andrea Zin (Rio de Janeiro/BR) 10:30 IL MO Intraocular implants Rubens Belfort, Jr. (São Paulo/BR) 10:40 IL MO Vitrectomy in uveitis Anat Loewenstein (Tel Aviv/IL) 10:50 IL MO Bevacizumab and Rainbizumab in uveitis Ahmad Mansour (Beirut/RL) 11:00 IL MO Glaucoma devices in uveitis Thomas Ness (Freiburg/D) 11:10 IL MO Antiviral therapy Careen Y. Lowder (Cleveland/USA) 14:30 IL MO Early detection: Key informant method for identifying blind children Mohammad Muhit (Dhaka/BD) 14:40 IL MO Treatment: Optimising the outcome of cataract surgery in children clinical aspects Perumalsamy Vijayalakshmi (Madurai/IND) 14:50 IL MO Treatment: Optimising the outcome of cataract surgery in children non-clinical aspects Paul Courtright (Moshi/EAT) 15:00 IL MO Treatment: Lessons learnt from school eye health program programmes Nathan G. Congdon (Baltimore/USA) 11:20 IL MO Cataract surgery in uveitis Soon Phaik Chee (Singapore/SGP) 15:10

158 154 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 Hall 6 16:00-17:30 MO-52 The Economics of Blindness: What Does Lost Vision Cost, How Much Can Prevention Save? Vision 2020 Prevention of Blindness Paul Lee (Durham/USA) Jill Keeffe (Melbourne/AUS) 16:00 IL MO The need for good epidemiological data on causes, prevalence and incidence of vision impairment for on vision impairment analyses Paul Lee (Durham/USA) 16:15 IL MO Is there a role for public health in promoting visual screening? Cost-effectiveness results from the United States David B. Rein (Atlanta/USA) 16:30 IL MO Modeling changes in mean deviation in glaucoma Bringing together the results of the CIGTS, OHTS, and AGIS studies using decision analytic methods Steven M. Kymes (St. Louis/USA) Hall 7 08:30-10:00 MO-53 ARVO : Translational Research Developing Innovative New Treatments for Glaucoma Glaucoma Peng T. Khaw (London/UK) Georg Michelson (Erlangen/D) 08:30 IL MO Tissue bioengineering Dong Feng Chen (Boston/USA) 08:40 IL MO Neuroprotection of retinal ganglion cells Henry Klassen (Irvine/USA) 08:50 IL MO Gene therapy for glaucoma Keith Martin (Cambridge/UK) 09:00 IL MO CNS implications of glaucoma damage and potential therapies Neeru Gupta (Toronto/CDN) 16:45 IL MO Willingness to pay for cataract surgery in rural China Mingguang He (Guangzhou/CN) 17:00 IL MO What are the sources of data that we use to establish costs? Jill Keeffe (Melbourne/AUS) 17:15 09:10 IL MO Nanostrategies to restore neurons in glaucoma Rutledge G. Ellis-Behnke (Cambridge/USA) 09:20 IL MO New methods of preventing scarring Peng T. Khaw (London/UK) 09:30 IL MO Identifying pressure response genes in the trabecular meshwork Terete Borras (Chapel Hill/USA) Hall 7 09:40 06:45-08:15 World Ophthalmic Education Colloquium Breakfast Attendance upon invitation only

159 WOC Monday, 7 June 2010 Hall 7 10:30-12:00 MO-54 EGS : Glaucoma Management: Hot Topics from the new EGS Guidelines Glaucoma Clive Migdal (London/UK) Francisco Javier Goñi Foncillas (Barcelona/E) John Thygesen (Copenhagen/DK) 10:30 IL MO Progression is the key; where are we going with perimetry Francisco Javier Goñi Foncillas (Barcelona/E) 14:30 IL MO European accreditation of training centers Wagih Aclimandos (London/UK) 14:40 IL MO ENET unifying European subspecialty Societies Marie-José Tassignon (Antwerp/B) 14:50 IL MO "Concordia pro visu": education meets research Tero Kivelä (Helsinki/FIN) 15:00 IL MO Harmonisation of training accross Europe Marko Hawlina (Ljubljana/SI) 15:10 Scientific Program Schedule Monday, 7 June 10:50 IL MO Target IOP where are we now? John Thygesen (Copenhagen/DK) Hall 7 16:00-17:30 MO-56 11:10 IL MO The combined approach to glaucoma medications Anton Bernhard Hommer (Vienna/A) APAO : Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asia-Pacific Region 11:30 IL MO The cutting edge glaucoma incisional surgery Tarek M. Shaarawy (Geneva/CH) 11:50 Retina Ian Constable (Nedlands/AUS) Timothy Lai (Hong Kong/CN) Xiaoxin Li (Beijing/CN) Hall 7 14:00-15:30 MO-55 EBO : From National towards European Training in Ophthalmology International Ophthalmology Marko Hawlina (Ljubljana/SI) Wagih Aclimandos (London/UK) Marie-José Tassignon (Antwerp/B) 14:00 IL MO European Board of Ophthalmology-what and why Peter J. Ringens (Amsterdam/NL) 16:00 IL MO Epidemiology of AMD and PCV in the Asia-Pacific region Tien Ying Wong (Singapore/SGP) 16:10 IL MO Molecular genetics of Asian AMD and PCV Chi-Pui Pang (Hong Kong/CN) 16:20 IL MO Comparison of angiographic features in neovascular AMD and PCV Adrian Koh (Singapore/SGP) 16:30 IL MO Optical coherence tomography imaging in AMD and PCV Won-Ki Lee (Seoul/ROK) 14:10 IL MO European Board of Ophthalmology diploma examination (EBOD) Catherine Creuzot-Garcher (Dijon/F) 14:20 IL MO European CME accreditation Gordana Sunaric-Megevand (Genève/CH) 16:40 IL MO Pharmacotherapy for neovascular AMD Taraprasad P. Das (Hyderabad/IND) 16:50 IL MO Role of Photodynamic therapy and Transpupillary thermal therapy in PCV Xiaoxin Li (Beijing/CN)

160 156 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June :00 IL MO Long-term outcome of monotherapy with verteporfin photodynamic therapy for PCV Mitsuko Yuzawa (Tokyo/J) 17:10 IL MO Anti-VEGF and combination therapy for PCV Timothy Lai (Hong Kong/CN) 17:20 IL MO Prevention of AMD and PCV Paul Mitchell (Sydney/AUS) Hall 8 08:30-10:00 MO-57 PAAO : A Close Look Into the Future: Pearls on New Cornea and External Diseases Techniques and Strategies of Treatment External Eye Disease, Cornea Denise de Freitas (São Paulo/BR) Richard L. Abbott (San Francisco/USA) 08:30 IL MO Update in the treatment of Acanthamoeba keratitis Denise de Freitas (São Paulo/BR) 08:40 IL MO New approaches for the treatment and keratoconus and keratectasia. What is the best choice? Joaquim Neto Murta (Lisboa/P) Hall 8 10:30-12:00 MO-58 Organisational Aspects: Training, Policy, Economics, Legal, Regulations, Interoperability Anja Tuulonen (Oulu/FIN) Jiri Jan (Brno/CZ) Isabel Oberacher-Velten (Regensburg/D) 10:30 IL MO Screening for retinopathy of prematurity a telemedicine project in Bavaria Isabel Oberacher-Velten (Regensburg/D) 10:45 IL MO The experiences of the EyeMo (mobile eye unit) in Northern Finland: process, quality end economics Anja Tuulonen (Oulu/FIN) 11:00 IL MO Signal analysis in functional OCT Leopold Schmetterer (Vienna/A) 11:15 IL MO Correcting Motion Artifacts of OCT Volume Scans by using a Novel Software Registration Method Markus Meier (Erlangen/D) 11:30 08:50 IL MO Platelet rich plasm in the treatment of ocular surface disease and corneal ulcers Jorge L. Alió (Alicante/E) 09:00 IL MO Molecular biology technique for keratitis diagnosis Mauro Nishi (São Paulo/BR) 09:10 IL MO Current Developments and strategies on lamelar corneal transplants Luis Isquierdo Jr. (Lima/PE) 09:20 IL MO Corneal cross-linking combined with topographyguided laser treatment Mirko R. Jankov (Belgrado/SRB) 09:30

161 WOC Monday, 7 June 2010 Hall 8 14:00-15:30 MO-59 JCAHPO : Teaching Allied Health Personnel International Ophthalmology William F. Astle (Calgary/CDN) Gudrun Bischoff (Hamburg/D) 14:00 IL MO Introduction & IJCAHPO Overview Teaching vs. training Training & Certification William H. Ehlers (Farmington/USA) 14:10 IL MO Accreditation & International Standards for Education Programs Peter Donshik (Bloomfield/USA) 14:25 IL MO International Core Curriculum ICO & IJCAHPO A teaching model for training the eye care team Foundation of knowledge & principles Resources: ICO, IJCAHPO, ATPO, CSOMP, COTP, Others William F. Astle (Calgary/CDN) Hall 8 16:00-17:30 MO-60 Lindberg Society : Exfoliation Syndrome From Molecules to Manifestations Miscellaneous Ursula Schlötzer-Schrehardt (Erlangen/D) Murat Irkec (Istanbul/TR) Gábor Holló (Budapest/H) 16:00 IL MO The LOXL1 gene function and implications Fridbert Jonasson (Reykjavik/IS) 16:10 IL MO Molecular pathophysiology of XFS closer to a solution? Ursula Schlötzer-Schrehardt (Erlangen/D) 16:20 IL MO Exfoliative glaucoma an open window to neurodegeneration and neuroprotection Robert Ritch (New York/USA) 16:30 IL MO Systemic associations and vascular dysfunction Murat Irkec (Istanbul/TR) Scientific Program Schedule Monday, 7 June 14:40 IL MO Implementing the ICO Curriculum in Africa A teaching model for training the eye care tea Boateng Wiafe (Kasoa/GH) 14:55 IL MO Teaching Methods Best Practices Synchronous Asynchronous Clinical Experiential learning Karl Golnik (Cincinatti/USA) 14:10 IL MO Retinoscopy Action Learning Presentation Provide attendees an interactive learning experience on retinoscopy Attendees will receive a course syllabus, checklist, training resources Course will demonstrate use of resources: online, simulation William H. Ehlers, William F. Astle (Farmington/USA, Calgary/CDN) 16:40 IL MO Ocular manifestations of XFS beyond glaucoma Gábor Holló (Budapest/H) 16:50 IL MO Exfoliative glaucoma clinical features and current treatment Anastasios G. P. Konstas (Thessaloniki/GR) 17:00 IL MO Asymmetry in manifestation still an enigma Tero Kivelä (Helsinki/FIN) 17:10 IL MO Cataract extraction in XFS: Management and prevention of complications Rupert Menapace (Vienna/A) 17:20 15:25 IL MO Conclusion & Gudrun Bischoff (Hamburg/D)

162 158 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 Hall 9 08:30-10:00 MO-41 Worldwide Program of Teaching Directors of Ophthalmic Residency Programs World Ophthalmic Educational Colloquium Karl Golnik (Cincinatti/USA) Pinar Aydin (Ankara/TR) Klaus-Peter Steuhl (Essen/D) 08:30 IL MO Introduction Karl Golnik (Cincinatti/USA) Hall 9 10:30-12:00 MO-42 The New Frontier of Changing Parameters of Residency Education World Ophthalmic Educational Colloquium Andrew G. Lee (Houston/USA) Marko Hawlina (Ljubljana/SI) Veit-Peter Gabel (Regensburg/D) 10:30 IL MO Introduction Andrew G. Lee (Houston/USA) 08:40 IL MO Principles of Performance Assessment Eduardo Mayorga Argañaraz (Buenos Aires/RA) 10:40 IL MO Harmonisation of Residency Education in Europe Marko Hawlina (Ljubljana/SI) 08:50 IL MO ICO International Basic Science and Clinical Sciences Assessments for Ophthalmologists David Taylor (London/UK) 10:50 IL MO Generational Learning: Teaching When the Times Are Changing Gabriela Palis (Buenos Aires/RA) 09:00 IL MO Resident Assessment: Objective Structured Clinical Examination (OSCE) Pinar Aydin (Ankara/TR) 11:00 IL MO New Models for Ophthalmic Educational Assessments: Dreyfus, Ericsson, and Schon Andrew G. Lee (Houston/USA) 09:10 IL MO The 360 Degree Evaluation Gabriela Palis (Buenos Aires/RA) 09:20 IL MO Can Professionalism and Communication Skills be Taught and Assessed? Andrew G. Lee (Houston/USA) 09:30 IL MO Videos/Vignettes for Teaching Professionalism Karl Golnik (Cincinatti/USA) 09:40 11:10 IL MO Teaching Learning: Changing Parameters in Resident Education Karl Golnik (Cincinatti/USA) 11:20 IL MO Curriculum: More Than Just Words: Paradigm Shift in the Structured Learning Plan for Residents Eduardo Mayorga Argañaraz (Buenos Aires/RA) 11:30 IL MO Competency vs. Striving for Excellence in Surgical Teaching, Specifically Cataracts Susan Ksiazek (Chicago/USA) 11:40 IL MO Selecting the Next Generation of Ophthalmologists Susan H. Day (San Francisco/USA) 11:50

163 WOC Monday, 7 June 2010 Hall 9 14:00-15:30 MO-43 Innovative Technologies for Teaching Ophthalmology World Ophthalmic Educational Colloquium Mark O. M. Tso (Baltimore/USA) Deepak P. Edward (Akron/USA) Karin U. Löffler (Bonn/D) 14:00 IL MO We are in the Age of Innovative Technologies Mark O. M. Tso (Baltimore/USA) 14:10 IL MO A Spectrum of Innovative Technologies for Teaching Ophthalmology Hans-Martin Helb (Bonn/D) 14:20 IL MO Simulators In Ophthalmic Surgery: Are we there yet? Deepak P. Edward (Akron/USA) 14:30 IL MO Animations in Teaching Ophthalmology Oliver Findl (Vienna/A) 14:40 IL MO Teaching Refraction through Animation Technology William H. Ehlers (Farmington/USA) 14:50 IL MO D Teaching Systems in Ophthalmology: Retina & Optic Nerve Wico W. Lai (Hong Kong/CN) 15:00 IL MO How to teach Ophthalmic Pathology using Innovative Technologies Deepak P. Edward (Akron/USA) 15:10 IL MO The Neuro-Ophthalmology Virtual Education Library: NOVEL Susan Ksiazek (Chicago/USA) 15:20 IL MO Conclusions Deepak P. Edward (Akron/USA) Hall 9 16:00-17:30 MO-44 Emerging Technologies for Ophthalmic Teaching and Learning: Internet Tools for Teaching Teaching Without Classrooms World Ophthalmic Educational Colloquium Eduardo Mayorga Argañaraz (Buenos Aires/RA) Mark O. M. Tso (Baltimore/USA) Karin U. Löffler (Bonn/D) 16:00 IL MO Introduction Eduardo Mayorga Argañaraz, Mark O. M. Tso (Buenos Aires/RA, Baltimore/USA) 16:10 IL MO Coping With Lack of Knowledge: An Online Tool to Diagnose Conditions You Never Knew Existed Bertil D. Damato (Liverpool/UK) 16:20 IL MO Interactive Teaching and Audience Response Systems Helmut Wilhelm (Tübingen/D) 16:30 IL MO Concept Mapping Software for Enhancing Teaching and Learning Selection and Application Gabriela Palis (Buenos Aires/RA) 16:40 IL MO Synchronous E-learning Considerations for Selecting the Right Software Karl Golnik (Cincinatti/USA) 16:50 IL MO Using the Web 2.0 Tool Box for Ophthalmology Teaching and Learning Helena Filipi (Lisbon/P) 17:00 IL MO Training Ophthalmic Technicians in the 21 st Century William H. Ehlers (Farmington/USA) 17:10 IL MO Simulation in Ophthalmic Surgical Training Colin A. McCannel (Los Angeles/USA) 17:20 Scientific Program Schedule Monday, 7 June

164 160 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 Hall 10 08:30-10:00 MO-65 AAO : Glaucoma Implants: Now and the Future Glaucoma James C Tsai (New Haven/USA) Keith Barton (London/UK) Hagen Thieme (Mainz/D) 08:30 IL MO Tube vs Trabeculectomy and other studies Kuldev Singh (Stanford/USA) Hall 10 10:30-12:00 MO-66 Minimally Invasive Ophthalmic Surgery Miscellaneous Daniel Mojon (St. Gallen/CH) Jorge L. Alió (Alicante/E) 10:30 IL MO Introduction to the session: Minimally invasive, the present and future of ophthalmic surgery Daniel Mojon, Jorge L. Alió (St. Gallen/CH, Alicante/E) 08:40 IL MO Flow dynamics of aqueous shunts. What do they do? Sheng Lim (London/UK) 08:50 IL MO Surface modification of shunts. Does it matter? Hagen Thieme (Mainz/D) 09:00 IL MO Size matters, but small is better Marlene Moster (Bala Cynwyd/USA) 09:10 IL MO Not yet shunting to the suprachoroidal space Walter Konen (Cologne/D) 09:20 IL MO Implanting the Baerveldt Shunt without ligation Keith Barton (London/UK) 09:30 IL MO Ahmed Implantation Technique James C. Tsai (New Haven/USA) 09:40 IL MO Conclusion and Future of aqeous shunts Keith Barton (London/UK) 09:50 10:40 IL MO Minimally invasive vitreoretinal surgery Anselm Kampik (Munich/D) 10:50 IL MO Minimally invasive strabismus surgery Daniel Mojon (St. Gallen/CH) 11:00 IL MO Minimally invasive refractive surgery Jorge L. Alió (Alicante/E) 11:10 IL MO Minimally invasive corneal surgery Roger Steinert (Orange/USA) 11:20 IL MO Minimally invasive cataract surgery H. Burkhard Dick (Bochum/D) 11:30 IL MO Minimally invasive glaucoma surgery Julian Garciá-Feijoó (Madrid/E) 11:40 IL MO Minimally invasive ocular surface surgery Shigeru Kinoshita (Kyoto/J) 11:50 IL MO Mimimally invasive tumor treatment Arun D. Singh (Cleveland/USA)

165 WOC Monday, 7 June 2010 Hall 10 14:00-15:30 MO-67 Retina: Vascular Disease 1 Free Paper Retina Carsten H. Meyer (Bonn/D) Gisèle Soubrane (Créteil/F) Thomas J. Wolfensberger (Lausanne/CH) 14:00 SL MO Macular teleanciectasis Ute Wolf-Schnurrbusch (Bern/CH) 14:09 FP MO Pharmacokinetics and pharmacodynamics of the sustained-release dexamethasone intravitreal implant Devin Welty, Joan-En Chang Lin, Mayssa Attar, Andrew Acheampong, Michael Robinson, Scott M. Whitcup (Irvine/USA) 14:16 FP MO Retinal Vascular Events After Anti-Vascular Endothelial Growth Factors Ahmad Mansour, Therese von Hanno, Peter Kofoed, Shree Kurup, Michel Shami, Eric Chen, Jad Akesby, Sabine Aisenbrey, Focke Ziemssen, Alay Banker, Wael Soliman, Zei-Lun Huang, Ozgur Artunay, Hamid Hosseini, Sami Uwaydat, Padmamalini Mahendradas, Leon Bynoe (Beirut/RL) 14:23 FP MO Spatial distribution of intraocular oxygen in advanced diabetic retinopathy Clemens Lange, Panagiotis Stavrakas, Julian da Silva, Ulrich Luhmann, Zdenek Gregor, James Bainbridge (London/UK) 14:30 FP MO Prevalence of retinopathy in patients with type 2 diabetes Preliminary report from BNDC trial, BIRDEM, Bangladesh M. K. Goswami (Dhaka/BD) 14:37 FP MO Efficacy outcomes of the CRUISE study of intravitreal ranibizumab in patients with macular edema secondary to central retinal vein occlusion Leonard Feiner, Roman G. Rubio, Namrata Saroj, Zhengrong Li, Amy Chen Rundle, Sarah Gray, Wendy Yee Murahashi (Kenilworth/USA, San Francisco/USA) 14:44 FP MO Intravitreal ranibizumab for the treatment of significant macular edema secondary to acute branch retinal vein occlusion Stefan Sacu, Gerlinde Matt, Wolf Bühl, Roman Dunavölgyi, Erna Schranz, Christian Prünte, Ursula Schmidt-Erfurth (Vienna/A) 14:51 FP MO A case of retinal regeneration in Norrie's disease Yun-Sik Yang, Seong-Min Hong, Ji-Yun Yang, Eun-Heui Jin (Icksan/ROK) 14:58 FP MO Incidence of damage to the crystalline lens and retina during intravitreal injections Carsten H. Meyer, Stefan Michels, Hans-Martin Helb, Stefan Mennel, Jörg C. Schmidt, Annette Hager, Eduardo B. Rodrigues (Bonn/D, Duisburg/D, Marburg/D, Zurich/CH, Hamburg/D) 15:05 FP MO Amalric Sign and CRAO-A Review Sribhargava Natesh, Mayuri Bhargava, Naresh Kumar Yadav, Rohit Shetty, Bhajung Shetty (Bangalore/IND) 15:12 Hall 10 16:00-17:30 MO-82 EUGOGO Strabismus Petros Perros (Newcastle upon Tyne/UK) Christoph Hintschich (Munich/D) Alison Dickinson (Newcastle upon Tyne/UK) Marian Ludgate (Cardiff/UK) 16:00 IL MO From Science to Clinical Management to Politics: Amsterdam Declaration Petros Perros (Newcastle upon Tyne/UK) 16:20 IL MO Evidence Based Medical Management of Thyroid Dysfunction and Orbitopathy Mario G. Salvi (Milan/I) 16:40 IL MO EUGOGO Consensus Statement and Surgical Management Lelio Baldeschi, Susanne Pitz, Anja K. Eckstein (Amsterdam/NL, Mainz/D, Essen/D) Scientific Program Schedule Monday, 7 June 17:00

166 162 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 Salon 21 10:30-12:00 MO-26 Miscellaneous 2 Free Paper Miscellaneous Dušica Pahor (Maribor/SI) Khristo P. Takhchidi (Moscow/RUS) Ines M. Lanzl (Munich/D) 10:30 SL MO Impact of U.S. Economic Stimulus Funding on Vision Research James Jorkasky (Rockville/USA) 10:39 SL MO Ocular findings in Hemodialysis Patients Dušica Pahor (Maribor/SI) 10:48 SL MO Ocular involvement in lysosomal storage diseases Ines Lanzl (Munich/D) 10:57 SL MO Modern ocular biomechanics as an effective tool for evaluation of advanced directions in clinical and experimental research Konstantin Kotliar, Elena Iomdina, Ivan Koshitz, Svetlana Bauer, Ines Lanzl (Munich/D) 08:30 IL MO Surgery for Duane Syndrome Frank Martin (Sydney/AUS) 08:40 IL MO Surgery for Dissociated Strabismus Anthony Murray (Cape Town/ZA) 08:50 IL MO ) Congenital ET; Surgery vs toxin 2) Choice of Surgery for Nystagmus Costantino Schiavi (Bologna/I) 09:00 IL MO ) Strabismus Surgery in High Myopia 2) Acute Ocular Trauma; Strabismus Concerns Jan-Tjeerd de Faber (Rotterdam/NL) 09:10 IL MO Surgery for Superior Oblique Palsy Miho Sato (Hamamatsu/J) 09:20 IL MO Topical Anesthesia in Strabismus Surgery Sonal Farzavandi (Singapore/SGP) 09:30 Roof Garden 10:30-12:00 MO-70 11:06 SL MO Five millions surgeries in the S. Fyodorov Eye Microsurgery Federal State Institution Khristo Takhchidi, Alexander Doga (Moscow/RUS) 11:15 FP MO Medically Unexplained Visual Loss (MUVL) in Singapore Leonard Yuen, Lisa Ong, Maria Goh, Tan Zhen Kiat, James Cullen (Singapore/SGP) MEACO : Management of Macular and Retinal Vascular Diseases Retina Manal Omran Taryam (Dubai/UAE) Sherif Shetta (Cairo/ET) Bernd Kirchhof (Cologne/D) 11:22 10:30 IL MO Introduction to Diabetic Macular edema Hassan A. Dhibi (Riyadh/SA) Roof Garden 08:30-10:00 MO-69 ISA : Clinical Challenges in Strabismus 10:45 IL MO Hours Pre operative Intravitreal Bevacizumab for Repair of Retinal Detachment in Eyes with Active Proliferative Diabetic Retinopathy Massan Mortada (Cairo/ET) Strabismus Derek Sprunger (Indianapolis/USA) Frank Martin (Sydney/AUS) Jan-Tjeerd de Faber (Rotterdam/NL) Costantino Schiavi (Bologna/I) 11:00 IL MO Staining epiretinal membranes Manal Omran Taryam (Dubai/UAE) 11:15 IL MO Vitrectomy for traction maculopathy Sherif Shetta (Cairo/ET)

167 WOC Monday, 7 June :30 IL MO Vitrectomy: intraoperative complications and how to deal with them Bernd Kirchhof (Cologne/D) 11:45 Roof Garden 14:00-15:30 MO-71 ARVO : Genetics of Eye Disease: Current Clinical Perspective Genetics Janey L. Wiggs (Boston/USA) David G. Hunter (Boston/USA) 14:00 IL MO Ocular Genetics NEI Perspective Introduction and Overview David G. Hunter (Boston/USA) Roof Garden 16:00-17:30 MO-72 AAO : Retinal Pharmacotherapy Retina Lihteh Wu (San Jose/CR) Albert J. Augustin (Karlsruhe/D) 16:00 IL MO Anti-VEGF in Central Retinal Vein Occlusions Lihteh Wu (San Jose/CR) 16:10 IL MO Update Regarding Extended Drug Delivery to the Posterior Segment William F. Mieler (Chicago/USA) 16:20 IL MO Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema: The Pan-American Collaborative Retina Study Group Results J. Fernando Arevalo (Caracas/Y) Scientific Program Schedule Monday, 7 June 14:04 IL MO Ocular Genetics: NEI Perspective Paul Sieving (Bethesda/USA) 14:16 IL MO Genetics of Strabismus Elizabeth Engle (Boston/USA) 14:28 IL MO Genetics of Leber's Congenital Amaurosis Elise Heon (Toronto/CDN) 14:40 IL MO Glaucoma Genetics David Mackey (East Melbourne/AUS) 14:52 IL MO AMD Genes and Risk Factors Eric Souied (Créteil/F) 16:30 IL MO Intravitreal Bevacizumab for Choroidal Neovascularization secondary to multifocal choroiditis Francesco Bandello (Milano/I) 16:40 IL MO Suprachoroidal Drug Delivery via Catheter Albert J. Augustin (Karlsruhe/D) 16:50 IL MO The Ability of In-Office Genetic Testing for Exudative Macular Degeneratione to Predict Response to Anti-VEGF Therapy Tarek S. Hassan (Royal Oak/USA) 17:00 IL MO A State of the Art in Antiangiogenic Therapy Evidence and Conclusions Ursula Schmidt-Erfurth (Vienna/A) 15:04 IL MO Pharmacogenomics and Approaches to Personalized Medicine Louis R. Pasquale (Boston/USA) 17:10 IL MO Macrophages and AMD Rationale for Treatment or Epiphenomenon Antonia M. Joussen (Berlin/D) 15:16 Open discussion and concluding remarks 17:20

168 164 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 ICC Lounge 08:30-10:00 MO-45 Editorial Management World Forum of Journal Editors Frank G. Holz (Bonn/D) José Cunha-Vaz (Coimbra/P) Alexander J. Brucker (Philadelphia/USA) 08:30 IL MO Ethical dilemmas in scientific publications: pitfalls and solutions for editors Diana Epstein (Glasgow/UK) 10:45 IL MO Voclosporin Quan Dong Nguyen (Baltimore/USA) 11:00 IL MO Ozurdex Marc D. de Smet (Amsterdam/NL) 11:15 IL MO Interferon alpha Christoph M. E. Deuter (Tübingen/D) 11:30 IL MO Anti-TNF-alpha blocking Antibodies Emmett T. Cunnigham (San Francisco/USA) 11:45 08:40 IL MO Self-citations Wolfgang Glänzel (Leuven/B) 08:50 IL MO Meeting abstracts, tabloids and peer-reviewed articles duplicate publications? Frank G. Holz (Bonn/D) 09:00 IL MO Affiliations of journals with scientific societies pros and cons José Cunha-Vaz (Coimbra/P) ICC Lounge 14:00-15:30 MO-47 Nanotechnology New Technology, Bioengineering Robert Ritch (New York/USA) Marco Zarbin (Roseland/USA) 09:10 IL MO Editorship the publishers' perspective Esther Wieland (Heidelberg/D) 09:20 IL MO Role of the editorial board expectations and limitations Alexander J. Brucker (Philadelphia/USA) 09:30 ICC Lounge 14:00 IL MO Building contact lenses with integrated radios and biosensors Babak Amir Parviz (Seattle/USA) 14:10 IL MO Intravitreal cell-encoated drug therapy for neuroprotection and anti-angiogenesis Jost B. Jonas (Mannheim/D) 14:20 IL MO Nanotechnology-mediated targeted nonviral gene therapy approaches to treat corneal diseases Rajiv R. Mohan (Columbia/USA) 10:30-12:00 MO-46 IUSG : Update on New Treatment Against Uveitis 14:30 IL MO Functionalized nanoparticles for targeted drug and gene delivery Uday B. Kompella (Aurora/USA) Uveitis, Intraocular Inflammation Robert Nussenblatt (Bethesda/USA) Manfred Zierhut (Tübingen/D) 10:30 IL MO Daclizumab Robert Nussenblatt (Bethesda/USA) 14:40 IL MO Using nanotechnology to control ocular inflammation Rutledge G. Ellis-Behnke (Cambridge/USA) 14:50 IL MO Therapeutic potential of stem cells for retinal regeneration Ting Xie (Kansas City/USA)

169 WOC Monday, 7 June :00 IL MO Eye-Opening Retinal Prostheses: Nanotechnology and the Neural-Electrical Interface Russell Andrews (Los Gatos/USA) 15:10 IL MO Nanotheragnostics in normal-tension glaucoma Sung Chul Park (Seoul/ROK) 15:20 IL MO Keynote Speech: Nanomedicine where is it headed? Carlo Montemagno (Cincinnati/USA) ICC Lounge Salon 11/12 14:00-15:30 MO-81 Disaster Response: Ophthalmology s Organizational Role International Ophthalmology Christian Luco (Santiago/RCH) 14:00 IL MO Collaboration with Host National Society Mildred M. G. Olivier (Hoffman Estates/USA) Scientific Program Schedule Monday, 7 June 16:00-17:30 MO-48 Google's Approach, Open Access Publishing World Forum of Journal Editors Ulrich Korwitz (Cologne/D) Harald Müller (Heidelberg/D) Bernd Kirchhof (Cologne/D) 16:00 IL MO Goals of Google Stefan Keuchel (Hamburg/D) 16:10 IL MO Google s digital books: Contra Jessica Sänger (Munich/D) 16:20 IL MO Digital books: Pro Harald Müller (Heidelberg/D) 16:30 IL MO Open access publishing in Medicine Ulrich Korwitz (Cologne/D) 16:40 IL MO Open Access to Research Data Anita Eppelin (Cologne/D) 16:50 IL MO A film repository Bernd Kirchhof (Cologne/D) 14:10 IL MO Relationships with NGOs and Governmental Organizations Michael W. Brennan (Burlington/USA) 14:20 IL MO Haiti Experience; Immediate Response Natalio Izquierdo (San Juan/PR) 14:30 IL MO Concepcion Experience Christian Luco (Santiago/RCH) 14:40 IL MO Tsunami Experience S. Natarajan (Mumbai/IND) 14:50 IL MO Strategies for Donor Solicitation Stephanie J. Marioneaux (Chesapeake/USA) 15:00 IL MO Volunteer Realities Philip R. Rizzuto (Providence/USA) 15:10 IL MO Assistance to War Displaced Physicians Manal Omran Taryam (Dubai/UAE) 15:20 IL MO Global Ophthalmology in Disaster Relief Efforts Stefan Seregard (Stockholm/S) 17:00

170 166 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June 2010 Room 42 08:30-10:00 MO-73 Glaucoma: Basics 2 Free Paper Glaucoma Anton Gerinec (Bratislava/SK) Lutz E. Pillunat (Dresden/D) 08:30 SL MO The new possibilities for exploiting of the genotype-phenotype correlation in primary congenital glaucoma Anton Gerinec (Bratislava/SK) 08:39 FP MO Atherogenic risk factors and Primary Open Angle Glaucoma Luís Abegão Pinto, Joana Ferreira, Ana Amaral, Paula Leitão, Isabel Domingues, João Lisboa (Belas/P) 08:46 FP MO Cerebrospinal fluid dynamics and subarachnoid space diameter in normal-tension glaucoma Hanspeter Killer, Gregor Jaggi, Neil Miller, Josef Flammer, Angel Mironow, Luca Remonda (Aarau/CH) 09:28 FP MO Immune-mediated injury and the retinal ganglion cell survival Ping Huang, Yan-Jiao Huo, Hong Li, Samuel Shao-Min Zhang, Chun Zhang (Beijing/CN) 09:35 FP MO Analysis of IgM autoantibody patterns as marker for acute phase immunoreactions in pseudoexfoliation glaucoma Katrin Lorenz, Marcus Schlich, Nils Böhm, Christina Kramann, Norbert Pfeiffer, Franz Grus (Mainz/D) 09:42 Room 42 10:30-12:00 MO-74 Uveitis/Intraocular Inflammation, Microbiology/Immunology 2 Free Paper Uveitis, Intraocular Inflammation Justus G. Garweg (Bern/CH) Ahmet Gul (Istanbul/TR) Jyotirmay Biswas (Chennai/IND) 08:53 FP MO The photoreceptor layer appears intact in advanced glaucomatous optic neuropathy: a spectral domain OCT study Imran Masood, Trushar Patel, Simon Longstaff (UK) 09:00 FP MO Elevated intraocular pressure reduces aquaporin-9 expression in rat optic nerve head and retina. Makoto Nakamura, Maiko Naka, Akiyasu Kanamori, Akira Negi (Kobe/J) 09:07 FP MO Comparison of Glaucomatous Optic Neuropathy and Blindness in Symptomatic and Asymptomatic Primary Angle Closure Glaucoma in Central India. Rekha Khandelwal, Shivani Bidaye, Suresh Ughade, Ketaki Shah (Nagpur/IND) 09:14 FP MO Increased Expression of Cellular Senescence in Cultured Trabecular Meshwork Cells by TGF-beta Ulrich Welge-Lüßen (Erlangen/D) 09:21 FP MO Does Intraocular Pressure (IOP) Reduction Affect Intracranial Pressure (ICP)? An animal Model Morteza Mehdizadeh (Shiraz/IR) 10:30 FP MO Anti-Inflammatory Effects of Topical Application of Curcuma Longa Extract in Experimental Uveitis Puneet Agarwal, Renu Agarwal, S. K. Gupta, Sushma Srivastava, Rohit Saxena, S. S. Agrawal (Kuala Lumpur/MAL, New Delhi/IND) 10:37 FP MO Mesenchymal Stem Cells Ameliorate Experimental Autoimmune Uveitis by Modulation of the Th1- dependent Immune Response Xiaomin Zhang, Xinjun Ren, Shaozhen Zhao, Xiaorong Li (Tianjin/CN) 10:44 FP MO Intravitreal Adalimumab for Uveitis-Related Macular Edema Anna Praidou, Sofia Androudi, Evangelia Tsironi, Christos Kalogeropoulos, Athina Theodoridou, Periklis Brazitikos (Thessaloniki/GR) 10:51 FP MO Risk factors for the development of macular edema in non-infectious uveitis Martin Rösel, Anne Ruttig, Claudia Schumacher, Carsten Heinz, Arnd Heiligenhaus (Münster/D)

171 WOC Monday, 7 June :58 FP MO Young age as risk factor for complicated course and visual outcomes in intermediate uveitis in children. Viera Kalinina Ayuso, Hermine ten Cate, Patricia van den Does, Aniki Rothova, Joke de Boer (Utrecht/NL) 11:05 FP MO Cataract Formation in Patients Treated with LX211 (Luveniq /voclosporin oral capsules) with Non-Infectious Uveitis Uwe Pleyer (Berlin/D) 11:12 FP MO Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis Christoph Tappeiner, Carsten Heinz, Martin Roesel, Arnd Heiligenhaus (Bern/CH, Münster/D) 11:19 FP MO The Many Faces of Ocular Tuberculosis and Short Course Oral Isoniazid Trial: a UKMMC Experience Siew Yuen Goh, Wan Haslina Wah, Hon Seng Wong, Othmaliza Othman, Muhaya Mohamed (Kuala Lumpur/MAL) 11:26 FP MO The expression of VEGF of OCM-1 cell line of human choroidal melanoma and OCM-1 cell line tumor implanted in nude mice Haiyan Liu (Shanghai/CN) 11:33 FP MO Role of Quantiferon TB GOLD test in serpiginous like choroiditis Jyotirmay Biswas, Swapnesh D. Sawant, S. Sudharshan, R. Gayathri, Lily K. Therese, H. N. Madhavan (Chennai/IND) 11:40 14:09 FP MO Lanreotide Autogel for persistent diabetic macular edema: a prospective study of effectiveness and quality of life Maria C. Hernaez-Ortega, Enrique Soto-Pedre, Jose A. Pinies (Castro-Urdiales/E) 14:16 FP MO NAVILAS : A New Paradigm in Retina Education Michael Ober, Michael Ulbig, Aljoscha Neubauer, Anselm Kampik (Southfield/USA, Munich/D) 14:23 FP MO Natural history of visual acuity changes in shamtreated patients in a randomized, controlled trial of Dexamethasone intravitreal implant in patients with Macular Edema (ME) due to branch or central Retinal Vein Occlusion (RVO) Mark Gillies, Julia A. Haller, Mark S. Blumenkranz, Francesco Bandello, Rubens Belfort, Jeffrey Heier, Anat Loewentstein, Young-Hee Yoon, Jenny Jiao, Xiao-Yan (Joanne) Li, Scott M. Whitcup (Sydney/AUS, Philadelphia/USA, Milano/I, São Paulo/BR, Stanford/USA, Tel Aviv/IL, Boston/USA, Seoul/ROK, Irvine/USA) 14:30 FP MO Effect of dexamethasone intravitreal implant on patient-reported visual functioning for the treatment of macular edema following retinal vein occlusion Jonathan W. Kowalski, Anne Rentz, Dennis Revicki, Francesco Bandello, Mark Gillies, Young-Hee Yoon, Charlie Liu, Scott M. Whitcup (Irvine/USA, Cologne/D, Bethesda/USA, Milano/I, Sydney/AUS, Seoul/ROK) 14:37 FP MO Kenalog-40 Induces Inflammatory Cytokines and Other Proteins in Eyes after Intravitreal Injection and In Human Macrophages: Biomarkers of Sterile Endophthalmitis Jeffrey L. Edelman, Maria Castro-Paiz, Quan Dong Nguyen, Diana Do, Michael Robinson (Irvine/USA) Scientific Program Schedule Monday, 7 June Room 42 14:00-15:30 MO-75 Retina: Miscellaneous 1 Free Paper Retina Karl Ulrich Bartz-Schmidt (Tübingen/D) José-Alain Sahel (Paris/F) Ursula Schmidt-Erfurth (Vienna/A) 14:00 SL MO How can we manage uveal melanoma in 2010 Laurence Desjardins (Paris/F) 14:44 FP MO Effectiveness of dexamethasone intravitreal implant in an animal model of chronic retinal neovascularization. James Burke, Yong Li, Ton Lin, Corine Ghosn, Scott M. Whitcup, Larry Wheeler, Abhiram Vilupuru, Susan Tsai, Alexandra Almazan (Irvine/USA) 14:51 FP MO Influence of anti-vegf treatment on retinal vessel diameters Christos Chryssafis, S. Asteriades, Paraschos Tranos, A. Vakalis, Aljoscha Neubauer (Thessaloniki/GR, Munich/D)

172 168 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June :58 FP MO R213W mutation in the XLRS1 gene causes severe retinoschisis with vitreous hemorrhage in a Chinese family Jun Xu, Hong Gu, Ningpu Liu (Beijing/CN) 15:05 FP MO Punctate inner choroidopathy: A case report with improvement after combined intraocular anti-vegf and photodynamic therapy Sebastian Weiß, Michael Meyer, Konstantinos Zinelis, Rolf Winter (Hannover/D) 15:12 Room 42 16:28 FP MO LX211 (Luveniq /voclosporin oral capsules) as in Clinically Quiescent Sight-Threatening Non- Infectious Uveitis: Results of the LX Study of the LUMINATE Clinical Program Manfred Zierhut, on behalf of the LUMINATE Study Group (Tübingen/D) 16:35 FP MO Visual acuity and quality of life in patients treated with LX211 (Luveniq /Voclosporin Oral Capsules) in an active uveitis affecting the posterior segments Talin Barisani-Asenbauer (Vienna/A) 16:42 FP MO Prevalence of hepatitis B & C in patients scheduled for cataract surgery A Hospital Based Study Shahid Shaikh (Karachi/PK) 16:00-17:30 MO-76 Uveitis/Intraocular Inflammation, Microbiology/Immunology 3 Free Paper Uveitis, Intraocular Inflammation Chi Chao Chan (Bethesda/USA) Didier Decaudin (Paris/F) Manfred Zierhut (Tübingen/D) 16:00 FP MO Improvement of uveitis with everolimus is associated with Treg cells Maren Hennig, Susanne Wasmuth, Dirk Bauer, Martin Busch, Beatrix Zureck-Imhoff, Solon Thanos, Arnd Heiligenhaus (Münster/D) 16:07 FP MO Evaluation of OCT as a Measure of Response to LX211 (Luveniq /Voclosporin Oral Capsules) Therapy in Active Non-Infectious Uveitis Carlos Pavesio (London/UK) 16:14 FP MO LX211 (Luveniq /voclosporin oral capsules) for Active Sight-Threatening Non-Infectious Uveitis Involving the Posterior Segment: Results of the LX Study of the LUMINATE Program Friederike Mackensen, for the LUMINATE investigators (Heidelberg/D) 16:49 FP MO Serologic Strain-typing of Toxoplasma Gondii Associated with Ocular Toxoplasmosis in the United States. Partho Kalyani, Chloe Gottlieb, Patrick Coady, Amy Liu, Michael Zegans, Fei Yu, H. Nida Sen, Robert Nussenblatt, Gary Holland, Michael Grigg (Los Angeles/USA, Bethesda/USA) 16:56 FP MO Clinical profile of CMV-associated anterior uveitis in immunocompetent patients Martina Angi, Flore Rozenberg, Phuc LeHoang, Bahram Bodaghi (Roma/I, Paris/F) 17:03 FP MO Ocular disease awareness and pattern of ocular manifestation in patients with biopsy proven lung sarcoidosis Maria Pefkianaki, Sofia Androudi, Vasileios Sourlas, Epameinondas Zakynthinos, Maria Kotoula, Konstantinos Gourgoulianis, Zoe Daniil, Evangelia Tsironi (Larissa/GR) 17:10 16:21 FP MO The Multicenter Uveitis Steroid Treatment (MUST) Trial: Design and Baseline Characteristics John H. Kempen, Michael M. Altaweel, Janet T. Holbroook, Douglas A. Jabs, Elizabeth A. Sugar (Philadelphia/USA)

173 WOC Monday, 7 June 2010 Room 44 10:30-12:00 MO-77 Oncology 2 Free Paper Norbert Bornfeld (Essen/D) Brenda L. Gallie (Toronto/CDN) Bożena Romanowska-Dixon (Krakow/PL) 10:30 SL MO TTT in intraocular tumors Bożena Romanowska-Dixon (Krakow/PL) 10:39 FP MO Vascular changes in uveal melanoma after radiotherapy Anush Amiryan (Moscow/RUS) 10:46 FP MO Long-term follow-up on patients treated with photodynamic therapy for amelanotic choroidal melanoma Irene Barbazetto, Thomas Lee, Reza Iranmanesh, James Klancnick, Brian Maar, David H. Abramson (New York/USA) 10:53 FP MO Comparison of different treatment modalities in therapy of juxtapapillary uveal melanomas Michael Freistühler, Harun Akgül, Theodora Gkika, Dirk Flühs, Wolfgang Sauerwein, Norbert Bornfeld (Essen/D) 11:00 FP MO Integrative Analysis of Differentially Expressed Genes from Choroidal Melanoma Fine Needle Biopsies Tara McCannel, Barry L. Burgess, Nagesh P. Rao, Stan F. Nelson, Bradley R. Straatsma (Los Angeles/USA) 11:07 FP MO Reinterpreting the evidence: Is better survival of patients with smaller uveal melanomas evidence of a treatment benefit? Zelia Correa, James J. Augsburger, Camila Simoes (Cincinnati/USA) 11:14 FP MO Optical Coherence Tomography in 18 Cases of Subfoveolar Choroidal Osteoma. Evidence for Photoreceptor Atrophy over the Decalcified Portion of the Tumor Benjamin Perez, Carol Shields, Jerry Shields (Mexico City/MEX, Philadelphia/USA) 11:21 FP MO Clinical and pathologic characteristics of iris melanomas: results of a multicenter international study Samira Khan, Paul Finger, Per Sandkull, Stefan Seregard, Daniel Gologorsky, Amy Schefler, Sander Dubovy, Timothy Murray, Tero Kivela, Sebastian Eskelin, Robert Raut, Christine Corriveau (New York/USA, Stockholm/S, Miami/USA, Helsinki/FIN, Montreal/CDN) 11:28 FP MO Conjunctival tumor in Hispanic population. Clinical serie in 100 patients from Chile Maria Manquez (Santiago/RCH) 11:35 FP MO Primary orbital malignant melanoma in Chinese Xiaolin Xu (Beijing/CN) 11:42 Room 44 14:00-15:30 MO-78 Oculoplasty/Orbita/Lids/Lacrimal System 2 Free Paper Oculoplasty, Orbita, Lids Brigita Drnovšek-Olup (Ljubljana/SI) Karl-Heinz Emmerich (Darmstadt/D) David Tse (Miami/USA) 14:00 SL MO The use of Titanium T-Plate as platform for globe alignment in severe paralytic strabismus David Tse, Erin Shriver, Kenneth Krantz, Jeffrey Tse, Hilda Capo, Craig McKeown (Miami/USA) 14:09 FP MO Composite (hydroxyapatite-silicon) integrated orbital implants experience with 80 cases Arkadiusz Pogrzebielski, Anna Michalik-Wójcik, Anna Markiewicz, Bożena Romanowska-Dixon (Kraków/PL) 14:16 FP MO Clinical impact of virtual models for computerassisted planning and surgery in orbital reconstruction Nils-Claudius Gellrich, Martin Rücker, Harald Essig, Horst Kokemüller, Frank Tavassol, André Eckardt, Alexander Schramm (Hannover/D) Scientific Program Schedule Monday, 7 June 14:23 FP MO Functional evaluation of patients with globe dislocations Yaroslav Grusha (Moscow/RUS)

174 170 WOC 2010 Monday, 7 June Scientific Program Schedule Monday, 7 June :30 FP MO Levator Excision with Fascia Lata Sling Surgery in Jaw Winking Ptosis by a Modified Technique Ashok Grover (New Delhi/IND) 14:37 FP MO Treatment of lagophthalmos with hyaluronic acid gel injection Elena Agafonova, Yaroslav Grusha, Dilyara Ismailova, Yulia Ivanchenko (Moscow/RUS) 14:44 FP MO Morphologic analysis of interpalpebral adhesions in different lateral tarsorraphy techniques Yulia Ivanchenko, Yaroslav Grucha, Anatoly Fyodorov (Moscow/RUS) 14:51 FP MO Exposure Keratopathy Associated with Thyroid Eye Disease Dilyara Ismailova, Yaroslav Grusha, Arkady Kasparov (Moscow/RUS) 14:58 FP MO The Mini Tarsal Strip Lateral Canthopexy Indications, Technique and Complications in 634 Cases James Oestreicher, Kia Tarassoly (Toronto/CDN) 16:07 FP MO EUREQUO a multinational project for improving outcomes in cataract and refractive surgery Mats Lundström (Karlskrona/S) 16:14 FP MO The MultiKeratome for cataract surgery curved with multiple points engineered to seal better and to minimize the induced astigmatism Tom Schossau, Matthew Giegengack, Gerald W. Zaidman, Shree K. Kurup (Scarsdale/USA) 16:21 FP MO OCT-Camera assisted intraoperative anterior and posterior segment surgery First results of the new intraoperative OCT (ioct) Maya Müller, Philipp Steven, Eva Lankenau, Marc Krug, Emrah Acidereli, Stephan Oelckers, Reginald Birngruber, Salvatore Grisanti, Gereon Hüttmann (Lübeck/D) 16:28 FP MO Multimodal imaging of corneal cross-linking effects Oliver Stachs, Marine Hovakimyan, Rudolf F Guthoff, Gereon Hüttmann, Alexander Krüger, Philipp Steven (Rostock/D, Lübeck/D) 15:05 FP MO Transcanalicular Laser-DCR with 5 mm Ballon- Dilatation Karl-Heinz Emmerich, Ralf Ungerechts,Hans- Werner Meyer-Rüsenberg (Darmstadt/D, Hagen/D) 15:12 Room 44 16:00-17:30 MO-79 New Technology, Bioengineering, Nanotechnology 2 Free Paper New Technology, Bioengineering Gabriel van Rij (Rotterdam/NL) Caiwen Xiao (Shanghai/CN) Marco Zarbin (Roseland/USA) 16:00 FP MO Laser-actived gold-nanoparticles as a potential new treatment modality for exsudative agerelated macular-degeneration Ina Hahn, Florian Levold, Claudine Strack, Jürgen Groll, Heidrun Keul, Gereon Hüttmann, Florian Rudnitzki, Elmar Endl, Nicole Eter (Bonn/D) 16:35 FP MO Evaluation of cortical activation patterns and white matter tracts in cases of amblyopia using fmri Rohit Saxena, Shikha Gupta, Senthil Kumaran, Vimla Menon, Pradeep Sharma (New Delhi/IND) 16:42 FP MO Simulation of the accommodation demand to estimate the power consumption of the artificial accommodation system Jörg Nagel, Ulrich Gengenbach, Helmut Guth, Gerog Bretthauer, Rudolf Guthoff (Eggenstein- Leopoldshafen/D, Karlsruhe/D, Rostock/D) 16:49 FP MO Optimized sensor concept for the Artificial Accommodation System Liane Rheinschmitt, Fabian Ritter, Jörg André Nagel, Ulrich Gengenbach, Georg Bretthauer, Rudolf F. Guthoff (Eggenstein-Leopoldshafen/D, Karlsruhe/D, Rostock/D) 16:56 SL MO Reconstruction of orbital wall defects with tissue-engineered bone enhanced by human bone morphogenetic protein 2 in a canine model Caiwen Xiao (Shanghai/CN) 17:05

175 WOC Scientific Program Scientific Program Schedule Tuesday, 8 June 2010 Tuesday, 8 June

176 ICC Hall 3 Hall 4/5 Hall 6 Hall 7 Hall 8 Hall 9 Hall 10 ICC Lounge Roof Garden Salon 11/12 Salon 19 Salon 20 Room 42 Room 43 Room 44 Highlight Free Paper WOC Course Industry Meetings Tuesday, 8 June TU-45 D'Amico, Liggett, Binder Retina Society Symp: Advances in Instrumentation TU-49 Baudouin, Messmer, Zagórski Iatrogenic Diseases of Ocular Surface TU-56 Hubbard, Abramoff, Hornegger Technical Aspects: Telecommunication, Comput. TU-61 Vergés, Zaldivar, Kohnen Panel: Phakic IOLs TU-65 Aydin, Lightman, Gloor A New Approach to Teaching Ophthalmology TU-72 Módis German, Polish, Danish and Hungarian on Keratoconus TU-46 Agarwal, Lang, Lang, Ryan, Spivey Ophthalmic Premier League (OPL) TU-50 Barisani-Asenbauer, Bodaghi, Heiligenhaus IOIS Symp: Pediatric Uveitis TU-57 Gilbert, Klauß Braindrain: Challenges and Solutions TU-62 Seiler The Femtosecond Face-off TU-66 Astle, Fielder, Anderson The Training of Para-ophthalmic Personnel TU-69 Wilkinson, Aylward, Eter Current Concepts in Retinal Detachment Surgery WOC-C-61 Coscas SD-OCT and AMD Treatment and Follow Up TU-58 Streiff Lecture TU-47 Kuppermann, Murray, Pleyer Uveitis a Global Challenge TU-41 Cochener, Beaconsfield, García-Delpech, Gallenga, Kampik FEOph Symp. TU-59 Helvestone, Paris, Gräf Therapy of Acquired Strabismus TU-63 Jordan, Caprioli, Thieme Glaucoma: Surgical therapy 2 TU-67 Verdaguer, Straatsma, Zagórski Improving Continuing Education Worldwide TU-70 Klintworth, Messmer, Heegaard ISOP Symp: Ophthalmic Pathology Update TU-73 Ohno, Chee, McCluskey APIISG : Uveitis Which One Should Not Miss TU-48 García Arumí, Pournaras, Binder Current Treatment Options TU-60 Bodaghi, Chee, Heinz Viral Uveitis TU-64 Jankov, Seiler Therapeutic Customized Ablation TU-68 Olson, Tassignon, Naumann Setting Up New Param. for Teaching Ophth. TU-71 Coscas IOAT : Ten Years to Go to the Global Elimination TU-74 Vargas, Tseng, Carriazo, Alfonso ALACCSA-R Symp: Cornea and Ocular Surface TU-52 Wolfram, West, Zhao Current Epidemiological Eye Studies TU-75 Nishi, Haefliger, Goes Multifocal and Accommodating IOL s TU-53 Chan, Coupland, Deuter Intraocular lymphoma TU-76 Güell, Tassignon, Zetterström ESCRS : New IOL Concepts TU-83 Zierhut IUSG Workshop: Diagnostic Criteria of Virus-induced Anterior Uveitis TU-54 TU-77 Jünemann, Blumenkranz Rejdak Ocular Regeneration Pharmacology and repair for in Posterior retinal degeneration Segment Diseases WOC-C-63 Garcia-Marcos Femtosecond (FS) Course in Ophthalmology TU-55 Lorenz, Maumenee Leber Congenital Amaurosis TU-78 Vinciguerra, Kezirian, Epstein Best Excimer Laser Meeting der International Agency for the Prevention of Blindness WOC-C-46 Feinbaum, Patel, Mrukwa-Kominek Achieving Excellence WOC-C-49 Hoerauf Current Management of Diabetic Macular Edema TU-80 Holladay, Reinstein, McDonnell Refractive surgery/refraction 4 WOC-C-47 Wylegala, Baudouin, Guthoff Corneal Imaging WOC-C-50 Viestenz, Kuhn Management of the ruptured Globe TU-81 Armitage, Birnbaum, Gottsch Cornea/External Disease: Misc., Surgical therapy 3 WOC-C-48 Hattenbach Current Concepts in the Manag. of Ret. Vessel Occlu. WOC-C-51 Lang Challenging Cases in Anterior Segment Surgery WOC-C-54 Scheuerle The optic disc fundusc., perimetry, laser scanning ophthalm. TU-79 Murube del Castillo, Ugurbas, Geerling Dry Eye: Latest Adv. in Surfoc. Dryness WOC-C-52 Meyer-Rüsenberg Blepharoplasty II TU-82 Haigis, Pham, Malyugin Cataract/biometry

177 Messe Stockholm Sao Paulo Abu Dhabi Oslo Hall Room Madrid Room Sydney Room Hong Kong Room Istanbul VIP Lounge 1 VIP Lounge 2 Radio Tower Lounge 1 Radio Tower Lounge 2 Hall TU-01 Lucke, Ducournau EVRS Symp: Innov. Techniques in Vitreor. Surgery TU-09 Bornfeld, Lemmen Vitreoretinales Update der Retinologischen Gesellschaft TU-13 Ahmed, Shaarawy, Erb Surgical Videos and Panel TU-17 Nussenblatt, Curnow, Thurau Proteomics and Genomics in Uveitis TU-21 Forsott, Ehlers, Duncker RGP Lenses: Non Surgical Treatm. of Refra. Errors TU-25 Arteaga, Kammann, Zetterström Cataract/biometry 3 WOC-C-42 Thieme Wetlab Glaucoma Drain Implants TU-29 Hattenbach, Coscas, Stout Retina: Vascular Disease 2 TU-33 Joussen, Theelen Retina: Diagnostics 3 TU-02 Vassileva, Németh, Kaskaloglu SEEOS/BSOS Symp: Countries in Transition TU-06 Adenis, Meyer-Rüsenberg, Seiff Ophthalm. Challenges in Aesthetic Surgery TU-10 Olsen, Holladay, Haigis Getting the Power Right: IOL Power Calculations TU-14 Nguyen, Fletcher, Ondiveeran Interventions in AMD Beyond Intrav. Injections TU-18 Hassan, Kaiser, Humayun ASRS Symp: The Future of Surg. and Med. Retina TU-22 Shields, Damato, Bornfeld Panel: Uveal Tumors TU-26 Goldstein, Mély, Tost Therap. Contact Lenses: Band. Lenses and Drug Release WOC-C-43 Auffarth, Dick Wetlab Phaco Course for Beginners TU-30 Baerveldt, Wormald, Young Glaucoma: Medical therapy TU-34 Lemmen, Pournaras Retina: Surgical therapy 2 TU-37 Thumann, Kaiser, Pauleikhoff Retina: AMD 3 TU-38 Pleyer EVER : How to get your work published? TU-42 Kampik, Bedri, Qureshi Sustainable Eye Health Programs Highlight Free Paper WOC Course Industry Meetings TU-03 Haefliger, Kirchhof, Scharrer DOC : Ocular Surgery TU-07 Lorenz Pediatric Cataract Surgery TU-11 Wolf, Lang, de Laey Netzhaut-Fallkonferenz TU-04 Obstbaum, Tetz Combinations Cataract and Other Surgeries TU-08 Landau, Schiefer, Aydin Unexplained Visual Loss TU-12 Seitz Consilium diagnosticum TU-15 Gupta, Cordeiro, Vorwerk Neural Based Targeting in Glaucoma TU-19 Cernák, Maier Eye Banking: Optimizing Techniques and Quality Control TU-23 Bhisitkul, Aylward, Heimann Evidence-based Managem. of Retinal Disease TU-27 Schrage, Langer, Gini Hot Topics in Ocular Traumatolog WOC-C-44 Auffarth Wetlab Phaco Course for the Advanced TU-31 Baudouin, Reinhard Cornea/External Disease: Medical therapy TU-35 Finger, Mitchell, Bandello Retina: Medical therapy 2 TU-39 Alió, Seiler ISRS/AAO : Cutting Edge Progress TU-43 Susanna, Jr, Singh, Healey WGA Symp: Managing Advanced Glaucoma TU-16 Orgül, Gramer, Harris Ocular Blood Flow Clinical Relevance for Glaucoma TU-20 Larkin, Pleyer, Sawatzki Immunology of Keratoplasty TU-24 Prajna, Neuhann Modern Manual Cataract Surgery TU-28 Kuhn, Schrader, Sullivan Globe Reconstruction after Severe Eye Injury WOC-C-45 Auffarth, Dick Wetlab Biaxial and Microcoaxial Phacoemulsification TU-32 Helbig, Pasyechnikova, Richard Retina: Surgical therapy 3 TU-36 Li, MacLaren, Wiedemann Retina: Basics TU-40 Finger, Seregard, Kivelä AJCC/UICC Symp: TNM based Classif. Syst. for Onc. Oncology TU-44 Cunha-Vaz, Sahel, Pfeiffer Networking for Clinical Trial Research in Europe Poster exhibition of Poster P-TU-001 to P-TU-265 Tuesday, 8 June TU-84 Going Blind

178 S I X T R E N T A C A R Y K L S Looking sharp means facing Sixt! (Sixt the official car rental partner of the World Ophthalmology Congress) Reservations and information: From Europe: +49(0)180/ (0,14 per min. from the German landlines, prices from mobile phones max. 0,42 per min) From North America: SIXTCAR From South America: SIXT (from Brazil; toll free) From Australia: or

179 WOC Tuesday, 8 June 2010 Stockholm 08:30-10:00 TU-01 EVRS : Innovative Techniques in Vitreoretinal Surgery Retina Klaus Lucke (Bremen/D) Didier Ducournau (Nantes/F) 08:30 IL TU Membrane Peeling without Vitrectomy Fabio Patelli (Milan/I) 08:40 IL TU Brilliant blue vs. ICG in macular hole surgery Klaus Lucke (Bremen/D) 08:50 IL TU ILM Peeling in Macular Edema Didier Ducournau (Nantes/F) 09:00 IL TU A New Theory of Lamellar Macular Hole Jerzy Nawrocki (Lodz/PL) 09:10 IL TU Posterior Hyaloid Peeling in Myopic Foveoschisis Hassan Mortada (Cairo/ET) 09:20 IL TU ILM Peeling in diabetic Retinopathy Giampaolo Gini (Prato/I) Stockholm 10:30-12:00 TU-02 SEEOS/BSOS : Countries in Transition Challenges and Achievements in Eye Care International Ophthalmology Petja Ivanova Vassileva (Sofia/BG) Janos Németh (Budapest/H) Mahmut Kaskaloglu (Izmir/TR) 10:30 IL TU Challenges of Diabetic Rethinopathy treatment in Serbia today Slobodanka Latinovic (Novi Sad/SRB) 10:40 IL TU Mini-invasive vitrectomy: expanded indications in complex cases Cesare Forlini (Ravenna/I) 10:50 IL TU The current state of ophthalmology in Turkey Mahmut Kaskaloglu (Izmir/TR) 11:00 IL TU Clear lens extraction 6 years follow-up Nikica Gabric (Zagreb/HR) 11:10 IL TU East meets West, South meets North harmonisation of ophthalmology training in Europe Marko Hawlina (Ljubljana/SI) Scientific Program Schedule Tuesday, 8 June 09:30 IL TU PVR Prophylaxis in Trauma Ferenc Kuhn (Birmingham/USA) 11:20 IL TU Prevention of blindness and visual rehabilitation Janos Németh (Budapest/H) 09:40 IL TU cppv and PVD Induction Back to the Future? Frank Koch (Frankfurt/D) 11:30 IL TU Russian experience in quality ophthalmic care Elena Khristovna Takhchidi (Moscow/RUS) 09:50 11:40 IL TU Cross-borders Education and Blindness Prevention Petja Ivanova Vassileva (Sofia/BG) 11:50

180 176 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Stockholm 14:00-15:30 TU-03 DOC : Ocular Surgery Progress and Perspective Ocular Surgery Eduard A. Haefliger (Binningen/CH) Bernd Kirchhof (Cologne/D) Armin Scharrer (Fürth/D) 14:00 IL TU Part I: Defining the"state of the art": Glaucoma Surgery what makes a gold standard? Günther K. Krieglstein (Cologne/D) 14:10 IL TU After-cataract prevention: Evaluating the standard and defining the gold standard Rupert Menapace (Vienna/A) Stockholm 16:00-17:30 TU-04 Combinations Cataract and Other Surgeries Cataract Stephen A. Obstbaum (New York/USA) Manfred Tetz (Berlin/D) 16:00 IL TU Cataract and Glaucoma Surgery Stephen A. Obstbaum (New York/USA) 16:20 IL TU Cataract and Canaloplasty Manfred Tetz (Berlin/D) 16:40 IL TU Cataract Surgery and Keratoplasty Marc Muraine (Rouen/F) 14:20 IL TU Avastin in wet AMD: State of the art or good enough for the savings? Susanne Binder (Vienna/A) 14:30 IL TU Surgical correction of Presbyopia: What can we do and what should we not do? Thomas F. Neuhann (Munich/D) 14:40 IL TU Part II: Assuring the quality: Guidelines for refractive surgery in Germany: 15 years of experience with the KRC Thomas Kohnen (Frankfurt/D) 17:00 IL TU Combined Trabeculectomy and Cataract Extraction Versus Trabeculectomy Alone in Primary Angle-closure Glaucoma Hin Yeung Tsai (Taichung/TJ) Stockholm 18:00-20:00 TU-84 Going Blind Vision 2020 Prevention of Blindness 14:50 IL TU Providing highest quality LASIK the LASIK TUEV certification and quality label Michael C. Knorz (Mannheim/D) 15:00 IL TU Tailoring indication to surgery to patients satisfaction Jan van Meurs (Rotterdam/NL) There are too many people with vision loss who could benefit from much earlier diagnosis and intervention and dramatically increased awareness of what's possible in vision rehabilitation. I would ask that physicians don't wait until we've lost much of our vision before they talk to us about vision rehabilitation, including the services and resources that can help us live most effectively and plan positively for the future. 15:10 IL TU Outcome of quality assessment and benchmarking in external cataract surgery: Rationale for using a survey versus a prospective follow-up design Burkhard Awe, Ursula Hahn, Stefanie Schmickler (Wilhelmshaven/D, Düsseldorf/D, Ahaus/D) 15:20 Please refer us to these specialists and don't ever tell patients that there is nothing more that can be done! There are always new skills to learn. Enormous progress has come through the power of strong advocates. We have many disability role models who broke the rules and made stunning progress! We need to do the same to increase public awareness of sight loss!

181 WOC Tuesday, 8 June 2010 Sao Paulo 10:30-12:00 TU-06 Ophthalmological Challenges in Aesthetic Surgery Oculoplasty Jean-Paul Adenis (Limoges/F) Hans-Werner Meyer-Rüsenberg (Hagen/D) Stuart Seiff (San Francisco/USA) 10:30 IL TU Brow lift Stuart Seiff (San Francisco/USA) 10:45 IL TU Lower lid blepharoplasty and midface lift Jean-Paul Adenis (Limoges/F) 14:20 IL TU Congenital Idiopathic Microcoria in an infant, IOL implantation in children with uveitis Scott R. Lambert (Atlanta/USA) 14:30 IL TU Combined Procedure for Treatment of Aphakia and Glaucoma after Infantile Cataract Surgery David A. Plager (Indianapolis/USA) 14:40 IL TU Secondary infantile cataract associated with presumed intrauterine infection Birgit Lorenz (Giessen) 14:50 IL TU Anterior and Posterior Capsulorexis in Children Charlotta Zetterström (Oslo/N) 15:00 Scientific Program Schedule Tuesday, 8 June 11:00 IL TU Laser blepharoplasty Hans-Werner Meyer-Rüsenberg (Hagen/D) 11:15 IL TU Minimal invasive surgery in aesthetic Raymond Douglas (Ann Arbor/USA) 11:30 IL TU Aesthetic oculofacial rejuvenation in Asians Reynaldo M. Javate (Manila/RP) 11:45 Sao Paulo 16:00-17:30 TU-08 Unexplained Visual Loss Neuro-Ophthalmology Klara Landau (Zurich/CH) Ulrich Schiefer (Tübingen/D) Pinar Aydin (Ankara/TR) Sao Paulo 14:00-15:30 TU-07 Pediatric Cataract Surgery Cataract Birgit Lorenz (Giessen/D) 16:00 IL TU Optical pitfalls Oliver Job (Lucerne/CH) 16:10 IL TU Seven easy steps to managing unexplained visual loss Andrew G. Lee (Houston/USA) 16:20 IL TU Easily Missed Retinal Disorders Murat Karacorlu (Istanbul/TR) 14:00 IL TU Sutureless pars plana anterior vitrectomy and capsulotomy for significant PCO in young children TBA 14:10 IL TU Sutured IOL's Edward G. Buckley (Durham/USA) 16:30 IL TU The How and the Why of non-organic visual loss Gordon Plant (London/UK) 16:40 IL TU Panel discussion / Case demonstration Klara Landau, Ulrich Schiefer, Pinar Aydin, Gordon Plant, Andrew G. Lee, Oliver Job, Murat Karacorlu (Zurich/CH, Tübingen, Ankara/TR, London/UK, Houston/USA, Lucerne/CH, Istanbul/TR)

182 178 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Abu Dhabi 08:30-10:00 TU-09 Vitreoretinal update Retinological Society (Session in German) Retina Norbert Bornfeld (Essen/D) Klaus-Dieter Lemmen (Düsseldorf/D) 08:30 IL TU Strategien zur Versorgung kombinierter Verletzungen von Vorder- und Hinterabschnitt aus der Sicht des Vorderabschnitts-Chirurgen Thomas Kohnen (Frankfurt/D) 10:45 IL TU IOL calculation using paraxial matrix optics Wolfgang Haigis (Würzburg/D) 11:00 IL TU Intraocular lens calculation in extreme ametropia Michel Puech (Paris/F) 11:15 IL TU Comparing ultrasound biometry with partial coherence interferometry for intraocular lens power calculations Thomas Olsen (Aarhus/DK) 11:30 Abu Dhabi 08:45 IL TU Strategien zur Versorgung kombinierter Verletzungen von Vorder- und Hinterabschnitt aus der Sicht des Hinterabschnitts-Chirurgen Peter Szurman (Tübingen/D) 14:00-15:30 TU-11 Retina Case Presentations with Focus on Fluorescein Angiography and Optical Coherence Tomography (Session in German) 09:00 IL TU Wehrmedizinische Aspekte der Versorgung einsatzbedingter schwerer Augenverletzungen Hermann O. C. Gümbel (Ulm/D) 09:15 IL TU Makulaödem bei diabetischer Retinopathie und bei retinalen Venenverschlüssen: Gewebsdestruktive oder medikamentöse Therapie? Horst Helbig (Regensburg/D) 09:40 IL TU Netzhautkomplikationen bei refraktiver Chirurgie Albrecht Lommatzsch, Daniel Pauleikhoff (Münster/D) Retina Sebastian Wolf (Bern/CH) Gabriele E. Lang (Ulm/D) Jean-Jacques de Laey (Gent/B) In this interactive conference interesting fluorescein angiographic and OCT findings are discussed. Short case presentations will be given including anamnesis and the important findings. Especially rare and dubious cases shall be discussed. Abu Dhabi Abu Dhabi 16:00-17:30 TU-12 10:30-12:00 TU-10 Getting the Power Right: IOL Power Calculations Cataract Thomas Olsen (Aarhus/DK) Jack T. Holladay (Bellaire/USA) Wolfgang Haigis (Würzburg/D) 10:30 IL TU Intraocular lens power calculations following keratorefractive surgery Jack T. Holladay (Bellaire/USA) Consilium diagnosticum (Session in German) Berthold Seitz (Homburg/D) Hans Hoerauf (Göttingen) Panel: Hans Hoerauf (Göttingen/D) Arnd Heiligenhaus (Münster/D) Barbara Käsmann-Kellner (Homburg/D) Daniel Mojon (St. Gallen/CH) Jan E. E. Keunen (Nijmegen/NL) Nelly Sivkova (Plovdiv/BG) Berthold Seitz (Homburg/D)

183 WOC Tuesday, 8 June 2010 In dem werden ungewöhnliche Krankheitsbilder vorgestellt. Ein internationales Panel und das Auditorium werden um diagnos - tischen und therapeutischen Rat gebeten. Oslo 08:30-10:00 TU-13 Surgical Videos and Panel Glaucoma Tarek M. Shaarawy (Geneva/CH) Carl Erb (Berlin/D) 08:30 IL TU Canaloplasty Norbert Korber (Cologne/D) 08:40 IL TU Glaukos istent Detlev Spiegel (Augsburg/D) Oslo 10:30-12:00 TU-14 Interventions in AMD Beyond Intravitreal Injections Retina Nhung Xuan Nguyen (Tübingen/D) Daniel Fletcher (San Francisco/USA) Veera Ramani Ondiveeran (Selangor Darul Ehsan/MAL) 10:30 IL TU Effectiveness of magnifying low vision aids in patients with age-related macular degeneration Nhung Xuan Nguyen (Tübingen/D) 10:40 IL TU Practical Ways to Help Patients Become Aware of Macular Scotomas and Minimize Their Impact on Reading Daniel Fletcher (San Francisco/USA) Scientific Program Schedule Tuesday, 8 June 08:50 IL TU ExPress Leon W. Herndon (Durham/USA) 09:00 IL TU SOLX Gold shunt Shlomo Melamed (Tel Hashomer/IL) 09:10 IL TU Trabectome Steven D. Vold (Rogers/USA) 10:50 IL TU Changing trends in Management of AMD- Malaysian Perspective Veera Ramani Ondiveeran (Selangor Darul Ehsan/MAL) 11:00 IL TU Quality of life and age-related macular degeneration: Does Anti-VEGF treatment in day to day settings impact vision-related QoL in AMD? Robert P. Finger (Bonn/D) 09:20 IL TU Ahmed Glaucoma valve Tarek M. Shaarawy (Geneva/CH) 11:10 IL TU Can diet reduce the genetic risk of AMD? Carolin Klaver (Rotterdam/NL) 09:30 IL TU Baerveldt glaucoma implant Keith Barton (London/UK) 09:40 IL TU Endocyclophotocoagulation TBA 11:20 IL TU Italian Smith-Kettlewell Read Test to assess reading difficulties in AMD Gianfrancesco Villani (Verona/I) 11:30 09:50

184 180 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Oslo 14:00-15:30 TU-15 Neural Based Targeting in Glaucoma Glaucoma Neeru Gupta (Toronto/CDN) M. Francesca Cordeiro (London/UK) Christian K. Vorwerk (Magdeburg/D) 14:00 IL TU Mitochondrial targets in glaucoma Neville N. Osborne (Oxford/UK) 14:10 IL TU Targeting RGCs and dendrites in glaucoma M. Francesca Cordeiro (London/UK) 16:10 IL TU Measurements of ocular blood flow Ingrida Janulevciene (Kaunas/LT) 16:20 IL TU The ischemic optic nerve in glaucoma Jost B. Jonas (Mannheim/D) 16:30 IL TU Genetic markers for ischemia in glaucoma Louis R. Pasquale (Boston/USA) 16:40 IL TU Circadian blood pressure and perfusion pressure in the glaucoma patient Vital P. Costa (São Paulo/BR) 16:50 IL TU Systemic medications and ocular blood flow in the glaucoma patient Makoto Araie (Tokyo/J) 14:20 IL TU Targeting the brain in glaucoma Neeru Gupta (Toronto/CDN) 17:00 14:30 IL TU Emerging stem cell therapies for glaucoma Christian K. Vorwerk (Magdeburg/D) Room Madrid 08:30-10:00 TU-17 14:40 IL TU Regenerative approaches for glaucoma Michael J. Young (Boston/USA) 14:50 IL TU Nano-strategies to protect neurons in glaucoma Rutledge G. Ellis-Behnke (Cambridge/USA) 15:00 Oslo Proteomics and Genomics in Uveitis Immunology, Molecular Biology, Microbiology Robert Nussenblatt (Bethesda/USA) S. John Curnow (Birmingham/UK) Stephan Thurau (Munich/D) 08:30 IL TU Genomics Tammy Martin (Portland/USA) 16:00-17:30 TU-16 Ocular Blood Flow Clinical Relevance for Glaucoma 08:45 IL TU Profiling of the human retinal endothelial cell; implications for the pathogenesis of uveitis Justine R. Smith (Portland/USA) Glaucoma Selim Orgül (Basel/CH) Eugen Gramer (Würzburg/D) Alon Harris (Indianapolis/USA) 16:00 IL TU Population based studies: perfusion pressure and blood flow in glaucoma Alon Harris (Indianapolis/USA) 09:00 IL TU Gene expression profiles in patients with noninfectious uveitis Robert Nussenblatt (Bethesda/USA) 09:15 IL TU Gene expression of pathogenic T cells in EAU Gerhild Wildner (Munich/D) 09:30 IL TU Proteomics in equine uveitis Cornelia A. Deeg (Munich/D) 09:45

185 WOC Tuesday, 8 June 2010 Room Madrid 10:30-12:00 TU-18 ASRS : The Future of Surgical and Medical Retina: Where Do We Go Next? Retina Tarek S. Hassan (Royal Oak/USA) Peter K. Kaiser (Cleveland/USA) Mark Humayun (Los Angeles/USA) 10:30 IL TU Evolving techniques of vitreous removal: Pharmacologic and Portable Vitrectomy Tarek S. Hassan (Royal Oak/USA) 10:40 IL TU The Future of Pharmacologic Treatment of Age- Related Macular Degeneration Peter K. Kaiser (Cleveland/USA) 10:50 IL TU The Retinal Prosthesis: Epiretinal Approach Mark Humayun (Los Angeles/USA) 11:00 IL TU Neuroprotection for Retinal Disease Baruch D. Kuppermann (Irvine/USA) Room Madrid 14:00-15:30 TU-19 Eye Banking: Optimizing Techniques and Quality Control External Eye Disease, Cornea Andrej Cernák (Bratislava/SK) Philip Maier (Freiburg/D) 14:00 IL TU Notification and evaluation of SAR and SEE UK model John Armitage (Bristol/UK) 14:10 IL TU Serious adverse reactions and events in the USA Patricia Dahl (Healdsburg/USA) 14:20 IL TU Quality control in eye banking, European versus USA model Diego Ponzin (Venice/I) 14:30 IL TU Clinical follow-up registration and eye banking: the Australian Graft registry Keryn A. Williams (Bredford Park/AUS) Scientific Program Schedule Tuesday, 8 June 11:10 IL TU Next-generation Vitrectomy Devices: Essential Features Carl C. Awh (Nashville/USA) 14:40 IL TU Clinical follow-up registration and eye banking in Europe Daniel Böhringer (Freiburg/D) 11:20 IL TU Genetic testing for AMD Is the Future here? David Chow (Reston/CDN) 11:30 IL TU Automation: Augmented Reality & Robotics Steven Schwartz (Los Angeles/USA) 11:40 IL TU Physical Determinants of Ocular Trauma Suber Huang (Shaker/USA) 11:50 IL TU The Future of Vitrectomy Systems Philip Ferrone (Riverhead/USA) 14:50 IL TU Implementation of the European Tissue Guidelines in different member states Vincent Borderie (Paris/F) 15:00 IL TU Eu Directories and international allocation of corneal grafts Arlinke G. Bokhorst (Leiden/NL) 15:10 IL TU Serum-free medium for orgen culture Katrin Engelmann (Chemnitz/D) 15:20 IL TU Precut tissue for lamellar keratoplasty Sonja Ute Heinzelmann (Freiburg/D)

186 182 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Room Madrid 16:00-17:30 TU-20 Immunology of Keratoplasty External Eye Disease, Cornea Daniel Frank P. Larkin (London/UK) Uwe Pleyer (Berlin/D) Birgit Sawatzki (Berlin/D) 16:00 IL TU HLA class II TBA 16:15 IL TU Immunology of corneal graft rejection: current understanding Daniel Frank P. Larkin (London/UK) 16:30 IL TU Future approaches on immunmodulation Uwe Pleyer (Berlin/D) 16:45 IL TU Tolerance induction: insights from the immunologists perspective Birgit Sawatzki (Berlin/D) 08:40 IL TU Contact Lens fitting after Keratoplasty Ömur Uçakhan Gündüz (Ankara/TR) 08:50 IL TU The use of semi-scleral contact lenses Orestes Miraglia (Belo Horizonte/BR) 09:00 IL TU Contact lenses and ectasias Cesar Lipener (Sao Paulo/BR) 09:10 IL TU Thin corneas and refractive surgery Julieta Goncalves (Porto Alegre/BR) 09:20 IL TU Anterior corneal "microfolds" in orthokeratology Sami El Hage (Houston/USA) 09:30 IL TU Clinical record of toric RGP lenses prescribed in the advanced astigmatic eyes Kajita Masayoshi (Fukushima/J) Room Sydney 10:30-12:00 TU-22 Panel: Uveal Tumors 17:00 IL TU Immunpharmacology: Update on clinical and experimental data Thomas Reinhard (Freiburg/D) 17:15 Panel Oncology Jerry Shields (Philadelphia/USA) Bertil D. Damato (Liverpool/UK) Norbert Bornfeld (Essen/D) Room Sydney 08:30-10:00 TU-21 RGP Lenses: Non Surgical Treatment of Refractive Errors and Ectatic Corneas Contact Lens and Refraction Panellist: Minoru Furuta (Fukushima/J) Michael Giblin (Sydney/AUS) Hans E. Grossniklaus (Atlanta/USA) Tero Kivelä (Helsinki/FIN) Maria E. Manquez (Santiago/RCH) Timothy G. Murray (Miami/USA) Jacob Pe'er (Jerusalem/IL) Carol L. Shields (Philadelphia/USA) Leonidas Zografos (Lausanne/CH) William H. Ehlers (Farmington/USA) Gernot I. W. Duncker (Halle/D) Lance Forsott 08:30 IL TU Toric Contact Lenses/Correction of astigmatism with contact lenses Ayfer Kanpolat (Ankara/TR)

187 WOC Tuesday, 8 June 2010 Room Sydney 14:00-15:30 TU-23 Evidence-based Management of Retinal Diseases Evidence Based Ophthalmology Robert B. Bhisitkul (San Francisco/USA) George William Aylward (London/UK) Heinrich Heimann (Liverpool/UK) 14:00 IL TU EBM in retinal practice Richard Wormald (London/UK) Room Sydney 16:00-17:30 TU-24 Modern Manual Cataract Surgery Cataract Srinivas Kamalakara Rao (Chennai/IND) N. Venkatesh Prajna (Madurai/IND) Thomas F. Neuhann (Munich/D) 16:00 IL TU Key issues in manual cataract surgical techniques Srinivas Kamalakara Rao (Chennai/IND) Scientific Program Schedule Tuesday, 8 June 14:10 IL TU Prophylaxis of retinal detachment George William Aylward (London/UK) 14:20 IL TU Initial treatment of rhegmatogenous retinal detachment Heinrich Heimann (Liverpool/UK) 14:30 IL TU Clinical trial results in the medical and surgical management of diabetic retinopathy Rajendra Apte (Saint Louis/USA) 14:40 IL TU Update on retinal venous occlusive disease Horst Helbig (Regensburg/D) 14:50 IL TU Evidence based comparisons of variable and monthly anti-vegf therapy in AMD Robert B. Bhisitkul (San Francisco/USA) 15:00 16:10 IL TU Manual small incision cataract surgery (M-SICS): my technique and results Huck Holz (Santa Clara/USA) 16:20 IL TU Sutureless large incision manual cataract extraction (SLIMCE): technique and results Srinivas Kamalakara Rao (Chennai/IND) 16:30 IL TU M-SICS: the fishhook technique and tips for avoiding complications Albrecht Hennig (Kathmandu Lahan/NEP) 16:40 IL TU Comparing outcomes of SLIMCE with phacoemulsification Yingpeng Liu (Shantou/CN) TU The Need for and the Approach to teaching manual cataract surgery N. Venkatesh Prajna (Madurai/IND) 17:00 IL TU The approach adopted by Project Vision in training doctors to perform manual cataract surgery Srinivas Kamalakara Rao (Chennai/IND) 17:10

188 184 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Room Hong Kong 08:30-10:00 TU-25 Cataract/Biometry 3 Free Paper Cataract Arturo Perez Arteaga (Tlalnepantla/MEX) Jochen Kammann (Davos/CH) Charlotta Zetterström (Oslo/N) 08:30 FP TU Application of the ESCRS recommendations on antibiotics for postoperative endophthalmitis prophylaxis following cataract surgery in the UK Salman Waqar, Salem Murjaneh, Maan Kasmiya, Julia Elizabeth Hale, Anthony Quinn (Exeter/UK) 09:19 FP TU Alkylphosphocholines for Intraocular Lens Coating Kirsten Eibl, Raffael Liegl, Marcus Kernt, Katja Obholzer, Armin Wolf, Ricarda Schumann, Christos Haritoglou, Anselm Kampik (Munich/D) 09:26 SL TU Contact lenses in children: indications and complications Susanne Marx-Gross (Mainz/D) 09:35 SL TU Month Results after Implantation of a New Accommodative IOL that Works with one focus 9:42 Room Hong Kong 08:37 FP TU Comparison of various torsional handpieces in MCCS Comparison of Mini-Flared 30 Kelman and Mini-Flared 45 Kelman and Reverse Mini-Flared 30 Kelman attending torsional phaco cases Choun-ki Joo, Kim Eun-kyoung (Seoul/ROK) 08:44 FP TU How to seal clear cornea incisions after cataract surgery: the role of a liquid ocular bendage Matteo Piovella (Monza/I) 08:51 FP TU Postoperative Refractive Error by Using A-scan in Cataract Surgery After Vitrectomy Seok Joon Kong, Seungbum Kang, Sung Kun Chung (Seoul/ROK) 10:30-12:00 TU-26 Therapeutic Contact Lenses: Bandage Lenses and Drug Release Contact Lens and Refraction Michael H. Goldstein (Boston/USA) René Mély (Saarlouis/D) Frank H. W. Tost (Greifswald/D) 10:30 IL TU The Hikaro Hamano Lecture: Pathophysiologic changes of ocular surface by contact lens wear Mitsuro Sawa (Tokyo/J) 08:58 FP TU Complications of couching and visual outcome after IOL implantation A study of 60 patients in Sudan Darfur Mohamed Siddig (Elafuon/SUD) 09:05 FP TU The use of the Eyesi surgical simulator in training phacoemulsification for medical students in King Faisal University, Saudi Arabia Mohamed Morsy (Hufuf/SA) 09:12 FP TU Prospective multicenter masked bilateral controlled randomized trial of YAG laser photolysis: the laser capsule opacity prevention (LCOP) study George Waring, Wolfram Wehner, Burkhard Dick, Siegfried Priglinger, Jorge Alió, Pavel Stodulka, Reinhardt Thyzel, Rudolf Walker (Atlanta/USA, Nürnberg/D, Linz/A, Alicante/E) 10:50 IL TU General Principles and Current Indications in Medical Contactology Peter Donshik (Bloomfield/USA) 11:00 IL TU When not to use Bandage Lenses Chong Yew Khoo (Singapore/SGP) 11:10 IL TU Scleral Lenses for Ocular Surface Diseases Deborah S. Jacobs (Needham/USA) 11:20 IL TU The vicious circle story: dry-eye surface contact lenses Gurdal Canan (Ankara/TR) 11:30 IL TU Extensions of Indications of bandage lenses René Mély (Saarlouis/D)

189 WOC Tuesday, 8 June :40 IL TU Use of therapeutic contact lenses for drug release: current status Frank H. W. Tost (Greifswald/D) 11:50 IL TU Therapeutic uses of tinted lenses Zoraida Fiol-Silva (Philadelphia/USA) Room Hong Kong 14:00-15:30 TU-27 Hot Topics in Ocular Traumatology Eye Trauma and Emergencies Norbert Franz Schrage (Cologne/D) Paul D. Langer (Newark/USA) Giampaolo Gini (Prato/I) 14:00 IL TU Management of Incompletely Repaired Orbital Fractures Paul D. Langer (Newark/USA) 14:10 IL TU Management of occult and non-occult orbitocranial penetrating injuries Roger Turbin (Newark/USA) 14:20 IL TU Secondary repair of anterior-posterior trauma of the globe Andreas Kay Cordes (Cologne/D) 14:30 IL TU Chemical trauma Norbert Franz Schrage (Cologne/D) 14:50 IL TU Rational approach to open globe injuries Giampaolo Gini (Prato/I) Room Hong Kong 16:00-17:30 TU-28 Globe Reconstruction after Severe Eye Injury Eye Trauma and Emergencies Ferenc Kuhn (Birmingham/USA) Wolfgang F. Schrader (Nürnberg/D) Paul Sullivan (London/UK) 16:00 IL TU A. Combined topical anesthesia and sedation for open-globe injuries in selected patients B. Partial vitrectomy in the management of openglobe injuries Francesco Boscia (Bari/I) 16:10 IL TU Choosing Wisely: How Does Initial Management of Open Globe Injuries Affect Ultimate Outcome? Vytautas Al Pakalnis (Columbia/USA) 16:20 IL TU Ocular trauma in outdoor sports Ron Adelman (New Haven/USA) 16:30 IL TU Outcomes of surgery for posterior segment intraocular foreign bodies a retrospective review of 17 years of clinical experience. Paul Sullivan (London/UK) 16:40 IL TU Primary silicone oil tamponade in the management of severe intraocular foreign body injuries: an 8-year follow-up Peter Szurman (Tübingen/D) 16:50 IL TU Results of early vitrectomy in severe open globe injuries Wolfgang F. Schrader (Nürnberg/D) Scientific Program Schedule Tuesday, 8 June 15:00 IL TU Round Table: Concensus Paper on treatment of chemical injuries Paul D. Langer, Roger Turbin, Andreas Kay Cordes, Norbert Franz Schrage, Giampaolo Gini, Harold Merle, Christopher A. Paterson (Newark/USA, Cologne/D, Prato/I, Fort de France/F) 17:00 IL TU Combined anterior and posterior segment injuries in children Petra Meier (Leipzig/D) 17:10 IL TU Pearls and pitfalls in the treatment of severe ocular trauma Ferenc Kuhn (Birmingham/USA) 17:20

190 186 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 VIP Lounge 1 08:30-10:00 TU-29 Retina: Vascular Disease 2 Free Paper Retina Lars-Olof Hattenbach (Ludwigshafen/D) Gabriel J. Coscas (Créteil/F) Tim Stout (Portland/USA) 08:30 SL TU CMV Retinitis Managed at the Primary Care Level in a Resource-Poor Setting by Non-Ophthalmologists: A description of an NGO program in Myanmar Heiden David (San Francisco/USA) 09:21 FP TU Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (R.A.B.A.M.E.S.) a prospective randomized multicenter trial Lars-Olof Hattenbach, Nicolas Feltgen, Amelie Pielen, Lutz Hansen, Katrin Lorenz, Norbert Pfeiffer, Hans Hoerauf, Caroline Jünemann, Fabian Höhn, Thomas Kreutzer, Siegfried G. Priglinger Jr., Alireza Mirshahi (Ludwigshafen/D, Göttingen/D, Freiburg/D, Mainz/D, Mannheim/D, Munich/D, Linz/A) 09:28 FP TU Efficacy Outcomes of the BRAVO Study of Intravitreal Ranibizumab in Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion Quan Dong Nguyen, Sarah Gray, Wendy Yee Murahashi, Namrata Saroj, Amy Chen Rundle, Roman G. Rubio (Baltimore/USA, San Francisco/USA) 08:39 FP TU The Association of Serum Apolipoproteins and C Reactive Protein with the Severity of Diabetic Retinopathy Muhammad Bayu Sasongko, Tien Yin Wong, Ryo Kawasaki, Jonathan Shaw, Alicia Jenkins, Jie Jin Wang (Melbourne/AUS) 08:46 FP TU Cost-effeciveness of automated algorithms versus manual grading for the detection of referable diabetic retinopathy Graham Scotland, Paul McNamee, Alan D Fleming, Keith Goatman, Sam Philip, Gordon J. Prescott, Peter F. Sharp, Graeme J. Williams, William Wykes, Graeme P. Leese, John A. Olson (Aberdeen/UK) 09:35 SL TU How fast does the Avastin concentration fall away in the eye? Measurements of the pharmacokinetics of Bevacizumab in the human eyes Carsten H. Meyer, Tim Krohne, Frank G. Holz (Bonn/D) 09:42 VIP Lounge 1 10:30-12:00 TU-30 Glaucoma: Medical Therapy 08:53 FP TU Intravitreal anti-vegf therapy in diabetic macular edema Stanislav Rodin, Veronika Aslanova (Odessa/UA) 09:00 FP TU Monotherapy for diffuse diabetic macular edema: Photocoagulation or Bevacizumab Vladimir Poposki, D. Vilaplana, D. Poposka, I. Alarcón I., O. Marínez-Giralt, M. Castilla (Barcelona/E) 09:07 FP TU Intravitreal anti-vegf therapy for retinal macroaneurysms with macular exsudation Magdalena Tönz, Stephan Michels, Rike Michels, Lukas Pfenninger (Zurich/CH) 09:14 FP TU Intraocular concentrations of growth factors and cytokines in diabetic macular edema and macular edema due to retinal vein occlusion Heeyoon Cho, Byung Ro Lee (Guri-city/ROK) Free Paper Glaucoma George Baerveldt (Irvine/USA) Richard Wormald (London/UK) Michael J. Young (Boston/USA) 10:30 FP TU Control of intraocular pressure and intraocular pressure hluctuation with fixed combination Brimonidine Timolol versus Brimonidine or Timolol monotherapy George L. Spaeth, Joseph Caprioli, Paula Bernstein, Rhett M. Schiffman (Philadelphia/USA) 10:37 FP TU A Randomized, Controlled Comparison of Conjunctival Hyperemia in Patients Treated with Bimatoprost 0.01% or Vehicle Who Were Previously Controlled on Latanoprost E. Randy Craven, Anup K. Khatana, Thomas K. Mundorf, Ching-chi Liu, Amy L. Batoosingh (Parker/USA)

191 WOC Tuesday, 8 June :44 FP TU Randomized, Investigator-Masked Study Comparing the Efficacy and Tolerability of Bimatoprost and Latanoprost in Patients After Initial Latanoprost Treatment Ehsan Sadri, Ronald Frenkel, Joseph Caprioli, Jason Bacharach, Ching-chi Liu, Amy L. Batoosingh (Newport Beach/USA) 10:51 FP TU Intraocular pressure-lowering efficacy of brinzolamide compared with placebo when added to travoprost/timolol fixed combination as adjunctive therapy in primary open-angle glaucoma or ocular hypertensive patients Ivan Goldberg, Jonathan Crowston, Barbara Cvenkel, Mark C. Jasek, Jeanette A. Stewart, William C. Stewart (Sydney/AUS) 11:33 FP TU Role of Herbal Drugs in the Management of Glaucoma An Experimental Study Suresh Gupta, Renu Agarwal, Sushma Srivastava, Rohit Saxena (New Delhi/IND, Kuala Lumpur/MAL) 11:40 VIP Lounge 1 14:00-15:30 TU-31 Cornea/External Disease: Medical therapy Free Paper Cornea, External Disease Scientific Program Schedule Tuesday, 8 June 10:58 FP TU Twelve-month, Randomized, Controlled Trial of the Efficacy and Safety of Bimatoprost 0.01%, %, and 0.03% in Patients With Glaucoma or Ocular Hypertension Michael Tepedino, L. Jay Katz, John S. Cohen, Amy L. Batoosingh, Carlos Felix, Vincent Shu, Rhett M. Schiffman (High Point/USA, Irvine/USA) 11:05 FP TU The effects of Combigan versus Cosopt on ocular perfusion pressure and blood flow in patients with open angle glaucoma Yochai Shoshani, Brent Siesky, Rita Ehrlich, Louis Cantor, Darrell WuDunn, Chi Wah Yung, Lynne McCranor, John Abrams, Julia Williams, David Hollander, Alon Harris (Indianapolis/USA) 11:12 FP TU Aqueous humor VEGF levels before and after intravitreal bevacizumab in eyes with neovascular glaucoma: a two-dose comparative study Yuzuru Sasamoto, Yusuke Oshima, Taku Wakabayashi, Atsuya Miki, Kenji Matsushita, Motohiro Kamei (Suita/J) 11:19 FP TU Trabeculectomy with Mitomycin-C versus trabeculectomy with 5-Fluorouracil for the treatment of childhood glaucoma Osama Badeeb (Jeddah/SA) Christophe Baudouin (Paris/F) Thomas Reinhard (Freiburg/D) 14:00 FP TU Visual rehabilitation after Descemet Membrane Endothelial Keratoplasty (DMEK) Results of the first 100 cases Konstantinos Droutsas, Lisanne Ham, Isabel Dapena, Kyros Moutsouris, Jaqueline van der Wees, Gerrit R. J. Melles (Rotterdam/NL) 14:07 FP TU Optimization of the Refractive Results of Corneal Collagen Crosslinking (CXL). Andriy Kovalov, Oksana Averyanova (Kiev/UA) 14:14 FP TU Collagen Crosslinking for Bullouse Keratopathy: 1,5 Year Follow-Up Guzel Bikbova, Mukharram Bikbov (Ufa/RUS) 14:21 FP TU Effect of topical application of terbinafine on fungal keratitis Qingfeng Liang, Xiu-ying Jin (Beijing/CN) 14:28 FP TU The effect of subconjunctival bevacizumab for corneal neovascularization Berraho Amina, Adil Megzari (Rabat/MA) 11:26 FP TU The success rate of trabeculectomy bleb needling augmented with 5-Fluorouracil Kaveh Vahdani, Adam Paget Booth, Aristeidis Konstantinidis (Plymouth/UK) 14:35 FP TU Low-Concentration Bevacizumab Topical Solution in Treatment of Corneal Neovascularization Jacek P. Szaflik, Urszula Kolodziejska, Anna Kaminska, Justyna Izdebska, Jerzy Szaflik (Warszawa/PL)

192 188 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June :42 FP TU Topical Bevacizumab eye drops for corneal neovascularisation preliminary results Pavel Studeny, Deli Sivekova, Magdalena Vokrojova, Andrej Farkas, Magdalena Netukova, Pavel Kuchynka (Prague/CZ) 14:49 FP TU An Ocular Surface Prosthesis for Visual Rehabilitation of Corneal Ectasia Deborah S. Jacobs, James Bradley, Inna Baran, Fateme Alipour, Perry Rosenthal (Needham/USA) 14:56 FP TU Fixed, dilated pupil, iris atrophy, cataract, and secondary glaucoma in Acanthamoeba keratitis Denise Freitas, Elcio Sato, Luiz Antonio Vieira, Patricia Contarini, Fabio Ramos, Annette Foronda (Sao Paulo/BR) 15:03 FP TU Oral pilocarpine for the treatment of dry eye symptoms in patients with aqueous-deficient and evaporative dry eye Tatsuro Miyamoto, Hiroshi Eguchi (Tokushima/J) 15:10 VIP Lounge 1 16:00-17:30 TU-32 Retina: Surgical Therapy 3 Free Paper Retina Horst Helbig (Regensburg/D) Gisbert Richard (Hamburg/D) Carol L. Shields (Philadelphia/USA) 16:00 SL TU month evaluation of Dexamethasone intravitreal implant in patients with macular edema due to central retinal vein occlusion Francesco Bandello, Julia A. Haller, Mark S. Blumenkranz, Rubens Belfort, Mark Gillies, Jeffrey Heier, Anat Loewentstein, Young-Hee Yoon, Jenny Jiao, Xiao-Yan Li, Scott M. Whitcup (Milano/I, São Paulo/BR, Sydney/AUS, Philadelphia/USA, Stanford/USA, Tel Aviv/IL, Boston/USA, Irvine/USA, Seoul/ROK) 16:16 FP TU Histology of fibrovascular membranes of proliferative diabetic rerinopathy after the intravitreal injection of bevacizumab Toshiaki Kubota, Hirofumi Morita, Norihiko Tou, Norikazu Nitta, Kenichi Kimoto, Akihiko Tawara, Hitoshi Satoh, Shohei Shimajiri (Yufu-shi/J) 16:23 FP TU Vitreous surgery combined with Brilliant blue-g dye assisted ILM peel for traumatic macular holes Atul Kumar, Varun Gogia (New Dehli/IND) 16:30 FP TU Heavy Silicone Oil versus Standard Silicone Oil in as vitreous tamponade in Inferior PVR (HSO Study): Interim Analysis of 94 consecutive patients Antonia M. Joussen, Christina Ocklenburg, Norbert Schrage, Bernd Kirchhof, Ralf-Dieter Hilgers (Berlin/D, Köln/D, Aachen/D) 16:37 FP TU Transcleral Posterior Chamber Paracentesis for Posterior Chamber Gas Entrapment with Anterior Chamber Angle Collapse Following Intravitreal C3F8 Injection in a Phakic Eye Yi-Ting Hsieh (Xindian/TJ) 16:44 FP TU High-resolution Fourier-domain Optical Coherence Tomography Findings in Eyes with Surgically Closed Macular Hole: Correlation between Visual Acuity Outcome and Inner Macular Volume Susanna Park (Sacramento/USA) 16:51 FP TU Vitreoretinal complications of regressed retinopathy of prematurity Takao Endo (Suita/J) 16:58 FP TU Safety testing of indocyanine green with different surgical light sources and the protective effect of optical filters Jost Hillenkamp, Sofia Dydykina, Alexa Klettner, Felix Treumer, Rudolf Vasold, Wolfgang Bäumler, Johann Roider (Kiel/D) 17:05 SL TU New technologies in the treatment of pathology of eye fundus Andrii R. Korol (Odessa/UA) 17:14 16:09 FP TU Intravitreal triamcinolone acetonide and intravitreal bevacizumab (Avastin) in diffuse diabetic macular edema (A comparative study). Rasheed El-Lakkany, Maha Shahin (Mansoura/ET)

193 WOC Tuesday, 8 June 2010 VIP Lounge 2 08:30-10:00 TU-33 Retina: Diagnostics 3 Free Paper Retina Antonia M. Joussen (Berlin/D) Thomas Theelen (Nijmegen/NL) 08:30 FP TU Functional impairment of pigment epithelial detachments determined by microperimetry Carolin Milojcic, Christoph Clemens, Nicole Eter, Frank G. Holz (Bonn/D) 09:19 FP TU The Relevance of Near-Infrared Autofluorescence in the Evaluation of Chorioretinal Diseases: 4 years experience Ulrich Kellner, Simone Kellner, Silke Weinitz, Elena Torres Suarez, Azadeh Golshahi (Bonn/D, Siegburg/D, Cologne/D) 09:26 FP TU Changes in macular morphology after macular hole closure visualized with Spectral Optical Coherence Tomography Zofia Michalewska, Janusz Michalewski, Jerzy Nawrocki (Lodz/PL) 09:33 Scientific Program Schedule Tuesday, 8 June 08:37 FP TU Quantitative computerized colour vision testing in diabetic retinopathy a possible screening tool? Rashid Alsaeidi, Christos Haritoglou, Thomas Kreutzer, Günther Rudolph, Michael Ulbig, Aljoscha Neubauer, Anselm Kampik (Munich/D) 08:44 FP TU Clinical Applications of Ultrasound in the Evaluation of Posterior Hyaloid Detachment Peter Stalmans (Leuven/B) 08:51 FP TU Fluorescein Angiography Changes after Intravitreal Injection of Bevacizumab (Avastin) Maha Shahin (Mansoura/ET) VIP Lounge 2 10:30-12:00 TU-34 Retina: Surgical Therapy 2 Free Paper Retina Klaus-Dieter Lemmen (Düsseldorf/D) Constantin J. Pournaras (Geneva/CH) 10:30 SL TU Macular surgery: The ILM story Constantin J. Pournaras (Geneva/CH) 08:58 FP TU Does internal longitudinal microstructure of retinal arteries and veins change with age in medically healthy persons? Konstantin Kotliar, Ali Kharoubi, Arno Schmidt- Trucksäss, Martin Halle, Ines Lanzl (Munich/D) 09:05 FP TU Fundus autofluorescence at two different wavelengths in patients with dry age-related macular degeneration Pavel Nechiporenko, Alla Lisochkina, Yuri Astakhov (Saint-Petersburg/RUS) 09:12 FP TU Fundus autofluorescence of congenital and acquired loss of macular pigment Thomas Theelen, Tos T. J. M. Berendschot, Johannes R. M. Cruysberg, B. Jeroen Klevering, Carel B. Hoyng (Nijmegen/NL) 10:39 FP TU Complications in 208 consecutive cases of laser vitreolysis for symptomatic vitreous opacities Scott Geller (Fort Myers/USA) 10:46 FP TU Vitreoretinal surgery, choice of endotamponade in Proliferative Diabetic Retinopathy Tatjana Josifova (Basel/CH) 10:53 FP TU The Heavy Tamponade Densiron-68 For Persistent Macular Holes Alexandra Lappas, Albert Caramoy, Andreas M. H. Foerster, Bernd Kirchhof (Köln/D) 11:00 FP TU Partial liquefaction of the vitreous gel and vitreo-retinal separation by intraocular injection of heparin Willi Halfter, Wingard Jeremy, Eller Andrew (Pittsburgh/USA)

194 190 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June :07 FP TU LED technology for intraoperative vitreoretinal illumination Stefan Dithmar, Alexandra Eva Hoeh, Mira Ruppenstein, Roman Amberger, Thomas Ach (Heidelberg/D) 11:14 FP TU Direct Artery Massage for Central Retinal Artery Occlusion: The Experimental and Clinical Research Lili Zhao, Ningli Wang, Ning Lu (Beijing/CN) 11:21 FP TU The transchoroidal implantation of subretinal active visual prostheses in blind RP patients: Surgical results in the first 12 patients. Potential and safety of this new complex surgical procedure allowing reproducible usable visual percepts. Helmut Sachs, Karl Ulrich Bartz-Schmidt, Florian Gekeler, Dorothea Besch, Uschi Brunner, Barbara Wilhelm, Robert Wilke, Walter Wrobel, Veit-Peter Gabel, Eberhart Zrenner (Tübingen/D) 11:28 FP TU Macular EpiRetinal brachytherapy in treated age-related macular degeneration patients (MERITAGE): interim results Tim Jackson, Pravin Dugel, Robert Petrarca, Jeff Nau (London/UK, Phoenix/USA, Freemont/USA) 11:35 FP TU Clinical treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS : A multicentered clinical trial. Igor Kozak, Stephen Oster, Marco Cortes, Kathrin Hartmann, Jae Suk Kim, Aljosha Neubauer, Anselm Kampik, William Freeman (La Jolla/USA) 11:42 VIP Lounge 2 14:00-15:30 TU-35 Retina: Medical Therapy 2 Free Paper Retina Paul T. Finger (New York City/USA) Paul Mitchell (Sydney/AUS) Francesco Bandello (Milano/I) 14:00 FP TU Evaluation of the re-treatment criteria effectiveness in the RESOLVE study Francesco Bandello, Yehia Hashad, Gabriela Burian, Andreas Weichselberger (Milano/I, Basel/CH) 14:07 FP TU Intravitreal Lucentis (ranibizumab) for radiation maculopathy: A pilot study Paul Finger, Kimberly Chin (New York/USA) 14:14 FP TU Intravitreal Bevacizumab (Avastin) treatment Trial in Macula Oedema of Retinal Venous Occlusive Diseases Muthusamy Malaravan, Dushyantha Wariyapola (Dehiwala/CL) 14:21 FP TU Alteration of the foveal avascular zone after intravitreal anti-vegf application in patients with branch retinal vein occlusion or diabetic macular disease Nikolaus Feucht, Mathias Maier, Konstantin Kotliar, Sarah Pfrommer, Ines Lanzl, Chris Patrick Lohmann (Munich/D) 14:28 FP TU Randomized clinical trial comparing grid laser, intravitreal triamcinolone, and combined triamcinolone and sequential grid laser for diabetic macular edema: one-year outcomes Shaheeda Mohamed, Carmen K. M. Chan, Dennis S. C. Lam (Hong Kong/HK) 14:35 FP TU Monthly Ranibizumab for non-proliferative macular telangiectasia type 2 (RAMA trial): A one-year prospective study Peter Charbel Issa, Robert P. Finger, Kathrin Kruse, Sönke Baumüller, Hendrik P. N. Scholl, Frank G. Holz (Oxford/UK, Bonn/D)

195 WOC Tuesday, 8 June :42 FP TU Efficacy and safety of intravitreal triamcinolone at the end of phacoemulsification surgery in patients with significant diabetic macular edema Enrique Rodriguez de la Rua, David Galarreta, Maria Isabel Lopez Galvez, Belen Carrasco, Lucia Manzanas, Cristina Perez Fernandez, Nestor Cortes Mora, Maria Teresa Sanchez Sanchez (Valladolid/E) 14:49 FP TU The Change of Vision Related Quality of Life After Panretinal Photocoagulation in Patients with Diabetic Retinopathy Angela Nurini Agni, Muhd Zafran Muhd Zafran bin Shamsudin (Yogyakarta/RI) 14:56 FP TU Double-Masked, Sham-Controlled, Randomized Study of Dexamethasone Intravitreal Implant for the Treatment of Uveitis Sue Lightman, Rubens Belfort, Careen Lowder, Steven Foster, Michael Robinson, Rhett M. Schiffman, Xiao-Yan Li, Harry Cui, Scott M. Whitcup (London/UK, São Paulo/BR, Cleveland/USA, Irvine/USA) 15:03 16:21 FP TU Apoptosis Rate and Mitochondria Respiration Function of Photoreceptor Cells of Rats Exposed by Toluene Syntia Nusanti (Jakarta/RI) 16:28 FP TU Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina Tim U. Krohne, Alexander Weidemann, Edith Aguilar, Toshihide Kurihara, Norihiko Takeda, Michael I. Dorrell, M. Celeste Simon, Volker H. Haase, Randall S. Johnson, Martin Friedlander (La Jolla/USA) 16:35 FP TU Time-related expression of glial fibrillary acidic protein in a non-intraocular-pressure related glaucoma model Vanessa D. Stahl, Stephanie C. Joachim, Oliver W. Gramlich, Laspas Panos, Norbert Pfeiffer, Franz H. Grus (Mainz/D) 16:42 FP TU Effects of growth factors bfgf, IGF-1 and VEGF165 on permeability and tight-junctions in microvascular retinal endothelial cells Heidrun Deissler, Gabriele E. Lang (Ulm/D) Scientific Program Schedule Tuesday, 8 June VIP Lounge 2 16:00-17:30 TU-36 Retina: Basics Free Paper Retina Robert E. MacLaren (London/UK) Peter Wiedemann (Leipzig/D) 16:00 FP TU Vascular endothelial growth factor (VEGF) clearance in rabbit eyes with posterior vitreous detachment induction Wei-Chi Wu (Kweishan/TJ) 16:49 FP TU VEGF and PEDF secretions over time following various laser irradiations on an RPE organ culture Yoko Miura, Felix Treumer, Alexa Klettner, Jost Hillenkamp, Ralf Brinkmann, Reginald Birngruber, Johann Roider (Lübeck/D, Kiel/D) 16:56 FP TU The influence of high glucose concentrations and elastin derived peptides on metalloproteinases (MMP-1, 2 and 9) and their inhibitors (TIMP-1, 2, 3, 4) expression in human retinal pigment cells. Mariola Dorecka, Tomasz Francuz, Wojciech Garczorz, Wanda Romaniuk, Jan Gmiński (Będzin/PL) 17:03 16:07 FP TU Specific expression of Erythrocyte tropomodulin in the retina of E-Tmod+/lacZ and E-Tmod-/- mice Lin Xie (ChongQing/CN) 16:14 FP TU Microglia invasion in retina during retinal ganglion cell loss in animals with experimental autoimmune glaucoma Oliver Gramlich, Stephanie C. Joachim, Vanessa D. Stahl, Clemens Cuny, Philip F. Gottschling, Norbert Pfeiffer, Franz H. Grus (Mainz/D)

196 192 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Radio Tower Lounge 1 08:30-10:00 TU-37 Retina: AMD 3 Free Paper Retina Gabriele Thumann (Aachen/D) Peter K. Kaiser (Cleveland/USA) Daniel Pauleikhoff (Münster/D) 08:30 FP TU Efficacy and safety of verteporfin PDT in combination with ranibizumab compared to ranibizumab monotherapy in AMD: 12-month outcome of the DENALI study Peter Kaiser, on behalf of the DENALI study group (Cleveland/USA) 08:37 FP TU Design and Rationale for the Phase 3 Study: VEGF Trap-Eye Investigation of Efficacy and Safety in Wet AMD (VIEW 2) Yuichiro Ogura, the VIEW 2 investigators (Nagoya/J) 09:12 FP TU Development of a gene therapy based on transfection of pigment epithelial cells with PEDF Gabriele Thumann, Olga Kazanskaya, Peter Walter, Sandra Johnen (Aachen/D) 09:19 FP TU Analysis of drusen SD-OCT (Spectral Domain Optical Coherence Tomography) characteristics and correspondent FAF (fundus autofluorescence) changes in dry AMD patients. Gennady Landa, Richard Rosen, John Pilavas, Patricia Garcia, Jeanne Rosenthal, Alfonso Ponce, Thomas Muldoon, Joseph Walsh (New York/USA) 09:26 FP TU Characteristics of Fixation in Patients with Geographic Atrophy recorded with the MP-1 Microperimeter Julia-Sophie Kroisamer, Ramzi G. Sayegh, Christian Simader, Ulla Scheschy, Christopher Kiss, Christian Prünte, Ursula Schmidt-Erfurth (Vienna/A) 09:33 08:44 FP TU What determines the functional outcome of AMD treated with Lucentis? Heinrich Gerding, Melanie Timmermann, Lars Hefner, Juliane Riese, Vlassios Loukopoulos (Olten/CH) Radio Tower Lounge 1 10:30-12:00 TU-38 EVER : How to Get Your Work Published? 08:51 FP TU Levels of aqueous humour trace elements in patients with age-related macular degeneration Robert Rejdak, Bernhard Michalke, Anwar Chaudhri, Piotr Stopa, Ursula Schlötzer-Schrehardt, Friedrich Kruse, Eberhart Zrenner, Anselm G. M. Jünemann (Lublin/PL, Erlangen/D, TübingenD) 08:58 FP TU Automatic Segmentation of Subretinal Fluid in Patients with Choroidal Neovascularization using Polarization-Sensitive Optical Coherence Tomography Christopher Schütze, Christian Ahlers, Bernhard Baumann, Michael Pircher, Erich Götzinger, René Donner, Joachim Ofner, Christoph Hitzenberger, Ursula Schmidt-Erfurth (Vienna/A) Miscellaneous Uwe Pleyer (Berlin/D) 10:30 IL TU Characteristics of a good paper Einar Stefánsson (Reykjavik/IS) 10:50 IL TU Ethical concerns in sientific publications Pinar Aydin (Ankara/TR) 11:10 IL TU The challenge to be a reviewer (view of the Editor and beyond..) Uwe Pleyer (Berlin/D) 09:05 FP TU Targeting Complement Factor 5 in combination with Vascular Endothelial Growth Factor (VEGF) Inhibition for Neovascular Age Related Macular Degeneration (AMD) a Phase 1 Study David S. Boyer (Los Angeles/USA) 11:30

197 WOC Tuesday, 8 June 2010 Radio Tower Lounge 1 14:00-15:30 TU-39 ISRS/AAO : Cutting Edge Progress All What the Practical Refractive Surgeon needs to Know Refractive Surgery Jorge L. Alió (Alicante/E) Theo Seiler (Zurich/CH) 14:00 IL TU Cutting Edge in Surface Ablation Gustavo Tamayo (Bogota/CO) 14:10 IL TU Cutting Edge in Femtolasers Ronald R. Krueger (Cleveland/USA) 14:20 IL TU Application of Retinal Stem Cells in Treating Retinal Degenerative Diseases Ting Xie (Kansas City/USA) 14:30 IL TU Cutting Edge in Phakic IOLs Jorge L. Alió (Alicante/E) 14:40 IL TU Cutting Edge in Cataract Surgery Amar Agarwal (Chennai/IND) 14:50 IL TU Cutting Edge in Corneal Surgery Mohamed Alaa El Danasoury (Jeddah/SA) 15:00 IL TU Femto Laser Refractive Cataract Surgery Stephen G. Slade (Houston/USA) 15:10 Radio Tower Lounge 1 16:00-17:30 TU-40 AJCC/UICC : TNM based Classification System for Oncular Oncology Oncology Paul T. Finger (New York City/USA) Stefan Seregard (Stockholm/S) Tero Kivelä (Helsinki/FIN) 16:00 IL TU Do You Speak Ocular Tumor? How using the 7 th editon AJCC-UICC Eye Cancer Staging System will Can Save Lives Paul T. Finger (New York City/USA) 16:08 IL TU The 7th edition AJCC-UICC Staging System for Ocular Adnexal Lymphoma: Use to Predict Systemic Lymphoma Sarah E. Coupland (Liverpool/UK) 16:16 IL TU How to use the 7th edition AJCC Staging of Melanoma of the Conjunctiva and Cornea to predict Local Control and Metastasis Bertil D. Damato (Liverpool/UK) 16:24 IL TU Internet-based, High resolution Cases Illustrating How to Use 7th edition AJCC Cancer Staging Deepak P. Edward (Akron/USA) 16:37 IL TU th Edition AJCC-UICC Staging Used to Predict Outcomes for Patients with Adenoid Cystic Carcinoma of the Lacrimal Gland: A Multicenter Collaborative Study Bita Esmaeli (Houston/USA) 16:40 IL TU Application of the AJCC 7 th Edition Carcinoma of the Eyelid staging system: A Medical Center pathology based, 15 year review Colby Fernelius (Tacoma/USA) Scientific Program Schedule Tuesday, 8 June 16:48 IL TU Incorporating the 7 th Edition AJCC-UICC Staging of Ocular Squamous Carcinoma into your Clinical Practice Leonard M. Holbach (Erlangen/D)

198 194 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June :56 IL TU th Edition AJCC-UICC Staging Predict Survival of Patients with Iris, Ciliary body and Choroidal melanoma Emma Kujala (Helsinki/FIN) 17:04 IL TU Retinoblastoma Care, Implementation of the 7 th edition AJCC-UICC Staging System for E-Cancer Care in Canada, Kenya and India Ashwin Mallipatna (Bangalore/IND) 17:12 IL TU th edition AJCC-UICC Staging Software for Uveal Melanoma Ernest Rand Simpson (Toronto/CDN) 17:20 Radio Tower Lounge 2 10:30-12:00 TU-42 Sustainable Eye Health Programs: Where Does the Government Fit In? Prevention of Blindness Radio Tower Lounge 2 14:00-15:30 TU-43 WGA : Managing Advanced Glaucoma Glaucoma Remo Susanna, Jr (São Paulo/BR) Kuldev Singh (Stanford/USA) Paul Healey (Sydney/AUS) 14:00 IL TU Who gets advanced glaucoma and why? Jamie Craig (Adelaide/AUS) 14:10 IL TU Predicting advanced glaucoma Anders Heijl (Malmö/S) 14:20 IL TU Achieving Target pressures in advanced glaucoma when to operate Ivan Goldberg (Sydney/AUS) 14:30 IL TU Surgical options for advanced pediatric glaucoma Anil Kumar Mandal (Hyderabad/IND) Anselm Kampik (Munich/D) Amir Bedri (Addis Adaba/ETH) Mohammed Babar Qureshi (Peshawar/PK) 10:30 IL TU Can programs be sustainable without Government participation Adekunle Olubola Hassan (Lagos/WAN) 10:45 IL TU High Impact, large scale NGO sector models of eye care delivery R. D. Thulasiraj (Madurai/IND) 11:00 IL TU Comprehensive eye care programs, A model within the Government structures Mohammed Daud Khan (Peshawar/PK) 14:40 IL TU Novel surgical options in advanced disease Fabian Lerner (Buenos Aires/RA) 14:50 IL TU Management of Advanced NTG Makoto Araie (Tokyo/J) 15:00 IL TU Now the pressure is low, what then? Robert Ritch (New York/USA) 15:10 IL TU Maximizing quality of life in advanced glaucoma George L. Spaeth (Philadelphia/USA) 15:20 11:15 IL TU An NGO having tried both approaches (Government and NGO sector) Mohammed Babar Qureshi (Peshawar/PK) 11:30

199 WOC Tuesday, 8 June 2010 Radio Tower Lounge 2 16:00-17:30 TU-44 Networking for Clinical Trial Research in Europe Miscellaneous José Cunha-Vaz (Coimbra/P) José-Alain Sahel (Paris/F) Norbert Pfeiffer (Mainz/D) 16:00 IL TU EVI.CRnet. the European Network for Clinical Research José Cunha-Vaz (Coimbra/P) 16:10 IL TU Perspectives for Investigator-Driven Clinical Trials in Retinal Disease José-Alain Sahel (Paris/F) 16:20 IL TU Perspectives for Investigator-Driven Clinical Trials in Glaucoma Norbert Pfeiffer (Mainz/D) 16:30 IL TU Perspectives for Investigator-Driven Clinical Trials in Ocular Surface and Inflammation Ilse Claerhout (Gent/B) 16:40 IL TU Perspectives for an European Reading Centre Network Tunde Peto (London/UK) 16:50 IL TU Perspectives for Investigator-Driven Clinical Trials in Cornea, Cataract and Refractive Surgery Jorge L. Alió (Alicante/E) 17:00 Hall 3 08:30-10:00 TU-45 Retina Society : Advances in Instrumentation and Adjuvant Pharmacology in Vitreoretinal Surgery Retina Donald J. D'Amico (New York/USA) Peter Liggett (New Haven/USA) Susanne Binder (Vienna/A) 08:30 IL TU Anti-VEGF Agents and Vitreoretinal Surgery for Proliferative Diabetic Retinopathy: Are There Surgical and Outcome Benefits? J. Fernando Arevalo (Caracas/Y) 08:40 IL TU Triamcinolone in Epiretinal Membrane Surgery: Surgical Visualization and Pharmacological Actions Thomas J. Wolfensberger (Lausanne/CH) 08:50 IL TU Advances in Posterior Segment Drug Delivery Eugene de Juan, Jr. (San Fransisco/USA) 09:00 IL TU Portable Vitrectomy with Plasmic Enzyme Assistance: An Evolving Approach Tarek S. Hassan (Royal Oak/USA) 09:10 IL TU Advances in Instrumentation of Vitreoretinal Surgery Mark Humayun (Los Angeles/USA) 09:20 IL TU Combined MIVS 23 Gauge Vitrectomy and Phacoemulsification in the Management of Complex Macular Pathology Timothy G. Murray (Miami/USA) Scientific Program Schedule Tuesday, 8 June 09:30 IL TU Endoscopic Visualization for Complex Vitreoretinal Pathology Christopher D. Riemann (Cincinnati/USA) 09:40 IL TU Current Status of Heavy Tamponade Liquids Eric R. Holz (Houston/USA) 09:50 IL TU Beyond 25 Gauge: Pros and Cons of 27 Gauge Macular Pucker Surgery Fabio Patelli (Milan/I)

200 196 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Hall 3 10:30-12:00 TU-46 Ophthalmic Premier League (OPL) Cataract This is a session called the Ophthalmic Premier League (OPL) to be conducted in the WOC 2010 in Berlin. This is similar to the European league games but with a difference as the OPL is connected to ophthalmology. There will be 4 teams with 4 captains, and each will have a total of 4 members in the team. Each team member will be given 4 minutes to show his or her most challenging cataract / complication cataract case using videos. In the video the speaker will need to show how he or she managed this case. There will be a good discussion on each case for the remaining time. There will be an ARS (Automatic response system) if available for audience to enjoy and vote which is the best team. All the speakers will have to be top class with excellent videos. Moderator: Amar Agarwal (Chennai/IND) Chairmen and Judges: Gerhard K. Lang (Ulm/D) Stephen J. Ryan (Los Angeles/USA) Bruce E. Spivey (San Francisco/USA) Gabriele E. Lang (Ulm/D) The Surgeless Sultans Keiki R. Mehta (Mumbai/IND) Captain Thomas F. Neuhann (Munich/D) Vice Captain Thomas Kohnen (Frankfurt/D) John Hovanesian (Laguna Hills/USA) Hall 3 14:00-15:30 TU-47 Uveitis a Global Challenge Retina Baruch D. Kuppermann (Irvine/USA) Philip I. Murray (Birmingham/UK) Uwe Pleyer (Berlin/D) 14:00 IL TU New insights: Clinical manifestations and prognosis of herpetic posterior uveitis Aniki Rothova (Utrecht/NL) 14:10 IL TU How "typical" is "typical"? Atypical presentations of ocular toxoplasmosis Miles R. Stanford (London/UK) 14:20 IL TU Ocular sarcoidosis definite, probable, possible Manabu Mochizuki (Tokyo/J) 14:30 IL TU Birdshot chorioretinopathy recent insights Ralph D. Levinson (Los Angeles/USA) 14:40 IL TU Eales' disease: a forgotten disorder? Jyotirmay Biswas (Chennai/IND) 14:50 IL TU Surgical treatment of posterior segment complications of uveitis in China Wu Liu (Beijing/CN) The Chopping Conquerors Uday Devgan (Los Angeles/USA) Captain Gabor Scharioth (Recklinghausen/D) Vice Captain Athiya Agarwal (Bangalore/IND) Brian Little (London/UK) 15:00 Hall 3 The Diffractive DareDevils Mohan Rajan (Chennai/IND) Captain Mahipal S. Sachdev (New Delhi/IND) Vice Captain Dandapani Ramamurthy (Coimbatore/IND) George Beiko (St. Catharines/CDN) The Bursting Buccaneers Roger Steinert (Orange/USA) Captain Joseph Colin (Bordeaux/F) Vice Captain Boris Malyugin (Moscow/RUS) Jorge L. Alió (Alicante/E) 16:00-17:30 TU-48 Current Treatment Options for Retinal Vascular Disease Retina José García Arumí (Barcelona/E) Constantin J. Pournaras (Geneva/CH) Susanne Binder (Vienna/A)

201 WOC Tuesday, 8 June :00 IL TU The results of the EAGLE-Study for central artery occlusion of the retina Hansjürgen T. Agostini (Freiburg/D) 16:15 IL TU Treatment of branch retinal vein occlusion in the antiangiogenic era Marta S. Figueroa (Madrid/E) 16:30 IL TU Anti-VEGF treatment options in retinal vein occlusion Constantin J. Pournaras (Geneva/CH) 16:45 IL TU Results of the ROVO-Study Susanne Binder (Vienna/A) 17:00 IL TU The management of retinal artery occlusion José García Arumí (Barcelona/E) 09:05 IL TU Ocular surgery resulting in ocular surface disease Elisabeth M. Messmer (Munich/D) 09:15 IL TU Acute iatrogenic damage to the anterior segment: case reports Rimvydas Asoklis (Vilnius/LT) 09:25 Hall 4/5 10:30-12:00 TU-50 IOIS : Pediatric Uveitis in Memoriam David Benezra Uveitis, Intraocular Inflammation Scientific Program Schedule Tuesday, 8 June 17:15 Hall 4/5 08:30-10:00 TU-49 Iatrogenic Diseases of Ocular Surface External Eye Disease, Cornea Christophe Baudouin (Paris/F) Elisabeth M. Messmer (Munich/D) Zbigniew Zagórski (Lublin/PL) 08:30 IL TU Introduction Zbigniew Zagórski (Lublin/PL) 08:35 IL TU Ocular surface toxicity: iatrogenic and factitious disease John K. G. Dart (London/UK) 08:45 IL TU The ocular surface of glaucoma patients treayted over the long-term Christophe Baudouin (Paris/F) 08:55 IL TU Ocular surface disease and systemic medications Catherine Creuzot-Garcher (Dijon/F) Talin Barisani-Asenbauer (Vienna/A) Bahram Bodaghi (Paris/F) Arnd Heiligenhaus (Münster/D) 10:30 IL TU JIA and Uveitis Paula Pivetti, Massimo Accorinti (Rom/I) 10:40 IL TU Outcome measures on uveitis in juvenile idiopathic arthritis: proposed guidelines from the international interdisciplinary working group for uveitis in childhood Arnd Heiligenhaus (Münster/D) 10:50 IL TU Congenital Toxoplasmosis Justus G. Garweg (Bern/CH) 11:00 IL TU Imaging in Pediatric Uveitis Bahram Bodaghi (Paris/F) 11:10 IL TU Results of an European Multicenter Survey on juvenile Uveitis Friederike Mackensen (Heidelberg/D) 11:20 IL TU QoL and Coping Mechanisms in Pediatric Uveitis Talin Barisani-Asenbauer (Vienna/A) 11:30

202 198 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Hall 4/5 14:00-15:30 TU-41 FEOph : Cutting Edge in Ophthalmology Miscellaneous Béatrice Cochener (Brest/F) Michèle Beaconsfield (London/UK) Salvador García-Delpech (Valencia/E) Pier Enrico Gallenga (Chieti/I) Anselm Kampik (Munich/D) 14:00 IL TU News in Presbyopic Surgery: Corneal Compensation of Presbyopia Jorge L. Alió (Alicante/E) 14:54 IL TU News in Glaucoma: Minimally Invasive Repair of Post-trabeculectomy Hypotony Norbert Pfeiffer (Mainz/D) 15:00 IL TU News in Glaucoma: New Surgical Devices David Salom (Valencia/E) 15:06 IL TU News in Oculoplastics: Non Surgical Treatment of Basal Cell Carcinoma Michèle Beaconsfield (London/UK) 15:12 IL TU News in Oculoplastics: Orbit Jean-Paul Adenis (Limoges/F) 15:18 14:06 IL TU News in Enzymatic Vitreolisys: Microplasmin Anselm Kampik (Munich/D) Hall 6 08:30-10:00 TU-56 14:12 IL TU News in Enzymatic Vitreolisys: Autologous Plasmin Patricia Udaondo (Valencia/E) Technical Aspects: Telecommunication, Computeraided Diagnosis Systems, Image Processing and Analysis, Process Flow, Electronic Patient Charts 14:18 IL TU News in Presbyopic Surgery: New Multifocal IOLs Matteo Piovella (Monza/I) 14:24 IL TU News Treating Corneal Neovascularization: Results from Germany Claus Cursiefen (Erlangen/D) 14:30 IL TU News Treating Corneal Neovascularization: Results from Spain Salvador García-Delpech (Valencia/E) Teleophthalmology and Computers Larry D. Hubbard (Madison/USA) Michael Abramoff (Iowa/USA) Joachim Hornegger (Erlangen/D) 08:30 IL TU Vessel structure segmentation via matched filtering and neural fibre layer detection using texture analysis Jiri Jan (Brno/CZ) 14:36 IL TU News Treating Retinal Diseases: Some New Ideas José-Alain Sahel (Paris/F) 08:40 IL TU Computer-aided Diagnosis of Diabetic Retinopathy Michael Abramoff (Iowa/USA) 14:42 IL TU News Treating Retinal Diseases: Choroidal Melanomas Laurence Desjardins (Paris/F) 08:50 IL TU Improving DR Algorithms Through Online Competition Gwénolé Quellec (Brest/F) 14:48 IL TU Ocular Surface News: New concepts, New Drugs, New approaches D. Juan Murube del Castillo (Madrid/E) 09:00 IL TU Quantification of Diabetic Retinopathy Lesions, Methodological Problems and Clinical Significance Toke Bek (Århus/DK) 09:10 IL TU A large-scale Verification of Automated Grading for Diabetic Retinopathy using Arbitration by Senior Ophthalmologists Alan D. Fleming (Aberdeen/UK)

203 WOC Tuesday, 8 June :20 IL TU Automated Detection of New Vessels on the Optic Disc Using Retinal Photography Keith Goatman (Aberdeen/UK) 09:30 Hall 6 10:30-12:00 TU-57 Braindrain: Challenges and Solutions Vision 2020 Preventation of Blindness Suzanne Gilbert (Berkeley/USA) Volker Klauss (Munich/D) 10:30 IL TU Training of Medical Personnel and the Predicament of Brain Drain Hans Werner Mundt (Berlin/D) 10:40 IL TU Challenges and Solutions from India N. Venkatesh Prajna (Madurai/IND) 10:50 IL TU Conditions that keep African Ophthalmologists in Africa/ Prevent Brain Drain Volker Klauss (Munich/D) 11:00 IL TU Recent Findings on Task-Shifting to optimize ophthalmologists service delivery Khumbo Kalua (Blantyre/MW) Hall 6 12:15-12:45 TU-58 Streiff Lecture Suzanne Gilbert (Berkeley/USA) Volker Klauss (Munich/D) Global Blindness Control What Can We Possibly Achieve by 2020? Gullapali N. Rao (Hyderabad/IND) Hall 6 14:00-15:30 TU-59 Therapy of Acquired Strabismus Strabismus Eugene Helvestone (Indianapolis/USA) Vincent Paris (Liège/B) Michael Gräf (Giessen/D) 14:00 IL TU N.III palsy Saxena Rohit (New Delhi/IND) 14:10 IL TU N.IV palsy Eugene Helvestone (Indianapolis/USA) 14:20 IL TU Trauma John P. Lee (London/UK) Scientific Program Schedule Tuesday, 8 June 11:10 IL TU Plenty of Ophthalmologists; How about Equity? Rainaldo Duerksen (Asunción/PY) 14:30 IL TU High myopia Tsuranu Yokoyama (Osaka/J) 11:20 IL TU Management & IT Strategies to Enhance Ophthalmologist Effectiveness and Satisfaction Suzanne Gilbert (Berkeley/USA) 11:30 IL TU Contribution of Paramedical team members Adrian Dennis Hopkins (Decatur/USA) 11:40 14:40 IL TU Botulinum Rosario Gomez de Liano (Madrid/E) 14:50 IL TU Prism therapy Jan Roelof Polling (Rotterdam/NL) 15:00

204 200 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Hall 6 16:00-17:30 TU-60 Viral Uveitis Uveitis, Intraocular Inflammation Bahram Bodaghi (Paris/F) Soon Phaik Chee (Singapore/SGP) Carsten Heinz (Münster/D) 16:00 IL TU Diagnostic and therapeutic challenges in herpetic anterior uveitis Emmet T. Cunnigham (Hillsborough/USA) 16:10 IL TU Acute retinal necrosis syndrome Bahram Bodaghi (Paris/F) 16:20 IL TU CMV and anterior uveitis Soon Phaik Chee (Singapore/SGP) 16:30 IL TU HIV associated uveitis in the era of HAART Gary N. Holland (Los Angeles/USA) 16:40 IL TU Emerging viruses and West Nile Virus Moncef Khairallah (Monastir/TN) 16:50 IL TU HTLV1, EBV and HHV6 associated uveitis Manabu Mochizuki (Tokyo/J) 17:00 IL TU Parvovirus and other non herpetic viruses Carsten Heinz (Münster/D) 17:10 Hall 7 08:30-10:00 TU-61 Panel: Phakic IOLs Panel Refractive Surgery Carlos Vergés (Barcelona/E) Roberto Zaldivar (Buenos Aires/RA) Thomas Kohnen (Frankfurt/D) 08:30 IL TU Angle-supported PIOL Thomas Kohnen (Frankfurt/D) 08:40 IL TU Iris-fixated PIOL Gernot I. W. Duncker (Halle/D) 08:50 IL TU CL/PRL Roberto Zaldivar (Buenos Aires/RA) 09:00 IL TU Complications of PIOL Carlos Vergés (Barcelona/E) 09:10 IL TU usefulness of PIOL in the spectrum of refractive options Thomas Kohnen, Roberto Zaldivar, Carlos Vergés, Gernot I. W. Duncker (Frankfurt//D, Houston/USA, Buenos Aires/RA, Barcelona/E, Halle/D) Hall 7 10:30-12:00 TU-62 The Femtosecond Face-off Refractive Surgery George Waring (Atlanta/USA) Theo Seiler (Zurich/CH) 10:30 IL TU Introduction: i. Physics of femtosecond mechanism of action ii. Descriptions of the 4 major lasers iii. Highlights of major physics differences between lasers Michael Mrochen (Zurich/CH)

205 WOC Tuesday, 8 June :40 IL TU Intralase George Waring (Atlanta/USA) 10:50 IL TU Femtec Mike P. Holzer (Heidelberg/D) 11:00 IL TU Visumax Dan Z. Reinstein (London/UK) 11:10 IL TU Ziemer Theo Seiler (Zurich/CH) 11:20 Hall 7 14:35 FP TU The Trabectome clinical feasibility and first results. Jens Jordan, Matthias Neuburger, Thomas Reinhard (Freiburg/D) 14:42 FP TU Therapeutic Effect of a Combined Laser Technique for Plateau Iris Glaucoma 18 months follow-up Poopalaratnam Sriharanathan (Colombo/CL) 14:49 FP TU Long-term results after Selective Laser Trabeculoplasty (= SLT ) in various forms of glaucoma. Presentation of 12-year postoperative results Peter Kaulen (Berlin/D) 14:56 FP TU Our methods of surgical treatment of refractory postburn glaucoma Petro Kostenko, S. Iakymenko (Odessa/UA) Scientific Program Schedule Tuesday, 8 June 14:00-15:30 TU-63 Glaucoma: Surgical Therapy 2 Free Paper Glaucoma 15:03 FP TU Combined phacoemulsification and nonpenetrating glaucoma surgery (NPGS) with goniosynechiolysis ab interno Alireza Mirshahi, Gabor Scharioth (Mainz/D, Recklinghausen/D) Jens F. Jordan (Freiburg/D) Joseph Caprioli (Los Angeles/USA) Hagen Thieme (Mainz/D) 14:00 FP TU Using Ex-press Implant in a Patient with Congenital Glaucoma Dida Kazakova (Sofia/BG) 15:10 Hall 7 16:00-17:30 TU-64 Therapeutic Customized Ablation 14:07 FP TU Successful tube-extender implantation to control congenital glaucoma awaiting penetrating keratoplasty surgery Carolina Pallás (Barcelonas/E) 14:14 FP TU Trypane blue test after incisional glaucoma surgery Gabor Scharioth (Recklinghausen/D) 14:21 FP TU Trabeculectomy Using Biodegradable Collagen Matrix Implant in Chronic Primary Glaucoma Patients: A Preliminary Study Astrianda Suryono (Jakarta/RI) Refractive Surgery Mirko R. Jankov (Belgrade/SRB) Theo Seiler (Zurich/CH) 16:00 IL TU Technological requirements for therapeutic customized treatments Paulo Schor (Sao Paulo/BR) 16:15 IL TU Wavefront vs topography guided treatments. Which one is better? Renato Ambrósio Jr. (Rio de Janeiro/BR) 14:28 FP TU Trabeculectomy and retrobulbar hemodynamics in glaucoma Andreas Remky, Marion Kaup, Anke Weber, Niklas Plange (Regensburg/D) 16:30 IL TU Surface ablation vs LASIK. Which one makes more sense? Arthur C. Cheng (Hong Kong/CN)

206 202 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June :45 IL TU Dealing with previous failures of refractive surgery: small optical zones, decentrations, etc. Mohamed Alaa El Danasoury (Jeddah/SA) 17:00 IL TU How to treat corneal scars, PKP etc. Arthur Cummings (Dublin/IRL) 17:15 IL TU Laser ablation and corneal collagen cross-linking. Can we make it? Aleksandr Stojanovic (Tromsø/N) Hall 8 08:30-10:00 TU-65 A New Approach to Teaching Ophthalmology to Medical Students: Strengths and Improvement for the New ICO Medical Student Handbook World Ophthalmic Educational Colloquium Pinar Aydin (Ankara/TR) Susan Lightman (London/UK) Balder P. Gloor (Zurich/CH) 08:30 IL TU Teaching: A Skill or a Talent? Pinar Aydin (Ankara/TR) 08:40 IL TU Teaching the Basic Knowledge Susan Lightman (London/UK) 08:50 IL TU Teaching Clinical Skills Simon Taylor (London/UK) 09:00 IL TU Teaching Emergency Ophthalmology to Medical Students Richard Andrews (London/UK) 09:10 IL TU Using a Virtual Eye Clinic Peter McCluskey (Sydney/AUS) Hall 8 10:30-12:00 TU-66 The Training of Para-ophthalmic Personnel with the Improved ICO Curriculum: Review of New Experiences World Ophthalmic Educational Colloquium William F. Astle (Calgary/CDN) Alistair Fielder (London/UK) Lynn D. Anderson (Saint Paul/USA) 10:30 IL TU Introduction William F. Astle (Calgary/CDN) 10:40 IL TU ICO Curriculum for Ophthalmic Assistants: A Teaching Model for Training the Eye Care Team William F. Astle (Calgary/CDN) 10:50 IL TU Visual Fields Education for Ophthalmic Nurses Lene Martin (Stockholm/S) 11:00 IL TU Teaching Optometrists in China Lu Fan (Wenzhou/CN) 11:10 IL TU Implementing the ICO Curriculum in Africa Boateng Wiafe (Kasoa/GH) 11:20 IL TU Implementing the ICO Curriculum in Barbados Sonja Johnston, Marilyn Watkins (Arima/TT, Bridgetown/BDS) 11:30 IL TU Development of an Accredited Training Program with Certification of Graduates Emad Abboud (Riyadh/SA) 11:40 09:20 IL TU Using the ICO Undergraduate Booklet Jasmin Singh (London/UK) 09:30 IL TU Designing an E-learning Module in Ophthalmology Lavnish Joshi (London/UK) 09:40

207 WOC Tuesday, 8 June 2010 Hall 8 14:00-15:30 TU-67 Improving Continuing Education Worldwide with ICO Programs World Ophthalmic Educational Colloquium Juan Verdaguer (Santiago/RCH) Bradley R. Straatsma (Los Angeles/USA) Zbigniew Zagórski (Lublin/PL) 14:00 IL TU Introduction Juan Verdaguer (Santiago/RCH) 14:10 IL TU Principles of Continuing Professional Development Bradley R. Straatsma (Los Angeles/USA) 14:20 IL TU The Role of ICO Guidelines for Planning CME Programs Zbigniew Zagórski (Lublin/PL) 14:30 IL TU Continuing Medical Education in Germany Friedrich Flohr (Hamburg/D) 14:40 IL TU ICO Programs for Continuing Medical Education in Developing Countries Juan Verdaguer (Santiago/RCH) 14:50 IL TU My Experience as an ICO Visiting Professor in Tanzania Anthony Murray (Cape Town/ZA) 15:00 IL TU My Experience as an ICO Professor in Algeria Gabriel J. Coscas (Créteil/F) 15:10 Hall 8 16:00-17:30 TU-68 Setting Up New Parameters for Teaching Ophthalmic Subspecialties in Developing and Developed Countries World Ophthalmic Educational Colloquium Randall J. Olson (Salt Lake City/USA) Marie-José Tassignon (Antwerp/B) Gottfried O. H. Naumann (Erlangen/D) 16:00 IL TU Strategies to Develop Ophthalmic Subspecialty Education Worldwide Stuart Seiff (San Francisco/USA) 16:10 IL TU Organization of Teaching Programs of Glaucoma for the Worldwide Ophthalmic Community Robert Ritch (New York/USA) 16:20 IL TU Establishing Training Programs of Pediatric Ophthalmology Across the Continents Anthony Murray (Cape Town/ZA) 16:30 IL TU Teaching Oculoplastic Surgery in Developed and Developing Countries John Richard O. Collin (London/UK) 16:40 IL TU How The Fellowship Compliance Committee of the Association of University Professors of Ophthalmology (USA) came to be a Voluntary Compliance Process in the USA Alfredo Sadun (Los Angeles/USA) 16:50 IL TU Our Experience with the Compliance Process of the Fellowship Compliance Committee in the USA Hans E. Grossniklaus (Atlanta/USA) 17:00 IL TU The Education of Cataract and Research in China vs. Sweden Per Soderberg, MD Scientific Program Schedule Tuesday, 8 June 17:10 IL TU Training of Cataract Surgeons Across the Continents Randall J. Olson, MD 17:20

208 204 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Hall 9 10:30-12:00 TU-69 Current Concepts in Retinal Detachment Surgery Retina Charles P. Wilkinson (Baltimore/USA) George William Aylward (London/UK) Nicole Eter (Bonn/D) 10:30 IL TU Interventions for preventing retinal detachment Jan van Meurs (Rotterdam/NL) 10:40 IL TU Pneumatic retinopexy: the first choice? Charles P. Wilkinson (Baltimore/USA) 10:50 IL TU Buckle surgery in times of vitrectomy Thomas J. Wolfensberger (Lausanne/CH) 11:00 IL TU Transconjunctival vitrectomy for retinal detachment surgery: How small shall we get? Nicole Eter (Bonn/D) 11:10 IL TU What have we learned from the SPR Study? Heinrich Heimann (Liverpool/UK) 14:10 IL TU Histopathology of crosslinking for keratoconus Elisabeth M. Messmer (Munich/D) 14:20 IL TU Pathology of LASIK/DSEK Hans E. Grossniklaus (Atlanta/USA) 14:30 IL TU Lacrimal drainage system pathology Steffen Heegaard (Copenhagen/DK) 14:40 IL TU Lacrimal gland tumors J. Oscar Croxatto (Buenos Aires/RA) 14:50 IL TU Optic nerve glioma Tom Cummings (Durham/USA) 15:00 IL TU Orbital tumors Tom Cummings (Durham/USA) 15:10 Hall 9 16:00-17:30 TU-71 IOAT : Ten Years to Go to the Global Elimination of Blinding Trachoma 11:20 IL TU Update on how to deal with PVR George William Aylward (London/UK) 11:30 Hall 9 Cornea Gabriel J. Coscas (Créteil/F) 16:00 IL TU Opening of the Meeting Gabriel J. Coscas (Créteil/F) 14:00-15:30 TU-70 ISOP : Ophthalmic Pathology Update Pathology Gordon Klintworth (Morrisville/USA) Elisabeth M. Messmer (Munich/D) Steffen Heegaard (Copenhagen/DK) 14:00 IL TU Recent advances in corneal dystrophies Gordon Klintworth (Morrisville/USA) 16:05 IL TU Priorities for the global trachoma elimination and its certification Silvio P. Mariotti, Ivo Kocur (Geneva/CH) 16:20 IL TU Challenges in the elimination of pockets of trachoma and implications on certification Hugh R. Taylor (Carlton/AUS) 16:35 IL TU Challenges that will be faced by ITI for the trachoma elimination Danny Haddad (Decatur/USA)

209 WOC Tuesday, 8 June :50 IL TU Challenges in trachoma elimination in low-income countries Amza Abdou (Niamey/RN) 17:05 IL TU Epidemiological dynamics of trachoma in the perspective of a global trachoma elimination Thomas M. Lietman (San Francisco/USA) 17:20 Hall 10 08:30-10:00 TU-72 German, Polish, Danish and Hungarian on Keratoconus Cornea László Módis (Debrecen/H) Hall 10 14:00-15:30 TU-73 APIISG : Uveitis Which One Should Not Miss Uveitis, Intraocular Inflammation Shigeaki Ohno (Sapporo/J) Soon Phaik Chee (Singapore/SGP) Peter McCluskey (Sydney/AUS) 14:00 IL TU Tuberculosis Narsing A. Rao (Los Angeles/USA) 14:10 IL TU Toxoplasmosis Khalid F. Tabbara (Riyadh/SA) 14:20 IL TU CMV Uveitis Soon Phaik Chee (Singapore/SGP) Scientific Program Schedule Tuesday, 8 June 08:30 IL TU New imaging techniques Jacek P. Szaflik (Warsaw/PL) 14:30 IL TU Acute Retinal Necrosis Hiroshi Goto (Shinjuku-ku/J) 08:45 IL TU Collegene cross-linking and biomechanics Jesper Hjortdahl (Aarhus/DK) 14:40 IL TU Behcet's Disease Shigeaki Ohno (Sapporo/J) 09:00 IL TU Lasers and keratoconus Zoltán Zsolt Nagy (Budapest/H) 14:50 IL TU VKH Disease Peizeng Yang (Chongqing/CN) 09:15 IL TU Surgical treatment Philip Maier (Freiburg/D) 15:00 IL TU Sclerouveitis Peter McCluskey (Sydney/AUS) 09:30 IL TU Acute keratoconus László Módis (Debrecen/H) 15:10 IL TU Sarcoidosis Annabelle A. Okada (Tokyo/J) 09:45 15:20

210 206 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Hall 10 16:00-17:30 TU-74 ALACCSA-R : Cornea and Ocular Surface: What's new? Cornea Jose M. Vargas (Valencia/Y) Scheffer C. G. Tseng (Miami/USA) Cesar Carriazo (Barranquilla/CO) José F. Alfonso (Oviedo/E) 16:00 IL TU Fibrin glue for pterigium surgery Luis Izquierdo (Lima/PE) 16:10 IL TU Clinical significance of lid margin pathologies in ocular surface reconstruction Scheffer C. G. Tseng (Miami/USA) 16:20 IL TU Dohlman Kpro personal Experience Jose M. Vargas (Valencia/Y) 16:30 IL TU Have we Over-Diagnosed Limbal Stem Cell Deficiency? Scheffer C. G. Tseng (Miami/USA) Roof Garden 08:30-10:00 TU-75 Multifocal and Accommodating IOL s Cataract Okihiro Nishi (Osaka/J) Eduard A. Haefliger (Binningen/CH) Frank J. Goes (Antwerp/B) 08:30 IL TU Lens Refilling: How Close to Nature Can We Get Eduard A. Haefliger (Binningen/CH) 08:40 IL TU NuLens Jorge L. Alió (Alicante/E) 08:50 IL TU Prediction of satisfaction ("happy patient project") Thomas F. Neuhann (Munich/D) 09:00 IL TU Mix and match options Frank J. Goes (Antwerp/B) 09:10 IL TU Bifocal lenses Paul H. Ernest (Jackson/USA) 16:40 IL TU Controlling Advanced Keratoconic Aberropia Sergio Kandelman (Rio de Janeiro/BR) 09:20 IL TU Shift IOL: They don't work Oliver Findl (Vienna/A) 16:50 IL TU Management of infectious keratitis with AM Jose M. Vargas (Valencia/Y) 09:30 IL TU Shift IOL: They do work Stephen G. Slade (Houston/USA) 17:00 IL TU Pterigium: Surgical Management Alonso Otto Solorzano (Cuernavaea/MEX) 09:40 Roof Garden 10:30-12:00 TU-76 ESCRS : New IOL Concepts in Cataract and Refractive Surgery Cataract José L. Güell (Barcelona/E) Marie-José Tassignon (Antwerp/B) Charlotta Zetterström (Oslo/N)

211 WOC Tuesday, 8 June :30 IL TU Best haptic design? Oliver Findl (Vienna/A) 10:40 IL TU Latest advances in the iris-claw style IOL José L. Güell (Barcelona/E) 10:50 IL TU Clinical outcomes and functional visual performance in new designs of multifocal IOLs: the Lentis Mplus Joaquim Neto Murta (Lisboa/P) 11:00 IL TU New trifocal diffractive IOL for a better intermediate and qualitative vision Béatrice Cochener (Brest/F) 11:10 IL TU Presbyopia treatment using second generation accommodative and multifocal IOL Matteo Piovella (Monza/I) 14:08 IL TU Inner retina: Chronic degeneration in glaucomatous optic neuropathy Diagnostics for the minimal functional and morphological damage Anselm G. M. Jünemann (Erlangen/D) 14:16 IL TU Inner retina: Chronic degeneration in glaucomatous optic neuropathy New neuroprotective strategies in glaucoma Pawel Grieb (Warsaw/PL) 14:24 IL TU Inner retina: Acute degeneration in retinal ischemia/trauma Characterization of acute neurodegeneration in different animal models Frank Schüttauf (Tübingen/D) 14:32 IL TU Inner retina: Acute degeneration in retinal ischemia/trauma The role of new drugs and alimentation in acute degeneration Tomasz Żarnowski (Lublin/PL) Scientific Program Schedule Tuesday, 8 June 11:20 IL TU Lens refilling: how far we are Ioannis G. Pallikaris (Voutes, Heraklion/GR) 11:30 IL TU Novel implants for aniridia Daniel Epstein (Bern/CH) 11:40 IL TU Implants for Ectopia Lentis Charlotta Zelterström (Oslo/N) 11:50 IL TU Artificial capsule Marie-José Tassignon (Antwerp/B) 14:40 IL TU Outer retina: Acute retinal degeneration in retinal detachment Toxicity of vital dyes Sebastian Thaler (Tübingen/D) 14:48 IL TU Outer retina: Chronic retinal degeneration Evolution of vitreoretinal surgery the smaller the better? Frank Koch (Frankfurt/D) 14:56 IL TU Outer retina: Chronic retinal degeneration Intrectomy clinical and preclinical results Michael Janusz Koss (Frankfurt/D) 11:50 Roof Garden 14:00-15:30 TU-77 Regeneration and Repair in Retinal Degeneration: Mechanisms and Approaches (RRR ) 15:04 IL TU Outer retina: Acute retinal degeneration in retinal detachment Biomarkers for neurodegeneration TBA 15:12 IL TU Outer retina: Acute retinal degeneration in retinal detachment Does retina regenerate- Spectral OCT data Jerzy Nawrocki (Lodz/PL) Retina Anselm G. M. Jünemann (Erlangen/D) Robert Rejdak (Lublin/PL) 15:20 IL TU Outer retina: Chronic retinal degeneration Mechanisms of photoreceptor degeneration and visual repair Eberhart Zrenner (Tübingen/D) 14:00 IL TU Inner retina: Chronic degeneration in glaucomatous optic neuropathy New aspects of retinal ganglion cell loss mechanisms Robert Rejdak (Lublin/PL)

212 208 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Roof Garden 16:00-17:30 TU-78 Best Excimer Laser Refractive Surgery Paolo Vinciguerra (Milano/I) Guy M. Kezirian (Scottsdale/USA) Daniel Epstein (Bern/CH) 16:00 IL TU Introduction Daniel Epstein (Bern/CH) ICC Lounge 08:30-10:00 TU-52 Current Epidemiological Eye Studies Ophthalmic Epidemiology Christian Wolfram (Mainz/D) Sheila West (Baltimore/USA) Jialiang Zhao (Beijing/CN) 08:30 IL TU Results of the Latino eye study Rohit Varma (Los Angeles/USA) 16:05 IL TU Survey of current excimer platforms Jorge L. Alió (Alicante/E) 16:15 IL TU Diverging approaches in excimer laser vision correction aberrometry, topography or other modalities? Charles P. Lin (Boston/USA) 08:45 IL TU The prevalence and impact on quality of life of uncorrected refractive error in a Latino population Sheila West (Baltimore/USA) 09:00 IL TU Neglected Areas of Research in Developing Countries R. D. Thulasiraj (Madurai/IND) 16:25 IL TU Criteria for safety and efficacy in excimer laser surgery Guy M. Kezirian (Scottsdale/USA) 09:15 IL TU Early detection of primary open angle closure glaucoma Jialiang Zhao (Beijing/CN) 16:35 IL TU All excimers are not created equal Christoph Binder (Schramberg/D) 09:30 16:45 IL TU Improvement potential and limits of excimer laser treatments George Waring (Atlanta/USA) 16:55 IL TU Laser correction of astigmatism: what does work and what does not? Peter McDonnell (Baltimore/USA) 17:05 IL TU Session highlights Paolo Vinciguerra (Milano/I) ICC Lounge 10:30-12:00 TU-53 Intraocular Lymphoma Uveitis, Intraocular Inflammation Chi Chao Chan (Bethesda/USA) Sarah E. Coupland (Liverpool/UK) Christoph M. E. Deuter (Tübingen/D) 17:15 10:30 IL TU Classification and molecular biology of intraocular lymphomas Sarah E. Coupland (Liverpool/UK) 10:40 IL TU Epidemiology and racial differences in intraocular lymphomas Jose S. Pulido (Rochester/USA)

213 WOC Tuesday, 8 June :50 IL TU Signs and symptoms of intraocular lymphomas Justine R. Smith (Portland/USA) 11:00 IL TU Diagnosis of intraocular lymphomas Chi Chao Chan (Bethesda/USA) 11:10 IL TU Overview of treatment of intraocular lymphoma Didier Decaudin (Paris/F) 11:20 IL TU Experience of intraocular lymphoma with methotrexate Christoph M. E. Deuter (Tübingen/D) 11:30 14:50 IL TU Treatment of choroidal neovascularization with modified gene therapy employing AAV and soluble FLT receptor Ian Constable (Nedlands/AUS) 15:00 ICC Lounge 16:00-17:30 TU-55 Leber Congenital Amaurosis: Classification and Treatment of Childhood Onset Severe Retinal Dystrophies Pediatric Ophthalmology, Genetics Scientific Program Schedule Tuesday, 8 June ICC Lounge 14:00-15:30 TU-54 Birgit Lorenz (Giessen/D) Irene H. Maumenee (Baltimore/USA) Ocular Pharmacology for Posterior Segment Diseases Pharmacology, Ocular Drug Delivery 16:00 IL TU Leber congenital amaurosis in Puerto Rico: natural history of LCA1, LCA6 and LCA8 and search for new genes Irene H. Maumenee (Baltimore/USA) Mark S. Blumenkranz (Stanford/USA) 14:00 IL TU Effect of ocular steroids on retinal wound healing following laser photocoagulation Daniel Palanker (Stanford/USA) 16:15 IL TU Laboratory Diagnosis of LCA Govindasamy Kumaramanickavel (Bangalore/IND) 16:30 IL TU The phenotypic spectrum of RPE65 mutations Birgit Lorenz (Giessen/D) 14:10 IL TU Non-viral methods of ocular cell transfection: extended drug delivery to the posterior pole TBA 14:20 IL TU Radiation targeting and dose verification for age-related macular degeneration Darius Moshfeghi (Stanford/USA) 16:45 IL TU Safety aspects of gene therapy Knut Stieger (Giessen/D) 17:00 IL TU The challenge of quantifiying morphology and function in LCA to monitor the effect of gene therapy Frederick W. Fitzke (London/UK) 14:30 IL TU Use of Lentivirus vectors for treatment of choroidal neovascularization by modified gene therapy Yusuke Murakami, Y. Ikeda, Tatsuro Ishibashi (Fukuoka/J) 17:15 14:40 IL TU Treatment of retinal venous occlusive disease with extended delivery formulation of dexamethasone Mark S. Blumenkranz (Stanford/USA)

214 210 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June 2010 Room 42 16:00-17:30 TU-79 Dry Eye: Latest Advances in Surfocular Dryness Cornea, External Disease D. Juan Murube del Castillo (Madrid/E) Suat H. Ugurbas (Zonguldak/TR) Gerd Geerling (Würzburg/D) 16:00 IL TU Modern concept of Dry Eye D. Juan Murube del Castillo (Madrid/E) 16:10 IL TU Diagnostic Tests to Select the Treatment: Part I José M. Benítez del Castillo Sánchez (Madrid/E) 16:20 IL TU Diagnostic Tests to Select the Treatment: Part II Jesus Merayo-Lloves (Madrid/E) Room 44 08:30-10:00 TU-80 Refractive Surgery/Refraction 4 Free Paper Refractive Surgery Jack T. Holladay (Bellaire/USA) Dan Z. Reinstein (London/UK) Peter McDonnell (Baltimore/USA) 08:30 FP TU Predicting Visual Quality Post-Laser Vision Correction Jack Holladay (Bellaire/USA) 08:37 FP TU FLEx refractive corrections for hyperopia Latest results of the clinical trials Marcus Blum, Kathleen Kunert, Urs Vossmerbaeumer, Walter Sekundo (Erfurt/D, Marburg/D) 16:30 IL TU Psychological and environmental treatment Gysbert van Setten (Danderyd/S) 16:40 IL TU Medical treatment: Etiologic, pathogenic and tear-stimulant Suat H. Ugurbas (Zonguldak/TR) 16:50 IL TU Medical treatment: Substitutive: artificial tears Luigi Bauchiero (Torino/I) 17:00 IL TU Medical Treatment, Autologous Serum, CyA, Antiinflamm Ashley Behrens (Baltimore/USA) 17:10 IL TU Surgical treatment of Mild and Medium Dry Eye Peter P. M. Raus (Mol/B) 17:20 IL TU Surgical Treatment of Severe Dry Eye Gerd Geerling (Würzburg/D) 08:44 FP TU Clinical Results of Aspheric Wavefront-guided LASIK Suphi Taneri, Saskia Oehler (Münster/D) 08:51 FP TU Corneal Vertex Versus Entrance Pupil Centration for hyperopic Corneal Ablations Timothy Archer, Dan Reinstein, Marine Gobbe (London/UK) 08:58 FP TU Long-term follow-up of PRK for myopia. A comparative study between excimer lasers Waldir Neira, Timo Tervo, Juha Holopainen (Helsinki/FIN) 09:05 FP TU Corneal modulation with excimer laser for simultaneous correction of Presbyopia & Ammetropia: Preliminary results after 3 months. Detlef Uthoff, Daniel Hepper, Markus Poelzl, Detlef Holland (Kiel/D) 09:12 FP TU Clinical measure of the quality of vision using a novel technique based on Moiré pattern interferometry in patients treated with presbylasik and an accommodative IOL: A preliminary study. Sudi Patel, Jorge Alió (Edinburgh/UK, Alicante/E) 09:19 FP TU Ray tracing analysis of corneas operated with a PresbyLASIK technique (PresbyMax ) Luis Moreno, Jorge Alió, Esperanza Sala (Alicante/ES)

215 WOC Tuesday, 8 June :26 FP TU Surgical correction of presbyopia with INTRACOR Cati Albou-Ganem, D. A. Lebuisson, Jean-Jacques Saragoussi, Raphael Amar (Paris/F) 09:33 FP TU Quality of vision after presbyopic LASIK: contrast sensitivity and stereo acuity Dan Reinstein, Timothy Archer, Marine Gobbe (London/UK) 09:40 FP TU Surgical correction of presbyopia with the AcuFocus Corneal Inlay a two year follow-up Melchior Hohensinn (Salzburg/A) 09:47 11:00 FP TU Comparison of Simultaneous and Sequential procedures in Combination Treatments for Keratoconus using Intrastromal Corneal Ring segments with Collagen Cross-Linking Juan Grandin (Mendoza/RA) 11:07 FP TU Two-year results of corneal collagen cross-linking using riboflavin and ultraviolet-a light for progressive keratoconus. Mashhoor Alfayez (Jeddah/SA) 11:14 FP TU Amniotic membrane transplantation on the ocular surface: A meta-analysis Hanif Suleman, E. Lazutina, J. J. Gicquel, A. M. Yeung, I. Mohammed, N. L. Tint, P. Desai, Harminder S. Dua (Nottingham/UK) Scientific Program Schedule Tuesday, 8 June Room 44 10:30-12:00 TU-81 Cornea/External Disease: Miscellaneous, Surgical Therapy 3 Free Paper Cornea, External Disease John Armitage (Bristol/UK) Florian Birnbaum (Freiburg/D) John D. Gottsch (Baltimore/USA) 10:30 SL TU What we have learned abouts Fuchs corneal dystrophy in the 100 years since Ernst Fuchs' initial description John D. Gottsch (Baltimore/USA) 10:39 FP TU The opacity patterns of Lisch corneal dystrophy Susanne Butros, Gerhard K. Lang, Gabriele E. Lang, Juan Alvarez de Toledo, Ulrich Teimann, Jens M. Rohrbach, Walter Lisch (Ulm/D, Barcelona/E, Tübingen/D, Hanau/D, Dortmund/D) 10:46 FP TU High-risk corneal transplantation what's new? Iva Dekaris, Nikica Gabric, Natasa Draca, Ante Barisic, Maja Pauk, Marija Anticic (Zagreb/HR) 10:53 FP TU Deep Anterior Lamellar Keratoplasty with Big Bubble Technique, assisted by Femtosecond laser, to treat keratoconus Adriana Lotfi (Mendoza/RA) 11:21 FP TU Surgical methods of treatment of post-burn persistent corneal ulceration Oleksiy Buznyk, Stanislav Iakymenko, Sergiy Shchypun (Odessa/UA) 11:28 FP TU Riboflavin-UVA induced cross-linking treatment for keratoconus and LASIK keratectasia an Asian perspective Li Lim, Hla Myint Htoon, Donald Tan, Lennard Yuen (Singapore/SGP) 11:35 FP TU Ophthalmologic tissue donation Changes and effects from German Tissue Law on example of Mitteldeutsche Corneabank Halle Update 2010 Diana Wille (Hannover/D) 11:42 Room 44 16:00-17:30 TU-82 Cataract/Biometry 4 Free Paper Cataract Wolfgang Haigis (Würzburg/D) Duy-Thoai Pham (Berlin/D) Boris Malyugin (Moscow/RUS) 16:00 SL TU Application of closing-capsular injection of viscous and arc capsulectomy in small-incision with non-phaco extra-capsular cataract extraction for hyper-mature cataract Baolinghuang Huang (Wuhu/CN)

216 212 WOC 2010 Tuesday, 8 June Scientific Program Schedule Tuesday, 8 June :09 FP TU Kinostat reduces the clinical onset and development of cataracts in diabetic dogs implications for humans? Peter Kador, Milton Wyman, Terah Webb, Dineli Bras, Kerry Ketring (Omaha/USA, Powell/USA, Worthington/USA, Cincinnati/USA) 16:16 FP TU Calculation of zero power lenses with current IOL power formulas Wolfgang Haigis, Jose R. Villada (Würzburg/D, Albacete/E) 16:23 FP TU IOL calculation in very long eyes Paul-Rolf Preußner, Peter Hoffmann, Jochen Wahl (Mainz/D) 16:30 FP TU Optimizing Torsional Phaco with OZil IP David Allen (Newcastle on Tyne/UK) 16:37 FP TU Laser cataract surgery: nucleus liquefaction using the LenSx intraocular femtosecond laser Michael C. Knorz (Mannheim/D) 16:44 FP TU Optical and clinical outcomes with the LENTIS Mplus LS-312 MF intraocular lens Ana Belen Plaza, Jorge Alió, Luis Moreno, Antonio Fimia, Mercedes Laguía, Roque Madrigal (Alicante/E) 16:51 FP TU Gauge Bi-Axial Technology for Lens Extraction without Ultrasonic Power for Soft Nucleus Arturo Pèrez-Arteaga (Tlalnepantla/MEX) 16:58 FP TU Optimized Diffractive Multifocal Intraocular Lens Centration Using A New Surgery Guidance System Omid Kermani, Uwe Oberheide (Köln/D) 17:05 FP TU Assessment of cyclotorsion errors in marker based toric IOL implantation Rudy Nuijts, Nienke Visser (Maastricht/NL) 17:12 FP TU Phacoemulsification in Subluxed Lenses with the Modified Capsular Tension Ring Boris Malyugin (Moscow/RUS) Salon 19 08:30-18:00 TU-83 IUSG Workshop: Diagnostic Criteria of Virusinduced Anterior Uveitis Uveitis Soon Phaik Chee (Singapore/SGP) Jolanda de Groot (Utrecht/NL) Aniki Rothova (Utrecht/NL) Bahram Bodaghi (Paris/F) Philip Murray (Birmingham/UK) Manfred Zierhut (Tübingen/D) Program 09:00 11:00 Virology and the Eye 1. Viruses and their clinical eye manifestations Jolanda de Groot-Mijnes 2. Herpesviruses and the immune system Maaike Ressing 3. Pathology of virus-induced anterior uveitis Kalpana Babu 11:15 13:15 AC-tap for VIAU 1. Techniques and pitfalls of AC tap analysis Jolanda de Groot-Mijnes 2. Antibody determination from the AC tap: Pro and Contra Justus Garweg 3. PCR determination from AC tap: Pro and Contra Colin Fink Literature Research: 4. Use of AC tap for detection of HSV: Colin Fink, Janet Davis 5. Use of AC tap for detection of VZV: Jolanda de Groot-Mijnes, Phil Murray 6. Use of AC tap for detection of Rubella virus: Jolanda de Groot-Mijnes, Aniki Rothova 7. Use of AC tap for detection of CMV: Justus Garweg 14:00 16:00 HSV 16:15 17:15 Rubella 17:19 In case of interest please contact Phil Murray: p.i.murray@bham.ac.uk The second part of the workshop will take place on Wednesday, 9 June 8:30 to 18:00

217 WOC Scientific Program Scientific Program Schedule Wednesday, 9 June 2010 Wednesday, 9 June

218 ICC Hall 3 Hall 4/5 Hall 6 Hall 7 Hall 8 Hall 9 Hall 10 ICC Lounge Roof Garden Salon 11/12 Salon 19 Salon 21 Room 42 Room 43 Room 44 Highlight Free Paper WOC Course Industry Meetings WE-09 Holmström, Trese, Thurau Retinopathy of Prematurity Uveitis WE-12 Collin, Guthoff, Kreiner Panel: Implant Materials and Tissue Interaction WE-17 Agarwal, Koch What Will You Do? WE-20 Zrenner, Mojon, Hedges Assessing Struct. and Funct. in Neuro-Ophthalm. WE-23 Kivelä, Hungerford, Desjardins OOG Symp: Complic. of Ocular Irradiation WE-26 Kuhn, Schrader Management of the Ruptured Eye WOC-C-56 Wolff Refractive Lens Surgery WE-15 Schraermeyer, Behar, Farrar Ocular Drug Delivery to the Posterior Segment WE-10 Kohnen German Society of Intraocular Lens Implantation WE-13 Weinreb, Konstas, Pfeiffer Glaucoma Rhythms WE-18 Scharioth, Alió Microincision Cataract Surgery WE-21 Schaefer, Seitz Wavefront and Aberration. WE-24 Gallie, Desjardins, Bechrakis Tumors of the Retina and Ret. Pigm. Epith. WE-27 Kuhn, Schrader, Pelayes ISOT Symp: Ocular traumatology: The Basics WE-29 Arevalo, Roca, Wu SPRV : Update on Pediatric Retina WOC-C-62 Kreissig, Aylward, Lincoff Present Options in the Management WE-42 Zierhut IUSG Workshop: Diagnostic Criteria of Virus-induced Anterior Uveitis WE-31 Award Ceremony and Handover of DOG Presidency WE-11 Coscas, Kampik EAO Symp: Impact of recent devel. on clinical practice WE-14 Zrenner, MacLaren Restoring Sight by Impl. and Tissue Engin. of the Retina WE-19 Rao, Stegmann, Mester The Malpositioned IOL and IOL Implant. in Eyes WE-22 Foulks, Holzchuh, Kaercher Update on Safety and Efficacy of Cont. Lens Sol. WE-25 Spahn, Garms, Rao The New Realities of Non- Governmental Development WE-28 Kuhn, Barak, Mortada Minisymposium: Ocular trauma WE-30 Murray, Smith, Biswas Panel The Teaching of Uveitis WE-16 AlRajhi, El-Maghraby, Spivey Vision 2020 Prevention of Blindness 2 Sitzung Klinische Monatsblätter für Augenheilkunde WOC-C-57 Kaiser, Wolf, Hoerauf Laser in Retinal Diseases Dos and Donts WOC-C-59 Carvalho Vasconcelos, Keeffe Introducing Pediatric Low Vision WE-40 Mitchell, Pitz Epidemiology WOC-C-58 Narendran, Azad, Dogra Current Trends in Managem. of Retinopathy WE-39 Burgoyne, Sekhar, Hornykewycz Glaucoma: Surgical therapy 3 WE-41 Arnold, Zrenner Neuro-Ophthalmology 2 WE-38 Azad, Mitchell, Kaiser Breaking News in Retina WOC-C-60 Giblin, Kivelä, Foerster Diagnosing Melanocytic Tumours of the Uvea 15 Wednesday, 9 June

219 Messe Stockholm Sao Paulo Oslo Hall Radio Tower Lounge 1 Radio Tower Lounge WE-01 Knorz, Alió Management of Complications in LASIK and Surface Ablation WE-04 Trauzettel, Subramanian, Gandhi Hemianopia: Features and Interventions WE-07 Pillunat, Fechtner, Zeyen Assessment of the Optic Nerve Head WE-35 Heimann, Moore Retina: Miscellaneous 2 WE-02 McDonald, Marshall, Dick Why Do We Still Perform Surface Ablations? WE-05 Meller, Tsai, Wylegala Management of Limbal Stem Cell Deficiency WE-08 Chong, Wedrich, Kirchhof Submacular Hemorrhage Management WE-33 Beaconsfield, Collin, Hintschich ESOPRS Symp: Manag. of Perioc. Tumours WE-36 Fröhlich, Congdon, Naidoo Refr. Error from School Age thr. Presbyopia WE-03 Wilson, Seitz The Refractive Cornea: Science Progress WOC-C-55 Agostini, Feltgen Management of Vascular Ocular Emergencies WE-34 Eter, Singer Retina: AMD 4 WE-37 Azad, Desjardins, Karacorlu Pediatric Ophthalmology & Genetics 3 Highlight Free Paper WOC Course Industry Meetings Wednesday, 9 June

220 he held eld iin n cconjunction onj nju unc ctio on w with ith The The 15 5tthh Co Congress ongre ess of of the the Chinese Chin ine ne ese Ophthalmological Ophtthalm mo olo ogic cal Society So ocie ety September S ep pte emb ber , , 2010 China C hin in na Na National atio onal Co Convention on nve nv ve entio on Ce Center ente er Be eij ijin ng, C hin in na Beijing, China * Over 500 international top-notch speakers * Over 8000 delegates (4000 international, 4000 from China) Advance A Adv Ad dv dva van v anc nce ce Registration Re egis gis ist strra atio on Deadline: De D ead adlin dline ne: Aug Aug 31, Au ww ww w.ap pao2 ao o2010b beij ijing.org rg Scientific S cie enttific ifi Pro Program ro ogra ram m Co Committee ommit itt tte te ee Chair: Dennis Lam Co- Xiaoxin Li / Charles McGhee Senior Secretary: Clement Tham S ubspecialty Subspecialty C onvener Convener 1 Cataract Secretary Secretary (from (from APAO APAO Central) Central) International International Coordinator Coordinator Asia Asia Coordinator Coordinator Pacific Pacific Rim Rim Coordinator Coordinator Host Host Coordinator Coordinator David Chang Philip Lam Richard Packard Abhay Vasavada Tim Roberts Ke Yao Shigeru Kinoshita Alvin Young Michael Belin Donald Tan Gerard Sutton Lixin Xie 3 Glaucoma Robert Ritch Clement Tham 4 Intraocular Inflammation, Uveitis & Scleritis Narsing Rao Timothy Lai Susan Lightman Vincent Raymond Calvin Pang Terete Borras Neil Miller Carmen Chan Andy Lee 7 Ocular Imaging Charles McGhee Christopher Leung Neeru Gupta 8 Ocular Microbiology and Ocular Infectious Diseases 2 Cornea and External Eye Disease 5 Laboratory Eye Research 6 Neuro-ophthalmology Jost Jonas Makoto Araie Paul Healey Jian Ge Shigeaki Ohno Sam Lertsumitkul Peizeng Yang Susumu Ishida Mark Gillies Zhengqin Yin Navin Jayakumar Helen Danesh-Meyer Shihui Wei Tin Aung Dipika Patel Ningli Wang Xuguang Sun Terrence O Brien Ben Lam David Hwang Srinivas Rao Kathy McClellan 9 Ocular Pathology & Tumors Jerry Shields David Liu Tero Kivelä Santosh Honavar Sehu Weng Wei Wang 10 Ophthalmic Education Mark Tso Peter McCluskey Mingwei Zhao 11 Ophthalmic Epidemiology Tien Wong Nathan Congdon Paul Foster Hidetoshi Yamashita Paul Mitchell Jialiang Zhao 12 Orbits and Oculoplastics David Tse Hunter Yuen Michael Grant Yoon-Duck Kim Tim Sullivan Xianqun Fan Frank Martin Dorothy Fan Marilyn Miller May May Choo Craig Donaldson Kanxing Zhao R Pararajasegaram Dennis Lam Mohamed Babar Qureshi Akira Murakami Garry Brian Youxin Chen Ronald Krueger Vishal Jhanji Michael Knorz Kazuo Tsubota Michael Lawless Jia Qu 16 Retina (Medical) Ian Constable Timothy Lai Alexander Brucker Taraprasad Das Diane Sharp Xiaoxin Li 17 Retina (Surgical) Zdenek Gregor Vincent Lee Stanley Chang Chi Chun Lai Andrew Chang Zhizhong Ma 13 Pediatric Ophthalmology & Strabismus 14 Prevention of Blindness 15 Refractive Surgery Nancy Yuen Eduardo Mayorga Argañaraz Gondhowiardjo Tjahjono Dennis Lam / Xiaoxin Li / Charles McGhee / Clement Tham 18 Miscellaneous APAO Central Secretariat: Tel: (852) Fax: (852) secretariat@apaophth.org Host Secretariat: Tel: (86) Fax: (86) apao2010@cma.org.cn w w ww w.ap pao ao2 o b beij ijin ng.o org 0beijing.org

221 WOC Wednesday, 9 June 2010 Stockholm 08:30-10:00 WE-01 Management of Complications in LASIK and Surface Ablation Refractive Surgery Michael C. Knorz (Mannheim/D) Jorge L. Alió (Alicante/E) 08:30 IL WE Ocular surface syndrome-dry eye Steven E. Wilson (Cleveland/USA) 08:40 IL WE Incidence of complications in a chain of highvolume surgical centers Jan Venter (London/UK) 08:50 IL WE Impact of complications in quality of life Konrad Pesudovs (Adelaide/AUS) 10:40 IL WE Patient Selection for Surface Ablation Thomas Claringbold (Clare/USA) 10:50 IL WE Pain Control for Surface Ablation Aleksander Stojanovic (Tromsø/N) 11:00 IL WE Epi-LASIK in 2010 Ioannis G. Pallikaris (Voutes, Heraklion/GR) 11:10 IL WE Surface Ablation to Enhance Premium (Presbyopia-correcting) IOLs George Waring (Atlanta/USA) 11:20 IL WE Recent Advances in Surface Ablation Research Marguerite McDonald (New Orleans/USA) 11:30 Stockholm Scientific Program Schedule Wednesday, 9 June 09:00 IL WE Prevention of ectasia a grading system is necessary R. Doyle Stulting (Atlanta/USA) 13:00-14:30 WE-03 The Refractive Cornea: Science Progress for the Corneal Refractive Surgeon 09:10 IL WE Management of Keratectasia Theo Seiler (Zurich/CH) 09:20 IL WE When and how should we use mitomcin C? H. Burkhard Dick (Bochum/D) 09:30 Refractive Surgery Steven E. Wilson (Cleveland/USA) Berthold Seitz (Homburg/D) 13:00 IL WE Advances in corneal biomechanics William J. Dupps Jr. (Cleveland/USA) Stockholm 10:30-12:00 WE-02 Why Do We Still Perform Surface Ablations? Refractive Surgery Marguerite McDonald (New Orleans/USA) John Marshall (London/UK) H. Burkhard Dick (Bochum/D) 10:30 IL WE The Pros and Cons of Surface Ablation in 2010 Paolo Vinciguerra (Milano/I) 13:10 IL WE New insights into cytokine control of myofibroblast development, persistence and death in the development and disappearance of haze after PRK Steven E. Wilson (Cleveland/USA) 13:20 IL WE Customized ablation wavefront-guided or wavefront-optimized? Michael C. Knorz (Mannheim/D) 13:30 IL WE Optical changes of the cornea after refractive surgery impact on IOL power calculation Achim Langenbucher (Homburg/D)

222 218 WOC 2010 Wednesday, 9 June Scientific Program Schedule Wednesday, 9 June :40 IL WE Efficacy of the combination of UV-Riboflavin crosslinking and PRK Theo Seiler (Zurich/CH) 13:50 IL WE The US trials on UV-Riboflavin crosslinking Stephen D. Klyce (Port Washington/USA) 14:00 IL WE Current limits of corneal laser surgery Thomas Kohnen (Frankfurt/D) 14:10 Sao Paulo Sao Paulo 10:30-12:00 WE-05 Management of Limbal Stem Cell Deficiency External Eye Disease, Cornea Daniel Meller (Essen/D) Ray Jui-Fang Tsai (Taipei/TJ) Edward Wylegala (Katowice/PL) 10:30 IL WE Novel Ex Vivo Expansion based on Preservation of Limbal Stem Cells and their Native Niche Cells Scheffer C. G. Tseng (Miami/USA) 08:30-10:00 WE-04 Hemianopia: Features and Interventions Low Vision Susanne Trauzettel-Klosinski (Tübingen/D) Prem Subramanian (Baltimore/USA) Rashmin Gandhi (Chennai/IND) 08:30 IL WE Training in Hemianopia Susanne Trauzettel-Klosinski (Tübingen/D) 08:40 IL WE Development of a Neuro hemifield test Prem Subramanian (Baltimore/USA) 10:40 IL WE Biologic view of ex vivo expansion for Limbal stem cells Graziella Pellegrini (Venezia/I) 10:50 IL WE Clinical application of ex vivo expansion of limbal stem cells and the mechanism for success Ray Jui-Fang Tsai (Taipei/CN) 11:00 IL WE Ex vivo expansion of autologous mucosal epithelial stem cells for limbal stem cell deficiency Tsutomu Inatomi (Kyoto/J) 11:10 IL WE Reconstruction of ocular surface using living related limbal grafts in children Edward Wylegala (Katowice/PL) 08:50 IL WE Bitemporal Hemianopia Neuro Ophthalmic Features and Investigation Rashmin Gandhi (Chennai/IND) 11:20 IL WE Keratinocytes for limbal stem cell replacement - insights into corneal epithelial differentiation Friedrich E. Kruse (Erlangen/D) 09:00 IL WE Epidemiology of Homonymous Hemianopia Sachin Kedar (Jackson/USA) 09:10 IL WE Hemianopia in neurosurgical practice: causes, features, outcomes Natalia Serova (Moscow/RUS) 11:30 IL WE Midterm Results of Cultivated Autologous and Allogeneic Limbal Epithelial Transplantation in Limbal Stem Cell Deficiency Daniel Meller (Essen/D) 11:40 09:20 IL WE The Roadmap of the Visual Pathway- Have you ever seen *i*? Satoshi Kashii (Osaka/J) 09:30

223 WOC Wednesday, 9 June 2010 Oslo 08:30-10:00 WE-07 Assessment of the Optic Nerve Head and Lamina Cribrosa Glaucoma Lutz E. Pillunat (Dresden/D) Robert Fechtner (Newark/USA) Thierry Zeyen (Leuven/B) 08:30 IL WE Ophthalmoscopic evaluation of the optic disk Jost B. Jonas (Mannheim/D) Oslo 10:30-12:00 WE-08 Submacular Hemorrhage Management Retina Lawrence P. Chong (Los Angeles/USA) Andreas Wedrich (Graz/A) Bernd Kirchhof (Cologne/D) 10:30 IL WE Natural History of macular subretinal hemorrhage in age-related macular degeneration Gisèle Soubrane (Créteil/F) Scientific Program Schedule Wednesday, 9 June 08:40 IL WE The role of optic disc stereophotographs Thierry Zeyen (Leuven/B) 08:50 IL WE Digitized optic disc imaging for glaucoma diagnosis Joseph Caprioli (Los Angeles/USA) 09:00 IL WE Digitized optic disc imaging for glaucoma progresssion Ted Garway-Heath (London/UK) 09:10 IL WE Correlation between structure and function Robert Fechtner (Newark/USA) 09:20 IL WE Biomechanics of the lamina cribrosa Eberhard Spörl (Dresden/D) 10:40 IL WE g Vitrectomy with r-tpa and Gas for submacular hemorrhage Anton Haas (Graz/A) 10:50 IL WE Intravitreal Bevacizumab for neovascular age-related macular degeneration with large submacular hemorrhage Ursula Schmidt-Erfurth (Vienna/A) 11:00 IL WE Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration Chang-Hao Yang (Taipei/TJ) 11:10 IL WE Pigmentepithelium Transplantation in massive submacular hemorrhage Peter Szurman (Tübingen/D) 09:30 IL WE In vivo biochemechanics of the optic disc Claude Burgoyne (Portland/USA) 09:40 IL WE Optic nerve blood flow in glaucoma Lutz E. Pillunat (Dresden/D) 09:50 11:20 IL WE Displacement of Submacular Hemorrhage by injection of Tissue Plasminogen Activator and expansile gas Wilson Heriot (Templestowe Lower/AUS) 11:30

224 220 WOC 2010 Wednesday, 9 June Scientific Program Schedule Wednesday, 9 June 2010 Radio Tower Lounge 1 10:30-12:00 WE-33 ESOPRS : Management of Periocular Tumours Oculoplasty, Lacrimal System, Orbit Michèle Beaconsfield (London/UK) John Richard O. Collin (London/UK) Christoph Hintschich (Munich/D) 10:30 IL WE Diagnosis and differential diagnosis Marco Puccioni (Florence/I) 10:40 IL WE Aetiology Tim Sullivan (Bernardsville/USA) 10:50 IL WE Surgical therapy (tumour clearance, local and distant) Michèle Beaconsfield (London/UK) 11:00 IL WE Principles of eyelid reconstruction Mehmet Unal (Ankara/TR) 11:10 IL WE Alternative (non-surgical) therapies Christoph Hintschich (Munich/D) 11:20 IL WE Treatment of local and distant recurrences John Richard O. Collin (London/UK) 11:30 Radio Tower Lounge 1 13:00-14:30 WE-34 Retina: AMD 4 Free Paper Retina 13:09 FP WE HORIZON Extension Trial of Ranibizumab (LUCEN- TIS) for Neovascular Age-related Macular Degeneration (AMD): Two-year Safety and Efficacy Results Michael Singer, Pamela Wong, Lisa Tuomi (San Antonio/USA) 13:16 FP WE Can intravitreal ranibizumab injection in AMD cause blindness? Mohamed El-Ashry, Gerasimos Lascaratos, Archana Vani, Anna-Marie Ambrecht, Baljean Dhillon (Edinburgh/UK) 13:23 FP WE Bonn Ophthalmology Online Network (BOON): first results of a pilot study Nicole Eter, Carolin Milojcic, Hans-Martin Helb (Bonn/D) 13:30 FP WE Intravitreal Ranibizumab Versus Bevacizumab In CNVM Due to ARMD A Prospective Study Partha Biswas, Subhrangshu Sengupta, Subhankar Home, Ajoy Paul, Ruby Choudhary (Kolkata/IND) 13:37 FP WE Comparison of combined treatment of intravitreal bevacizumab or intravitreal recombinant tissue plasminogen activator with expansile gas for large subretinal fovea involving haemorraghes secondary to age related neovascular macular degeneration Wolfgang Mayer, Imad Hakim, Christos Haritoglou, Arnd Gandorfer, Michael Ulbig, Anselm Kampik, Armin Wolf (München/D) 13:44 FP WE Using aspheric monofocal intraocular lenses as intraocular low vision devise for eyes with macular damage Cosme Ildefonso Naval, Analyn T. Suntay, Carmela Q. Olivares (San Juan/RP) 13:51 FP WE Optical coherence tomography and autofluorescence findings in areas with geographic atrophy due to age-related macular degeneration Steffen Schmitz Valckenberg, Monika Fleckenstein, Arno P. Göbel, Thomas Hohman, Frank G. Holz (Bonn/D) Nicole Eter (Bonn/D) Michael Singer (San Antonio/USA) 13:00 SL WE Update on the molecular genetics of age related macular degeneration Andrew Lotery (Southampton/UK) 13:58 FP WE Influence of antocianozidi on ocular blood flow in patients with non-exudative age-related macula degeneration Tatyana Kiseleva, Ekaterina Kravchuk, Sergey Vlasov (Moscow/RUS)

225 WOC Wednesday, 9 June :05 FP WE Fundus Autofluorescence Abnormalities and Local Macular Pigment Density Simon Rothenbuehler, Ute Wolf-Schnurrbusch, Sebastian Wolf (Bern/CH) 14:12 Radio Tower Lounge 2 08:30-10:00 WE-35 Retina: Miscellaneous 2 Free Paper Retina Heinrich Heimann (Liverpool/UK) Anthony T. Moore (London/UK) 08:30 FP WE Retinoblastoma in sub-saharan African: Challenges and prospects Dupe Ademola-Popoola, Foluso Owoeye, Sunday Abuh (Ilorin/WAN) 08:37 FP WE The results of risk-adapted therapy in patiens with unilateral retinoblastoma Tatiana Ushakova, Igor Dolgopolov, Olga Gopovtzova, Alentina Pavlovskaya, Irina Matveeva, Igor Glekov, Vladimir Polyakov, Geordge Mentkevich (Moscow/RUS) 09:14 FP WE Which Vessel Segments are Suited for Measurements with the Retinal Vessel Analyzer? Christoph Wirtz (Bochum/D) 09:21 FP WE Natural Evolution from Macular Retinoschisis to Full-thickness Macular Hole in Highly Myopic Eyes Chuan-bin Sun, Zhe Liu, Ke Yao (Hangzhou/CN) 09:28 FP WE Prophylaxis of Retinal Detachment: To do, not to do, to observe Bojimir Petrovski (Sofia/BG) 09:35 FP WE Momolayer RPE transplantation for treatment of hemorrhagic ARMD An expanding procedure of RPE-Bruch s membrane complex transplantation Changguan Wang, Yuntao Hu, Hongliang Dou, Xuefeng Feng (Beijing/CN) 09:42 Radio Tower Lounge 2 10:30-12:00 WE-36 Refractive Error from School Age through Presbyopia: Combating the World's Leading Cause of Visual Disability Vision 2020 Prevention of Blindness Scientific Program Schedule Wednesday, 9 June 08:44 SL WE Inherited macular disease Anthony T. Moore (London/UK) 08:53 FP WE Normative comparison of generic- and visiontargeted health-related quality of life (HRQL) outcomes in patients with vision loss due to macular edema following retinal vein occlusion Anne Rentz, Jonathan W. Kowalski, Dennis Revicki, Anat Loewentstein, Scott M. Whitcup (Köln/D, Irvine/USA, Tel Aviv/IL) 09:00 FP WE Clinical Effect of Valproic Acid in Patients with RP and ARMD Shalesh Kaushal (Worcester/USA) 09:07 FP WE The regeneration of adult retinal ganglion cells through improper targets Sarah Pfrommer, Solon Thanos (München/D) Stephan J. Fröhlich (Nürnberg/D) Nathan G. Congdon (Baltimore/USA) Kovin Naidoo (Durban/ZA) 10:30 IL WE Population density and myopia risk among Chinese children Nathan G. Congdon (Baltimore/USA) 10:40 IL WE The ICEE Approach to Vision Centres Brien A. Holden (Sydney/AUS) 10:50 IL WE New evidence for the impact of environment on refractive error in Children Paul Mitchell (Sydney/AUS) 11:00 IL WE The accuracy of self-refraction among Chinese secondary school children He Mingguang (Guangzhou/CN)

226 222 WOC 2010 Wednesday, 9 June Scientific Program Schedule Wednesday, 9 June :10 IL WE The potential role of adjustable-power spectacles in refractive correction programs Graeme E. Mackenzie (Oxford/UK) 11:20 IL WE Human resources in refractive error programs: training, motivation, retention Kovin Naidoo (Durban/ZA) 11:30 IL WE Refractive error in Germany Stephan J. Fröhlich (Nürnberg/D) 11:40 13:35 FP WE First experiences in the treatment of ROP with VEGF-inhibitors Synke Meltendorf, Thoralf Wecke, Simone Tuchen, Sven Walter, Arne Viestenz, Wolfgang Behrens- Baumann (Magdeburg/D) 13:42 FP WE Visual perceptual and neurocognition deficits in visually impaired children do we overlook the obvious? Barbara Käsmann-Kellner, Christine Basel, Berthold Seitz (Homburg/D) 13:49 SL WE Batten Disease one disease but many diagnoses Frank Stehr (Hamburg/D) Radio Tower Lounge 2 13:00-14:30 WE-37 13:58 Pediatric Ophthalmology & Genetics 3 Hall 3 Free Paper Pediatric Ophthalmology Rajvardhan Azad (New Delhi/IND) Laurence Desjardins (Paris/F) Murat Karacorlu (Istanbul/TR) 13:00 FP WE Phakic(iris-Fixated) IOLs for anisomyopic amblyopia in children: pilot study Mustafa Ibrahim (Dammam/SA) 13:07 FP WE An Independent Long Term Outcome Study of Bilateral Pseudophakia in Children Malcolm Ing (Honolulu/USA) 13:14 FP WE Breaking down barriers in communicating complex Retinoblastoma information: can pictures be the solution? Hannah Chiu, Helen Dimaras, Rob Downie, Brenda Gallie (Richmond Hill/CDN) 08:30-10:00 WE-09 Retinopathy of Prematurity Uveitis Pediatric Ophthalmology, Genetics Gerd Holmström (Uppsala/S) Michael T. Trese (Royal Oak/USA) Stephan Thurau (Munich/D) 08:30 IL WE ROP in premature and extremely premature infants Gerd Holmström (Uppsala/S) 08:45 IL WE Role of digital imaging in ROP Anna Ells (Calgary/CDN) 09:00 IL WE Indications and options for treatment Michael T. Trese (Royal Oak/USA) 13:21 FP WE International Intraocular Retinoblastoma Classification and histopathology classification Junyang Zhao (Beijing/CN) 13:28 FP WE Visual function in children with hypoxic-ischemic encephalopathy Dorota Pojda-Wilczek (Katowice/PL) 09:15 IL WE Uveitis in childhood Therapy Stephan Thurau (Munich/D) 09:30 IL WE Uveitis in childhood Indication for surgery Bahram Bodaghi (Paris/F) 09:45

227 WOC Wednesday, 9 June 2010 Hall 3 10:30-12:00 WE-10 Update Deutschsprachige Gesellschaft für Intraokularlinsen-Implantation, interventionelle und refraktive Chirurgie German Society of Intraocular Lens Implantation, Interventional and Refractive Surgery (Session in German) Cataract Thomas Kohnen (Frankfurt/D) Duy-Thoai Pham (Berlin/D) Hall 3 13:00-14:30 WE-11 EAO : Impact of Recent Developments on Clinical Practice Miscellaneous Gabriel J. Coscas (Créteil/F) Anselm Kampik (Munich/D) 13:00 IL WE Surgical Retina Anselm Kampik (Munich/D) Scientific Program Schedule Wednesday, 9 June 10:30 IL WE State of the Art Standard IOL Stephan Kohnen (Aachen/D) 13:10 IL WE Medical Retina Gabriel J. Coscas (Créteil/F) 10:40 IL WE Premium IOL Überblick Gerd U. Auffarth (Heidelberg/D) 13:20 IL WE Glaucoma Josef Flammer (Basel/CH) 10:50 IL WE Nachbehandlung nach refraktivchirurgischen Eingriffen Thomas Kohnen (Frankfurt/D) 11:00 IL WE Qualitätsmanagent in der refraktiven und Kataraktchirurgie Ekkehard Fabian (Rosenheim/D) 11:10 IL WE Trabekulektomie vs Kanaloplastik Maya Müller (Lübeck/D) 11:20 IL WE Neue Injektorsysteme Jörn Kuchenbecker (Berlin/D) 11:30 IL WE Intraokulare Medikamenteneinbringung Manfred Tetz (Berlin/D) 11:40 IL WE OCT-Diagnostik am vorderen Augenabschnitt Christopher Wirbelauer (Frankfurt(Oder)/D) 13:30 IL WE Cornea Jorge L. Alió (Alicante/E) 13:40 IL WE Cataract Surgery Marie-José Tassignon (Antwerp/B) 13:50 IL WE Neuroophthalmology Klara Landau (Zurich/CH) 14:00 IL WE Ocular Surface Joaquim Neto Murta (Lisboa/P) 14:10 IL WE Rare Diseases José-Alain Sahel (Paris/F) 14:20

228 224 WOC 2010 Wednesday, 9 June Scientific Program Schedule Wednesday, 9 June 2010 Hall 4/5 08:30-10:00 WE-12 Panel: Implant Materials and Tissue Interaction in Ophthalmic Plastic and Reconstructive Surgery Panel Oculoplasty, Lacrimal System, Orbit John Richard O. Collin (London/UK) Rudolf F. Guthoff (Rostock/D) Christine F. Kreiner (Hennigsdorf/D) 08:30 IL WE Osmoexpansion of orbital structures a 10 years experience Rudolf F. Guthoff (Rostock/D) 08:40 IL WE Applied features of different orbital implants Michail Kataev (Moscow/RUS) 08:50 IL WE Implant exposure and its management Jean-Paul Adenis (Limoges/F) 09:00 IL WE Minimal invasive application of osmoexpanders and its local tissue reaction Michael P. Schittkowski (Göttingen/D) 09:10 IL WE Tissue reactions in filler therapy Christine F. Kreiner (Hennigsdorf/D) Hall 4/5 10:30-12:00 WE-13 Glaucoma Rhythms Glaucoma Robert N. Weinreb (La Jolla/USA) Anastasios G. P. Konstas (Thessaloniki/GR) Norbert Pfeiffer (Mainz/D) 10:30 IL WE Circadian rhythms in human health and disease Neeru Gupta (Toronto/CDN) 10:40 IL WE What have we learned about IOP from the sleep laboratory? Jonathan Liu (Omaha/USA) 10:50 IL WE Aqueous humor rhythms Arthur J. Sit (Rochester/USA) 11:00 IL WE Should the one-eye therapeutic trial be abandoned? Anthony Realini (Morgantown/USA) 11:10 IL WE Are blood pressure and perfusion pressure risk factors for glaucoma? Selim Orgül (Basel/CH) 09:20 IL WE Frontalis sling materials John Richard O. Collin (London/UK) 11:20 IL WE Continuous monitoring of IOP with a contact lens Matteo Leonardi (Lausanne/CH) 09:30 IL WE Biomaterials as medpore in orbital floor fractures Luigi Colangelo (Chieti/I) 09:40 IL WE Jones Tubes for lacrimal canalicular obstructions Daniel Weil (Buenos Aires/RA) 09:50 11:30 IL WE Continuous monitoring of IOP with an implantable device Samir A. Melki (Brookline/USA) 11:40 IL WE Implications for glaucoma management Robert N. Weinreb (La Jolla/USA) 11:50

229 WOC Wednesday, 9 June 2010 Hall 4/5 13:00-14:30 WE-14 Restoring Sight by Implants and Tissue Engineering of the Retina New Technology, Bioengineering Eberhart Zrenner (Tübingen/D) Robert E. MacLaren (London/UK) 13:00 IL WE Retinal prostesis Mark Humayun (Los Angeles/USA) 13:10 IL WE Seeing with subretinal electronic implants Eberhart Zrenner (Tübingen/D) 13:20 IL WE Trans-corneal electrical stimulation to rescue the death of retinal neurons Takashi Fujikado (Osaka/J) 13:30 IL WE How mechanisms of retinal disease will guide forthcomming gene therapy approaches Robert E. MacLaren (London/UK) 13:40 IL WE Retinitis pigmentosa and ips cells Masayo Takahashi (Kobe/J) 13:50 IL WE Seoul Artificial Retina Project Hum Chung (Seoul/ROK) 14:00 Hall 6 08:30-10:00 WE-17 What Will You Do? Cataract Amar Agarwal (Chennai/IND) Hans-Reinhard Koch (Bonn/D) This will teach important pearls and management strategies when a clinician is faced with a difficult clinical scenario. This will be highlighted with the help of surgical videos. Each speaker will share an interesting clinical case which will be discussed with other faculties and the audiance. Amar Agarwal (Chennai/IND) Hans-Reinhard Koch (Bonn/D) 08:30 IL WE Management of zonulopathy in Marfan's Tim Roberts (Chatswood/AUS) 08:40 IL WE Video Suhas Haldipurkar (Panvel/IND) 08:50 IL WE To keep or not to keep the capsular bag Marie-José Tassignon (Antwerp/B) 09:00 IL WE Video Biro Zsolt (Pécs/H) 09:10 IL WE Video Hadi Prakoso (Jakarta/RI) Scientific Program Schedule Wednesday, 9 June 09:20 IL WE Video Hans-Reinhard Koch (Bonn/D) 09:30

230 226 WOC 2010 Wednesday, 9 June Scientific Program Schedule Wednesday, 9 June 2010 Hall 6 10:30-12:00 WE-18 Microincision Cataract Surgery: Mastering the Phakonit / Mics Technique Cataract This symposium will highlight different aspects of Micro Incision Cataract surgery. It would include Micro phakonit biaxial and coaxial Micro Inicion surgery. The experts will also teach applications of different techniques in difficult as well as routine cataract cases. Gabor B. Scharioth (Recklinghausen/D) Jorge L. Alió (Alicante/E) 10:30 IL WE Ideal tips and power modulation for MICS Takayuki Akahoshi (Tokyo/J) 10:40 IL WE A Low Fluidics Strategy for Micro-coaxial Torsional Phaco for Dense Cataracts Khiun F. Tjia (Zwolle/NL) 10:50 IL WE Microphakonit: 700 micron cataract surgery in tough cases Amar Agarwal (Chennai/IND) 11:00 IL WE Step by Step: Surgical Advantages of 700 micron Technology during Lens Extraction Arturo Perez Arteaga (Tlalnepantla/MEX) 11:10 IL WE Is it possible to Manage any Cataract Case with Biaxial technique? L. Felipe Vejarano (Popayán/CO) 11:20 IL WE MICS with the Infiniti Vision System George Beiko (St. Catharines/CDN) 11:30 Hall 6 13:00-14:30 WE-19 The Malpositioned IOL and IOL Implantation in Eyes with Deficient Capsules Cataract Srinivas Kamalakara Rao (Chennai/IND) Robert Stegmann (Pretoria/ZA) Ulrich Mester (Sulzbach/D) 13:00 IL WE Secondary IOL implantation in eyes with partial or complete capsular support Robert Stegmann (Pretoria/ZA) 13:10 IL WE Iris fixation of IOLs in aphakic eyes TBA 13:20 IL WE Anterior chamber IOL placement in aphakic eyes what to do and what not to do TBA 13:30 IL WE Scleral fixation of the IOL into the sulcus techniques and pearls Srinivas Kamalakara Rao (Chennai/IND) 13:40 IL WE Comparison of AC and scleral fixated IOLs TBA 13:50 IL WE Dealing with the malpositioned IOL TBA 14:00 IL WE Influence on optical quality on malpositioned IOL Ulrich Mester (Sulzbach/D) 14:10 IL Techniques in retrieving and fixing a posterior dislocated IOL Vincent Y. W. Lee (Hong Kong/CN) 14:20

231 WOC Wednesday, 9 June 2010 Hall 7 08:30-10:00 WE-20 Assessing Structure and Function in Neuro- Ophthalmology Neuro-Ophthalmology Eberhart Zrenner (Tübingen/D) Daniel Mojon (St. Gallen/CH) Thomas R. Hedges (Boston/USA) 08:30 IL WE Using OCT for Neuro-ophthalmic disorders Carlos Mendoza (Ciudad de la Habana/C) Hall 7 10:30-12:00 WE-21 Wavefront and Aberration. How to Optimize "Quality of Vision" in Contactology Contact Lens and Refraction Tanja Schaefer (Curitiba/P) Berthold Seitz (Homburg/D) 10:30 IL WE Newton Kara José Lecture; Keratoconus. Contact lenses and cross-linking Cleusa Coral-Ghanem (Joinville/BR) Scientific Program Schedule Wednesday, 9 June 08:40 IL WE Using OCT and ERG to Distinguish Retinopathy from Optic Neuropathy Thomas R. Hedges (Boston/USA) 08:50 IL WE What can a comparison of multifocal ERG and OCT results tell us about the locus/nature of visual defects? TBA 09:00 IL WE Visual hallucinations: who, what, when, why? Francois Borruat (Lausanne/CH) 09:10 IL WE Chromatic pupillometry in patients with outer photoreceptor disease: correlation with ERG and visual field Aki Kawasaki (Lausanne/CH) 09:20 IL WE Objective visual assessment along the visual pathway: optophysiology and electrophysiology Michael Bach (Freiburg/D) 10:40 IL WE The corneal aberrometry and contact lens Tanja Schaefer (Curitiba/P) 10:50 IL WE Wavefront in Presbyopia and Contact Lenses Nilo Holzchuh (São Paulo/BR) 11:00 IL WE Wavefront. What equipment? Paulo Ricardo (Goiania/BR) 11:10 IL WE Corneal Topography and Abberometer Measurement in RGP Lens Wear Naoyuki Maeda (Osaka/J) 11:20 IL WE Thirty Years of Follow Up and the New Possibilities Using the Wavefront Ari de Souza Pena (Niteroi/BR) 11:30 09:30 Hall 7 13:00-14:30 WE-22 Update on Safety and Efficacy of Contact Lens Solutions Contact Lens and Refraction Gary Foulks (Louisville/USA) Nilo Holzchuh (São Paulo/BR) Thomas Kaercher (Heidelberg/D) 13:00 IL WE Solution compatibility with silicone lenses Ebru Toker (Istanbul/TR)

232 228 WOC 2010 Wednesday, 9 June Scientific Program Schedule Wednesday, 9 June :10 IL WE Contact lens disinfection compliance in Brazil Paulo Ricardo (Goiania/BR) 13:20 IL WE Update on contact lense disinfection systems in USA Bruce H. Koffler (Lexington/USA) 13:30 IL WE Contact lens disinfection system performance in Japan Rioji Yanai (Yamaguthi/J) 13:40 IL WE Role of osmolarity in contact wear and care Michael A. Lemp (Lake Wales/USA) 13:50 IL WE Corneal infections related to Contact Lenses Yoshikazu Shimonura (Osakasayama-shi/J) 14:00 IL WE Influence of Cosmetics and Cleansing Products for the Eyes on Soft Contact Lenses Junko Tsukiyama (Wakayama/J) 09:00 IL WE How to prevent the complications of proton beam irradiation of the ocular surface Leonidas Zografos (Lausanne/CH) 09:10 IL WE Retinal complications of brachytherapy and proton beam irradiation: dosage and irradiation field Michael H. Foerster (Berlin/D) 09:20 IL WE The treatment of persisting serous retinal detachment due to irradiation Bertil D. Damato (Liverpool/UK) 09:30 IL WE Radiation optic neuropathy: if prevention fails Raffaele Parrozzani (Padova/I) 09:40 IL WE Thoughts on Management of Radiation Macular Edema Carol L. Shields (Philadelphia/USA) 09:50 14:10 Hall 8 Hall 8 08:30-10:00 WE-23 10:30-12:00 WE-24 Tumors of the Retina and Retinal Pigment Epithelium OOG : Complications of Ocular Irradiation: Prevention and Treatment Oncology Oncology Tero Kivelä (Helsinki/FIN) John Hungerford (London/UK) Laurence Desjardins (Paris/F) 08:30 IL WE Pathology of radiation induced ocular complications Stefan Seregard (Stockholm/S) Brenda L. Gallie (Toronto/CDN) Laurence Desjardins (Paris/F) Nikolaos E. Bechrakis (Innsbruck /A) 10:30 IL WE Genetics and diagnosis of retinoblastoma Laurence Desjardins (Paris/F) 10:40 IL WE Retinoblastoma in developing countries Vikas Khetan (Tamil Nadu/IND) 08:40 IL WE Complications of direct ocular irradiation: the clinical scenario Arun D. Singh (Cleveland/USA) 08:50 IL WE The eye as an indirect target of orbital and periorbital irradiation Edoardo Midena (Padova/I) 10:50 IL WE Optimizing radiotherapy of retinoblastoma Norbert Bornfeld (Essen/D) 11:00 IL WE Systemic chemotherapeutic protocols in retinoblastoma John Hungerford (London/UK)

233 WOC Wednesday, 9 June :10 IL WE Intraarteral chemotherapy in retinoblatoma: Pro David H. Abramson (New York/USA) 11:20 IL WE Intraarteral chemotherapy in retinoblatoma: Contra Brenda L. Gallie (Toronto/CDN) 11:30 IL WE RPE and ciliary epithelium tumors Leonidas Zografos (Lausanne/CH) 11:40 IL WE Retinal vascular tumors Nikolaos E. Bechrakis (Innsbruck/A) 14:00 IL WE Elevating the priority of Eye Care within WHO Ala Alwan (Geneve/CH) 14:10 Hall 9 08:30-10:00 WE-26 Management of the Ruptured Eye Eye Trauma and Emergencies Scientific Program Schedule Wednesday, 9 June 11:50 Ferenc Kuhn (Birmingham/USA) Wolfgang F. Schrader (Nürnberg/D) Hall 8 13:00-14:30 WE-25 08:30 IL WE Video Peter Szurman (Tübingen/D) The New Realities of Non-Governmental Development in 2010 and Beyond World Forum of Prevention of Blindness Kathy Spahn (New York/USA) Christian Garms (Bensheim/D) Gullapali N. Rao (Hyderabad/IND) 13:00 IL WE Introduction, and Fundraising in the New Decade Kathy Spahn (New York/USA) 13:10 IL WE The Need to Reach Beyond the Eye Care World and Partner with Other Initiatives Gullapali N. Rao (Hyderabad/IND) 13:20 IL WE Partnering with Disability Initiatives Johannes Trimmel (Vienna/A) 08:40 IL WE Video Ferenc Kuhn (Birmingham/USA) 08:50 IL WE Video Cesare Forlini (Ravenna/I) 09:00 IL WE Video: Combined pars plana vitrectomy and artificial iris diaphragm implant after globe rupture Tommaso Rossi (Rome/I) 09:10 IL WE Video: Ab interno' intravitreal suturing of a large traumatic scleral perforation at the posterior pole Jörg Christian Schmidt (Duisburg/D) 09:20 IL WE Panel discussion on cases presented by the moderators Ferenc Kuhn (Birmingham/USA) 13:30 IL WE Partnering with Infectious Disease Initiatives Danny Haddad (Decatur/USA) 13:40 IL WE Partnering with Chronic Disease Initiatives Hugh R. Taylor (Carlton/AUS) 13:50 IL WE Partnering with Poverty Alleviation Initiatives and the MDGs Huck Holz (Santa Clara/USA)

234 230 WOC 2010 Wednesday, 9 June Scientific Program Schedule Wednesday, 9 June 2010 Hall 9 10:30-12:00 WE-27 ISOT : Ocular Traumatology: The Basics Trauma Ferenc Kuhn (Birmingham/USA) Wolfgang F. Schrader (Nürnberg/D) David Pelayes (Buenos Aires/RA) 10:30 IL WE Counseling and Diagnostics Ferenc Kuhn (Birmingham/USA) 10:40 IL WE How to exercise for trauma surgery on the animal eye Siegfried Priglinger (Linz/A) 10:50 IL WE Primary anterior segment surgery Frank Wilhelm (Schwerin/D) 11:00 IL WE Prevention and treatment of posttraumatic endophthalmitis David Pelayes (Buenos Aires/RA) 11:10 IL WE Primary and secondary posterior segment surgery Wolfgang F. Schrader (Nürnberg/D) 11:20 IL WE Pole to pole surgery Cesare Forlini (Ravenna/I) 11:30 IL WE Ocular tension variations in trauma injuries Giampaolo Gini (Prato/I) Hall 9 13:00-14:30 WE-28 Minisymposium: Ocular Trauma Caused by War and Terrorist Attacks Eye Trauma and Emergencies Ferenc Kuhn (Birmingham/USA) Adiel Barak (Tel-Aviv/IL) Hassan Mortada (Cairo/ET) 13:00 IL WE Ophthalmic combat injuries in the German sector of Northern Afghanistan , Management and outcome Hermann O. C. Gümbel (Ulm/D) 13:10 IL WE Management of war and terror related eye injuries on the British mainland and in her theatres of war Robert A. Scott (Birmingham/UK) 13:20 IL WE Treating concept for mass casualties in Russia Ernest V. Boiko (Sankt Petersburg/RUS) 13:30 IL WE Experience from Terror attacks in India S. Natarajan (Mumbai/IND) 13:40 IL WE Experience from war and terror related eye injuries in Egypt Hassan Mortada (Cairo/ET) 13:50 IL WE Management of eye injuries after terror attacks in Israel Adiel Barak (Tel-Aviv/IL) 11:40 14:00 IL WE Terror related open-globe injuries in turkey Güngör Sobaci (Ankara/TR) 14:10 IL WE Conclusion Ferenc Kuhn (Birmingham/USA)

235 WOC Wednesday, 9 June 2010 Hall 10 10:30-12:00 WE-29 SPRV : Update on Pediatric Retina Retina J. Fernando Arevalo (Caracas/Y) José Roca (Lima/PE) Lihteh Wu (San Jose/CR) 10:30 IL WE Vitreo-Retinal Surgery in Children with Uveitis J. Fernando Arevalo (Caracas/Y) 10:40 IL WE Coat s Disease José Roca (Lima/PE) 10:50 IL WE Familial exudative vitreoretinopathy Lihteh Wu (San Jose/CR) 11:00 IL WE Small-gauge Vitrectomy for Pediatric Retinal Detachment Andres Kychenthal (Vitacura/RCH) Hall 10 13:00-14:30 WE-30 Panel The Teaching of Uveitis at Residency Level and Fellowships Panel Uveitis, Intraocular Inflammation Philip I. Murray (Birmingham/UK) Ronald E. Smith (Los Angeles/USA) Jyotirmay Biswas (Chennai/IND) 13:00 IL WE Education in Brasil Cristina Mucchioli (Brooklyn/USA) 13:15 IL WE Education in Japan Shigeaki Ohno (Sapporo/J) 13:30 IL WE Education in India Jyotirmay Biswas (Chennai/IND) 13:45 IL WE Education in USA Ronald E. Smith (Los Angeles/USA) Scientific Program Schedule Wednesday, 9 June 11:10 IL WE Stage 5 retinopathy of prematurity: then and now Michael T. Trese (Royal Oak/USA) 14:00 IL WE Education in UK Philip I. Murray (Birmingham/UK) 11:20 IL WE Anti-angiogenics in ROP Hugo Quiroz-Mercado (Mexico City/MEX) 14:15 IL WE Education in Germany Christoph M. E. Deuter (Tübingen/D) 11:30 IL WE Plasmin enzyme-assisted vitreoretinal surgery in congenital X-linked retinoschisis Kimbely A. Drenser (Royal Oak/USA) Roof Garden 11:30-13:00 WE-31 11:40 IL WE Choroidal Neovascularization in Children Audina Berrocal (Miami/USA) 11:50 Awards and Fundings (list of the awards available at page 18) Bestowal of the Honorary Membership of the DOG to Prof. Petja Ivanova Vassileva, Bulgaria Handover of DOG Presidency to Prof. Thomas Reinhard, Freiburg Photo Shooting Award Winners

236 232 WOC 2010 Wednesday, 9 June Scientific Program Schedule Wednesday, 9 June 2010 ICC Lounge 08:30-10:00 WE-15 Ocular Drug Delivery to the Posterior Segment Pharmacology, Ocular Drug Delivery Ulrich Schraermeyer (Tübingen/D) Francine Behar (Paris/F) Jane Farrar (Dublin/IRL) 08:30 IL WE Transport of intravitreally injected proteins through the retina Ulrich Schraermeyer (Tübingen/D) 08:40 IL WE Non-viral ocular gene therapy Francine Behar (Paris/F) 08:50 IL WE Aspects of ocular gene therapy work with sirna Jane Farrar (Dublin/IRL) 09:00 IL WE Transporter and receptor targeted drug delivery to the retina Ashim K. Mitra (Kansas City/USA) 09:10 IL WE Drug delivery platforms, drug sensors Mark Humayun (Los Angeles/USA) 09:20 IL WE Drug Transporters in Corneal Epithelium and Retinal Pigment Epithelial Cells: Potential Role in Drug Delivery Arto Urtti (Helsink/FIN) 09:30 ICC Lounge 13:00-14:30 WE-16 Vision 2020 Prevention of Blindness 2 Free Paper Vision 2020 Prevention of Blindness Abdulaziz AlRajhi (Riyadh/SA) Akef El-Maghraby (Jeddah/SA) Bruce E. Spivey (San Francisco/USA) 13:00 FP WE Diabetic Eye Disease in the Pacific: a problem demanding attention now Konstanze Fischer-Harder, Garry Brian, Jaqueline Ramke, Louise Maher, Biu Sikivou, John Szetu (Suva/FJI) 13:07 FP WE Cataract surgical outcomes during micro surgical training in China Guan Chunhong, Richard LeMesurier, Andreas Mueller (South Melbourne/AUS, Nanchang City/CN) 13:14 FP WE AGENT (Afro-German-Eye-Net) Program for Continuous Medical Education of Ophthalmologists in Africa Martin M. Nentwich, Michaela Wilke, Katrin Winter, Ulrich C. Schaller, Anselm Kampik, Volker Klauss (Munich/D) 13:21 FP WE Rapid assessment of avoidable blindness in the Occupied Palestinian Territories (East Jerusalem, West Bank and Gaza) a population-based survey. Far Chiang, Hannah Kuper, Robert Lindfield, Tiarnan Keenan, Na'el Seyam, Denise Magauran, Nasrallah Khalilia, Habes Batta, Ziad Abdeen, Nicholas Sargent (London/UK, Northolt/UK) 13:28 FP WE Developing international research capacity for VISION Robert Lindfield, Shaheen Shah, Clare Gilbert (London/UK) 13:35 FP WE Ongoing Community Eye Health Status of the People Affected with Leprosy in some of the SARC Countries Swapan K. Samanta (Tamluk/IND) 13:42 FP WE Prevalence of low vision amongst students attending all the Schools for the blind in Oyo State, Nigeria, and the need for visual aids. Adedamola Mosuro (Lagos/WAN) 13:49 FP WE Ophthalmic subspecialization in Ibadan, West Africa Tunji Oluleye, Benedictus Ajayi, Adeyinka Ashaye, Ronke Baiyeroju, Ayotunde Ajaiyeoba, Charles Bekibele, Oluyemi Fasina, Bolutife Olusanya, Bade Ogundipe, Olufunmi Ogun, Sola Olawoye, Olutoke Ayorinde (Ibadan/WAN) 13:56

237 WOC Wednesday, 9 June 2010 Room 42 13:00-14:30 WE-38 Breaking News in Retina Retina, Vitreous Rajvardhan Azad (New Delhi/IND) Paul Mitchell (Sydney/AUS) Peter K. Kaiser (Cleveland/USA) 13:00 IL WE VEGF Trap-Eye for Diabetic Macular Edema: The DA VINCI Study Diana Do (Baltimore/USA) 13:15 IL WE Efficacy and safety of intravitreal ranibizumab as adjunctive therapy to laser photocoagulation or as monotherapy in diabetic macular edema: 12-month results from the RESTORE study Paul Mitchell (Sydney/AUS) 13:30 IL WE The phase 1 results of KH902 a improved version of VEGF Trap Peter K. Kaiser (Cleveland/USA) Room 43 10:30-12:00 WE-39 Glaucoma: Surgical Therapy 3 Free Paper Glaucoma Claude Burgoyne (Portland/USA) Karin Hornykewycz (Dresden/D) 10:30 FP WE Drainage of the anterior and vitreous chamber with Ahmed glaucoma valve in uncontrolled pediatric and adult glaucoma Roman Troyanovsky, Oleg Sinyavsky, Svetlana Solonina, Julia Antipova, Alexandr Golovin (St-Petersburg/RUS) 10:37 FP WE Canaloplasty as alternative to goniotrepanation and deep sclerectomy clinical experience Maren Klemm, Claudia Rebel, Johannes Steinberg, Mario Matthaei (Hamburg/D) 10:44 FP WE Tabeculectomy without suturing the conjuntiva Josef Weindler (Esslingen/D) Scientific Program Schedule Wednesday, 9 June 13:45 IL WE Epimacular Brachytheryp in the treatment of exsudative age-related macular degneration Pravin Dugel (Phoenix/USA) 14:00 IL WE Pfizer A Trial, A Phase 2/3 Randomized, Controlled, Double-Masked, Multi-Center, Comparative Trial, in Parallel Groups, Compares the Safety and Efficacy of Intravitreous Injections of 0.3 mg Pegaptanib Sodium (Macugen ), Given as Often as Every 6 Weeks for 2 years, to Sham Injections, in Subjects with Diabetic Macular Edema (DME). Frank G. Holz (Bonn/D) 14:15 IL WE Pascal Laser in DME Pain vs. Performance Rajvardhan Azad (New Delhi/IND) 10:51 FP WE Longtime Efficiency of Combined Cataract-Surgery and Excimer-Laser-Trabeculotomy in Glaucoma Surgery 12 month results Marc Töteberg-Harms, Peter Paul Ciechanowski, Cornelia Hirn, Jens Funk (Zurich/CH) 10:58 FP WE Effect of Selective-Laser-Trabeculoplasty (SLT) on ocular hemodynamics in glaucoma Karin Hornykewycz, Eberhard Spoerl, Richard Stodtmeister, Lutz E. Pillunat (Dresden/D) 11:05 FP WE Clinical study on Ahmed glaucoma valve implantation for 12 eyes with glaucoma after vitrectomy Hong-Ping Cui, Xin-Rui Gao, Qian Li, Xin Liao, Fang Wang (Shanghai/CN) 11:12 FP WE One-site versus two-site fornix based phacotrabeculectomy in patients with cataract and pseudoexfoliative glaucoma Zdravko Mandic, Mia Zoric Geber, Katia Novak Laus, Ivanka Petric Vickovic (Zagreb/HR)

238 234 WOC 2010 Wednesday, 9 June Scientific Program Schedule Wednesday, 9 June :19 FP WE Posterior chamber aspiration as an adjuvant of intravitreal bevacizumab for the treatment of decompensated neovascular glaucoma Walter Noske, Hermann Burau (Brandenburg/D) 11:26 FP WE Safety and efficacy of topical bevacizumab in the early bleb failure after trabeculectomy Tomasz Zarnowski, Justyna Klos-Rola, Maria Tulidowicz-Bielak, Anselm Jünemann (Lublin/PL, Erlangen/D) 11:33 FP WE The result of management in primary angle closure glaucoma for Indonesian s eyes Ikke Wiyogo (Jakarta/RI) 08:58 FP WE High Coverage with Azithromycin and effect on Trachoma and C. trachomatis infection in mesoendemic villages in Tanzania Sheila West (Baltimore/USA) 09:05 FP WE Retinal Detachment after Phaco Cataract Extraction with posterior capsular defekt Ulrich Giers (Detmold/D) 09:12 FP WE Identifying the content for a novel vision-related quality of life questionnaire for visually impaired children and young people Valerie Tadic, Sarah Keeley, Gillian Lewando-Hundt, Jugnoo Rahi (London/UK, Coventry/UK) 11:40 Room 44 08:30-10:00 WE-40 Epidemiology Free Paper Epidemiology Paul Mitchell (Sydney/AUS) Susanne Pitz (Mainz/D) 08:30 FP WE Ocular manifestations of Fabry s disease: an update from the Fabry Outcome Survey with focus on longitudinal and pediatric data Susanne Pitz, Andrea Sodi, Pauline Wilson, Roberto Ebner, Roberto Ebner, Gere Sunder-Plassmann (Mainz/D) 08:37 FP WE Regional Differences in Rates of Exfoliation Syndrome Throughout the United States Joshua D. Stein, Nidhi Talwar, Julia E. Richards, Denise S. Kim, David M. Reed, Bin Nan, Jae Hee Kang, Janey L. Wiggs, Louis Pasquale (Ann Arbor/USA) 09:19 FP WE The Incidence of Neonatal Endophthalmitis in the United States May Be Declining Andrew Moshfeghi, Resmi Charalel, Tina Hernandez-Boussard, John Morton, Darius Moshfeghi (Palm Beach Gardens/USA) 09:26 FP WE Australian National Survey of Diabetic Retinopathy Management by General Practitioners and Optometrists Daniel Ting, Joshua Yuen, Antony Clark, Jonathan Ng, Nigel Morlet, Hugh Taylor, David Preen (Perth/AUS) 09:33 FP WE Complicated diabetic retinopathy among Egyptian patients Khaled G. Abu El Einen, Hany Hamed El Defrawy El Defrawy, hany elmekawey, Yasser Sayed Saif Saif, Mahmoud Gamal Elboraey Elboraey, Hoda Ibrahim Rizk Rizk (Giza/ET) 09:40 08:44 FP WE Agricultural pesticide use and childhood orbital malignant tumor Jayanta Das (Guwahati/IND) 08:51 FP WE Prevalence and risk factors of undercorrected refractive errors among Singaporean Malay adults: the Singapore Malay Eye Study Mohamad Rosman, Tien Yin Wong, Wan Ting Tay, Louis Tong, Seang Mei Saw (Singapore/SGP)

239 WOC Wednesday, 9 June 2010 Room 44 10:30-12:00 WE-41 Neuro-Ophthalmology 2 Free Paper Neuro-Ophthalmology Anthony C. Arnold (Los Angeles/USA) Eberhart Zrenner (Tübingen/D) 10:30 FP WE Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation Cameron F. Parsa (Baltimore/USA) 10:37 FP WE Charles Bonnet syndrome in a Low Vision department Heike Elflein, Susanne Pitz (Mainz/D) 10:44 SL WE Restoration of vision: restoration hot spots in hemianopia after stroke are influenced by local topographic interactions Bernhard A. Sabel, Iris Mueller, Markus Preuss, Fred Wolf, Tobias Guenther (Magdeburg/D) 10:53 FP WE Clinical analysis of empty sella syndrome with visual disturbance LI Juanjuan (Kunming/CN) 11:28 FP WE Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension: Ocular Safety Assessment Barbara Wirostko, Charles Tressler, Lie-Ju Hwang, Gary Burgess, Alan M. Laties (New York/USA) 11:35 Salon 19 08:30-18:00 WE-42 IUSG Workshop: Diagnostic Criteria of Virus- Induced Anterior Uveitis Uveitis Soon Phaik Chee (Singapore/SGP) Jolanda de Groot (Utrecht/NL) Aniki Rothova (Utrecht/NL) Bahram Bodaghi (Paris/F) Philip Murray (Birmingham/UK) Manfred Zierhut (Tübingen/D) 09:00 10:30 CMV 10:45 12:15 VZV Scientific Program Schedule Wednesday, 9 June 11:00 FP WE Pulfrich Pendulum Phenomenon in Patients with a Demyelinating Optic Neuropathy Joana Ferreira, Luís Abegão Pinto, Duarte Amado, João Paulo Cunha (Lisboa/P) 11:07 FP WE Clinical features of acute & subacute optic neuritis/ perineuritis in Hong Kong Chinese patients Ching Yan Noel Chan (Hongkong/HK) 13:30 18:00 Planning of the Validation Study for all 3 Viruses In case of interest please contact Phil Murray: p.i.murray@bham.ac.uk The first part of the workshop will take place on Tuesday, 8 June 8:30 to 18:00. 11:14 FP WE Proportion and Characteristics of Dyschromatopsia Among Glue Sniffers Emil Sjahreza, Muhammad Sidik (Jakarta/RI) 11:21 FP WE Spectrum of neuro-ophthalmic diseases and challenges encountered in an indigenous black population in West-Africa: A tertiary hospitalbased review. Olufunmilola A. Ogun, Benedictus Ajayi, Charles Bekibele, Ayotunde Ajaiyeoba (Northampton/UK, Ibadan/WAN)

240 World Ophthalmology Congress 2014 Tokyo WOC2014 Tokyo XXXIV International Congress of Ophthalmology April 2 6, 2014 President Tetsuro Oshika, M.D. Professor and Chairman, Department of Ophthalmology Institute of Clinical Medicine, University of Tsukuba Venue: Tokyo International Forum / Imperial Hotel Tokyo Secretariat c/o Congress Corporation Kohsai-kaikan Bldg., 5-1 Kojimachi, Chiyoda-ku, Tokyo , Japan Phone: Fax: woc2014tokyo@congre.co.jp

241 WOC Courses and Wetlabs

242 23 rd INTERNATIONAL CONGRESS OF GERMAN OPHTHALMIC SURGEONS October 21 st 24 th, 2010 Congress Center Hamburg VIDEO LIVE SURGERY OCTOBER 21 ST AND 22 ND, 2010 MAIN TOPICS (Simultaneous translation English - German) Honorary Lectures Cataract surgery DOC ISRS / AAO Glaucoma surgery Vitreoretinal surgery Corneal surgery Orbita, lacrimal and lid surgery Forum Eye surgery in the developing countries *DEADLINE June 15 th, 2010 FREE PAPER SESSION* SCIENTIFIC POSTERS/ePOSTERS* SURGICAL FILMS* Organizer / Registration: MCN Medizinische Congressorganisation Nürnberg AG Neuwieder Str. 9, Nürnberg, Germany Phone: ++49/911/ , FAX: ++49/911/ , doc@mcnag.info 23 rd International Congress of German Ophthalmic Surgeons, Congress Center Hamburg, October 21 st - 24 th, 2010 Please send me: a Preliminary Program Name MCN Medizinische Congressorganisation Nürnberg AG Neuwieder Str NÜRNBERG GERMANY Street Country/Zip Code/City Phone Fax

243 WOC Saturday, 5 June 2010 Sao Paulo 08:30-10:00 WOC-AAD-C-01 Differential Diagnosis of Macular Diseases Chair: Gabriele E. Lang (Ulm/D) Speakers: Arnd Gandorfer (Munich/D), Gabriele E. Lang (Ulm/D), Peter Walter (Aachen/D) Course fees: 50 c / 75 c Assessment and diagnosis of macular diseases according to clinical, angiographic, and OCT-findings with practical guidelines for patient work-up and management. The exact diagnosis of macular diseases is important for decisions concerning treatment and prognosis. The differential diagnosis of macular diseases however, is difficult. The most common clinical findings, characteristica angiographic features, and OCT-findings of macular dystrophies and different macular degenerations will be presented. Besides the classical macular dystrophies and age-related macular degeneration, which can display a highly variable image, more rare macular diseases will also be addressed. The course will end with an interactive macula quiz of particularly interesting cases. 08:30 Age-related Macular Degeneration Gabriele E. Lang (Ulm/D) 08:50 Macular Dystrophies Peter Walter (Aachen/D) 09:10 Different Macular Diseases Arnd Gandorfer (Munich/D) Sao Paulo 10:30-12:00 WOC-AAD-C-02 Glaucoma without High Pressure Normal- Tension Glaucoma Chair: Thomas S. Dietlein (Düsseldorf/D) Speakers: Thomas S. Dietlein (Düsseldorf/D), Detlev Spiegel (Augsburg/D) Course fees: 50 c / 75 c Optimisation of the diagnostics and treatment of normal pressure glaucoma. In this course the important pathomechanisms, which cause damage in normal-tension glaucoma will be explained so that the practising ophthalmologist can take the necessary diagnostic steps and start the necessary treatment. An extensive medical history as well as a well-directed examination on the slit-lamp already displays the most vital information. Which additional information is necessary and when it is necessary, as well as where such examinations take place, will be covered. When, how intensely, and in which ways intraocular pressure should be lowered, and which additional treatment options exist will also be explained. Particularly the significance of vasoactive substances will be discussed. Examples of clinical cases will be presented and discussed. Sao Paulo 14:00-15:30 WOC-AAD-C-03 Diabetic Retinopathy Chair: Anselm Kampik (Munich/D) Saturday, 5 June Courses and Wetlabs 09:30 Interactive Macula Quiz All speaker Speakers: Anselm Kampik (Munich/D), Klaus-Dieter Lemmen (Düsseldorf/D), Michael W. Ulbig (Munich/D) 09:50 Course fees: 50 c / 75 c Teaching standardised treatment options according to ETDRS criteria A presentation pathogenesis and stage classification of diabetic maculopathy with a diagnosis for laser treatment with different laser wavelengths, followed by a discussion of the effects of risk factors like pregnancy and high blood pressure, and the assessment of intensified diabetes management with insulin pump or pancreas transplant, as well as a critical discussion of medicinal treatment.

244 240 WOC 2010 Courses and Wetlabs Saturday, 5 June Saturday, 5 June 2010 Sao Paulo 16:00-17:30 WOC-AAD-C-04 Optic Disc Elevation Differential Diagnosis and Work Up Chair: Jan Schroeter (Berlin/D) Speakers: Klaus Rüther (Berlin/D), Jan Schroeter (Berlin/D) Course fees: 50 c / 75 c Swelling of the optic disc can have different causes. Besides an elevated intracranial pressure optic disc drusen, inflammatory and ischemic processes have to be thought of. Hyperopia and a reduced disc size or tilted disc can also be causative. The morphological appearance of the optic nerve is mostly not specific for the underlying causes, so functional testing and often cerebral imaging is necessary. The course will give an overview of different pathologies leading to a swelling of the optic disc. Strategies to obtain the correct diagnoses and the necessity and order of different examinations (e.g. CT, MRI, lumbar puncture) will be discussed. The most common diseases leading to a swelling of the optic disc will be presented in detail including ischemic anterior optic neuropathy, both the arteritic and non arteritic form, neuritis nervi optici, optic disc drusen, chronic and acute papilledema, compressive optic neuropathy, tumors of the optic nerve. The course is intended for ophthalmologist interested in neuroophthalmology and the differential diagnoses of optic disc swelling. Room Istanbul 10:30-12:00 WOC-C-06 Wetlab Refractive Surgery 2 Chair: Gernot I. W. Duncker (Halle/D) Speakers: Gernot I. W. Duncker (Halle/D), Bettina Jendritza (Mannheim/D), Markus Kohlhaas (Dortmund/D), Christopher Wirbelauer (Frankfurt/D) Course fees: 100 c / 125 c The surgical techniques (LASIK, PRK, LASEK, Epi-LASIK, phaco IOLs, Intacs, AK+ LRI) will be demonstrated in the KRC-Wet-Labs and the participants will be able to practise them on pig eyes. The emphasis is on the practical exercises in refractive techniques. Room Istanbul 2010, 14:00-15:30 WOC-C-07 Wetlab: Endotamponades in Vitreoretinal Surgery An Introduction to Beginners Chair: Gisbert Richard (Hamburg/D), Borja Corcostegui (Barcelona/E), David S. H. Wong (Hong Kong/HK) Speakers: Borja Corcostegui (Barcelona/E), Gisbert Richard (Hamburg/D), Lars Wagenfeld (Hamburg/D), David S. H. Wong (Hong Kong/HK) Room Istanbul Course fees: 100 c / 125 c 08:30-10:00 WOC-C-05 WetLab Refractive Surgery 1 Chair: Thomas Kohnen (Frankfurt/D) Speakers: Ekkehard Fabian (Rosenheim/D), Jürgen Kampmeier (Ulm/D), Thomas Kohnen (Frankfurt/D), Carlo Lackerbauer (Munich/D), Walter Sekundo (Marburg(D) Course fees: 100 c / 125 c The surgical techniques (LASIK, PRK, LASEK, Epi-LASIK, phaco IOLs, Intacs, AK+ LRI) will be demonstrated in the KRC-Wet-Labs and the participants will be able to practise them on pig eyes. The subject of this course is the handling of different endotamponades (gases, oils, and heavy liquids). The focus lies on practical Wet-Lab exercises on pig eyes. This course is aimed at colleagues who are familiar with the basics of vitrectomy, yet have little or no practical experience in the use of endotamponades. Gasendotamponades Gisbert Richard (Hamburg/D) Heavy fluides Borja Corcostegui (Barcelona/E) Siliconoil Lars Wagenfeld (Hamburg/D) Heavy Siliconoil David S. H. Wong (Hong Kong/HK)

245 WOC Saturday, 5 June 2010 Room Istanbul 16:00-17:30 WOC-C-08 Wetlab Surgical Measurement in the Early Phase of Chemical and Thermal Eye Burns Hans Gert Struck (Halle/D), Laszlo Kiraly (Halle/D), Norbert Franz Schrage (Cologne/D) Speakers: Norbert Franz Schrage (Cologne/D), Hans Gert Struck (Halle/D) Salon 11/12 08:30-10:00 WOC-AAD-C-09 Corneal Degeneration / Dystrophy Chair: Hans Eberhard Völcker (Heidelberg/D) Speakers: Gerhard K. Lang (Ulm/D), Hans Eberhard Völcker (Heidelberg/D) Course fees: 50 c / 75 c Saturday, 5 June Courses and Wetlabs Course fees: 100 c / 125 c Aim: Studying the management of surgical complications with regards to early therapy following medium and severe chemical and thermal burns. Ophthalmologists should reach a high standard of quality in these fundamental techniques. Content: There will be exercises in the mechanical cleansing and rinsing of pig eyes with lime corrosion, followed by training in the surgical techniques of peridotomy, peridectomy, necrosis excision, Tenonplastic, amnioplasty, and keratoplasty according to Putschkowskaja. These fundamental techniques of surgical treatment will be practised on isolated rabbit eyes and orbitae. Diagnosis and implementation of these surgical techniques in new scientifically founded concepts of early and follow-up therapy of ocular chemical and thermal burns will be discussed. This will be based on the longstanding clinical and research experience of the Halle and Aachen teaching hospitals. Clinical diagnosis and differential diagnosis of corneal dystrophies and corneal degenerations, taking into account histopathological findings as well as genetic and treatment related aspects Corneal degenerations can be a symptom of the generic ageing process or appear in combination with specific conditions. In particular these corneal transformations, including the marginal ulcer, their morphology and treatment will be covered. As opposed to the degenerative transformations, which take place without any genetic predisposition and increasingly apply to old age, the term 'corneal dystrophy' includes hereditary, symmetric, and bilateral conditions, which occur both in isolated form as well as in combination with other systemic conditions. The epithelial, stromal, and endothelial dystrophies will be presented with particular attention paid to the clinical differential diagnosis, which takes genetic, morphological, and treatment aspects into account. Hall 9 Physiopathology of eye burns, Modulation of the biological reaction by antiinflammatory and surgical therapy Hans Gert Struck (Halle/D) 10:30-12:00 WOC-C-10 Evidence-Based Ophthalmology How to Get It and How to Use It Mechanism and prognostic evaluation of corrosives, Prognostic value of eye burns classification Norbert Franz Schrage (Cologne/D) Richard Wormald (London/UK), Gianni Virgili (Florence/I) Strategies in therapy Hans Gert Struck, Norbert Franz Schrage (Halle/D, Cologne/D) Speakers: Jennifer Burr (Aberdeen/UK), David Friedman (Baltimore/USA), Iris Gordon (London/UK), Gianni Virgili (Florence/I), Richard Wormald (London/UK) Course fees: 50 c / 75 c 10:30 EBM and EBO Introduction Richard Wormald (London/UK)

246 242 WOC 2010 Courses and Wetlabs Saturday, 5 June Saturday, 5 June :40 How to get EBO - Searching, Filtering, Synthesizing and Disseminating Richard Wormald, Iris Gordon (London/UK) 11:00 How to Use it - in clinic and operating theatre David Friedman (Baltimore/USA) 11:10 How to Use it - Policy and Guidelines Jennifer Burr (Aberdeen/UK) 11:20 Diagnostic test accuracy reviews Gianni Virgili (Florence/I) Hall 9 16:00-17:30 WOC-C-12 Advanced Biaxial Microphaco and Coaxial Phaco / Microphaco Techniques in Challenging (White and Suprahard) Cataracts: A Video Course Chair: Arup Chakrabarti (Trivandrum/IND) Speakers: Amar Agarwal (Chennai/IND), Jorge L. Alió (Alicante/E), Arup Chakrabarti (Trivandrum/IND), Sri Ganesh (Bangalore/IND), Boris Malyugin (Moscow/RUS), Som Prasad (Wirral/UK) 11:30 Hall 9 14:00-15:30 WOC-AAD-C-11 Crosslinking of the Cornea: When, How and Why? Chair: Claus Cursiefen (Erlangen/D) Speakers: Claus Cursiefen (Erlangen/D), Gerd Geerling (Würzburg/D) Course fees: 50 c / 75 c Course fees: 50 c / 75 c Description: Biaxial micro incision cataract surgery, as well as coaxial microphacoemulsification are fast becoming increasingly popular techniques to deal with cataracts. These techniques have been found to be effective in standard cataract situations. However, the application of these techniques can also be extended to deal with difficult situations including white and suprahard cataracts. This video based course will present a rationale approach for biaxial microphacoemulsification and coaxial phaco /microphaco in challenging white and suprahard cataracts. Fluid dynamics, instrumentation, basic surgical techniques, simple and practical hints to overcome difficulties will be discussed. Crosslinking of the cornea is a new emerging technique for surgical treatment of keratoconus. Aim of this course to outline the current indications for corneal crosslinking in patients with keratoconus and beyond, to explain the surgical treatment itself and postoperative care of patients and fincally to discuss complications and their prevention and management. The participant should be confident afterwards to deal with patients having undergone crosslinking of the cornea. Objective: Attendees will be able to perform standard phaco as well as biaxial / coaxial microphacoemulsification for challenging cataracts. 16:00 Introduction and Problems to Anticipate in a White and Suprahard Cataract Arup Chakrabarti (Trivandrum/IND) 16:05 Review of Dyes to Stain the Anterior Capsule, the Staining Techniques and Capsulorhexis in White and Suprahard Cataracts Arup Chakrabarti (Trivandrum/IND) 16:15 Coaxial Phaco in White and Suprahard Cataracts Arup Chakrabarti (Trivandrum/IND) 16:25 C-MICS with the Newer Machines TBA

247 WOC Saturday, 5 June :35 C-MICS/B-MICS with the Newer Machines (Signature) for White and Suprahard Cataracts Sri Ganesh (Bangalore/IND) 16:45 B-MICS / C-MICS with the Newer Machines (Stellaris) in White and Suprahard Cataracts Boris Malyugin (Moscow/RUS) 16:55 Biaxial Microphaco and Microphaconit-700 micron Cataract Surgery in White and Suprahard Cataracts Amar Agarwal (Chennai/IND) 17:05 Learning Pearls, Pitfalls and Complications in Biaxial Microphacoemulsification and Coaxial Microphaco in White and Suprahard Cataracts Som Prasad (Wirral/UK) 17:15 Newer Micro-incision IOLs for Bi-Axial/Co-Axial Microphaco Jorge L. Alió (Alicante/E) Hall 10 08:30-10:00 WOC-C-13 The Aging Lid Functional Effects and their Treatment Chair: Karl-Heinz Emmerich (Darmstadt/D) Speakers: Karl-Heinz Emmerich (Darmstadt/D), Gabriele M. Emmerich (Darmstadt/D), Hans-Werner Meyer-Rüsenberg (Hagen/D), Uwe Peter Press (Trier/D) Course fees: 50 c / 75 c Age-related changes of the lid have numerous functional and aesthetic consequences. A series of lid changes can thus lead to malpositioning of the lid with a variety of implications for vision and wettability of the eye as well as the lacrimal glands. Causes, implications and the demonstration of therapeutic surgical measures are the core and focus of this course. The psychosomatic aspects will also be outlined and discussed. Hall 10 10:30-12:00 WOC-C-14 Management of Complex Glaucoma Gerd Geerling (Würzburg/D), Franz Grehn (Würzburg/D), Maya Müller (Lübeck/D) Speakers: Gerd Geerling (Würzburg/D), Franz Grehn (Würzburg/D), Thomas Klink (Würzburg/D), Maya Müller (Lübeck/D), Manfred Zierhut (Tübingen/D) Course fees: 50 c / 75 c This course presents the management of complex glaucoma situations such as congenital glaucoma and the combination of glaucoma and lens, cornea, and retina mutations. The secondary glaucoma in uveitis will be addressed separately. Alongside conservative therapy, indications for surgery, the question of single or double procedure surgery, as well as further features of surgical procedures and aftercare, will be dealt with. 10:30 Congenital Glaucoma Franz Grehn (Würzburg/D) 10:40 Uveitis and Glaucoma Manfred Zierhut (Tübingen/D) 10:50 Cataract and Glaucoma Thomas Klink (Würzburg/D) 11:00 Retinal disease and Glaucoma Maya Müller (Lübeck/D) 11:10 Keratoplasty and Glaucoma Gerd Geerling (Würzburg/D) Saturday, 5 June Courses and Wetlabs

248 244 WOC 2010 Courses and Wetlabs Saturday, 5 June Saturday, 5 June 2010 Hall 10 14:00-15:30 WOC-C-15 Modern OCT imaging: Clinical Value and Perspectives Chair: Ursula Schmidt-Erfurth (Vienna/A) Speakers: Matthias Bolz (Vienna/A), Jay S. Duker (Boston/USA), Christopher Kiss (Vienna/A), Christian Prünte (Binningen/CH), Srinivas R. Sadda (Los Angeles/USA), Ursula Schmidt-Erfurth (Vienna/A) 14:30 OCT in retinal vascular disease Christopher Kiss (Vienna/A) 14:40 OCT in macular surgery Christian Prünte (Binningen/CH) 14:50 Perspectives and developments Srinivas R. Sadda (Los Angeles/USA) Hall 10 16:00-17:30 WOC-AAD-C-16 Course fees: 50 c / 75 c KRC Advanced Course for the Refractive Surgery The course OCT Present and Future offers a compact state-of-the-art and comprehensive update regarding options and relevance of modern OCT-technology over a vast spectrum of retinal pathologies and expert insights.oct is a milestone in ophthalmologic diagnostics with the opportunity of a non-invasive, high-resolution representation of all retinal compartments e.g. vitreoretinal interface, intraretinal layers and subretinal space. Already, conventional OCT provides important and clinically relevant information about the condition of the central retina for diagnosis and therapeutic indication. Applications of OCT are all the frequent and severe retinal diseases such as age-related macular degeneration (AMD), diabetic retinal disease (DRP) and vascular pathologies. With the evolution of the high-resolution technology the value of OCT has increased significantly, since a precise imaging of all details and, based on rasterscanning, a complete three-dimensional representation at all locations became available. Accordingly, modern OCT offers a realistic and quantified analysis of diseases of the central retina. Hence, OCT has become one of the most important parameters in the anti-angiogenetic therapy with high relevance for indication, prognosis and long-term management. For the understanding of pathogenesis OCT provides essential novel insights e.g. in diabetic retinopathy. 14:00 Overview on state-of-the-art technology Jay S. Duker (Boston/USA) 14:10 OCT in AMD Ursula Schmidt-Erfurth (Vienna/A) 14:20 OCT in diabetic macular disease Matthias Bolz (Vienna/A) Chair: Thomas Kohnen (Frankfurt/D) Speakers: Michael C. Knorz (Mannheim/D), Thomas Kohnen (Frankfurt/D), Thomas F. Neuhann (Munich/D) Course fees: 50 c / 75 c Presenting the current developments in refractive surgery This course will present the state of affairs in the development of the refractive surgical method. Alongside this the discussion among participants is a key element of this course. We are happy to discuss cases brought forward by participants. Room 44 08:30-10:00 WOC-AAD-C-17 Episcleritis and Scleritis Chair: Manfred Zierhut (Tübingen/D) Speakers: Uwe Pleyer (Berlin/D), Manfred Zierhut (Tübingen/D) Course fees: 50 c / 75 c Differentiation between the different sclera conditions and their differential diagnoses. Choice of an effective treatment. Following a brief outline of the basics and the pathophysiology of sclera conditions, the current classification of the different forms shall be evaluated. Furthermore, the diagnostically and differentially recommended examination techniques will

249 WOC Saturday, 5 June 2010 be introduced. Lastly, locally and systemically applied medication (antiphlogistics, immunosuppressants, biologica) as well as surgical options will be discussed. Participants are encouraged to introduce their own problem patients. Room 44 10:30-12:00 WOC-AAD-C-18 Diagnosis and Treatment of Peripheral Retinal Degeneration Chair: Bernd Kirchhof (Cologne/D) Speakers: Bernd Kirchhof (Cologne/D), Peter Wiedemann (Leipzig/D) Course fees: 50 c / 75 c Classification and prognostic significance of the manifold manifestations of peripheral retinal degenerations with regards to the risk of amotio. We shall define retina s periphery and its anatomical characteristics. We differentiate between peripheral retinal degeneration following primarily trophic- and primarily traction-dependant dysplasia. We distinguish between peripheral retinal degenerations according to their significance for the development of amotio. Aside from morphological criteria, epidemiologial data is consulted to justify the diagnosis of prophylactic retinopexy. Room 44 16:00-17:30 WOC-AAD-C-20 Glaucoma Surgery Follow-up Care Chair: Franz Grehn (Würzburg/D) Speakers: Franz Grehn (Würzburg/D), Thomas Klink (Würzburg/D), Jochen Wahl (Mainz/D) Course fees: 50 c / 75 c Optimising postoperative care with the aim of maximising the long-term success of glaucoma surgeries. Identification and treatment of postoperative complications Characteristic signs of postoperative scarring using standardised assessment of filtering bleb evaluation DD postoperative hypotony DD postoperative increase in intraocular pressure 5-FU use in postoperative care Needling of the filtering bleb Possible revision surgeries This course is aimed at ophthalmologists in hospitals and medical practices in particular because in the future most postoperative care will be done in outpatient departments or ophthalmic practices. Saturday, 5 June Courses and Wetlabs Room 44 14:00-15:30 WOC-AAD-C-19 Diagnosis and Treatment of Keratomycoses Chair: Wolfgang Behrens-Baumann (Magdeburg/D) Speakers: Wolfgang Behrens-Baumann (Magdeburg/D) Course fees: 50 c / 75 c How do I recognise a keratomycosis? How do I test my presumptive diagnosis? Treatment optimisation in fungal keratitis The characteristics of keratomycosis will be shown on example cases. Medical history, risk factors, and fungal occurrence will be discussed and advice on securing the diagnosis. Eventually antimycotics, their dosage, use and sensible application will be covered with regards to the different fungal strains.

250 246 WOC 2010 Courses and Wetlabs Sunday, 6 June Sunday, 6 June 2010 Room Istanbul 08:30-10:00 WOC-C-21 Wetlab Basic Course on Penetrating Corneal Grafting Techniques Chair: Gernot I. W. Duncker (Halle/D) Speakers: Gernot I. W. Duncker (Halle/D), Bernhard Nölle (Kiel/D), Berthold Seitz (Homburg/D), Frank Wilhelm (Schwerin/D) Course fees: 100 c / 125 c The different surgical steps of penetrating keratoplasty on the pig eye and regular corneoskleral buttons will be presented and practised in this basic course. Different trephine systems will be used. Tips and tricks regarding the surgical procedure will be given, and the suture technique will be practised extensively. This focus of this course lies on the practical applications. Room Istanbul 10:30-12:00 WOC-C-22 Wetlab for the Advanced: Lamellar Grafting Techniques Chair: Gernot I. W. Duncker (Halle/D) Speakers: Gernot I. W. Duncker (Halle/D), Jörg. H. Krumeich (Bochum/D), Friedrich E. Kruse (Erlangen/D), Gerrit R. J. Melles (Rotterdam/NL) Course fees: 100 c / 125 c Hall 8 08:30-10:00 WOC-AAD-C-23 Immunology of the Eye: Intraocular Inflammations Chair: Uwe Pleyer (Berlin/D) Speakers: Uwe Pleyer (Berlin/D), Stephan Thurau (Munich/D) Course fees: 50 c / 75 c The aim of this course is to present the current state of knowledge with regards to immunodependant eye conditions and to offer rational decision-making advice with regards to diagnosis and treatment. Intraocular inflammations are the subject focus. Upon briefly addressing pathophysiological basics, current aspects of diagnosis and treatment will be discussed on clinical examples. Among others, the following topics shall be covered: Diagnostic strategies for uveitis: When should (or shouldn't) one start diagnostics? Which types of patients indicate invasive diagnostics (e.g. ppv). Aspects of interdisciplinary cooperation, significance of the DRGs for diagnostics and treatment. Conservative treatment: Indications and implementation. Systemic treatment - when? How? Monitoring and unwanted effects. Options and limits of new kinds of therapy (e.g. biologica?) (CME-Therapy). Surgical therapy: Indications and implementation (cataract/glaucoma). Is pseudophakia generally something to aim for? Characteristics of childhood perioperative care in intraocular surgeries Indications for ppv. Additionally participants are encouraged to introduce their own problem patients. This advanced course introduces the new techniques of lamellar keratoplasty, which will be practised and simulated on the pig s eye. The characteristics of this surgical procedure as well as tips for handling the individual methods will be given, while there is an emphasis on their practical application in order to familiarise the participants with the new equipment. Room Istanbul 14:00-15:30 WOC-C-36 Modern Pars Plana Vitrectomy DryLab (Basics) Frank Koch (Frankfurt/D), Norbert Bornfeld (Essen/D), Helge Krüger (Frankfurt/D) Speakers: Norbert Bornfeld (Essen/D), Lars-Olof Hattenbach (Ludwigshafen/D), Frank Koch (Frankfurt/D), Helge Krüger (Frankfurt/D), Klaus Lucke (Bremen/D), Stephan Nikolic (Hannover/D), Pankaj Singh (Frankfurt/D), Clemens Wagner (Mannheim/D) Course fees: 100 c / 125 c

251 WOC Sunday, 6 June 2010 The Virtual Reality Pars plana Vitrectomy DryLab was developed in order to realise evidence-based ophthalmosurgical training. The strategies that ensure reliability and success of retina and vitreous surgery as well as fundamental principles of intraocular surgical interventions in the vitreous body will be trained and tested within the VRmagic-Vitrectomy simulator. Experienced colleagues will guide you through targeting strategies, methods of vitreous excision in different retina/vitreous affections, vitreous membrane detachment, as well as the intravitreal application of medication. The simulator will capture a performance profile and your achievements will be evaluated. 14:00 EYESi technology, part 1 Clemens Wagner (Mannheim/D) 14:10 Abstract-to-real transfer Frank Koch (Frankfurt/D) 14:20 EYESi Diagnosis and treatment Pankaj Singh (Frankfurt/D) 14:30 Complication management Lars-Olof Hattenbach (Ludwigshafen/D) 14:40 EYESi-Expertise Stephan Nikolic (Hannover/D) 14:50 VR in Aviation + Ophthalmology Klaus Lucke (Bremen/D) ophthalmosurgical training. The strategies that ensure reliability and success of retina and vitreous surgery as well as fundamental principles of intraocular surgical interventions in the vitreous body will be trained and tested within the VRmagic-Vitrectomy simulator. Experienced colleagues will guide you through targeting strategies, methods of vitreous excision in different retina/vitreous affections, vitreous membrane detachment, as well as the intravitreal application of medication. The simulator will capture a performance profile and your achievements will be evaluated. 16:00 EYESi technology, part 2 Markus Schill (Mannheim/D) 16:10 Deliberate Practice Frank Koch (Frankfurt/D) 16:20 Limitations of VR-Training Hans Hoerauf (Göttingen/D) 16:30 Guidelines based on expertise Hermann O. C. Gümbel (Ulm/D) 16:40 EYESi-Expertise Maya Müller (Lübeck/D) 16:50 VR in Aviation + Ophthalmology Klaus Lucke (Bremen/D) Hall 8 Sunday, 6 June Courses and Wetlabs Room Istanbul 16:00-17:30 WOC-C-37 14:00-15:30 WOC-AAD-C-24 Corneal Ulcers and Conjunctival Scarring. What to Do? Modern Pars Plana Vitrectomy DryLab (Advanced) Frank Koch (Frankfurt/D), Michael Janusz Koss (Frankfurt/D) Speakers: Hermann O. C. Gümbel (Ulm/D), Hans Hoerauf (Göttingen/D), Frank Koch (Frankfurt/D), Michael Janusz Koss (Frankfurt/D), Klaus Lucke (Bremen/D), Maya Müller (Lübeck/D), Markus Schill (Mannheim/D) Course fees: 100 c / 125 c The Virtual Reality Pars plana Vitrectomy DryLab was developed in order to realise evidence-based Chair: Elisabeth M. Messmer (Munich/D) Speakers: Arnd Heiligenhaus (Münster/D), Elisabeth M. Messmer (Munich/D) Course fees: 50 c / 75 c Instructions on diagnosis and treatment of problematic disease patterns The correct diagnosis and treatment of the different types of corneal ulcers portrays quite a challenge to the ophthalmologist. The differential diagnosis of conjunctival scarring, particularly in early stages, can also be problematic.

252 248 WOC 2010 Courses and Wetlabs Sunday, 6 June Sunday, 6 June st part of the course: Systematic outline of the clinic, the diagnostic approach, as well as the treatment in pathogenedependant, trophic and immunological corneal ulcers. 2 nd part of the course: Etiology, clinic, diagnosis and differential diagnosis as well as conservative and operative treatment options in conjunctival scarring. Hall 8 16:00-17:30 WOC-AAD-C-25 Visual Agnosia and Other Central Visual Impairments by neurologists, neuroradiologists, neuropsychologists and neuro-ophthalmologists. Adequate explanation of the cause for the visual symptoms and information about the realistic chances of spontaneous recovery in visual function are important elements of medical counselling. Where possible, the patients closest relatives should be included in these discussions as they too need to understand their specific problems. Salon 19 08:30-10:00 WOC-AAD-C-26 Complications in Plastic-Reconstructive and Aesthetic Surgery of the Lids and the Periorbital Region Chair: Ulrich Schiefer (Tübingen/D) Chair: Ulrich Schaudig (Hamburg/D) Speakers: Ulrich Schiefer (Tübingen/D) Course fees: 50 c / 75 c Visual agnosias disturb the visual recognition of e.g. objects (or related features), faces, places, paths or letters. They are caused by lesions of higher visual centers located in the parieto-temporal and occipito-temporal cortical visual areas or their associated subcortical connections. Given the wellvascularized tissue of the poststriate visual cortex, damage to vision in these regions is comparatively uncommon (found in approximately 2% of cases of posterior brain disease) and is often transient, managing to recover within a few weeks following onset. Agnosias are primarily a neurological entitiy. However, in case of visual agnosias the patient experiences disturbances in vision and will therefore primarily contact his eye doctor. A general ophthalmologist might be somewhat puzzled by the obvious discrepancy between normal morphological findings and peculiar visual symptoms. Quite often patients are threatened by this kind of visual disturbances and do not spontaneously report on their specific problems as they assign these as precursors of progressive mental derangement. Adequate explanation of the cause for the visual symptoms and information about the realistic chances of spontaneous recovery in visual function are important elements of medical counselling. Where possible, the patient s closests relatives should be included in theses discussion as the too need to understand the specific problems of the patient. The aim of this course is to make the ophthalmological colleagues sensitive for typical signs and symptoms of visual agnosias. Appropriate diagnostic and therapeutic care of such patients requires a multidisciplinary approach, including participation Speakers: Gerd Geerling (Würzburg/D), Uwe Peter Press (Trier/D), Ulrich Schaudig (Hamburg/D) Course fees: 50 c / 75 c Recognising and treating typical and crucial complications postoperatively and long-term following surgical procedures on the lids and the periorbital region This new theoretical course aims to provide an overview over possible complications according to the systematic of lid-surgical procedures. What are the causes of typical complications and how can they be prevented as early as in the preoperative planning stage by choosing the appropriate surgical approach? Which side-effects can occur that are not considered to be complications? On the other hand, what is considered an actual complication and how do I approach these patients? What are the indications for a surgical follow-up procedure? The management of complex developments and possible treatment will be addressed according to case studies. Salon 19 10:30-12:00 WOC-AAD-C-27 The Interdisciplinary Context of Multiple Sclerosis and Myasthenia Gravis Chair: Susanne Pitz (Mainz/D) Speakers: Martin Eicke (Idar-Obenstein/D), Susanne Pitz (Mainz/D) Course fees: 50 c / 75 c

253 WOC Sunday, 6 June 2010 The presentation of current diagnostic and treatment strategies in multiple sclerosis and myasthenia gravis. Patients suffering from multiple sclerosis (MS) and myasthenia gravis are often treated interdisciplinary: While the ophthalmologist often makes the first diagnosis, the neurologist generally initiates treatment. This often leads to differing diagnostic and treatment strategies in both areas of expertise. Does every patient with acute neuritis nervi optici (NNO) for example require neurological examination? Are MRIs (with or without contrast dye), clinical neurophysiology or lumbar punctures always absolutely necessary? How important is the intravenous steroid treatment in acute NNOs and other acute MS-episodes? What are the indicators for episode prevention with Interferon-ß? Which diagnostic strategy is most appropriate in response to suspected myasthenia? Is the Tensilon test absolutely necessary? How important are clinical neurophysiology and the identification of autoantibodies for acetylcholine receptors? Is a CT of the thorax generally imperative? Which surgical treatments are currently possible? In this course we would like to evaluate current concepts regarding both conditions and give rational decision-making advice on typical question. This course is aimed at professional as well as trainee colleagues. Fortunately German ophthalmologists display increasing interest in short-term and long-term work in third world countries, within the worldwide Vision 2020 programme, 'The Right To Sight'. This course is intended to prepare German ophthalmologists for imported conditions as well as broaden their knowledge of epidemiology, pathology, and the diagnostics of such conditions and to thus provide some all-round preparation for working abroad. Tips will be given on advising travelling patients on the risks associated with the individual regions as well as on the concrete risks for patients suffering from chronical ophthalmic conditions. The following conditions are considered the most crucial imported eye conditions: Trachoma, onchocerciasis, loiasis, leprosy, acute hemorrhaging conjunctivitis (Apollo), dengue fever, leishmaniasis, paratisoses like echinococcosis. Contacts for national and international organisations for international developmental cooperation (International none Governemental Organizations) will be mentioned briefly. Salon 19 16:00-17:30 WOC-AAD-C-29 Retinopathy of Prematurity Clinical Diagnosis and Treatment Chair: Heinrich Gerding (Olten/CH) Sunday, 6 June Courses and Wetlabs Salon 19 14:00-15:30 WOC-AAD-C-28 Speakers: Arnd Gandorfer (Munich/D), Heinrich Gerding (Olten/CH) Ophthalmic Conditions in Third World countries / Ophthalmic Travel Medicine Chair: Volker Klauss (Munich/D) Speakers: Volker Klauss (Munich/D), Markus Schulze Schwering (Ahlen/D) Course fees: 50 c / 75 c Motivation and further training for participants in the field of ophthalmic conditions in the tropics. Due to the rise in global travel of tourists and businesspeople as well as an increase in international migration, these days Germany is faced with more and more cases of ophthalmic conditions that are typically associated with tropical and subtropical regions. Course fees: 50 c / 75 c Optimisation of the ophthalmologic provisioning of premature infants The course is intended to train participants for providing optimized clinical care for premature children. The programme covers the necessary knowledge on etiology, pathophysiology and classification of retinopathy of prematurity. Current international guidelines for performing screening examinations of premature babies will be presented and compared. Adequate examination techniques of premature children and documentation of clinical findings will be presented as well as current and future treatment approaches including laser photocoagulation, cryotherapy, anti- VEGF injections, cerclage and vitrectomy.

254 250 WOC 2010 Courses and Wetlabs Monday, 7 June Monday, 7 June 2010 Room Sydney 08:30-10:00 WOC-C-30 Sutureless = Happiness? Pearls and Pitfalls in Transconjunctival Vitreoretinal Surgery Chair: Lars-Olof Hattenbach (Ludwigshafen/D) Speakers: Carl-Friedrich Arndt (Reims/F), Stefan Dithmar (Heidelberg/D), Nicolas Feltgen (Göttingen/D), Lars-Olof Hattenbach (Ludwigshafen/D), Maya Müller (Lübeck/D), Siegfried Priglinger (Linz/A) Course fees: 50 c / 75 c In sutureless vitreoretinal surgery, one must often deal with specific problems usually not encountered with conventional vitrectomy systems. This course will be highlighted by interactive case discussions as well as experienced faculty providing pitfalls and pearls of various sutureless transconjunctival vitrectomy systems. Focus will be on specific technical issues, typical or unsuspected difficulties, innovative treatment approaches, combined microincision cataract surgery, and complicating patient variables. Participants are encouraged to be a part of the discussion by providing opinions on different treatment avenues. glaucoma probability score (GPS). The validity of the HRT findings as the gold standard of three dimensional papilla analysis is supported by the data of high resolution optical coherence tomography (spectral OCT): localised reflectivity loss through nerve fiber bundle loss, which are detected by HRT, correlate with the thinning of the nerve fiber layer in high resolution spectral OCTs. 10:30 The HRT in glaucoma research Balwantray C. Chauhan (Halifax/CDN) 10:45 The development of the Spectral OCT Kester Nahen (Heidelberg/D) 11:00 Spectral OCT for the Evaluation of the lamina cribrosa Claude Burgoyne (Portland/USA) 11:15 Clinical use of HRT and Spectral OCT in Glaucoma Reinhard O. W. Burk (Bielefeld/D) Room Sydney 14:00-15:30 WOC-C-32 Laser Treatment of Retinal Diseases Room Sydney 10:30-12:00 WOC-C-31 HRT and Spectral OCT in Glaucoma Reinhard O. W. Burk (Bielefeld/D), Claude Burgoyne (Portland/USA), Balwantray C. Chauhan (Halifax/CDN) Speakers: Claude Burgoyne (Portland/USA), Reinhard O. W. Burk (Bielefeld/D), Balwantray C. Chauhan (Halifax/CDN), Kester Nahen (Smithfield/USA) Course fees: 50 c / 75 c This course discusses and explains HRT glaucoma diagnostics. Structural parameters like papilla size, neuroretinal rim area, excavation can be captured. Macro-papillae with large excavation areas and depth values must possess at least the neuroretinal rim parameters of normal papillae. Discriminant functions, which can estimate the probability of the existence of glaucomatous visual field defects, will be assessed (FSM, RB). One option of analysis without interactive examination is the Chair: Gabriele E. Lang (Ulm/D) Speakers: Francesco Bandello (Milano/I), Hans Hoerauf (Göttingen/D), Gabriele E. Lang (Ulm/D) Course fees: 50 c / 75 c Laser photocoagulation is still the gold standard in the treatment of several retinal diseases. Diabetic retinopathy and retinal vein occlusions are discussed in detail concerning diagnostic procedures, staging, indication and techniques of laser treatment. Other diseases like retinal holes, Coats disease, macroaneurysm, optic pits with serous detachment of the retina, central serous chorioretinopathy and peripheral hemorrhagic exudative chorioretinopathy are presented. The most common mistakes in laser treatment are also discussed. Finally the combination of laser and pharmacological treatment of retinal diseases are described. 14:00 Laser Treatment of Diabetic Retinopathy, Vein Occlusions and Other Diseases Gabriele E. Lang (Ulm/D)

255 WOC Monday, 7 June :40 Combination of Laser with Pharmacological Treatment Francesco Bandello (Milano/I) 15:05 Common Mistakes in Laser Treatment Hans Hoerauf (Göttingen/D) Room Sydney 16:00-17:30 WOC-C-33 Blepharoplasty of the Upper and Lower Eye Lids: Innovative Concepts for Excellent Surgical Results Room Istanbul 14:00-15:30 WOC-C-34 Wetlab Glaucoma Surgery for Beginners Chair: Norbert Pfeiffer (Mainz/D) Speakers: Walter Konen (Cologne/D), Norbert Pfeiffer (Mainz/D), Lutz E. Pillunat (Dresden/D), Manfred Tetz (Berlin/D), Hagen Thieme (Mainz/D), Jochen Wahl (Mainz/D) Course fees: 100 c / 125 c Monday, 7 June Courses and Wetlabs Chair: Klaus G. Riedel (Munich/D) Speakers: Hans-Werner Meyer-Rüsenberg (Hagen/D), Klaus G. Riedel (Munich/D) Course fees: 50 c / 75 c Blepharoplasty for the correction of upper and lower dermatochalasis is, with increasing tendencies, the most popular form of cosmetic surgery. The success rate with regards to aesthetics and function, depends on the preoperatve analysis of diagnostic findings, individual choice of inscision, and an atraumatic surgical technique. Independent from the chosen equipment, scalpel, high frequency needle or laser, modern blepharoplasty is comprised of more than the mere removal of excess skin. All types of tissue in the eyelids may need to be tackled: skin, muscle, lid band, orbital septum, and orbital fat compartments. The crucial part is what remains on the lid, rather than what is removed. The correct position oft the scin crease determines the method of surgical lid closure. Individual characteristics have to remain to achieve excellent surgical results. Despite all the advances of medication-based glaucoma treatment, surgical intervention remains inevitable for many glaucoma patients. This course teaches the fundamentals of preparation technique, in particular of penetrating methods. The non-penetrating methods, however, shall be addressed as well. The flap preparation in trabeculectomy, iridectomy as well as trabeculotomy will be practised on the pig's eye, after a brief theoretical introduction. Furthermore deep flap preparation during deep sclerectomy shall be demonstrated. This course is aimed at beginners in glaucoma surgery as well as offering the opportunity to revise and expand upon previously gained knowledge on the subject. Room Istanbul 16:00-17:30 WOC-C-35 Wetlab Glaucoma Surgery for the Advanced Chair: Norbert Pfeiffer (Mainz/D) Speakers: Walter Konen (Cologne/D), Norbert Pfeiffer (Mainz/D), Lutz E. Pillunat (Dresden/D), Manfred Tetz (Berlin/D), Hagen Thieme (Mainz/D), Jochen Wahl (Mainz/D) Course fees: 100 c / 125 c This course is aimed at the more experienced glaucoma surgeon. It expands upon the basics taught in the beginners' course. Non-penetrating methods like sclerectomy and viscocanalostomy will be demonstrated and practised. Additionally the handling of implants like the Ahmed Valve and Molteno Implants will be demonstrated.

256 252 WOC 2010 Courses and Wetlabs Monday, 7 June Monday, 7 June 2010 Room 43 08:30-10:00 WOC-C-38 Update on Tonometry Chair: Harry Mark (North Haven/USA) Speakers: Harry Mark (North Haven/USA) Course fees: 50 c / 75 c Conclusion a. Nomograms b. Flow-chart c. Which tonometer is best. d. The future Room 43 10:30-12:00 WOC-C-39 A Flexible Ring in a Corneal Pocket for the Treatment of Keratoconus and Myopia Synopsis: Year after year patents are issued for new tonometers, each claiming to be more accurate and comfortable, though none measures true intra-ocular pressure. This course will present the latest tonometers and the evidence concerning the physical parameters of the eye that influence all tonometric reading. Clinical examples of their application in myopia, normal-tension glaucoma, and ocular hypertension will illustrate their utility. Albert Daxer (Linz/A), Haifa Mahmood (Manama/BRN) Speakers: Albert Daxer (Linz/A), Millicent Grim (Dubai/UAE), Haifa Mahmood (Manama/BRN), Ali Rahji (Riyadh/SA), Pavel Studeny (Sokolov/CZ) Course fees: 50 c / 75 c Objective: At the end of this course attendees will be able to apply tonometric information more confidently and reliably in the diagnosis and management of glaucoma, and decide when to obtain ancillary data, such as corneal thickness. The course will also help attendees choose a tonometer. Introduction a. Many U.S. patent applications for new tonometers annually. b. Brief history. Helmholtz s first tonometer. c. Need for standard quantification Geometry and physics a. Size and shape. 1. Acrophthalmos. 2. Brachophthalmos. b. Envelope. 1. Cornea 2. Sclera. 3. Optic foramen. c. Contents. 1. Aqueous. 2. Vitreous. d. Pressure from within (IOP). e. Pressure from without the tonometer s f. Imbert-Fick law: the elusive mmhg Objectives: Attendees will understand corneal intrastromal implantations surgery (CISIS) using a flexible, continous ring implant placed within a closed corneal pocket for the btreatment of keratoconus and myopia. Description: The course will review clinically important aspects of CISIS including surgical techniques, inclusion criteria, and nomograms, complications and side effects, case studies and statistical data. The surgical techniques are demonstrated via educational videos. Room 43 14:00-15:30 WOC-C-40 Modern Surgery of the Posterior Segment of the Eye Necessity of ancillary data a. Central corneal thickness b. Corneal curvature c. Ocular volume (axial length, A and B scans) d. Elasticity (scleral thickness) e. Corneal hysteresis f. Terminology and reimbursement Clinical application a. Glaucoma suspect, risk factors. b. Normal/low-tension glaucoma c. Ocular hypertension d. Gender differences e. Myopia and glaucoma Joaquin Barraquer (Barcelona/E), Rafael Barraquer (Barcelona/E), Jeroni Nadal (Barcelona/E) Speakers: Joaquin Barraquer (Barcelona/E), Rafael Barraquer (Barcelona/E), Javier Elizalde (Barcelona/E), Jeroni Nadal (Barcelona/E) Course fees: 50 c / 75 c In this 90 minutes multi-authored Course the following topics are discussed:

257 WOC Monday, 7 June ) Surgical management of proliferating vitreoretinopathy with special emphasis on different techniques of peeling of the epiretinal and retroretinal membranes, the use of biological colorants and intraocular tamponnades. 2) Presentation of an update of modern surgical techniques in macular surgery, different options, use of biologic colorants and indications for peeling of the internal limiting membrane. 3) Biopsy techniques for cytogenic studies of uveal melanoma, especially cytogenic phenotyping, an universally accepted procedure in ocular oncology to evaluate the risk of metastatic desease in uveal melanoma. Different approaches for microsurgical procedures to achieve the obtention of adequate tumor samples are described in detail. 4) Conservative resection of uveal melanoma is reviewed on the basis of personal experience with different techniques of local conservative resection as a valid option in the management of selected cases of uveal melanoma. 5) Finally: Ligature of afferent vessel for retinal haemangioma, a new surgical technique for management of yuxtapapillar capillar haemangioma is described. Ligature of the afferent artery to the tumor has been performed and proved to be effective to reduce the volume of the haemangioma and exudative activity at the level of the posterior pole. Images from the different authors personal casuistics will be shown to illustrate the presentations. Ligature of afferent vessel for retinal hemangioma Jeroni Nadal (Barcelona/E) Room 43 16:00-17:30 WOC-C-41 Complications in Vitreoretinal Surgery David S. H. Wong (Hong Kong/HK), Paul Sullivan (London/UK), Karl Ulrich Bartz-Schmidt (Tübingen/D) Speakers: George William Aylward (London/UK), Keith Barton (London/UK), Karl Ulrich Bartz-Schmidt (Tübingen/D), Rubens Belfort, Jr. (São Paulo/BR), Carlos Pavesio (London/UK), Paul Sullivan (London/UK), Charles P. Wilkinson (Baltimore/USA), David S. H. Wong (Hong Kong/HK) Course fees: 50 c / 75 c Per operative Complications of scleral buckling surgery Paul Sullivan (London/UK) Retinal Trauma from vitreoretinal surgery Karl Ulrich Bartz-Schmidt (Tübingen/D) Inflammation and Infection after vitreoretinal surgery Rubens Belfort, Jr. (São Paulo/BR) Glaucoma after vitreoretinal surgery Keith Barton (London/UK) Complications of tamponade agents David S. H. Wong (Hong Kong/HK) Complications of vitrectomy for diabetic retinopathy Charles P. Wilkinson (Baltimore/USA) Monday, 7 June Courses and Wetlabs Conservative resection of uveal melanoma Rafael Barraquer (Barcelona/E) Biopsy techniques for cytogenic study of uveal Melanoma Javier Elizalde (Barcelona/E) Macular Surgery Joaquin Barraquer, Jeroni Nadal (Barcelona/E) Surgical management of proliferating vitreoretinopathy Jeroni Nadal (Barcelona/E)

258 254 WOC 2010 Courses and Wetlabs Tuesday, 8 June Tuesday, 8 June 2010 Hall 10 10:30-12:00 WOC-C-61 SD-OCT and AMD Treatment and Follow Up Chair: Gabriel J. Coscas (Créteil/F) Speakers: Gabriel J. Coscas (Créteil/F), Srinivas R. Sadda (Los Angeles/USA), Gisèle Soubrane (Créteil/F), Giovanni Staurenghi (Milano/I), Sebastian Wolf (Bern/CH) Salon 11/12 14:00-15:30 WOC-C-63 Femtosecond (FS) Course in Ophthalmology Chair: M. Garcia-Marcos (Malaga/E) Speakers: Federico A. Aliste (Sevilla/E), M. Garcia-Marcos (Torre del Mar/E), Rafael Rubio (Malaga/E), Jose V. Rodriguez (Las Palmas/E), Alberto Villarrubia (Córdoba/E) Course fees: 50 c / 75 c Course fees: 50 c / 75 c 10:30 Principles of SD-OCT and advantages in AMD Florence Coscas (Créteil/F) 14:00 Indications and advantajes with FS Federico Alonso Aliste (Sevilla/E) 10:45 Differences of the SD-OCTs Sebastian Wolf (Bern/CH) 14:10 Lasik with FS Rafael Rubio (Malaga/E) 11:00 SD-OCT characteristics of choroidal neovascularization (Before, during and after treatment) Giovanni Staurenghi (Milano/I) 11:15 SD-OCT analysis of Outer retinal layers changes (hyper-reflective dots: prognostic value during management of exudative AMD) Gabriel J. Coscas (Créteil/F) 11:30 Polypoidal Vascular choroidopathy and AMD Gisèle Soubrane (Créteil/F) 14:20 Intracorneal rings with FS Jose Vicente Rodriguez (Las Palmas/E) 14:30 Arcuates with FS M. Garcia-Marcos (Malaga/E) 14:40 Keratoplasty with FS Alberto Villarrubia (Córdoba/E) Room Istanbul 11:45 Morphology and structure of retinal pigment epithelium detachments in AMD (Before, during and after treatment) Bruno Lumbroso (Roma/I) 08:30-10:00 WOC-C-42 Wetlab Glaucoma Drain Implants Chair: Hagen Thieme (Mainz/D) Speakers: Thomas S. Dietlein (Düsseldorf/D), Hagen Thieme (Mainz/D), Christian K. Vorwerk (Magdeburg/D) Course fees: 100 c / 125 c This course is aimed at experienced glaucoma surgeons. Glaucoma implants are gaining more and more acceptance as part of the repertoire of the glaucoma surgeon. This course shall introduce the most important models (Molteno, Ahmed Valve, and Baerveldt Implant) as well as convey skills for safe implantation. Furthermore, alongside the episcleral models, chamber angle models will be addressed and their practical application shall be practised.

259 WOC Tuesday, 8 June 2010 Room Istanbul 10:30-12:00 WOC-C-43 Wetlab Phaco Course for Beginners Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick (Bochum/D) Speakers: Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick (Bochum/D), Thomas S. Dietlein (Düsseldorf/D), Hagen Thieme (Mainz/D), Christian K. Vorwerk (Magdeburg/D) outline the appropriate techniques for complex circumstances like narrow pupils, synechiae, hard lenses, mature and hypermature lenses, previous operations, and loose zonulae. The ideal procedure will be demonstrated both theoretically as well as by means of video clip examples. Avoidance and management of generic complications like tear of anterior capsule, capsular rupture, vitreous prolaps, zonular tear-off, loss of nucleus, IOL luxation, corneal burn, iris defects, and expulsive bleeding will be discussed and practised. This course is aimed at advanced phaco-surgeons. Room Istanbul Tuesday, 8 June Courses and Wetlabs Course fees: 100 c / 125 c 16:00-17:30 WOC-C-45 This course will outline the individual stages of phacoemulsification surgery in a step-by-step approach. In order to avoid and adjust complicated surgical procedures, individual viewpoints and approaches of the best respective methods will be presented. Wetlab Biaxial and Microcoaxial Phacoemulsification Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick (Bochum/D) The incision types and architecture as well as their relevance, dependant on the individual circumstances, will be addressed. Possible measures to deepen the anterior chamber, widen the pupil, capsulorhexis techniques, hydrodissection and hydrodelineation will be introduced. The different techniques of nucleusprocessing (e.g. Divide and Conquer, chop-techniques) will be addressed regarding the respective situations. There will be an introduction of the common intraocular lenses and their implant characteristics as well as the rules of conduct in complicated surgery progressions. Some advice will be given as to how to avoid decentration of the lens, lens defects and cataracta secundaria. Room Istanbul 14:00-15:30 WOC-C-44 Wetlab Phaco Course for the Advanced Chair: Gerd U. Auffarth (Heidelberg/D) Speakers: Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick (Bochum/D), Ekkehard Fabian (Rosenheim/D), Helmut Höh (Neubrandenburg/D), Gangolf Sauder (Stuttgart/D) Course fees: 100 c / 125 c This course shall provide user information for biaxial as well as microcoaxial phacoemulsification technique, various phacoemulsification equipment and techniques, instruments, and appropriate micro-incision-intraocular lenses. Following an introduction to the underlying technologies and relevant instruments, the diagnosis, aims, and limits of biaxial and microcoaxial phacoemulsification will be discussed. After reviewing the advantages and disadvantages of the different procedures, we will explain in detail the practical implementations of bi- and microcoaxial phacoemulsification including the necessary instruments, implant techniques and clinical findings of respective foldable lenses. Intraand postoperative complications as well as their prevention and management will be addressed. Speakers: Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick (Bochum/D), Helmut Höh (Neubrandenburg/D), Gangolf Sauder (Stuttgart/D) Course fees: 100 c / 125 c The generic problems of advanced surgeons will be presented in theory and practice. After an introduction of the individual preferred techniques of the course administrators the course will move on to

260 256 WOC 2010 Courses and Wetlabs Tuesday, 8 June Tuesday, 8 June 2010 Room 42 08:30-10:00 WOC-C-46 Achieving Excellence: Teamwork in Cataract and Refractive Surgery Claes Feinbaum (Lund/S), Sudhir Patel (Alicante/E), Ewa Mrukwa-Kominek (Katowice/PL) Speakers: Claes Feinbaum (Lund/S), Ewa Mrukwa-Kominek (Katowice/PL), Sudhir Patel (Alicante/E) Course fees: 50 c / 75 c Room 42 10:30-12:00 WOC-C-47 Corneal Imaging Rudolf F. Guthoff (Rostock/D), Edward Wylegala (Katowice/PL), Christophe Baudouin (Paris/F) Speakers: J. Oscar Croxatto (Buenos Aires/RA), Rudolf F. Guthoff (Rostock/D), Pedram Hamrah (Boston/USA), Bartlomiej J. Kaluzny (Bydgoszcz/PL), Antoine Labbé (Paris/F), Edward Wylegala (Katowice/PL), Christophe Baudouin (Paris/F) 08:30 Introduction Key topics and chief aims of the course Sudhir Patel (Alicante/E) 08:35 Modern Cataract Surgery: Review of most popular techniques today & top tips to avoid complications Ewa Mrukwa-Kominek (Katowice/PL) 08:45 Modern Refractive Surgery: Review of most popular techniques today & top tips to avoid complications Ewa Mrukwa-Kominek (Katowice/PL) 08:55 The Why, What and Which of Pre-operative Assessment in Cataract Surgery: Referral criteria, patient education to avoid complications, essentials of clinical assessment, grading key clinical markers Claes Feinbaum (Lund/S) Course fees: 50 c / 75 c 10:30 Corneal innervation new insights with confocal in-vivo microscopy Rudolf F. Guthoff (Rostock/D) 10:40 Application of confocal microscopy in infectious keratopathies Antoine Labbé (Paris/F) 10:50 Comparison of confocal and histopathological images J. Oscar Croxatto (Buenos Aires/RA) 11:00 Spectral vs time- domain OCT applying in different Descemet membrane corneal pathology Edward Wylegala (Katowice/PL) 09:05 The Why, What and Which of Pre-operative Assessment in Refractive Surgery Surgery: Referral criteria, patient education to avoid complications, essentials of clinical assessment, grading key clinical markers Claes Feinbaum (Lund/S) 09:15 Essentials for Success after cataract surgery: Patient education = Patient satisfaction Sudhir Patel (Alicante/E) 11:10 Swept source OCT for quantitative assessment of the cornea Bartlomiej J. Kaluzny (Bydgoszcz/PL) 11:20 In Vivo Imaging and Quantification of Corneal Inflammation Pedram Hamrah (Boston/USA) Room 42 09:30 Essentials for Success after refractive surgery: Patient education = Patient satisfaction Sudhir Patel (Alicante/E) 14:00-15:30 WOC-C-48 Current Concepts in the Management of Retinal Vessel Occlusion 09:45 Wind up: Interactive question & answer session Claes Feinbaum, Sudhir Patel (Lund/S, Alicante/E) Chair: Lars-Olof Hattenbach (Ludwigshafen/D)

261 WOC Tuesday, 8 June 2010 Speakers: Stefan Dithmar (Heidelberg/D), Nicolas Feltgen (Göttingen/D), Lars-Olof Hattenbach (Ludwigshafen/D), Siegfried G. Priglinger Jr. (Linz/A) Course fees: 50 c / 75 c Over the past years, various novel treatment strategies have expanded our options in the management of retinal vessel occlusion. However, there is still no consensus among ophthalmologists about the optimal approach. This course provides an overview of the histopathologic and clinical features of retinal vein and retinal artery occlusion. Current concepts such as the intravitreal administration of anti-vegf (vascular endothelial growth factor) drugs, surgical techniques including the cannulation of retinal vessels, or the use of thrombolytic or anticoagulant agents are reviewed to determine whether these treatments are likely to improve major clinical outcomes. Case presentations will serve as an open forum for an interactive group discussion with regards to complicated clinical scenarios and treatment decisions. Room 43 08:30-10:00 WOC-C-49 Current Management of Diabetic Macular Edema Chair: Hans Hoerauf (Göttingen/D) Speakers: Nicole Eter (Bonn/D), Nicolas Feltgen (Göttingen/D), Hans Hoerauf (Göttingen/D), Johann Roider (Kiel/D), Georg Spital (Münster/D) Room 43 10:30-12:00 WOC-C-50 Management of the Ruptured Globe Arne Viestenz (Magdeburg/D), Ferenc Kuhn (Birmingham/USA) Speakers: Gregorio Gabela (Quito/EC), Ferenc Kuhn (Birmingham/USA), David Pelayes (Buenos Aires/RA), Wolfgang F. Schrader (Nürnberg/D), Arne Viestenz (Magdeburg/D) Course fees: 50 c / 75 c Globe ruptures have a very unfortunate prognosis. A prominent hyposphagma or monocle hematoma often masks the sheltered globe rupture. Quick surgical dressing is crucial alongside the assurance of the diagnosis, as there is a threat of posttraumatic endophthalmitis and expulsive bleeding. In the first part this course will present guidance in diagnostic decision making and techniques of primary wound treatment as well as avoidable pitfalls. There will be a discussion of surgery videos of limbus-parallel ruptures, ruptures behind the straight eye muscle, and atypical ruptures. Recommendations regarding the prevention of posttraumatic endophthalmitis will be provided. The second part will address the controversies of primary vitrectomy (proactive regime) and preemptively indenting surgery, as well as the ideal time for surgical intervention, and the management of secondary complications. 10:30 Surgery of traumatic macular hole David Pelayes (Buenos Aires/RA) Tuesday, 8 June Courses and Wetlabs Course fees: 50 c / 75 c The diabetic macular edema are one of the most crucial challenges of clinical everyday life and is bound to gain even more significance in the future, due to the continuous rise cases of diabetis mellitus. While vitrectomy and the introduction of the intravitreal injection of Triamcinolon and Anti-VEFG medication significantly broadened the therapeutic spectrum, straight-forward recommendations are still lacking. Laser treatment is still considered the standard treatment for focal as well as diffuse forms. The lecturers shall present the different therapeutic approaches in detail, evaluate their significance according to current research and discuss diagnoses and determination in case studies with the participants. 10:40 Timing of surgery in ruptured globes Wolfgang F. Schrader (Nürnberg/D) 10:50 Primary wound repair Gregorio Gabela (Quito/EC) 11:00 Management of secondary complications after globe rupture Arne Viestenz (Magdeburg/D) 11:10 Retinal surgery after globe rupture Ferenc Kuhn (Birmingham/USA)

262 258 WOC 2010 Courses and Wetlabs Tuesday, 8 June Tuesday, 8 June 2010 Room 43 14:00-15:30 WOC-C-51 Challenging Cases in Anterior Segment Surgery Chair: Gerhard K. Lang (Ulm/D) Speakers: Jochen Kammann (Davos/CH), Gerhard K. Lang (Ulm/D), Duy-Thoai Pham (Berlin/D), Peter Wagner (Ulm/D) Room 43 16:00-17:30 WOC-C-52 Blepharoplasty II Complication, Analysis, Management, and Prevention Strategies Chair: Hans-Werner Meyer-Rüsenberg (Hagen/D) Speakers: Hans-Werner Meyer-Rüsenberg (Hagen/D), Klaus G. Riedel (Munich/D) Course fees: 50 c / 75 c Course fees: 50 c / 75 c Challenges in anterior segment surgery can be both extractive and refractive! Even with the most modern phaco techniques there are occasionally still complicated anterior segment situations, which demand the modification of the standard techniques and the preoperative planning of operative strategies. Topics: Luxatio (ICCE, VKL) or Subluxatio lentis ( slow-motion phaco, stabilisation of the capsular bag), dense cataracts ( catarocks ) Explantation/recentration and sutural fixation of IOLs Cataract surgery in combination with silicon oil drainage or perforating keratoplasty In the Federal Republic of Germany an estimated 10,000 blepharoplasties are done each year by doctors of various fields. Hence both surgically as well as conservatively active ophthalmologists will be faced with the issues arising from less ideal blepharoplasties. In case studies, this course will present the possible complications, followed by an analysis of the respective causes as well as possible management suggestions where they would be applicable. Prevention strategies that can ensure successful blepharoplasty will be discussed. Room 44 14:00-15:30 WOC-C-54 Iris hooks, capsular tension ring, iris diaphragm, aniridia lens Watch the signs: Pupillary-snap Sign, Spiderweb Sign, Argentina-flag Sign, Bounce Sign, Misled Fluid Sign Iris sutures in traumatic mydriasis (iris sphincter suture), iridodyalisis (refixation sutures) Anterior vitrectomy technique and opticcapture techniques Cataract surgery combined with pars plana vitrectomy Cyclodialysis occlusion The Optic Disc Funduscopy, Perimetry, Laser Scanning Ophthalmoscopy Chair: Alexander Friedrich Scheuerle (Heidelberg/D) Speakers: Andreas G. Böhm (Radebeul/D), Alexander Friedrich Scheuerle (Heidelberg/D), Eckart Schmidt (Radebeul/D) Course fees: 50 c / 75 c Course, video sequences, and interactive discussion This interactive workshop illustrates different pathologies of the optic disc and their specific diagnostic profile with a focus on glacoma.

263 WOC Wednesday, 9 June 2010 Oslo 13:00-14:30 WOC-C-55 Management of Vascular Ocular Emergencies Chair: Nicolas Feltgen (Göttingen/D), Hansjürgen T. Agostini (Freiburg/D) Speakers: Hansjürgen T. Agostini (Freiburg/D), Nicolas Feltgen (Göttingen/D), Andreas Hetzel (Freiburg/D), Wolf A. Lagrèze (Freiburg/D) Hall 10 08:30-10:00 WOC-C-56 Refractive Lens Surgery Chair: Josef Wolff (Heppenheim/D) Speakers: Stephan Kohnen (Aachen/D), Thomas Kohnen (Frankfurt/D), Anja Liekfeld (Potsdam/D), Walter Sekundo (Marburg/D), Josef Wolff (Heppenheim/D) Wednesday, 9 June Courses and Wetlabs Course fees: 50 c / 75 c Course fees: 50 c / 75 c The goal of this course is to discuss the most frequent vascular emergencies of the eye and visual pathways with regard to symptoms, diagnosis and state of the art therapies from both an ophthalmological and a neurological point of view. Starting with insights as to how patients perceive vascular malfunction, the presentation will cover transitory ischemia of the retina, occlusion of retinal veins and arteries, anterior ischemic neuropathy, apoplexy of the central visual system, and oculomotor emergencies. This systematic course will include interactive elements and will focus on the interdisciplinary management of these patients. 13:00 Introduction Hansjürgen T. Agostini (Freiburg/D) 13:10 More than just seeing worse Symptoms Andreas Hetzel, Wolf A. Lagrèze (Freiburg/D) 13:20 Retinal vein occlusions Nicolas Feltgen (Göttingen/D) 13:30 Retinal artery occlusions Hansjürgen T. Agostini (Freiburg/D) Within the scope of refractive surgery more and more surgical procedures of the lens are being developed. This involves modern intraocular lenses, which are implanted either underneath the natural lens (phaco IOL) or following its extraction (RLA), depending on the respective diagnosis. Particular attention will be paid to diagnosis-specific and individual feasibilities in high myopia, hyperopia, astigmatism, and presbyopia, or their possible combinations. The individual procedures and lens types will be presented and evaluated and particularly phaco IOLs multifocal lenses toric IOLs. will be covered. Refractive lens surgery is also increasingly used in cataract surgery. The respective options that arise from the choice of modern IOLs will also be evaluated in combination with cornea procedures. In particular this will cover: multifocal lenses toric IOLs Astigmatism correction by choice of incision and additional cornea procedures 13:40 AION, Tersons Syndrome, Motility disorders Wolf A. Lagrèze (Freiburg/D) 13:50 Central ischemia of the visual system Andreas Hetzel (Freiburg/D)

264 260 WOC 2010 Courses and Wetlabs Wednesday, 9 June Wednesday, 9 June 2010 Room 42 08:30-10:00 WOC-C-57 Laser in Retinal Diseases Dos and Donts Hans Hoerauf (Göttingen/D), Sebastian Wolf (Bern/CH), Peter K. Kaiser (Cleveland/USA) Speakers: Diana Do (Baltimore/USA), Peter K. Kaiser (Cleveland/USA), Darius Moshfeghi (Stanford/USA), Johann Roider (Kiel/D), Gisèle Soubrane (Créteil/F), Sebastian Wolf (Bern/CH) Course fees: 50 c / 75 c Room 42 10:30-12:00 WOC-C-58 Current Trends in Management of Retinopathy of Prematurity Venkatapathy Narendran (Coimbatore/IND), Rajvardhan Azad (New Delhi/IND), Mangat Dogra (Chandigarh/IND) Speakers: Rajvardhan Azad (New Delhi/IND), Mangat Dogra (Chandigarh/IND), Venkatapathy Narendran (Coimbatore/IND), Kalpana Narendran (Coimbatore/IND), Parag K. Shah (Coimbatore/IND) DRCR.net laser results Diana Do (Baltimore/USA) Pattern scan laser technology Darius Moshfeghi (Stanford/USA) Course fees: 50 c / 75 c 10:30 Introduction Venkatapathy Narendran (Coimbatore/IND) PDT-Combination therapy for AMD Peter K. Kaiser (Cleveland/USA) Laser photocoagulation in choroidal neovascularization: is there still an indication? Gisèle Soubrane (Créteil/F) SRT, temperature controlled laser, sublethal laser effectes, scanning laser systems Johann Roider (Kiel/D) Combination therapy for DME Sebastian Wolf (Bern/CH) 10:35 Pathogenesis and Classification Parag K. Shah (Coimbatore/IND) 10:45 Risk factors & Screening Venkatapathy Narendran (Coimbatore/IND) 10:55 Laser in ROP: Indications & Technique Mangat Dogra (Chandigarh/IND) 11:05 Surgical management of ROP Rajvardhan Azad (New Delhi/IND) 11:15 Rehabilitaion of ROP Kalpana Narendran (Coimbatore/IND)

265 WOC Wednesday, 9 June 2010 Room 43 08:30-10:00 WOC-C-59 Introducing Pediatric Low Vision in Ophthalmology Practice Galton Carvalho Vasconcelos (Belo Horizonte/BR), Jill Keeffe (Melbourne/AUS) Speakers: Galton Carvalho Vasconcelos (Belo Horizonte/BR), Lucienne Chaves Fernandes (Belo Horizonte/BR), Jill Keeffe (Melbourne/AUS), Linda Lawrence (Salina/USA) Course fees: 50 c / 75 c Synopsis: This course will focus on the basic concepts of low vision in children, especially in infancy. It will review definitions in low vision, early identification and assessment, the need of a multidisciplinary team and aspects of the inclusion of children with low vision. Two important themes are going to be reviewed: retinopathy of prematurity and congenital glaucoma. and questions will be encouraged at the end. The course is directed to general ophthalmologists and pediatric ophthalmologists. By the end of the course, attendees will be able to learn (1) basic concepts of pediatric of low vision, (2) early and effective strategies to assess the principal causes of low vision in children at an office setting, (3) the benefits of early intervention in pediatric low vision, (4) the importance of continuous multidisciplinary communication among different specialists. 08:30 Early Identification and assessment Linda Lawrence (Charleston/USA) 08:50 Multidisciplinary team Galton Carvalho Vasconcelos (Belo Horizonte/BR) 09:00 Inclusion Jill Keeffe (Melbourne/AUS) Room 43 13:00-14:30 WOC-C-60 Diagnosing Melanocytic Tumours of the Uvea: New Techniques and Guidelines for Referral Michael Giblin (Sydney/AUS), Tero Kivelä (Helsinki/FIN), Michael H. Foerster (Berlin/D) Speakers: James Augsburger (Cincinnati/USA), Norbert Bornfeld (Essen/D), Michael H. Foerster (Berlin/D), Michael Giblin (Sydney/AUS), Tero Kivelä (Helsinki/FIN), Carol L. Shields (Philadelphia/USA) Course fees: 50 c / 75 c 13:00 The frequency and prognosis of melanocytic tumours of the uvea relative to size James Augsburger (Cincinnati/USA) 13:10 How large are small uveal melanomas when they first metastasise? Tero Kivelä (Helsinki/FIN) 13:20 How to recognise a small melanocytic lesion which may grow, and when to refer? Carol L. Shields (Philadelphia/USA) 13:30 Optical coherence tomography and autofluo-rescence in assessing melanocytic tumours Michael H. Foerster (Berlin/D) 13:40 When, why and how to biopsy a small melanocytic tumour? Norbert Bornfeld (Essen/D) 13:50 A small melanocytic tumour which needs treatment: radiotherapy or thermotherapy? Michael Giblin (Sydney /AUS) Wednesday, 9 June Courses and Wetlabs 09:10 Retinopathy of Prematurity Jill Keeffe (Melbourne/AUS) 09:20 Congenital Glaucoma Lucienne Chaves Fernandes (Belo Horizonte/BR) 09:30 Linda Lawrence, Galton Carvalho Vasconcelos, Jill Keeffe, Lucienne Chaves Fernandes (Charleston/ USA, Belo Horizonte/BR, Melbourne/AUS)

266 262 WOC 2010 Courses and Wetlabs Wednesday, 9 June Wednesday, 9 June 2010 Salon 11/12 10:30-12:00 WOC-C-62 Present Options in the Management of Primary Rhegmatogenous Retinal Detachment: Teaching Course with International Faculty Ingrid Kreissig (Mannheim/D), George William Aylward (London/UK), Harvey Lincoff (New York/USA) Speakers: George William Aylward (London/GB), Thorsten Böker (Dortmund/D), Ingrid Kreissig (Mannheim), Harvey Lincoff (New York/USA), William F. Mieler (Chicago/USA), Shuichi Yamamoto (Sakura/J) Course fees: 50 c / 75 c 10:30 1. Diagnostics: 1.1. The 4 Rules to find the primary break Ingrid Kreissig (Mannheim/D) 10: Lattice degeneration and breaks in the fellow eye: What to do or not to do? George William Aylward (London/GB) 10:50 2. Minimal E.O. Surgery (Segm. Sponge(S), Nondrainage): Indications, complications, longterm results Thorsten Böker (Dortmund/D) 11:00 3. Pneumatic Retinopexy: Indications, complications, longterm results William F. Mieler (Chicago/USA) 11:10 4. Cerclage With Drainage: A look at cerclage after 50 years Harvey Lincoff (New York/USA) 11:20 5. Primary Vitrectomy: Rationale, indications, complications, longterm results Shuichi Yamamoto (Sakura /J) 11:30 6. Reoperation: The 4 Rules to find the undetected break Ingrid Kreissig (Mannheim/D) 11:40 7. Comparison of Present Techniques for Repair of Primary Retinal Detachment: Morbidity, results, socio-economic issues Thorsten Böker (Dortmund/D)

267 WOC Posters

268 Vorsprung durch Wissen 1. Mehr Know-how Monat für Monat neueste wissenschaftliche Erkenntnisse für Diagnostik und Therapie 2. Mehr Fortbildung Mit CME-Beiträgen Wissen auffrischen und Punkte sammeln 3. Mehr Benefit Beiträge komfortabel und schnell online recherchieren Jetzt 3 Ausgaben gratis testen! ò Ja, ich möchte die nächsten 3 Ausgaben der Zeitschrift Der Ophthalmologe kostenlos testen. Sollte ich von der Zeitschrift nicht überzeugt sein, teile ich Ihnen dies innerhalb von 14 Tagen nach Erhalt des 3. Heftes mit. Wenn ich die Zeitschrift weiterlesen möchte, brauche ich nichts zu tun und erhalte die Zeitschrift zum Preis von 327,- EUR inkl. 7% MwSt. (12 Hefte jhrl.) in 2010 für mindestens 1 Jahr (als Ärztin/Arzt in Aus- und Weiterbildung, Student/in 196,20 EUR inkl. 7% MwSt. Nachweis anbei) zzgl. Versandkosten (Inland 26,- EUR/Ausland 68,- EUR). Das Abonnement kann ich bis 2 Monate vor Ende des Bezugszeitraumes kündigen. (Preisänderungen und Irrtümer vorbehalten) Faxantwort: Oder einsenden an: Springer Customer Service Center GmbH Haberstraße 7 D Heidelberg Leserservice@springer.com Tel.: Name, Vorname Straße, Hausnummer ò Ja, bitte senden Sie mir aktuelle Angebote und Newsletter gerne auch per PLZ, Ort Datum, Unterschrift Ich bin tätig in ò Klinik ò Praxis Springer-Verlag GmbH, Tiergartenstraße 17, Heidelberg Zweigniederlassung der Springer-Verlag GmbH, Heidelberger Platz 3, Berlin Amtsgericht Berlin-Charlottenburg, HRB B Geschäftsführer: Derk Haank, Martin Mos, Peter Hendriks Springer ist Teil der Fachverlagsgruppe Springer Science + Business Media

269 WOC Saturday, 5 June :30 to 17:00 Posters Poster exhibition of Poster P-SA-001 to P-SA-282. All poster authors will attend their posters from 15:30 to 17:00 hrs. Moderation Poster sessions on Saturday Gerd Geerling (Wuerzburg) Dušica Pahor (Maribor) Co- Christoph M. E. Deuter (Tübingen) H. Burkhard Dick (Bochum) Michael Diestelhorst (Cologne) Stephan Eckert (Ulm) Lars-Olof Hattenbach (Ludwigshafen) Mathias Seeliger (Tübingen) Alexander Reis (Triesen) Heimo Steffen (Wuerzburg) Cataract/Biometry 1 P01 P-SA-008 Benefits of using ASPHERIC implants in Cataract surgery Mohamed Attitich (Rabat/MA) P-SA-009 Bi-axial Prechoping with two 25 G cannulas at the iris plane. Arturo Pèrez-Arteaga (Tlalnepantla/MEX) P-SA-010 Comparison of biometric measurements with ultrasound and a new laser interference biometer in cataract eyes Mike P. Holzer, Charlotte Jepsen, Tanja M. Rabsilber, Gerd U. Auffarth (Heidelberg/D) P-SA-011 Complication rate and risk factors for intraoperative complications in resident-performed phacoemulsification surgery Wolfgang Herrmann, Andrea briszi, Horst Helbig (Regensburg/D) Saturday, 5 June Posters P-SA-001 Accuracy of IOLMaster in axial length measurement in silicone oil-filled eyes Jing Sun, Situo Liang (Shanghai/CN) P-SA-002 Accuracy of the IOL calculation formula SRK/T vs. Haigis for the Acri.Smart 46LC (now CT Asphina 409M) Ruediger Schmid, Holger Luedtke (Ulm/D) P-SA-003 Application of Femtosecond Laser in Cataract Surgery for the Creation of Multi-planar Self- Sealing Corneal Incisions Roger Steinert, Enrique Baragan (Irvine/USA) P-SA-004 Application of Tokyo University Egogram in cases with multifocal IOL Hiroko Bissen-Miyajima, Shinichi Oki, Mami Yoshino, Izumi Kamei (Tokyo/J) P-SA-005 Argentina's Flag- phaco in an intumescent mature cataract (managing a run-out rhexis) Manish Mahendra (Kanpur/IND) P-SA-006 Astigmatism correction after cataract surgery, toric IOL vs conventional IOL + opposite clear corneal incisions Daniel Nahra (Barcelona/E) P-SA-007 Axial length measurement in eyes with macular edema: A-scan ultrasound versus IOLMaster. Jing Sun, Situo Liang (Shanghai/CN) P-SA-012 Correlation between risk factors and intraoperative complications in phacoemulsification surgery performed by trainees Anna Praidou, Evgenia Kanonidou, Matheos Antoniadis, Aggeliki Doudou, Sofia Androudi, Periklis Brazitikos (Thessaloniki/GR) P-SA-013 Does implantation of a Capsular Tension Ring in context with phacoemulsification influence the refractive outcome in highly myopic eyes? Andrea Schild, Andre Rosentreter, Martin Hellmich, Thomas Dietlein (Cologne/D, Duesseldorf/D) P-SA-014 Ectopia Lentis a vitreo-retinal surgical approach Seddiqu Salahim (Sana'a/ADN) P-SA-015 Effectiveness of Cataract Surgery with Phacoemulsification for Nanophthalmos Kaori Suzuki, Yukihiko Suzuki, Asaka Kudou, Mitsuru Nakazawa (Hirosaki/J) P-SA-024 Manual Small Incision Cataract Surgery (Manual SICS) a friend in need is a friend indeed Bhaskar Bhattacharyya (Kolkata/IND) P-SA-025 MRSA Endophthalmitis A Wake-up Call for the Ophthalmologist Gerald Schultz (Indio/USA) P-SA-026 Multicenter and site-specific results on behaviour and performance of the Tecnis 1-Piece IOL Christopher Wirbelauer, Duy-Thoai Pham (Frankfurt(Oder)/D, Berlin/D)

270 266 WOC 2010 Posters Saturday, 5 June Saturday, 5 June :30 to 17:00 P-SA-027 Office based cataract surgery Architectural and Technical choices for an independence of hospitalisation structure Three Years of an innovative concept in France Efficiency, Quality and costs. François Blondeau (Chateau d'olonne/f) P-SA-028 Optimizing Fluidics using both Venturi and Peristaltic Pumps during Phacoemulsification Surgery Uday Devgan (Los Angeles/USA) P-SA-029 Postoperative Ptosis following cataract surgery Yanin Suwan (Songkhla/T) P-SA-037 The power definition of multifocal IOL using IOL Master and A-scan biometry Mami Yoshino, Hiroko Bissen-Miyajima, Kunihiko Nakamura, Shinichi Oki (Tokyo/J) P-SA-038 Tilt and decentration of five kinds of aspheric IOLs in vivo from Scheimpflug imaging Xiaojie Xing, Xin Tang, Hui Song (Tianjin/CN) P-SA-039 Toric IOL Versus Adjustable Incision for Treatment of Mild to Moderate Astigmatism in Phacoemulsification Khaled Kotb Ali (Cairo/ET) P-SA-030 Reliable Presbyopia surgery with a toric bifocal MICS IOL (BIOL) 2 years and 70 eyes Detlev Breyer (Duesseldorf/D) P-SA-031 Results of a prospective study to evaluate the quality of vision with two aberration-free aspheric intraocular lenses (with and without blue lightfilter) vs. a conventional spherical IOL Michael Wolter-Roessler, Michael Küchle (Lauf/D, Erlangen/D) P-SA-032 Safety and efficacy of phacoemulsification in various types of post uveitic cataracts Manish Mahendra (Kanpur/IND) P-SA-033 Stenotrophomonas maltophilia endophthalmitis after cataract extraction. Marcelino Rio Torres, Meisy Ramos Lopéz, Juan Raúl Hernández Silva (Habana/C) P-SA-034 Surgically induced astigmatism (SIA) after coaxial micro incision cataract surgery (MICS) through 2.2mm incision in comparison to small incision cataract surgery (SICS) through 3.0mm incision Bernhard Steinhuber, Lilly Speicher, Wolfgang Philipp (Innsbruck/A) P-SA-035 Technique for Centration of the Tecnis Aspheric Multi-focal Lens Implant in the Visual Axis of Cataract Surgery Patients Uday Devgan (Los Angeles/USA) P-SA-036 The meaning of galactose metabolism for congenital cataract a 12-year analysis Christoph Raum, Gabriele Gusek-Schneider, Anselm G. M. Jünemann (Erlangen/D) P-SA-040 Visual performance of +3.0D aspheric AcrySof ReSTOR Apodized Diffractive IOL: A Prospective Comparative Trial Fang Tian, Hong Zhang (Tianjin/CN) Cornea/Eye Bank: Surgical Therapy P-SA-041 A technique to salvage big-bubble deep lamellar keratoplasty after inadvertent full-thickness trephination Siamak Zarei-Ghanavati, Mehran Zarei-Ghanavati (Mashhad/IR) P-SA-042 Autologic Perforating Keratoplasy Khakima Karim-Zade, Safarali Mirsoev, Alexander Enikeev (Dushanbe/TAD) P-SA-043 Better visual outcomes using a microkeratome for endothelial donor lamella preparation during DSAEK compared with the preparation using a femtosecond laser Jan Markus Vetter, Melissa Faust, Walter Sekundo (Mainz/D) P02 P-SA-044 Central and peripheral corneal iron deposits after the AcuFocus Intracorneal Inlay (ACI 7000) implantation Gerhard Nix, Orang Seyeddain, Wolfgang Riha, Melchior Hohensinn, Günther Grabner, Alois Dexl, Elisabeth Messmer (Salzburg/A, Mänchen/D) P-SA-045 Clinical confirmation of DMEK possibility after previous DSEK surgery Rosa Gundorova, Oganes Oganesyan, Mary Smetanina, Daria Danilova (Moscow/RUS) P-SA-046 Clinical evaluation of highly aberrated eyes: the importance of the patient self perception. Juliane Paranhos (Goiania/BR)

271 WOC Saturday, 5 June :30 to 17:00 P-SA-047 Clinical Evaluation of non-descemet s Stripping Automated Endothelial Keratoplasty (ndsaek) Toshinori masaki, Akira Kobayashi, Hideaki Yokogawa, Kazuhisa Sugiyama (Kanazawa/J) P-SA-048 Clinical outcomes after DMEK-S surgery combined with cataract extraction Deli Sivekova, Magdalena Vokrojova, Katerina Liehneova, Magdalena Netukova, Pavel Studeny (Prague/CZ) P-SA-049 Clinical outcomes in patients 2 years after DMEK-S surgery Pavel Studeny, Deli Sivekova, Katerina Liehneova, Magdalena Vokrojova, Michal Hyndrak (Prague/CZ) P-SA-050 Comparative study of steam cautery and subablative Er:YAG laser therapy in microbial keratitis Juergen Kampmeier, Peter Wagner, Simone Stopper, Eva Koler, Gerhard K. Lang, Detlef Russ (Ulm/D) P-SA-057 Deep Anterior Lamellar Keratoplasty for Treatment of Herpetic Corneal Scars Banu Torun Acar, Suphi Acar (Istanbul/TR) P-SA-058 Descemet s Stripping Automated Endothelial Keratoplasty (DSAEK) for Congenital Hereditary Endothelial Dystrophy (CHED) Ali Alrajhi (Riyadh/SA) P-SA-059 Disturbance of tight junction proteins in gelatinous drop-like dystrophy Enken Gundlach, Claudia Auw-Hädrich, Constantin Uhlig, Thomas Reinhard (Freiburg/D) P-SA-060 DSAEK with Carriazo-Pendular-Mikrokeratome and a newly designed Artificial Anterior Chamber first clinical results Jan Darius Unterlauft, Katharina Weller, Johann Schmiedl, Gunda Kann, Kasper Berit, Gerd Geerling (Wuerzburg/D) Saturday, 5 June Posters P-SA-051 Comparison of corneal inflammation after flap creation using a mechanical microkeratome and a 200 khz femtosecond laser an in vitro organ culture study Wolfgang Mayer, Armin Wolf, Martin Grüterich, Carlo Lackerbauer, Anselm Kampik, Daniel Kook (Munich/D) P-SA-052 Comparison of Pterygium Recurrence rate after pterygium resection and conjunctival autograft with additive phototherapeutic keratectomy Julia Promesberger, Sharmila Kohli, Matthias Schmidt, Constantin E. Uhlig (Münster/D) P-SA-053 Complications after penetrating and lamellar keratoplasty at pations with outcomes of herpetic keratitis Tetyana Gaydamaka, Galyna Drozhyna, Sergiy Grechko (Odessa/UA) P-SA-054 Conjunctival covering of autologus stem cells in the treatment of the herpetic neurotrophic keratopathy Eygene Ilyina, Pavel Bezditko (Kharkov/UA) P-SA-055 Corneal Intrastromal Implantation Surgery (CISIS) for Keratoconus Albert Daxer (Ybbs/A) P-SA-061 DSAEK, Preparation of the donor tissue with the Carriazo-pendular-microkeratome and an artificial anterior chamber. Gregor Schaaf, Arash Amjadi, Norbert Schrage (Hürth/D, Cologne/D) P-SA-062 Evaluation of Three Lamellar Keratoplasty Techniques in Keratoconic Eyes: Results One Year After Surgery. Luigi Mosca (Rom/I) P-SA-063 Evolution of astigmatism in keratoconic eyes implanted with intracorneal ring segments David Pablo Piñero Llorens, Jorge Alió (Alicante/E) P-SA-064 Factors influencing the consent for cornea donation requested via telephone interview Martin Hermel, Andre Steinfeld, Sabine Salla, Nicole Hamsley, Peter Walter, Stefanie Stiel (Aachen/D) P-SA-065 Histopathologic changes after deep anterior lamellar keratoplasty (DALK) using the big-bubble technique Joachim Braun, Carmen Rummelt, Ursula Schlötzer-Schrehardt, Friedrich Kruse, Claus Cursiefen (Erlangen/D) P-SA-056 Deep Anterior Lamellar Keratoplasty for Pellucid Marginal Corneal Degeneration Abdullah Al-Turbaq (Riyadh/SA) P-SA-066 Impact of histopathological findings for the treatment strategy of Schnyder corneal dystrophy (SCD) Tobias Hager, Andrea Hasenfus, Berthold Seitz (Homburg/D)

272 268 WOC 2010 Posters Saturday, 5 June Saturday, 5 June :30 to 17:00 P-SA-067 In vivo confocal microscopy of AcuFocus corneal inlays Wolfgang Riha, Orang Seyeddain, Melchior Hohensinn, Gerhard Nix, Günther Grabner, Elisabeth Messmer (Innsbruck/A, Munich/D) P-SA-068 Interface reflectivity measured by Pentacam and visual outcome following Descemet stripping automated endothelial keratoplasty (DSAEK) Sonja Ute Heinzelmann, Daniel Böhringer, Philip Maier, Thomas Reinhard (Freiburg/D) P-SA-069 lamellar corneal tattooing for better cosmetical appearance in corneal scars Syska Widyawati, Johan Hutauruk (Jakarta/RI) P-SA-077 Regeneration of subepithelial nerve plexus and its correlation with corneal sensation after fs-lasik: a 6 month follow-up study Andrey Zhivov, Oliver Stachs, Philipp Martius, Marcus Blum, Wilfried Bissmann, Rudolf F. Guthoff (Rostock/D, Erfurt/D) P-SA-078 Remote results of deep lamellar keratoplasty (DLK) at keratoconus III-IV stage. Nadiya Bobrova, Elena V. Ivanovskaya, G. Droggina, Tetyana B. Gaydamaka, Borys M. Kogan (Odessa/UA) P-SA-079 Results of penetrating keratoplasty in keratoconus Omar Beltaief, Khalil Errais (Tunis/TN) P-SA-070 Long-term outcome of penetrating keratoplasty combined with simultaneous vitrectomy without temporary keratoprosthesis Amelie Pielen, Bernd Junker, Daniel Böhringer, Hansjürgen T. Agostini, Thomas Reinhard (Freiburg/D) P-SA-071 Morphological and Functional Correlations in Riboflavin UV A Corneal Collagen Cross-Linking for Keratoconus Cosimo Mazzotta, Stefano Baiocchi, Rosario Denaro, Aldo Caporossi (Siena/I) P-SA-072 Nd:YAG laser supported superficial keratectomy for deep band keratopathy Heinrich Holak, Katja Schielke, Malgorzata Jaworska, Nikolai Holak, Heinrich Holak (Salzgitter/D) P-SA-073 Outcomes after Type 1 Boston Keratoprosthesis and Glaucoma Tube Shunt Jessica Wong, Thasarat Vajaranant, Jacob Wilensky, Jose de la Cruz (Chicago/USA) P-SA-074 Pneumodescematopexy using 6 % C3F8 Sheshadri Mahajan (Nasik/IND) P-SA-075 Poor corneal wettability, its influence on surface ablations outcomes. Claes Feinbaum (Landskrona/S) P-SA-076 Recent tendencies in indications for penetrating keratoplasty in Bulgaria Nikolay Surchev, Yordanka Kirilova, Tatyana Hergeldzhieva-Fileva, Petja Vassileva (Sofia/BG) P-SA-080 Rethinking Keratoconus with Bioptics Susan Senft, Dalel Tartak, Maria Tartak (Kailua-Kona/USA) P-SA-081 Salzmann s nodular degeneration on a corneal graft twenty-one years after penetrating keratoplasty Arnulf G. Schnaidt, Zisis Gatzioufas, Andreas C. Schröder, Ursula Löw, Susanne C. Goebels, Frank Schirra, Berthold Seitz (Homburg/D) P-SA-082 Superficial keratectomy, PTK and MMC as combined treatment option for Salzmann s Nodular Degeneration Stephan Linke, Toam Katz, Gisbert Richard, R. Baile, Riad Khaireddin (Hamburg/D) P-SA-083 Surgical treatment for suppurative corneal ulcers Halina Sitnik (Minsk/BY) P-SA-084 Traumatic Wound Dehiscence after Deep Anterior Lamellar Keratoplasty Siamak Zarei-Ghanavati, Mehran Zarei-Ghanavati (Mashhad/IR) P-SA-085 Treating hydrops keratoconus by epikeratoplasty with corneocompression Mukharram Bikbov, Guzel Bikbova (Ufa/RUS) P-SA-086 Visual perception changes and optical stability after ICRS implantation: Comparison between 4 months and 1 year after surgery. Juliane Paranhos, Paulo Schor (Goiania/BR, São Paulo/BR)

273 WOC Saturday, 5 June :30 to 17:00 Genetics P03 P-SA-087 A Novel Stop Codon Mutation in Rhodopsin Gene in Two Indonesian Families with Autosomal Recessive Retinitis Pigmentosa Arief Kartasasmita, Akira Murakami, Keiko Fujiki, Takuro Fujimaki, Iwan Sovani, Erwin Iskandar (Bandung/RI, Tokyo/J) P-SA-088 ABCA4 and ROM1: Implications for modification of the PRPH2-associated macular dystrophy phenotype Charlotte Poloschek, Michael Bach, Wolf Lagrèze, Esther Glaus, Johannes Lemke, Wolfgang Berger, John Neidhardt (Freiburg/D) P-SA-089 Clinical and Genetic Investigation of Isolated Microspherophakia in a Consanguineous Tunisian Family Ouechtati Farah, Ben Yahia Salim, Nouira Sonia, Chakroun Sonia, Abdelhak Sonia, Moncef Khairallah (Monastir/TN) P-SA-090 Detection of polymorphism in códon 72 of gene p53 in glaucoma patients and its socio-economic correlation Rodrigo Egidio, Francisco Rodrigues, Euler Franco, Katia Verolli (Goiania/BR) P-SA-091 Exclusion of known chromosomal loci in a family with dominant optic atrophy: Evidence for novel genetic background? Monika Oldak, Jacek P. Szaflik, Aneta Federowicz, Ewa Langwinska-Wosko, Kamil Szulborski, Joanna Kosi ska, Rafal Ploski, Jerzy Szaflik (Warsaw/PL) P-SA-092 Mutation screening of CHX10 and RAX genes in Chinese nanophthalmos Jing Tao, Ningli Wang, Naiqing Weng, Bowen Zhao, Qian Liu (Beijing/CN) P-SA-093 Patient and Control Recruitments for Genetic Investigation of Macular Diseases David Liu, Scarlet Chan, Dennis Lam, Calvin Pang (Hong Kong/HK) P-SA-094 Polymorphism in codon of gene p53 in glaucoma patients and its correlation with systemic diseases Francisco Rodrigues, Rodrigo Egidio, Euler Franco, Katia Verolli (Goiania/BR) P-SA-095 Positional Cloning of Disease Gene in A Chinese XLRP Pedigree Qingsong Yang, Ningli Wang, Hongyan Jia, Kai Ma, Liqin Gao (Beijing/CN) P-SA-096 RDH5 Mutation Analysis in a Series of Israeli Patients Affected by Fundus Albipunctatus: Detection of Novel Mutations. Eran Pras, S. Ravech, D. Sharon, E. Banin, Y. Rotenstreich, I. Avni, A. Abu (Qiryat Ono/IL) P-SA-097 Single Nucleotide Polymorphisms in Promoter Region of Matrix Metalloproteinase 1, 2, and 3 in Japanese with High Myopia Hisako Hayashi, Hideo Nakanishi, Ryo Yamada, Kenji Yamashiro, Isao Nakata, Noriaki Shimada, Kyoto Ohno, Manabu Mochizuki, Mineo Ozaki, Shin Yoshitake, Shoji Kuriyama, Masaaki Saito, Tomohiro Iida, Nagahisa Yoshimura (Kyoto/J) P-SA-098 TGFBI gene mutations caused a corneal dystrophy in Ukranian families Galyna Drozhyna, Natalia Pasiechnikova, Vladimir Pampucha, Ljudmila Livchits, Tetyana Gaydamaka, Valerij Vit (Odessa/UA) P-SA-099 The 972G>C polymorphism of the hmyh gene in AMD Jerzy Szaflik, Ewelina Synowiec, Urszula Kolodziejska, Jacek P. Szaflik, Janusz Blasiak (Warszawa/PL) Glaucoma P-SA-100 One-Year Incidence of Dry Eye with Latanoprost (LAT) or Travoprost-Z (TRAV-Z) in Patients With Open-Angle Glaucoma (OAG) and Ocular Hypertension (OH) Sameer Kotak, Gail Schwartz, Joel Fain, Jack Mardekian (New York/USA) P04 P-SA gauge pars plana Vitrectomy for the Management of Malignant Glaucoma after Ex-PRESS Mini Glaucoma Shunt Mounira J. Dridi, Mathias Maier, Jens Huber, Chris Patrick Lohmann, Aharon Wegner (Munich/D) P-SA-102 Ability of the Flashlight Test to Discriminate Between Eyes with Open and Narrow Angles Carolina Pelegrini Barbosa, Bruno Landgren, Aline Katia Siqueira Sousa, Tiago S. Prata, Augusto Paranhos (São Paulo/BR) P-SA-103 Analysis of light-dark change of iris and anterior chamber angle in the non-glaucoma subjects with or without exfoliation syndrome Takanori Mizoguchi (Nagasaki/J) Saturday, 5 June Posters

274 270 WOC 2010 Posters Saturday, 5 June Saturday, 5 June :30 to 17:00 P-SA-104 Arcuate scotoma suggests optic disc may be sinking in glaucoma Syed Hasnain (Porterville/USA) P-SA-105 Assessment of the ISNT Rule by Peripapillary Retinal Nerve Fiber Thickness in Primary Open Angle and Angle-Closure Glaucoma Tsung-Yu Ho, Ching-Yu Cheng, Catherine Jui-Ling Liu, Pei-Jung Lee, Yu-Chieh Ko, Shui-Mei Lee (Taipei/TJ) P-SA-106 Associations of FOS Curve, False-Positive and False-Negative Responses with the Performance of Fully Automated Kinetic Perimetry (Program K) in Virtual Patients Shigeki Hashimoto, Chota Matsumoto, Sachiko Okuyama, Sonoko Takada, Eiko Arimura, Fumi Tanabe, Jens Paetzold, Ulrich Schiefer, Yoshikazu Shimomura (Osaka-Sayama/J, Tübingen/D) P-SA-107 Bleb-related Infection after Filtering Surgery Shinya Komori, Nobumichi Takahashi, Nobuhide Hori, Akira Sawada, Kiyofumi Mochizuki, Tetsuya Yamamoto (Gifu/J) P-SA-108 Clinical features of hypoperfusion retinopathy complicating neovascular glaucoma Shihui Wei (Beijing/CN) P-SA-109 Clinical usefulness of CLOCK CHART for detection of visual field abnormalities in patients with glaucoma and macula diseases Mariko Shoji, Chota Matsumoto, Sachiko Okuyama, Sonoko Takada, Eiko Arimura, Shigeki Hashimoto, Fumi Tanabe, Yoshikazu Shimomura (Osaka Sayama/J) P-SA-110 Color Doppler imaging correlations with quantitative analysis of the optic disc in primary open angle glaucoma. Corina Tudor (Sibiu/RO) P-SA-111 Comparing the effect of POAG serum on the protein profiles of neuroretinal cells and human trabecular meshwork cells Katharina Bell, Gail Seigel, Lars Choritz, Norbert Pfeiffer, Franz Grus (Mainz/D) P-SA-112 Comparison of Dynamic Contour Tonometry vs. Goldmann Applanation Tonometry and Biometry of the Anterior Segment pre and post Cataract Surgery Mitja Alexander Heinrich, Achim Langenbucher, Wolfgang Behrens-Baumann, Arne Viestenz (Magdeburg/D, Homburg/D) P-SA-113 Comparison of functional and morphological diagnostics in glaucoma patients and healthy subjects Matthias Klamann, Anja Grünert, Anna-Karina B. Maier, Florian M. A. Heußen, Sibylle Winterhalter, Antonia M. Joussen, Klaudia K. Huber (Berlin/D) P-SA-114 Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography to Detect the Retinal Nerve Fiber Layer Thickness in Primary Angle Closure Glaucoma Mei-Ju Chen, Ching-Yu Chen, Catherine Jui-Ling Liu, Ching-Kuang Chou, Shui-Mei Lee (Taipei/TJ) P-SA-115 Comparison of the effect of Latanoprost and Tafluprost on 24-hour intraocular pressure in Normal-tension Glaucoma Noriko Yasuda, Kenji Nakamoto (Tokyo/J) P-SA-117 Correlation between central corneal thickness and retinal nerve fiber layer thickness in primary open-angle glaucoma patients Lachaya Orapiriyakul, Boonchai Wangsupadilok (Hatyai Songkhla/T) P-SA-118 Correlation Between Bleb Trabeculectomy Morphology with Intraocular Pressure in Primary Glaucoma Dian Estu, Edi Supiandi, Widya Artini, Joedo P (Jakarta/RI) P-SA-119 Could smoking be regarded as an additional risk factor in elder women with primary open angle glaucoma? Vicente Zanon-Moreno, Jose Javier Garcia-Medina, Maria A. Moreno-Nadal, Pedro Sanz-Solana, Maria D. Pinazo-Duran (Valencia/E) P-SA-120 Effect of anti-glaucoma therapy on 24-hour IOP for primary glaucoma patients with open angle and angle closure Shoichi Sawaguchi, Hiroshi Sakai, Yoshikuni Arakaki, Ichiko Medoruma, Eriko Tomoyose (Nishihara/J)

275 WOC Saturday, 5 June :30 to 17:00 P-SA-121 Effect of soft contact lens fitting on the noncontact tonometry readings and corneal behavior during tonometry observed by high speed camera Yoshiaki Kiuchi, Joji Takenaka, Makoto Kaneko, Kenji Yamada, Takumi Gosho (Hiroshima/J) P-SA-122 Efficacy of Rho-kinase inhibition in reducing glial reactivity and promoting retinal ganglion cell (RGC) survival in vitro Aysegül Tura, Karl-Ulrich Bartz-Schmidt, Sigrid Henke-Fahle (Lübeck/D, Tübingen/D) P-SA-123 Evaluation of peripheral anterior chamber depth of fellow eyes of acute angle closure by Scanning Peripheral Anterior Chmaber Depth Analyzer Yoshikuni Arakaki, Ichiko Medoruma, Michiko Yonahara, Eriko Tomoyose, Yuko Nakamura, Hiroshi Sakai, Shoichi Sawaguchi (Nishihara/J) P-SA-124 Exudative retinal detachment in a child with Sturge-Weber syndrome three years after trabeculotomy for congenital glaucoma Isabel Oberacher-Velten, Tina Dietrich, Roman Regler, Horst Helbig (Regensburg/D) P-SA-129 Inter-Eye Symmetry of Corneal Biomechanical Properties in Glaucomatous Eyes Anthony Realini, Robert Weinreb (Morgantown/USA, La Jolla/USA) P-SA-130 New options for glaucoma therapy Tomislav Ivandic, Boris Ivandic (Munich/D) P-SA-131 Postural changes of intraocular pressure affect the inter-eye difference both in visual field damage and retinal nerve fiber layer thickness reduction in the same patients with primary open-angle glaucoma. Junji Mizokami, Kumiko Ishikawa, Maiko Naka, Koji Hirai, Yuko Yamada, Makoto Nakamura, Akira Negi (Hyogo/J) P-SA-132 Quality of life (QOL) among patients with primary open angle glaucoma (POAG) Iman Fahmy, Manal H. Abu El Ela (Giza/ET) P-SA-133 Reliability of ICare tonometer in different measurement situations Gombos Katalin, Kalman Reka, Zsarnoti Katalin (Budapest/H) Saturday, 5 June Posters P-SA-125 Glaucoma monitoring quality and its role in the disease progression. Oksana Vitovska (Kiev/UA) P-SA-126 Glaucoma Short-term Progression Detected by Retinal Thinning Assessed by Using Spectral- Domain Optical Coherence Tomography Satoshi Mori, Masanori Hangai, Noriko Nakano, Masayuki Nukada, Hideo Nakanishi, Yuriko Kotera, Hanako Ikeda, Hajime Nakamura, Nonaka Atsushi, Nagahisa Yoshimura (Kyoto/J) P-SA-134 Risk Factors for Progression to Advanced Glaucoma in Ghana Andrew Francis, Michael Gyasi, Li Deng, Haiyan Gong (Boston/USA) P-SA-135 Role of functional single nucleotide polymorphisms of MMP-1, MMP-2 and MMP-9 in open angle glaucomas Georg Mossböck, Martin Weger, Christoph Faschinger, Christina Zimmermann, Yosuf El-Shabrawi (Graz/A) P-SA-127 How to Preserve Conjunctiva During Glaucoma Surgery? Jorge Topete-Jimenez (Guadalajara/MEX) P-SA-128 In vitro evaluation of apoptic effects of single and combined use of alpha tocopherol and current antifibrotics, in human tenon s fibroblast and endothelium cells Kaya N. Engin, Bülent Yemi ci, Serap Erdem Kuruca, Uǧur Serbes, Gül Özcan Arıcan, Kadriye Akgün Dar, Ebru Gürel, Selim Kocabora, Beyza Çetin, Sabriye Karadenizli (Istanbul/TR) P-SA-136 Seasonal Isolates from Bacteria in Bleb Surface of Eyes Trabeculectomized with Adjunctive Mitomycin C Nobumichi Takahashi, Shinya Komori, Toshihiko Katada, Akira Sawada, Kiyofumi Mochizuki, Tetsuya Yamamoto (Gifu/J) P-SA-137 Selective Laser Trabeculoplasty: Hypotensive Efficacy, Anterior Chamber Inflammation and Postoperative Pain Paolo Frezzotti, Ilaria Motolese, Sabrina Peruzzi, Vincenzo Mittica, Pietro Mittica, Mario Fruschelli, Eduardo Motolese (Siena/I)

276 272 WOC 2010 Posters Saturday, 5 June Saturday, 5 June :30 to 17:00 P-SA-138 The different changes of anterior segment after cataract surgery in normal eyes and eyes with filtered primary angle closured glaucoma Li Mei, Xing Liu, Dandan Wang, Ye Yang, Yangfa Zeng, Jingjing Huang (Guangzhou/CN) P-SA-139 The Impact of Glaucoma Stage on the Ocular Biomechanics Michael Haustein, Savvakis Hadjiraftis, Lutz E. Pillunat, Eberhard Spoerl (Dresden/D) P-SA-147 Color stimulator for electrophysiological investigations in the human eye Dietmar Link, Sascha Klee, Bernd Ulrich Seifert, Jens Haueisen (Ilmenau/D) P-SA-148 Color-vision disturbances in patients with occlusive arterial disease with or without coronary heart disease Carl Erb, Eva-Maria Fischer, Stefanie Lichtenberg (Berlin/D) P-SA-140 The Magnitude and Determinants of Intentional and Non-Intentional Adherence to Glaucoma Medication in Individuals with Glaucoma Xue Ling Chong, Tin Aung, Gwyneth Rees, Wan Ling Wong, Ecosse Lamoureux (Singapore/SGP) P-SA-149 Comparison of visual field indices of flimmer perimetry (Pulsar) with standard achromatic perimetry (Octopus 311) in patients with cyclic citrullinated peptide positive rheumatoid arthritis (CCP-RA) in comparison to controls. Katja Göbel, Carl Erb (Berlin/D) P-SA-141 The Prevalence of primary open-angle Glaucoma in a Moroccan population: 1182 cases Nawal Jennane, Tarik El Alloussi, Youssef Zekraoui, Adil Megzari, Amina Berraho (Rabat/MA) P-SA-142 Trabeculectomy with Amniotic Membrane Transplantation in Refractory Glaucoma Asaad Ghanem, Ihab Nafie, Hatem El-Awady, Salah Mady (Mansoura/ET) P-SA-143 Variability of serum oxidative stress indicators according to biochemical datae and clinical parameters of glaucoma Kaya N. Engin, Bülent Yemis ci, Ulviye Yiǧit, Ahmet Aǧaçhan, Cihan Cos kun (Istanbul/TR) Physiological Optics/Psychophysics/ Electrophysiology P05 P-SA-150 Contrast sensitivity, ocular higher-order aberration, and corneal surface light scattering after instillation of timolol maleate gel-forming solution and brinzolamide ophthalmic suspension Takahiro Hiraoka, Masakazu Daito, Fumiki Okamoto, Takahiro Kiuchi, Tetsuro Oshika (Tsukuba/J) P-SA-151 Functional and hemodynamic parameters in glaucoma patients with increased intraocular pressure. Elena Ponomareva, Armine Kazaryan, Ludmila Martinova (Moscow/RUS) P-SA-152 Functional estimates of inner retinal output and corresponding measures of nerve fibre layer thickness in healthy eyes Ieva Sliesoraityte, Bogomil Voykov, Eric Tröger, Anne Kurtenbach, Eberhart Zrenner (Tübingen/D) P-SA-144 A New ERG Paradigm to Evoke S-cone Potentials Andreas Schatz, Andre Messias, Robert Wilke, Eberhart Zrenner (Tübingen/D) P-SA-153 Occult Macular Dystrophy case report Dorota Pojda-Wilczek, Wanda Romaniuk (Katowice/P) P-SA-145 Application of a fundus-controlled color stimulator for selective cone excitation Sascha Klee, Dietmar Link, Patrick Bessler, Jens Haueisen (Ilmenau/D) P-SA-146 Blue-blocking filters are of minor effect on retinal function as assessed with the multifocal electroretinogram Wolfgang Behrens-Baumann, Michael Hoffmann, F. Spors, Achim Langenbucher, Sven Walter, J. Reupsch, Arne Viestenz (Magdeburg/D, Homburg/D) P-SA-154 Optimization of electrode position in recording multifocal visually evoked potential in Japanese individuals Kumiko Ishikawa, Junji Mizokami, Maiko Naka, Koji Hirai, Yuko Yamada, Makoto Nakamura, Akira Negi (Kobe/J)

277 WOC Saturday, 5 June :30 to 17:00 P-SA-155 Phosphene Thresholds Elicited by Transcorneal Electrical Stimulation in Healthy Subjects and Patients with Retinal Diseases Lubka Naycheva, Andreas Schatz, Tobias Röck, Gabriel Willmann, Karl Ulrich Bartz-Schmidt, Eberhart Zrenner, Florian Gekeler (Tübingen/D) P-SA-156 Relationship between reading performance and quality of a life in patients whith presbyopia Maryna Shchadnykh, Olesya Zavoloka, Pavel Bezditko, Darya Zubkova (Kharkiv/UA) P-SA-157 The impact of individual Zernike coefficients on retinal image quality a simulation study Jens Bühren, Thomas Kohnen (Frankfurt/D) P-SA-164 Comparison of Spectral-Domain Optical Coherence Tomography and Fundus Autofluorescence in Patients with Geographic Atrophy Ramzi Gilbert Sayegh, Christian Simader, Ulrike Scheschy, Alessio Montuoro, Christopher Kiss, Stefan Sacu, David Kreil, Christian Prünte, Ursula Schmidt-Erfurth (Vienna/A) P-SA-165 Correlation between Visual Acuity and Spectral Domain Optical Coherence Tomography Features in Patients with Neovascular Age-related Macular Degeneration Sandra Liakopoulos, Tina Ristau, Pearse A. Keane, Jared Updike, Alexander C. Walsh, Alicia Engin, Steffen Hillebrand, Bernd Kirchhof, SriniVas R. Sadda (Cologne/D, Los Angeles/USA) Saturday, 5 June Posters Retina: AMD P06 P-SA-158 A computer-based documentation and data management system of clinically relevant parameters during repeated anti-vegf injections Carsten H. Meyer, Hans-Martin Helb, Frank G. Holz (Bonn/D) P-SA-159 Age-Related Macular Degeneration in Patients with Diabetic Retinopathy Nahoko Ogata, Tadanobu Yoshikawa, Tsuyoshi Otsuji, Masato Matsuoka, Kayako Matsuyama, Kanji Takahashi (Moriguchi/J) P-SA-166 Detection of Esterified Cholesterol in Murine Bruch s Membrane Wholemounts with a Novel Cholesterol Dye Marie Christine Dettbarn, Martin Rudolf, Johannes Knobloch, Salvatore Grisanti (Lübeck/D) P-SA-167 Development of a Novel Method to Detect Single Nucleotide Polymorphism of Age-related Maculopathy Susceptibility 2 (ARMS2) Gene for Clinical Laboratories Kenji Yamashiro, Norimoto Gotoh, Hideo Nakanishi, Hisako Hayashi, Isao Nakata, Akitaka Tsujikawa, Atsushi Otani, Hiroshi Tamura, Sotaro Ooto, Nagahisa Yoshimura (Kyoto/J) P-SA-160 Changes of Ocular Hemodynamics in Patients with Pathologicaltortuousity of the Internal Carotid Artery Sergey Avetisov, Tatyana Kiseleva, Sergey Vlasov, Alexandr Gavrilenko, Andrey Kuklin, Arsen Abramyan, Irina Omarganova (Moscow/RUS) P-SA-168 Differential Role of TNF-alpha Receptors in the development of choroidal neovascularization Irina Semkova, Monika Jasielska, Xuan Shi, Kristina Schmidt, Dimitrios Karagiannis, Jerzy Mackiewicz, Norbert Kociok, Antonia M. Joussen (Duesseldorf/D, Berlin/D) P-SA-161 Characterization of a spontanously immortalized cell line derived from neovascular CNV membranes (CNV-RPE) Maria Magdalena Guichard, Christoph Ehlken, Gottfried Martin, Hansjürgen Agostini (Freiburg/D) P-SA-162 Clinical experiences with loading doses of anti- VEGF Lucentis in the treatment of exsudative AMD Markus Motschmann, A. Krappe, H.-W. Schlote, T. Brosius, D. Kersten (Haldensleben/D) P-SA-163 Comparison of intravitreal bevacizumab alone versus combined with photodynamic therapy for small CNV lesions of age-related macular degeneration Mihoko Suzuki, Fumi Gomi, Miki Sawa, Motokazu Tsujikawa (Suita/J) P-SA-169 Do intravitreal ranibizumab injections for wet age-related macular degeneration affect the vitreomacular interface? Sreekanth Sreekantam (Birmingham/UK) P-SA-170 Early effects of triamcinolone acetonide on matrix metalloproteinases and endostatin in human choroidal neovascularization Olcay Tatar, Kei Shinoda, Edwin Kaiserling, Gabor B. Scharioth, Grazia Pertile, Klaus Lucke, Claus Eckardt, Tillmann Eckert, Silvia Bopp, Bernd Kirchhof, Efdal Yoeruek, Salvatore Grisanti, Karl Ulrich Bartz-Schmidt (Tübingen/D, Bremen/D, Recklinghausen/D, Cologne/D, Lübeck/D, Tokyo/J)

278 274 WOC 2010 Posters Saturday, 5 June Saturday, 5 June :30 to 17:00 P-SA-171 Effect of Atorvastatin and Aspirin on the threshold retinal sensitivity in patients with nonexudative age-related macular degeneration Maryna Karliychuk (Chernivtsi/UA) P-SA-172 Evaluation of Safety for Bilateral Same-day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Therapy Luiz H. Lima (New York/USA) P-SA-173 Filtering blue light reduces light-induced oxidative stress, senescence, and accumulation of extracellular matrix oroteins in human RPE cells Marcus Kernt, Raffael Liegl, Katja Obholzer, Renate Scheler, Axel Walch, Aljoscha Neubauer, Kirsten Eibl, Armin Wolf, Michael Ulbig, Arndt Gandorfer, Anselm Kampik (Munich/D) P-SA-174 Fixation site and scotoma size in patients with retinal pigment epithelium tears after Ranibizumab treatment Katja Christina Schielke, Tomas Ilginis (Aalborg/DK) P-SA-175 Focal Macular Electroretinograms after Photodynamic Therapy Combined with Intravitreal Bevacizumab Kohei Ishikawa, Shinsuke Ozawa, Yasuki Ito, Mineo Kondo, Hiroko Terasaki (Nagoya/J) P-SA-180 Inner Segment-Outer Segment Junctional Layer Integrity and Corresponding Retinal Sensitivity in Dry and Wet forms of Age-Related Macular Degeneration Gennady Landa, Richard Rosen, Emily Su, Patricia Garcia, William Seiple, Alfonso Ponce, Jeanne Rosenthal, Ronald Gentile, Thomas Muldoon, Joseph Walsh (New York/USA) P-SA-181 Intravitreal Bevacizumab (Avastin) Treatment for Neovascular Age-related Macular Degeneration: Twelve-Month Results Andrius Cimbalas, Ausra Liveikiene, Rasa Sirtautiene, Kristina Kuoliene, Rimvydas Asoklis (Vilnius/LT) P-SA-182 Intravitreal injection of tyrosine kinase inhibitor PTK787 reduces the size of laser-induced chorioretinal neovascularisation in a mouse model Anne Wiermann, Birthe Meyer-Rüsenberg, Sebastian Bigdon, Gisbert Richard, Oliver Zeitz, Michelle Berna (Munich/D, Hamburg/D) P-SA-183 Intravitreal ranibizumab therapy for exudative age-related macular degeneration (AMD) affects the retinal autoimmunity. Agnieszka Kubicka-Trząska, Izabella Karska-Basta, Krzysztof Morawski, Bożena Romanowska-Dixon (Kraków/PL) P-SA-176 Geographic Atrophy in AMD: Junctional Zone Classified by High-resolution Spectral Domain OCT Imaging Monika Fleckenstein, Steffen Schmitz-Valckenberg, Christian K. Brinkmann, Robert P. Finger, Peter Charbel Issa, Frank G. Holz (Bonn/D) P-SA-177 High resolution in vivo and in vitro imaging of human RPE cells using structured illumination microscopy Thomas Ach, Gerrit Best, Mira Ruppenstein, Christoph Cremer, Stefan Dithmar (Heidelberg/D) P-SA-178 Induction of the Angiopoietin/Tie System by oxidative Stress and Light Armin Wolf, Marcus Kernt, Wolfgang Mayer, Anselm Kampik, Claudia Priglinger-Alge (Munich/D) P-SA-179 Influence of vitreous on anti-vegf therapy in patients with CNV secondary to AMD in the excite study Ulrike Sponer (Vienna/A) P-SA-184 Late Outgrowth Endothelial Progenitor Cells in Patients with neovascular AMD and effect of Lucentis treatment Michelle Berna-Thill, Rebecca Grierson, Frank Kunst, Nina Krüger, Birthe Meyer-Rüsenberg, Anne Wiermann, Marc Jean Berna, Gisbert Richard (Hamburg/D) P-SA-185 Mecamylamine reduces the size of laser induced CNV in a mouse model and inhibits VEGFR-2 phosphorylation in vitro Birthe Meyer-Rüsenberg, Anne Wiermann, Sebastian Bigdon, Nina Krüger, Frank Kunst, Rebecca Grierson, Christos Skevas, Gisbert Richard, Marc J. Berna, Oliver Zeitz, Michelle Thill (Hamburg/D) P-SA-186 Morphological and functional response of the retinal pigment epithelium (RPE) after selective retina therapy (SRT) in cultivated porcine RPEchoroid explants Felix Treumer, Yoko Miura, Johannes Baltz, Alexa Klettner, Ralf Brinkmann, Reginald Birngruber, Johann Roider, Jost Hillenkamp (Kiel/D)

279 WOC Saturday, 5 June :30 to 17:00 P-SA-187 Morphometry of Cell Phenomena in Histological Sections of Geographic Atrophy due to Age-related Macular Degeneration Joshua Torrent Despouy, Anna Wagner, Salvatore Grisanti, Susan Vogt, Russell Read, Christine Curcio, Martin Rudolf (Lübeck/D) P-SA-188 Natural course of pigment epithelium detachment (PED) during induction treatment with Anti-VEGF therapy for neovascular age-related macular degeneration Johann Rüping, Nicole Eter, Christos Haritoglou, Anselm Kampik, Armin Wolf (Munich/D) P-SA-189 New insights of the underestimated impairment of quality of life in age-related macular degeneration a review of the literature Birthe Meyer-Rüsenberg, Gisbert Richard (Hamburg/D) P-SA-190 Non-responders to ranibizumab in the treatment of neovascular age-related macular degeneration Christina Kramann, Katrin Lorenz, Isabella Zwiener, Bernhard Stoffelns, Norbert Pfeiffer (Mainz/D) P-SA-196 Quantification of the therapeutic response of intraretinal, subretinal and subpigmentepithelial compartments in exudative AMD during antiangiogenic therapy Isabelle Golbaz, Christian Ahlers, Christopher Schütze, Sabine Schriefl, Ferdinand Schlanitz, Christian Simader, Christian Prünte, Ursula Schmidt-Erfurth (Vienna/A, Binningen/CH) P-SA-197 Screening for patient eligibility using fundus autofluorescence in a randomized interventional clinical trial for geographic atrophy secondary to agerelated macular degeneration Christian Karl Brinkmann, Steffen Schmitz- Valckenberg, Monika Fleckenstein, Nina Stratmann, Florian Alten, Glenn J. Jaffe, Thomas C. Hohman, Frank G. Holz (Bonn/D) P-SA-198 SDOCT and angiography related prognostic factors for visual acuity outcome after Ranibizumab in patients with neovascular AMD Tina Ristau, Dzenita Smailhodzic, Steffen Hillebrand, Jared Updike, Alexander C. Walsh, Bernd Kirchhof, SriniVas R. Sadda, Sandra Liakopoulos (Cologne/D, Los Angeles/USA) Saturday, 5 June Posters P-SA-191 One year results of prospective, multi-center study of photodynamic therapy for polypoidal choroidal vasculopathy Tomohiro Iida, Ophthalmic PDT study group (Fukushima/J) P-SA-192 Oxidative DNA damage in patients with age-related macular degeneration Orhan Ates, Osman Ceylan, Hamit Alp, Sedat Azizi, Bekir Ondas (Erzurum/TR) P-SA-193 Peripheral Exudative Hemorrhagic Chorioretino - pathy Guido Kürzinger, Gabriele E. Lang (Ulm/D) P-SA-194 Peripheral Fundus Autofluorescence is increased in AMD Tamer Wasfy, Carolin Fischer, Johann Rüping, Armin Wolf, Michael Ulbig, Anselm Kampik, Marcus Kernt (Munich/D) P-SA-195 Pigment epithelial detachments in AMD evaluated by spectral domain OCT, near-infrared reflectance, fluorescein and indocyanine green angiography Christoph Clemens, Carolin Milojcic, Frank G. Holz, Nicole Eter (Bonn/D) P-SA-199 Serum Uric Acid Levels and its Association With Age-Related Macular Degeneration (ARMD) Siddharth Subramani, Sim Ee Khor, Bethel Indira Livingstone, Utkarsh V. Kulkarni (Aberdeen/UK) P-SA-200 Short-term progression of neovascular AMD Marion Munk, Christopher Kiss, Florian Sulzbacher, Stefan Eisenkoelbl, Wolfgang Huf, Ursula Schmidt- Erfurth (Vienna/A) P-SA-201 Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Bevacizumab for Neovascular Age-related Macular Degeneration Guoge Han, Junyi Wang, Changzheng Chen, Yiqiao Xing, An Huai Yang (Wuhan/CN) P-SA-202 Sorafenib Reduces Expression of VEGF-Receptor 1/2 and Prevents Human Retinal Pigment Epithelium Cells from Light-Induced Over-Expression of VEGF Marcus Kernt, Raffael Liegl, Christoph Hirneiss, Aljoscha Neubauer, Claudia Alge-Priglinger, Kirsten Eibl, Carl-Arnold Lackerbauer, Michael Ulbig, Anselm Kampik, Armin Wolf (Munich/D)

280 276 WOC 2010 Posters Saturday, 5 June Saturday, 5 June :30 to 17:00 P-SA-203 The analysis of the NEI-VFQ-25 as an Evaluation Tool for the Quality of Life of Russian Patients with Age-Related Macular Degeneration. Alla Lisochkina, Yury Astakhov, Nina Vanchakova, Pavel Nechiporenko, Tatyana Kuznetsova (Saint-Petersburg/RUS) P-SA-204 The assessment of matrix metalloproteinases 3 gene 5A/6A (-1171) polymorphism in age-related macular degeneration Rasa Liutkeviciene, Giedre Sinkunaite, Sandrita Simonyte, Abdonas Tamosiunas, Dalia Zaliuniene, Vytautas Jasinskas, Olivija Gustiene, Vaida Mizariene, Diana Zaliaduonyte-Peksiene, Vaiva Lesauskaite (Kaunas/LT) P-SA-205 The Effect of Oxidative Stress on Components of the Endothelial Glycocalyx Armin Wolf, Marcus Kernt, Mathias Jacob, Kirsten Eibl, Anselm Kampik, Claudia Alge-Priglinger (Munich/D) P-SA-206 The influence of vitreomacular adhesion on efficacy of treatment of neovascular age-related macular degeneration with intravitreal bevacizumab injections Mojca Urbancic, Polona Jaki Mekjavic, Aleksandra Kraut, Mojca Globocnik Petrovic (Ljubljana/SI) P-SA-207 The Influence of Vitreomacular Interaction on the Development of Exudative Age-Related Macular Degeneration: 4-Year-Results of a Longitudinal Study Sebastian Waldstein, Ulrike Sponer, Christian Simader, Stefan Sacu, Ursula Schmidt-Erfurth (Vienna/A) P-SA-208 The macular mapping test as tool for vision assessment and monitoring of anti-vegf therapy in patients with NV-AMD Nikolaus Feucht, Werner Eisenbarth, Christian Enders, Manfred MacKeben, Mathias Maier (Munich/D) P-SA-209 The progression rate of wet age-related macular degeneration after inicial treatment with bevacizumab Liga Radecka, Guna Laganovska (Riga/LV) P-SA-210 The structural changes in the central retina in patients with age-related macular degeneration. Ganna Kruglova, Pavel Bezdetko (Kharkov/UA) P-SA-211 Twelve-month Safety and Visual Acuity Outcome of a Pilot Study Exploring Ranibizumab Combined with Proton Beam Irradiation as Treatment for Exudative Age-Related Macular Degeneration Susanna Park, Inder Daftari, Theodore Phillips, Lawrence Morse (Sacramento/USA) P-SA-212 Verteporfin photodynamic therapy in combination with anti-vegf ranibizumab therapy in AMD patients: Second year outcomes in the MONT BLANC study Paolo Lanzetta, on behalf of the MONT BLANC study group (Udine/I) P-SA-213 Vision related quality of life after intravitreal injection of Anti-VEGF is "better" really "better"? Daniela Claessens, Bernd Kirchhof (Cologne/D) P-SA-214 Visual Acuity and Fixation Correlation in Agerelated Macular Degeneration Albert Caramoy, Sabine Schröder, Jonathan Foerster, Sascha Fauser, Bernd Kirchhof (Cologne/D) Strabismus P-SA-215 A case of superior oblique palsy caused by endoscopic paranasal sinus surgery Takashi Negishi, Akiko Hikoya, Yoko Tsuchiya, Mayu Sawada, Yoshihiro Hotta, Miho Sato (Hamamatsu/J) P07 P-SA-216 Alerted Functional Connectivity of Primary Visual Cortex in Adult Comitant Strabismus using restingfunctional MRI Xiaohe Yan, Xiaoming Lin, Yuan Zhou, Lijuan Xu, Tianzi Jiang, Yingming Chen, Shaojie Song (Munich/D) P-SA-217 Characteristics and Outcomes of Inferior Rectus Recession under Topical Anesthesia in Thyroid Myopathy using Absorbable versus Non-Absorbable Sutures. Ingrid Franco, Sonal Farzavandi, Seah Lay Leng, Choo Chai Teck, Chee Soon Phaik (Singapore/SGP) P-SA-218 Clinical study of the binocular visual function in strabismus patients between before and after strabismus surgery Fang Zhang (Wenzhou/CN) P-SA-219 Clinical usefulness and the accuracy of Distance Krimsky method for the distance deviation measurement Kwang Sic Joo, Nam Ju Moon (Seoul/ROK)

281 WOC Saturday, 5 June :30 to 17:00 P-SA-220 Congenital - infantile esotropia vs. refractive errors Branko Stankov, Milorad Ljutica, Radovan Stojkovic, Darko Bubalo, Vinko Regoda (Beograd/SRB) P-SA-221 Disruption of white matter tract integrity in adult comitant strabismus: A diffusion tensor imaging study. Xiaohe Yan, Xiaoming Lin, Qifeng Wang, Tianzi Jiang, Yingming Chen (Munich/D) P-SA-222 Influence of Intermuscular Septum on Eye Movement Fumiko Kishimoto, Hiroshi Ohtsuki (Ibara/J) P-SA-231 Transposition of the Inferior Oblique under Inferior Rectus Insertion for Treating Patients with Double Elevator Palsy Lejin Wang, Juan Bu, Jing Li, Yanlei Jia, Mei Sun (Beijing/CN) Uveitis/Intraocular Inflammation, Microbiology/Immunology P-SA-232 A culture independent metagenomic analysis of contact lens storage case Hiroshi Eguchi, Tomomi Kuwahara, Tatsuro Miyamoto (Tokushima/J) P08 Saturday, 5 June Posters P-SA-223 Intended Undercorrection in Surgical Management on Adult Intermittent Exotropia Apatsa Lekskul, Apatsa Lekskul (Bangkok/T) P-SA-224 Interocular suppression and visual acuity development during occlusion therapy of amblyopic patients aged between 5 and 16 years Stephan Kämmerling, Iris Bachert, Julia Kracht, Marc Lüchtenberg, Maria Fronius (Frankfurt/D) P-SA-233 Advantages of 55 degree lens in compare with 30 degree lens in Wide-Angle Imaging in HRA2- Spectral OCT and Angiograph in 10 uveitis patients Undine Simmet, Mathias Maier, Chris Patrick Lohmann, Nikolaus Feucht (Munich/D) P-SA-234 Anti Tumor Necrosis Factor Monoclonal Antibodies (Infliximab) in Treatment of Behcet s Disease Maja Zivkovic (Nis/SRB) P-SA-225 Intracystic 70% isopropyl alcohol injection for post operative conjunctival inclusion cysts. Mihir Kothari (Mumbai/IND) P-SA-226 Mechanisms of binocular fusion in patients with superior oblique paresis Kristina Irsch, David Guyton, Murilo Roggia, Pittaya Phamonvaechavan, Howard Ying (Baltimore/USA) P-SA-228 Stereoacuity before and after neutral zone shifting in congenital nystagmus with vertical compensatory head posture Wei Zhang (Tianjin/CN) P-SA-229 Strabismus in pathologic myopes Manabu Mochizuki, Kyoko Ohno-Matsui, Akiko Tanaka, Yuko Shibata, Muka Moriyama, Kengo Hayashi, Takashi Tokoro, Makiko Yamashita, Noriaki Shimada (Tokyo/J) P-SA-230 The role of inferior oblique myectomy in improving ocular nystagmus Momen Moustafa (Cairo/ET) P-SA-235 Antiendotoxin immunity in patients with HLA-B27 associated endogenous anterior uveitis Ganna Kopayenko, Gennadiy Zhaboedov, Nanuli Ivanova (Simferopol/UA) P-SA-236 Causes of visual loss in Uveitis in the 21st century. Paul Muambi B. Kabasele, S. R. Taylor, J. Singh, C. Hooper, Susan Lightman (London/UK) P-SA-237 Changes in the Eyes in Patients with Juvenile Rheumatoid Arthritis Marko Zlatanovic (Nis/SRB) P-SA-239 CMV-Retinitis: A review of treatment procedures between 1996 and 2009 Claudia Metz, Eva Biewald, Bernhard Jurklies, Norbert Bornfeld (Essen/D) P-SA-240 Common sense to prevent endophthalmitis Albert Galand (Neupré/B) P-SA-241 Commparison of three methods of imaging the central retina in chronic uveitis patients: Stratus OCT, Spectralis OCT and HRT retina modul Eva Jakob, Alexander Scheuerle, Stephan Schulz, Friederike Mackensen (Heidelberg/D)

282 278 WOC 2010 Posters Saturday, 5 June Saturday, 5 June :30 to 17:00 P-SA-242 Depigmentation of peripapillary crescent in Vogt- Koyanagi-Harada disease Yumiko Yamaguchi, Tomohiro Otani, Shoji Kishi (Maebashi/J) P-SA-243 Elevated levels of heparin binding epidermal growth factor-like growth factor in aqueous humor of patients with acute anterior uveitis Salvador Garcia-Delpech, Stephanie Rohrweck, David Salom, Patricia Udaondo, Maria Jesus Lopez-Prats, Manuel Diaz-Llopis (Valencia/E) P-SA-251 Inflammatory cytokine responses to tuberculin and retinal autoantigens in vitro from a patient with Bacillus Calmette-Guérin-induced uveitis Aylin Garip, Maria Diedrichs-Möhring, Cornelia Deeg, Stephan Thurau, Gerhild Wildner (Munich/D) P-SA-252 Interleukin-18 gene polymorphisms in Chinese patients with Vogt Koyanagi Harada disease Timothy Lai, Pancy Tam, Chenghong Lan, Sylvia Chiang, Carmen Chan, Chi-Pui Pang, Dennis Lam (Kowloon/HK) P-SA-244 Endogenous Candida Endophthalmitis: Outcomes from Early Vitrectomy Lavnish Joshi, Ahmed Sallam, Aldrin Khan, Peter McCluskey, William A Lynn, Kiran Manku, Sue Lightman (London/UK) P-SA-245 Endophthalmitis Caused by Pseudomonas aeruginosa in Taiwan Kuan-Jen Chen, Ming-Hui Sun (Taoyuan/TJ) P-SA-253 Intravitreal rituximab for primary intraocular lymphoma Ermioni Panidou, Rainer Guthoff, M. Griebel (Wuerzburg/D) P-SA-254 Long-term results of therapy with mycophenolate mofetil in non-infectious uveitis Deshka Doycheva, Christoph Deuter, Nicole Stuebiger, Manfred Zierhut (Tübingen/D) P-SA-246 Episcleral osseous lesion Melanie Jäger, Birgit Lorenz (Giessen/D) P-SA-247 Expression of toll like receptors in Behçet s disease with refractory uveitis following infliximab treatment Takeshi Kezuka, Masaru Takeuchi, Naoyuki Yamakawa, Yoko Okunuki, Yoshihiko Usui, Jun-ichi Sakai, Hiroshi Goto (Tokyo/J) P-SA-255 Monitoring uveitis patients with the digital 200 widefield-angiography system Optomap fa Eva Jakob, Bianca Dobner, Christian Kahlert, Stefan Dithmar (Heidelberg/D) P-SA-256 Necrotizing sarcoid granulomatosis: oular manifestation in three children Claudia Schumacher, Anne Lohr, Martin Roesel, Norbert Wagner, Arnd Heiligenhaus (Münster/D) P-SA-248 Favourable outcome after cataract surgery with IOL implantation in selected JIA associated uveitis patients Rafael Grajewski, Beatrix Zurek-Imhoff, Martin Roesel, Carsten Heinz, Arnd Heiligenhaus (Cologne/D, Münster/D) P-SA-249 Fuchs Heterochromic Uveitis: a Review of 27 Cases Jenzeri Salah, Jelliti Bechir, Attia Sonia, Haj Taher Olfa, Zouid Sonia, Moncef Khairallah (Monastir/TN) P-SA-250 Indocyanine Green Angiography in Acute Vogt Koyanagi Harada Disease: Signs at Presentation and their Evolution under Treatment Kahloun Rym, Hasnaoui Wafa, Gargouri Salma, Zaouali Sonia, Ben Yahia Salim, Moncef Khairallah (Monastir/TN) P-SA-257 Nuclear factor- B inhibitor, dehydroxy methyl epoxyquinomicin, ameliorates experimental autoimmune uveoreitnitis in mice Daiju Iwata (Sapporo/J) P-SA-258 Ocular cysticercosis a pediatric clinical report Gil Calvão-Santos, Joel Ferreira, José Guilherme-Monteiro, José Salgado-Borges (São Mamede de Infesta/P) P-SA-259 One and a half blind eye in a tuberculosis patient: a case review Rona A. Nasaruddin, Wan Haslina Wah, Ropilah Abdul Rahman, Ropilah Abdul Rahman (Kuala Lumpur/MAL) P-SA-260 Outcome of phacoemulsification for uveitic cataract in Vogt-Koyanagi Harada (VKH) disease Victoria Wong, Rose Chan, Carmen Chan, Timothy Lai (Kowloon/HK)

283 WOC Saturday, 5 June :30 to 17:00 P-SA-261 Patient with previously undiagnosed Autoimmune Hypophysistis (AH) presenting with bilateral recurrent cystoid macular oedema (CMO) secondary to Intermediate uveitis Venkat Kotamarthi, Muhammad Amjad, Arun Sachdev (Manchester/UK) P-SA-262 Preoperative treatment of posttraumatic endophthalmitis Dauletbekov Daniyar, Daniyar Dauletbekov (Almaty/KZ) P-SA-263 Primary intraocular lymphoma, a diagnostic challenge. Case report Claudia Zorn, Alexander Erben, Eva Glaser, Mathias Maier, Chris Patrick Lohmann, Elen Büschlepp, Uwe Pleyer, Korinna Jöhrens (Munich/D) P-SA-271 Spectral Domain Optical Coherence Tomography (SD-OCT) and time domain (TD) in Toxoplasmic Retinochoroiditis Bruno Diniz, Mariann Midori Yabiku, Carlos Alexandre Garcia Filho, Rafael Ernane Andrade, Rubens Belfort Jr (São Paulo/BR) P-SA-272 Spectrum of Ocular Tuberculosis in Selayang Hospital Hanizasurana Hashim, Shelina Oli Mohamed, Roslin Azni Aziz, Tara Mary George, Nor Fariza Ngah (Kuala Lumpur/MAL) P-SA-273 Spontaneous fungal endophthalmitis in healthy man Keembiyage Dayawansa, Jayantha Edirisooriya (Kandy/CL) Saturday, 5 June Posters P-SA-264 Prognostic factors and Outcomes in Endogenous Klebsiella pneumoniae Endophthalmitis Marcus Ang, Aliza Jap, Soon-Phaik Chee (Singapore/SGP) P-SA-265 Rat-to-human transmission of cowpox infection with membraneous conjunctivitis Silke Brüx, H. Kramp, H. Teutloff, M. Knorr, F. Hessler (Kalkar/D) P-SA-266 Reemergence of ocular syphilis two atypical cases of ocular syphilis Diamar Pardo-López, Ana Marina Suelves-Cogollos, Stephanie Rorhweck, Ruth López-Lizcano, Salvador García-Delpech, Manuel Díaz-Llopis (Valencia/E) P-SA-267 Retinal Pigment Epithelium Layer Changes in Vogt- Koyanagi-Harada Disease Using Scanning Laser Ophthalmoscopy Indirect Viewing Satoshi Ishiko, Reiko Kinouchi, Eiichi Sato, Yuji Kato, Akitoshi Yoshida (Asahikawa/J) P-SA-268 Rituximab in the treatment of refractory ophthalmic Wegener s Granulomatosis Simon Taylor, Lavnish Joshi, Alan Salama, Charles Pusey, Sue Lightman (London/UK) P-SA-269 Scleritis necrotizing: A case Report about a patient with Wegener granulomatosis Graciela Graneros (San Miguel de Tucuman/RA) P-SA-270 Serous Retinal Detachment Secondary to Acute Toxoplasmic Retinochoroiditis. Gargouri Selma, Zaouali Sonia, Ammari Wafa, Jelliti Bechir, Messaoud Riadh, Moncef Khairallah (Monastir/TN) P-SA-274 Subthreshold Micropulse Diode Laser Treatment for Uveitic Macular Edema Bruno Diniz, Carolina Pelegrini Barbosa, Daniel Lavinsky, Tiago Arantes, Rubens Belfort Jr. (São Paulo/BR) P-SA-275 Successful Treatment of Acute Annular Outer Retinopathy with Combination of Oral Ciclosporin A and Prednisolone Nor' Ain Mohd Rawi, Othmaliza Othman, Wan Haslina Wan Abdul Halim, Che Muhaya Mohamad (Kuala Lumpur/MAL) P-SA-276 Susceptibility trends of Staphylococcus epidermidis and Staphylococcus aureus ocular isolates A four year study. Evgenia Kanonidou, Christina Kanonidou, Anna Praidou, Vasilios Konidaris, Paraskevi Zotta, Irini Chatziralli, Nikolas Ziakas (Thessaloniki/GR) P-SA-277 Sympathetic ophthalmia following pars plana vitrectomy Regine Augsten, Bernhard Theiß, Jens Dawczynski, Ulrich Voigt, Ekkehart Königsdörffer (Jena/D) P-SA-278 The Immunohistological Comparison of Vitreous Body Injection in both Autologous and Homologous Forms with Hyalgan in Rabbits Knee Jionts Mahnaz Mosallaei, Negar Azarpira, Morsal Mehriar (Shiraz/IR) P-SA-279 The Value of Real-time PCR in Cytomegalovirusassociated anterior segment inflammation Michiko Kandori, Keiko Yakura, Naoki Komatsu, Chizu Touge, Yoshifumi Ikeda, Dai Miyazaki, Yoshitsugu Inoue (Yonago/J)

284 280 WOC 2010 Posters Saturday, 5 June Saturday, 5 June :30 to 17:00 P-SA-280 Transeptal Triamcinolone Injection In The Management of Non-Infectious Uveitis Harvey Uy (Makati City/RP) P-SA-281 Visual loss in Behçet s disease. Jasmin Singh, Simon Taylor, Miles Stanford, Susan Lightman (London/UK) P-SA-282 Vogt-Koyanagi-Harada disease simulating acute posterior multifocal placoid pigment epitheliopathy Noriko Nishikawa, Reiko Kinouchi, Satoshi Ishiko, Akitoshi Yoshida (Asahikawa/J) Sunday, 6 June :30-17:00 Poster exhibition of Poster P-SU-001 to P-SU-277. All poster authors will attend their posters from to hrs. Moderation Poster sessions on Sunday Alexander A. Bialasiewicz (Doha) Antonia M. Joussen (Berlin) Co- Oliver Ehrt (Munich) Anselm G. M. Jünemann (Erlangen) Franz H. Grus (Mainz) Carsten H. Meyer (Bonn) Susanne Pitz (Mainz) Susanne Butros (Ulm) Philip Maier (Freiburg) Jürgen Kampmeier (Ulm) Claus Cursiefen (Erlangen) Anatomy/Pathology P09 P-SU-001 Adenoid cystic carcinoma of the inferior medial eyelid. Anima Buehler (Freiburg/D) P-SU-002 Aspects regarding the arterial vascularization of the optic nerve Carmen Bolintineanu, Sorin Bolintineanu, Alina Sisu, Izabella Sargan, Loredana Stana, Luminioara Rosu (Timisoara/RO) P-SU-003 Biometrics: Anatomy of the human eye Hector Barajas (Mexico City/MEX) P-SU-004 Central Corneal Thickness, Lamina Cribrosa and Peripapillary Scleral Histomorphometry in Chinese Eyes Ruojin Ren (Beijing/CN) P-SU-005 Computed tomographic diagnosis in the tumoral pathology of orbits Carmen Bolintineanu, Sorin Bolintineanu, Monica Vaida, Elena Pop, Corina Matu, Iulia Ciobanu (Timisoara/RO) P-SU-006 Lens artifacts in human fetal eyes Martina C. Herwig, Annette M. Müller, Frank G. Holz, Karin U. Loeffler (Bonn/D) P-SU-007 Mixed lid tumour with an anusual high fraction of lipomatous tissue Sylvia Stadler, Claudia Auw-Hädrich (Freiburg/D)

285 WOC Sunday, 6 June :30-17:00 P-SU-008 The eye: Atlas of anatomical history Hector Barajas (Mexico City/MEX) P-SU-009 The spectrum of histopathological diagnoses in non-infectious orbital inflammation. Hazlita Isa, L. T. Tan, S. R. J. Taylor, P. J. Luthert, Susan Lightman (London/UK) P-SU-018 The Redwing-D Knowledgebase: Comprehensive Patent Informatics for Ocular Drugs and Diagnostics from 1970 Onward Hermann Mucke, Eva Mucke, Peter M. Mucke (Vienna/A) Conjunctiva/Contact Lenses P11 Sunday, 6 June Posters Biochemistry/Pharmacology P10 P-SU-010 An Analysis of Corneal Anesthesia Data from Patents Reveals Information Not Represented in the Peer Review Literature Hermann Mucke, Eva Mucke, Peter M. Mucke (Vienna/A) P-SU-020 A novel usage of pterygium tissue as an autologous graft in treating necrotising scleritis Othmaliza Othman, Norshamsiah Md Din, Howe Sen Kok (Kuala Lumpur/MAL) P-SU-021 Contact lens dry eye: new therapeutic approach. Lorenzo Mannucci (Padova/I) P-SU-011 Biochemical analysis of indocyanine green and infracyanine green solutions: ph, anions, osmolarity, precipitation and decomposition products Eduardo Rodrigues, Fernando Marcondes Penha, Elaine de Paula Fiod Costa, Mauricio Maia, Carsten H. Meyer, Michel Eid Farah (Florianopolis/BR, Bonn/D) P-SU-012 Detection of CXCR4 and CXCR7 at the ocular surface and in the lacrimal apparatus Julia Dieckow, Ute Schulze, Friedrich Paulsen (Halle/D) P-SU-013 Different Effects of PDGF and TGF-beta on fibroblast contractility and cell morphology Tobias Meyer-ter-Vehn (Wuerzburg/D) P-SU-014 Glucocorticoid-induced changes of Na+, K+-ATPase in lens: effect by a glucocorticoid receptor antagonist Guoli Xie, Hong Yan (Xi'an/CN) P-SU-022 Decreased bioavilability of thioredoxin may contribute to oxidative stress in the lens of diabetes Marjorie Lou (Lincoln/USA) P-SU-023 Development and antigen-related modulation of conjunctiva-associated lymphoid tissue (CALT) Sebastian Siebelmann, Uta Gehlsen, Salvatore Grisanti, Maya Mueller, Philipp Steven (Lübeck/D) P-SU-024 Doxycycline Effect in the Cytokine Profile and in the Pro/Anti-apoptotic proteins in pterygia derived cells Miguel Angel Vazquez Membrillo, Araceli Rojas- Diaz, Ximena Mira-Lorenzo, Atzin Robles- Contreras, Iliana Peñaloza-Roman, Ellery Lopez-Star, Teresa Valdez-Gonzalez, Francisco Martinez-Castro, Maria del Carmen Jimenez-Martinez, Victor Manuel Bautista De Lucio (Edo Mex/MEX) P-SU-025 Effect of Pterygium Surgery on Corneal Topography Banu Torun Acar, Suphi Acar (Istanbul/TR) P-SU-015 Increased Oxidative DNA damage and Lipid Peroxidation in Cultured Orbital Fibroblasts from Patients with Graves Ophthalmopathy Chieh-Chih Tsai, Hui-Chuan Kau, Shu-Ching Kao, Shu-Mei Lee (Taipei/TJ) P-SU-016 Metabonomics in ophthalmology Anna Midelfart (Trondheim/N) P-SU-017 The Effects of Prostaglandin Analogues on intracellular Ca2+ concentrations in EP-Receptor- Deficient Mice Ciliary Arteries Sanae Abe (Akita/J) P-SU-026 Effects of chemical disinfection contact lens care solutions on Acathamoeaba castellani Jacek P. Szaflik, Lidia Chomicz, Gabriela Olędzka, Jerzy Szaflik (Warszawa/PL) P-SU-027 Extensive Conjunctival Lymphangioma. A case report. Markus van Son, Magdalena Sara Tönz, Stephan Michels, Bernhard Schuknecht, Stephan Estermann (Zurich/CH) P-SU-028 Fitting contact lenses in childhood Beata Kettesy, Annamária Nagy, András Berta (Debrecen/H)

286 282 WOC 2010 Posters Sunday, 6 June Sunday, 6 June :30-17:00 P-SU-029 High risk of pseudomonas infection in contact lens induced keratitis in Eastern India Suman Saha, Jayangshu Sengupta, Archana Khetan (Kolkata/IND) P-SU-030 Impression Cytology in SLK: A Diagnostic Guideline Nibaran Gangopadhyay, Jayangshu Sengupta, Archana Khetan, Suman Saha, Merle Fernandes (Kolkata/IND) P-SU-031 Intravital multidimensional two-photon microscopy reveals rapid cellular dynamics in conjunctivaassociated lymphoid tissue Philipp Steven, Uta Gehlsen, Sebastian Siebelmann, Norbert Koop, Regina Orzekowsky-Schroeder, Salvatore Grisanti, Gereon Hüttmann (Lübeck /D) P-SU-032 Isolation, Characterization and Functional Activity of Adult and Fetal Human Conjunctival Epithelial Progenitors Nick Di Girolamo, Jeanie Chui, Sarah Davies, Denis Wakefield (Sydney/AUS) P-SU-033 Myopia Control and the Future of Ortho-k Ken Kopp (Mesa/USA) P-SU-034 Non invasive multi-dimensional two-photon microscopy enables optical characterization of key players in ocular surface inflammation Uta Gehlsen, Gereon Huettmann, Regina Orzekowsky-Schroeder, Norbert Koop, Sebastian Siebelmann, Philipp Steven (Lübeck/D) P-SU-035 Patterns of contact lenses wearing among students and attitudes towards a future refractive surgery. Evgenia Kanonidou, Anna Praidou, Christina Kanonidou, Paraskevi Zotta, Vasiliǫs Konidaris, Irini Chatziralli, Nikolas Ziakas (Thessaloniki/GR) P-SU-036 Topical cyclosporine A 0.05% in the treatment of severe vernal keratoconjunctivitis in Vietnamese patients. Tho Nguyen (Ho Chi Minh/VN) Cornea/Eye Bank: Basics P12 P-SU-037 Anisotropic Swelling Behavior of the Cornea Toyoaki Matsuura, Masahiko Annaka, Futoshi Taketani, Eiichi Yukawa, Tokuko Hara, Yoshiaki Hara (Kashihara /J) P-SU-038 Cell morphology and pluripotency marker expression in limbal epithelial stem cells cultured in different media Henning Thomasen, Emre Türkeli, Mikk Pauklin, Klaus-Peter Steuhl, Daniel Meller (Essen/D) P-SU-039 Confocal Microscopy in Chronic and Delayed Mustard Gas Keratopathy Siamak Zarei-Ghanavati, Mohammad-Reza Jafarinasab, Mojgan Rezaei-Kanavi, Farid Karimian, Mohammad-Reza Soroush, Mohammad-Ali Javadi (Mashhad/IR) P-SU-040 Effects of Selenium on Endothelial cells of mid-term stored corneas in the rabbit Chen Qu (Shanghai/CN) P-SU-041 Evaluation of a medium with human AB-serum for xenofree cornea preservation Burkhard von Jagow, Christian Ohrloff, Halvard Bönig (Frankfurt/D) P-SU-042 Expression of stem cell markers in conjunctival intraepithelial neoplasias Anne Pester, Mikk Pauklin, Henning Thomasen, Friedrich Otterbach, Kurt Werner Schmid, Klaus-Peter Steuhl, Daniel Meller (Essen/D) P-SU-043 Expression of the RAGE-receptor system and its ligands in Fuchs endothelial corneal dystrophy Hans Sebastian Walter, Stephan Hoffmann, D. Hasenfus, Berthold Seitz (Karlsruhe/D, Homburg/D) P-SU-044 Preliminary study of mesenchymal stem cells derived from murine corneal stroma Xiu-Jun Song, Jian-Min Lu (Shijiazhuang/CN) P-SU-045 Regulatory T cells as therapeutic option following keratoplasty in baby rats Johannes Schwartzkopff, Christian Jarsch, Laura Bredow, Yvonne Kern, Daniel Böhringer, Thomas Reinhard (Freiburg/D) P-SU-046 The Role of TNF-Rp-55 and TNF-Rp-75 on the Angiogenesis and Lymphangiogenesis in Corneal Neovascularization Johannes Gonnermann (Duesseldorf/D)

287 WOC Sunday, 6 June :30-17:00 Epidemiological Studies P-SU-047 Associations Between Dietary Factors and Intraocular Pressure Laurence Lim, Seang Mei Saw (Singapore/SGP) P-SU-048 Common causes of visual handicap and blindness in the registered blind people from the region of Eastern Herzegovina Ceklic Lala, Slobodanka Latinovic (Sarajevo/BIH, Novi Sad/SRB) P-SU-049 Early detection and treatment of eye diseases in children in Poland Beata Chrzanowska, Alina Bakunowicz-Lazarczyk (Bialystok/PL) P13 P-SU-050 Epidemiology of ocular casualty among the Egyptian population: a five year retrospective study Hany Elmekawey, Abueleinen K. G. Khaled, Abdelmaboud M. Mohamed, Khafagy A. Amr (Giza/ET) P-SU-051 Factors related to Sunlight Exposure and the Longterm Incidence of Cataract and Cataract Surgery The Blue Mountains Eye Study Gowri Kanthan, Paul Mitchell, Elena Rochtchina, Jie Jin Wang (Strathfield/AUS, Sydney/D) P-SU-052 Global Inequality in Eye Health: Country Level Analysis from the Global Burden of Disease Study Koichi Ono, Yoshimune Hiratsuka, Akira Murakami (Tokyo/J) P-SU-057 Ophthalmia Neonatorum: The true extent of the disease? Jaswant Sandhu, Kwok Yin Chan, Stephanie Hardy (Wolverhampton/UK) P-SU-058 Personal costs in retinal diseases a cost of illness study Gabriele Porz, Hendrik P. N. Scholl, Frank G. Holz, Robert P. Finger (Brohl-Lützing/D, Bonn/D) P-SU-059 Population-based study of microaneurysm number and distribution in the macula of Chinese type 2 diabetics with early diabetic retinopathy William Tao-Hsin Tung, Jorn-Hon Liu, Ch-Ming Liu (Taipei/TJ) P-SU-060 Prevalence and risk factors for myopia in college students in Shanghai. Jing Sun, Xianqun Fan, Jibo Zhou (Shanghai/CN) P-SU-061 Prevalence of anisometropia among 18 year old students in Poland Ewa Majdanik, Damian Czepita (Szczecin/P) P-SU-062 Prevalence of cataract blindness and visual impairment in Russian city. Sergey Branchevskiy, Khristo Takhchidi, Igor Malov (Samara/RUS, Moscow/RUS) P-SU-063 Prevalence of Demodex folliculorum and Demodex brevis on eyelashes in a Polish population Andrzej Grobelny, Damian Czepita (Szczecin/P) Sunday, 6 June Posters P-SU-053 LOXL1 gene polymorphisms and glaucoma secondary to familial amyloidotic polyneuropathy in Japanese Toshiyuki Kyomoto, Takanobu Kikuchi, Teruyoshi Miyahara, Toshinori Murata, Kana Tojo, Shu-ichi Ikeda (Matsumoto/J) P-SU-064 Prevalence of diabetes and diabetic retinopathy in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey Fatima Kyari, Selvaraj Sivasubramaniam, Tunde Peto, Clare Gilbert, The Nigeria National Blindness and Visual Impairment Study Group (London/UK) P-SU-054 Normal Intraocular Pressure, Corneal diameter, and Cupping In Newborns Osama Badeeb (Jeddah/SA) P-SU-055 Ocular Hypertension Lorraine-France study (HOLF) Olivier Henckes, Toufic Maalouf, Michel Helfenstein, Franck May, Jean Luc George (Nancy/F) P-SU-056 Ophthalmia Neonatorum: Clinical Features, Outcomes and Under-reported Notification in a Large UK General Hospital Manjit Singh Mehat (Birmingham/UK) P-SU-065 The impact of visual impairment and eye diseases on quality of life in Taiwanese patients utilizing eye care services Jen-Chieh Lin, Mei-Shu Lai (Taipei/TJ) P-SU-066 The prevalence and causes of visual impairment in Sichuan Province: findings from the China Second National Sample Survey on Disability Min Wei, Sophia Pathai, Ying Chuan Fan (New York/USA)

288 284 WOC 2010 Posters Sunday, 6 June Sunday, 6 June :30-17:00 Epidemiology P14 P-SU-067 An Overview of Shih-Pai Eye Study Wen-Ming Hsu, Ching-Yu Cheng, Tung-Mei Kuang, Pei-Yu Lin, Catherine Jui-Ling Liu, Shih-Jen Chen, Jorn-Horn Liu (Taipei/TJ) P-SU-068 Burden and severity of ophthalmic zoster in 2007 in France: a hospital study Gilles Berrut, Xavier Bresse, Karine Bloch, Jérôme Fernandes, Alexandre Vainchtock (Nantes/F) P-SU-077 Saints and the Eye Muhammad Younis, Ahmad Mansour, Joseph Walsh (Manchester/RL) P-SU-078 The Fate of Injured and Persecuted Ophthalmologists as well as Persons Closely Related to Ophthalmology in National Socialism ( ), Particularly Dealing with those of Jewish Faith or Heritage. Udo Hennighausen (Heide/D) P-SU-069 Epidemiology of Primary Glaucoma in the Kyrgyz Republic Olzhobai Dzhumagulov (Bishkek/KIS) P-SU-070 Epidemiology of Pterygium in Aged Population in Beijing Country, China Qingfeng Liang, Liang Xu (Beijing/CN) P-SU-071 Ophthalmic Zoster in the UK: Burden in Secondary Care (2007) Ian Power, Xavier Bresse, Azharul Mannan, Christopher Morgan (Lyon/F) P-SU-072 Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: implications for baseline ophthalmic screening Sophia Pathai, Alaka Deshpande, Clare Gilbert, Stephen Lawn (New York/USA) P-SU-073 The influence of selected environmental factors on the frequency of refractive errors among schoolage children. Magdalena Dalz, Maria Dalz (Pozna /PÖ) External Disease P-SU-079 A no suture conjunctival graft approach to pterygium surgery Aneesur Rahman (Petaling Jaya/MAL) P16 P-SU-080 Blepharitis therapy with the topical anti-inflammatory macrolide antibiotic Azithromycin 1.5% Antonio Bergua, Matthias Zenkel, Jeanette Gabel (Erlangen/D) P-SU-081 Effective Treatment of Ligneous Conjunctivitis with Topical Plasminogen Concentrates Abdullah Al-Turbaq (Riyadh/SA) P-SU-082 Investigative study of new cases of Acanthamoeba keratitis: an emergent infection in the management of external ocular diseases Denise Freitas, Fabio R. S. Carvalho, Juliana F. Camargo, Annette S. Foronda (Sao Paulo/BR) P-SU-083 Long-term assessment of pterygium surgery by conjunctival autograft with fibrin adhesive. Eduardo Conesa, Esther Mata, Carlos De Pablo, Cristina Montón (Madrid/E) Ethics/Medical History/Traffic Ophthalmology P15 P-SU-074 MÜR D : A Turkish Ophthalmology Textbook in XVth Century Anatolia Do an Ceyhan (Van/TR) P-SU-075 Albrecht von Graefe - "Father of glaucoma" Milan Ivanisevic, Lovro Bojic, Robert Stanic, Petar Ivanisevic (Split/HR) P-SU-084 Morganella Morganii Conjunctivitis: Case Report Maria Fernanda Abalem de Sá, Leticia de Castro Moura Brasil, Marcio Penha Morterá Rodrigues, Daniella Socci da Costa (Rio de Janeiro/BR) P-SU-085 Ocular rosacea: Glycomics analysis of tear and saliva for disease biomarkers. Ana Carolina Vieira, Sureyya Ozcan, Hyun Joo Ann, Carlito Lebrilla, Mark Mannis (Rio de Janeiro/BR) P-SU-076 Folk Treatment of Eye Diseases using Medicinal Herbs in Croatia Vjekoslav Dorn (Zagreb/HR) P-SU-086 Predictive factors of keratoplasty in keratoconus Nestor Cortes Mora, David Galarreta, Fernando Sánchez-Mannarelli, Alejandro Portero-Benito, Belen Carrasco, David Peña, Jesus Merayo-Lloves (Valladolid/E)

289 WOC Sunday, 6 June :30-17:00 P-SU-087 Prevention and treatment of meibomian gland dysfunction Maria Pimenidi (Moscow/RUS) P-SU-088 Tear proteomic analysis of dry eye syndrom in type 2 diabetes mellitus patients Bing Li, Minjie Sheng, Feng Liu, Guoquan Yan, Anjuan Lin, Weifang Wang, Yanhong Li, Chunlei Xie, Fei Zhao (Shanghai/CN) P-SU-089 The effect of vancomycin eye ointment for MRSA/MRSE ocular surface infection Masahiko Fukuda, Chie Sotozono, Masao Ohishi, Keiko Yano, Hideki Orikasa, Yoshikazu Shimomura (Osaka-Sayama/J) P-SU-090 The Efficacy of Topical Levofloxacin 0.5% in Treating Levofloxacin-Resistant Pseudomonas Aeruginosa Induced Keratitis Kianti Darusman (Jakarta/RI) P-SU-091 The Expression of Matrix Metallo Proteinase-1 (MMP-1) in Primary Pterygium After Subconjunctival Injection of Triamcinolone Acetonide and Mitomycin C Suhardjo Suhardjo, Ayu Suryaningsih Oetoyo, Dharmawan M Sophian (Yogyakarta/RI) P-SU-092 Unilateral epidemic keratoconjunctivitis with membrane formation Mentor Gorani, Merita Ilazi, Mentor Ilazi (Prishtina/KS) Glaucoma: Basics P17 P-SU-093 Agmatine and oxidative stress-induced cytotoxicity in primary retinal ganglion cells and Müller glial cells Samin Hong, Chan Yun Kim, Yoko Iizuka, Gong Je Seong (Seoul/ROK) P-SU-094 Comparison of IgG and IgM Autoantibody Patterns in Glaucoma Patients Sabine Beck, Nils Boehm, Marcus Schlich, Joachim Richter, Karin Pfirrmann, Norbert Pfeiffer, Franz Grus (Mainz/D) P-SU-095 FGF plays a regulatory role in the early stages of the ciliary body development. Justyna Klos-Rola, Tomasz Zarnowski, Jeanette Hyer (Lublin/PL) P-SU-096 Involvement of glutamate in retinal degeneration induced by pressure elevation in isolated retina Makoto Ishikawa, Yukitoshi Izumi, Takeshi Yoshitomi (Akita/J) P-SU-097 Malignant Melanoma and the Use of Latanoprost: A Risk Assessment Charles Tressler, Robert Wiseman, Theresa Dombi, Bart Jessen, Kui Huang, Kenneth Kwok, Ken Salatka, Barbara Wirostko (New York/USA) P-SU-098 Matrix-metalloproteinases and their inhibitors in the aqueous humor of glaucoma patients: effect of antiglaucoma drugs Matthias Zenkel, Jasmina Djordjevic-Jocic, Piotr Lewczuk, Anita Krysta, Anselm Jünemann, Friedrich Kruse, Johannes Kornhuber, Ursula Schlötzer-Schrehardt (Erlangen/D) P-SU-099 Morphological changes of trabeculectomy specimens in patients with uveitic glaucoma. Carsten Heinz, Ozan Tektas, Arnd Heiligenhaus, Elke Lütjen-Drecoll (Münster/D, Erlangen/D) P-SU-100 Plasminogen activator inhibitor-1 in the aqueous humor of patients with pseudoexfoliation syndrome with or without glaucoma Konstantinos Zinelis, Ioannis Tsinopoulos, Nikolaos Kopsachilis, Sebastian Weiß, Rolf Winter, Michael Wolfgang Meyer (Hannover/D) P-SU-101 Possible stress factors working on retinal nerve fibers at the scleral rim. Jens Georg Hetland (Oslo/N) P-SU-102 Pro370Leu mutant myocilin impairs mitochondrial functions in human trabecular meshwork cells Yuan He (Xi'an/CN) P-SU-103 Proteome analyses of HMGB-1 in a rat experimental glaucoma model and its role in neurodegeneration Maurice Schallenberg, Harut Melkonyan, Guang-Yu Li, Solon Thanos (Essen/D, Münster/D) P-SU-104 Retinal ganglion cells in the Experimental Autoimmune Glaucoma Model die through apoptosis Stephanie C. Joachim, Oliver W. Gramlich, Zacharias Loos, Panagiotis Laspas, Vanessa D. Stahl, Norbert Pfeiffer, Franz H. Grus (Mainz/D) Sunday, 6 June Posters

290 286 WOC 2010 Posters Sunday, 6 June Sunday, 6 June :30-17:00 P-SU-105 Substrate elasticity modulates TGF-beta signaling in human trabecular meshwork cells Hong Han, Thomas Wecker, Franz Grehn, Schlunck Günther (Wuerzburg/D) P-SU-106 The effect of central corneal thickness on intraocular pressure measurements by Goldmann applanation tonometer and non-contact tonometer in a military hospital Yener Celik, Levent Ersoy (Istanbul/TR) P-SU-113 Trial of Static program for AMA s Visual Field Score by Humphrey Custom Program compared to Goldmann measurement Junko Kamo, Ryo Harada (Kofu/J) P-SU-114 Visual outcome of long-term survivors with inborn error of metabolism Hideki Oohashi (Isehara/J) Neuro-Ophthalmology P19 Low Vision P18 P-SU-107 Association between quality of life and changes in visual acuity in Japanese patients with low vision Meiko Yanagisawa, Satoshi Kato, Shiho Kunimatsu, Megumi Kobayashi, Makiko Ochiai, Nobuyuki Shoji (Tokyo/J) P-SU-108 Development and validation of The Eye Clinic Opinion Satisfaction (TEC-OS) questionnaire for Low Vision Aid Sakshi Mehrotra, Abhas Mehrotra (Chandigarh/IND) P-SU-109 Educational Inclusion at a Private University in Brazil: Accessibility and Pedagogical Aspects in the Humanities, Economics and Business and Science and Engineering Courses M. Cristina de O. Regina (Campinas/BR) P-SU-110 Efficacy of dexamethasone intravitreal implant for the treatment of uveitis based on patient-reported vision function outcome measures Jonathan W. Kowalski, Heather Gelhorn, Rupali K. Naik, Anne Rentz, Harry Cui, Careen Lowder, Rubens Belfort Jr., Steven Foster, Sue Lightman, Scott M. Whitcup (Irvine/USA, Cologne/D, São Paulo/BR, London/UK, Irvine/USA) P-SU-111 First results of the IOL-Vip system Visual rehabilitation of patients with low-vision due to severe age-related macular degeneration Ramin Khoramnia, Christoph Winkler von Mohrenfels, Josefina Salgado, Barbara Schwaiger, Michaela Engel, Chris Lohmann (Munich/D) P-SU-112 Language development in children with retinopathy of prematurity Galton Carvalho Vasconcelos, Erika Parlato Oliveira, Janaina Couto Sacramento, Silmara de Abreu Melgaço (Belo Horizonte/BR) P-SU-115 A case of hypertrophic pachymeningitis with optic neuritis-like symptoms Sachi Abe, Akira Sugano, Teiko Yamamoto, Takeo Kato, Manabu Wada, Takamasa Kayama, Sunao Takemura, Hidetoshi Yamashita (Yamagata/J) P-SU-116 A case of Miller Fisher syndrome Ilona Ryseck (Hamburg/D) P-SU-117 A case report about mucormycosis in sinus sphenoidalis misdiagnosed to apical orbital syndrome result from tumor Shihui Wei (Beijing/CN) P-SU-118 A Case Report: Recurrence of an Orbital Tumor V. Nandini, Z. A. Zurina, N. Vairavan, V. Waran (Kuala Lumpur/MAL) P-SU-119 A proposal about pseudo-barre-lieou syndrome Masayoshi Kajita (Tokyo/J) P-SU-120 Abducens ocular neuromyotonia in a patient with nasopharyngeal carcinoma following concurrent chemo-radiotherapy Hui-Chuan Kau, Chieh-Chih Tsai (Taipei/TJ) P-SU-121 Acute zonal occult outer retinopathy presented with annular scotoma and periphlebitis in a Japanese girl Masashi Nishimura, Naohiro Ikeda, Tomohiro Ikeda, Akiko Masuda, Osamu Mimura (Nishinomiya/J) P-SU-122 Alpha2-adrenergic receptors ans their core involvement in the process of axonal regeneration in the retina Verena Prokosch, Lambros Panagis, Gerd-Fabian Volk, Caterina Dermon, Solon Thanos (Münster/D)

291 WOC Sunday, 6 June :30-17:00 P-SU-123 Analysis of ocular motor dysfunctions related to multiple sclerosis Shihui Wei (Beijing/CN) P-SU-124 Bilateral vitreous hemorrhages predict poor vision in Shaken Baby Syndrome in Japan. Yuri Kobayashi, Makiko Itou, Michiko Tanaka, Tadashi Yokoi, Sachiko Nishina, Shizuko Ohba, Makiko Okuyama, Noriyuki Azuma (Tokyo/J) P-SU-134 Crossed Quadrant Homonymous Hemianopia Post Myocardial Infarction: A Case Report Indira Nadras, Norlelawati Abu, Bethel Livingstone (Seremban/MAL) P-SU-135 Demanding treatment of neuromyelitis optica in Japanese patient Aya Sakamoto, Masashi Nishimura, Shuhei Kasama, Keiko Tanaka, Osamu Mimura (Nishinomiya/J) Sunday, 6 June Posters P-SU-125 Cerebrospinal fluid dynamics between the basal cisterns and the perioptic space in patients with papilledema Hanspeter Killer, Gregor Jaggi, Neil Miller, Luca Remonda (Aarau/CH) P-SU-136 Diffusion tensor imaging (DTI)-based white matter mapping in children with amblyopia: underdevelopment of optic radiation study Hong Yan, Yongxing Xing, Guangbing Cui, Junjie Zhi (Xi'an/CN) P-SU-126 Characteristic of Ocular Motor Disorder Patients in Neuroophthalmology Division, DR Ciptomangunkusumo Hospital, Syntia Nusanti (Jakarta/RI) P-SU-127 Clinical analysis of amaurosis fugax caused by cardiovascular and cerebrovascular disease Shihui Wei (Beijing/CN) P-SU-128 Clinical Analysis of Different Ocular Changes in Intraocular Anecurysm of Different Locations Shihui Wei (Beijing/CN) P-SU-129 Clinical analysis of mucormycosis 9 A case report Shihui Wei (Beijing/CN) P-SU-130 Clinical analysis of ocular manifestations related to Takayasu arteritis Shihui Wei (Beijing/CN) P-SU-131 Clinical characteristic and optimization of treatment of optico-kinetic disadaptation syndrome in children with perinatal encephalopathy. Sevinj Salmanova, Elmar Kasimov, Sima Huseynova (Baku/ASE) P-SU-132 Comparison of Retinal Nerve Fiber Layer Measurements Using Time Domain and Spectral Domain Optical Coherence Tomography in Optic Nerve Head Drusen Francisco J. Muñoz-Negrete, Laura Guerrero, Gema Rebolleda, Elena Jarrín (Madrid/E) P-SU-137 Evaluating visual field states in patients with optic neuropathy: VEP measurements in relative defect visual field Eileen Poloski, Nicole Dettler, Bernhard A. Sabel, Christoph S. Herrmann, Carolin Gall (Magdeburg/D) P-SU-138 Experimental mouse model of optic neuritis Shihui Wei (Beijing/CN) P-SU-139 First report of primitive neuroectodermal tumors originally in Optic nerve Shihui Wei (Beijing/CN) P-SU-140 Fluorescein angiography in patients with nonarteritic anterior ischemic optic neuropathy. Thalia Vasiliou, Marion Kaup, Niklas Plange, Andreas Remky (Aachen/D) P-SU-141 High titres of serum anti-aquaporin-4 (AQP4) antibody after successful plasmapheresis in AQP4- positive optic neuritis Eiji Murotani, Shinji Ohkubo, Mayumi Sakurai, Kazuhisa Sugiyama, Mitsuhiro Kawano, Mineo Takagi, Keiko Tanaka (Kanazawa/J) P-SU-142 Idiopathic Bilateral Iris Atrophy Elizabeth Palkovacs, Karl Golnik (Cincinnati/USA) P-SU-143 Incidence of cerebral venous sinus thrombosis in patients with idiopathic intracranial hypertension. Shihui Wei (Beijing/CN) P-SU-133 Correcting Strabismus in Patients with Central Nervous System Lesions Juan Bu, Lejin Wang, Jing Li, Xin Tian (Beijing/CN)

292 288 WOC 2010 Posters Sunday, 6 June Sunday, 6 June :30-17:00 P-SU-144 Internuclear Ophthalmoplegia as an Initial Manifestation of Multiple Sclerosis A Case Report Filipa Rodrigues, Cláudia Costa-Ferreira, Manuela Amorim, Raquel Soares, José Salgado-Borges (Aveiro/P) P-SU-145 Lymphocytic hypophysitis presenting as optic neuritis Katja Christina Schielke, Sophie Anna Holak, Linda M. Buchanan, J. Angus Scott (Aalborg/DK, Berlin/D) P-SU-153 Phosphene thresholds during repetitive transorbital alternating current stimulation (rtacs) relate to severity of vision loss in patients with optic neuropathy Romualda Michalik, Carolin Gall, Anton B. Federov, Stephan Brandt, Bernhard A. Sabel (Kleinmachnow/D, Magdeburg/D) P-SU-154 Pituitary ectopia in a case of bilateral optic nerve hypoplasia-a case report Tsui-Kang Hsu (Taipei/TJ) P-SU-146 Multifocal Photopic Negative Response (mfphnr) and Visual Field (VF) in patients with optic nerve lesions Ari Kamei, Eiichiro Nagasaka (Oshu/J) P-SU-147 Multiple Meningiomatosis, Mesencephalic Venous Anomaly and Cerebral Calcifications: Ocular Manifestations. Clinical Case Francisco Javier Hernandez Martinez, Purificacion Piñas Garcia, Araceli Trueba Lawand (Sevilla/E) P-SU-148 Multipotent Neural Progenitor Cells Support Regeneration Of Axons Within The Rat Optic Nerve Carolin Chiwitt, Petar Charalambous, Mirjam Augustin, Solon Thanos (Münster/D) P-SU-149 Ocular clinical characteristics in Lymphocytic hypophysitis Shihui Wei (Beijing/CN) P-SU-150 Ocular complications with acoustic neuroma surgical resection Muhammad Amjad, A. Garrick, I. Marsh, C. Noonan (Manchester/UK) P-SU-155 Pituitary Tumor Apoplexy Long-term Follow-up Marketa Machackova, Dagmar Hejcmanova, Ivan Latr (Hradec Kralove/CZ) P-SU-156 Preliminary exploration of intracranial aneurysms with ophthalmic symptoms Shihui Wei (Beijing/CN) P-SU-157 Preliminary report of contrast sensitivity values after idiopathic optic neuritis Shihui Wei (Beijing/CN) P-SU-158 Relationship between anti-aquaporin-4 antibody and anti-myelin oligodendrocyte glycoprotein antibody in patients with optic neuritis Ryusaku Matsuda, Takeshi Kezuka, Yoshimiti Matsunaga, Yoshihiko Usui, Naoyuki Yamakawa, Keiko Tanaka, Hiroshi Goto (Tokyo/J) P-SU-159 Relationship between Macular Ganglion Cell Complex Parameters and Visual Field Sensitivity in Chiasmal Compression Shinji Ohkubo, Tomomi Higashide, Hisashi Takeda, Eiji Murotani, Kazuhisa Sugiyama (Kanazawa/J) P-SU-151 Ophthalmic Herpes Zoster: Natural history, morbidity, treatment and prevention Peter Wutzler, Arnd Heiligenhaus, Angus Thomson, Isabelle Bertrand (Jena/D, Münster/D, Lyon/F) P-SU-160 Restoration of vision restoration: training improves visual fields in glaucoma a double-blind, randomized, placebo-controlled clinical trial Bernhard A. Sabel, Julia Gudlin (Magdeburg/D) P-SU-152 Optic Disc Drusen-diagnose, clinical manifestations, and prognosis Sonja Cekić, Gordana Stanković Babić, Jasmina D- ord ević Jocić, Jovica Mršić, Ivan Jovanović (Nis/SRB) P-SU-161 Restoration of vision: Improvements of parafoveal visual field are associated with increased reading speed after training of light detection in patients with homonymous visual field defects Daniela Komm, Bernhard A. Sabel, Carolin Gall (Magdeburg/D) P-SU-162 Restoration of vision: development of a pre-clinical model for repetitive transorbital alternating current stimulation after optic nerve crush Petra Henrich-Noack, Nadine Voigt, Sylvia Prilloff, Bernhard A. Sabel (Magdeburg/D)

293 WOC Sunday, 6 June :30-17:00 P-SU-163 Retrospective analysis of optic neuritis among the patients of multiple sclerosis Shihui Wei (Beijing/CN) P-SU-164 Study of the threshold defect of branch retinal vein occlusion Shihui Wei (Beijing/CN) P-SU-165 Study of visual evoked potential with irregular pattern stimulation in normal human subject S. M. Shushtarian, Sara Mohammadi, M. J. Motamedi, T. Davari (Tehran/IR) P-SU-166 Study of visual function and retinal morphology in the mice model of experimental optic neuritis Shihui Wei (Beijing/CN) P-SU-167 The analysis of clinic characters of slightly indirect traumatic optic neuropathy Shihui Wei (Beijing/CN) P-SU-168 The clinical research of correlation factors of abducens nerve paralysis of 47 hospitalized patients Shihui Wei (Beijing/CN) P-SU-169 The Contribution of Ultrasound to the Diagnosis and Follow-Up of Giant Cell Arteritis. A Pilot Study Ana Suelves, J. I. Tembl, Enrique España-Gregori, Stephanie Rohrweck, Diamar Pardo-Lopez, Salvador Garcia-Delpech, Patricia Udaondo, Manuel Díaz-Llopis (Xirivella/E, Valencia/E) P-SU-170 The situation of ocular ischemic diseases cured by carotid artery endarterectomy Shihui Wei (Beijing/CN) P-SU-171 To analyse the clinical features of The diseases in occipital lobe Shihui Wei (Beijing/CN) P-SU-172 To analyse the correlation of the of the lesions in visual pathway posterior to the chiasm with eye symptom. Shihui Wei (Beijing/CN) P-SU-173 VEP and other visual functions before and after surgical excision of tumors compressing anterior visual pathway. Jawahar Lal Goyal, Lanalyn Thangkhiew, Usha Yadava (Noida/IND) P-SU-174 Vision- and health- related quality of life in stroke patients with homonymous visual field defects depend on severity of visual function loss Caroline Wagenbreth, Gabriele H. Franke, Bernhard A. Sabel, Carolin Gall (Magdeburg/D) P-SU-175 Vision- and health-related quality of life before and after vision restoration training in cerebrally damaged patients. Anja Lindig, Bernhard A. Sabel, Carolin Gall (Oldenburg/D, Magdeburg/D) P-SU-176 Visual Field Deficit in Patient with the Optic Nerve Drusen and the Pineal Cyst-case report Ana Pepic, Biljana Draganic, Jelena Mladenovic, Dusanka Mrvos-Cobeljic (Belgrade/SRB) P-SU-177 Visual fields, visual acuity and driving performance in patients with pituitary adenoma before and after surgery Evelin Schneider, Gwendolyn Gramer, Eugen Gramer (Wuerzburg/D) P-SU-178 Visual functions assesment in case of functioning pituitary micraodenomas Brigita Budiene, Rasa Liutkeviciene, Rita Lukauskiene, Kestutis Sinkunas (Kaunas/LT) New Technology, Bioengineering, Nanotechnology P-SU-179 Classification of Ophthalmic Viscoelastic Devices using the Weissenberg Number Bernd-Kristof Müller, Helmut Ritter, Yong Keun Kim, Dirk-Henning Menz (Duesseldorf/D) P20 P-SU-180 Comparison Between Simulated and Real Ablations in Customized Contact Lens Luciana de Matos, Claudia Francesconi, Enos de Oliveira, Luis Alberto Vieira de Carvalho (São Carlos/BR) P-SU-181 Cultivation of human cornea cells on the surface of siloxan-gidrogel contact lenses. Oleg Germanovich Makeev, Sergey Aleksandrovich Korotkih, Elena Stepanovna Knyazeva, Maxim Gerasimov, Anastasya Evgenevna Zvereva (Ekaterinburg/RUS) P-SU-182 Effects of riboflavin and UV irradiation on sclera rigidity Muka Moriyama, Kyoko Oono, Ikuo Morita, Manabu Motizuki, Sakuya Tamada, Takuya Kisimoto, Akio Yasuda (Tokyo/J) Sunday, 6 June Posters

294 290 WOC 2010 Posters Sunday, 6 June Sunday, 6 June :30-17:00 P-SU-183 Evaluation of conjunctival circulation using scanning laser ophthalmoscope Michiya Takamatsu, Takashi Sone, Yoshiaki Kiuchi (Hiroshima/J) P-SU-184 FLASH software to improve basic ophthalmological education: Retinoscopy Trainer and Goldmann Perimetry Trainer Heiko Wassill, Birgit Lorenz, Thomas Stoll, Mini Köhler, Thomas Kowarsch (Giessen/D) P-SU-185 Injectabilty of viscoelastic solutions Dirk-Henning Menz, Yong Keun Kim, Cora Keil (Königsbrunn/D) P-SU-186 One year experience with a novel tonometer and contact glass disinfection device (Tonoclean) Aljoscha Neubauer, Ronald Spaltmann, Werner Reis, Christoph Hirneiss (Munich/D) P-SU-187 Optical coherence tomography assisted anterior segment surgery OCTAASS Gabor Scharioth (Recklinghausen/D) P-SU-188 Quantitative proteomic analysis of human aqueous humor by mass spectrometry Andreas Pollreisz, Marion Funk, Florian P. Breitwieser, Stefan Sacu, André Mueller, Melanie Planyavsky, Jacques Colinge, Michael Georgopoulos, Keiryn L. Bennett, Guilio Superti- Furga, Ursula Schmidt-Erfurth (Vienna/A) P-SU-189 Surface Quality Characteristics of Intraocular Lenses Assessed by Atomic Force Microscopy Partha Biswas, Koel Choudhury, Subhrangshu Sengupta, Ajoy Paul, Rashmi Mukherjee (Kolkata/IND) P-SU-190 Which physical actuation principles are suitable for driving the optics of an implantable mechatronic accommodation system? Thomas Martin, Ulrich Gengenbach, Georg Bretthauer, Rudolf Guthoff (Eggenstein- Leopoldshafen/D, Karlsruhe/D, Rostock/D) Oculoplasty/Orbita/Lids/Lacrimal System P-SU-191 A case of congenital tarsal kink syndrome treated with everting sutures Aristeidis Konstantinidis, Kave Vahdani, James Benzimra, Khaik Kee Peh, Vladimir Thaller (Plymouth/UK) P-SU-192 A case report on the management of an orbital foreign body Livia Teo, Audrey Looi, Lay Leng Seah (Singapore/SGP) P21 P-SU-193 A Modified Container with Drainage Tube for Secondary Reconstruction of Severe Contracted Eye Socket Ming Lin, Xianqun Fan (Shanghai/CN) P-SU-194 A novel disease-specific quality of life questionnaire closely correlates with objective parameters in Graves orbitopathy Katharina A. Ponto, George J. Kahaly, Susanne Pitz, Gerhard Hommel, Norbert Pfeiffer (Mainz/D) P-SU-195 Amniotic membrane grafting in Epidermal nevus syndrome Brahm Guliani, Shreekant Damgude, Anuj Mehta, Krishan Malik, Vishnu Gupta (Coimbatore/IND) P-SU-196 An unusual course of a case with orbital cellulitis Jan Köhler, Thomas Büchner, Burkhard Wiechens (Hannover/D) P-SU-197 Anthropometry of the Arabian eyes Amal Bukhari (Jeddah/SA) P-SU-198 Ascending Nasolacrimal System Obstruction in a pediatric age patient with Lichen Planus. Pelin Kaynak-Hekimhan, Serhat Imamoglu, Can Ozturker, Birsen Gokyigit, Ahmet Demirok, Omer Faruk Yilmaz (Istanbul/TR) P-SU-199 Basal Cell Carcinoma of the Eyelid in Young Woman Lidija Perez (Bitola/MK) P-SU-200 Benign fibrous histiocytoma of the eyelid Stephan Eckert, Gerhard Klaus Lang (Ulm/D)

295 WOC Sunday, 6 June :30-17:00 P-SU-201 Comparative experimental study of biological integration of different implantation materials used for orbital surgery Tatiana Bakaeva, Anatoly Fedorov, Yaroslav Grusha (Moscow/RUS) P-SU-202 Conjunctival alterations in ocular pemphigoid: a confocal laser-scanning microscopy study. Giulia Renieri, Eva Hecht, Esther von Stebut- Borschitz, Norbert Pfeiffer, Susanne Pitz (Mainz/D) P-SU-203 Correction of Telecanthus and ptosis in Patients with the Blepharophimosis Syndrome Ashok Grover (New Delhi/IND) P-SU-204 Dig deeper into the tear proteome: advanced protein profiling in dry eye patients Klaus Thomas Ude, Nils Boehm, Michaela Wiegand, Norbert Pfeiffer, Franz Grus (Mainz/D) P-SU-212 How accurate is clinical and radiological evaluation of orbital lesions in comparison to orbital biopsy? Antigoni Koukkoulli (Leeds/UK) P-SU-213 In Vivo Efficacy of Bone Marrow Stromal Cells Coated Beta-Tricalcium Phosphate for the Reconstruction of Orbital Defects in the Canine Huifang Zhou, Xianqun Fan, Caiwen Xiao (Shanghai/CN) P-SU-214 Late presentation of congenital nasolacrimal duct obstruction. Can be cured by simple probing? Osama Shalaby, M. Ashraf El Desouky (Tanta/ET) P-SU-215 Lid reconstruction without local blood supply a new method combining Hughes-flap, skin graft and tarso-marginal graft for lower lid defects extending into the canthus Falk Sommer (Dresden/D) Sunday, 6 June Posters P-SU-205 Dry Eye and Pterygium Khakima Karim-Zade, Zukhra Akhrorova (Dushanbe/TAD) P-SU-216 Looi Suture Technique for Anchoring the Lateral Tarsal Strip to the Orbital Wall Joy Chan, Audrey Looi (Singapore/SGP) P-SU-206 Dry Eye Disease Activity Log A New Tool in Management of Patients with Dry Eye Disease Jayant Venkatramani Iyer, Hak Tien Louis Tong (Singapore/SGP) P-SU-217 Management of orbital venous malformation with intralesional injection of Pingyangmycin:a primary study Renbing Jia (Shanghai/CN) P-SU-207 Early Gold Weight Implants in the management of paralytic lagophthalmos Esther Mata, Eduardo Conesa, Carlos De Pablo (Madrid/E) P-SU-208 Effects of Botulinum Toxin-A in Orbicularis Oculi Muscle of Patients with Blepharospasm Pilot Study Tammy Osaki, Midori Osaki, Suely Marie, Rubens Belfort, Jr., Teissy Osaki (Sao Paulo/BR) P-SU-209 Evaluation of Motility in Primary pegged anophthalmic implant Hadi Khazaei (Bangalore/IND) P-SU-218 Metastases in oropharyngeal carcinoma Lutz Becker (Ulm/D) P-SU-219 Minimally invasive surgery of blepharoptosis by short-pulsed CO2 laser irradiation with Mueller muscle tucking and visual function improvement. Kazuhiko Dannoue, Nobuyuki Miyata, Eiichi Okada, Satoki Ueno (Kawasaki/J) P-SU-220 Minor conjunctivitis expands to fulminant necrotic fasciitis due to infection with Streptococcus pyogenes Inez Brunotte, Sebastian Weiß, Konstantinos Zinelis, Rolf Winter, Michael Meyer (Hannover/D) P-SU-210 Granulocytic sarcoma of lacrimal gland preceding the blast phase of acute non-lymphoblastic leukemia. Jutarat Pomsathit (Bangkok/T) P-SU-211 Histopathologic evaluation of eyelid lesions: When to order, when to omit? Yasser Y. M. Hassan Al-Faky (Riyadh/SA) P-SU-221 Modified Staged Correction For Blepharophimosis- Ptosis-Epicanthus Inversus Syndrome Xin Song, Xianqun Fan (Shanghai/CN) P-SU-222 Moh s Micrographic Surgery for Chinese Patients with Eyelid Basal Cell Carcinoma Terence Goh, David Liu, Kelvin Chong, Ben Wong, Gary Tse, HK Ng, Dennis Lam (Kowloon/HK)

296 292 WOC 2010 Posters Sunday, 6 June Sunday, 6 June :30-17:00 P-SU-223 Mucosal spread of sebaceous cell carcinoma and conjunctival melanoma through the lacrimal system to the ethmoid sinus and nose. Manpreet Chhabra, Jill Melicher Larson, Jeffrey Nerad (Cincinnati/USA) P-SU-224 Myxofibrosarcoma of the orbit Sharifah Intan Syed Osman (Selangor/MAL) P-SU-225 New technique for recanalisation of nasolacrimal duct Mirsad Ibisevic (Sarajevo/BIH) P-SU-226 Oculoplastic reconstruction of the periocular region after severe facial burns a case report Peter Galambos, Hans-Werner Meyer-Rüsenberg, Ulrich Schaudig (Hamburg/D) P-SU-227 One-step surgical management of severe orbito-temporal neurofibromatosis Jin Li, Xianqun Fan (Shanghai/CN) P-SU-228 Ophthalmic Complications and their Avoidance During Functional Endoscopic Sinus Surgery Imtiaz Chaudhry, Yonca Arat, Waleed Al-Rashed, Elsanusi Elzaridi, Adel Alsuhaibani, Manal Bouhaimad, Milton Boniuk (Riyadh/SA, Houston/USA) P-SU-229 Orbital apex syndrome in Songklanagarind hospital Orapan Aryasit (Songkhla/T) P-SU-230 Primary non-hodgkin's lymphoma of the lacrimal sac: a case report Natha Chongpison (Bangkok/T) P-SU-231 Profound visual loss in a patient receiving periorbital treatments of poly-(l)-lactic acid Steve Roberts, Bryan Arthurs, Mark Gans, Jean Deschenes, Mashad Darvish (Montreal/CDN) P-SU-234 Reconstruction of Severe Anophthalmic Orbits and Atresic Eye Sockets after Enucleation and Irradiation of Retinoblastoma by Vascular Anastomosed Free Dorsal Flap Transplantation and Autogenous Dermal Fat Implantation Xiaoping Bi, Xianqun Fan, Huifang Zhou (Shanghai/CN) P-SU-235 Recurrent preseptal cellulitis of the upper eye lid Teresa Wacker, Gerhard K. Lang, Peter Wagner, Stephan Eckert (Ulm/D) P-SU-236 Sinus thrombosis as intracranial complication of phlegmon of orbit. Darya Zubkova, Pavel Bezditko, Maryna Shchadnykh, Olesya Zavoloka (Kharkiv/UA) P-SU-237 Spontaneous lid repair technique for medial canthal basocelular carcinoma. Amalia Amadora Ascarza (Cap Fed Bs As/RA) P-SU-238 Spontaneous recovery of fronto-orbital blow in fracture in a child Yefei Wang, Xianqun Fan, Huifang Zhou, Caiwen Xiao (Shanghai/CN) P-SU-239 Surgical correction and prevention of complications in congenital blepharoptoses complicated by vertical motility disorders Svetlana Tronina, Nadiya Bobrova (Odessa/UA) P-SU-240 Surgical therapy of bilateral upper eyelid ptosis in a case of Kearns-Sayre syndrome Christian Flöhr, Thomas Büchner, Burkhard Wiechens (Hannover/D) P-SU-241 Ten-year follow-up of a case series of primary epithelial neoplasms of the lacrimal gland: clinical features, surgical treatment and histopathologic findings Renato Damasceno (Erlangen/D) P-SU-232 Quantitative Morphometry of Orbit in Chinese Adults by a Three-dimensional Reconstruction Method Yongrong Ji (Shanghai/CN) P-SU-233 Raising the quality of life in an ageing Society by Oculplastic Surgery challenge and potential for the Oculoplastic Surgeon Hüseyin Aral, Daniel Martin Handzel (Cologne/D) P-SU-242 The Eyelid and Orbit Nomogram in Indian eyes: A randomized cross sectional study Prashant Yadav, Neelam Pushker, Varun Gogia, Shikha Gupta, Mandeep Bajaj, Bhavna Chawla, Mahesh Chandra (New Delhi/IND) P-SU-243 The importance of axial globe projection in the pathogenesis of involutional lower eyelid malposition Renato Damasceno (Erlangen/D)

297 WOC Sunday, 6 June :30-17:00 P-SU-244 The importance of being earnest Bipasha Mukherjee (Chennai/IND) P-SU-245 The management of orbital cavernous haemangionas a case series study Morgan Yang, Chai Teck Choo, Audrey Looi, Lay Leng Seah (Singapore/SGP) P-SU-246 The role of CD40-CD154 interaction in the pathogenesis of Graves orbitopathy (GO) Melissa Thanos, Elena Ströher, Erich Gulbins, Klaus Peter Steuhl, Joachim Esser, Anja Eckstein (Essen/D) P-SU-247 The use of Desmarres clamp for controlled bleeding during excision of lid lesions Tsiang Ung, Jonathan Chan, Ben While, Tahir Farooq (Sheffield/UK) P-SU-248 The use of FloSeal in external DCR Ralf Ungerechts, Melanie Jäger, Hans-Werner Meyer-Rüsenberg, Karl-Heinz Emmerich (Darmstadt/D, Hagen/D, Giessen/D) P-SU-249 Transcanalicular diode laser dacryocystorhinostomy (TDCR) methods, indications and first results Leonard Holbach, Anselm G. M. Jünemann, Mansour Tarif, Ludwig M. Heindl, Rudolf Walker, Reinhard Thyzel, Friedrich Kruse (Erlangen/D) P-SU-250 Ultrasound Biomicroscopic Evaluation of the Lacrimal Drainage System Yasser Y. M. Hassan Al-Faky (Riyadh/SA) P-SU-277 Psycho-emotional status of vegetative dysfunction in patients With Sjoegren s Syndrome Boris Kogan (Odessa/UA) Retina: Basics P22 P-SU-251 ApoA-I Mimetic Peptide Reduces Lipid Deposition in Murine Bruch s Membrane after Intravitreal Injection Martin Rudolf, Mark E. Clark, Jeffrey D. Messinger, Salvatore Grisanti, David Garber, Christine A. Curcio (Lübeck/D, Birmingham/USA) P-SU-252 Characterisation of Primary Adult Human Retinal Microglia Balini Balasubramaniam, Elizabeth Nicholson, Debra A. Carter, Eric J. Mayer, Andrew D. Randall, Andrew D. Dick (Bristol/UK) P-SU-253 Effect of ultraviolet A1 and infrared A irradiation on viability and vascular endothelial growth factor secretion of retinal pigment epithelial cells. Stefan Koinzer, Alexa Klettner, Felix Treumer, Agatha Schwarz, Christian Jantschitsch, Kirstin Reinecke, Johann Roider (Kiel/D) P-SU-254 Generation of retinal pigment epithelial cells from human induced pluripotent stem cells Tim U. Krohne, Mandy Lehmann, David F. Friedlander, Alison Dorsey, Wenlin Li, Ding Sheng, Martin Friedlander (La Jolla/USA) P-SU-255 Generation of transgenic zebrafish lines with human rhodopsin mutations Motokazu Tsujikawa, Yuzuru Sasamoto, Nagakazu Matsumura, Takeshi Nakao (Suita/J) P-SU-256 GM-CSF protects rat photoreceptors from death by activating the SRC-dependent signalling and elevating anti-apoptotic factors and neurotrophins Maurice Schallenberg, Petar Charalambos, Uwe Schröer, Solon Thanos (Essen/D, Münster/D) P-SU-257 Involvement of P2X7 receptors in the hypoxia-induced death of rat retinal neurons Tetsuya Sugiyama, Hidehiro Oku, Maho Shibata, Masayuki Fukuhara, Shota Kojima, Tsunehiko Ikeda (Takatsuki/J) P-SU-258 Laminin and other Basement Membrane Proetins Alterations in the Mouse Retina of three different diabetic mouse strains Elizabeth Abari, Alexander Kunze, Irina Semkova, Norbert Kociok, Ursula Hartmann, Mats Paulsson, Antonia M. Joussen (Duesseldorf/D, Berlin/D) P-SU-259 Linoleic acid stimulates monocyte chemoattractant factor (MCP)-1 expression through toll-like receptor 4 and NF-kappaB signal transduction pathway in retinal pigment epithelial cells Chang-Hao Yang, I-Mor Fang, Chung-May Yang (Taipei/TJ) P-SU-260 Macrophage mediated VEGF expression in retinal neovascularization Kristina Schmidt, Tina Lucas, Michael Piekarek, Sabrina Klein, Elizabeth Abari, Irina Semkova, Norbert Kociok, Sabine A. Eming, Antonia M. Joussen (Duesseldorf/D, Berlin/D) P-SU-261 Pharmacological Study of Proliferative Vitreoretinopathy Wu Wen-Chuan (Kaohsiung City/TJ) Sunday, 6 June Posters

298 294 WOC 2010 Posters Sunday, 6 June Sunday, 6 June :30-17:00 P-SU-262 Photoreceptor Cell Death in a Zebrafish Model of Autosomal Dominant Retinitis Pigmentosa Takeshi Nakao, Motokazu Tsujikawa (Suita/J) P-SU-263 Progression of Diabetic Retinopathy and diabetic nephropathy are they parallel A Alghadyan (Alkhober/SA) P-SU-264 Protective Effects of Tempol Against Indocyanine Green Induced Toxicity In Rats Tomasz Choragiewicz, Andreas Schatz, Gabriel Willmann, Bogomil Voykov, Florian Gekeler, Michal Fiedorowicz, Frank Schuettauf, Tomasz Zarnowski, Robert Rejdak, Sebastian Thaler (Lublin/PL, Tübingen/D) P-SU-265 Regulation of the casein kinase - 2 in retinal pigment epithelial cells Stephan Hoffmann, Hans-Sebastian Walter, Berthold Seitz, Mathias Montenarh (Homburg/D) P-SU-266 Replacement of photoreceptor cells in dystrophic adult retinas by cell transplantation Gila Jung, Gisbert Richard, Xiaoli Yang, Marius Ader, Udo Bartsch (Hamburg/D) P-SU-267 Retinal damage in Kimba mouse model Li Cairui, Ali Rahman Ireni, May Lai Choo (Dali/CN) P-SU-272 Transdifferentiation and the involvement of Müller glial cells in epiretinal cell proliferation of idiopathic macular holes Ricarda G. Schumann, Markus Schaumberger, Kirsten Eibl, Christos Haritoglou, Anselm Kampik, Arnd Gandorfer (Munich/D) Retina: Trauma/Emergencies P-SU-273 Soccer: one sport, two eye injuries Gil Calvão-Santos, Joel Ferreira, João Chibante, António Gomes da Rocha, José Salgado-Borges (São Mamede de Infesta/P) P-SU-274 Subjective and Objective Visual Disability Assessment in Patients with Open Globe Injuries Mayuri Bhargava, Usha Vasu (Bangalore/IND) P-SU-275 Traumatic retinal detachment: our surgical approach Volha Yarmak, Tatsiana Imshenetskaya (Saslauje/BY, Minsk/BY) P-SU-276 Valsalva Retinopathy after vigorous sexual activity under the influence of Sildenafil Andre Schafia, Zisis Gatzioufas, Kouris Ninios, Ursula Löw, Berthold Seitz (Homburg/D) P23 P-SU-268 Systemic regulation of renin expression in the retinal pigment epithelium Olaf Strauss, Marisa Brockmann, Christian Meyer, Vladimir Todorov, Michael Desch, Armin Kurtz, Vladimir Milenkovic (Regensburg/D, Bielefeld/D) P-SU-269 The Diabetic Retinopathy as a Cause of Visual Acuity Decrease Ihar Zabarouski, Tatsiana Imshanetskaya, Galina Semak, Inna Malinouskaya (Minsk/BY) P-SU-270 The distribution and characteristics of bone marrow-derived cells in the retina during physiological and pathological angiogenesis Keiko Kataoka, Koji M. Nishiguchi, Shu Kachi, Hiroko Terasaki (Nagoya-city/J) P-SU-271 Towards a stem cell-based intraocular delivery system for therapeutically relevant gene products Udo Bartsch, Gila Jung, Stephan Linke, Kristoffer Weber, Boris Fehse, Bettina Petrowitz (Hamburg/D)

299 WOC Monday, 7 June :30-17:00 Poster exhibition of Poster P-MO-001 to P-MO-298. All poster authors will attend their posters from 15:30 to 17:00 hrs. Moderation Poster sessions on Monday Gerd U. Auffarth (Heidelberg), Chair Salvatore Grisanti (Lübeck), Chair Co- Florian Birnbaum (Freiburg) Silvia Bopp (Bremen) Andrea Hassenstein (Hamburg) Bernhard Jurklies (Essen) Anja Liekfeld (Potsdam) Mathias Maier (Munich) Frank H. W. Tost (Greifswald) Rainer Guthoff (Wuerzburg) Hansjürgen T. Agostini (Freiburg) Cornea/Eye Bank: Diagnostics P-MO-001 A challenging case of perforated corneal ulcer in Stevens-Johnson syndrome treated with conjunctival hood Rajeeb Alam, Syed A. Hassan, Halim Khan, Rezaul Karim (Dhaka/BD) P24 P-MO-002 A novel method to detect subclinical keratoconus: corneal volume measurements with pentacam system. Hasan Basri Cakmak, Nagihan Ugurlu, Nurullah Cagıl, Hüseyin Simavlı, aban im ek (Ankara/TR) P-MO-007 In vivo confocal microscopy of fungal keratitis a case report Simon Trpin, Levin Vrhovec, Tomaz Gracner (Maribor/SI) P-MO-008 Tear Film Osmolarity and Dry Eye Severity Index in Patients with Rheumatoid Arthritis or Sjögren Syndrome Marc Schargus, Franziska Wolf, Ben Sulivan, Martin Feuchtenberger, Gerd Geerling (Wuerzburg/D) P-MO-009 The Effect of Topical Cyclosporine A Compared with Preservative-free Artificial Tears in Dry Eye Syndrome Choun-Ki Joo (Seoul/ROK) P-MO-010 The effect of wide incision cataract surgery to corneal sensibility and dry eye Paramastri Arintawati (Hiroshima/J) P-MO-011 The Value of Real-Time Polymerase Chain Reaction for the Diagnosis and Treatment of Acanthamoeba Keratitis Yoshifumi IKeda, Keiko Yakura, Ryu Uotani, Fumie Otani, Atsuko Miyake, Ryoko Ishikura, Dai Miyazaki, Yoshitsugu Inoue, Tsuyoshi Mito, Atsushi Shiraishi, Yuichi Ohashi, Yusuke Saeki, Kenji Yagita (Yonago/J) Cornea/Eye Bank: Medical Therapy P25 Monday, 7 June Posters P-MO-003 Bilateral herpetic keratouveitis: a case report with atypic presentatıon Osman Ceylan, Tugrul Akin, Orhan Ates (Erzurum/TR) P-MO-004 Congenital Hereditary Stromal Dystrophy (CHSD): A diagnostic and management challenge Rajeeb Alam (Dhaka/BD) P-MO-005 Determination of significant variables for keratoconus grading by factor analysis Nagihan Ugurlu, Hasan Basri Cakmak, Nurullah Cagıl, Elif Damar, aban im ek (Ankara/TR) P-MO-006 Evaluation of corneal topographic features and corneal aberrations of keratoconus using ROC (Receiver Operating Characteristic) curves Omar Salamanca, Alejandro de la Torre (Cali/CO) P-MO-012 Antibiotic resistance and clinical outcome in culture proven cases of microbial keratitis over a 5-year period Levin Vrhovec, Simon Trpin, Dusica Pahor (Maribor/SI) P-MO-013 Changing trends of bacterial keratitis after penetrating keratoplasty in Saudi Arabia Samar Al-Swailem, Michael Wagoner, M. Bridget Zimmerman, John Sutphin (Riyadh/SA) P-MO-014 Clinical Performance of an Osmoprotective Formulation for Dry Eye Therapy Peter Simmons, Joseph Vehige, Alan Sasai, Cindy Carlisle-Wilcox, Melissa Blue, Francis Lai (Irvine/USA) P-MO-015 Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis Anna-Karina Maier, Sevil Özlügedik, Jessica Rottler, Matthias Klamann, Sibylle Winterhalter, Klaudia Huber, Florian Heussen, Antonia Joussen (Duesseldorf/D)

300 296 WOC 2010 Posters Monday, 7 June Monday, 7 June :30-17:00 P-MO-016 Immunosuppression with Mycofenolate Mofetil (MMF) in high-risk keratoplasties Jessica Rottler, Maier Anna-Karina, Sevil Özlügedik, Florian Heussen, Matthias Klamann, Klaudia Huber-van der Velden, Sybille Winterhalter, Antonia Joussen (Essen/D) P-MO-017 Management of keratopathies by tear substitutes: the right protocol. Lorenzo Mannucci (Padova/I) P-MO-018 Mesenchymal Stem Cells Prolong the Survival of Corneal Allograft in Rats by Inhibiting Th1-dependent Immune Response Xiaomin Zhang, Chunna Jiao, Xiaorong Li, Shaozhen Zhao (Tianjin/CN) P-MO-019 Optical quality of the cornea following collagen cross-linking for keratoconus Martin Baumeister, Jens Bühren, Thomas Kohnen (Frankfurt/D) P-MO-020 Photodynamic Therapy of Corneal Neovascularization with Verteporfin Abdullah Al-Turbaq (Riyadh/SA) Glaucoma: Diagnostics P26 P-MO-055 The effect of anterior chamber depth on intraocular pressure after uneventful phacoemulsification in nonglaucomatous eyes Tansu Gonen, Kadircan Keskinbora, Fatih Horozoglu (Tekirdag/TR) P-MO-027 A case report of trabeculectomy for high intraocular pressure with hemodialysis Yukinobu Okajima, Tetsuo Tochikubo, Hiroshi Watanabe (Tokyo/J) P-MO-028 A comparison of clinical diagnostic accuracy between Octopus standard automated perimetry, Pulsar perimetry, Moorfields Motion Displacement Test and Heidelberg Retinal Tomography in glaucoma detection. Justyna Oleszczuk, Ciara Bergin, Eamon Sharkawi (Warsaw/PL) P-MO-029 Analysis of parapapillary fundus autofluorescence using modified fundus photography and scanning laser ophthalmoscopy Ricarda Wienrich, Achim Langenbucher, Wolfgang Behrens-Baumann, Arne Viestenz (Magdeburg/D) P-MO-021 The effect of human and rabbit serum on the recovery of the wounded corneal surface in the Ex vivo Eye Irritation test Norbert Schrage (Cologne/D) P-MO-022 The influence of 0.15 % hyaluronic acid solution (OXYAL) treatment on ocular aberrations in dry eye patients Anna Rogowska-Godela, Katarzyna Buczak- Gasińska, Ewa Mrukwa-Kominek (Katowice/PL) P-MO-023 Topical Gancyclovir 0,15% Ophthalmic Gel for Herpes Keratitis Treatment Camila Geraissate, Heloisa Nascimento, Rubens Belfort Jr, Denise Freitas (Sao Paulo/BR) P-MO-024 Treatment of dry eye caused by inadequate lid closure. Claes Feinbaum (Landskrona/S) P-MO-025 UVA-Riboflavin Collagen Crosslinking in Corneal Ulcer Sebastian Kupferschmid, Gerhard K. Lang (Ulm/D) P-MO-030 Angle closure glaucoma managed with lens extraction and viscodissection of the angle: a comparison of anterior segment OCT and UBM. Trushar Patel, Imran Masood, TK Jonathan Chan (Sheffield/UK) P-MO-031 Clinical Use of Transpalpebral Diaton Tonometry after Keratophotorefractive Surgeries Alla Illarionova, Tair Dzafarly (Moscow/RUS) P-MO-032 Comparison of Fourier Domain Optical Coherence Tomography (FD-OCT) Measurements in Subjects With and Without Pupil Dilation Esther Hoffmann (Mainz/D) P-MO-033 Comparison of optic disc topographic measurements using Fourier-Domain optical coherence tomography and confocal scanning laser ophthalmoscopy in glaucoma patients and normal subjects Andreas Schulze, Julia Lamparter, Stefan Günther, Norbert Pfeiffer, Esther Hoffmann (Mainz/D) P-MO-034 Correlations of Retinal Nerve Fiber Layer and Ganglion Cell Complex Measurements Using Fourier- Domain Optical Coherence Tomography with Visual Field Loss in Japanese Glaucoma Patients Motohiro Shirakashi, Kiyoshi Yaoeda, Haruki Abe (Niigata/J)

301 WOC Monday, 7 June :30-17:00 P-MO-035 Dark adaptation and macular blood flow in patients with primary chronic open-angle glaucoma, pseudoexfoliation glaucoma or congenital glaucoma. Zisis Gkatzioufas, Marilita Moschos, Ursula Löw, Christian Jonescu-Cuypers, Berthold Seitz (Homburg/D) P-MO-036 Detection of psychophysical and structural abnormalities in an outpatient setting using frequency doubling technology (FDT) perimetry, scanning laser polarimetry (GDx-VCC), and optical coherence tomography (Stratus OCT) Daniel Herzog, Joachim Herzog, Nicola Rauch, Lorenz Barleon, Norbert Pfeiffer, Esther Hoffmann (Mainz/D) P-MO-037 Differences in corneal biomechanics of patients with unilateral open angle glaucoma Christoph Hirneiss (Munich/D) P-MO-038 DynamicContourTonometry, Goldmann Applanation Tonometry and TonoPen vs. intracameral readings A Comparison of three measurement devices in patients with corneal pathologies Matthias Neuburger, Philip Maier, Florian Birnbaum, Juliane Großwendt, Sonja Lautebach, Daniel Böhringer, Thomas Reinhard, Jens F. Jordan (Freiburg/D) P-MO-039 EDMAGS (Evonik-Degussa-Mainz-Glaucoma-Study) IV: The Glaucoma Probability Score of the Heidelberg Retina Tomograph (HRT 3.0) as a Screening Unit for Glaucoma Lorenz Barleon, Claudia Deters, Esther Hoffmann, Jochen Wahl, Peter Morfeld, Andrea Lichtmeß, Sibylle Haas-Brähler, Rolf Breitstadt, Norbert Pfeiffer (Mainz/D) P-MO-040 Electrophysiological Detection of Glaucoma using Silent Substitution Technique Patrick Bessler, Sascha Klee, Ulrich Kellner, Jens Haueisen (Ilmenau/D) P-MO-043 Imaging of Nerve Fiber Layer Defects in Glaucoma using Speckle Noise-reduced Spectral-domain Optical Coherence Tomography Masayuki Nukada, Masanori Hangai, Satoshi Mori, Noriko Nakano, Yuriko Kotera, Hideo Nakanishi, Hanako Ikeda, Hajime Nakamura, Atushi Nonaka, Nagahisa Yoshimura (Anshuyamakawatyo/J) P-MO-044 Iris Color & Central Corneal Thickness in Glaucoma. Does Blue Iris portend Thick Cornea? Sriram Sonty, Sindhura Pisipati, Afzal Ahmad (Flossmoor/USA) P-MO-045 Learning Curve of Flicker Defined Form Perimetry Julia Lamparter, Andreas Schulze, Ann-Christin Schuff, Norbert Pfeiffer, Esther M. Hoffmann (Mainz/D) P-MO-046 Low hysteresis, low pachymetry, low Goldmann tonometry in healthy and glaucomatous Mexican patients: comparison of Goldmann, pascal and ocular response analyzer Jesús Jiménez-Roman, Oscar Albis-Donado, Daniel de la Torre-Tovar (Mexico City/MEX) P-MO-047 Macular ganglion cell complex in glaucoma Jose Javier Garcia-Medina, Manuel Garcia-Medina, Francisca Fernandez de Benito, Vicente Zanon- Moreno, Maria Dolores Pinazo-Duran (Huercal- Overa/E, Almeria/E) P-MO-048 Normal Tension Glaucoma Mislead Diagnosis; case presentation Alina Popa Cherecheanu, Ruxandra Pascu, Mihai Ghita (Bucharest/RO) P-MO-049 Optic neuropathy in Alzheimer s disease versus glaucomatous optic neuropathy Fatmire Berisha, Gilbert T. Feke, Clement L. Trempe, J. Wallace McMeel, Norbert Pfeiffer, Charles L. Schepens (Mainz/D) Monday, 7 June Posters P-MO-041 Evaluation of filtering blebs using the Wuerzburg bleb classification score compared to other clinical findings Sandra Furrer, Marc Töteberg-Harms, Cornelia Hirn, Peter Paul Ciechanowski, Jens Funk (Zurich/CH) P-MO-042 Factors Associated with Retinal Nerve Fiber Layer Thickness Measurements Using Scanning Laser Polarimetry with Variable Corneal Compensation and Enhanced Corneal Compensation in Normal Japanese Subjects Takayuki Tanaka, Motohiro Shirakashi, Kiyoshi Yaoeda, Haruki Abe (Niigata/J) P-MO-050 Post traumatic 360 degree recession angle glaucoma Luís Abegão Pinto, Ana Amaral, Paula Leitão, Joana Ferreira, João Lisboa (Belas/P) P-MO-051 Racial Differences in Central Corneal Thickness in Narrow Angle Glaucoma Patients and correlation with the Severity of Glaucoma from a Community Practice Afzal Ahmad, Sriram Sonty, Sindhura Pisipati (Flossmoor/USA)

302 298 WOC 2010 Posters Monday, 7 June Monday, 7 June :30-17:00 P-MO-052 Role of optical coherence tomography in measuring retinal nerve fibre thickness in normal subjects and patients of open angle glaucoma Arif Adenwala (Sharjah/UAE) P-MO-053 Screening method for visualisation of a glaucomatous ciliary body condition Vi tor Morkhat, Maryia Morkhat (Vitebsk/BY) P-MO-054 Simultaneous GDX & OCT Imaging in Glaucomatous eyes with Disc Hemorrhages showing Visual Field Defects preceding Disc Damage on Imaging with minimum 6 Months Follow-up. Sriram Sonty, Afzal Ahmad (Flossmoor/USA) P-MO-056 The usefulness of anterior segment optical coherence tomography for evaluation of the iridocorneal angle width before and after laser peripheral iridotomy in a cohort of 150 narrow-angle glaucoma patients Ewa Mielniczuk, Ewa Mrukwa-Kominek, Lukasz Drzyzga, Wanda Romaniuk (Katowice/PL) P-MO-057 The Visual Disability Likelihood Score: Comparison with Standard Measures of Vision George L. Spaeth (Philadelphia/USA) Glaucoma: Medical Therapy P27 P-MO-058 Comparison of the effects of travoprost plus timolol preserved with either benzalkonium chloride (BAK) or polyquad (PQ) on cultured human ocular surface epithelial cells David A. Ammar, Malik Y. Kahook (Aurora/USA) P-MO-059 Comparison of the Effects of Travoprost Preserved with Benzalkonium Chloride (BAK) Versus Polyquad (PQ) on Cultured Human Ocular Surface Epithelial Cells David A. Ammar, Malik Y. Kahook (Aurora/USA) P-MO-060 A randomized crossover study comparing efficacy of latanoprost and travoprost in open-angle glaucoma. Akira Sawada, Tetsuya Yamamoto (Gifu/J) P-MO-062 Central Corneal Thickness as a Parameter in Patients with Glaucoma or Ocular Hypertension: Results of the German MoviX Survey Ines Ecke, Claudia Guzy, Richard Stodtmeister (Rodalben/D) P-MO-063 Comparison of Latanoprost and Timolol in Pediatric Glaucoma Patients: a Phase 3, 12-week, Double-Masked Multicenter Study Tomoko Maeda, Katherine Chi-Burris, Barbara Wirostko, PANDA Study Group (San Diego/USA) P-MO-064 Comparison of the effects of tafluprost and l atanoprost on intraocular pressure and ocular surface findings Katsuyoshi Suzuki, Takeshi Sagara, Hideaki Yoshino, Masako Nakayama, Miho Enoki, Shinji Hirano, Norihisa Takahashi, Kayoko Tokuhisa, Yasuhito Ishida, Shinichiro Teranishi, Rie Matsuda, Atsuko Tanaka, Teruo Nishida (Ube-city/J) P-MO-065 Effect of a new audible and visual reminder system on adherence with topical ocular therapy Manuel Hermann, Lebriz Ersoy, Michael Diestelhorst (Cologne/D) P-MO-066 Efficacy of Selective Laser Trabeculoplasty as firstline treatment of primary open-angle glaucoma in Moroccan patients Youssef Zekraoui, Adil Megzari, Tarik El Alloussi, Othmane Bourmani, Abdelkarim Boulanouar, Amina Berraho (Rabat/MA) P-MO-067 Evaluation of 24-hour post-dose efficacy of travoprost-timolol and latanoprost-timolol fixed-combinations in patients with open-angle glaucoma Navroop Gill, David B. Yan (Toronto/CDN) P-MO-068 Intravitreal injection of bevacizumab for neovascular glaucoma post vitrectomy. Aya Oi, Tetsuo Tochikubo, Yuka Suzuki, Hiroshi Watanabe (Tokyo/J) P-MO-069 Mikelan LA 2% ophthalmic solution Phase 4 investigation of the effectiveness and safety Kazuhide Kawase (Gifu/J) P-MO-061 Cataract and ocular hypertension in children on inhaled corticosteroid therapy Adel Aljazzaf (Kuwait/KWT) P-MO-070 Ocular Hypotensive Efficacy of Bimatoprost (0.03%) over a 64 Hour Period in Patients with Elevated Intraocular Pressure Muthusamy Malaravan, Dushyantha Wariyapola (Dehiwala/CL)

303 WOC Monday, 7 June :30-17:00 P-MO-071 Patient- and Physician-Reported Satisfaction Following Treatment with Bimatoprost 0.01% or Vehicle in Patients with Glaucoma or Ocular Hypertension (OHT) E. Randy Craven, Ton Lin, Thomas K. Mundorf, Michael Tepedino, Ronald Frenkel, John G. Walt, Ching-chi Liu, Amy L. Batoosingh (Parker/USA) P-MO-072 Patient Satisfaction Before and After Changing Ocular Hypotensive Therapy to Latanoprost/Timolol Fixed-Combination (LTFC) Kristian Gerstmeyer, Friedhelm Leverkus, Carsten Oliver Schmidt, Thomas Kohlmann (Minden/D) P-MO-073 Prospective, Observational Study of the Long-term Effect of Latanoprost/Timolol Fixed Combination (LTFC) in Patients with Glaucoma or Ocular Hypertension Oliver Schwenn, Barbara Heckmann, Claudia Guzy (Frankfurt/D) P-MO-079 Buckling surgery for retinal detachment in Nairobi, Kenya between 2005 and 2009: case series K. H. Martin Kollmann, Oscar M. Onyango, Patrick T. Nyaga, Carl-Ludwig Schönfeld (Nairobi/EAK, Munich/D) P-MO-080 Knowledge, skills and productivity of primary eye care providers in Tanzania Paul Courtright (Moshi/EAT) P-MO-081 Ocular multibacillary leprosy profile among Filipinos released from multi-drug therapy Ronnie Manaysay, Ian Paredes (Manila/RP) P-MO-082 Prevalence and Causes of Decreased Vision in a Tunisian Diabetic Population Ben Yahia Salim, Messaoud Riadh, Hasnaoui Wafa, Khochtali Ines, Jenzeri Salah, Moncef Khairallah (Monastir/TN) Monday, 7 June Posters P-MO-074 Relationship Between Patient Tolerability and Efficacy When Switching from Dorzolamide/Timolol to Brimonidine/Timolol Fixed Combination in the Treatment of Open Angle Glaucoma Jacqueline Freudenthal, Dan Pericak, Susan Simonyi, David B. Yan (Toronto/CDN) P-MO-075 Retrobulbar hemodynamics after oculopression with and without prior Dorzolamide treatment Klaudia Huber-van der Velden, Matthias Klamann, Andreas Remky (Cologne/D, Aachen/D, Berlin/D) P-MO-076 Toxicological evaluation of preservative-containing and preservative-free prostaglandin analogs on the 3D-reconstituted corneal epithelium (SkinEthic ) system Hong Liang (Paris/F) P-MO-077 Treatment of Glaucomatous Visual Fields by Novel Nutritional Supplement: Comparison of Group and Individual Approach. Meir Gorban (Givataim/IL) International Ophthalmology P-MO-078 Are wet and dry labs old fashioned? Jorge Topete-Jimenez, Gerardo Gabriel Perez- Solorzano, Ivan Dario Sanchez-Amaya (Guadalajara/MEX) P28 P-MO-083 Prevention of traumatic corneal ulcer an intervention project in a rural province in Cambodia Manfred Mörchen, Sun Sarin, M. P. Upadhyay (Phnom Penh/K) P-MO-084 Pseudophakic rhegmatogenous retinal detachment in a large Asian tertiary eye centre a cohort study Desmond Quek, Shu Yen Lee, Hla Myint Htoon, Chong Lye Ang (Singapore/SGP) P-MO-085 Renaissance of the slit-lamp Marcus-Matthias Gellrich (Kellinghusen/D) P-MO-086 The Offer of Cataract Surgery: Determinants of Acceptance following Outreach Eye Clinics in South India. David G. Kupitz, Frank G. Holz, Seetha Chandrasekhar, Bharath Balasubramaniam, R. V. Ramani, Robert P. Finger (Bonn/D) P-MO-087 Translating successes at Aravind to sub Saharan Africa Susan Lewallen, Thulasiraj Ravilla (Moshi/EAT) P-MO-088 Vitreoretinal Training program Munich Nairobi: 10 years of experience Carl-Ludwig Schönfeld, Oscar M. Onyango, Patrick T. Nyaga, K. H. Martin Kollmann, Volker Klauss, Anselm Kampik (Munich/D, Nairobi/EAK)

304 300 WOC 2010 Posters Monday, 7 June Monday, 7 June :30-17:00 Miscellaneous P-MO-089 A case of mucosa-associated lymphoid tissue (MALT) lymphoma with difficulties of remove due to infiltration into extraocular muscles Yuka Suzuki, Tetsuo Tochikubo, Aya Oi, Hiroshi Watanabe (Tokyo/J) P29 P-MO-090 Acupuncture and Chinese herb for Dry Eye disease Ying-Ling Chen, Mark Chun-Cheng Hou, Lun- Chien Lo, Chang-Pin Lin (Changhua/TJ) P-MO-091 Anterior OCT diagnostic possibilities in conjunctival tumors and filtering blebs Mykolas Pajaujis, Rimvydas Asoklis, Donatas Petroska (Vilnius/LT) P-MO-092 Bibliometric Analysis in Ophthalmology: journal impact factor change over the last decade Muhammad Younis, Ahmad Mansour, George Mollayes (Manchester/RL) P-MO-093 Central corneal thickness, intraocular pressure and degree of myopia in a myopic population of Southeast Spain Manuel Garcia-Medina, Jose Javier Garcia-Medina, Francisca Fernandez de Benito, Vicente Zanon- Moreno, Maria Dolores Pinazo-Duran (Almeria/E) P-MO-094 Comparison of Intraocular Pressure after Minimal Incision Cataract Surgery Using the Soft-shell Technique and various Ophthalmic Viscoelastic Devices including the dual OVDs Sealing Technique Takao Tanaka (Tokyo/J) P-MO-095 Influence of eye concomitant pathology on the surgery complications frequency at the following operations Olga Levanova (Kirow/RUS) P-MO-096 Isaac Newton on the Eye and Vision Harry Mark (North Haven/USA) P-MO-097 Lifesaving Ophthalmology Case reports of young patients with intracerebral tumoration diagnosed by an ophthalmologist Stephanie Rohrweck, Ana Suelves, Diamar Pardo, Salvador Garcia-Delpech, David Salom, Patricia Udaondo, Manuel Diaz-Llopis (Valencia/E) P-MO-099 Optical visual acuity simulation with a virtual eye model based on cubic spline reconstruction of the cornea. Luis Moreno, Jorge Alió, Antonio Fimia (Alicante/E) P-MO-100 Prototype for evaluating surgical corneal residual astigmatism Liliane Ventura, Homero Schiabel, Jean-Jacques De Groote, Sidney Julio Faria e Sousa (Sao Carlos/BR) P-MO-101 Prototype for evaluation of UVA natural protection of the cornea Liliane Ventura, Victor A. C. Lincoln, Homero Schiabel, Sidney Julio Faria e Sousa (Sao Carlos/BR) P-MO-102 Silicone oil as carrier for drug-delivery interaction between silicone oil and corticosteroids Benjamin Braun, Thorsten Lechner, Ulrike Wolf, Hans Hoerauf, Dirk-Henning Menz (Hipstedt/D, Göttingen/D) P-MO-103 The Impact of Free Access on Citations to the Vision Literature Pamela Sieving (Bethesda/USA) P-MO-104 The learning curve on ophthalmologic surgery: experimental model versus traditional and practical model Eglis Esteban García Alcolea (Ciudad Habana/C) P-MO-105 Whether the traditional idea of treatment of the opening injury of the anterior chamber needs to be changed? Zhizhong Ma (Beijing/CN) Refractive Surgery/Refraction P-MO-131 Personal experience with Toric ARTIFLEX Camille Budo (Sint-Truiden/B) P-MO-106 Advanced Cataract Surgery with Multifocal IOL Implantation: Two-Year Follow-Up Matteo Piovella (Monza/I) P-MO-107 Advanced Surface Ablation in High Myopia at JoGJA Lasik Center Dr.Yap Eye Hospital Wasisidi Gunawan (Jogjakarta/RI) P30 P-MO-098 Ocular infections due to Methicillin-resistant staphylococcus aureus Cecilia Moeller, M. C. S. Yu, P. Bispo, A. S. Moriyama, A. C. Pignatari, A. L. Höfling-Lima (São Paulo/BR) P-MO-108 Bilateral acute angle-closure glaucoma after implantation of an angle-supported anterior chamber lense Matthias Schmidt, Julia Promesberger, Constantin E. Uhlig (Münster/D)

305 WOC Monday, 7 June :30-17:00 P-MO-109 Cataract surgery with implantation of the M-FLEX 630F multifocal IOL with +3,0 and +4,0 diopters addition for near. Ewa Mrukwa-Kominek, Pawel Stala, Katarzyna Buczak-Gasinska (Katowice/PL) P-MO-110 Choosing a proper aspheric IOL designs for an individual eye Stefan Pieh, Werner Fiala (Vienna/A) P-MO-111 Clinical outcomes of LASIK for high hyperopia: to D Dan Reinstein, Timothy Archer, Marine Gobbe (London/UK) P-MO-112 Comparison of different presbyopia treatments: Refractive lens exchange with multifocal intraocular lens implantation Vs. LASIK Monovision Ante Barisic, Nikica Gabric, Iva Dekaris, Ivana Romac, Maja Bohac, Branka Juric, Vlade Glavota (Zagreb/HR) P-MO-113 Complications of lamellar keratorefractive surgery Volodymyr Usov, Elena Dragomyretskaya (Odessa/UA) P-MO-114 Correction of corneal astigmatism in cataract and refractive lens surgery 3-month-results with the Acri.Comfort 646 TLC Daniel Martin Handzel, Raimund M. Remmel, Claudia M. Dardenne, Detlev R. H. Breyer (Bonn/D) P-MO-115 Correction of irregular astigmatism in post transplanted corneas with topography based photorefractive keratectomy (Topolink) G. Macedo, Rossen Hazarbassanov, E. Martinez, A. L. Höfling-Lima (Sao Paulo/BR) P-MO-118 Effect of the amount of myopic correction on long-term changes of higher-order wavefront aberrations after advanced surface ablationphotorefractive keratectomy (ASA-PRK) Sang-Bumm Lee, Jin-Seon Kim, Jun-yeup Lee (Daegu/ROK) P-MO-119 Effects of Femtosecond Laser-assisted Multilayer Intrastromal Ablation in the Mid-peripheral Cornea: Clinical Findings in Two Patients Zhen-Yong Zhang, Xing-Ru Zhang, Ren-Yuan Chu (Shanghai/CN) P-MO-120 Evaluation of Keratometry: Natural corneal changes, measurement accuracy, influence of incision sizes and their effect for toric IOL calculations Wolfram Wehner (Nürnberg/D) P-MO-121 Extended depth of focus intra-ocular lens tolerance to typical corneal aberrations Alex Zlotnik, Ido Raveh, Shai Ben Yaish, Oren Yehezkel, Michael Belkin, Zeev Zalevsky (Hashomer/IL) P-MO-122 Female/male differences in acceptance and satisfaction of multifocal IOLs Magda Rau (Cham/D) P-MO-123 Femtosecond laser assisted astigmatic keratotomy (Femto-AK) for high postkeratoplasty astigmatism: one-year follow-up Laszlo Kiraly, Anna Sasse, Gernot Duncker (Halle/D) P-MO-124 First results after the light-adjustable-lens implantation Tobias Neuhann, Elisabeth Jakobs (Munich/D) Monday, 7 June Posters P-MO-116 Correction of post-keratoplasty astigmatism with astigmatic keratotomy using the femtosecond laser Daniel Kook, Jens Bühren, Anna Sophia Bauch, Oliver Klaproth, Victor Derhartunian, Thomas Kohnen (Munich/D, Frankfurt/D) P-MO-117 Effect of mitomycin C on refractive results after laser-assisted subepithelial keratectomy to correct myopia. Montserrat Garcia-Gonzalez, Marta Ibarz-Barbera, Esther Arranz-Marquez, Laura De Benito-Llopis, Miguel A. Teus (Madrid/E) P-MO-125 Improvement of precise axis marking for TIOLs at the slit-lamp with the assistance of a special ocular Wolfram Wehner (Nürnberg/D) P-MO-126 Intracor Presbyopic Correction Combined with Cataract Surgery Carlos Gutierrez-Amoros (La Coruña/E) P-MO-127 Intrastromal Correction of Presbyopia with Femtosecond Laser Wilhelm Großmann (Duisburg/D) P-MO-128 Lasik in High Hyperopia Diego de Ortueta (Recklinghausen/D)

306 302 WOC 2010 Posters Monday, 7 June Monday, 7 June :30-17:00 P-MO-129 LASIK with Optimized Prolate Ablation Profile (OPA) versus LASIK with Conventional Ablation Profile using NIDEK Platform. 12 Months Results Alaa El Danasoury (Jeddah/SA) P-MO-130 Lens Surgery Inclusion Criteria for Glaucoma Prevention in Eyes with shallow ACD and Narrow Angle Matteo Piovella (Monza/I) P-MO-132 PRK and Off Flap Epi-Lasik in Different Age at JoGJA Lasik Center Dr.Yap Eye Hospital Rinanto Prabowo (Jogjakarta/RI) P-MO-133 Quality of vision and quality of life after implantation with the multifocal Diffractiva Diff-s IOL in a series of 200 eyes with cataract. Serge Zaluski (Perpignan/F) P-MO-134 Refractive Surgery to the Rescue Arun Gulani (Jacksonville/USA) P-MO-135 ReStor Multifocal Lens in Radial Keratotomy Eyes Arun Gulani (Jacksonville/USA) P-MO-141 Toric multifocal IOL after twice penetrating injury Hans-Jürgen Buchwald, Gerhard K. Lang (Ulm/D) P-MO-142 Up-regulation of the production of interferongamma and the gene expression of the inducible no-synthase after excimer laser ablation in rat corneas Javier Prada, Thanh Ngo-Tu (Berlin/D) P-MO-143 Visual Recovery After Corneal Enhancement in Either Femtosecond or Microkeratome Created Flaps Marta Ibarz, Montserrat Garcia-Gonzalez, Laura de Benito, Miguel Teus (Madrid/E) P-MO-144 Wavefront Analysis of centration in Hyperopic LASIK: Line of Sight vs. Visual Axis Uwe Oberheide, Georg Gerten, Karl Schmiedt, Omid Kermani (Cologne/D) P-MO-145 What lies Beneath? Dipanjan Pal, Alokesh Ganguly (Kolkata/IND) Retina/Chorioidea/RPE/Vitreous P31 P-MO-136 Shape change of crystalline lens of human eyes after accommodation Xiaobing Wang, Qinghua Chen, Aizhen Liu, Ping Liu (Beijing/CN) P-MO-137 Sudden changes in intraocular pressure during flap preparation: Comparison between 4 femtosecond lasers and one microkeratome in porcine eyes Jan Markus Vetter, Christian Teping, Wolf E. Weingärnter, David Garcia-Bardon, Adrian Gericke, Paul R. Preussner, Walter Sekundo (Mainz/D) P-MO-138 The influence of high order aberrations (HOAs) on the dynamic visual acuity (DVA) between preand post LASIK. Futoshi Taketani, Toyoaki Matsuura, Tokuko Hara, Yoshiaki Hara (Kashihara Nara/J) P-MO-139 Tilt, Decentration and anterior chamber depth of ICL: Result of an one year period Yunwoong Chung, Sung Kun Chung (Seoul/ROK) P-MO-140 Topographical changes after Myopic LASEK Diego de Ortueta (Recklinghausen/D) P-MO-146 One-year follow-up of the treatment of SRH in AMD with combined 23-gauge core vitrectomy and injection of rtpa, expansile gas and bevacizumab Carolin Perz, Julia Konrad, Nikolaus Feucht, Chris Patrick Lohmann, Mathias Maier (Munich/D) P-MO-147 Choroidal Folds in Supra venacaval obstruction; A case Report Mohamed Naved Abdul Karim, Deepa S. Rathore, Peter Baranyovits (Kettering/UK) P-MO-148 Corneal epitheliopathy following Trabeculectomy with intraoperative 5-Fluorouracil (5FU) or Mitomycin C (MMC) and postoperative adjunctive 5-Fluorouracil in 381 Patients Constantin Reiter, S. Wimmer, A. Schultheiss, Thomas Klink, Franz Grehn, Gerd Geerling (Wuerzburg/D) P-MO-149 Differential diagnosis of rod or cone dystrophy using optical coherence tomography Midori Yokochi, Shoji Kishi (Maebashi/J) P-MO-150 Effect of HDAC Inhibitors on Retinal Cells Shalesh Kaushal (Worcester/USA)

307 WOC Monday, 7 June :30-17:00 P-MO-151 Effects of VEGF-antagonists on RPE cells in vitro Alexa Klettner, Tim Meyer, Friederike Möhle, Daniela Wesch, Dieter Kabelitz, Johann Roider (Kiel/D) P-MO-152 Evaluation of Ophthalmic complications in type II diabet mellitus Babol-Iran Abbas Soleymani, Amin Gorjizadeh, S. R. Hosseini (Babol/IR) P-MO-153 Impaired retinal blood flow in patients with type 2 diabetes mellitus and chronic kidney disease Taiji Nagaoka, Atsushi Takahashi, Eiichi Sato, Kenji Sogawa, Tsuneaki Omae, Seigo Nakabayashi, Akihiro Ishibazawa, Ichiro Tanano, Tomofumi Tani, Akitoshi Yoshida (Asahikawa/J) P-MO-154 Internal limiting membrane which could be peeled over the optic nerve head in vitreous surgery for optic disc pit maculopathy Toshiyuki Fujiwara (Akita/J) P-MO-155 Intraocular Worm Tri Wahyu Widayanti, Angela Nurini Agni (Yogyakarta/RI) P-MO-156 Macrophages in the ultrastructure of PDR membranes and subretinal AMD membranesa possible role in neoangiogenesis. Christina Nicolaeva Vidinova, Pravoslava Gougoutchkova, Kalin Vidinov (Sofia/BG) P-MO-160 New genetic approaches to understanding choroidal neovascularization in relation to Vascular Endothelial Growth Factor (VEGF) And Brain Derived Neurotrophic Factor (BDNF) expression in super p53 mice. Maria D. Pinazo-Duran, Roberto Gallego-Pinazo, Vicente Zanon-Moreno, Sheila Pons-Vázquez, Jose Javier Garcia-Medina, Ignacio Vinuesa Silva, Manuel Serrano (Valencia/E) P-MO-161 Photodynamic therapy (PDT) for the treatment of corneal neovascularization in children M. Fortunato, Giuseppe Carollo, R. Maggi, A. Ubaldi, L. Buzzonetti (Palermo/I) P-MO-162 Picture of macula in optical coherence tomography in retinal detachment in children with various etiology description of casus Erita Filipek, Lidia Nawrocka, Maria Forminska- Kapuscik, Ewa Mrukwa-Kominek, Ewa Pieczara (Katowice/PL) P-MO-163 Retinal nerve fiber layer thickness following pars plana vitrectomy for rhegmatogenous retinal detachment Yuta Ueno, Fumiki Okamoto, Yoshifumi Okamoto, Tetsuro Oshika (Tsukuba/J) P-MO-164 Spontaneous closure of postoperative persisting full thickness macular hole Karen Schaal, Till Oppermann, Johann Roider, Stefan Dithmar (Heidelberg/D, Kiel/D) Monday, 7 June Posters P-MO-157 Modulation of cytokine expression by protein tyrosine phosphatase inhibition in retinal pigment epithelial cells David Arthur Märker, Renate Foeckler, Vladimir Milenkovic, Olaf Strauss, Horst Helbig, Tina Dietrich (Regensburg/D) P-MO-158 Monitoring Disease Progression in Macular Telangiectasia Type 2 on Spectral-Domain Optical Coherence Tomography Sönke Baumüller, Peter Charbel Issa, Hendrik P. N. Scholl, Steffen Schmitz Valckenberg, Frank G. Holz (Bonn/D) P-MO-159 Morning Glory Disc anomaly with cystic appearance in orbit and retinal detachment in a premature infant Susanne Butros, Gerhard K. Lang, Cecilia Setiobudi, Hans-Jürgen Buchwald (Ulm/D) P-MO-165 Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy Ichiro Maruko, Yukinori Sugano, Akira Ojima, Tetsuju Sekiryu, Tomohiro Iida (Fukushima/J) P-MO-166 Sub-Tenon Injection of Triamcinolone Acetonide without oral steroid in Vogt-Koyanagi-Harada syndrome Mariko Enoki, Shoji Kishi (Maebashi/J) P-MO-167 The application of silicone saccus lacrimalis supporting tube in nasal endoscopic dacryocystorhinostomy (DCR) Jin Lu Fan, Di Lu (Heng Yang/CN) P-MO-168 The characteristics of coloboma of the choroid with optical coherence tomography Li Juanjuan (Kunming/CN)

308 304 WOC 2010 Posters Monday, 7 June Monday, 7 June :30-17:00 P-MO-169 The relationship between Peripheral Neuropathy and Diabetic Retinopathy in an Asian population (The Singapore Malay Eye Study) Gavin Tan, Yingfeng Zheng, Chee Weng Fong, E Shyong Tai, Su Chi Lim, Charumathi Sabanayagam, Tien Y. Wong (Singapore/SGP) P-MO-170 The time till ganglion cell death during ischemia occurs can be extended by vitrectomy with a neuroprotective irrigation solution Maximilian Schultheiss, Martin Spitzer, Hannah Ruschenburg, Hannah Ruschenburg, Peter Heiduschka, Charlotte Frank, Kai Januschowski, Karl Ulrich Bartz-Schmidt, Peter Szurman (Stuttgart/D, Tübingen/D) P-MO-171 Vasoproliferative retinal tumour Case report Sarah Pfrommer, Mathias Maier, Christian Mayer, Verena Engelmann, Chris Patrick Lohmann (Munich/D) P-MO-172 Vision-related quality of life and visual function following vitrectomy and triamcinolone injection for diabetic macular edema Ayami Masuda, Fumiki Okamoto, Takahiro Hiraoka, Tetsuro Oshika (Tsukuba/J) P-MO-177 Effect of Intravitreal ranibizumab (Lucentis) in the treatment of various causes of macular edema. Hany Elmekawey, Amr Khafagy Amr, Khaled Abo Elenein Khaled, Safwat Elkady Safwat (Giza/ET) P-MO-178 Effects of Intravitreal Injection of Anti-VEGF Agents on Macular edema due to Retinal Vein Occlusion Eriko Kirii, Teiko Yamamoto, Hitomi Miura, Hidetoshi Yamashita (Yamagata/J) P-MO-179 Efficacy of Intravitreal Bevacizumab Combined with Photodynamic Therapy for Polypoidal Choroidal Vasculopathy Fumi Gomi, Miki Sawa, Taku Wakabayashi, Yuzuru Sasamoto, Mihoko Suzuki, Motokazu Tsujikawa (Suita/J) P-MO-180 Efficiency in combined usage of local and general corticosteroid therapy during acute phase of Vogt- Koyanagi-Harada diseases Gunay Rustambayova (Baku/ASE) P-MO-181 Experience with Avastin (bevacizumab) for Radiation Maculopathy and Optic Neuropathy Paul Finger (New York/USA) P-MO-173 Visual outcomes of pleoptics for anisomyopic amblyopia with myelinated retinal nerve fibers Fumiko Ikeda, Shoji Kishi (Maebashi/J) P-MO-182 Exsudative Retinal Detachment Associated With Systemic Scleroderma Anna Cucera, Gabriele E. Lang, Gerhard K. Lang (Ulm/D) Retina: Medical Therapy P-MO-174 A study of in vivo laser-tissue interaction and healing response from 20 ms versus 100 ms pulse Pascal photocoagulation burns Mahiul Muqit, George R. Marcellino, David B. Henson, Jane Gray, Lorna B. Young, Niall Patton, Stephen J. Charles, George S. Turner, Paulo E. Stanga (Manchester/UK) P-MO-175 Acute retinal necrosis a case report Piotr Oleksy, Izabella Karska-Basta, Agnieszka Kubicka-Trz ska, Joanna Kobylarz, Bozena Romanowska-Dixon (Krakow/PL) P32 P-MO-176 Cellular structure and morphofunctional condition of corneal epithelium at Zymosan activated autoserum application in complex treatment of bacterial keratitis Tatyana Volkovich (Vitebsk/BY) P-MO-183 Extended sub retinal hemorrhage secondary to intravitreus bevacizumab. Ruben Edel Martínez Serrano, Jose Luis Estrada Rodríguez (Querétaro/MEX) P-MO-184 Hemodilution Therapy in Central Retinal Artery Occlusion B. A. Ehrhardt, Guido R. K. Kürzinger, Gabriele E. Lang (Ulm/D) P-MO-185 Intravitreal Bevacicumab injection in ROP case series of 6 infants Björn Harder, Jost B. Jonas, Frank Schlichtenbrede (Mannheim/D) P-MO-186 Intravitreal bevacizumab for the treatment of macular edema secondary to central retinal vein occlusion Phalangthep Prapatjukkit, Mansing Rattanasukon (Bangkok/T)

309 WOC Monday, 7 June :30-17:00 P-MO-187 Intravitreal Bevacizumab for treatment of choriodal neovascularization secondary to Best s disease in a 4-year-old child Katrin Lorenz, Bernhard Stoffelns, Christina Kramann, Norbert Pfeiffer, Heike Elflein (Mainz/D) P-MO-188 Intravitreal bevacizumab treatment of choroidal neovascularization secondary to pathologic myopia (PM) in Japanese patients. Kengo Hayashi, Kyoko Ohno-Matsui, Muka Moriyama, Noriaki Shimada, Wakako Hayashi, Manabu Mochizuki (Tokyo/J) P-MO-189 Intravitreal Dexamethasone as a Coadjuvant Therapy with for Ranibizumab Loading Phase in Choroidal Neovascularization Cristina Marin-Lambies, Roberto Gallego-Pinazo, Rosa Dolz-Marco, Andrea Diaz, Sebastian Martinez- Castillo, Manuel Diaz-Llopis (Valencia/E) P-MO-190 Intravitreal injections of ranibizumab in patients with diabetic macular edema resistant to focal/grid laser treatment. Sofia Aggeli, Marios Giannakopoulos, Olga Makri, Panagiotis Vasilakis, Constantine Georgakopoulos, Nikolaos Pharmakakis (Patras/GR) P-MO-195 Manchester Study of Single-session Pascal Targeted Retinal Photocoagulation [MTRAP] using Widefield Optos Angiography in Proliferative Diabetic Retinopathy Paulo Stanga, Mahiul Muqit, David Henson, George Marcellino, Jane Gray, Rita McLauchlan, Lorna Young, Niall Patton, Stephen Charles, George Turner (Manchester/UK) P-MO-196 Micropulse versus bevacizumab in central serous retinopathy Isabell Beger, Michael Koss, Frank Koch (Frankfurt/D) P-MO-197 Nature or Nurture Retinal Pigment Epithelial Detachments and Tears Treated with Ranibizumab Helena Cilliers, Li Ping Chow, Theocharis Papanikolaou, Douglas Newman (Oxford/UK) P-MO-198 Open-Label Phase 2 Study of Dexamethasone Intravitreal Implant for Treatment of Diabetic Macular Edema (DME) in Vitrectomized Patients: Interim Results David S. Boyer, Sunil Gupta, David Faber, Ching-Chi Liu, Xiao-Yan (Joanne) Li, Scott M. Whitcup (Los Angeles/USA, Irvine/USA) Monday, 7 June Posters P-MO-191 Intravitreal ranibizumab in retinal macroaneurysm Andrea Wenkstern, Heike Petersen (Uzwil/CH) P-MO-192 Intravitreal Ranibizumab Treatment for Macular Diseases: a tertiary eye centre experience Mary Ho, David T. L. Liu, Vincent Y. W. Lee, Chi-Lai Li, Dennis S. C. Lam (Hong Kong /HK) P-MO-193 Levels of intravitreal cytokines in patients with diabetic retinopathy given injection of anti-vascular endothelial growth factor antibody prior to vitrectomy Yukihiko Suzuki, Kaori Suzuki, Yasuhiro Miyagawa, Hitoshi Yamazaki, Mitsuru Nakazawa (Hirosaki/J) P-MO-194 Macular function and photopic negative response after single injection of intravitreal bevacizumab for myopic neovascularization Akiko Takahashi, Kohei Ishikawa, Shinji Ueno, Yasuki Ito, Mineo Kondo, Hiroko Terasaki (Nagoya/J) P-MO-199 PI3K/Akt mediates the expression of type collagen induced by TGF-β in human retinal pigment epithelial cells Katsuhiko Yokoyama, Kenichi Kimoto, Toshiaki Kubota (Yufu/J) P-MO-200 Posterior subtenon s triamcinolone acetonide injection in a patient with hypertensive optic neuropathy Heeyoon Cho, Insuk Song, Byung Ro Lee (Kyungggi-do/ROK) P-MO-201 Posterior vitreous detachment following intravitreal drug injection Ulrich Geck, Nicole Pustolla, Husnia Baraki, Hans Hoerauf (Göttingen/D) P-MO-202 Randomised control trial to evaluate the preferred method of anaesthesia for intravitreal injections Sudipto Bhatta, Sakkaf Ahmed Aftab, Raazia Janjua, Aamir Pasha Siddiqui (Sheffield/UK) P-MO-203 Safety profile of diabetic macular edema patients treated over 12 months with ranibizumab in the RESOLVE study Justus G. Garweg, on behalf of the RESOLVE study group (Bern/CH)

310 306 WOC 2010 Posters Monday, 7 June Monday, 7 June :30-17:00 P-MO-204 Serum-VEGF-levels in premature infants after intravitreal application of bevacizumab for retinopathy of prematurity Isabel Oberacher-Velten, Roman Regler, Viola Radeck, Horst Helbig (Regensburg/D) P-MO-205 Six months results of intravitreal bevacizumab versus triamcinolone for the treatment of macular edema caused by retinal vein occlusion: a retrospective analysis Patricia Kook, Eva Schäffner, Nikolaus Feucht, Mathias Maier, Chris P. Lohmann (Munich/D) P-MO-206 Strategies for successful ex vivo genetic engineering of pigment epithelial cells Sandra Johnen, Christiane Stickelmann, Michael Stöcker, Peter Walter, Gabriele Thumann (Aachen/D) P-MO-207 The benefit of a therapeutical core Vitrectomy using the Intrector in exudative AMD Slawomir Cisiecki, Michael Koss, Katharina Schramm, Janusz Michalewski, Frank Koch (Lodz/PL, Frankfurt/D) P-MO-208 The effect of intravitreal Bevacizumab on the treatment of central serous chorioretinopathy Hakyoung Kim (Seoul/ROK) P-MO-213 Therapeutic effect of oral bisphosphonate on choroidal neovascularization in the human eye. Shigeru Honda, Takayuki Nagai, Naoshi Kondo, Masahide Fukuda, Sentaro Kusuhara, Yasutomo Tsukahara, Akira Negi (Kobe/J) P-MO-214 Topical use of Ketorolac 0.5% for pain control in patients undergoing intravitreal administration of drugs Olga Makri, Panagiotis Vasilakis, Sofia Aggeli, Marios Giannakopoulos, Artemis Exarchou, Nikolaos Pharmakais, Constantine Georgakopoulos (Patras/GR) P-MO-215 Transient choroidal thinning after intravitreal injection for myopic choroidal neovascularization Yukari Jo, Yasushi Ikuno (Suita/J) P-MO-216 Treatment of Retinitis Pigmentosa with 9-cis retinal a Clinical Trial Ygal Rotenstreich, Aviv Shaish, Gili Ferman-Atar, Dror Harats, Michael Belkin (Kfar Bilu/IL) P-MO-217 Warfarin and intra-vitreal injections: Practice in the United Kingdom Nishant Kumar, Stathis Liazos, Christopher Baddon (London/UK) P-MO-209 The efficiency of intravitreal triamcinolone acetonide for persistent conventionally treated diabetic macular edema Hasan Arzoallxhiu, Isak Jurik (Prizren/KS) P-MO-210 The Learning Curve for Performing Focal Laser with the NAVILAS Michael Ulbig, Michael Ober, Aljoscha Neubauer, Marcus Kernt, Anselm Kampik, William Freeman, Igor Kozak (Munich/D) P-MO-211 The practice of intravitreal triamcinolone acetonide at a district general hospital in England Gulrez Ansari, Mehul Damani, Karima Nesnas, Manju Chandran, Geeta Menon (Fleet/UK) P-MO-212 The relationship between spectral-domain optical coherence tomography findings and injection frequency of bevacizumab in exudative age-related macular degeneration Kaori Sayanagi (Osaka/J) Retina: Surgical Therapy P-MO-218 Macular pucker surgery with and without delamination of the internal limiting membrane Christoph Krüger (Cologne/D) P33 P-MO-219 Anatomic and functional outcome after surgical removal of idiopathic macular epiretinal membrane Lee Po-Yen, Wu Wen-Chuan (Kaohsiung/TJ) P-MO-220 Case report: bullous retinoschisis invading the macula in a patient with high hyperopia Maria Heynemann, Stefan Mennel, Walter Sekundo (Giessen/D) P-MO-221 Clinical management modalities for premacular hemorrhages associated with Valsalva retinopathy Joaquin Castro-Navarro, Ieva Sliesoraityte, Carmen González-Castaño (Oviedo/E, Tübingen/D) P-MO-222 Comparison of anatomical success rate of primary vitrectomy and scleral buckling procedure in rhegmatogenous retinal detachment Christos Haritoglou, Ulrich Brandlhuber, Carolin Fischer (Munich/D)

311 WOC Monday, 7 June :30-17:00 P-MO-223 Comparison of standard and 23g vitrectomy in the treatment of epiretinal membranes a cross sectional study Caroline Gummersbach, Norbert Schrage, Andreas Cordes (Bergisch Gladbach/D, Cologne/D) P-MO-224 Correlation between autofluorescence, macular sensitivity and external limiting membrane structure after macula-off retinal detachment repair Mario R. Romano, Vito Romano, Martina Angi, Ciro Costagliola, Paolo Vinciguerra (Milano/I) P-MO-225 Correlation between macular hole size and postoperative visual outcome in eyes with idiopathic macular holes Masahiro Ishida, Atsuya Takeuchi, Seiji Takagi, Goji Tomita, Shinobu Takeuchi (Tokorozawa/J) P-MO-226 Crosslinked hyaluronic acid as a slow release system for dexamethasone Charlotte Frank (Tübingen/D) P-MO-227 Design and clinical results of the Mirror Telescopic Implant LMI-SI for the treatment of pseudophakic eyes that suffer also from AMD. Isaac Lipshitz, Amar Agarwal (Hertzlia/IL, Chennai/IND) P-MO-228 Early emulsification of 2000er silicone oil in minimal invasiv transconjunctival vitreoretinal surgery Mathias Maier, Verena Engelmann, Sarah Pfrommer, Carolin Perz, Chris Patrick Lohmann (Munich/D) P-MO-229 Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy Li Cairui (Dali/CN) P-MO-230 Effect of vitrectomy for idiopathic macular hole or epiretinal membrane on peripapillary retinal nerve fiber layer. Eiko Tsuiki, Mao Kusano, Kiyoshi Suzuma, Takeshi Kumagami, Takashi Kitaoka (Nagasaki/J) P-MO-231 Endogenous fungal endophthalmitis in intravenous drug abusers Xhevat Lumi, Mojca Urbancic, Rok Grcar (Ljubljana/SI) P-MO-232 Hso as 1st choice in complicated retinal detachment: Checkmate in two moves! Cesare Forlini, Paolo Rossini, Matteo Forlini (Ravenna/I) P-MO-233 Indocyanine Green (ICG) Increases Light-Induced Oxidative Stress, Senescence, and Accumulation of Extracellular Matrix Proteins in Human RPE Cells Johann Rüping, Christos Haritoglou, Rafael Liegl, Christoph Hirneiss, Aljoscha Neubauer, Arnd Gandorfer, Michael Ulbig, Anselm Kampik, Marcus Kernt (Munich/D) P-MO-234 Intraocular pressure changes immediately after intravitreal injection of Triamcinolone Acetonide and Ranibizumab Gul Arikan, A. Osman Saatci, F. Hakan Oner (Izmir/TR) P-MO-235 Intraocular Pressure Elevation after Vitrectomy for Proliferative Diabetic Retinopathy Fumiki Okamoto, Yumi Hasegawa, Yoshimi Sugiura, Takahiro Hiraoka, Tetsuro Oshika (Tsukuba/J) P-MO-236 Macular changes in spectral domain OCT after membrane peeling Bernd Junker, Amelie Pielen, Daniel Böhringer, Hansjürgen T. Agostini, Lutz Lothar Hansen, Nicolas Feltgen (Freiburg/D, Göttingen/D) P-MO-237 Management of Submacular Hemorrhage Associated with Retinal Pigment Epithelial Detachment Kwang-Soo Kim, Yu-Cheol Kim (Daegu/ROK) P-MO-238 New approaches of treatment of rhegmatogenous retinal detachment with inferior breaks. Galyna Levytska, Stanislav Rodin, Zoya Rozanova, Nikolay Umanets, Ivan Levitsky (Odessa/UA) P-MO-239 Ophthalmodynamometric pressure in eyes with proliferative diabetic retinopathy Yoshimi Sugiura, Fumiki Okamoto, Takahiro Hiraoka, Tetsuro Oshika (Tsukuba/J) P-MO-240 Perfect mixture? Siluron 2000 The new premium endotamponade Hakan Kaymak, Christian Lingenfelder, Wilfried Kugler, Nadine Hagedorn (Ulm/D) P-MO-241 Persistent Fetal Vasculature in the last ten years: what are the surgical outcomes? Hannah Chiu, Peter Kertes, Wai-ching Lam (Richmond Hill/CDN) P-MO-242 Pneumatic retinopexy for the repair of retinal detachments Nazmiye Erol, Seyhan Topbas, Ela Gündüz (Eskisehir/TR) Monday, 7 June Posters

312 308 WOC 2010 Posters Monday, 7 June Monday, 7 June :30-17:00 P-MO-243 Quantification of Changes in Horizontal Distortion of Macular Topography after Surgical Removal of Idiopathic Epiretinal Membranes Hyeong Gon Yu (Seoul/ROK) P-MO-244 Retinal Re-Detachment After Primary Buckling Surgery Roman Regler, Mohamed Afia, Horst Helbig, Carsten Framme (Regensburg/D) P-MO-245 Retinal Re-Detachment after Scleral Buckling Procedure Frank Schlichtenbrede, Babara Bort, Alexander Decker, Jost B. Jonas (Mannheim/D) P-MO-246 Retrospective review of retinal detachment in Hong Kong Cheuk Ki Chan (Hong Kong/HK) P-MO-247 Rhegmatogenous retinal detachment cases with decreased visual acuity postoperatively. Hirofumi Kinoshita, Kiyoshi Suzuma, Noritake Miyamura, Takeshi Kumagami, Takashi Kitaoka (Nagasaki/J) P-MO-248 Scleral buckling for retinal detachment with subretinal fibrosis Sofia Androudi, Anna Praidou, Evangelia Tsironi, Vassilis Konidaris, Evgenia Kanonidou, Periklis Brazitikos (Thessaloniki/GR) P-MO-249 Sequential epiretinal membrane removal with internal limiting membrane peeling in brilliant blue G-assisted macular surgery Ricarda G. Schumann, Arnd Gandorfer, Kirsten Eibl, Paul B. Henrich, Anselm Kampik, Christos Haritoglou (Munich/D) P-MO-250 Siderosis secondary to intraocular foreign body. Ruben Edel Martínez Serrano, Jose Luis Estrada Rodríguez (Querétaro/MEX) P-MO-253 Subretinal versus preretinal application of r-tpa to treat subretinal macular hemorrhage Stefan Mennel (Marburg/D) P-MO-254 Surgical and visual outcome after autologous plasmin assisted vitrectomy for stage5 retinopathy of prematurity Yasutomo Tsukahara, Hisanori Imai, Shigeru Honda, Mizuki Tagami, Sentaro Kusuhara, Akira Negi (Kobe/J) P-MO-256 Tear film stability in the early postoperative period of 23-gauge microincision vitrectomy Taichi Takahata, Azusa Fujikawa, Kiyoshi Suzuma, Noritake Miyamura, Takashi Kitaoka (Nagasaki/J) P-MO-257 The Effect of Intravitreal Bevacizumab Injection in Diabetic Patients with Macular Edema Receiving Cataract Surgery Li-chung John Chi, Wen-Chen Wu (Kaohsiung/TJ) P-MO-258 The finding of MRI in vitreous humor injected silicone oil Hiroshi Watanabe, Aya Ooi, Yuka Suzuki, Tetuo Tochikubo (Tokyo/J) P-MO-259 The outcome of primary pneumatic retinopexy Kaveh Vahdani, Georgios Makrygiannis, Aristeidis Konstantinidis, Vasant Raman (Plymouth/UK) P-MO-260 The outcome of TPPV in patients with retinal detachment with ILM peeling comparing to the patients with no membrane peeling. Malgorzata Pietras-Trzpiel, Tomasz Chorągiewicz, Tomasz Żarnowski, Robert Rejdak (Lublin/PL) P-MO-261 The Relevant Factors of Macular Holes Closure Types in Patients of Idiopathic Macular Holes after Pars Plana Vitrectomy Junyi Wang, Guoge Han, Haifeng Mei, Yiqiao Xing, Anhuai Yang (Wuhan/CN) P-MO-251 Subclinical choroidal detachment at sclerotomy sites after 23-gauge vitrectomy analysis with anterior segment Optical Coherence Tomography Rainer Guthoff, Heidi Riederle, Berit Kasper, Winfried Goebel (Wuerzburg/D) P-MO-252 Subjective auditory perceptions during vitreo-retinal surgery under local anaesthesia Fariha Shafi, Randhir Chavan, Mark Hero (Coventry/UK) P-MO-262 Treatment effects in treating diabetic macular edema by single intravitreal bevacizumab Jia-Kang Wang (Taipei/TJ) P-MO-263 Treatment efficiency in serous pigment epithelial detachment in age related macular degeneration Matthias Schmidt, Steffi Jeep, Constantin E. Uhlig (Münster/D)

313 WOC Monday, 7 June :30-17:00 P-MO-264 Treatment of massive subretinal hematoma associated with age-related macular degeneration using pars plana vitrectomy combined with intentional giant retinal tear formation Eisuke Ishizaki, Atsuko Nakaizumi, Masanori Fukumoto, Takaki Sato, Masahiro Minami, Mari Ueki, Tsunehiko Ikeda (Takatsuki/J) Trauma P-MO-272 Anatomical outcome and prognostic factors following intraocular foreign body removal Rodney John Morris, Saravanan Veerappan Rathinasabapathy, Narendran Venkatapathy, Parag Shah, Dheepha M. (Coimbatore/IND) P35 Monday, 7 June Posters P-MO-265 Ultra-early histological alteration of the retina following photocoagulation treatment in diabetic retinopathy as measured by Spectral domain optical coherence tomography Long Su, Hao Kang, Hong Zhang, Xiaorong Li (Tianjin/CN) P-MO-266 Vitrectomy in patients with familial amylidotic polyneuropathy to recover good visual acuity Akira Imai, Teruyoshi Miyahara, Toshinori Murata (Matsumoto/J) P-MO-267 Vitrectomy vs Photocoagulation in Patients with Optic Disc PIT Associated Maculopathy Case Reports. Izabella Karska-Basta, Agnieszka Kubicka-Trząska, Piotr Oleksy, Joanna Kobylarz, Bożena Romanowska-Dixon (Kraków/PL) P-MO-268 Vitreoretinal Surgeries with Subconjunctival Anesthesia in Anticoagulated Patients Amina Malik (Cincinnati/USA) Teleophthalmology P-MO-269 Automated detection of hard exudates in retinal images Parnian Kasae, Alfredo Ruggeri (Padova/I) P-MO-270 Integration of a teleophthalmology service (electronic referrals with imaging) into a regional ophthalmology unit James Cameron, Shyamanga Borooah, Roshini Sanders (Edinburgh/UK) P34 P-MO-271 Nonmydriatic Screening for Diabetic Retinopathy by Ultra-Widefield Scanning Laser Ophthalmoscopy (Optomap) Compared to ETDRS 7-Field Imaging Indrawati Hadi, Aljoscha Neubauer, Florian Pinter, Stefanie Guthmann, Christos Haritoglou, Michael Ulbig, Anselm Kampik, Marcus Kernt (Munich/D) P-MO-273 Blunt Trauma Caused by a Tea-towel Is drying up really this dangerous! Charalambos Tossounis, Luke Clifford, Mehrdad- Sam Attaran, David Farnworth (Portsmouth/UK) P-MO-274 Clinical manifestation of epithelial downgrowth 48 years after penetrating eye trauma Anne Mellein, André Rosentreter, Inga Wedemeyer, Thomas S. Dietlein (Cologne/D) P-MO-275 Cluster bomb ocular injuries Ahmad Mansour, Muhammad Younis, Ayman Ghaddar, Ahmad Mokaddam, Mohamad Al Hajj-Ali (Beirut/RL) P-MO-276 Comparison of ocular trauma indices in grading severity of injury and predicting visual disability after open globe injuries Mayuri Bhargava, Usha Vasu (Bangalore/IND) P-MO-277 Iatrogen ocular affections after application of 2-Octyl Cyanoacrylate Birgit Große, Anna Cucera, Sebastian Kupferschmid, Gerhard K. Lang (Ulm/D) P-MO-278 Outcome after severe blunt trauma of the eyeball due to battery explosion Katarina Hurtikova, Leonie Troeber, Susanne C. Goebels, Ursula Löw, Frank Schirra, Berthold Seitz (Homburg/D) P-MO-279 Pediatric Ocular Trauma: The Analysis of Causes and Outcomes from a Tertiary Eye Centre in Eastern India. Radha Das, Kumar Saurabh, Sudipta Das, Deepak Agrawal (Kolkata/IND) P-MO-280 Predicting visual outcome after an open globe injury using ocular trauma score (OTS) Gowri Supramaniam, S. E. Khor, M. M. Choo, Bethel I. Livingstone (Seremban/MAL)

314 310 WOC 2010 Posters Monday, 7 June Monday, 7 June :30-17:00 P-MO-281 Severe self-induced ocular mutilation as the first episode of psychosis Dagmar Hejcmanova, Lisa Catherine Bytton Díaz, Marketa Machackova, Michaela Hulkova (Hradec Kralove/CZ) P-MO-282 Soccer-related ocular trauma in a tertiary ophthalmologic center in Brazil Cristina Miyamoto, Elisabeth Nogueira Martins (São Paulo/BR) P-MO-283 Treatment of corneal iron-containing foreign bodies Volodymyr Usov, Tatyana Zhmud (Odessa/UA) P-MO-290 Myopia Control in Teenager Population by Corneal Refractive Therapy (CRT): Results of 4 years Follow-up Andriy Kovalov, Oksana Averyanova (Kiev/UA) P-MO-291 Our experience with PDT for the management of corneal neovascularization in children Giuseppe Carollo (Palermo/I) P-MO-292 Outcome of penetrating keratoplasty (PKP) after fungal keratitis in Middle Delta region of Egypt Osama Shalaby, Rabab El Seht, M. Sameh El Shorbagy (Tanta/ET) Cornea/Eye Bank P-MO-284 Analysis of the efficiency of various application methods of ophthalmic medication Kwang Sic Joo, Du Hwan Oh, Nam Ju Moon, Yeoun Sook Chun, Jae Chan Kim (Seoul/ROK) P-MO-285 Candida Keratitis: The new enemy Nibaran Gangopadhyay, Jayangshu Sengupta, Archana Khetan, Suman Saha, Merle Fernandes (Kolkata/IND) P36 P-MO-286 Cultivation of rabbit acinar lacrimal gland cells on denuded and undenuded amniotic membrane with and without co-cultivation of 3T3 fibroblasts Karsten Kasper, Stefan Schrader, Doris Deininger, Gerd Geerling (Wuerzburg/D) P-MO-287 Effects of bone marrow mesenchymal stem cells on cell proliferation and growth factors expression of limbal epithelial cells in vitro Nan Hu, Xiaohong Mao (Nantong/CN) P-MO-288 Evaluation of the need for and benefit of a communication training for consent for cornea donation by telephone Stephanie Stiel, Sabine Salla, Andre Steinfeld, Peter Walter, Lukas Radbruch, Martin Hermel (Aachen/D) P-MO-289 Keratoconus coexisting with pigment dispersion syndrome the cases report Justyna Izdebska, Anna Kaminska, Agnieszka Czeszyk-Piotrowicz, Joanna Jedrzejczak- Mlodziejewska (Warsaw/PL) P-MO-293 Parameters for personal approval of cornea donation Julia Promesberger, Constantin E. Uhlig (Münster/D) P-MO-294 Reduced Endothelial Cell Loss following Limbo- Keratoplasty Laura Bredow, Daniel Böhringer, Johannes Schwartzkopff, Thomas Reinhard (Freiburg/D) P-MO-295 Severe conjunctival cicatrisation with limbal stem cell failure following bone marrow transplantation Richard J. Symes, Caroline L. Furness, Bronwen E. Shaw, Andrena McElvanney (London/UK) P-MO-296 The changes of the clinical manifestations and tear cytokines after the treatment with Tears again on dry eye syndrome Kwang Sic Joo, Du Hwan Oh, In Ki Park, Yeoun Sook Chun, Jae Chan Kim (Seoul/ROK) P-MO-297 The Meibomian glands a hair without a hair shaft cytokeratin expression of the Human Meibomian glands Erich Knop, Milena Ludescher, Nadja Knop (Berlin/D, Hannover/D) P-MO-298 Therapeutic Descemet Sparing Anterior Keratoplasty:The best choice? Jayangshu Sengupta, Dipanjan Pal, Archana Khetan, Suman Saha, Nibaran Gangopadhyay, Merle Fernandes (Kolkata/IND)

315 WOC Tuesday, 8 June :30-17:00 Poster exhibition of Poster P-TU-001 to P-TU-265. All poster authors will attend their posters from to hrs. Moderation Poster sessions on Tuesday Katrin Engelmann (Chemnitz) Sekundo, Walter (Marburg) Co- Marcus Blum (Erfurt) Stefan Clemens (Greifswald) Carl Erb (Berlin) Hermann O. C. Gümbel (Ulm) Christos Haritoglou (Munich) Gerald Langmann (Graz ) Frank Schirra (Homburg/Saar) Ulrich Mester (Sulzbach) Daniel Mojon (St. Gallen) Cataract/Biometry 2 P37 P-TU year position stability of an angle-supported foldable hydrophobic acrylic phakic intraocular lens evaluated by Scheimpflug photography Oliver Klaproth, Thomas Kohnen (Frankfurt/D) P-TU-002 Asymmetric phacobisection Almazbek Botbaev (Bishkek/KIS) P-TU-003 Brown Cataract A challenge to the Ophthalmologist! Swati Zawar (Nashik/IND) P-TU-008 Comparison of Tecnis 1-piece multifocal vs. monofocal intraocular lenses: a prospective clinical multicentre study Tanja M. Rabsilber, Annett Mannsfeld, Julia Villalba, Il-Joo Limberger, Mike P. Holzer, Gerd U. Auffarth (Heidelberg/D) P-TU-009 Defocus Curve Profiles of Patient s Implanted Binocularly with Refractive, Binocularly with Diffractive, or with a Combination of Diffractive- Refractive Intraocular Lenses Phill Buckhurst, Sunil Shah, James Wolffsohn (Birmingham/UK) P-TU-010 Differences in reading performance using the Salzburg Reading Desk (SRD) after multifocal and monofocal intraocular lens implantation Max Rasp, Gerhard Nix, Alois Dexl, Ana Belen Plaza, Jorge Alió, David Pablo Piñero Llorens, Günther Grabner (Salzburg/A, Alicante/E) P-TU-011 Effective followability and less BSS consumption with combined peristaltic and venturi pump during phaco emulsification Ekkehard Fabian (Rosenheim/D) P-TU-012 Endothelial cell integrity, phaco efficiency and nuclear fragment control using Ellips transversal phaco with Venturi pump VS longitudinal phaco with peristaltic pump. Matteo Piovella (Monza/I) Tuesday, 8 June Posters P-TU-004 Changes in anterior chamber depth and refractive power after cataract surgery with or without simultaneous vitreous surgery. Mao Kusano, Eiko Tsuiki, Kiyoshi Suzuma, Takeshi Kumagami, Takashi Kitaoka (Nagasaki/J) P-TU-005 Clinical and functional analysis of the phacoemulsification results in the cataract extraction of different etiology Ivanov Gheorghe (Chisinau/MD) P-TU-006 Clinical impact of spherical aberration on contrast sensitivity of different intraocular lenses Hanno Goeppert, Andreas Christian Schroeder, Welk Stephanie, Frank Schirra, Karin Brueckner, Achim Langenbucher, Berthold Seitz (Homburg/D) P-TU-007 Clinical impact of spherical aberration on focal depth of different intraocular lenses Sarah Kuehlmeyer, Andreas Christian Schroeder, Eva Filser, Tobias Hager, Christian Jonescu-Cuypers, Hans Sebastian Walter, Achim Langenbucher, Berthold Seitz (Homburg/D) P-TU-013 Factors influencing corneal biomechanical changes following microincision cataract surgery (MICS) and standard coaxial phacoemulsification Jorge Alió, Maria Cecilia Gertrudis Agdeppa, David Pablo Piñero Llorens, Jose Luis Rodriguez Prats, Francisco Amparo (Alicante/E) P-TU-014 Functional vision in presbyopia correcting IOLs. Randomized Double Masked Clinical Trial comparing Dual optic accommodating IOL vs multifocal IOL Ricardo Alarcon, Victor Bohorquez, Ivan Osma (Bogota/CO) P-TU-015 Influence of ocular spherical aberration on optical quality after cataract surgery depending on intraocular lens asphericity Christian Hofmann, Oliver Klaproth, Jens Bühren, Thomas Kohnen (Frankfurt/D)

316 312 WOC 2010 Posters Tuesday, 8 June Tuesday, 8 June :30-17:00 P-TU-016 Influence of surgically induced corneal spherical aberration on retinal image quality after cataract surgery Thomas Kohnen, Oliver Klaproth, Christian Hofmann, Jens Bühren (Frankfurt/D) P-TU-017 Intracameral white mass associated with anterior uveitis in a patient with anterior polar cataract Ulrich Brandlhuber, Armin Wolf, Christos Haritoglou, Daniel Kook (Munich/D) P-TU-018 Intraocular lens power calculation following INTRACOR Tanja M. Rabsilber, Annett Mannsfeld, Angela Ehmer, Wolfgang Haigis, Gerd U. Auffarth, Mike P. Holzer (Heidelberg/D) P-TU-019 Intraoperative and clinical results of phacoemulsification with ultrasound ellips through 2.2mm incision for hard cataract Ahmed Assaf (Kairo/ET) P-TU-020 Iris claw (Verisyse /Artisan ) intraocular lens implantation in cases with subluxated lenses due to Marfan syndrome. George Voyatzis, Bushra Al-Deiri, Alan Fitt (Peterborough/UK) P-TU-025 Oculentis LENTIS Mplus: A new concept of multifocal intraocular lens technology Gerd U. Auffarth, Tanja M. Rabsilber, R. Philips, Jan Novák (Heidelberg/D) P-TU-026 Optivis Multifocal Progressive Diffractive Lens: Three Months Clinical Outcomes Matteo Piovella (Monza/I) P-TU-027 Outcomes with Refractive and Diffractive multifocal intra ocular lens Dandapani Ramamurthy (Coimbatore/IND) P-TU-028 Performance of three biometry devices in patients with different grades of age-related cataract Georgios Mylonas, Stefan Sacu, Wolf Bühl, Markus Ritter, Michael Georgopoulos, Ursula Schmidt- Erfurth (Vienna/A) P-TU-029 Postoperative Capsular Block Syndrome Anterior Segment Optical Coherence Tomography Findings Amy L. Wong (Hong Kong/HK) P-TU-030 Postoperative Results after Implantation of a toric IOL (B1AWTY) for small corneal astigmatism Andreas K. Cordes, Norbert F. Schrage (Cologne/D) P-TU-021 Long-term results after bilateral congenital cataract surgery pars plana lensectomy versus ECCE and IOL implantation Imad Hakim, Wolfgang Mayer, Daniel Kook, Guenther Rudolph, Anselm Kampik (Munich/D) P-TU-022 Misleading axial length measurements due to a dense posterior vitreous surface membrane in a diabetic patient case report Christoph Fidel Mayer, Michaela Velikay-Parel (Graz/A) P-TU-023 Morphometric Analysis of Cornea Endothelial Post Phacoemulsification Viscoadaptive Compare to Medium Viscosity Combines with Chondroitin Sulphate Amir Shidik (Jakarta/IR) P-TU-024 Near, intermediate and distance vision outcomes with the Crystalens HD accommodating intraocular lens Ana Belen Plaza, Jorge Alió, David Pablo Piñero Llorens (Alicante/E) P-TU-031 Pseudophakic nuclear cataract Andreas Christian Schroeder, Christian Lingenfelder, Hans Sebastian Walter, Gregory Dame, Berthold Seitz (Homburg/D) P-TU-032 Quality of information about Cataract on the internet Markus Groppe, Kwesi Amissah-Arthur, Achmed El-Amir, Vaughan Tanner (High Wycombe/UK) P-TU-033 Refractive surprise Juliana Helou, Anna Cucera, Gerhard K. Lang (Ulm/D) P-TU-034 Results of Low Contrast visus in AT.Lisa 366 D Implantation Harry Domack (Schweinfurt/D) P-TU-035 State of art hands on surgical training made easy Vikas Mahatme (Nagpur/IND)

317 WOC Tuesday, 8 June :30-17:00 P-TU-036 Surgically-induced astigmatism in phacoemulsification: 2.2mm versus eleven scalpel blade clear corneal incisions Hermelino Oliveira Neto, Israel Cardoso Neto, Ronald Fonseca Reis, José Bessa Jr (Feira de Santana-Bahia/BR) P-TU-037 Visual Function in Patient s Implanted with the New Lentis Mplus Multifocal Intraocular Lens Sunil Shah, Phill Buckhurst, James Wolffsohn (Birmingham/UK) P-TU-038 Visual outcomes following microincision cataract surgery (MICS) in Kuantan, Malaysia Thevi Thanigasalam (Temerloh/MAL) P-TU-046 Prophylactic Treatment for Cytosine Arabinoside (Ara-C) induced Keratoconjunctivitis William Sheehan, Amit Patel (Bristol/UK) P-TU-047 Report of our graft-versus-host-disease consultation hour Katharina Hauer, Philipp Eberwein, Daniel Böhringer, Thomas Reinhard, Hans Mittelviefhaus (Freiburg/D) P-TU-048 Toxicity of ranibizumab (Lucentis ) to cultured human corneal endothelial cells in vitro Michael Wolfgang Meyer, Stephan Reichl, Katharina Bauer, Inez Brunotte, Konstantinos Zinelis, Sebastian Weiß, Rolf Winter (Hannover/D) Tuesday, 8 June Posters P-TU-039 Vizualisation of Anterior Segment Whit Sd-Oct Rt-100 Lukan Mishev (Sofia/BG) Cornea/Eye Bank: Miscellaneous P38 P-TU-040 Bilateral Cornea Plana in two siblings: Management Vishnu Gupta, Anuj Mehta, Shreekant Damgude, Rupsanchita Das, Brahm Guliani, Krishan Malik (Coimbatore/IND) P-TU-049 Treatment of traumatic corneal abrasion: A three arm, prospective, randomized study Moreno Menghini, Pascal Knecht, Claude Kaufmann, Ronald Kovacs, Stephanie Watson, Klara Landau, Martina Bösch (Zurich/CH) P-TU-050 Update on ocular graft-versus-host-disease (GVHD) report of the consensus conference on chronic GVHD Tina Dietrich, Claus Cursiefen, Daniel Wolff (Regensburg/D, Erlangen/D) P-TU-041 Bilateral Esclerocornea, case report Ruben Edel Martínez Serrano, Alejandra Etualin González, Jose Luis Estrada Rodríguez (Querétaro/MEX) P-TU-042 Cosmetic corneal tattooing (in corneal opacities) using new pigment Chitra Pande, Vikas Mahatme (Nagpur/IND) P-TU-043 Influencing corneal wound healing after corneal burn using amniotic membrane and mesenchymal stem cells. Philipp Eberwein, Andreas Heidt, Johannes Schwartzkopff, Yvonne Kern, Daniel Böhringer, Thomas Reinhard (Freiburg/D) P-TU-044 Keratitis and corneal ulceration due to contact lenses Michael R. R. Böhm, Inga Domenghino, Holger Busse, Ralph-Laurent Merté (Münster/D) Glaucoma: Miscellaneous P-TU-051 Analysis of intraocular pressure measurements influenced by corneal curvatures and thicknesses among three tonometries. Sheng-Yao Hsu, Rong-Kung Tsai (Kaohsiung/TJ) P-TU-052 Assessment of Ciliary body area in pupil block Peter Good (Birmingham/UK) P-TU-053 Cerebrospinal Fluid Pressure in Glaucoma. Ruojin Ren (Beijing/CN) P-TU-054 Comparison of Cost and Distribution of Patients after Different Initial Treatments for Primary Open Angle Glaucoma Hye Bin Yim, Tong Yun Kwag, Jee Hyun Kwag, Yeon Deok Kim, Aman Shah B. Abdul Majid, Kui Dong Kang (Incheon/ROK) P39 P-TU-045 Outcomes of amniotic membrane transplantation in chemical injuries of ocular surface Swati Tomar (Jaipur/IND) P-TU-055 Correlation of Vision Threatening Glaucoma with prolonged and unmonitored use of Topical Steroids Rekha Khandelwal, Shivani Bidaye, Suresh Ughade, Mohana Majumdar (Nagpur/IND)

318 314 WOC 2010 Posters Tuesday, 8 June Tuesday, 8 June :30-17:00 P-TU-056 Depression and sleep disorders in progressed glaucoma: an indication for melatonergic antidepressants? Christos Skevas, Agorastos Agorastos, Mario Matthaei, Christina-Georg Huber, Oliver Zeitz, Gisbert Richard, Maren Klemm (Hamburg/D) P-TU-057 Free floating iris cyst at the anterior eye chamber. Wolfram Hofmüller, Arne Viestenz, Sven Walter, Wolfgang Behrens-Baumann (Magdeburg/D) P-TU-058 Intraocular pressure after phacoemulsification in eyes with exfoliative glaucoma and primary open-angle glaucoma Tomaž Gračner, Nenad Špička, Mojca Hudovernik, Bojan Gračner, Dušica Pahor (Maribor/SI) P-TU-059 Masked, Randomized, Parallel Comparison of Physician and Patient Reported Outcomes (PROS) after Switching to Bimatoprost 0.03% vs Continuing on Latanoprost 0.05%. Ehsan Sadri, Ronald Frenkel, Jodi Luchs, Michael Rotberg, Thomas K. Mundorf, John G. Walt, Chingchi Liu, Amy L. Batoosingh (Newport Beach/USA) P-TU-060 The Humanistic and Economic Burden of Glaucoma: An Update Steven M. Kymes, Gail Schwartz, Richard G. Fiscella, Caroline Burk, Vaishali D. Patel (St. Louis/USA) P-TU-061 The Relationship Between Obstructive Sleep Apnea Syndrome and Glaucoma Gul Arikan, Mehmet Ozgur Zengin, Ibrahim Oztura, Uzeyir Gunenc, Mehmet Ergin (Izmir/TR) P-TU-062 Unusual presentation of unilateral acute angle closure glaucoma on a child Karunarathna Rajapaksha, Keembiyage Dayawansa (Kandy/CL) Glaucoma: Surgical Therapy P40 P-TU-063 Ahmed valve implantation in refractory glaucoma secondary to sturge-weber syndrome: case series Othmaliza Othman, Wan Haslina Wan Abdul Halim, Norshamsiah Md Din, Ropilah Abdul Rahman (Kuala Lumpur/MAL) P-TU-064 Application of gelatin hydrogel and chymase inhibitor in a canine filtration surgery model Shota Kojima, Tetsuya Sugiyama, Maho Shibata, Denan Jin, Shinji Takai, Yasuhiko Tabata, Tsunehiko Ikeda (Takatsuki/J) P-TU-065 Canaloplasty outcome analysis by anterior segment optical coherence tomography Thomas Theelen, Cathrien A. Eggink (Nijmegen/NL) P-TU-066 Capsule exzision and Ologen implantation for revision after glaucoma drainage device surgery Andre Rosentreter, Anne C. Mellein, Walter W. Konen, Thomas S. Dietlein (Hürth/D, Cologne/D) P-TU-067 Cataract surgery for acute angle closure secondary to scleral buckling Kodo Medoruma, Ichiko Medoruma, Hideo Nakamura, Shoichi Sawaguchi (Nishihara-cho Okinawa-ken/J) P-TU-068 Clinical Results of Selective Laser Trabeculoplasty in Open-Angle Glaucoma in Japanese Eyes: Comparison of 180 Degree with 360 Degree SLT Maho Shibata, Tetsuya Sugiyama, Osamu Ishida, Mari Ueki, Shota Kojima, Takaaki Okuda, Tsunehiko Ikeda (Takatsuki/J) P-TU-069 Combined Phaco-Trabeculectomy for Progressive Normal-Tension Glaucoma Associated with High Myopia Atsuya Miki, Aya Terubayashi, Shinichi Usui, Kenji Matsushita, Yasushi Ikuno (Osaka/J) P-TU-070 Conditions of preoperative and early postoperative intraocular pressure for predicting the lower pressure control in a trabeculectomy. Satoshi Okimoto, Yoshiaki Kiuchi, Junichi Kawahara (Hiroshima/J) P-TU-071 Endoscopic cyclophotocoaguation combined with phacoemulsification Zora Ignjatovic, Zoran Kuljaca, Katarina Misailovic, Maja Beko, Nada Radovic, Andjela Tolic (Selgrade/SRB) P-TU-072 Evaluation of Filtering Blebs after Trabeculectomy using Anterior Segment Optical Coherence Tomography Akiko Narita, Jiro Seguchi (Okayama/J) P-TU-073 Express Shunt in selected glaucoma patients First results Claudia Rebel, Mario Matthaei, Johannes Steinberg, Maren Klemm (Hamburg/D) P-TU-074 Glaucoma and penetrating keratoplasty after pseudomonas corneal infection Carolina Pallás (Barcelona/E)

319 WOC Tuesday, 8 June :30-17:00 P-TU-075 High-frequency ultrasound evaluation of Schlemm s Canal and suture traction after Canaloplasty Anne Brüggemann, Joshua Torrent Despouy, Swaantje Peters, Salvatore Grisanti, Maya Mueller (Lübeck/D) P-TU-076 Investigation of a modified PNIPAAm hydrogel for portential use in drug-eluting glaucoma drainage devices Hagen Thieme, Robert Roskamp, Maria Wegner, Norbert Pfeiffer, Lars Choritz (Mainz/D) P-TU-077 Mid-term outcome of inferior-approch trabeculotomy takuro matsuba (Osaka/J) P-TU-078 Non Penetrating Deep Sclerectomy Between Safety and Efficacy Dorin Chiselita, Alina Cantemir, Irina Ilies (Ia i/ro) P-TU-079 Selective Laser Trabeculoplasty for Uveitis Induced Elevated Intraocular Pressure Hyoung Sub Shim, Taehyuk Koh, Hwang Ki Kim, Yong Ho Sohn (Incheon/ROK) P-TU-085 Breast cancer metastasis to the choroid in a male patient case report Arkadiusz Pogrzebielski, Piotr Oleksy, Izabella Karska-Basta, Bo ena Romanowska-Dixon (Kraków/P) P-TU-086 Choroidal Mets. Enucleation? Jorge Topete-Jimenez, Jorge Topete-Jimenez (Guadalajara/MEX) P-TU-087 Clinical and Imaging Features in Metastatic Uveal Tumors Xiaoda Bi (Shanghai/CN) P-TU-088 Combined Treatment T2N0M0 Patients with Choroidal Melanoma with 106 RU+ 106 RH Plaques and Transpupillary Thermotherapy (TTT) Larisa Naumenko (Minsk/BY) P-TU-089 Congenital simple hamartoma of the retinal pigment epithelium Gregor Willerding, Hilmar Tillack, Joachim Wachtlin, Nikolaos E. Bechrakis, Michael H. Foerster (Berlin/D, Innsbruck/A) Tuesday, 8 June Posters P-TU-080 Trabeculectomies in Eyes with Glaucoma in a Patient with Osteogenesis Imperfecta Julia Rosbach, Norbert Pfeiffer, Katharina A. Ponto, Katrin Lorenz, Urs Vossmerbaeumer, Hagen Thieme (Mainz/D) P-TU-081 Two-years Follow-up of Trabeculectomy with Biodegradable 3D Porous Collagen-Glycosaminoglycan Scaffold for Treatment of Refractory Glaucoma Henry Shen-Lih Chen, Wei-Cherng Hsu (Taipei/TJ) P-TU-082 YAG-laser-goniopuncture after deep sclerectomy a morphologic analysis Matthias Keserü, Gisbert Richard, Maren Klemm (Hamburg/D) Oncology P41 P-TU-083 Adjuvant topical treatment of recurrent conjunctival squamous cell carcinoma with Mitomycin C Orlin Velinov, Holger Busse, Ralph-Laurent Merté (Münster/D) P-TU-084 Adult onset asthma and periocular xanthogranuloma associated with reactive lymphoid hyperplasia: one case report Rimvydas Asoklis, Laura Butkiene, Ona Garlaite, Donatas Petroska (Vilnius/LT) P-TU-090 Conjunctival Melanoma. Origin from primary acquired melanosis (PAM) and nevus shows less risk for melanoma-related death than origin de novo. Carol Shields, Jeremy Markowitz, Irina Belinsky, Nina George, Hal Schwartzstein, Sara Lally, Arman Mashayekhi, Jerry Shields (Philadelphia/USA) P-TU-091 CyberKnife: a new treatment option for uveal melanomas Ulrich Christoph Schaller, Martin Nentwich, Annemarie Klingenstein, Berndt Wowra, Alexander Muacevic, Anselm Kampik (Munich/D) P-TU-092 Differential diagnosis of iris and/or ciliary body melanoma. Bozena Romanowska-Dixon, Anna Markiewicz, Barbara Jakubowska (Krakow/P) P-TU-093 Differential diagnosis of proptosis in childhood Monica Lang, Andreas Chantzaras, Karl-Heinz Emmerich (Darmstadt/D) P-TU-094 Diverse Clinical Spectrum of Bilateral Diffuse Uveal Melanocytic Proliferation Syndrome. Camila Simoes, Zelia Correa, James Augsburger (Cincinnati/USA)

320 316 WOC 2010 Posters Tuesday, 8 June Tuesday, 8 June :30-17:00 P-TU-095 Endoresection of large choroidal melanoma after stereotactic radiotherapy Stefan Christmann (Cologne/D) P-TU-096 Evaluation of Bulbus Shift after Retrobulbar Anesthesia in Cyberknife Radiosurgery for the Therapy of Large Uveal Melanoma Martin M. Nentwich, Christoph Fürweger, Alexander Muacevic, Berndt Wowra, Annemarie Klingenstein, Anselm Kampik, Ulrich C. Schaller (Munich/D) P-TU-097 Expression of Galectin-3 and Epha2 in metastatic and non-metastatic uveal melanomas Julia Lüke, Vlatka Vukoja, Tim Brandenbusch, Matthias Lüke, Aysegül Tura, Martin Rohrbach, Salvatore Grisanti (Lübeck/D, Tübingen/D) P-TU-098 Expression of ocular mucins in conjunctival melanoma, conjunctival compound naevi and normal conjunctiva Vinodh Kakkassery, Claudia Gavranic, Johannes Holle, Antonia Joussen (Berlin/D) P-TU-099 Eye manifestation of Waldenström s macroglobulinemia Antje Zimmermann, Melanie Jäger (Linden/D) P-TU-100 Factors influencing the course of pediatric orbital malignancy in Third world countries Issues beyond the therapeutic regimen Jayanta Das (Guwahati/IND) P-TU-101 Giant papillary conjunctivis as primary manifestation of a non-hodgkin lymphoma Susanne C. Goebels, Andrea Hasenfus, Leonie Troeber, Arnulf Schnaidt, Frank Schirra, Berthold Seitz (Homburg/D) P-TU-102 Identification of ionizing radiation-responsive micro RNAs in uveal melanoma cells Yixiong Zhou, Xianqun Fan (Shanghai/CN) P-TU-103 Incidence and Recurrence Rates of Ocular Surface Squamous Neoplasia in Gaborone, Botswana: 1998 to 2007 Oathokwa Nkomazana (Gaborone/RB) P-TU-104 Malignant Triton Tumor Without Von Recklinghausen s Neurofibromatosis in a 16-year-old Indonesian Girl: A Case Report Neni Anggraini, Rino Pattiata (Jakarta/RI) P-TU-105 Masquerade Syndrome Caused by Intraorbital Lymphoma Two Case Reports Darko Ler, Joziča Baralič, Senad Pozder, Jasna Muhovič-Bejtič, Ibrahim Pačo (Sarajevo/BIH) P-TU-106 MicroRNA-200 Is Commonly Repressed in Conjunctival MALT Lymphoma and Potentiates Expression of Cyclin E2 Jiping Cai (Shanghai/CN) P-TU-107 Myxoid/Round Cell Conjunctival Liposarcoma: A Case Report Giuri Stela, Raica Marius, Munteanu Mihnea, Munteanu Gheorghe (Timisoara/RO) P-TU-108 Optical coherence tomographic features of optic disc melanocytoma in Chinese patients Jasmine WS Ngai (Hong Kong /HK) P-TU-109 Optical Coherence Tomography Pathological Correlation of Optic Disc Melanocytoma Paul Finger, Sribhargava Natesh, Tatyana Milman (New York City/USA, Bangalore/IND) P-TU-110 Orbital metastasis from colorectal cancer Benjamin Perez, Nicolas Leon-Gonzalez, Nicolas Leon-Perez, Abelardo Rodriguez-Reyes (Mexico/MEX) P-TU-111 Outpatient Cytologic Evaluation of Ocular Surface Squamous Neoplasia Ekaterina A. Semenova, Tatyana Milman, Paul T. Finger, Madhavi Kurli, Susan Schneider, Sribhargava Natesh, Codrin E. Iacob, Steven A. McCormick (Moscow/RUS) P-TU-112 Pars plana lensectomy in External Beam Radiotherapy induced Cataract in Retinoblastoma Markus Holdt, Barbara Schaperdoth-Gerlings, Christine Jurklies, Norbert Bornfeld (Essen/D) P-TU-113 Photodynamic therapy a novel therapeutic approach for superficial eyelid basal cell carcinoma Jan Ricar, Renata Ricarova, P. Cetkovska, K. Pizinger (Pilsen/CZ) P-TU-114 Presence of tumor cells in the bloodstream, before and after surgical intervention in uveal melanoma Georgios Charitoudis, Vasileios Petousis, Ronny Schuster, Ulrich Keilholz, Michael H. Foerster, Nikolaos E. Bechrakis (Berlin/D, Innsbruck/A)

321 WOC Tuesday, 8 June :30-17:00 P-TU-115 Recent progress in radiotherapy for optic nerve tumor Xiaoda Bi (Shanghai/CN) P-TU-116 Regression patterns and visual acuity of macular tumours following chemoreduction for Retinoblastoma Christina Weiss, Christine Jurklies, Regina Wieland, Angelika Eggert, Wolfgang Sauerwein, Norbert Bornfeld (Essen/D) P-TU-117 Retinoblastoma in Belarus: today's approach Hanna Furmanchuk (Minsk/BY) P-TU-118 Rho-kinases-associated glioma migration effects on neuronal cell bodies and fibers in vitro Vera Clemens, Solon Thanos (Münster/D) P-TU-119 Serum panel for detection of metastasis in uveal melanoma patients Daniela Süsskind, Ayse Tura, Michael Partsch, Karl Ulrich Bartz-Schmidt, Sigrid Henke Fahle (Tübingen/D) P-TU-126 Treatment of retinal detachment occuring after brachytherapy of uveal melanomas: triamcinolone acetonide vs pars plana vitrectomy Theodora Gkika, Mete Gök, Michael Freistühler, Harun Akgül, Dirk Flühs, Wolfgang Sauerwein, Norbert Bornfeld (Essen/D) P-TU-127 Tumor-Associated Lymphangiogenesis in the Development of Conjunctival Malignant Melanoma Ludwig M. Heindl, Carmen Rummelt, Leonard Holbach, Gottfried Naumann, Friedrich Kruse, Claus Cursiefen (Erlangen/D) P-TU-128 UBM in intraocular tumors Anna Markiewicz, Bozena Romanowska-Dixon, Barbara Jakubowska (Krakow/P) Pediatric Ophthalmology & Genetics P42 P-TU-129 A case of aniridia with a unilateral lens malposition Mayu Sawada, Miho Sato, Akiko Hikoya, Chunxia Wang, Shinsei Minoshima, Noriyuki Azuma, Yoshihiro Hotta (Shizuoka/J) Tuesday, 8 June Posters P-TU-120 Signet ring cell carcinoma of the lid in a young woman Eva Glaser, Christian Mayer, Ramin Khoramnia, Gregor Weirich, Chris Patrick Lohmann (Munich/D) P-TU-121 The clinical and histopathological study of conjunctival and corneal tumors Pham Thi Khanh Van (Ha Noi/VN) P-TU-130 Analysis of abnormal head postures in pediatric patients Steffi Tech, Christina Gerth (Rostock/D) P-TU-131 Anterior segment dysgenesis, report of Mexican family. Ruben Edel Martínez Serrano, Alejandra Etualin González (Querétaro/MEX) P-TU-122 The main tumor-associated retinal symptoms, caused by small uveal melanoma: the correlation analysis. Svetlana Saakyan, Natalya Urovskaya (Moscow/RUS) P-TU-123 The mir gene is amplified and overexpressed in retinoblastoma Eva Biewald, Harald Stephan, Pieter Mestdagh, Johannes Hubertus Schulte, Alexander Schramm, Angelika Eggert, Norbert Bornfeld (Essen/D) P-TU-132 Beta-blockers as the new treatment method in capillary orbital and adnexal hemangioma. Gabriela Gondova (Bratislava/SK) P-TU-133 Case Series on Phthiriasis Palpebrum in children Shing Kin Yau, Tak Yau Tam (Kowloon/HK) P-TU-134 Clinical Characteristics of Taiwanese Children with optic neuritis Ming-Hui Sun (Taoyuan/TJ) P-TU-124 The role of HPV serotype 16 and 18 in OSSN Agus Supartoto, Syenny Budi Handoko, Sri Yuli Handayani (Yogyakarta/RI) P-TU-125 The role of transpupillary thermotherapy in combined treatment of retinoblastoma. Svetlana V. Saakyan, Ekaterina A. Semenova, Robert A. Tatzkov, Olga A. Ivanova (Moscow/RUS) P-TU-135 Congenital eye anomalies in children with mixed cognation of parents Khakima Karim-Zade, Abdujamil Toshmatov, Rano Kholmatova, A. Rakhmonov, H. Mirsakhanova (Khujand/TAD)

322 318 WOC 2010 Posters Tuesday, 8 June Tuesday, 8 June :30-17:00 P-TU-136 Congenital Unilateral Absence of Superior Rectus without Craniofacial Anomaly Mohammad Reza Talebnejad, Mahnaz Mosallaei (Shiraz/IR) P-TU-137 Development of Ocular Optical Components and Refractive Error in Infants Ping Wang (Changsha/CN) P-TU-138 Endovitreal melphalan as local retinoblastoma (RB) chemotherapy Nadiya Bobrova, T. A. Sorochynska (Odessa/UA) P-TU-139 Epidemiological, clinical and therapeutic aspects of congenital glaucoma: a report of 159 cases Adil Megzari, Bencherifa Fatiha, Berraho Amina (Rabat/MA) P-TU-146 Myofibroma of the Conjunctiva Invading the Cornea in Infancy Gerassimos Lascaratos, Manish Gupta, Laura Bridges, Mary MacRae (Edinburgh/UK) P-TU-147 Neonatal Marfan syndrome A rare form with limited diagnostic and therapeutic opportunities Nicola Rauch, Daniel Herzog, Heike Elflein, Pfeiffer Norbert (Mainz/D) P-TU-148 Nystagmus secondary to drug exposure in utero Manish Gupta, Gerassimos Lascaratos, Alan Mulvihill, Brian Fleck, Nick George (Edinburgh/UK) P-TU-149 Open Globe Injuries in Children Marlene Schörkhuber, Mona Schneider, Werner Wackernagel, Andreas Wedrich (Linz/A) P-TU-140 Etiological Aspects of Congenital Cataract: Case Study of 107 Cases (179 Eyes) Tarik El Alloussi, Imane Ahmiti, Sanaa Haddad, Obaida El Yamouni, Ramzia Sebbah, Sanaa Idrissi-Alami, Mostapha El Mrabh, Fatiha Benchérifa, Amina Berraho (Rabat/MA) P-TU-141 Factors affecting recurrence in successfully treated cases of anisometropic amblyopia Shraddha Puranik, Rohit Saxena, Vimla Menon, Pradeep Sharma, Swati Phuljhele (New Delhi/IND) P-TU-142 Genetic homogeneity and phenotypic variability in East Asian patients with achromatopsia Joo Hyun Choi, Yoon Jeon Kim, Hyun Taek Lim, Hyejin Lee (Seoul/ROK) P-TU-143 Lay vision screening: Can the Plusoptix vision screener replace the LEA symbol chart and random dot stereotest? Joannah Vaughan, David Wheeler, Allison Summers (Portland/USA) P-TU-144 Long term preservation of visual function in hereditary mucoepithelial dysplasia Venkata Avadhanam, Keith Martin (London/UK) P-TU-145 Morphological and functional outcomes in oneyear-old patients following diode laser photocoagulation for retinopathy of prematurity a prospective study at ho chi minh city eye hospital Thao Nguyen Uyen Vo (Ho Chi Minh/VN) P-TU-150 Outcome of probing or intubation for congenital naso-lacrimal duct obstruction in NHS Lothian Six year Audit Manish Gupta, Gerassimos Lascaratos, Mary MacRae, Alan Mulvihill, Brian Fleck (Edinburgh/UK) P-TU-151 Outcomes of ROP treatment in Extremely Low Birth Weight (ELBW) infants David Gunn, David Cartwright, Glen A. Gole (Windsor/AUS) P-TU-152 Parinaud oculoglandular syndrome Aneta Skupin, Melanie Jäger, Birgit Lorenz (Giessen/D) P-TU-153 Penetrating Keratoplasty in a 6 week Child with Peters anomaly a case report. Andreas K. Cordes, Axel Schmitz, Norbert Schrage (Cologne/D) P-TU-154 Peripapillary choroidal neovascularization (CNV) associated with optic nerve drusen in 13-year-old child options for anti-vegf therapy Andrzej Dmitriew, Anna Gotz-Więckowska, Joanna Siwiec-Proscinska (Poznan/P) P-TU-155 Phenotype variability in a family with microphthalmia and coloboma Christina Gerth, Kathy Williamson, Rudolf F. Guthoff, David R. FitzPatrick, Veronica van Heyningen (Rostock/D, Edinburgh/UK)

323 WOC Tuesday, 8 June :30-17:00 P-TU-156 Primary intraocular lens implantation in pediatric cataract with posterior lenticonus-case report. Krystyna Kanigowska, Miroslawa Gralek (Warsaw/PL) P-TU-157 Radial pupillotomy for treatment of extreme pupillary ectopia Nina Bobisch, Norbert Schrage, Andreas Cordes (Cologne/D) P-TU-166 Ultrastructural investigation of cornea wound healing in full-thickness and 2/3 depth sutures Nadiya Bobrova, Valeriy Vit, Natalia Dumbrova, Natalia Molchanyuk, Vasiliy Shevchyk, Tatiyana Romanova (Odessa/UA) P-TU-167 Unilateral optic nerve aplasia associated with microphthalmos A case report Gordana Stankovic-Babic (Nis/SRB) Tuesday, 8 June Posters P-TU-158 Refraction Anomalies in Children of Kazakhstan Tursungul Botabekova (Almaty/KZ) P-TU-159 Screening Results of First Class Primary Schools Children in Albania Enno Qerimi (Durres/AL) P-TU-160 Spectral domain optical coherence tomography images of serous retinal detachment associated with optic disc pit in a 7-year-old child Anu Maudgil, Jonathan Chan (Sheffield/UK) P-TU-161 Structural and functional outcomes of premature infants screened for retinopathy of prematurity in a tertiary-care hospital in Malaysia May May Choo, U-teng Chan, Nurliza Khaliddin, Ayu Saad Mas (Kuala Lumpur/MAL) P-TU-162 The Factors affecting Pattern Visual Evoked Potential in Amblyopes Jun-ho Choi, Sun-young Jang, Song-hee Park (Seoul/ROK) P-TU-168 Unproportional microphthalmia in a child with Hallermann-Streiff syndrome Werner Schmidt (Giessen/D) P-TU-169 Use of Spectral Domain OCT to Image Pediatric Macular and Posterior Pole Pathology Naz Raoof, Tsiang Ung, Julie Bailey, T. K. Chan (Sheffield/UK) Retina: Diagnostics P43 P-TU-170 A comparison between mydriatic digital fundus photographs and fundus fluorescein angiogram in the diagnosis of proliferative diabetic retinopathy early Shobana Nadarajah (Petaling Jaya/MAL) P-TU-171 Assessment of the Retinal Nerve Fiber Layer Thickness with Optical Coherence Tomography in Eyes with Various Degrees of Optic Nerve Head Drusen Urszula Gajdzik-Gajdecka, Ewa Mrukwa-Kominek, Wanda Romaniuk (Katowice/PL) P-TU-163 The phenomenon of movement perception in congenital nystagmus: clinical studies and possible implications concerning the suppression of oscillopsia Barbara Käsmann-Kellner, Berthold Seitz (Homburg/D) P-TU-164 To know the awareness amongst the children & their parents regarding the conditions causing childhood blindness between age-group 0-18 years. Seema Deshmukh, Vikas Mahatme, Sanyogita Joshi (Nagpur/IND) P-TU-165 Treating amblyopia: are we beginning too late? Carlos Eduardo Resende Gomes, Galton Carvalho Vasconcelos, Sabrina Cavaglieri, Henderson Celestino de Almeida (Conselheiro Lafaiete/BR) P-TU-172 Association between the ocular involvement and cardiovascular involvement or the distribution of skin and mucous membrane lesions in patients with pseudoxanthoma elasticum. Hiroshi Tamura, Akitaka Tsujikawa, Hideo Nakanishi, Kenji Yamashiro, Sotaro Ooto, Atsushi Otani, Atsushi Utani, Nagahisa Yoshimura (Kyoto/J) P-TU-173 Atypical retinal changes in sympathetic ophthalmia. Galina Vashkevich, Olga Sashneva, Tatsiana Imshenetskaya, Irina Puchkova, Eleonora Parhovchenko, Arkadyi Puchkov (Minsk/BY) P-TU-174 Blind spot enlargement syndrome in acute zonal occult outer retinopathy (AZOOR) Ramona Verena Neutzner, Melanie Jäger, Birgit Lorenz (Giessen/D)

324 320 WOC 2010 Posters Tuesday, 8 June Tuesday, 8 June :30-17:00 P-TU-175 Changes of the ocular fundus in patients with amaurosis fugax Vakhramova Natalia, Ramazanova Lya (Moscow/RUS) P-TU-176 Comparison of Selective Pixel Profiling (SPP) and Image Tracked Averaging for Signal to Noise Enhancement in Optical Coherance Tomography Carl Glittenberg, Ilse Krebs, Kerstin Steindl, Sarah Moussa, Eva Smretschnig, Susanne Binder (Vienna/A) P-TU-177 Correlation of OCT and intraoperative vitreous characteristics in full-thickness macular holes. Magdalena Tönz, Stephan Michels, Matthias Becker (Zurich/CH) P-TU-178 Correlation of Peripheral Findings in wide-field Fundusphotography and high-resolution OCT with the Progression Rate in Areas of Geographic Atrophy due to dry Age-Related Macular Degeneration Ute Wolf-Schnurrbusch, Simon Rothenbuehler, Volker Enzmann, Sebastian Wolf (Bern/CH) P-TU-179 Does Foveal Thickness Predict Microalbuminuria in Diabetics? Wan Haslina Wah, Muhaya Mohamed (Kuala Lumpur/MAL) P-TU-184 How to Cope with Segmentation Errors in Measurement of Macular Thickness with Spectral Domain Optical Coherence Tomography Byung Ro Lee, Yumi Song, Yong Woon Shin (Seoul/ROK) P-TU-185 Influence of lens opacities due to cataract on the detection of drusen in SD-OCT Sabine Schriefl, Rupert Menapace, Christian Ahlers, Eva Stifter, Danielle Boullanger, Isabelle Golbaz, Ferdinand Schlanitz, Ursula Schmidt-Erfurth (Vienna/A) P-TU-186 Interchangeability between different scan protocols of Spectralis optical coherence tomography in normal eyes Yaroslava Chopovska, Stephan Wismann, Melanie Jäger, Birgit Lorenz (Giessen /D) P-TU-187 In-vivo choroidal thickness imaging after PDT Lyudmyla Metzger, Horst Helbig, Maria-Andreea Gamulescu (Zwiesel/D, Regensburg/D) P-TU-188 Macular Hole: 10 and 20-mhz ULTrasound Images and Spectral-Domain Optical Coherence Tomography Juliana Bottós, Virginia Torres, Liliane Kanecadan, Andrea Martinez, Nilva Moraes, Norma Allemann (Barcelona/E) P-TU-180 Dynamic retinal vessel analysis how different parameters create a whole picture Ines Lanzl, Konstantin Kotliar (Munich/D) P-TU-181 Effects of the intraocular dye brilliant blue mixed with Glucose on the isolated superfused bovine retina Kai Januschowski, Sebastian Mueller, Jolene Hayes, Matthias Lüke, Peter Szurman (Tübingen/D, Lübeck/D) P-TU-189 Myelinated retinal nerve fibers Kaoutar El Ouazzani Chahdi, Mohamed Benharbit, Ibtissam Mansouri, Halima Saadiya Mouhdi, Youssef Amrani, Btissam Ouazzani Tnachri, Wafae Ibrahimy, Rajae Daoudi (Rabat/MA) P-TU-190 New screening method using unreflective transillumination ophthalmoscopy in diagnosis of chorioretinal pathology Maryia Morkhat, Vi tor Morkhat (Vitebsk/BY) P-TU-182 Foveal Thickness and Diabetic Retinopathy in Type 2 Diabetes Mellitus: A Comparative Study in Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Malaysia. Wan Haslina Wah, Ropilah Abdul Rahman, Muhaya Mohamed (Kuala Lumpur/MAL) P-TU-183 Fundus autofluorescence imaging using ultra-widefield scanning laser ophthalmoscopy in patients with geographic atrophy secondary to age-related macular degeneration Katharina Lammersdorf, Monika Fleckenstein, Frank G. Holz, Steffen Schmitz Valckenberg (Bonn/D) P-TU-191 Non-mydriatic Ultra-widefield Scanning Laser Ophthalmoscopy (Optomap) versus 2 field fundus photography in diabetic retinopathy Kristine Kaldefoss, Lala Ceklic, Aljoscha Neubauer, Stefanie Guthmann, Christos Haritoglou, Anselm Kampik, Michael Ulbig, Marcus Kernt (Munich/D) P-TU-192 OCT signs in refractory diabetic macular oedema. Ina Malinouskaya, Tatiana Imshanetskaya, Igor Zaborovski (Minsk/BY)

325 WOC Tuesday, 8 June :30-17:00 P-TU-193 Outer photoreceptor layer thickness obtained by spectral domain optical coherence tomography in normal eyes and variable macular diseases Byung Ro Lee, Yong Woon Shin, In Seok Song, Yumi Song (Seoul/ROK) P-TU-194 Reproducibility of Fluorescence Lifetime Imaging (FLIM) at the Human Retina based on Multi- Exponential Component Fit Alexander Dietzel, Matthias Klemm, Edgar Nagel, Dietrich Schweitzer, Jens Haueisen (Ilmenau/D) P-TU-195 Usefulness of monochromatic conversions to blue component in digital color photographs in branch retinal vein occlusion. Takeya Kohno, Yoshio Okazaki, Manabu Yamamoto, Norito Miki, Hisashi Iwami, Makoto Yamaguchi, Shinsuke Ataka, Michiko Hirabayashi, Kunihiko Shiraki (Osaka/J) Retina: Miscellaneous P44 P-TU-202 Long-term outcome and risk factors for recurrence in untreated patients with central serous chorioretinopathy Andrew Fok, Poemen Chan, Timothy Lai, Yolanda Yip, Dennis Lam (Hong Kong/HK) P-TU-203 Long-term follow-up of extrafoveal retinal holes following internal limiting membrane peeling Mira Ruppenstein, Thomas Ach, Stefan Dithmar (Heidelberg/D) P-TU-204 Microperimetric assessment of fundus alterations characteristic for Pseudoxanthoma Elasticum Nina Peters, Robert P. Finger, Peter Charbel Issa, Hendrik P. N. Scholl, Frank G. Holz (Bonn/D) P-TU-205 Morphological and elecrophysiological changes of retinal structure after treatement with Dipiperon shown by Fourier Domain OCT Daria Loos, Jens Huber, Patricia Kook, Chris P. Lohmann (Munich/D) Tuesday, 8 June Posters P-TU-196 Automatic Dosimetry Control for Gentle Retinal Photocoagulation Ralf Brinkmann, Kerstin Schlott, Stefan Koinzer, Lars Ptaszynski, Marco Bever, Alex Baade, Reginald Birngruber, Johann Roider (Lübeck/D, Kiel/D) P-TU-198 Desferrioxamine Related Maculopathy after a single dose Mohamed Naved Abdul Karim, Satish Chadha, Delicia Jayakumar, Trudi Blamires (Kettering/UK) P-TU-206 Relationship between retinal nerve fiber layer thickness and visual field function in HIV-infected patients without retinitis Tiago Arantes, Claudio Garcia, Ivan Maynart Tavares, Paulo Augusto Arruda Mello, Cristina Muccioli (Sao Paulo/BR) P-TU-207 Retinal phototoxicity after phacoemulsification Eva-Maria Lackner, Christoph Fidel Mayer, Andreas Wedrich (Graz/A) P-TU-199 Efficacy and ocular drug distribution using the dexamethasone intravitreal implant in a monkey model of macula edema James Burke, Ton Lin, Kai-Ming Zhang, Werhner Orilla, Clayton Spada, Maria Escobar, Corine Ghosn, Joan-En Chang Lin, Rhett M. Schiffman, Larry Wheeler, Scott M. Whitcup (Irvine/USA) P-TU-200 Endogenous Candida chorioretinitis in a healthy infant Makiko Ito, Tadashi Yokoi, Yuri Kobayashi, Sachiko Nishina, Noriyuki Azuma (Tokyo/J) P-TU-201 Estimation of the Incidence of Vascular Anomalies in Eyes with Optic Nerve Head Drusen. Urszula Gajdzik-Gajdecka, Ewa Mrukwa-Kominek, Malgorzata Machalska, Jadwiga Pietrzycka, Magdalena Smuzynska (Katowice/PL) P-TU-208 Retinal transplantation therapy for rd1 mice Michiko Mandai, Kohei Homma, Masayo Takahashi (Kobe/J) P-TU-209 Risk Factors for Retinal Breaks in Patients with Symptom of Floaters Apichart Singalavanija (Bangkok/T) P-TU-210 Study of vitreoretinal adhesion in exudative age-related macular degeneration treated with antivegf Andrea Diaz Barron, Mª Dolores Pilar Vicente Fernandez, Cristina Marín Lambies, Rosario Fons Martinez (Valencia/E) P-TU-211 Subconjunctival Reflux and Need for Paracentesis after Intravitreal Injection of 0.1 ml Bevacizumab: Comparison between 27 gauge and 30 gauge Needle Alireza Mirshahi, Katrin Lorenz (Mainz/D)

326 322 WOC 2010 Posters Tuesday, 8 June Tuesday, 8 June :30-17:00 P-TU-212 The occurrence of ptosis following posterior subtenons injection of triamcinolone acetonide Hannah Sharma, Katie Isaac, Samer Elsherbiny (Birmingham/UK) P-TU-213 Treatment of peripapillary choroidal neovascularizations in early childhood Michael R. R. Böhm, Matthias Schmidt, Constantin E. Uhlig (Münster/D) Retina: RPE Diseases P45 P-TU-214 Changes in Macular Morphology and Function after Half Dose Verteporfin-PDT for Central Serous Chorioretinopathy Ruka Uetani, Kohei Ishikawa, Piao Chang-Hua, Yasuki Ito, Mineo Kondo, Hiroko Terasaki (Nagoya/J) P-TU-215 Characteristics of Vitelliform Macular Dystrophy in Adults Stefan J. Lang, Guido R. K. Kürzinger, Gabriele E. Lang (Ulm/D) Retina: Vascular Diseases P-TU-220 Adiponectin suppresses adherent leukocytes in retinal vessels induced by a high-fat diet. Yasuhiro Ito, Shintaro Nakao, Yoshihisa Okamoto, Souska Zandi, Hidenobu Tanihara (Kumamoto/J) P-TU-221 Bevacizumab (Avastin ) for ocular metastasis of gastric cancer Thoralf Wecke, Manuela Hinz, Christian Vorwerk, Wolfgang Behrens-Baumann (Magdeburg/D) P46 P-TU-222 Capillary Nonperfusion in Vascularized Retina in Aggressive Posterior Retinopathy of Prematurity and Efficacy of Preoperative Laser Photocoagulation Including Vascularized Retina Posterior to the Ridge Tadashi Yokoi, Makiko Ito, Sachiko Nishina, Yuri Kobayashi, Noriyuki Azuma (Tokyo/J) P-TU-223 Central vein occlusion and hypertensive crisis caused by a previously unkown renal artery stenosis in a case of fibromuscular dysplasia Christian Flöhr, Jörg Hattingen, Burkhard Wiechens (Hannover/D) P-TU-216 Correlation between retinal sensitivity, tested by microperimetry, and the status of underlying inner/outer segment junctional photoreceptor layer, assessed by Spectral Domain Optical Coherence Tomography in Central Serous Retinopathy Richard Rosen, Gennady Landa, Joseph Nezgoda, Emily Su, Patricia Garcia, Alfonso Ponce, Thomas Muldoon, Ronald Gentile, Joseph Walsh (New York/USA) P-TU-217 One-year follow-up of iatrogenic iodate retinopathy Lars Wagenfeld, Gisbert Richard, Oliver Zeitz (Hamburg/D) P-TU-218 Spectral Domain Optical Coherence Tomography study of morphological features of Stargardt s Disease and its correlation with Central Visual Function Mayuri Bhargava, Sribhargava Natesh, Naresh Kumar Yadav, Anand Vinekar, Rajani Battu, Shailaja L (Bangalore/IND) P-TU-219 The effect of acetazolamide treatment on cystoid macular edema and visual function in retinitis pigmentosa Antje S. Bernd, Andreas Schatz, Bogomil Voykov, M. Dominik Fischer, Martin Wiesen, Ieva Sliesoraityte, Eberhart Zrenner (Tübingen/D) P-TU-224 Cilioretinal arteries in diabetic eyes are associated with increased retinal blood flow velocity and occurrence of diabetic macular edema Gennady Landa, Richard Rosen, Wendewesssen Amde, Jeanne Rosenthal, Joseph Walsh (New York/USA) P-TU-225 Clinically significant macular edema in diabetic patients with hypertension Noriko Miyamoto, Kazuhiro Ishida, Yasuo Kurimoto (Kobe/J) P-TU-226 Coagulation disorders and the risk of retinal vein occlusion: a subgroup analysis Claudia Hattenbach, Inge Scharrer, Lars-Olof Hattenbach (Ludwigshafen/D) P-TU-227 Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans Carsten H. Meyer, Frank G. Holz, Tim U. Krohne (Bonn/D) P-TU-228 Correlation of leaking microaneurysms with retinal thickening in diabetic retinopathy Lukas Reznicek, Marcus Kernt, Christos Haritoglou, Michael Ulbig, Anselm Kampik, Aljoscha Neubauer (Munich/D)

327 WOC Tuesday, 8 June :30-17:00 P-TU-229 Correlation of macular pigment distribution in type 2 idiopathic macular telangiectasia and morphologic abnormalities detected by spectral-domain OCT Miki Sawa, Yuzuru Sasamoto, Motokazu Tsujikawa, Fumi Gomi (Suita/J) P-TU-230 Diabetic retinopathy and maculopathy in metabolic syndrome Milka Mavija, Zoran Mavija, Vesna Jaksic, Svetislav Milenkovic, Dijana Risimic, Tanja Veselinovic, Natalija Kosanovic-Jakovic (Banjaluka/BIH, Beograd/SRB) P-TU-238 Intravitreal Bevacizumab in Macular Edema of Branch Retinal Venous occlusion Satyen Deka (Guwahati/IND) P-TU-239 Is iris fixation of IOL in patients with aphakia and diabetic retinopathy the right indication? Joerg Christian Schmidt (Marburg/D) P-TU-240 Low glomerular filtration rate is associated with more advanced diabetic retinopathy Vesna Jaksic, Milka Mavija, Svetislav Milenkovic, Ivan Stefanovic, Dijana Risimic (Beograd/SRB) Tuesday, 8 June Posters P-TU-231 Dysregulation of Bone Marrow Derived Endothelial Progenitor Cell Bioactivity via VEGF Triggers Abnormal Vascular Development of Murine Retinopathy of Prematurity Yoshihiro Nakagawa, Masuda Haruchika, Rie Ito, Takahiro Suzuki, Kenji Kawai, Takayuki Asahara (Isehara/J) P-TU-232 Effect of Intravitreal Angiogenesis Inhibitors on Hyperreflective Exudative Foci in Diabetic Macular Edema Documented by Optical Coherence Tomography Christoph Mitsch, Berthold Pemp, Gabor Deak, Sonja Prager, Gerald Schmidinger, Christoph Scholda, Matthias Bolz, Ursula Schmidt-Erfurth (Vienna/A) P-TU-233 Effect of intravitreal bevacizumab on retinal vein diameter in branch retinal vein occlusion Tomohiro Otani, Yumiko Yamaguchi, Shoji Kishi (Maebashi/J) P-TU-234 Effect of nutrition on development of cataract and diabetic retinopathy in type II diabetic rat model Heeyoon Cho, Yunjeong Lee, Yeonhee Noh (Kyungggi-do/ROK) P-TU-235 Extensive internal limiting membrane peeling and gas tamponade for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm Shigeki Suzuki (Kounosu/J) P-TU-236 Haemodilution Therapy in Central Retinal Vein Occlusion Jens Ulrich Werner (Ulm/D) P-TU-237 In vivo OCT characterization of ischemic retina in diabetic retinopathy Lukas Reznicek, Marcus Kernt, Christos Haritoglou, Anselm Kampik, Michael Ulbig, Aljoscha Neubauer (Munich/D) P-TU-241 M3 muscarinic acetylcholine receptors mediate cholinergic responses in murine retinal arterioles Adrian Gericke, Jan Sniatecki, Evgeny Goloborodko, Franz Grus, Jürgen Wess, Norbert Pfeiffer (Mainz/D) P-TU-242 Monolateral macular hemorrhage in systemic lupus erythematosus Orlin Velinov, Michael Frosch, Constantin Uhlig (Münster/D) P-TU-243 Netrin-4 and Its Receptors Have an Impact on Neoangiogenesis in the Mouse Retina Sabrina Klein, Liang Yong, Irina Semkova, Elizabeth Abari, Kristina Schmidt, Norbert Kociok, Klaus Meyer, Wiliam J. Brunken, Manuel Koch, Antonia Joussen (Duesseldorf/D, New York/USA) P-TU-244 Patterns of macular edema in high resolution OCT scans and response to bevacizumab therapy in retinal vein occlusion Mira Ruppenstein, Alexandra Hoeh, Karen Schaal, Thomas Ach, Stefan Dithmar (Heidelberg/D) P-TU-245 Predictors for Visual Outcome after Anti-VEGF Therapy of Central Retinal Vein Occlusion and Branch Retinal Vein Occlusion Ute Wolf-Schnurrbusch, Carsten Framme, Simon Rothenbuehler, Sebastian Wolf (Bern/CH) P-TU-246 Retinal microglia in the mouse model of oxygeninduced retinopathy Franziska Fischer, Gottfried Martin, Hansjürgen Agostini (Freiburg/D) P-TU-247 Retinal vasculitis as a paraneoplasic syndrome in the context of a gastric adenocarcinoma Purificacion Piñas Garcia, Luis Castillon Torre, Francisco Javier Hernandez Martinez (Sevilla/E)

328 324 WOC 2010 Posters Tuesday, 8 June Tuesday, 8 June :30-17:00 P-TU-248 Risk evaluation in patients with acute non-arteriitic central retinal artery occlusion Stefanie Pantenburg, A. Pielen, B. Junker, A. Wolf, B. Jurklies, K. Kampik, N. Feltgen (Goettingen/D, Essen/D, Wuerzburg/D) P-TU-249 Role of Intravitreal Bevacizumab in Diabetic Vitreous Hemorrhage Satyen Deka (Guwahati/IND) P-TU-250 Spontaneous exophthalmus due to a carotid sinus cavernosus fistula successful interventionell treatment with GDC coils in three patients Jörg Hattingen, Jan Köhler, Richard Glombik, Andreas Schwartz, Ekkehard Gmelin, Burkhard Wiechens (Hannover/D) P-TU-251 Systemic diseases associated with central retinal vein occlusion Marianne Shahsuvaryan (Yerevan/ARM) P-TU-252 The association between the oxidative stressrelated gene polymorphisms and the diabetic retinopathy in Type2 Diabetes Shinko Nakamura, Shigehiko Kitano (Tokyo/J) P-TU-253 The characteristics of acute retinal necrosis with optical coherence tomography Li Juanjuan (Kunming/CN) P-TU-254 The effect of placental growth factor splice variants on the neovascularization in the mouse retina Norbert Kociok, Daniel Hoffmann, Elizabeth Abari, Sabrina Klein, Kristina Schmidt, Sabine Eming, Antonia Joussen (Duesseldorf/D, Berlin/D) P-TU-255 The effects of Intravitreal Bevacizumab for cystoid macular edema (CME) due to retinal vein occlusions Mehrdad-Sam Attaran (Hannover/D) Vision 2020 Prevention of Blindness P-TU-259 Case Study-Short term Impact and lessons of a systematic eye care development intervention Kolawole Ogundimu, Elizabeth Elhassan, Suleiman Buhari (Accra7GH) P-TU-260 Community eye health of Pediatric age group in the slums area of one of the Metropolis of Eastern India Khandkar Fariduddin (Kolkata/IND) P-TU-261 Five Year Cataract Surgical Rate in Shanghai, China from 2005 to 2009 Jianfeng Zhu (Shanghai/CN) P47 P-TU-262 Outcome of trachoma treatment in chidren and their families from a public school Barbalha City, Ceará, Brazil Vitor Luna De Sampaio, Clarice Maria Pinheiro Callou, Carlos Teixeira Brandt, Luíza Stella Correia Ferreira, Eduardo José Pinheiro Callou (Barbalha/BR) P-TU-263 Preoperative Visual Acuity of Eyes Undergoing Cataract Surgery in Rural and Urban Nepal Reeta Gurung, Mohan Krishna Shrestha, Andreas Mueller, Sanduk Ruit (Kathmandu/NEP) P-TU-264 Prevention of Diabetic Blindness in Rural China by Multiple Approaches Zhizhong Ma (Beijing/CN) P-TU-265 Tibet's (almost) forgotten children How a blind person made blind children read Sibylle Scholtz, Gerd U. Auffarth (Ettlingen/D, Heidelberg/D) P-TU-256 The Roles of Artery-vein Relation of an Arteriovenous Crossing and Vein Bifurcation in Branch Retinal Vein Occlusion Qingyuan Liang (Toronto/CDN) P-TU-257 The use of intravitreal bevacizumab in Coats patients Choi Mun Chan (Singapore/SGP) P-TU-258 Time course of the effect of bavacizumab on macular edema in central retinal vein occlusion Mehrdad-Sam Attaran (Hannover/D)

329 WOC Administrative Meetings Thursday, 3 June :00 16:00 VOL-Sitzung Salon 21 15:00 17:00 Tropfschulung Salon 22 17:30 18:30 Initiativkreis Glaukom des BVA Salon 22 Friday, 4 June :15 13:45 Meeting der Initiativgruppe zur Früherkennung diabetischer Augenerkrankungen (IFdA) Salon 19 16:00 17:30 Sitzung der Kommission Qualitätssicherung Salon 21 11:30 13:30 Arbeitskreis klinischer Fragen des wissenschaftlichen Beirats der Pro Retina Deutschland e.v. Salon 22 14: Arbeitstreffen der Sektion DOG-Ophthalmoplastische und rekonstruktive Chirurgie Salon 22 18:00 20:00 Arbeitskreis Psychosomatik in der Augenheilkunde Salon 22 12:30 14:00 Vorstandsitzung der Retinologischen Gesellschaft Raum 46 16:30 17:00 Sitzung der Sektion DOG-Neuroophthalmologie Room 46 Administrative Meetings Saturday, 5 June :00 17:00 ICO World Ophthalmology Roundtable on Leadership Development (WORLD) and ICO General Assembly Hall 7 07:15 14:00 AOI Meeting and Luncheon Radio Tower Lounge 1 12:15 13:45 Mitgliederversammlung der Sektion DOG-Kornea VIP Lounge 1 14:00 15:30 Arbeitsgruppe Internet und medizinische Informationsverarbeitung Salon 11/12 16:00 18:00 Sitzung der Sektion DOG-Gewebetransplantation und Biotechnologie Salon 11/12 12:30 13:30 Mitgliederversammlung der Bielschowsky- Gesellschaft Salon 13/14 12:30 13:45 Sitzung der Sektion DOG-Glaukom Salon 15/16 16:30 18:00 Meeting der Deutschen Ophthalmologischen Chefärzte Room 56 Sunday, 6 June :00 11:00 Meeting BVA-Leitlinienkomission Salon 20 12:00 13:30 Sitzung der Sektion DOG-Internationale Ophthalmologie Salon 20 10:00 15:00 Meeting Augenärztegenossenschaft Brandenburg e. G. Room 24 12:00 14:00 Sitzung der Makulakommission Salon 22

330 326 WOC 2010 Administrative Meetings Administrative Meetings 09:00 10:00 Studientreffen zur FANCY-Studie Room 45 12:00 13:45 ICO Education Committee Room 46 Monday, 7 June :30 08:15 World Ophthalmic Education Colloquium Hall 7 (only upon invitation) 12:15 13:45 General Assembly of the DOG Hall 4/5 12:00 13:45 ICO Fellowships Alumni Reception Salon 11/12 08:30 10:00 Treffen der Woche des Sehens Salon 19 10:30 12:30 Treffen der Vision 2020 Initiativgruppe Salon 19 14:00 15:30 Mitgliederversammlung der Sektion Uveitis der DOG Salon 19 09:30 12:00 Herausgebersitzung Der Ophthalmologe 2010 Salon 20 14:00 15:30 Kommissionssitzung Refraktive Chirurgie Salon 20 16:00 17:30 EBO Executive Board Salon 20 14:30 15:30 Uveitis Award 2010 Salon 21 16:00 17:00 General Assembly European Vision Institute Salon 21 12:30 13:30 EVICR.net Meeting Salon 22 14:30 16:00 Meeting Steering Committee European Vision Institute Room 37 14:00 16:00 ICO Advisory Group on Sub-Saharan Africa Room 45 Tuesday. 8 June :00 18:00 Meeting der International Agency for the Prevention of Blindness Salon 20 Wednesday, 9 June :30 13:00 Award Ceremony and Handover of DOG Presidency Roof Garden

331 WOC In Alphabetical Order of Company Names Aeon Astron Breakfast Saturday, 5 June :15 08:15 Hall 9 Can MMC be replaced? ologen for eye tissue repair Chair: Julio Lin, VP, Aeon Astron Europe B.V. 07:15-07:20 Opening Michael Lai, CEO, Aeon Astron Europe B.V. Alcon Lunch Sunday, 6 June :30 13:30 Hall 2 Individualizing The Management of Glaucoma Moderators: Prof. Kuldev Singh, USA Prof. Norbert Pfeiffer, Germany Patient Profiling to Individualize Glaucoma Therapy Dr. Francisco Goñi, Spain Clinical Trial Results: Travoprost Timolol Fixed Combination Prof. Norbert Pfeiffer, Germany Company Symposia 07:20-07:35 Introduction of ologen Collagen Matrix Jessie Ni, PhD, Aeon Astron Europe B.V. 07:35-07: Experiences with ologen Collagen Matrix in Trabeculectomy Prof. Markus Kohlhaas, MD, Germany 07:50-08:05 Use of ologen Collagen Matrix in Strabismus Surgery Prof. Emilio C. Campos, MD, Italy 08:05-08:15 General Julio Lin, VP, Aeon Astron Europe B.V. Alcon Lunch Saturday, 5 June :30 13:30 Hall 2 Changing the Standard of Care in Cataract Surgery Chair: Prof. Rudy M.M.A. Nuijts Prevalence of Astigmatism and Impact on Vision Prof. James Wolffsohn, United Kingdom Management of Astigmatism in Cataract Surgery Prof. Peter Szurman, Germany Practical Experience with ACRYSOF Toric Prof. Rudy M.M.A. Nuijts, Netherlands Integrating ACRYSOF Toric in Your Daily Practice Dr. Bret Fisher, United States Changing the Cataract Surgery Standard of Care: The Belgium Case Prof. Philippe Kestelyn, Belgium New Fixed Combination Therapeutic offerings Prof. Gábor Holló, Hungary Alternative Preservatives in Topical Glaucoma Medications Prof. Christophe Baudouin, France Glaucoma Surgery with Ex-PRESS Mini Glaucoma Shunt Prof. Carlo E. Traverso, Italy Allergan Lunch Saturday, 5 June :30 13:30 Hall 7 Retina New Approaches to the Management of Macular Edema Prof A. Kampik, MD/ Prof. G. Coscas, MD 12:30 12:32 Introduction and Welcome Prof. A. Kampik, MD 12:32 12:43 Inflammation A Major Contributor to the Etiology of Macular Edema Prof. G. Soubrane, MD PhD 12:43 12:54 Steroids in the Management of Macular Edema Young Hee Yoon, MD 12:54 13:06 New Options for the Management of Macular Edema Dr. J. A. Haller, MD 13:06 13:18 Steroids in the Management of Uveitis Prof. S. Lightman, MD PhD

332 328 WOC 2010 Company Symposia 13:18 13:30 Management of Macular Edema in Clinical Practice Combination Treatment (an option for the future) Dr. A. Loewenstein, MD Allergan Breakfast Monday, 7 June :15 08:15 Hall 4/5 Glaucoma Optimal Glaucoma Management Prof. Anders Heijl, MD/ Prof. Remo Susanna Jr, MD Bausch + Lomb Lunch Friday, 4 June :30 13:30 Hall 8 Circle of Nutritional Competence AMD und Mikronährstoffe: Stand der Wissenschaft und welchen Einfluss haben sie? (AMD and micronutrients - status quo in science and their influence) Chair: Prof. Dr. Ulrich Welge-Lüßen, Erlangen 1. "Oxidativer Stress in der Pathogenese der AMD und der Einfluss von Mikronährstoffen" Prof. Dr. Ulrich Welge-Lüßen, Erlangen 07:15 Introduction and Welcome Prof. Anders Heijl, MD / Prof. Remo Susanna Jr, MD 07:18 Optimal Glaucoma Management the Patient in Focus Prof. Remo Susanna Jr, MD 07:31 Rate of Progression a Measure for Optimal Management of our Glaucoma Patients Prof. Anders Heijl, MD 07:44 Successfully Optimizing First Line Therapy in Glaucoma Prof. David B. Yan, MD 07:57 Optimal Glaucoma Management is Fixed combination the Solution for the Progressing Patients? Prof. Luca Rossetti, MD 08:10 Closure Prof. Anders Heijl, MD Prof. Remo Susanna Jr, MD Bausch + Lomb Surgical Saturday, 5 June :30 13:30 Bausch+Lomb-Stand, 12 A/16 Meet the expert Meet Stellaris PC 2. Klinische Evidenz für den Einsatz von Mikronährstoffen bei AMD ein aktueller Überblick PD Dr. Erdem Ergun, Wien 3. Welche Rolle spielen genetische Faktoren bei AMD und können Mikronährstoffe diese positiv beeinflussen? Prof. Dr. André Reis, Erlangen Bausch + Lomb Lunch Sunday, 6 June :30 13:30 Hall 4/5 Inflammation following standard cataract surgery is it still an issue? Welcome & Introduction Chair: Prof. Dr. Jorge Alio, Spain Prevention of serious infection and inflammation following standard cataract surgery Prof. Dr. Uwe Pleyer, Germany Early detection and treatment of endophthalmitis Prof. Dr. Jorge Alio, Spain Prevention and treatment of cystoid macular oedema following cataract surgery David Spalton, UK Concluding remarks Prof. Dr. Jorge Alio, Spain

333 WOC BAYER Schering Pharma Lunch Sunday, 6 June :30 13:30 Hall Oslo An Update on VEGF Trap-Eye Frank Holz (Germany), Ursula Schmidt-Erfurth (Austria) Introduction Biology of VEGF Trap-Eye Georges von Degenfeld (Germany) Phase II results in AMD Peter Kaiser (USA) Phase III trials in AMD Yuichiro Ogura (Japan) GEUDER LS Lunch- Saturday, 5 June :30 13:30 Hall Stockholm GEUDER Lunch- 1. Patient-focused refractive Micro-Incisional Cataract Surgery Best practices and insider tips to increase patient s satisfaction Prof. Gerd U. Auffarth, MD 2. Sutureless Vitrectomy with UnoColorline Trocar System and Hattenbach Screw-Cut Technique First encouraging experiences with the new screw-cut technique for self-sealing transconjunctival sclerotomies Prof. Lars-Olof Hattenbach, MD Company Symposia Development for other indications Jost B. Jonas (Germany) Summary Chibret Lunch Friday, 4 June :45 13:45 Hall 4/5 Ohne BAC zum Therapiererfolg - die Kunst des Weglassens Chair: Prof. Dr. Günther K. Krieglstein Talk 1: Zur Logik der Konservierungsstoff-Freiheit Prof. Dr. Günther K. Krieglstein, Germany Talk 2: Vorteile von konservierungsmittelfreien Antiglaukomatosa für Augenärzte und Patienten PD Dr. Elisabeth M. Messmer, Germany Talk 3: Konservierungsmittelfreie Glaukomtherapie: für wen ist sie notwendig und sinnvoll? Prof. Dr. Norbert Pfeiffer, Germany 3. Endotamponades: Air, Gas or Silicone Oil? Indications, Contraindications and Best Practices Fine-needle aspiration biopsy of intraocular tumors: new tools David E. Pelayes MD, PhD HeidelbergEngineering Lunch Sunday, 6 June :30 13:30 Hall Stockholm HeidelbergEngineering Lunch : Eye to Eye Chair: Dr. Stephan Schulz Multimodal imaging in wet AMD Blue Laser Fundus autofluorescence imaging in advanced dry AMD new concepts for emerging therapies Heidelberg Edge Perimeter (HEP) in clinical practice Definition of glaucomatous progression in structural and functional imaging

334 330 WOC 2010 Company Symposia MERCK Lunch (German) Friday, 4 June :30 13:30 Hall 4/5 Ohne BAC zum Therapiererfolg die Kunst des Weglassens Talk 1: Das eine tun, ohne das andere zu lassen: Erhalt des Gesichtsfeldes und der Augenoberfläche bei Glaukompatienten" N.N. Talk 2: Konservierungsmittelfreie Glaukomtherapie: für welche Patienten sind BAC-freie Präparate sinnvoll? N.N. Talk 3: Vorteile von konservierungsmittelfreien Antiglaukomatosa für Augenärzte und Patienten N.N. MERCK Evening (International) Sunday, 6 June :00 19:00 Hall 3 Current concepts and new data for the management of glaucoma in the 21 st century Chair: Dr. Norbert Pfeiffer, Germany Talk 1: Managing risk factors of the patient with uncontrolled IOP Dr. Stefano Miglior, Italy Talk 2: Understanding 24-hour IOP fluctuation: new data on known glaucoma therapies Dr. Tasos Konstas, Greece Talk 3: Predictors of visual field progression Dr. Antonio Martinez, Spain MERCK Lunch (International) Saturday, 5 June :30 13:30 Hall 3 "Preservative Free Therapy: Addressing Unmet Needs in the Treatment of Glaucoma" Chair: Dr. Robert Weinreb, US Talk 1: Ocular Surface Disease and the Effects of Preserved Glaucoma Treatments Dr. Malik Kahook, US Talk 2: Prevalence of Ocular Surface Disease in Glaucoma Patients Dr. Robert Weinreb, US Talk 3: Introducing a Novel Preservative Free Glaucoma Treatment Dr. Carlo Traverso, Italy Talk 4: Tafluprost Phase IIIb Clinical Review Dr. Norbert Pfeiffer, Germany Talk 4: Preserving eye health with preservative-free glaucoma therapies Dr. Cindy Hutnick, Canada MSD Ophthalmics Lunch Saturday, 5 June :10-13:00 Hall 3 Preservative Free Therapy: Addressing Unmet Needs in the Treatment of Glaucoma Chair: Dr. Robert Weinreb, US Talk 1: Ocular Surface Disease and the Effects of Preserved Glaucoma Treatments Dr. Malik Kahook, US Talk 2: Prevalence of Ocular Surface Disease in Glaucoma Patients Prof. Dr. Robert Weinreb, US Talk 3: Introducing a Novel Preservative Free Glaucoma Treatment Dr. Carlo Traverso, Italy Talk 4: Tafluprost Phase IIIb Clinical Review Prof. Dr. Norbert Pfeiffer, Germany

335 WOC MSD Ophthalmics Evening Sunday, 6 June :00-19:30 Hall 3 Current concepts and new data for the management of glaucoma in the 21 st century Chair: Prof. Dr. Norbert Pfeiffer, Germany Talk 1: Managing risk factors of the patient with uncontrolled IOP Dr. Stefano Miglior, Italy NOVARTIS Lunch Friday, 4 June Hall Stockholm Therapie neovaskulärer Erkrankungen: AMD-Therapie unter real life Bedingungen / DME und RVO Aufbruch zu neuen Ufern Vorsitz: Prof. Anselm Kampik, München BOON ein integratives Monitoring-Model für intravitreale Injektionstherapien Prof. Nicole Eter, Bonn Company Symposia Talk 2: New Clinical Evidence on 24-Hour IOP Management Prof. Dr. Tasos Konstas, Greece Talk 3: Predictors of visual field progression Dr. Antonio Martinez, Spain Talk 4: Preserving eye health with preservative-free glaucoma therapies Dr. Cindy Hutnick, Canada NOVARTIS Lunch Sunday, 6 June :30 13:30 Hall Abu Dhabi Improving vision for patients with DME: New Compelling Evidence Chair: Gabriele Lang, Germany 12:30 Epidemiology & current evidence for treatment success of ranibizumab in diabetic macular edema patients in the Phase II RESOLVE study (including Q&A) Gabriele Lang, Germany 12:40 Improving vision with ranibizumab in patients with diabetic macular edema in the Phase III RESTORE study (including Q&A) Paul Mitchell, Australia 13:05 Further clinical trial evidence of treating patients with diabetic macular edema (including Q&A) Neil M. Bressler, USA Ranibizumab-Therapie bei neovaskulärer AMD: Neue Ergebnisse der WAVE-Studie Dr. Robert Finger, Bonn Therapie des diabetischen Makulaödems aktuelle Aspekte und Ergebnisse der RESTORE Studie Prof. Antonia Joussen, Charité Berlin Anti-VEGF Therapie und Laserkoagulation bei Venenastverschlüssen Beobachtungen aus der Branch Retinal Vein Occlusion Associated Macular Edema Studie (R.A.B.A.M.E.S.) Prof. Lars-Olof Hattenbach*, Ludwigshafen *Weitere Autoren: Feltgen N, Pielen A, Hansen LL, Lorenz K, Pfeiffer N, Hoerauf H, Jünemann C, Höhn F, Kreutzer T, Priglinger S, Mirshahi A OCULUS Breakfast Sunday, 6 June :15 08:15 Hall 7 Corneal measurement for keratoconus detection New methods of evaluation of anterior segment data for keratoconus detection, refractive procedures as well as for glaucoma specialists are demonstrated. The results of a preliminary study are presented. Prof. Dr. Renato Ambrósio Jr., Brasil

336 332 WOC 2010 Company Symposia OCULUS Lunch Friday, 4 June :45 13:45 Hall 7 Die OCULUS Pentacam und das Nidek OCT Innovative Diagnostik im täglichen Einsatz 12:45 Uhr: Premiumdiagnostik mit der OCULUS Pentacam Dr. Alexander Petzold, Leipzig 13:15 Uhr: Die optische Kohärenztomografie (OCT) in der augenärztlichen Praxis Dr. Gernot Petzold, Kulmbach Pfizer Breakfast 12:35-12:45: Structure and Function Robert N. Weinreb, MD 12:45 13:00: Vision Functioning (Observed) George l. Spaeth, MD 13:00 13:10: Patient-Reported Functioning Rohit Varma, MD, MPH 13:10-13:20 Management Decisions Ivan Goldberg, MB, BS, FRANZCO, FRACS 13:20 13:30 Concludlng Remarks and Questions Norbert Pfeiffer, MD Monday, 7 June :15 08:15 Hall Sao Paulo Patient Perspective on DME: Maximizing Quality of Life in the Management of Diabetic Macular Edema (DME) Chair: Rohit Varma, MD, MPH 07:15 07:25: Chair's Welcome and Introduction Rohit Varma, MD, MPH 07:25 07:30: Living with DME: A Patient Testimony 07:30 07:50: Evaluating the Whole Patient: OME, Quality of Life and Associated Comorbidities Seenu M. Hariprasad, MD 07:50 08:10: Economic Burden of DME: A UK Perspective Peter H. Seanlon, MBBS, FRCP, DCH 08:10 08:15: Concluding Remarks and Questions Rohit Varma, MD, MPH Pfizer Lunch Saturday, 5 June :10 14:00 Hall Sao Paulo Glaucoma The Linkage between Function, Functioning and Quality of Life Chair: Norbert Pfeiffer, MD 12:30 12:35: Chair's Welcome and Introduction Norbert Pfeiffer, MD Pfizer Evening Sunday, 6 June :00 19:30 Hall Sao Paulo A Fresh Look at DME: An Interactive on Interdisciplinary Management of Diabetic Macular Edema (DME) Chair: Tien Wong, MD, MPH, PhD 18:00 18:15: Chair s Welcome and Introduction Tien Wong, MD, MPH, PhD 18:15 18:35: Evaluating DME and Associated Comorbidities: A Comprehensive Clinical Approach Massimo Porta, MD, PhD 18:35 18:55: Current Management of DME: Monitoring Progression Ursula Schmidt-Erfurth, MD 18:55-19:15: Current Management of DME: Treatment Considerations Lloyd P. Aielto, MD. PhD 19:15 19:30: Is Current Management Effective? Tien Wong, MD, MPH, PhD

337 WOC SANTEN Lunch Sunday, 6 June :30 13:30 Hall 3 Progress in Glaucoma Management: where are we now? Chair: Prof. Migdal Is glaucoma screening effective? Prof. Dr. N. Pfeiffer Dry eye, glaucoma and eye drops Prof. Dr. Christophe Baudouin Further IOP reduction within the normal range - the role of prostaglandins in NTG Prof. Dr. M. Aihara How do preservative-free prostaglandins compare? a clinical overview Prof. Dr. Lutz E. Pillunat SANTEN Lunch Monday, 7 June :30 13:30 Hall 7 Zeiss Breakfast Sunday, 6 June :15 08:45 Roof Garden New Frontierts in OCT Imaging Chair: José Cunha-Vaz, MD, PhD Change Analysis: Using OCT to manage Macular Disease" José Cunha-Vaz, MD, PhD Visualizing the Vitreoretinal Interface with OCT: Understanding the Role of Epiretinal Membranes in Retinal Disease. Alain Gaudric, MD New OCT Applications for Glaucoma: Optic Nerve Head Analysis and RNFL Progression Giacomo Savini, MD Learn how the experts apply the new features from Cirrus HD-OCT to optimize daily clinical care. The panelists will discuss how HD-OCT is providing more and better information for the diagnosis and management of retina and glaucoma disease. Company Symposia LEVOFLOXACIN in the Prevention and Treatment of Ocular Infections Chair: Prof. Richard L. Abbott Ocular Pharmacokinetics: Principles and Fluorocinolole Related Implications Prof. Urtti The treatment of bacterial keratitis Prof. Richard L. Abbott The influence of fluoroquinolones on corneal endothelial cells Prof. Oshika Prevention of endophthalmitis in cataract surgeries Dr. Chan Zeiss Lunch Friday, 4 June :30 13:30 Roof Garden AAD/DOG Lunch Zukunft willkommen! Die Grundsäulen einer erfolgreichen Augenarztpraxis Chair: Dr. Martin A. Zeitz, Henning Goebel Speakers: Dr. Martin A. Zeitz, optimed GmbH Düsseldorf Henning Goebel, optimed GmbH Düsseldorf Der Gesundheitsmarkt ändert sich rasant. Hierdurch entstehen nicht nur Risiken, sondern auch Chancen für die Augenärzte. Die politischen Rahmenbedingungen und der zunehmende Wettbewerb machen es erforderlich, die Weichen jetzt richtig zu stellen und die eigene Praxis fit für die Zukunft zu machen. Erfahren Sie im Zeiss-Lunchsymposium, wie Sie Ihre Augenarztpraxis erfolgreich positionieren können: Strategieentwicklung, Workflow-Optimierung sowie Marketing und Servicequalität werden darüber entscheiden, ob Ihr Unternehmen Augenarztpraxis in fünf Jahren zu den Gewinnern oder den Verlierern zählen wird.

338 334 WOC 2010 Company Symposia Zeiss Lunch Saturday, 5 June :30 13:30 Roof Garden Cataract Workflow Innovations Chair: Wolfgang Haigis, PhD Modern Biometry for the Problems of today and tomorrow Wolfgang Haigis, PhD Clinical Experience with the new IOLMaster 500 Oliver Findl, MD With ReLEx a unique method of vision correction by femtosecond-only laser application is now available. Its current application and also future potential will be addressed. Laser Blended Vision provides age optimized treatment as a new option of the MEL 80 / CRS-Master platform. Very well received by the surgeons, we will hear about its results and patient satisfaction. ZIEMER Breakfast Saturday, 5 June :15 08:15 Hall 8 Innovative Management of Astigmatism Correction with ZEISS Toric Solution Dominique Piétrini, MD How to improve Outcomes and optimize Surgical Workflow with the Monofocal Aspheric CT AS- PHINA 613P Preloaded IOL and the SkyJet Advanced Injector in small Incisions NN Zeiss Lunch Monday, 7 June :30-13:30 Roof Garden ReLEx and Laser Blended Vision - the start of a new era in refractive surgery Chair: Dan Reinstein, MD Laser Blended Vision the Safest and Most Effective Solution for Emmetropic, Myopic and Hyperopic Presbyopia Dan Reinstein, MD Patient Satisfaction after Laser Blended Vision Peter Brincker, MD ReLEx a New Method of Laser Vision Correction Entered the Market Jesper Hjortdal, MD Femtosecond Lenticule Extraction in Hyperopic Cases Where are we today? Marcus Blum, MD Minimally Invasive ReLEx Procedures in Low, Moderate and High Myopia Rupal Shah, MD Ocular Wavefront Changes after ReLEx Procedures Igor Solomatins, MD Come and see two exciting topics introduced by Carl Zeiss. GALILEI USER MEETING Chair: Dr. Jennifer Lewis 07:15-07:30 Highlights of GALILEI Software and Showcase of GALILEI Presentations at the ASCRS 2010 Jennifer Lewis, PhD 07:30-07:45 Clinical Applications of the GALILEI (Keratoconus, Refractive Surgery and Lamellar Surgery) Pavol Veselý, MD 07:45-08:00 GALILEI in a Refractive Practice: Identification of Keratoconus Suspects and other risk cases. Comparison of available methods. Markus Pölzl, MD 08:00-08:15 The symposium is open for all WOC/DOG attendees interested in the GALILEI Dual Scheimpflug Analyzer.

339 WOC Patientensymposium des Deutschen Blinden- und Sehbehindertenverbandes und des Allgemeinen Blinden- und Sehbehindertenvereins Berlin: Risiken, Forschung, Therapien die Augenheilkunde im Jahr 2010 This will be held in German Raum Stockholm Donnerstag, 3. Juni 2010 Patientensymposium 09:00-13:00 Uhr Prof. Dr. Carl Erb, Schlosspark-Klinik Berlin Prof. Dr. Nicole Eter, Universitäts-Augenklinik Bonn Dr. Robert Finger, Universitäts-Augenklinik Bonn Dr. Christine Stamm, Beratungsstelle für Sehbehinderte Berlin Kursinhalte Moderation: Dr. Christine Stamm 09:00 Uhr Begrüßung 09:05 Uhr Prof. Dr. Carl Erb, Schlosspark-Klinik Berlin Allgemeinerkrankungen und ihre Auswirkungen auf das Auge 10:00 Uhr Dr. Robert Finger, Universitäts-Augenklinik Bonn: Der Weltkongress der Augenheilkunde in Berlin zum Stand der Forschung zur Verhütung von Blindheit im Jahr :45 Uhr Pause 11:15 Uhr Prof. Dr. Nicole Eter, Universitäts- Augenklinik Bonn: Neue Therapien zur Behandlung der Makula- Degeneration neue Hoffnung? FR-01 zur Verleihung des Sicca-Förderpreises 2010 des Ressorts Trockenes Auge im BVA: Aktuelle Forschung zum Trockenen Auge This will be held in German Sao Paulo Friday, 4 June :00-13:30 Der Sicca-Förderpreis des Ressorts Trockenes Auge im BVA in einer Gesamthöhe von Euro wird nun mittlerweile seit 10 Jahren von Bausch & Lomb Dr. Mann Pharma Berlin gestiftet. Er dient der Unterstützung, Motivation und interdisziplinären Zusammenarbeit junger Forscherinnen und Forscher im deutschsprachigen Raum auf diesem Sektor. Im Rahmen des s werden aktuelle Forschungsprojekte zum Trockenen Auge und Erkrankungen der Augenoberfläche präsentiert. Horst Brewitt (Hannover/D) Thomas Kaercher (Heidelberg/D) 11:00 IL FR Kultivierung und Charakterisierung adulter Stammzellen der Tränendrüse Philipp Ackermann (Halle/Saale) 11:05 IL FR Osmolarität des Tränenfilms bei Augengesunden und Patienten mit Trockenem Auge Meral Bulgen, Elisabeth M. Messmer (München) 11:10 IL FR Behandlung von Patienten mit Keratokonjunktivitis sicca mit Augenakupunktur Anna Cucera (Ulm) 11:15 IL FR Die Relevanz von Harnstoff im Tränenfilm bei der Pathogenese der Konjunctivitis sicca Matthias Dunse (Halle/Saale) Other Symposia (in German) 12:15 Uhr Fragen und Antworten 13:00 Uhr Ende der Veranstaltung Maximale Teilnehmerzahl: 350 Anmeldung erforderlich unter Tel. 030 / (Allgemeiner Blinden- und Sehbehindertenverein Berlin) Teilnahmegebühren: keine 11:20 IL FR Untersuchungen zur Wirkung von Kräften der extrazellulären Umgebung auf Wachstum und Differenzierung von humanen Corneazellen Philipp Eberwein (Freiburg) 11:25 IL FR Verbesserung des Überlebens allogener Epitheltransplantate durch Gentherapie Thomas Armin Fuchsluger, Klaus-Peter Steuhl, S. Ergun (Boston/USA, Essen) 11:30 IL FR Induktion von humoraler und zellulärer Immunantwort der Augenoberfläche durch lokale Antigen-Applikation Uta Gehlsen (Lübeck)

340 336 WOC 2010 Other Symposia (in German) 11:35 IL FR Epidemiologie der okulären Graft versus Host Disease und Verlaufsbeobachtung unter immunsuppressiver Therapie mit der Fragstellung nach der Rolle der Becherzellen Eva Jakob (Heidelberg) 11:40 IL FR Ist die Replikation von Hornhaut-Endothelzellen duch lentiviralen Gentransfer induzierbar? Daniel Kampik (Würzburg) 12:20 IL FR Eine neue therapeutische Strategie bei entzündlichen Erkrankungen der Augenoberfläche? Die gezielte Hemmung antigenpräsentierender Zellen durch Sanglifehrin A. Johannes Schwartzkopff (Freiburg) 12:25 IL FR Konjunktiva-assoziiertes lymphatisches Gewebe (CALT) ein Epiphänomen? Sebastian Siebelmann (Lübeck) 11:45 IL FR Einfluss potentiell osmoprotektiv wirksamer Tränenersatzpräparate auf die Osmolarität des Tränenfilms beim Hund Regina M. E. Korth, Gwendolyna Romkes, Corinna Eule (Berlin) 11:50 IL FR Pollen-Enzyme schädigen menschliche Tränenflüssigkeit und Bindehautzellen Ein Ansatz zum Verständnis des SNAK (saisonale nicht-allergische Konjunktivitis)-Syndroms Dieter Franz Rabensteiner, Eva-Maria Spreitzhofer, Jutta Horwath-Winter, Otto Schmut (Graz/A) 11:55 IL FR iblink Ein Computer basierter Ansatz zur Diagnose und Therapie des Bildschirm-assoziierten Trockenen Auges Dieter Franz Rabensteiner, Jutta Horwath-Winter, Otto Schmut (Graz/A) 12:00 IL FR Konzentrationsbestimmung von ausgewählten antimikrobiellen Peptiden und Surfactantproteinen in der Tränenflüssigkeit von Neugeborenen, Kindern und Erwachsenen Gesa Friederike Schäfer (Magdeburg) 12:05 IL FR Prospektive Studie zur Evaluierung der Tränenfilmosmolarität als Verlaufsparameter des trocknen Auges bei Patienten mit allogener Stammzelltransplantation und Graft versus Host Reaktion (GvHD) mittels der TearLab Osmometrie Marc Schargus, Gerd Geerling (Würzburg) 12:10 IL FR SP-G und SP-H zwei neue unbekannte Surfactant Proteine des Tränenfilms Martin Schicht, Lars Bräuer (Halle/Saale) 12:15 IL FR Co-Kultur menschlicher Bindehautzellen mit teilungsfähigen subkonjunktivalen Fibroblasten: Simulation einer Stammzellnische für konjunktivale Progenitorzellen Stefan Schrader, Maria Notara, Michèle Beaconsfield, Stephen J. Tuft, Gerd Geerling, Julie T. Daniels (Lübeck, London/GB, Würzburg) 12:30 IL FR Die Bedeutung von Feinstaub und UV-Licht für die Entwicklung eines Umwelt induzierten Trockenen Auges Katrin Sturmbauer, Dieter Franz Rabensteiner, Otto Schmut (Graz/A) 12:35 IL FR Modifikation der Expression von Stammzell- und Pluripotenzmarkern in limbalen epithelialen Stammzellen durch unterschiedliche Kulturmedien Henning Thomasen, Klaus-Peter Steuhl, Daniel Meller (Essen) 12:40 IL FR Randomisert kontrollierte Studie zur Verwendung von autologem Serum zur Prävention einer Augenoberflächenstörung bei adjuvanter 5-Fluorouracil-Injektion nach filtrierender Glaukomchirurgie Jan Darius Unterlauft, Karsten Kasper, Gerd Geerling (Würzburg)

341 WOC Official Social Program Opening Ceremony Saturday, 5 June 2010, 18:30-20:00 ICC, Hall 1 Do not miss the WOC 2010 Opening Ceremony, Saturday 5 June 2010 at 6.30pm Follow us and discover past, present and future during the Opening Ceremony: Pay tribute to our ancestor Albrecht von Graefe Explore the iconic Berlin, the vibrant capital of Germany and its Queen Look into the future with WOC 2012 to be held in Abu Dhabi, United Arab Emirates. Social Program Join us in welcoming the Who is Who of ophthalmology marching in and coming from across the world and be part of the promotion of scientific excellence reflected throughout the International Award Ceremony. Featured in HD sequences, the beauty of the Eye will be omnipresent during the Opening Ceremony and strives to represent the vision and mission of our fascinating profession. Admire the breathtaking pictures of Eyeland Design. Enjoy phantastic music and entertainment. The WOC Reception is the perfect get-together for the international ophthalmologist community and allied specialties to meet old friends and make new ones in a friendly atmosphere. On behalf of the International Council of Ophthalmology, the German Society of Ophthalmology, the German Academy of Ophthalmology and both, the WOC 2010 Executive Committee and Scientific Programme Committee, we take pleasure in welcoming you to this key event. Prof. Dr. Gerhard K. Lang President of the DOG President WOC 2010 Bruce E. Spivey, MD, MS, Med International Council of Ophthalmology President see also p. 39 WOC Reception Saturday, 5 June 2010, 20:00-22:00 ICC, Hall 2 WOC in Concert Sunday, 6 June 2010, 20:00-21:30 Venue: French Church of Friedrichstadt (French Cathedral)/ Französische Friedrichstadtkirche am Französischen Dom, directly at the Gendarmenmarkt. Tube Station on the U2 Line: Französische Str. Entrance free No bus transfer Organizers: Georg Fischer Varvitsiotis (Conductor) and Franz Grehn Ophthalmologists play for Ophthalmologists The musicians play masterpieces from Carl Philipp Emmanuel Bach Léon Boëllmann Leopold Mozart Wolfgang Amadeus Mozart Johann Joachim Quantz Robert Schumann Louis Vierne Ludwig van Beethoven see also p. 41

342 338 WOC 2010 Social Program WOC toberfest Monday, 7 June 2010, 7:30-12:00 WOC toberfest will be a typical Bavarian-like Oktoberfest with beer, German food and entertainment. You should not miss this special social highlight! We cordially invite you to come and join us for a Bavarian-style Oktoberfest at the WOC toberfest in the Hangar II of Tempelhof Airport. With traditional Oktoberfest brass band music, beer and Bavarian specialties, we plan to enjoy a lively, intercultural evening. Of course, there will also be non-alcoholic drinks and vegetarian food. We are offering some other attractions for adults and children so as to celebrate this WOC toberfest as a family party. All participants are also most welcome to wear their own national dress at this event, as wearing different and colorful national dresses conveys a sense of friendly solidarity. Our motto for the evening is: meet old friends and make new friends in a relaxed and friendly atmosphere. Program for Accompanying Persons If you are interested in participating in sightseeing tours please go to the congress website at and contact the agency Interklassik by quoting "WOC 2010". The Interklassik team will also be happy to advise you concerning the organisation of pre and post congress tours. Interklassik Concierge & Event GmbH E WOC2010@interklassik.de T +49 (30) F + 49 (30)

343 WOC Information for Authors Opening hours of the Media Check The central Media Check is located in Main Lobby, Lobby Level Thursday, 3 June :00 19:00 Friday, 4 June :00 18:30 Saturday, 5 June :30 18:30 Sunday, 6 June :30 18:30 Monday, 7 June :30 18:30 Tuesday, 8 June :00 18:30 Wednesday, 9 June :30 14:00 Speaking Times Lectures free paper session: 9 minutes Oral presentation: 7 minutes In order to guarantee a smooth organization of the entire program, all speakers are requested to keep to their allocated presentation times. The chairperson of each session will be entitled to interrupt a presentation if a speaker exceeds the time allocated. Information for Authors Videos Video presentations are an important and effective mean of displaying scientific results. Therefore, the best seven videos will be displayed and discussed during the video session on Sunday, 6 June, 14:00 15:30 in the Radio Tower Lounge 2. The WOC will publish awarded videos on its homepage. Therefore, authors who would like to make their video available to the WOC are requested to consider that the videos do not show any data which are subject to payment for copyrights and technical reproduction. The WOC 2010 Video Award of the DOG, donated by Carl Zeiss Meditec VG, will be granted at the end of the Video Session with Presentation of Awards (Sunday, 6 June, 14:00 15:30). Poster Presentation Poster presentations are an important and effective means of displaying scientific results. Printed posters will be displayed in indicated sessions and E-posters during the entire congress. First authors of posters must be present at their poster at the times indicated below. Chairpersons will check the presence of poster authors. Each day three outstanding posters will be awarded an amount of 300 c each. All posters must be prepared in English. Standard poster walls will be available in the Poster Exhibition. The maximum size of a poster is DIN A0 (84.10 cm wide x cm high). Adhesive material and staff will be available to poster authors from the Poster Help Desk in the poster exhibition area. The organisers will remove posters that will not have been removed by the times indicated below. Poster Presentation Poster P-SA-001 to P-SA-282 and P-SU-001 to P-SU-277 must be mounted on Saturday, 5 June 2010, 8:30 and removed on Sunday, 6 June 2010, 17:30. Poster P-MO-001 to P-MO-298 and to P-TU-001 to P-TU-265 must be mounted on Monday, 7 June 2010, 8:30 and removed on Tuesday, 8 June 2010, 17:30.

344 340 WOC 2010 Information for Authors Information for Authors Poster Session with First authors are requested to attend their posters for questions and discussions as follows: P-SA-001 to P-SA-282 Saturday, 5 June 2010, 15:30 17:00 at the poster P-SU-001 to P-SU-277 Sunday, 6 June 2010, 15:30 17:00 at the poster P-MO-001 to P-MO-298 Monday, 7 June 2010, 15:30 17:00 at the poster P-TU-001 to P-TU-265 Tuesday, 8 June 2010, 15:30 17:00 at the poster Electronic Posters In addition to the conventional poster presentation, a facility for all delegates to view any poster on a LCD display screen during the entire congress will be available. To optimize the preparation of this presentation, all authors are asked to observe the following requirements: Maximum five pages (without animation) in Microsoft PowerPoint. All images and graphics should be. Posters will be displayed in landscape format with a screen resolution of 1024 x 768 dpi. (Powerpoint On-Screen show 4:3) Projection Facilities A central Media Check will be available during the entire congress. Own laptops cannot be connected in the rooms. All presentations must be uploaded in advance to the network. All authors will receive a separate from M Events Cross Media GmbH with access information and instruction. Presentations that are attached to an cannot be processed. Only MS-Powerpoint (XP and higher) and PDF presentations with video formats as specified on the upload site are permitted for this conference. Do not forget to bring your video files as they cannot be embedded into the presentation. Please submit your files at least 2 hours before your talk. If you speak in the first session in the morning please submit your files the day before or use the internet upload. You may check and/or alter your presentation yourself in the Media Check (ICC Lounge) up to two hours prior to your presentation. Please note that the M Events staff members cannot revise your presentation. For the submission of your presentation on site, CDs, USB Sticks, or similar will be accepted. After the conference all submitted files will be deleted from all storage media.

345 WOC Information for Authors Publication of Scientific Papers of DOG members Scientific contributions that have been accepted for oral presentation have to be handed in in publishable format for peer reviewing no later than 31 October Publication is possible in either German or English. Please send your manuscript to the respective editors: Contributions in German for review by the journal "Der Ophthalmologe" should be submitted online only. Full details concerning submission are available at: or directly at: Editor-in-Chief Professor Frank G. Holz Universitäts-Augenklinik Bonn Ernst-Abbe-Str Bonn Contributions in German for review by the journal "Klinische Monatsblätter für Augenheilkunde" should be sent online to: Editors-in-Chief Professor Gerhard K. Lang, Professor Gabriele E. Lang Universitäts-Augenklinik Ulm Prittwitzstr Ulm Information for Authors Contributions in English for review by the journal "Graefe s Archive for Clinical and Experimental Ophthalmology" should be submitted online only. Full details concerning submission are available at: or directly at: Editor-in-Chief Professor Bernd Kirchhof Klinikum der Universität zu Köln Zentrum für Augenheilkunde Kerpener Str Cologne Copyright for oral presentations to be made at the congress by DOG members belongs to the society. Therefore authors of oral presentations are obliged to submit their contributions for review and publication to one of the following journals: "Der Ophthalmologe", "Klinische Monatsblätter für Augenheilkunde" or "Graefe s Archive for Clinical and Experimental Ophthalmology". Upon request, the presentation may also be published in another journal. In this case, the author is asked to send an informal application to the Secretary of the DOG. Contributions published in other journals shall annotate: "presented at the 108 th DOG Congress". All authors are kindly asked to observe the "Instructions for Authors" of the respective journals. Manuscripts not accepted for publication after the review process will be returned to the respective author with the reviewers evaluation.

346 342 WOC 2010 DOG Membership DOG Membership Colleagues who wish to become members of the German Society of Ophthalmology (DOG) can do so by clicking on membership at Please complete the online application form, or download the form, complete it and send it to: Geschäftsstelle der DOG e.v. Platenstr Munich Tel. +49 (89) Fax +49 (89) geschaeftsstelle@dog.org Opening hours Monday to Friday: 8:00-12:30 Annual Membership Fees Consultants / specialists national and international, c 200 who do not belong to any of the following groups Medical students in training (assistant doctors), c 100 Consultants / specialists and medical students c 100 from neighbouring Eastern European countries Pensionary members c 100 Paying members of the DOG will automatically receive a copy of the journal Der Ophthalmologe or alternatively the English language journal Graefe s Archive for Clinical and Experimental Ophthalmology at no extra cost. If Der Ophthalmologe is chosen, Graefe s Archive for Clinical and Experimental Ophthalmology can be ordered at a reduced annual rate of c 60. Copies of journals received at reduced rates are exclusively for the personal use of DOG members and may not be passed on to libraries or institutes.

347 WOC Travel and accommodation Grants France 2010 European DOG and SFO would like to extend and intensify the scientific cooperation and exchange between Germany and France. For this purpose, a joint symposium will be organized at the annual SFO and DOG congress, the topic of this symposium generally being the topic of the preceding congress in the respective country. Young physicians in practice and/or research are invited to submit their contributions, which should be related to the topic of the symposium. The contributions should possibly be the result of a real German-French cooperation. A DOG/SFO commission will select up to four articles of all the submitted abstracts. The first authors will receive from his/her society a travel allowance of c 1000,- to participate in the congress. In addition, the first author of the respective best abstract will receive a grant of c 2000,- to be used for a stay of several weeks in a hospital of the other country. Language skills are welcome, but not an absolute requirement. The official languages of the DOG-Congress are German and English, those of the SFO-Congress French and English. Grants France 2010 Applications including a short description (20 25 lines) should be sent to: geschaeftsstelle@dog.org You will find more detailed information about application and deadlines on the DOG-Homepage Reise und Aufenthaltsstipendium Frankreich 2010 Europäisches DOG und SFO wollen die Zusammenarbeit und den Austausch zwischen Deutschland und Frankreich auch auf wissenschaftlichem Gebiet weiter intensivieren. Im Rahmen der Kongresse beider Fachgesellschaften findet dazu jeweils ein gemeinsames statt. Thema ist jeweils das Kongressthema des vorausgehenden Kongresses im jeweils anderen Land. Junge, klinisch und/oder wissenschaftlich tätige Mitarbeiter/innen werden aufgefordert, freie Beiträge einzureichen, die zum Thema des jeweiligen s passen sollten. Besonders wünschenswert wäre es, falls diese Arbeiten das Ergebnis einer realen deutsch-französischen Zusammenarbeit dokumentieren. Aus den eingereichten freien Beiträgen wählt die Kommission der DOG/SFO bis zu vier Beiträge aus. Die Erstautoren/innen erhalten von ihrer Fachgesellschaft einen Reisekostenzuschuss zu dem jeweiligen Kongress in Höhe von c 1.000,-. Der Erstautor des jeweils besten Beitrags erhält zusätzlich einen Reisekostenzuschuss in Höhe von c 2.000,-, der für einen mehrwöchigen Aufenthalt an einer Klinik des jeweiligen anderen Landes zu verwenden ist. Sprachkenntnisse sind willkommen, aber nicht Bedingung. Die Kongresssprachen der DOG-Kongresse sind Deutsch und Englisch, die der SFO- Tagungen Französisch und Englisch. Anträge inkl. einer Kurzbeschreibung von max. 20 bis 25 Zeilen Text sind per zu richten an: geschaeftsstelle@dog.org Details zur Bewerbung, Abgabefristen sowie den genauen Themen der Symposien werden auf der DOG Homepage veröffentlicht.

348 Dr. R. Kaden Verlag Der Ophthalmologe unter den Verlagen

349 WOC Sponsors and Exhibitors The WOC 2010 gratefully acknowledges the support of all Sponsors and Exhibitors Company 1a Medico GmbH 15 B/38 1st Q Deutschland GmbH & CO. KG 15 A/15 A. R. C. Laser GmbH 15 A/12 AAO American Academy of Ophthalmology EF 08 Aaren Scientific, Inc. 17 B/27 Abbott Medical Optics Inc. 15 A/03 Accutome, Inc. 17 A/10 Aeon Astron Europe B. V. 15 A/26 ADTA 15/02 AKRUS GmbH 12 B/21 ALBOMED GmbH 15 A/34 ALCHIMA 15 A/19 Alcon Laboratories, Inc. 12 B/30 Allergan Inc. 14/07 anteis SA 15 B/48 APAO EF 13 APAO 2011 EF 03 Appasamy Associates 17 B/48 argus Individuell Optic GmbH 17 B/42 asico 15 B/53 Association for Research in Vision and Ophthalmology EF 12 ASCRS Media 17 A/14 Der Augenspiegel 12 A/12 AuroLab 12 B/25 Bausch & Lomb 12 A/16 Bayer Schering Pharma AG 14/09 Biermann Verlag 14/08 BioResonator 15 B/54 Bio Tech 14/04 Block Optic Ltd. 15 A/16 BOD EF/22 Bohus Biotech AB 15 B/51 bon Optic Vertriebsgesellschaft mbh 15 B/50 brumaba GmbH & Co. KG 14/15 Caruso & Freeland 17 B/43 Christoffel-Blindenmission 17 B/56 CCS Pawlowski GmbH 17 A/31 Cochrane Eyes and Vision Group 17 A/22 Chibret GmbH 14/06 Clarity Medical Systems 17 B/34 concept ophthalmologie EF 17 Civilian Research & Development Foundation 17 A/21 CROMA-PHARMA Dtl. GmbH 15 A/04 Cataract & Refractive Surgery Today 17 A/23 CSO Costruzione Strumenti Oftalmici S.r.l. 15 B/50 Deutscher Blinden- und Sehbehindertenverband e.v. 17 B/50 Deutsche Gesellschaft für Gewebetransplantation ggmbh 12 A/17 Dioptex GmbH 12 B/28 DMG Deutsche Myastenie Gesellschaft e.v. 17 B/74 Dockx Medical B.V. 17 B/67 DOMILENS GmbH 15 B/41 DOMS Eye-Technology GmbH & Co. KG 17 A/31 D.O.R.C. International b.v. 12 B/33 Deutsche Uveitis Arbeitsgemeinschaft e. V. 17 B/63 Hall Area/Number Sponsors and Exhibitors

350 346 WOC 2010 Sponsors and Exhibitors Sponsors and Exhibitors Company Hall Area/Number Dual Laser Ltd. OY 15 B/52 European Journal of Ophthalmology EF/07 Ellex 14/12 Elektronik & Präzisionsbau Saalfeld GmbH 17 A/31 ESCRS EF 05 EVER EF 14 Eyemaginations 12 A/01 Eyemetrics Optic Service AG 15 A/16 Eyetec GmbH 15 A/16 FCI France Chirurgie Instrumentation 12 B/27 Ferrara Ophthalmics 12 B/26 FIDUS 12 B/39 Frastema S.R.L. 17 B/42 Gebauer Medizintechnik GmbH 17 B/77 GEUDER AG 15 A/17 Grüner Laser Products GmbH & Co. KG 15 A/05 Haag-Streit International 13/01 Heidelberg Engineering GmbH 15 B/44 Heine Optotechnik GmbH & Co. KG 17 B/70 Albert Heiss GmbH & Co. KG 12 B/20 Heuser Ophthalmologie und Medizintechnik 12 B/31 HEXAL AG 14/03 HOYA Surgical Optics GmbH 14/14, 15 A/01 HumanOptics AG 12 B/22 Icare Finland Oy 15 A/20 ICO International Council of Ophthalmology EF 06 ifa Systems AG 12 A/18 Initiative Auge e.v. Main Foyer ICC Insight Instruments, Inc. 12 A/06 integration.ag 12 A/18 IOA International Orthoptic Association 17 A/24 IRIDEX Corporation 15 A/07 ivis Technologies s.r.l. 17 B/45 Jaypee Brothers Medical Publishers Pvt. Ltd. 17 B/29 JCAHPO 17 A/18 Jen-Ophthalmo 17 A/31 Katena Products, Inc. 15 A/02 Keeler Ltd. 15 A/27 Kowa Europe GmbH 15 B/50 Franz Kuschel 17 B/72 LCA Pharmaceutical 15 B/40 Leica Microsystems AG 15 A/32 Lightmed Corporation 17 B/68 LUMENIS (Germany) GmbH 17 B/33 Dieter Mann GmbH 15 A/08 Mani, INC. 15 B/36 MEACO EF 02 Medizingeräte + Chirurgiebedarf GmbH 15 A/30 Mathme Eye Bank Eye Hospital India 17 A/20 med_tec Medizintechnik Vertriebs-GmbH 15 A/19 MEDA CO., LTD 17 B/76 Medical Workshop 12 B/42 Medicel AG 15 A/21 Medicontur Medical Engineering Ltd. 15 B/48 Mediphacos 12 A/07 MED-LOGICS, INC. 15 B/43 medways e.v. 17 A/31 Merck Sharp & Dohme 14/06 Metrovision 17 B/47

351 WOC Sponsors and Exhibitors Company Hall Area/Number Micro Technologie Ophtalmique SA 15 A/24 MID Labs, Inc. 15 A/29 Morcher GmbH 15 B/37 Moria SA 15 A/19 MSD 14/06 NeoMedix Corporation 17 B/54 NeoVista Inc 17 A/07 New World Medical, Inc. 17 B/75 Nidek Co., Ltd. 15 A/11 Novartis Pharma GmbH 14/11 Novartis Pharma AG 14/11 Ocular Instruments 15 A/06 Ocular Surgery News / SLACK EF 19 Oculentis GmbH 17 A/11 OCULUS Optikgeräte GmbH 15 A/10 OD-OS GmbH 12 A/05 Oertli Instrumente AG 15 B/45 OGI Ophthalmologische Geräte und Instrumente 12 B/42 OIS 17 A/15 OmniVision GmbH 12 B/37 OPHTEC BV 17 A/06 Ophthalmic Design GmbH 17 A/04 OphthaSWISS AG 15 A/34 OPKO Instrumentation 15 B/46 Optima Pharmazeutische GmbH 15 B/50 OptiMedica International Pte. Ltd. 17 A/12 Optitech Eye Care 14/02 Opto Global Pty Ltd 15 A/19 Optopol Technology 12 A/09 Optos GmbH 12 A/13 Optovue, Inc. 17 A/35 OTE Ophthalmology Time Europe EF 18 Peschke Medizintechnik GmbH 15 B/56 Pfizer Ophthalmics 12 B/35 Pharma Stulln GmbH 14/01 Plusoptix GmbH 15 A/33 Precision Vision 17 B/52 Prevor GmbH 15 A/22 ProRetina 17 A/17 PXE EF/21 Quantel Medical 12 A/14 Rayner Intraocular Lenses Ltd. 17 A/36 Reichert Ophthalmic Instruments 17 B/44 Right Mfg. Co.Ltd. 15 B/50 Roland Consult 15 B/35 Rowiak GmbH 12 A/17 Fritz Ruck 12 A/10 RUMEX International Co. 15 A/23 S. Karger AG Basel EF 10 Santen 16/01 Schairer 17 A/02 SCHWIND 17 A/03 SFO EF/15 SOE EF 16 SOE 2010 EF 16 Sonomed, Inc. 17 B/53 SOOFT Italia S.p.A. 15 B/50 Stiftung Auge Main Foyer ICC Surgitrac Co. Ltd. 15 A/25 Sponsors and Exhibitors

352 348 WOC 2010 Sponsors and Exhibitors Sponsors and Exhibitors Company SUZHOU KANGJIE MEDICAL INSTRUMENT CO., LTD. 17 B/28 Synergetics Germany GmbH 12 B/29 T.MED GmbH 12 A/10 Takagi Seiko Co., Ltd. 17 B/41 Théa 15 A/14 Georg Thieme Verlag KG 12 A/02 Thrombogenics 17 A/37 Titan Surgical 15 A/28 Tomey GmbH 15 B/55 Topcon Europe B.V 17 A/05 TRB CHEMEDICA AG 15 B/47 TRIOPTICS GmbH 17 B/49 Trusetal Verbandstoffwerk GmbH 12 B/32 U.S. IOL / Stephens Instruments 17 A/26 UFSK-International OSYS GmbH 12 B/23 Ulrich Zuhnemer KG 12 B/42 URSAPHARM Arzneimittel GmbH & Co. KG 12 A/11 Vision 2020 EF 11 Visiontech Medical Optics Ltda. 12 B/41 Volk Optical Inc. 15 A/27 VRmagic GmbH 15 B/42 W2O Medizintechnik AG 12 B/20 WEFIS GmbH 12 B/40 Wexler Surgical 17 A/38 WGA World Glaucoma Association EF 20 Wirmsberger & Böhm 17 A/01 Wisepress, Ltd. 17 B/73 WOC 2012 EF/01 WOC 2014 EF 04 Carl Zeiss Meditec AG 13/02 ZIEMER OPHTHALMIC SYSTEMS AG 17 B/40 Hall Area/Number Status: 29 April 2010 E-Posters and Internet Hall 17 Congress Bags Hall 17

353 349 WOC 2010 Industrial Exhibiton Plans

354 350 WOC 2010 Industrial Exhibiton Plans Plan Industrial Exhibition Overview

355 WOC Hall 12 Industrial Exhibiton Plans

356 352 WOC 2010 Industrial Exhibiton Plans Hall 15 Hall 15 Katena Croma Pharma AMO Abbott Ocular 15 A/04 Instr. Dieter Mann 15 A/06 Thea Oculus Nidek A.R.C. Eyetec / Block Optic Eyemetrics 1st Q Coffee Shop Geuder Domilens bon Optic Kowa Europe Optima C.S.O S.O.O.F:T Right On Ice Shop Peschke Santen Hall 16 Iridex 15 A/08 15 A/07 Grüner Laser Albomed OphthaSwiss Roland Consult Mani 1aMedico Bohus Dual Laser 15 B/38 15 B/51 15 B/52 Heidelberg Engineering 15 A/05 15 A/14 15 A/10 15 A/16 15 A/15 15 A/11 15 A/33 Leica med_tec Opto Global 15 A/19 Moria / Alchimia MTO Aeon Volk Titan MID Oertli Keeler Surg. Labs M+C VRmagic Med-Logics 15 A/27 15 A/28 15 A/29 15 A/30 15 B/42 15 B/43 15 B/45 TRB Chemedica Medicontur anteis 15 A/12 15 A/17 15 A/34 Plusoptix 15 A/32 15 B/55 15 B/56 15 B/35 15 B/40 LCA 15 B/41 15 B/36 15 B/37 15 B/44 15 B/50 asico 15 B/53 Tomey Icare Prevor Medicel 15 A/20 15 A/21 15 A/2215 A/23 15 A/24 15 A/2515 A/26 15 B/48 15 B/46 15 B/47 16/01 OPKO 15 A/02 15 A/03 Morcher Surgitrac BioResonator 15 B/54 Rumex

357 WOC Hall 17 Industrial Exhibiton Plans

358 354 WOC 2010 Industrial Exhibiton Plans Hall 14

359 WOC Entrance Foyer ICC Industrial Exhibiton Plans

360 With great pleasure, we invite our colleagues and the ophthalmic industry throughout the world to Sydney for the 2011 Congress of the Asia Pacific Academy of Ophthalmology. The Scientific Program Committee is assembling an exciting and stimulating scientific program, which will enable both comprehensive ophthalmologists and sub-specialists the opportunity to update their knowledge and skills. Australia and New Zealand have a long history of world-class expertise in clinical practice and ophthalmological research. This, combined with the warm and relaxed Aussie spirit, will ensure your Congress experience is professionally enhancing and personally rejuvenating. We encourage our global colleagues and the international ophthalmic industry to join us, to participate and to experience our unique Australian hospitality. Your journey to Sydney will be more than worthwhile, professionally and personally. A/Prof Ivan Goldberg Prof Frank Martin Prof Charles McGhee Congress President Chairman, Congress Chairman, Scientific Sponsorship and Exhibition Program Committee Scientific Program will include: International guest speakers on all subspecialties Live Cataract and Refractive Surgery Symposia Workshops Sponsorship and exhibition packages are now available. The floorplan is also available for preview and space selection. For more information on sponsorship and exhibition opportunities please sponsorship@apaosydney2011.com Your invitation to Sydney in Key Dates Registration and Abstract Submission now open online Abstract submissions deadline 22 October 2010 Early-bird registrations close 15 January ASIA PACIFIC ACADEMY OF OPHTHALMOLOGY CONGRESS MARCH 2011 SYDNEY CONVENTION AND EXHIBITION CENTRE / SYDNEY AUSTRALIA AN INTERNATIONAL FOCUS ON OPHTHALMOLOGY

361 WOC Information from A to Z A Accommodation/Hotel Reservation Berlin's hotel landscape is one of the most up-do-date in Europe. In the last 10 years the number of hotel beds in the city has more than doubled. Berlin now has nearly 100,000 hotel beds at its disposal. Almost all the large hotels chains are already present on the Spree or plan to come to the German capital. Hotel rooms in various price categories have been booked for WOC 2010 by HRS, the worldwide hotel reservation service. Information The HRS homepage is available in 32 languages. The list of search result can be tailored according to different search criteria such as distance to the congress venue, hotel category, currency etc. You will also find more information by clicking on the hotels listed after your request. Hotel reservations can be made via HRS at the congress website Furthermore, the participants of the WOC 2010 have the possibility to book one of the three headquarter hotels, Westin Grand, Adlon, Hilton, see also at B Business Center The Business Center of the ICC is situated in the entrance hall and offers a full range of services including faxing, copying, printing, telephone cards, etc. Opening hours during WOC 2010: From 08:00 to 18:00 (on 9 June until 14:00). C Cancellation Policy Cancellations of registration will only be accepted in writing sent to the PCO by or fax. The notification must include all relevant information regarding the bank account to which a possible refund may be remitted. In case of cancellation before 10 May 2010 registration fees will be refunded minus a handling fee of c 50. After this date there will be no refund. Car Park A total of 12,000 parking spaces are available on and around the grounds. The parking garage of the ICC provides 650 parking spaces. Elevators and cash desk machines are located at the south entrance of the ICC. Prices are as follows: Rate per hour: c 2.00 / Rate per day: c 7.50 Climate Berlin enjoys pleasant, sunny summers when days are long and temperatures can sometimes exceed 25 to 30 C, also in June. However the summer months are also unpredictable and days can rapidly change from sunshine to cloud. Rain can fall all year round. Cloak Room Services for checking in coats and luggage will be available in the entrance hall of the ICC. Clothing Clothing is informal for all occasions. Raincoat and umbrella might be helpful. CME Credits/Certification The congress will be accredited by the respective Accreditation Council for Continuing Medical Education for Germany and Europe to provide continuing medical education credits for physicians.

362 358 WOC 2010 Information Information from A to Z Congress bags Every participant will get a voucher for one congress bag which can be picked up in Hall 17 b. Congress Organizer Professional Congress Organizer (PCO) Please do not hesitate to contact the PCO if you require any additional information or assistance. Porstmann Kongresse GmbH (PCO) Alte Jakobstr Berlin,Germany T F E pco@woc2010.de Opening Hours of the PCO Counter on site Wednesday, 2 June :00 to 18:00 Thursday, 3 June :00 to 19:00 Friday, 4 June :00 to 18:30 Saturday, 5 June :30 to 18:30 Sunday, 6 June :30 to 19:30 Monday, 7 June :30 to 18:30 Tuesday, 8 June :00 to 18:30 Wednesday, 9 June :30 to 14:00 Telefon (on site) T F Congress program The final program of the WOC 2010 will be available in the congress bags (Hall 17 b). Congress Venue ICC - Internationales Congress Centrum Berlin Messedamm Berlin Germany Currency The currency in Germany is Euro (c). Please visit for the latest currency rate. E Electricity In Germany electricity is supplied at 220 V/50 Hz. Please note that for some devices from foreign countries converters will be needed. Exhibition The commercial exhibition will be located in halls 12, 13 and 14, 15, 16 and 17 of the Berlin Fairground (Messe Berlin). The exhibition area will also house catering areas and the poster exhibition from Friday through Tuesday. The opening hours of commercial exhibition are as follows: Friday, 4 June :00 17:00 Saturday, 5 June :00 17:00 Sunday, 6 June :00 17:00 Monday, 7 June :00 17:00 Tuesday, 8 June :00 17:00

363 WOC Information from A to Z H How to travel to Berlin by plane, by train, by car By Plane 75 different airlines operate flights to Berlin from112 destinations in 44 countries. Berlin has two airports: Tegel Airport (TXL) in the North-West of the city. Distance to City West: 5 km/ to City East: 8 km Schönefeld Airport (SXF) in the South of Berlin. Distance to City West: 22 km/ to City East: 18 km Information By Train Berlin can by easily reached from all directions by rapid InterCityExpress (ICE), InterCity (IC), EuroCity (EC) and InterRegio (IR) trains. central stations are Hauptbahnhof and Ostbahnhof. Travel time from... to Berlin (ICE connections) Departure from Amsterdam Brussels Düsseldorf Frankfurt /Main Hamburg Cologne Copenhagen Leipzig London Munich Paris Prague Warsaw Vienna Zurich Travel time 6 h 7 h 40 min 4 h 09min 3 h 29min 2 h 10min 4 h 18min 7 h 25min 1 h 31min 10 h 32min 6 h 19min 9 h 09min 5 h 5 h 49min 9 h 49min 8 h 17min More information is available at the counters of the Deutsche Bahn (DB) and on the homepage By Car The motorway network radiates out of Berlin in the form of a star. From Munich, Frankfurt/Main and Dortmund use the A 10 Berliner Ring then the A 115 (Avus) Stadtautobahn (citymotorway). From Hamburg or Rostock use the A 10 then the A 111. From Dresden, Cottbus and Frankfurt/Oder use the A 10 then the A 113 and A 100. Please note that for all cars a special sticker is required to drive into the city centre since Berlin has been declared as environmental zone on 1st January The ICC is located outside of the environmental zone. Further information also in English available at: you

364 360 WOC 2010 Information Information from A to Z K Kids Club - Room 35, ICC In order to support the work life balance, the WOC 2010 is offering day care for children up to the age of 14 years. Accordingly furnished rooms will be available in the congress center where professional and certified educators will offer your children an attractive and varied program. As the number of places is limited we recommend you to register your child in time. Last minute registration for your children will be possible on site, please come to the PCO counter in the ICC. Opening hours 3 June - 9 June 2010, 08:00 am - 06:00 pm L Language The official language of the Congress is English. No simultaneous interpretation will be offered. AAD in German, WOC in English Liability The PCO Porstmann Kongresse GmbH acts solely as an agent and is not liable for any losses, accidents, injuries to persons or damage to property of any kind. This does not affect the liability of persons or companies charged with providing the relevant service. Oral arrangements require a written confirmation. The sole court of jurisdiction is Berlin. Delegates accept the above mentioned conditions by registering for the congress. Local time Germany is on Central European Time (CET) and is one hour ahead of Greenwich Mean Time, 6 hours ahead of Eastern Standard Time and 9 hours ahead of Pacific Standard Time. Summer Time extends from the last Sunday in March to the last Sunday in October. P Parking A total of 12,000 parking spaces are available on and around the grounds. The parking garage of the ICC provides 650 parking spaces. Elevators and cash desk machines are located at the south entrance of the ICC. Prices are as follows: Rate per hour: c 2.00 Rate per day: c 7.50

365 WOC Information from A to Z Press Service The press office staff welcomes all journalists to the WOC 2010 congress in Berlin, Germany. Journalists will be admitted free of charge and may participate in all sessions. A valid press card is necessary for your registration which will be accomplished in the press office (rooms 31, 32, 33 on the East Gallery) where you will also receive your conference badge. All necessary information regarding the conference, its speakers, press conferences as well as background material will here be available as well. The press office can be used as a workplace. Information On-site Press Office Our Opening Hours: Thursday, 3 June :00 to 18:00 Friday, 4 June :00 to 18:00 Saturday, 5 June :00 to 17:00 Sunday, 6 June :00 to 18:00 Monday, 7 June :15 to 17:00 Tuesday, 8 June :15 to 17:00 Wednesday, 9 June :15 to 14:00 Our Contact Data on site: T +49 (0) F +49 (0) Our Contact Data: Press Office WOC 2010 Silke Stark/Corinna Spirgat P.O.B Stuttgart, Germany T +49 (0) or -293 F +49 (0) E stark@medizinkommunikation.org, spirgat@medizinkommunikation.org The WOC 2010 press office staff is available before, during and after the congress. Journalists who are interested in interviews with speakers or specialists or need additional background information should contact the press office. Camera crews are kindly asked to pre-register with the press office as well. Official WOC 2010 Press Conferences Press Conference WOC 2010 Date: Thursday, 3 June 2010, 12:00 to 13:00 Room: Radio Tower Lounge 2 (At the radio tower courtyard: entrance Kleiner Stern, access via hall 17) The press conference is held in German. International Press Conference WOC 2010 Date: Tuesday, 8 June 2010, 12:15 to 13:15 Room: ICC Berlin, Room 43 (located on the press level on the walkway) The press conference is held in English. EuroTimes, official media partner WOC 2010 Mr. Colin Kerr ESCRS, Temple House Temple Road Blackrock, Co Dublin Ireland T: F: escrs@escrs.org

366 362 WOC 2010 Information Information from A to Z R Registration Membership of the German Society of Ophthalmology (DOG)/Professional Association of German Ophthalmologists (BVA) or confirmation of any oral presentation, video or poster does not automatically include the registration for the WOC Therefore, all members of the DOG/BVA and all speakers are requested to register prior to the congress. Registration can be made solely online. Please note the registration and payment terms. Bookings that are liable to pay have to be balanced immediately by credit card or direct debit payment (only for German bank accounts) at the end of the registration. Your billing information including credit card numbers will be automatically encrypted by SSL and therefore prevent any unauthorized or unscrupulous persons from prying into the transmission. Please register via the congress homepage After having completed your online registration you will automatically receive an invoice including a booking confirmation and your personal barcode via . Please print this barcode. The barcode will enable you to print your name badge at a self-service terminal on site without having to line up. Registration Fees On-site registration fee from 11 May 2010 Entire congress Delegates c 650 Members of the German Society of Ophthalmology c 325 (DOG)/ Professional Association of German Ophthalmologists in Practice (BVA) Residents 1 c 525 (up to 35 years of age) Students 1 c 70 Accompanying Persons c 70 Industry and Research Attendees c 650 Day Ticket/Pass c 250 (available for one day only) Day Ticket/Pass for Members of the DOG/BVA c 125 (available for one day only) WOC toberfest c 80 Children from 7 to 14 years c 25 (free up to 6 years) 1 Residents/Students: The barcode will not be activated before a valid certificate (official certificate of the head of department including the date of birth/ student ID valid for June 2010) will have been submitted via (pco@woc2010.de) or fax ( ) to Porstmann Kongresse GmbH. Late submission will not be accepted. Please send your certificate at your earliest convenience after online registration.

367 WOC Information from A to Z Registration of Groups Registration of groups can be made via the congress website by using the official registration system. Please add new participants via one main account and use personal addresses in order to create personal barcodes for each participant. If you have any question or need assistance, please contact the PCO via pco@woc2010.de Restaurants, Bars and Nightlife Berlin is a dynamic, cosmopolitan and creative city and the capital of Germany. East meets West, tradition and innovation coexist in the metropolis at the heart of a changing Europe. Berlin is characterized by its turbulent past and offers today a multitude of cultural places of interests, restaurants as well as a vibrant nightlife. Please find several recommendations and addresses on the congress website at Information S Sightseeing A number of sightseeing tours will be offered by Interklassik Concierge & Event GmbH, see at or send an to woc2010@interklassik.de. Interklassik provides also tickets for theatre, opera or other cultural events. Sponsorship Opportunities & Exhibition See the Sponsor s and Exhibitor s list on page 345. For details, please contact: Mr. Thomas Hausfeld th@woc2010.org Smoking Policy Please note that smoking is prohibited in the Congress Center. T Transportation Berlin offers excellent public transportation facilities. The BVG, Berlin s public transport system, operates Bus, U-Bahn (underground) and S-Bahn (city train). To go to the ICC from the city it is necessary to use the ticket for the AB zone (single fare ticket), there are several stops (Bus, U- and S-Bahn) nearby. The ICC is located next to the city motorway close to the Kaiserdamm in the West of Berlin. Fare Zone AB Short trip c 1.30 (up to three stations with U- and S-Bahn or up to six stations with bus and tram) Single ticket c 2.10 (valid two hours in the same direction, zone AB) 4-Trip Ticket c 8.00 (valid two hours in the same direction, zone AB) Day ticket c 6.10 (valid to 3:00 hrs at the following day, zone AB) 7-Day Pass c (The 7-Day Pass is valid on seven consecutive calendar days. Validity begins on the first day of the validity period printed on the card or from the time of validation and ends on the seventh calendar day, at 24:00) Please note that Schönefeld Airport is out of the fare zone AB. A ticket for the fare zone ABC (c 2.80) has to be bought in order to get to the congress venue or to the city center. (Day ticket zone fare ABC, c 6.50). Further information:

368 364 WOC 2010 Information Information from A to Z Arrival at the venue ICC by using public transportation: U-Bahn / S-Bahn / Bus In the direction of Stop / Station line number U2 S+U Pankow < > U Ruhleben Kaiserdamm S41 Circle line (clockwise) Messe Nord/ICC S42 Circle line (counterclockwise) Messe Nord/ICC S46 Königs Wusterhausen < > Westend Messe Nord/ICC S75 Wartenberg < > Spandau Messe Süd (Eichkamp) S5 Strausberg Nord < > Olympiastadion Messe Süd (Eichkamp) BUS M49 BUS X34 BUS X49 BUS 104 BUS 139 Heerstraße/Nennhauser Damm < > S+U Zoologischer Garten S Messe Nord/ICC Kladow, Kaserne Hottengrund < > S+U Zoologischer Garten S Messe Nord/ICC Staaken, Hahneberg < > S Messe Nord/ICC S Messe Nord/ICC Neu-Westend, Brixplatz < > Stralau, Tunnelstraße Messegelände/ICC Hakenfelde, Werderstraße < > S Messe Nord/ICC S Messe Nord/ICC A search function on the BVG website helps you to individually organize your journey by public transport:

369 WOC

370 366 WOC 2010 Information Information from A to Z Tourist Information Berlin WelcomeCard This special offer contains a public transport ticket for the City Railway (S-Bahn), subway (U-Bahn), tram and bus, plus local train services, for 2, 3 or 5 days in Berlin or in Berlin and Posdam. The WelcomeCard also provides savings of up to 50 % on over 140 top sights and cultural highlights. Berlin (AB fare zones incl. Tegel Airport) Valid for one Person Berlin and Potsdam (ABC fare zones incl. Tegel and Schönefeld Airports) (Children under 6 years travel free) Valid for one adult and max. 3 children up o 14 years 48 hrs for c hrs for c hrs for c hrs for c 25 5 Days for c days for c 34,50 Please find further information at

371 WOC Information from A to Z V Venue The World Ophthalmology Congress WOC 2010 will be held at: ICC Berlin (Internationales Congress Centrum) Messedamm 22, Berlin, Germany Information For more information, please visit the ICC website The ICC Berlin (Internationales Congress Centrum Berlin) ranks among the biggest, most advanced and most successful congress venues in the world. With its 80 halls and rooms seating between 20 and 9,100, its versatile facilities, superb technical installations and comprehensive range of services, ICC Berlin is the perfect choice for any convention, show or concert.

372 368 WOC 2010 Information Adverts Inside Front Cover Inside Back Cover Outside Back Cover 2 Allergan Inc. Pfizer Carl Zeiss Meditec AG Alcon Laboratories, Inc. 216 APAO APAO ARVO 52 Der Augenspiegel 6 Bausch & Lomb 90 DGII DOC Dr. Kaden Verlag 62 EVER International Council of Ophthalmology (ICO) 38 Merck Sharp & Dohme 128 Novartis Pharma GmbH 40 OCULUS Optikgeräte GmbH 66 Ophthalmology Times Europe 20 Pifzer 132 SFO SIXT 264 Springer-Verlag GmbH 42 Star Alliance 30 WOC WOC 2014 Bookmark International Council of Ophthalmology (ICO)

373 WOC A Abari E. Abbott R. L. Abboud E. Abdeen Z. Abdou A. Abdul Karim M. N. Abdul Majid A. S. B. Abdul Rahman R. Abe H. Abe S. Abegão Pinto L. Abiose A. Abramoff M. Abrams J. Abramson D. H. Abramyan A. Abri S. Abu A. Abu El Einen K. G. Abu El Ela M. H. Abu N. Abuh S. Acar S. Accorinti M. Ach T. Acheampong A. Acidereli E. Ackermann P. Ackland P. Aclimandos W. Acosta R. Adamis A. P. Adelman R. Ademola-Popoola D. Adenis J.-P. P-SU-258 P-SU-260 P-TU-243 P-TU-254 SU SU-76 SU MO-57 ES-05 ES TU WE TU P-MO-147 P-TU-198 P-TU-054 MO P-SA-259 P-SA-259 P-TU-063 P-TU-182 P-MO-034 P-MO-042 P-SU-017 P-SU-115 MO P-MO-050 SU SA SU SU-74 TU-56 TU TU SA MO WE P-SA-160 SU P-SA-096 MO WE P-SA-132 P-SU-134 WE P-SA-057 P-SU-025 TU P-SA-177 P-TU-203 P-TU-244 SU TU MO MO FR MO MO-55 MO MO MO SA TU WE TU-06 TU TU WE Adenwala A. P-MO-052 Ader M. P-SU-266 Adhami-Moghadam F.SU Afia M. P-MO-244 Aftab S. A. P-MO-202 Ağaçhan A. Agafonova E. Agarwal A. Agarwal A. Agarwal P. Agarwal R. Agdeppa M. C. G. Aggeli S. Agni A. N. Agorastos A. Agostini H. T. Agrawal D. Agrawal S. S.-M. Aguilar E. Ahlers C. Ahmad A. Ahmad I. Ahmed I. K. Ahmiti I. Aiello L. P. Aihara Aisenbrey S. Ajaiyeoba A. Ajayi B. Ajayi B. G. K. Akahoshi T. Akar M. Akesby J. Akgül H. Akhrorova Z. Akin T. Akova Y. Al Alawi E. K. Al Arrayed H. Al Hajj-Ali M. Al Sawidi K. Alam R. Alarcón I. I. P-SA-143 MO SA-07 SA SA SU SU TU TU-46 WE-17 WE P-MO-227 WOC-C SA TU MO MO TU P-TU-013 P-MO-190 P-MO-214 P-MO-155 TU P-TU-056 TU Po-MO P-SA-070 P-SA-161 P-MO-236 P-TU-246 WOC-C-55 WOC-C WOC-C P-MO-279 MO TU MO TU P-SA-196 P-TU-185 P-MO-044 P-MO-051 P-MO-054 MO SU MO-73 TU-13 TU TU P-TU-140 MO LS MO MO WE WE WE WE SU WE SU MO MO MO P-TU-126 P-SU-205 P-MO-003 SU SU SA P-MO-275 MO P-MO-001 P-MO-004 TU Alarcon R. Albert T. Albis-Donado O. Albou-Ganem C. Al-Deiri B. Al-Faky Y. Y. M. H. Alfayez M. Alfonso J. F. Alge-Priglinger C. Alghadyan A. Alió J. L. Alipour F. Aliyeva S. Aljazzaf A. Allemann N. Allen D. Allikmets R. Almazan A. Alonso Aliste F. Alonso Mesonero M. Alp H. Alqahtani J. AlRajhi A. Al-Rashed W. Alsaeidi R. Alsuhaibani A. Al-Swailem S. Altaweel M. M. Alten F. P-TU-014 SA SU P-MO-046 TU P-TU-020 P-SU-211 P-SU-250 TU SU MO-15 TU-74 P-SA-202 P-SA-205 P-SU-263 SA SU-10 SU SU-13 SU SU SU MO-15 MO MO-39 MO MO MO-66 MO MO TU TU-39 TU TU TU TU TU TU TU TU TU WE-01 WE WE-18 P-MO-099 P-SA-063 P-TU-010 P-TU-013 P-TU-024 WOC-C TU MO P-MO-061 P-TU-188 MO TU SA MO WOC-C SU P-SA-192 P-SA-021 SA-19 SU MO-30 MO-64 WE-16 P-SA-058 P-SU-228 TU P-SU-228 SU P-MO-013 MO P-SA-197 Author Index

374 370 WOC 2010 Author Index Al-Turbaq A. Alvarez de Toledo J. P. Alves M. R. Alwan A. Amado D. Amansakhatov S. Amar R. Amaral A. Amazigo U. Amberger R. Ambrecht A.-A. Ambrósio Jr. R. Amde W. Amina B. Amini P. Amiryan A. Amissah-Arthur K. Amjad M. Amjadi A. Ammar D. A. P-MO-020 P-SA-056 P-SU-081 SU SU SU TU SU WE WE SU TU MO P-MO-050 SU TU WE SA SU TU BS P-TU-224 P-TU-139 TU SA MO P-TU-032 P-SA-261 P-SU-150 P-SA-061 P-MO-058 P-MO-059 P-SU-144 Amorim M. Amouroux-Gicquel N. SU Amparo F. P-TU-013 SA Amr A. P-MO-177 Amr K. A. P-SU-050 Amrani Y. P-TU-189 Anderson L. D. TU-66 Andrade R. E. MO P-SA-271 Andrew E. TU Andrews R. TU Andrews R. SU-38 MO Androudi S. MO MO P-MO-248 P-SA-012 Ang C. L. P-MO-084 Ang M. P-SA-264 Anggraini N. P-TU-104 Angi M. MO P-MO-224 Anglade E. SU Ann H. J. P-SU-085 Annaka M. P-SU-037 Ansari G. P-MO-211 Ansari-Astaneh M.-R. SU Anticic M. TU Antipova J. WE Antoniadis M. P-SA-012 Apte R. TU Arafa L. SA Araie M. MO-22 MO TU TU Arakaki Y. Aral H. Aramberri Agesta J. Arantes T. P-SA-120 P-SA-123 P-SU-233 SU P-SA-274 P-TU-206 SU Arat Y. P-SU-228 Archer T. C. SA TU TU P-MO-111 Arden G. MO Arevalo J. F. SA-41 SA SA SU MO MO TU WE-29 WE Arıcan G. Ö. P-SA-128 Arikan G. P-MO-234 P-TU-061 Arimura E. P-SA-106 P-SA-109 Arintawati P. P-MO-010 Arliani N. SA Armitage J. O. SU-19 SU TU TU TU-81 Arnold A. C. WE-41 Arranz-Marquez E. P-MO-117 Arruda Mello P. A. P-TU-206 Arrufat S. SU Artal P. SA-05 SA SU Arteaga A. P. TU-25 WE Artes P. MO Arthurs B. P-SU-231 Artini W. P-SA-118 Artunay O. MO Aryasit O. P-SU-229 Arzoallxhiu H. P-MO-209 Asahara T. P-TU-231 Asbell P. A. SU-09 Ascarza A. P-SU-237 Ashaye A. O. SU WE Ashraf El Desouky M. P-SU-214 Aslanova V. TU Asoklis R. TU P-MO-091 P-SA-181 P-TU-084 Asp S. SU Assaf A. P-TU-019 SA Astakhov Y. MO P-SA-203 SA TU Asteriades S. MO Astle W. F. MO-58 MO MO TU-66 TU TU Ataka S. P-TU-195 Ates O. P-MO-003 P-SA-192 Atsushi N. P-SA-126 Attar M. MO Attaran M.-S. P-MO-273 P-TU-255 P-TU-258 Attitich M. Auffarth G. U. Augsburger J. J. Augsten R. Augustin A. J. Augustin M. Aung T. Auw-Hädrich C. Avadhanam V. Averyanova O. Avetisov S. Avni I. Awe B. Awh C. C. Aydin P. Aylward G. W. Ayorinde O. Azad R. Azarpira N. Aziz R. A. Azizi S. Azuara-Blanco A. Azuma N. P-SA-008 SU-10 SU SU SU WE Po-MO P-SA-010 P-TU-008 P-TU-018 P-TU-025 P-TU-265 WOC-C-43 WOC-C-44 WOC-C-45 SU MO P-TU-094 WOC-C P-SA-277 MO-16 MO MO-72 MO SA P-SU-148 SA-31 SU P-SA-140 MO-33 MO SA SU P-SA-059 P-SU-007 P-TU-144 P-MO-290 TU P-SA-160 P-SA-096 TU TU SA MO-41 MO TU-08 TU TU TU-65 TU SU-48 SU-51 MO TU-23 TU TU-69 WOC-C-62 WOC-C WE WE-37 WE-38 WE WOC-C-58 WOC-C P-SA-278 P-SA-272 P-SA-192 SU-03 SU P-SU-124 P-TU-129 P-TU-200 P-TU-222

375 WOC B Baade A. Babak J. Babu K. Babu N. Bach M. Bacharach J. Bachert I. Bachmann B. Baddon C. Badeeb O. Bae E.-h. Baerveldt G. Bagheri A. Baig N. B. Baile R. Bailey J. Bainbridge J. W. B. Baiocchi S. Baiyeroju R. Bajaj M. Bakaeva T. Bakunowicz- Lazarczyk A. Balasubramaniam B. Baldeschi L. Baltz J. Banandur P. Bandello F. Banerjee D. Banin E. Banker A. Bao Y. Z. Barabino S. Baradaran-Rafiee A. Baragan E. Barajas H. Barak A. Baraki H. Baralić J. Baran I. Baranyovits P. Barbazetto I. Barbosa C. P. P-TU-196 SA SU P-MO-255 SA SU SU-11 SU WE P-SA-088 TU P-SA-224 MO TU P-MO-217 P-SU-054 TU SU SU-06 SU TU-30 SU SA P-SA-082 P-TU-169 SU MO P-SA-071 SU WE P-SU-242 P-SU-201 P-SU-049 SU P-MO-086 P-SU-252 SU-22 SU MO P-SA-186 SU SA-34 SA SU MO MO MO MO MO TU TU-35 TU WOC-C MO P-SA-096 MO SU SA SU-35 SU SU P-SA-003 P-SU-003 P-SU-008 WE-28 WE P-MO-201 P-TU-105 TU P-MO-147 MO P-SA-102 P-SA-274 Barisani-Asenbauer T. SU MO TU-50 TU Barisic A. P-MO-112 SU TU Barkana Y. SA SA Barleon L. P-MO-036 P-MO-039 Barraquer J. SU-70 SU SU SU SU SU SU SU SU WOC-C-40 WOC-C Barraquer M.-E. SU-70 SU SU SU Barraquer R. SU-70 SU SU SU WOC-C-40 WOC-C Barreto F. SU Barrows J. M. MO Barry P. SA-06 SA Barton K. SU MO-31 MO-65 MO MO TU WOC-C Bartsch D.-U. SA P-SU-266 P-SU-271 Bartz-Schmidt K. U. SA-06 MO MO-75 TU P-MO-170 P-SA-155 P-SA-170 P-SA-122 P-TU-119 WOC-C-41 WOC-C Basel C. Batoosingh A. L. Batta H. Battu R. Bauch A. S. Bauchiero L. Baudouin C. Bauer D. Bauer K. WE P-MO-071 P-TU-059 TU TU TU WE P-TU-218 SU P-MO-116 TU TU-31 TU-49 TU WOC-C-47 LS MO P-TU-048 Bauer L. MO Bauer S. MO Baumann B. MO MO TU Baumeister M. P-MO-019 Baumgarten S. SU Bäumler W. TU Baumüller S. P-MO-158 TU Bautista De Lucio V. M.P-SU-024 Bayramoğlu S. SA Beaconsfield M. FR SU-76 SU MO-11 TU-41 TU WE-32 WE-33 WE Bechir J. MO P-SA-249 P-SA-270 Bechrakis N. E. MO SU-34 SU WE-24 WE P-TU-089 P-TU-114 Beck S. P-SU-094 SA Becker L. P-SU-218 Becker M. P-TU-177 Becker M. D. SU-27 SU Bedri A. SA TU-42 Beger I. P-MO-196 Behar F. WE-15 WE Behrens A. TU Behrens-Baumann W. SU-28 SU WE P-MO-029 P-SA-112 P-SA-146 P-TU-057 P-TU-221 WOC-AAD-C-19 Beiko G. SA-27 SA TU WE Bek T. TU Bekibele C. SU WE WE Beko M. P-TU-071 Belfort Jr R. SA SU SU SU-40 SU-64 MO-03 MO MO-32 MO MO MO MO-50 MO MO Author Index

376 372 WOC 2010 Author Index Belfort Neto R. Belin M. W. Belinsky I. Belkin M. Bell K. Bellucci R. Belshi A. Beltaief O. Benchérifa F. Benelli U. Bengtsson B. TU TU P-SA-271 P-SA-274 P-SU-110 P-SU-208 P-MO-023 WOC-C MO SU SU P-TU-090 P-MO-121 P-MO-216 SU P-SA-111 MO SU-42 P-SA-079 P-TU-140 SU MO MO P-TU-189 Benharbit M. Benítez del Castillo Sánchez J. M. TU Bennett K. L. SA P-SU-188 Benz M. S. SU Benzimra J. P-SU-191 Berendschot T. T. J. M. TU Berger A. SU Berger W. P-SA-088 Bergin C. P-MO-028 Bergmanson J. TU Bergua A. P-SU-080 Berisha F. P-MO-049 Berit K. P-SA-060 Berna M. J. P-SA-182 P-SA-184 P-SA-185 Bernardes N. SU Berna-Thill M. P-SA-184 Bernd A. S. P-TU-219 Bernstein P. TU Berraho A. P-MO-066 P-SA-141 P-TU-140 Berrocal A. Berrut G. Berta A. Bertone C. Bertrand I. Berzas C. Besch D. Bessa Jr J. Bessler P. Best G. Beuerman R. Bever M. Bezditko P. Bhandary S. Bhargava M. WE P-SU-068 P-SU-028 SU-75 SU SA P-SU-151 SU-09 TU P-TU-036 P-MO-040 P-SA-145 P-SA-177 MO SU P-TU-196 P-SA-210 SA MO P-SA-054 P-SA-156 P-SU-236 MO MO P-MO-276 P-SU-274 P-TU-218 SU Bhatta S. Bhattacharyya B. Bhisitkul R. B. Bi X. Bialasiewicz A. A. Bianchi P. E. Bidaye S. Biewald E. Bigdon S. Bikbov M. Bikbova G. Binder C. Binder S. Birnbaum F. Birngruber R. Birulya I. Bischoff G. Bispo P. Bissen-Miyajima H. Bissmann W. Biswas J. Biswas P. Blakeman A. Blamires T. Blanch R. Blanco-Mateos G. Blasiak J. Bleeker J. C. Bleich S. Bloch K. Blomberg L. Blondeau F. Bloomer M. Blue M. Blum M. P-MO-202 P-SA-024 TU-23 TU P-SU-234 P-TU-087 P-TU-115 SU SA-14 SA Po-SU SA SU MO P-TU-055 P-SA-239 P-TU-123 P-SA-182 P-SA-185 P-SA-085 TU P-SA-085 TU TU SA-03 SA SA-32 SU TU TU-45 TU-48 TU P-TU-176 MO-30 MO TU-81 Po-MO P-MO-038 SU-38 MO TU P-SA-186 P-TU-196 SA SA SA-14 MO-59 MO P-MO-098 SU-14 SU P-SA-004 P-SA-037 P-SA-077 MO-74 MO TU WE-30 WE P-SU-189 WE SU P-TU-198 MO SU SU P-SA-099 SU SA P-SU-068 SU P-SA-027 SU P-MO-014 TU Po-TU P-SA-077 Blumenkranz M. S. Bobisch N. Bobrova N. F. Bock R. Bodaghi B. Boehm N. Boeker T. Boes T. Bohac M. Böhm M. R. R. Bohorquez V. Böhringer D. Boiko E. V. Bojic L. Böker T. Bokhorst A. G. Boland M. Bolintineanu C. Bolintineanu S. Bolz M. Bönig H. Boniuk M. Booth A. P. Bopp S. Borasio E. Borderie V. MO MO MO MO TU TU-54 TU P-TU-157 SU-55 SU P-SA-078 P-SU-239 P-TU-138 P-TU-166 SA SA SU-27 SU-33 SU MO TU-50 TU TU-60 TU TU-83 WE MO P-SU-094 P-SU-204 SA WOC-C SU P-MO-112 SU SU P-TU-044 P-TU-213 P-TU-014 SA SU-19 SU SU TU P-MO-038 P-MO-236 P-MO-294 P-SA-068 P-SA-070 P-SU-045 P-TU-043 P-TU-047 WE P-SU-075 WOC-C TU SU SU WE P-SU-002 P-SU-005 P-SU-002 P-SU-005 MO P-TU-232 WOC-C P-SU-041 P-SU-228 TU Po-MO P-SA-170 MO TU-19-06

377 WOC Bornfeld N. Borooah S. Borras T. Borruat F. Bort B. Bösch M. Boscia F. Botabekova T. Botbaev A. Bottós J. Boucard C. Bouhaimad M. Boulanouar A. Boullanger D. Bourmani O. Bouzouaya C. Boyer D. S. Bradley J. Branchevskiy S. Brandenbusch T. Brandlhuber U. Brandt S. Bras D. Bräuer L. Braun B. Braun J. Brazitikos P. Bredow L. Breitstadt R. Breitwieser F. P. Brennan M. W. Bresse X. Bretthauer G. Brewitt H. Breyer D. R. H. Brezin A. P. Brian G. Bridges L. Brinkmann C. K. Brinkmann R. SU-39 SU SU SU MO MO-77 MO TU-09 TU-22 WE P-SA-239 P-TU-112 P-TU-116 P-TU-123 P-TU-126 WOC-C-36 WOC-C P-MO-270 MO SU WE P-MO-245 P-TU-049 TU P-TU-158 P-TU-002 SA P-TU-188 SU P-SU-228 P-MO-066 P-TU-185 P-MO-066 SU P-MO-198 TU TU P-SU-062 P-TU-097 P-MO-222 P-TU-017 P-SU-153 TU FR P-MO-102 SA P-SA-065 SU MO P-MO-248 P-SA-012 P-MO-294 P-SU-045 P-MO-039 P-SU-188 MO P-SU-068 P-SU-071 SA-27 MO MO P-SU-190 FR-01 SU P-SA-018 P-SA-030 P-MO-114 MO WE P-TU-146 P-SA-176 P-SA-197 P-SA-186 P-TU-196 TU Briszi A. Brock K. Brockmann M. Brodie A. Bron A. J. Brosius T. Brucker A. J. Brueckner K. Bruggemann A. Bruijning J. Brummeisl W. Brunken W. J. Brunner U. Brunotte I. Brüx S. Bu J. Bubalo D. Buchanan L. M Büchner T. Buchwald H. Buckhurst P. Buckley E. G. Buczak-Gasinska K. Budenz D. Budiene B. Budo C. Buehler A. Buehler K. J. Buhari S. Bühl W. Bühren J. Bukhari A. Bulgen M. Burau H. Burgess B. L. Burgess G. Burggraaff M. C. Burgoyne C. Burian G. Burk C. Burk R. O. W. Burke J. Burlutsky G. P-SA-011 SU P-SU-268 SU SA-20 SA SU-63 SU P-SA-162 SA-33 SU MO P-TU-006 SA P-TU-075 MO MO P-TU-243 TU P-SU-220 P-TU-048 P-SA-265 P-SA-231 P-SU-133 P-SA-220 P-SU-145 P-SU-196 P-SU-240 SU P-MO-141 P-MO-159 P-TU-009 P-TU-037 TU P-MO-109 P-MO-022 SU P-SU-178 SU MO P-MO-131 P-SU-001 MO-62 MO P-TU-259 SU MO P-TU-028 SA MO P-MO-019 P-MO-116 P-SA-157 P-TU-015 P-TU-016 P-SU-197 FR WE MO WE MO WE WE-39 WOC-C-31 WOC-C MO TU P-TU-060 WOC-C-31 WOC-C MO P-TU-199 SU Burnier M. N. Burr J. Burzer S. Busch M. Büschlepp E. Busin M. Busse H. Butkiene L. Butros S. Buznyk O. Buzzonetti L. Bynoe L. Bytton Díaz L. C. Byun Y. J. C Cagıl N. Cai J. Cairui L. Cakmak H. B. Caligaris L. Callahan D. Calvão-Santos G. Camargo J. F. Cameron J. Campos E. C. Canan G. Cantemir A. Cantor L. Canut I. Capo H. Capone A. Caporossi A. Caprioli J. Caramoy A. Cardoso Neto I. Carlisle-Wilcox C. Carollo G. Carassa R. Carlton J. Carrasco B. Carreño E. Carriazo C. Carter D. A. Cartwright D. Carvalho F. R. S. MO-33 MO SU-57 SU SA WOC-C SA MO P-SA-263 SU P-TU-044 P-TU-083 P-TU-084 P-MO-159 TU TU P-MO-161 MO P-MO-281 SA P-MO-002 P-MO-005 P-TU-106 P-MO-229 P-SU-267 TU P-MO-002 P-MO-005 SU SU P-SA-258 P-SU-273 P-SU-082 P-MO-270 SU SU MO TU P-TU-078 TU SU SU MO MO SU P-SA-071 SU TU TU TU-63 WE P-SA-214 TU P-TU-036 P-MO-014 P-MO-161 P-MO-291 SA SA SA P-SU-086 TU SU SU TU-74 P-SU-252 P-TU-151 P-SU-082 Author Index

378 374 WOC 2010 Author Index Carvalho Vasconcelos G. Casella A. M. Caspi R. R. Cassoux N. Castilla M. Castillon Torre L. Castin R. Castro-Navarro J. Castro-Paiz M. Cate H. Cavaglieri S. Cekić S. Ceklic L. Celestino de Almeida H. Celik Y. Cernák A. Çetin B. Cetkovska P. Ceyhan D. Ceylan O. Chadha S. Chai Teck C. Chakrabarti A. Chakravarthy U. Chamot L. Chan A. S. Y. Chan C. C. Chan C. K. Chan C. K. M. Chan C. M. L. Chan C. Y. N. Chan J. Chan K. Y. Chan P. Chan R. Chan S. Chan T. K. Chan T. K. J. Chan U.-t. Chandra M. Chandrakumar M. Chandran M. Chandra Sekhar S. Chang L. Chang S. Chang-Hua P. Chantzaras A. Chanudet E. Charalambos P. Charalel R. SU P-SU-112 P-TU-165 WOC-C-59 WOC-C WOC-C MO SU SU TU P-TU-247 MO P-MO-221 MO SU P-TU-165 P-SU-152 P-TU-191 P-TU-165 P-SU-106 SU-17 TU-19 P-SA-128 P-TU-113 P-SU-074 P-MO-003 P-SA-192 P-TU-198 P-SA-217 WOC-C-12 WOC-C WOC-C WOC-C MO-45 SU SU MO-76 TU-53 TU P-SA-252 P-SA-260 P-MO-246 TU SA SU MO P-TU-257 WE P-SU-216 P-SU-247 P-TU-160 P-SU-057 SU P-TU-202 P-SA-260 P-SA-093 P-TU-169 ES P-MO-030 P-TU-161 P-SU-242 SU P-MO-211 P-MO-086 MO MO P-TU-214 P-TU-093 SU P-SU-256 P-SU-148 WE Charbel Issa P. Charitoudis G. Charles S. J. Chatziralli I. Chaudhri A. Chaudhry I. Chauhan A. Chauhan B. MO P-MO-158 P-SA-176 P-TU-204 TU P-TU-114 P-MO-195 P-MO-174 P-SA-276 P-SU-035 TU P-SU-228 SU SU WOC-C-31 WOC-C SU TU P-MO-252 SU Chaum E. Chaumet-Riffaud P. Chavan R. Chaves Fernandes L. Chavez-Mondragon E. SU Chawla B. P-SU-242 Chee Chew Y. SA-44 SA Chee S. P. MO TU-60 TU TU-73 TU TU-83 P-SA-264 Cheeseman R. Chen C. Chen C.-Y. Chen D. F. Chen E. Chen H. S.-L. Chen J. Chen K.-J. Chen M.-J. Chen Q. Chen Rundle A. Chen S.-J. Chen T.-h. Chen X. Chen Y. Chen Y.-L. Cheng A. C. Cheng C.-Y. Cheng L. Chentsova E. Cheung C. Chew P. Chhabra M. Chi L.-c. J. Chiang F. Chiang M. Chiang S. Chibante J. Chibisova A. N. Chi-Burris K. Chin K. Chiselita D. Chiu H. Chiwitt C. Cho H. SU P-SA-201 SU P-SA-114 MO MO P-TU-081 SU P-SA-245 P-SA-114 P-MO-136 MO TU P-SU-067 MO SU P-SA-216 P-SA-221 P-MO-090 SU-60 TU P-SA-105 P-SU-067 SA SU SU SA P-SU-223 P-MO-257 WE SA-29 MO P-SA-252 P-SU-273 SU P-MO-063 TU SA-31 P-TU-078 P-MO-241 WE P-SU-148 P-MO-200 P-TU-234 TU Choi J. H. Chomicz L. Chong K. Chong L. P. Chong X. L. Chongpison N. Choo C. T. Choo M. L. Choo M. M. Chopovska Y. Choragiewicz T. Choritz L. Chou C.-K. Choudhary R. Choudhury K. Chow D. Chow L. Christmann S. Chryssafis C. Chrzanowska B. Chu D. Chu R.-Y. Chui J. Chun Y. S. Chung H. Chung S. K. Chung Y. Chunhong G. Ciechanowski P. P. Cilliers H. Cimbalas A. Cinatl J. Ciobanu I. Cisiecki S. Claerhout I. Claessens D. Claoué C. Claringbold T. Clark A. Clark M. E. Clarke J. C. K. Clemens C. Clemens S. Clemens V. Clifford L. Coady P. Cochener B. Cohen J. S. Cohn H. C. Colangelo L. Colenbrander A. P-TU-142 SU P-TU-162 P-SU-026 P-SU-222 WE-08 P-SA-140 P-SU-230 SA P-SU-245 P-SU-267 P-MO-280 P-TU-161 P-TU-186 P-SU-264 P-MO-260 P-SA-111 P-TU-076 P-SA-114 WE P-SU-189 TU P-MO-197 P-TU-095 MO P-SU-049 SU P-MO-119 P-SU-032 P-MO-284 P-MO-296 WE P-MO-139 TU P-MO-139 WE P-MO-041 WE P-MO-197 P-SA-181 MO P-SU-005 MO P-MO-207 TU P-SA-213 SU-13 SU WE WE P-SU-251 SA P-SA-195 TU SA SU Po-TU P-TU-118 P-MO-273 MO SU-36 SU TU-41 TU WE-32 MO TU MO-13 SU-42 WE MO-23 MO-23-01

379 WOC Colin J. Colinge J. Collin J. R. O. Colvard M. Conesa E. Congdon N. G. Conlon J. Constable I. Contarini P. Conte M. Conzelmann I. Coral-Ghanem C. Corcostegui B. Cordeiro M. F. Cordes A. K. SU-36 SU-58 MO-40 MO TU P-SU-188 SA SA-42 SA TU WE-12 WE WE-33 WE SU P-SU-083 P-SU-207 MO-51 MO WE-36 WE MO MO-56 TU TU SA SU WE WOC-C-07 WOC-C SU TU-15 TU TU TU P-MO-223 P-TU-157 P-TU-030 P-TU-153 SU SU Cornelissen F. Corrêa Z. M. Correa de Carvalho C. SU Correa Z. MO P-TU-094 Correia Ferreira L. S. P-TU-262 Corriveau C. MO Cortes M. TU Cortes Mora N. P-SU-086 TU Cortese M. SU Coscas F. WOC-C Coscas G. J. TU-29 TU TU-71 TU WE-11 WE WOC-C-61 WOC-C LS-08 Cos kun C. Costa E. Costa V. P. Costa-Ferreira C. Costagliola C. Coupland S. E. Couroucli X. P-SA-143 SU TU P-SU-144 P-MO-224 SU SU SU-67 SU MO-18 MO TU TU-53 TU SU Courtney R. SU Courtright P. SA SU MO P-MO-080 Couto Sacramento J. P-SU-112 Couturier J. SU Crabb D. P. MO Craig J. TU Crane I. J. SU Craven E. R. P-MO-071 TU Cremer C. P-SA-177 Creuzot-Garcher C. MO TU Cristóvão L. M. SU Crossland M. D. MO Crowston J. TU Croxatto J. O. TU WOC-C Cruysberg J. R. M. TU Cucera A. FR P-MO-182 P-MO-277 P-TU-033 Cui G. P-SU-136 Cui H. P-SU-110 TU Cui H.-P. WE Cullen J. MO Cumberland P. SU Cummings A. TU Cummings T. J. SU TU TU Cunha J. P. WE Cunha-Vaz J. MO-45 MO MO-61 MO TU-44 TU Cunnigham E. T. MO TU Cuny C. SA TU Curcio C. A. P-SA-187 P-SU-251 Curnow S. J. SU TU-17 Cursiefen C. SU-78 TU Po-SU P-SA-065 P-TU-050 P-TU-127 WOC-AAD-C-11 Cvenkel B. TU Cvintal V. SU Czepita D. P-SU-061 P-SU-063 Czeszyk-Piotrowicz A. P-MO-289 D da Silva J. Daftari I. Dahl P. Dai Y. Daito M. Dalz M. Damani M. Damar E. MO P-SA-211 TU SU P-SA-150 P-SU-073 P-SU-073 P-MO-211 P-MO-005 Damasceno R. Damato B. D. Dame G. Damgude S. D'Amico D. J. Damico L. A. Dana R. Danieliene E. Danielius R. Daniels J. T. Daniil Z. Danilova D. Daniyar D. Dannoue K. Daoudi R. Dapena I. Dar K. A. Dardenne C. M. Dart J. K. G. Darusman K. Darvish M. Das J. Das R. Das S. Das T. P. Dashevsky A. Dauletbekov D. Davari T. Davies S. Dawczynski J. Daxer A. Day S. H. Dayawansa K. de Abreu Melgaço S. De Benito-Llopis L. de Boer J. De Carvalho J. H. de Castro Moura Brasil L. de Faber J.-T. de Freitas D. de Groot J. De Groote J.-J. P-SU-241 P-SU-243 SU SU MO MO TU-22 TU TU WE P-TU-031 P-SU-195 P-TU-040 SA-36 MO-29 TU-45 MO SU SU SU FR MO P-SA-045 SU P-SA-262 P-SU-219 P-TU-189 TU P-SA-128 P-MO-114 SU-28 SU MO-35 MO TU P-SU-090 P-SU-231 P-TU-100 WE P-MO-279 P-TU-040 P-MO-279 MO SA SU P-SA-262 P-SU-165 P-SU-032 P-SA-277 SU P-SA-055 WOC-C-39 MO SU MO P-SA-273 P-TU-062 P-SU-112 P-MO-117 P-MO-143 MO SU P-SU-084 SU MO-69 MO MO MO-57 MO TU P-MO-023 P-SU-082 TU-83 P-MO-100 Author Index

380 376 WOC 2010 Author Index de Juan, Jr. E. TU de Keizer R. J. W. SU SU de Klein A. SU de la Cruz J. P-SA-073 de Laey J.-J. TU-11 de la Torre A. P-MO-006 de la Torre-Tovar D. P-MO-046 de la Paz M. SU de Matos L. P-SU-180 De Moraes G. V. MO MO SA de O. Regina M. C. P-SU-109 SU de Oliveira E. P-SU-180 de Ortueta D. P-MO-128 P-MO-140 De Pablo C. P-SU-083 P-SU-207 de Paula Fiod Costa E. P-SU-011 de Sá M. F. P-SU-084 De Smedt S. SU de Smet M. D. MO SU de Souza Pena A. WE Deak G. P-TU-232 Decaudin D. MO-76 TU Decker A. P-MO-245 Deeg C. A. TU P-SA-251 DeForge L. MO Deininger D. P-MO-286 Deissler H. TU Dejiao L. SA Deka S. P-TU-238 P-TU-249 Dekaris I. P-MO-112 SU SU TU Dekel I. SA Del Amo Freire J. P-SA-023 Del Monte M. A. SU-52 Dembovetskaya A. SU Demirok A. P-SU-198 Denaro R. P-SA-071 SU Deng L. P-SA-134 Denisova E. SU Derhartunian V. P-MO-116 Dermon C. P-SU-122 Desai P. TU Desch M. P-SU-268 Deschenes J. P-SU-231 Deshmukh S. P-TU-164 SU Deshpande A. P-SU-072 Desjardins L. SA-09 SA SU-39 SU MO TU WE-23 WE-24 WE WE-37 Deters C. P-MO-039 Dettbarn M. C. P-SA-166 Dettler N. P-SU-137 Deuter C. M. E. Deva J. Devgan U. Dexl A. Dharmasena A. Dhibi H. A. Dhillon B. Di Girolamo N. Diaz A. Diaz Barron A. Diaz-Llopis M. Dib E. Dichtl M. Dick A. D. Dick H. B. Dickenson A. J. SU MO TU-53 TU WE Po-SA P-SA-254 SA TU P-SA-028 P-SA-035 P-SA-044 P-TU-010 SA SU MO SU WE MO P-SU-032 P-MO-189 P-TU-210 MO P-MO-097 P-MO-189 P-SA-243 P-SA-266 P-SU-169 MO SU P-SU-252 SA SU-45 MO-19 MO MO TU WE WE-02 Po-SA WOC-C-43 WOC-C-45 SU MO-82 P-SU-012 Dieckow J. Diedrichs-Möhring M. P-SA-251 Diesenberger D. SU Diestelhorst M. Po-SA P-MO-065 Dietlein T. S. P-SA-013 P-MO-274 P-TU-066 WOC-AAD-C-02 Dietrich T. Dietzel A. Diez-Andino P. Dimaras H. Diniz B. Dirisamer M. Dithmar S. Djordjevic-Jocic J. P-MO-157 P-SA-124 P-TU-050 P-TU-194 SU SU SU WE P-SA-271 P-SA-274 SU SA-43 SA SU MO-03 TU P-MO-164 P-SA-177 P-SA-255 P-TU-203 P-TU-244 P-SU-098 Dmitriew A. P-TU-154 Do D. MO MO WE WOC-C Dobner B. P-SA-255 SU Dobrowolski D. MO SA SU Doga A. MO SU Dogra M. WOC-C-58 WOC-C Dolgoff R. MO Dolgopolov I. WE Dolz-Marco R. P-MO-189 Domack H. P-TU-034 Dombi T. P-SU-097 Domenghino I. P-TU-044 Domingues I. MO Dominika J. MO SA Dong C. SA Dong G. SU Donner R. TU Donshik P. MO TU D- ord ević J. P-SU-152 Dorecka M. TU Dorn V. P-SU-076 Dorrell M. I. TU Dorsey A. P-SU-254 Dou H. WE Doubal F. SU Doudou A. P-SA-012 Doughty M. J. SU Douglas R. TU Downie R. SU WE Doycheva D. P-SA-254 Draca N. TU Draeger J. A. SA Draganic B. P-SU-176 Dragomyretskaya E. P-MO-113 Drenser K. A. WE Drexler W. MO-61 MO Dridi M. J. P-SA-101 Drnovšek-Olup B. MO MO-78 Droggina G. P-SA-078 Droutsas K. TU Drozhyna G. P-SA-053 P-SA-098 Dryja T. P. SU Drzyzga L. P-MO-056 Du M.-Q. SU Dua H. S. SU-35 SU MO-17 MO TU Duarte Silva E. J. SU Dubovy S. MO Ducournau D. TU-01 TU Duerksen R. SU SU TU Dugel P. TU WE Duker J. S. WOC-C Dumbrova N. P-TU-166 Dunavölgyi R. MO-67-07

381 WOC Duncker G. I. W. Dunse M. Dupps Jr. W. J. Duquesnoy R. J. Dutton G. Dydykina S. Dzafarly T. Dzhumagulov O. Dziegielewski K. E Eagle Jr R. C. Eberwein P. Ebner R. Eckardt A. Eckardt C. Ecke I. Eckert S. Eckert T. Eckstein A. K. Edelman J. L. Edirisooriya J. Edmond J. C. Edward D. P. Eggert A. Eggink C. A. Eghtedari M. Egidio R. Eguchi H. Eha J. Ehlers W. H. Ehlken C. Ehmer A. Ehrhardt B. A. Ehrlich R. Ehrt O. SU-47 TU-21 TU TU P-MO-123 WOC-C-06 WOC-C-21 WOC-C-22 FR SU MO-39 MO WE SU-19 SU SA-10 SA SU TU P-MO-031 P-SU-069 MO SU MO FR P-TU-043 P-TU-047 WE WE MO P-SA-170 P-MO-062 Po-SA P-SU-200 P-SU-235 P-SA-170 MO SU-22 SU P-SU-246 MO P-SA-273 SU MO-43 MO MO MO TU P-TU-116 P-TU-123 P-TU-065 P-SA-238 P-SA-238 P-SA-090 P-SA-094 P-SA-232 TU TU MO MO MO MO TU-21 P-SA-161 P-TU-018 P-MO-184 TU SA-47 SA SU MO-51 Po-SU Eibl K. Eid Farah M. Einolahi B. Eisenbarth W. Eisenkoelbl S. El Alloussi T. El Danasoury M. A. P-MO-249 P-SA-173 P-SA-202 P-SA-205 P-SU-272 TU MO P-SU-011 SU P-SA-208 MO P-SA-200 P-MO-066 P-SA-141 P-TU-140 SA SA-26 SA SU-59 SU TU TU P-MO-129 WE TU P-TU-140 El Defrawy H. H. E. D. El Hage S. El Mrabh M. El Ouazzani Chahdi K. P-TU-189 El Seht R. P-MO-292 El Shorbagy M. S. P-MO-292 El Yamouni O. P-TU-140 El-Amir A. P-TU-032 El-Ashry M. WE El-Awady H. P-SA-142 El-Baz A. SA Elboraey M. G. E. WE Elfakey Y. SU Elflein H. P-MO-187 P-TU-147 WE Elhassan E. Elizabeth Hale J. Elizalde J. Elizondo A. El-Lakkany R. Ellis-Behnke R. G. Ells A. El-Maghraby A. Elmekawey H. El-Shabrawi Y. Elsherbiny S. Elshiwy H. E. Elzaridi E. Eming S. A. Emmerich K.-H. Enders C. Endl E. Endo T. Engel M. Engelbert M. Engelmann K. Engelmann V. Engin A. P-TU-259 TU WOC-C SU TU MO MO TU WE WE-16 P-MO-177 P-SU-050 WE P-SA-135 P-TU-212 MO P-SU-228 P-TU-254 P-SU-260 SU-71 SU MO-78 MO P-SU-248 P-TU-093 WOC-C-13 P-SA-208 MO TU P-SU-111 MO TU Po-TU P-MO-171 P-MO-228 P-SA-165 Engin K. N. Engle E. Enikeev A. Enoki M. Enzmann V. Eppelin A. Epstein D. Epstein D. Erb C. Erben A. Ergin M. Ergun S. Ermilov V. Ernest P. H. Erol N. Errais K. Ersoy L. Escobar M. Eshmambetov A. Eskelin S. Esmaeli B. España-Gregori E. Espinoza R. Esser J. Essig H. P-SA-128 P-SA-143 SA SA-45 SA MO P-SA-042 P-MO-064 P-MO-166 P-TU-178 MO TU TU-78 TU MO SU TU-13 Po-TU P-SA-148 P-SA-149 P-SA-263 P-TU-061 FR MO TU P-MO-242 P-SA-079 P-MO-065 P-SU-106 P-TU-199 SA MO SU TU P-SU-169 MO SU P-SU-246 MO SU Estermann S. P-SU-027 Estrada Rodríguez J. L. P-MO-183 P-MO-250 P-TU-041 Estu D. Eter N. Etualin González A. Etya'ale D. Eule C. Eun-kyoung K. Exarchou A. F Faal H. Faber D. Fabian E. Fahmy I. Fain J. Falk N. Fan J. L. Fan L. P-SA-118 MO TU TU-69 WE-34 WE P-SA-188 P-SA-195 P-TU-041 P-TU-131 SA SA-48 SA SU FR TU P-MO-214 SA SA P-MO-198 WE P-TU-011 P-SA-132 P-SA-100 SU P-MO-167 TU Author Index

382 378 WOC 2010 Author Index Fan X. Fan X.Q. Fan Y. C. Fang I.-M. Fang S. K. Fantes F. Farah M. E. Farah O. Faria e Sousa S. J. Fariduddin K. Farkas A. Farnworth D. Farooq T. Farrar J. Farvili E. Farzavandi S. Faschinger C. Fasina O. Fass O. N. Fatiha B. Fauser S. Faust M. Fazelipour S. Fazzi E. Fechtner R. Federov A. Federowicz A. Fedorov A. Fedorov A. B. Fehse B. Feinbaum C. Feiner L. Feke G. T. Felix C. Feltgen N. Feng X. Fengyuan S. Ferman-Atar G. Fernandes J. Fernandes L. C. SU SU SU MO P-SU-060 P-SU-193 P-SU-213 P-SU-221 P-SU-227 P-SU-234 P-SU-238 P-TU-102 SA-44 SA P-SU-066 P-SU-259 SA-30 SA SA-11 SA MO P-SA-089 P-MO-100 P-MO-101 P-TU-260 SU TU P-MO-273 P-SU-247 WE-15 WE SA MO P-SA-217 MO P-SA-135 WE SU P-TU-139 P-SA-214 P-SA-043 SU SA-10 SA MO WE-07 WE P-SU-153 P-SA-091 P-SU-201 SU SU P-SU-271 P-MO-024 P-SA-075 WOC-C-46 WOC-C WOC-C WOC-C MO P-MO-049 TU P-MO-236 P-TU-248 TU WOC-C-55 WOC-C WE SA P-MO-216 P-SU-068 WOC-C WOC-C Fernandes M. P-MO-285 P-MO-298 P-SU-030 Fernandez A. P. MO Fernandez de Benito F.P-MO-047 P-MO-093 Fernelius C. TU Ferrara D. Ferreira J. Ferrone P. Ferry J. Feucht N. Feuchtenberger M. Fiala W. Fichter N. Fiedorowicz M. Fielder A. Figueroa M. S. Filipek E. Filipi H. Filser E. Fimia A. Fimmers R. Findl O. Finger P. T. Finger R. P. Fingerle V. Fintelmann R. Fiol-Silva Z. Fiscella R. G. Fischer C. Fischer E.-M. Fischer F. Fischer M. D. Fischer-Harder K. Fishkind W. J. Fitt A. Fitzke F. W. FitzPatrick D. R. SA MO P-MO-050 P-SA-258 P-SU-273 WE TU SU P-MO-146 P-MO-205 P-SA-208 P-SA-233 SA TU P-MO-008 P-MO-110 MO P-SU-264 MO TU-66 LS TU P-MO-162 MO P-TU-007 P-MO-099 TU SU SU-16 SU MO TU TU MO TU-35 TU TU-40 TU P-MO-181 P-TU-109 P-TU-111 SU-64 SU SU-74 MO TU TU P-MO-086 P-SA-176 P-SU-058 P-TU-204 SU SU SA-16 TU P-TU-060 P-MO-222 P-SA-194 P-SA-148 P-TU-246 P-TU-219 WE SA-05 SA TU P-TU-020 TU P-TU-155 Flammer J. Flanagan J. G. Fleck B. Fleckenstein M. Fleming A. Fleming A. D. Fletcher D. C. Flöhr C. Flohr F. Flores-Limas S. Flühs D. Foeckler R. Foerster A. M. H. Foerster J. Foerster M. H. Fok A. Fong C. W. Fons Martinez R. Forlini C. Forlini M. Forminska- Kapuscik M. Foronda A. S. Forrester J. V. Förster C. Fortunato M. Foster A. Foster C. S. Foster P. Foster S. Foulks G. Fox K. Framme C. Franceschetti A. SA-12 SA SA MO-31 MO WE MO P-TU-148 P-TU-150 P-SA-176 P-SA-197 P-TU-183 WE SU TU TU TU-14 TU P-SU-240 P-TU-223 TU SU MO P-TU-126 P-MO-157 TU P-SA-214 SA-35 SU MO-24 WE WOC-C-60 WOC-C P-TU-089 P-TU-114 P-TU-202 P-MO-169 P-TU-210 SU MO TU WE WE P-MO-232 MO P-MO-232 P-MO-162 TU P-SU-082 SU SU-31 SU MO MO P-MO-161 SU SU SU-08 SU SU P-SU-110 TU SU-63 SU WE-22 SU SA-32 SA P-MO-244 P-TU-245 SA-15 SA SU-46 SU-46-03

383 WOC Francesconi C. Francis A. Francis P. J. Franco E. Franco I. Francuz T. Frank C. Franke G. H. Frech M. Freedman S. Freeman W. R. Freistühler M. Freitas H. Frenkel R. Frentz M. Fresina M. Freudenthal J. Freund K. B. Frezzotti P. Friberg T. Friedlander D. Friedlander M. Friedman D. Fröhlich S. J. Fronius M. Frosch M. Fruschelli M. Frutos J. M. Fu T. Fu Y. Fuchsluger T. Fujikado T. Fujikawa A. Fujiki K. Fujimaki T. Fujimoto J. G. Fujiwara T. Fukuda M. Fukuhara M. Fukumoto A. Fukumoto M. Funk J. Funk M. Furmanchuk H. Furness C. L. Furrer S. Furuta M. Fürweger C. Fyodorov A. P-SU-180 P-SA-134 SU P-SA-090 P-SA-094 P-SA-217 TU P-MO-170 P-MO-226 P-SU-174 SU SU SU P-MO-210 TU SA SU MO MO P-TU-126 SU P-MO-071 P-TU-059 TU MO SU SU SU P-MO-074 SA P-SA-137 MO P-SU-254 P-SU-254 TU SA-23 SA SA-24 SA WOC-C WE-36 WE P-SA-224 P-TU-242 P-SA-137 SU SU SU FR SU WE P-MO-256 P-SA-087 P-SA-087 MO P-MO-154 SA MO P-MO-213 P-SU-089 P-SU-257 SA P-MO-264 MO P-MO-041 WE P-SU-188 SA P-TU-117 P-MO-295 P-MO-041 SU TU P-TU-096 MO G Gabel J. Gabel V.-P. Gabela G. Gabric N. Gabryte E. Gajdzik-Gajdecka U. Galambos P. Galand A. Galarreta D. Gall C. Gallego-Pinazo R. Gallenga P. E. Gallie B. L. Gamaly T. Gamulescu M.-A. Gandhi R. Gandolfi S. Gandorfer A. Ganesh S. Gangopadhyay N. Ganguly A. Gans M. Ganssauge M. Gao L. Gao X.-R. Garber D. Garcia C. Garcia P. García Alcolea E. E. García-Alvarez C. P-SU-080 MO-42 TU WOC-C P-MO-112 SU SU TU TU SU P-TU-171 P-TU-201 P-SU-226 P-SA-240 P-SU-086 TU P-SU-137 P-SU-153 P-SU-161 P-SU-174 P-SU-175 SU SU P-MO-160 P-MO-189 TU-41 WE-32 SU SU MO-77 WE-24 WE WE SU SA P-TU-187 WE-04 WE SA-11 SA SU WE P-MO-233 P-MO-249 P-SA-173 P-SU-272 WOC-AAD-C WOC-AAD-C WOC-C P-MO-285 P-MO-298 P-SU-030 SU MO P-MO-145 TU P-SU-231 MO P-SA-095 SA WE P-SU-251 P-TU-206 SU MO P-SA-180 P-TU-216 TU P-MO-104 SU SU García Arumí J. García-Barberán I. Garcia-Bardon D. García-Delpech S. García-Feijoó J. Garcia Filho C. A. Garcia-Gonzalez M. Garcia-Marcos M. Garcia-Medina J. J. Garcia-Medina M. Garczorz W. Garg P. Garg S. Garip A. Garlaite O. Garms C. Garrett Q. Garrick A. Garway-Heath T. Garweg J. G. Gatinel D. Gatzioufas Z. Gaudric A. Gavranic C. Gavrilenko A. Gayathri R. Gaydamaka T. Ge J. Geck U. Gedde S. Geerling G. MO SU TU-48 TU SU P-MO-137 TU-41 TU WE-32 P-MO-097 P-SA-243 P-SA-266 P-SU-169 MO P-SA-271 P-MO-117 P-MO-143 WOC-C-63 WOC-C P-MO-047 P-MO-093 P-MO-160 P-SA-119 P-MO-047 P-MO-093 TU SU SU P-SA-251 P-TU-084 WE-25 SU P-SU-150 SU-01 SU MO-14 MO WE SU-24 SU MO MO-74 TU P-MO-203 SA SU-47 MO SU-69 P-SA-081 P-SU-276 SU-48 SU-49 P-TU-098 P-SA-160 MO P-SA-053 P-SA-078 P-SA-098 MO P-MO-201 SA FR FR FR SU MO-64 MO TU-79 TU Po-SA P-MO-008 P-MO-148 P-MO-286 P-SA-060 WOC-C-14 WOC-C Author Index

384 380 WOC 2010 Author Index Gehlsen U. Geinoz J. Gekeler F. Gelhorn H. Geller S. Gellrich M.-M. Gellrich N.-C. Gengenbach U. Gentile R. Georgakopoulos C. George J. L. George N. George T. M. Georgiou T. Georgopoulos M. Geraissate C. Gerasimov M. Gerding H. Gericke A. Gerinec A. Gerstmeyer K. Gerten G. Gerth C. Ghaddar A. Ghanem A. Gheorghe I. Gheorghe M. Ghita M. Ghosn C. Giancardo L. Giannakopoulos M. Giblin M. Gicquel J.-J. Giebel A. Giegengack M. Giers U. Gilbert C. Gilbert S. FR P-SU-023 P-SU-031 P-SU-034 SU P-SA-155 P-SU-264 TU P-SU-110 TU P-MO-085 MO SU MO MO P-SU-190 MO P-SA-180 P-TU-216 P-MO-190 P-MO-214 P-SU-055 P-TU-090 P-TU-148 P-SA-272 SU P-SU-188 P-TU-028 SA P-MO-023 P-SU-181 TU WOC-AAD-C-29 P-MO-137 P-TU-241 SU-41 MO MO-73 MO P-MO-072 P-MO-144 SA P-TU-130 P-TU-155 P-MO-275 P-SA-142 SA P-TU-005 P-TU-107 P-MO-048 MO P-TU-199 SU P-MO-190 P-MO-214 TU WOC-C-60 WOC-C SU SU TU SU SU MO WE MO-07 MO MO-51 MO WE P-SU-064 P-SU-072 TU-57 TU Gill N. P-MO-067 Gillies M. MO MO MO TU Gini G. TU TU-27 TU TU WE Girkin C. A. MO Giuliari G. P. MO Gkatzioufas Z. P-MO-035 Gkika T. MO MO P-TU-126 Glänzel W. MO Glaser E. P-SA-263 P-TU-120 Glasser A. MO Glaus E. P-SA-088 Glavota V. P-MO-112 Glekov I. WE Glittenberg C. P-TU-176 Globocnik Petrovic M. P-SA-206 Glombik R. P-TU-250 Gloor B. P. SU TU-65 Gmelin E. P-TU-250 Gmiński J. TU Goatman K. SU TU TU Gobbe M. P-MO-111 TU TU Göbel A. P. WE Göbel K. P-SA-149 Goebel W. P-MO-251 Goebels S. C. P-MO-278 P-SA-081 P-TU-101 Goeppert H. P-TU-006 Goerig M. SU Goes F. J. TU-75 TU Goetz A. E. SU Gogia V. P-SU-242 TU Goh M. MO Goh S. Y. MO Goh T. P-SU-222 Gök M. MO P-TU-126 Gokyigit B. P-SU-198 Golbaz I. MO P-SA-196 P-TU-185 Goldberg I. SA-30 MO TU TU Goldberg R. SU Goldstein M. H. TU-26 Gole G. A. P-TU-151 Golnik K. SU-40 MO-41 MO MO MO MO MO P-SU-142 Goloborodko E. P-TU-241 Gologorsky D. MO Golovin A. WE Golshahi A. TU Goltz C. SA Goltz H. SU Gomes da Rocha A. P-SU-273 Gomez L. SA Gomez de Liano R. MO TU Gomi F. P-MO-179 P-SA-163 P-TU-229 SA Goncalves J. TU Gondova G. P-TU-132 Gonen T. P-MO-055 Gong H. P-SA-134 Goñi Foncillas F. J. MO-54 MO Gonnermann J. P-SU-046 González-Castaño C. P-MO-221 Good P. P-TU-052 Goodale M. SA Gopovtzova O. WE Gorani M. P-SU-092 Gorban M. P-MO-077 Gorby M. MO Gordillo L. MO Gordon I. WOC-C Gorjizadeh A. P-MO-152 Gos R. MO Gosho T. P-SA-121 Goswami M. K. MO Gothwal V. K. MO Goto H. SU TU P-SA-247 P-SU-158 Gotoh N. P-SA-167 Gottlieb C. MO Gottlob I. SU-23 SU SU-55 MO-06 MO Gottsch J. D. TU-81 Gottschling P. F. SA TU Gotz- Więckowska A. P-TU-154 Götzinger E. MO TU Gougoutchkova P. P-MO-156 Gourgoulianis K. MO Goyal J. L. P-SU-173 Grabner G. SA SA SU-47 MO-38 MO P-SA-044 P-SA-067 P-TU-010 Gračner B. P-TU-058 Gračner T. P-MO-007 P-TU-058 Gräf M. SA SA SU-18 SU TU-59 WE-41 Gragoudas E. S. MO-63 Graham E. MO-03 MO Grajewski R. MO P-SA-248

385 WOC Gralek M. P-TU-156 Gramer E. TU-16 P-SU-177 Gramer G. P-SU-177 Gramlich O. W. SA TU TU P-SU-104 Grandin J. TU Graneros G. P-SA-269 Gray J. P-MO-174 P-MO-195 Gray S. MO TU Grcar R. P-MO-231 Grechko S. P-SA-053 Gregor Z. J. MO-02 MO MO Gregory D. G. SA Grehn F. SA SU SU-07 SU MO-08 P-MO-148 P-SU-105 WOC-C-14 WOC-C WOC-AAD-C-20 Greveniotis P. SU Grieb P. TU Griebel M. P-SA-253 Grierson R. P-SA-184 P-SA-185 Grigg M. SU MO Grisan E. SU Grisanti S. SA SU MO Po-MO P-SA-166 P-SA-170 P-SA-187 P-SU-023 P-SU-031 P-SU-251 P-TU-075 P-TU-097 Grobelny A. P-SU-063 Groll J. MO Groppe M. P-TU-032 Große B. P-MO-277 Große Darrelmann B. SA Großmann W. P-MO-127 Grossniklaus H. E. SA-43 SA SU SU MO-33 TU TU Großwendt J. P-MO-038 Group the AJCC-UICC Study TU Grover A. SA-44 SA MO P-SU-203 Grucha Y. MO Grünert A. P-SA-113 Grupcheva C. SA Grus F. H. Grusha Y. Grüterich M. Grzybowski A. Gu H. Gudlin J. Güell J. L. SA SA MO-22 MO MO Po-SU P-SA-111 P-SU-094 P-SU-204 P-TU-241 P-SU-104 TU TU MO MO MO P-SU-201 MO P-SA-051 SU MO P-SU-160 SA SU-77 MO TU-76 TU WE P-SU-132 P-SA-161 Guenther T. Guerrero L. Guichard M. M. Guilherme-Monteiro J.P-SA-258 Gul A. SA-40 SA MO-74 Gulani A. Gulbins E. Guliani B. Gümbel H. O. C. Gummersbach C. Gunawan W. Gundlach E. Gundorova R. Gündüz E. Gündüz Ö. U. Gunenc U. Gunn D. Günther S. Gupta A. K. Gupta M. Gupta N. Gupta S. Gupta S. K. Gupta V. Gürel E. Gurung R. Gusek-Schneider G. Gustiene O. Guth H. SU P-MO-134 P-MO-135 P-SU-246 P-SU-195 P-TU-040 TU WE Po-TU WOC-C P-MO-223 P-MO-107 P-SA-059 P-SA-045 P-MO-242 TU P-TU-061 P-TU-151 P-MO-033 P-SU-105 SU P-TU-146 P-TU-148 P-TU-150 MO TU-15 TU WE MO P-MO-198 P-SU-242 TU MO P-SU-195 P-TU-040 P-SA-128 P-TU-263 P-SA-036 SU P-SA-204 MO Guthmann S. P-MO-271 P-TU-191 Guthoff R. Po-MO P-MO-251 P-SA-253 Guthoff R. F. SA-16 SA-46 SA SU-32 SU-38 SU MO-34 MO MO MO MO WE-12 WE P-SA-077 P-SU-190 P-TU-155 WOC-C-47 WOC-C Gutierrez-Amoros C. P-MO-126 Guymer R. TU Guyton D. P-SA-226 Guzy C. P-MO-062 P-MO-073 Gyasi M. P-SA-134 H Haas A. WE Haas-Brähler S. P-MO-039 Haase V. H. TU Habela M. SA Haddad D. TU WE Haddad S. P-TU-140 Hadi I. P-MO-271 Hadipour Jahromy M. SU Hadjiraftis S. P-SA-139 Haefliger E. A. TU-03 TU-75 TU Hafez M. SU Hafezi F. SU-59 SU Hagedorn N. P-MO-240 Hager A. MO Hager T. P-SA-066 P-TU-007 Hahn I. MO Hahn U. TU Haigis W. MO TU-10 TU TU-82 TU P-TU-018 Hakim I. P-TU-021 WE Halberstadt M. MO Haldipurkar S. WE Halfter W. TU Halle M. TU Haller J. A. SU MO MO MO TU LS Ham L. TU Hamoudi R. A. SU Author Index

386 382 WOC 2010 Author Index Hampejsková L. Hamrah P. Hamsley N. Han G. Han H. Han J.-F. Handayani S. Y. Handoko S. B. Handzel D. M Hangai M. Hansen L. L. Hara T. Hara Y. Harada R. Harats D. Harder B. Hardy S. Haritoglou C. Haritoglou I. Harris A. Hartmann K. Hartmann U. Hartnett M. E. Haruchika M. Hasegawa Y. Hasenfus A. Hasenfus D. Hashad Y. Hashim H. Hashimoto S. Hasnain S. Hass P. E. Hassan A. O. Hassan S. A. Hassan T. S. Hassenstein A. Hathaway M. Hattenbach C. SU SU WOC-C P-SA-064 P-MO-261 P-SA-201 P-SU-105 Su P-TU-124 P-TU-124 P-SU-233 P-MO-114 P-MO-043 P-SA-126 TU WE-34 P-MO-236 P-MO-138 P-SU-037 P-MO-138 P-SU-037 P-SU-113 P-MO-216 P-MO-185 P-SU-057 SU SU TU TU WE Po-TU P-MO-222 P-MO-233 P-MO-249 P-MO-271 P-SA-188 P-SU-272 P-TU-017 P-TU-191 P-TU-228 P-TU-237 SU TU-16 TU TU SA SU TU P-SU-258 SU P-TU-231 P-MO-235 P-SA-066 P-TU-101 P-SU-043 MO TU P-SA-272 P-SA-106 P-SA-109 P-SA-104 MO SA SA SA TU P-MO-001 MO TU-18 TU TU SA Po-MO MO P-TU-226 Hattenbach L.-O. Hattingen J. Haueisen J. Hauer K. Haughney P. Haustein M. Hawlina M. Hayashi H. Hayashi K. Hayashi W. Hayes J. Hazarbassanov R. M. Hazarika M. He M. He Y. Healey P. Hecht E. Heckmann B. Hediger A. Hedges T. R. Heegaard S. Hefner L. Hegde K. Heidt A. Heiduschka P. Heier J. Heijl A. Heiligenhaus A. MO TU-29 TU Po-SA P-TU-226 WOC-C-30 WOC-C WOC-C-48 P-TU-223 P-TU-250 P-MO-040 P-SA-145 P-SA-147 P-TU-194 P-TU-047 MO P-SA-139 SU-11 SU MO-42 MO MO-55 MO TU P-SA-097 P-SA-167 P-MO-188 P-SA-229 P-MO-188 P-TU-181 SU P-MO-115 MO SU MO WE P-SU-102 SA TU-43 P-SU-202 P-MO-073 MO SA WE-20 WE SU SU-34 SU TU-70 TU TU SU P-TU-043 MO P-MO-170 MO MO MO TU SU-02 SU MO-14 TU BS BS SU-27 SU SU SU MO MO-21 MO MO-49 MO MO Heimann H. Heindl L. M. Heinrich M. A. Heinz C. Heinzelmann S. U. Hejcmanova D. Helb H.-M. Helbig H. Helfenstein M. Hellebrand H. Hellmich M. Hellstrom A. Helou J. Helvestone E. Henckes O. Hendrikse F. Hengerer F. Henke Fahle S. Hennig A. Hennig M. Hennighausen U. Henrich P. B. Henrich-Noack P. Henson D. B. Hepper D. Hergeldzhieva- Fileva T. Heriot W. MO TU-50 TU P-SA-248 P-SA-256 P-SU-099 P-SU-151 SU TU-23 TU WE-35 SA P-SU-249 TU P-TU-127 P-SA-112 SU MO MO MO TU-60 TU P-SA-248 P-SU-099 TU P-SA-068 P-MO-281 P-SU-155 SA MO MO WE P-SA-158 SA SU-79 TU TU TU-32 P-MO-157 P-MO-204 P-MO-244 P-SA-011 P-SA-124 P-TU-187 P-SU-055 SU P-SA-013 MO P-TU-033 SU TU-59 TU P-SU-055 SU SU P-TU-119 P-SA-122 TU MO P-SU-078 MO P-MO-249 P-SU-162 P-MO-195 P-MO-174 TU SU SU SU SU P-SA-076 WE-08-06

387 WOC Herman W. SU Hermann M. P-MO-065 Hermel M. P-MO-288 P-SA-064 Hernaez-Ortega M. C. MO Hernandez Martinez F. P-SU-147 Hernandez Martinez F. J. P-TU-247 Hernández Silva J. R. P-SA-023 P-SA-033 Hernandez- Boussard T. WE Herndon L. W. TU Hernowo A. SU Hero M. P-MO-252 Herrmann C. SU Herrmann C. S. P-SU-137 Herrmann W. P-SA-011 SA Herwig M. C. P-SU-006 Herzog D. MO P-MO-036 P-TU-147 Herzog J. P-MO-036 Hessler F. P-SA-265 Hetland J. P-SU-101 Hetzel A. WOC-C WOC-C Heußen F. M. A. P-SA-113 P-MO-015 P-MO-016 Heynemann M. P-MO-220 Higashide T. P-SU-159 Hikoya A. A. P-SA-215 P-TU-129 Hilgers R.-D. TU Hillebrand S. P-SA-165 P-SA-198 Hillenkamp J. P-SA-186 TU TU Hingst V. MO Hintschich C. SA-42 SA MO-82 WE-33 WE Hinz M. P-TU-221 Hirabayashi M. P-TU-195 Hirai K. P-SA-131 P-SA-154 Hirakata A. SA Hirano S. P-MO-064 Hiraoka T. P-MO-172 P-MO-235 P-MO-239 P-SA-150 Hiratsuka Y. P-SU-052 Hirn C. MO P-MO-041 WE Hirneiss C. P-MO-037 P-MO-233 P-SA-202 P-SU-186 Hirota A. SU Hirsch-Kauffmann Jokl D. SU-46 SU Hisatomi T. SA Hitzenberger C. MO MO MO TU Hjortdal J. Hn M. Ho M. Ho T.-Y. Hoang-Xuan T. Hoeh A. E. Hoerauf H. Hoffmann D. Hoffmann E. M. Hoffmann M. Hoffmann P. Hoffmann S. Höfling-Lima A. L. Hofmann C. Hofmüller W. Hohensinn M. Hoh S. T. Hohman T. C. Höhn F. Holak H. Holak N. Holak S. A. Holbach L. M. Holbroook J. T. Holden B. A. Holder G. E. Holdt M. Holladay J. T. Holland D. Holland G. N. Hollander D. SU TU MO P-MO-192 P-SA-105 MO P-TU-244 SU TU TU-12 TU P-MO-102 P-MO-201 WOC-C WOC-C WOC-C-49 WOC-C-57 P-TU-254 SU-01 SU MO-13 MO TU P-MO-032 P-MO-033 P-MO-036 P-MO-039 P-MO-045 P-SA-146 TU P-SU-043 P-SU-265 P-MO-098 P-MO-115 P-TU-015 P-TU-016 P-TU-057 P-SA-044 P-SA-067 SA SA MO WE P-SA-197 MO TU P-SA-072 P-SA-072 SU SU P-SA-072 SU P-SU-145 SU-57 MO-18 MO TU P-SU-249 P-TU-127 MO WE SU-11 SU P-TU-112 SA MO TU-10 TU TU-80 TU TU MO MO TU TU Holle J. Holló G. Holmström G. Holopainen J. M. Holz E. R. Holz F. G. Holzchuh N. Holzer M. P. Home S. Homma K. Hommel G. Hommer A. B. Honda S. Hong L. Hong S. Hong S.-M. Hooper C. Hooymans J. Hopkins A. D. Hopkinson A. Hori N. Hornegger J. Hornykewycz K. Horozoglu F. Horwath-Winter J. Hosseini S. R. Hosseini H. Hotta Y. Hou M. C.-C. Hou X. R. Hovakimyan M. P-TU-098 MO-60 MO WE-09 WE SU-37 TU TU SA SA-33 SA SU SU SU MO MO-45 MO MO-68 MO TU TU TU WE WE P-MO-158 P-MO-086 P-SA-158 P-SA-176 P-SA-195 P-SA-197 P-SU-006 P-SU-058 P-TU-183 P-TU-204 WE WE-22 SA SU SU-80 TU P-SA-010 P-TU-008 P-TU-018 WE P-TU-208 P-SU-194 MO-12 MO MO P-MO-213 P-MO-254 Su P-SU-093 MO P-SA-236 SU SU-32 SU TU SU P-SA-107 TU-56 WE-39 WE P-MO-055 FR FR P-MO-152 MO P-SA-215 P-TU-129 P-MO-090 SU MO SU Author Index

388 384 WOC 2010 Author Index Hovanesian J. Hoyng C. B. Hsieh Y.-T. Hsu S.-Y. Hsu T.-K. Hsu W.-C. Hsu W.-M. Hsueh S. Htoon H. M. Hu N. Hu W. K. Hu X.-W. Hu Y. Huang B. Huang J. Huang K. Huang P. Huang S. Huang Y. Huang Z.-L. Huber C.-G. Huber J. Huber K. Huber-van der Velden K. Hudovernik M. Huf W. Hulkova M. Humayun M. Hungerford J. Hunter D. G. Hunter M. Huo Y.-J. Hurtikova K. Huseynova S. Hutauruk J. Hüttmann G. Hwang L.-J. Hyer J. Hyndrak M. Hyvärinen L. I Iacob C. E. Iakymenko S. Ibarz-Barbera M. Ibisevic M. Ibrahim M. Ibrahim O. Ibrahimy W. Ichimura K. Ideguchi K. Idrissi-Alami S. Ignjatovic Z. TU TU TU P-TU-051 P-SU-154 P-TU-081 P-SU-067 SA P-MO-084 TU P-MO-287 SU SU WE TU P-SA-138 P-SU-097 MO TU SU MO P-TU-056 P-SA-101 P-TU-205 P-MO-015 P-SA-113 P-MO-016 P-MO-075 P-TU-058 P-SA-200 P-MO-281 TU-18 TU TU WE WE WE-23 WE SA MO-71 SU MO P-MO-278 P-SU-131 P-SA-069 MO MO MO P-SU-031 P-SU-034 WE P-SU-095 P-SA-049 SU SA P-TU-111 SU TU P-MO-117 P-MO-143 P-SU-225 SU WE SA P-TU-189 SU SU P-TU-140 P-TU-071 Iida T. Iijima H. Iizuka Y. Ikeda F. Ikeda H. Ikeda N. Ikeda S.-i. Ikeda T. Ikeda T. Ikeda Y. Ikuno Y. Ilako D. R. Ilazi M. Ilginis T. Ilies I. Illarionova A. Ilyina E. Imai A. Imai H. Imaizumi M. Imamoglu S. Imamura Y. Imshanetskaya T. Inatomi T. Ines K. Ing M. Inoue M. Inoue Y. Investigators for the LUMINATE Iomdina E. Iranmanesh R. Ireni A.-R. Irkec M. Irsch K. Irschick E. Isa H. Isaac K. Isaacson P. G. Ishibashi T. Ishibazawa A. Ishida K. Ishida M. Ishida O. Ishida Y. Ishikawa K. Ishikawa M. P-MO-165 P-SA-097 P-SA-191 MO P-SU-093 P-MO-173 P-MO-043 P-SA-126 P-SU-121 P-SU-053 P-SU-121 P-SU-257 P-MO-264 P-TU-064 P-TU-068 TU P-MO-011 P-SA-279 P-MO-215 P-TU-069 SA SA-37 SA SA P-SU-092 P-SU-092 P-SA-174 P-TU-078 P-MO-031 P-SA-054 P-MO-266 P-MO-254 SU P-SU-198 SA SA MO-24 MO MO P-SU-275 P-SU-269 P-TU-192 P-TU-173 WE P-MO-082 WE SA MO P-MO-011 P-SA-279 MO MO MO P-SU-267 MO-60 MO P-SA-226 MO P-SU-009 P-TU-212 SU SA-43 TU P-MO-153 P-TU-225 P-MO-225 P-TU-068 P-MO-064 P-MO-194 P-SA-131 P-SA-154 P-SA-175 P-TU-214 P-SU-096 Ishiko S. Ishikura R. Ishizaki E. Iskandar E. Ismailova D. Isquierdo Jr. L. Ito M. Ito R. Ito Y. Itou M. Ivanchenko Y. Ivandic B. Ivandic T. Ivanisevic M. Ivanisevic P. Ivanova N. Ivanova O. A. Ivanovskaya E. V. Ivarsen A. Iwami H. Iwata D. Iyer J. V. Izdebska J. Izquierdo L. Izquierdo N. J Jaafar M. Jabs D. A. Jackson M. L. Jackson T. Jacob M. Jacobi C. Jacobs D. S. Jacobson L. Jafarinasab M.-R. Jaffe G. J. Jäger M. Jager M. J. Jaggi G. Jägle H. Jaki Mekjavic P. Jakob E. Jakobs E. Jakobsen J. E. Jaksic V. Jakubowska B. James D. K. P-SA-267 P-SA-282 P-MO-011 P-MO-264 P-SA-087 MO MO MO P-TU-200 P-TU-222 SU P-TU-231 P-MO-194 P-SA-175 P-TU-214 P-TU-220 P-SU-124 MO MO P-SA-130 P-SA-130 P-SU-075 P-SU-075 P-SA-235 P-TU-125 P-SA-078 SU P-TU-195 P-SA-257 P-SU-206 P-MO-289 TU MO TU MO SU-52 SU MO MO TU P-SA-205 SA TU SA P-SU-039 P-SA-197 P-TU-152 P-SA-246 P-SU-248 P-TU-099 P-TU-174 P-TU-186 SA-35 SU MO P-SU-125 SU-72 SU P-SA-206 FR P-SA-241 P-SA-255 P-MO-124 SU-07 SU P-TU-230 P-TU-240 P-TU-092 P-TU-128 SU-75-10

389 WOC Jan J. Jang S.-y. Janjua R. Jankov M. R. Jansonius N. M. Jantschitsch C. Januleviciene I. Januschowski K. Jap A. Jarrín E. Jarsch C. Jasek M. C. Jasielska M. Jasinskas V. Javadi M.-A. Javate R. M. Jaworska M. Jayakumar D. Jedrzejczak- Mlodziejewska J. Jeep S. Jeng B. Jenkins A. Jennane N. Jepsen C. Jeremy W. Jessen B. Ji J. Ji Y. Jia H. Jia R. Jia Y. Jiang L. Jiang T. Jiang W. Jiao C. Jiao J. Jimenez- Martinez M. d. C. Jimenez R. Jiménez-Roman J. Jin X.-y. Jin D. Jin E.-H. Jo Y. Joachim S. C. Job O. Jobke S. Johnen S. Johnson R. S. Johnston S. Jöhrens K. Jonas J. B. MO-58 TU P-TU-162 P-MO-202 MO TU-64 SA-31 SA SU P-SU-253 TU P-SA-116 P-MO-170 P-TU-181 P-SA-264 P-SU-132 P-SU-045 TU P-SA-168 P-SA-204 P-SU-039 SA SU-71 SU TU P-SA-072 P-TU-198 P-MO-289 P-MO-263 SU TU P-SA-141 P-SA-010 TU P-SU-097 MO P-SU-232 P-SA-095 P-SU-217 SU P-SA-231 SU P-SA-216 P-SA-221 SU P-MO-018 MO MO MO TU P-SU-024 SA P-MO-046 TU P-TU-064 MO P-MO-215 P-SU-104 SA TU TU TU TU SU P-MO-206 TU TU TU P-SA-263 SA-12 SA SU MO TU WE P-MO-185 P-MO-245 Jonasson F. MO Jonescu-Cuypers C.-P. SU SU P-MO-035 P-TU-007 Jonuscheit S. SU Joo C.-K. P-MO-009 TU Joo K. S. P-MO-284 P-MO-296 P-SA-219 Jordan J. F. TU-63 TU P-MO-038 Joshi L. TU P-SA-244 P-SA-268 Joshi S. P-TU-164 Josifova T. TU Josselin P. M. Joussen A. M. Jovanović I. Juanjuan L. Jünemann A. G. M. Jünemann C. Jung G. Junker B. Jürgens C. Juric B. Jurik I. Jurklies B. Jurklies C. Jurkunas U. Jurowski P. Jyothi S. SU SU MO-01 MO TU TU-33 Po-SU P-SA-113 P-SA-168 P-SU-258 P-SU-260 P-MO-015 P-MO-016 P-TU-098 P-TU-243 P-TU-254 P-SU-152 P-MO-168 P-SA-019 P-TU-253 WE SA MO-12 MO TU TU-77 TU WE Po-SU P-SA-036 P-SU-098 P-SU-249 TU P-SU-266 P-SU-271 P-MO-236 P-SA-070 P-TU-248 SA P-MO-112 P-MO-209 Po-MO P-SA-239 P-TU-248 P-TU-112 P-TU-116 SU MO MO K Ka Fat, Thomas T. Kabasele P. M. B. Kabelitz D. Kaçaniku G. Kachalina G. Kachi S. Kadinskaya M. Kador P. Kaercher T. Kahaly G. J. Kahlert C. Kahook M. Y. Kaiser P. K. Kaiserling E. Kajita M. Kakizaki H. Kakkassery V. Kaldefoss K. Kalinina Ayuso V. Kalogeropoulos C. Kalua K. Kaluzny B. J. Kalyani P. Kamei A. Kamei I. Kamei M. Kaminska A. Kammann J. Kämmerling S. Kamo J. Kampik A. MO P-SA-236 P-MO-151 SU MO SU P-SU-270 SA TU FR-01 WE-22 P-SU-194 P-SA-255 P-MO-058 P-MO-059 SA SU TU-18 TU TU-37 TU WE-38 WE WOC-C-57 WOC-C P-SA-170 SA P-SU-119 SA P-TU-098 P-TU-191 MO MO TU WOC-C MO P-SU-146 P-SA-004 TU P-MO-289 TU TU-25 P-SA-224 P-SU-113 SU SU-50 SU-51 MO-11 MO MO MO MO TU TU TU TU-41 TU TU-42 WE-11 WE WE WE-32 WE P-SA-051 P-SA-173 P-SA-178 P-SA-188 P-SA-194 P-SA-202 P-SA-205 P-SU-272 P-MO-088 P-MO-210 Author Index

390 386 WOC 2010 Author Index Kampik D. Kampik K. Kampmeier J. Kanamori A. Kandelman S. Kandori M. Kanecadan L. Kaneda K. Kaneko M. Kang H. Kang J. H. Kang K. D. Kang S. Kanigowska K. Kann G. Kanonidou C. Kanonidou E. Kanpolat A. Kanthan G. Kao S.-C. Kapica A. Kaplan J. Kar D. Karacorlu M. Karadenizli S. Karagiannis D. Karahan E. Karam E. Karim R. Karimian F. Karim-Zade K. Kara-José N. Karliychuk M. Karnowski T. Karska-Basta I. Kartasasmita A. Kasae P. Kasama S. Kashii S. Kashiwagi K. Kasimov E. Kaskaloglu M. P-MO-233 P-MO-249 P-MO-271 P-TU-021 P-TU-091 P-TU-096 P-TU-191 P-TU-228 P-TU-237 WOC-AAD-C-03 LS-08 LS FR P-TU-248 Po-SU P-SA-050 MO SU TU P-SA-279 P-TU-188 SU P-SA-121 P-MO-265 WE P-TU-054 TU P-TU-156 P-SA-060 P-SA-276 P-SU-035 P-MO-248 P-SA-012 P-SA-276 P-SU-035 SA-13 TU P-SU-051 SU P-SU-015 MO MO MO TU TU WE-37 P-SA-128 P-SA-168 SA SA SU P-MO-001 P-SU-039 P-SA-042 P-SU-205 P-TU-135 SA P-SA-171 SU P-SA-183 P-MO-175 P-MO-267 P-TU-085 P-SA-087 P-MO-269 P-SU-135 SU-29 SU SU-40 WE MO P-SU-131 TU-02 TU Käsmann-Kellner B. Kasmiya M. Kasparov A. Kasper B. Kasper K. Kassel J. Katada T. Kataev M. Katalin G. Katalin Z. Kataoka K. Katargina L. A. Kato S. Kato T. Kato Y. Katowitz J. A. Katschke Jr. K. J. Katz L. J. Katz T. Kau H.-C. Kaufmann C. Kaulen P. Kaup M. Kaushal S. Kawahara J. Kawai K. Kawano M. Kawasaki A. Kawasaki R. Kawase K. Kayama T. Kaymak H. Kaynak-Hekimhan P. Kayode Kazakova D. Kazanskaya O. Kazaryan A. Kazlauskas A. Keane P. A. Kedar S. Kee C. Keeffe J. Keeley S. Keenan T. Keil C. Keilholz U. Keindl T. K. Kelley R. F. Kellner S. Kellner U. Kempen J. H. Kermani O. Kern T. Kern Y. SU SU WE P-TU-163 TU MO P-MO-251 FR P-MO-286 MO P-SA-136 WE P-SA-133 P-SA-133 P-SU-270 SU P-SU-107 P-SU-115 P-SA-267 MO-34 MO MO TU P-SA-082 SU P-SU-015 P-SU-120 P-TU-049 TU P-SU-140 TU P-MO-150 WE P-TU-070 P-TU-231 P-SU-141 SU WE TU P-MO-069 P-SU-115 P-MO-240 P-SU-198 SA TU TU P-SA-151 SU P-SA-165 WE SA MO-52 MO WOC-C-59 WOC-C WOC-C WOC-C WE WE P-SU-185 P-TU-114 SU MO TU SU TU P-MO-040 MO P-MO-144 SA TU SA P-SU-045 P-TU-043 Kernt M. Kersten D. Kertes P. Keserü M. Keskinbora K. Ketring K. Kettesy B. Keuchel S. Keul H. Key J. E. Kezirian G. M. Kezuka T. Khairallah M. Khaireddin R. Khakpour S. Khaled A. E. Khaled A. K. G. Khaliddin N. Khalifa M. Khalilia N. Khan A. Khan H. Khan M. D. Khan S. Khan W. Khandelwal P. Khandelwal R. Kharoubi A. Khatana A. K. Khaw P. T. Khazaei H. Khetan A. Khetan V. Kholmatova R. Khoo C. Y. Khor S. E. Khoramnia R. Ki C. S. P-MO-210 P-MO-233 P-MO-271 P-SA-173 P-SA-178 P-SA-194 P-SA-202 P-SA-205 P-TU-191 P-TU-228 P-TU-237 SU TU P-SA-162 P-MO-241 P-TU-082 MO P-MO-055 TU P-SU-028 MO MO SA-14 SA TU-78 TU P-SA-247 P-SU-158 MO TU P-MO-082 P-SA-089 P-SA-249 P-SA-250 P-SA-270 P-SA-082 SU P-MO-177 P-SU-050 P-TU-161 SU WE P-SA-244 P-MO-001 TU MO MO SA SU MO P-TU-055 TU TU SU-06 SU SU MO MO-53 MO P-SU-209 MO P-MO-285 P-MO-298 P-SU-029 P-SU-030 WE P-TU-135 SA-15 SA P-MO-280 P-SA-199 P-SU-111 P-TU-120 SA-28-09

391 WOC Kibata Githeko A. Kikkawa D. O. Kikuchi T. Kilangalanga N. J. Kilic E. Killer H. Kim I. Kim Y. M. Kim C. S. Kim C. Y. Kim D. S. Kim H. Kim H. J. Kim H. K. Kim J. C. Kim J. S. Kim J.-o. Kim J.-S. Kim K.-S. Kim R. Kim Y. D. Kim Y. J. Kim Y. K. Kim Y. Y. Kim Y.-C. Kimoto K. Kimura H. King A. J. Kinoshita H. Kinoshita S. Kinouchi R. Kiraly L. Kirchhof B. Kirii E. Kirilova Y. MO-62 MO MO SU-22 SU P-SU-053 SA SU MO P-SU-125 MO SA SA P-SU-093 SA WE P-MO-208 SA P-TU-079 P-MO-284 P-MO-296 SA SU TU SU P-MO-118 P-MO-237 SU P-TU-054 P-TU-142 SU P-SU-179 P-SU-185 SA P-MO-237 P-MO-199 TU SA MO P-MO-247 SA-16 SA SU-38 SU MO MO-49 MO MO TU P-SA-267 P-SA-282 P-MO-123 WOC-C-08 SA MO MO-27 MO-48 MO MO-70 MO TU-03 TU TU WE-08 P-SA-165 P-SA-170 P-SA-198 P-SA-213 P-SA-214 WOC-AAD-C-18 P-MO-178 P-SA-076 SU SU Kiseleva T. Kishi S. Kishimoto F. Kisimoto T. Kiss C. Kitano S. Kitaoka T. Kiuchi T. Kiuchi Y. Kivelä T. Kiyosaki K. Klamann M. Klancnik J. Klaproth O. Klassen H. Klatt C. Klauss V. Klaver C. Klee S. Klein H. Klein M. L. Klein S. Klemm M. Klett A. P-SA-160 SA WE P-MO-149 P-MO-166 P-MO-173 P-SA-242 P-TU-233 P-SA-222 P-SU-182 TU MO P-SA-164 P-SA-200 WOC-C P-TU-252 P-MO-230 P-MO-247 P-MO-256 P-TU-004 P-SA-150 P-SA-121 P-SU-183 P-TU-070 SU SU-34 MO MO MO MO TU TU-40 WE-23 WOC-C-60 WOC-C SU P-MO-015 P-MO-016 P-MO-075 P-SA-113 MO MO MO P-MO-116 P-TU-001 P-TU-015 P-TU-016 MO SA SA SU-65 SU-74 TU-57 TU WE P-MO-088 WOC-AAD-C-28 TU P-MO-040 P-SA-145 P-SA-147 SA MO P-SU-260 P-TU-243 P-TU-254 P-TU-056 P-TU-073 P-TU-082 P-TU-194 WE SA-42 SA Klettner A. Klevering B. J. Klingenstein A. Klink T. Klintworth G. Klos-Rola J. Klyce S. D. Knecht P. Knobloch J. Knop E. Knop N. Knorr M. Knorz M. C. Knyazeva E. S. Ko Y.-C. Kobayashi A. Kobayashi M. Kobayashi Y. Kobylarz J. Kocabora S. Koch D. D. Koch F. Koch H.-R. Koch M. Kociok N. Kocur I. MO P-MO-151 P-SA-186 P-SU-253 TU TU TU P-TU-091 P-TU-096 SU SU SU-45 P-MO-148 WOC-C SU-12 TU-70 TU P-SU-095 WE SA WE P-TU-049 P-SA-166 SA-20 SA SU P-MO-297 SA-20 SA P-MO-297 P-SA-265 SA-26 SA SU MO-38 MO TU TU WE-01 WE P-SU-181 P-SA-105 SA P-SA-047 P-SU-107 P-SU-124 P-TU-200 P-TU-222 P-MO-175 P-MO-267 P-SA-128 SU SU-16 MO-37 MO MO TU TU P-MO-196 P-MO-207 WOC-C-36 WOC-C WOC-C-37 WOC-C WE-17 WE P-TU-243 P-SA-168 P-SU-258 P-SU-260 P-TU-243 P-TU-254 SU-65 SU TU Author Index

392 388 WOC 2010 Author Index Koffler B. H. Kofoed P. Kogan B. Koh A. Koh H. J. Koh T. Kohl S. Köhler J. Köhler M. Kohlhaas M. Kohli S. Kohlmann T. Kohnen S. Kohnen T. Kohno T. Koinzer S. Koizumi I. Kojima S. Kok H. S. Kokemueller H. Koler E. Koleva-Georgieva D. Kolker A. Koller T. Kollmann K. H. M. Kolodziejska U. Komatsu N. Komm D. Komori S. Kompella U. B. SU-09 SU WE MO P-SA-078 P-SU-277 MO SA P-TU-079 MO P-SU-196 P-TU-250 P-SU-184 SA-13 SA P-SA-052 P-MO-072 SU WE WOC-C SA-07 SA SU-15 SU MO MO MO-40 MO TU TU TU TU-61 TU TU WE WE-10 WE P-MO-019 P-MO-116 P-SA-157 P-TU-001 P-TU-015 P-TU-016 WOC-C-05 WOC-AAD-C-16 WOC-C P-TU-195 P-SU-253 P-TU-196 SU P-SU-257 P-TU-064 P-TU-068 P-SU-020 SU MO P-SA-050 SA SU SU-58 SA-37 SA SA SA SA P-MO-079 P-MO-088 P-SA-099 TU P-SA-279 P-SU-161 P-SA-107 P-SA-136 MO Kondo M. Kondo N. Konen W. Kong S. J. Konidaris V. Königsdörffer E. Konrad J. Konstantinidis A. Konstas A. Konstas A. G. P. Kook D. Kook M. S. Kook P. Koop N. Kopayenko G. Kopp K. Kopsachilis N. Korber N. Kornhuber J. Korobelnik J.-F. Korotkih S. A. Korth R. M. E. Korwitz U. Kosanovic-Jakovic N. Kose D. Koshitz I. Kosińska J. Koss M. J. Kostenko P. Kotak S. Kotamarthi V. Kotb Ali K. Kotera Y. Kothari M. Kotliar K. Kotoula M. Koukkoulli A. Kovacs R. Kovalov A. Kowalski J. W. Kowarsch T. P-MO-194 P-SA-175 P-TU-214 P-MO-213 MO P-TU-066 TU P-MO-248 P-SA-276 P-SU-035 P-SA-277 P-MO-146 P-MO-259 P-SU-191 TU MO SU MO WE-13 MO MO P-MO-116 P-SA-051 P-TU-017 P-TU-021 SA MO P-MO-205 P-TU-205 P-SU-031 P-SU-034 P-SA-235 P-SU-033 P-SU-100 TU P-SU-098 SA SA P-SU-181 FR MO-48 MO P-TU-230 SU MO P-SA-091 MO TU P-MO-196 P-MO-207 WOC-C-37 TU P-SA-100 P-SA-261 P-SA-039 P-MO-043 P-SA-126 P-SA-225 SU MO P-TU-180 SU TU TU MO P-SU-212 P-TU-049 P-MO-290 TU MO P-SU-110 WE P-SU-184 Kozak I. Kozeis N. Kozobolis V. Kracht J. Kramann C. P-MO-210 P-MO-210 SU TU SU SU P-SA-224 MO P-MO-187 P-SA-190 SU P-SA-265 MO MO Kramar E. Kramp H. Kranebitter N. Krantz K. Kranz-Opgen-Rhein B. SU Krappe A. P-SA-162 Kraut A. P-SA-206 Kravchuk E. SA WE Krawczyk A. SU Krebs I. P-TU-176 Kreil D. P-SA-164 Kreiner C. F. WE-12 WE Kreissig I. Krema H. Kreutzer T. Kriechbaum K. Krieglstein G. K. Krishna P. V. Krogmann F. Krohne T. U. Kroisamer J.-S. Krueger R. R. Krug M. Krüger A. Krüger C. Krüger H. Krüger N. Kruglova G. Krupin T. Kruse F. E. WOC-C-62 WOC-C WOC-C MO TU TU MO SA-11 SA SA-21 SA-28 SU-05 SU TU MO SU-46 SU TU TU P-SU-254 P-TU-227 TU MO SA SA-02 SU TU MO MO P-MO-218 WOC-C-36 P-SA-184 P-SA-185 P-SA-210 MO-12 MO SA SA SU-17 SU-77 SU MO-17 MO MO TU TU TU WE P-SA-065 P-SU-098 P-SU-249 P-TU-127

393 WOC Kruse K. TU Krysta A. P-SU-098 Ksiazek S. MO MO Kuang T.-M. P-SU-067 Kubicka-Trza ska A. P-SA-183 P-MO-175 P-MO-267 Kubota A. SU Kubota T. P-MO-199 SU TU Kuchenbecker J. WE Küchle M. P-SA-031 Kuchynka P. TU Kudou A. P-SA-015 Kuehlmeyer S. P-TU-007 Kugler W. P-MO-240 Kuhn D. SA-15 SA Kuhn F. TU TU-28 TU WE-26 WE WE WE-27 WE WE-28 WE WOC-C-50 WOC-C Kujala E. TU Kuklin A. P-SA-160 Kuljaca Z. P-TU-071 Kulkarni U. V. P-SA-199 Kumagami T. P-MO-230 P-MO-247 P-TU-004 Kumar A. MO TU Kumar N. P-MO-217 SU Kumar S. SU SU MO TU-56 Kumaramanickavel G. TU Kumaran S. MO SU Kunert K. TU Kunimatsu S. P-SU-107 Kunst F. P-SA-184 P-SA-185 Künster A. SU Kunze A. P-SU-258 Kuoliene K. P-SA-181 Kuper H. WE Kupferschmid S. SU P-MO-025 P-MO-277 Kupitz D. G. P-MO-086 Kuppermann B. D. SA-22 SA MO TU TU-47 Kuri J. V. MO Kurihara T. TU Kurimoto Y. P-TU-225 Kuriyama S. P-SA-097 Kurli M. P-TU-111 Kuroda S. SA Kurtenbach A. P-SA-152 Kurtz A. P-SU-268 Kuruca S. E. Kurup S. K. Kurz H. Kürzinger G. R. K. Kusano M. Küstner M. Kusuhara S. Kuwahara T. Kuznetsova T. Kwag J. H. Kwag T. Y. Kwok K. Kyari F. Kychenthal A. Kymes S. M. Kyomoto T. L Labbé A. Lacey J. Lackerbauer C.-A Lackner E.-M. Laganovska G. Lagrèze W. A. Laguía M. Lai F. Lai M.-S. Lai T. Lai W. W. Laidlaw D. A. H. Lala C. Lally S. Lam W. C. Lamard M. Lambert S. R. Lammer J. Lammersdorf K. Lamminen H. Lamoureux E. Lamparter J. Lan C. Landa G. P-SA-128 SU MO MO SU P-SA-193 P-MO-184 P-TU-215 P-MO-230 P-TU-004 SU P-MO-213 P-MO-254 P-SA-232 P-SA-203 P-TU-054 P-TU-054 P-SU-097 P-SU-064 WE MO P-TU-060 P-SU-053 WOC-C SU-05 SU P-SA-051 P-SA-202 P-TU-207 MO-25 P-SA-209 SA SU-72 SU P-SA-088 WOC-C WOC-C TU P-MO-014 P-SU-065 MO MO-56 MO P-SA-252 P-SA-260 P-TU-202 MO SU P-SU-048 P-TU-090 SU P-MO-241 SU TU MO P-TU-183 SU-30 SU P-SA-140 P-MO-033 P-MO-045 P-SA-252 MO P-SA-180 P-TU-216 P-TU-224 TU Landau K. Landgren B. Lang G. E. Lang G. K. Lang G. L. Lang M. Lang S. Lange C. Langenbucher A. Langer P. D. SA-38 SA SU SU TU-08 TU WE P-TU-049 P-SA-102 MO-02 MO SA TU-11 TU TU-46 TU P-MO-182 P-SA-193 P-TU-215 WOC-AAD-C WOC-AAD-C WOC-AAD-C WOC-AAD-C WOC-C-32 WOC-C SU SU-53 SU SU-54 SU-56 SU TU-46 TU P-MO-025 P-MO-141 P-MO-159 P-MO-182 P-MO-277 P-SA-050 P-SU-200 P-SU-235 P-TU-033 WOC-C-51 P-MO-184 P-TU-093 P-TU-215 MO SA WE P-SA-146 P-MO-029 P-SA-112 P-TU-006 P-TU-007 TU-27 TU TU SU SU Po-TU Langman M. E. Langmann A. Langmann G. Langwinska-Wosko E. P-SA-091 Lankenau E. MO Lanzetta P. P-SA-212 Lanzl I. M. MO-26 MO MO P-TU-180 TU TU Lappas A. Larkin D. F. P. TU TU-20 TU Author Index

394 390 WOC 2010 Author Index LaRoche R. Lascaratos G. Laspas P. Laties A. M. Latinovic S. Latr I. Lautebach S. Lavinsky D. Lawn S. Lawrence L. Lay Leng S. Lazutina E. Leach N. Lebrilla C. Lebuisson D. A. Lechner T. Lee A. G. Lee B. R. Lee H. Lee J. P. Lee J.-y. Lee P. Lee P.-J. Lee S. Y. Lee S.-B. Lee S.-M. Lee T. Lee V. Y. W. Lee W.-K. Lee Y. Leese G. P. Lehmann M. LeHoang P. Leitão P. Lekskul A. Le Mesurier R. Lemke J. Lemmen K.-D. Lemp M. A. Lenz B. Leon-Gonzalez N. SU P-TU-148 P-TU-150 P-TU-146 WE P-SU-104 SA WE P-SU-048 TU P-SU-155 P-MO-038 P-SA-274 P-SU-072 WOC-C WOC-C SA P-SA-217 TU SU TU P-SU-085 TU P-MO-102 SA-38 SA SU-29 SU MO MO-42 MO MO TU TU SU SU SU P-MO-200 P-TU-184 P-TU-193 TU P-TU-142 MO-09 MO TU P-MO-118 MO-52 MO P-SA-105 P-MO-084 P-MO-118 P-SA-105 P-SA-114 P-SU-015 MO WE P-MO-192 MO P-TU-234 TU P-SU-254 MO MO P-MO-050 P-SA-223 P-SA-223 WE P-SA-088 SU-76 SU TU-09 TU-34 WE SA P-TU-110 Leon-Perez N. Leonardi M. Ler D. Lerner F. Lesauskaite V. Leung D. Y.-l. Leung Y. L. D. Levanova O. Leverkus F. Levinson R. D. Levitsky I. Levold F. Levy C. Levytska G. Lewallen S. Lewando-Hundt G. Lewczuk P. Leys A. Li B. Li C. Li C.-L. Li G.-Y. Li H. Li J. Li Q. Li R. Li W. Li X. Li X. Li X. X. Li X.-Y. Li X.-Y. Li X.-Y. Li X.-Y. Li Y. Li Y. Li Z. Liakopoulos S. Liang H. Liang Q. Liang S. Liao X. Liazos S. Lichtenberg S. Lichter P. Lichtmeß A. Lieb W. E. Liebmann J. M. P-TU-110 WE P-TU-105 TU P-SA-204 SA SA P-MO-095 P-MO-072 SA TU P-MO-238 MO SA P-MO-238 SA SA P-MO-087 WE P-SU-098 MO-02 MO P-SU-088 SU TU-36 P-MO-192 P-SU-103 MO P-SA-231 P-SU-133 P-SU-227 WE SU P-SU-254 SA-34 SA MO-56 MO MO P-MO-018 P-MO-265 SU SU MO MO MO MO P-MO-198 TU TU MO P-SU-088 SU SU MO P-SA-165 P-SA-198 P-MO-076 P-SU-070 P-TU-256 TU P-SA-001 P-SA-007 WE P-MO-217 P-SA-148 SU-20 SU SU-21 P-MO-039 Po-SU MO-13 MO Liegl R. Liehneova K. Liekfeld A. Liesegang T. J. Lietman T. M. Liggett P. Lightman S. Lim H. T. Lim L. Lim L. Lim L. Lim S. Lim S. C. Lim T. H. Lima L. H. Limberger I.-J. Lin X. Lin A. Lin C.-P. Lin J.-C. Lin J.-E. C. Lin M. Lin P.-Y. Lin T. Lin X. Lincoff H. Lincoln V. A. C. Lindell J. Lindfield R. Lindig A. Lindsell B. Lingenfelder C. Link D. Linke S. Linke S. Lipener C. Lipshitz I. Lisboa J. Lisch W. Lisochkina A. P-MO-233 P-SA-173 P-SA-202 TU P-SA-048 P-SA-049 SU Po-MO WOC-C MO-21 MO TU TU-45 TU TU-65 TU P-SA-236 P-SA-244 P-SA-268 P-SA-281 P-SU-009 P-SU-110 LS P-TU-142 SU SA MO P-SU-047 TU MO P-MO-169 MO P-SA-172 SA P-TU-008 P-SA-221 P-SU-088 TU P-MO-090 P-SU-065 MO P-TU-199 P-SU-193 P-SU-067 MO P-MO-071 P-TU-199 P-SA-216 WOC-C-62 WOC-C P-MO-101 SU WE WE P-SU-175 MO P-MO-240 P-TU-031 P-SA-145 P-SA-147 P-SA-082 P-SU-271 SU TU SA SA-32 SA P-MO-227 MO P-MO-050 SA-18 TU MO P-SA-203 TU-33-07

395 WOC Little B. Liu A. Liu C. Liu C. J.-L. Liu C.-C. Liu C.-c. Liu C.-M. Liu D. Liu D. T. L. Liu F. Liu H. Liu J. Liu J.-H. Liu N. Liu N. P. Liu P. Liu Q. Liu R. Liu S. Liu W. Liu X. Liu Y. Liu Z. Liutkeviciene R. Livchits L. Liveikiene A. Livingstone B. I. Ljutica M. Lo L.-C. Loewenstein A. Löffler K. U. Lohmann C. P. TU MO P-MO-136 MO MO P-MO-198 P-SA-105 P-SA-114 P-SU-067 MO P-MO-071 P-TU-059 TU TU P-SU-059 P-SA-093 P-SU-222 P-MO-192 P-SU-088 MO WE P-SU-059 P-SU-067 MO Su Su SA P-MO-136 P-SA-092 SU SU SA SA TU P-SA-138 TU WE P-SA-204 P-SU-178 P-SA-098 P-SA-181 P-SU-134 P-MO-280 P-SA-199 P-SA-220 P-MO-090 MO MO-32 MO MO-50 MO MO MO MO TU WE LS SU-12 MO-43 MO-44 P-SU-006 SA SU-35 MO TU P-MO-146 P-MO-171 P-MO-205 P-SA-101 P-SA-233 P-SA-263 P-SU-111 P-MO-228 P-TU-120 P-TU-205 Lohmann D. Lohr A. Lommatzsch A. Lommatzsch P. K. Longstaff S. Looi A. Loos D. Loos Z. Lopes M. d. F. Lopez Galvez M. I. Lopez-Lara F. J. López-Lizcano R. Lopez-Prats M. J. Lopez-Star E. Lorenz B. Lorenz K. Lossbrandt U. Lotfi A. Lou J. Lou M. Loukopoulos V. Lovisolo C. F. Löw U. Lowder C. Y. Loyet K. Lu D. Lu J. Lu J.-m. Lu N. Lu W. Lubatschowski H. Lubimova N. V. Lucas T. Luchs J. Lüchtenberg M. Lucke K. SA-09 SA P-SA-256 TU SU MO P-SU-192 P-SU-216 P-SU-245 P-TU-205 P-SU-104 SU TU SU P-SA-266 P-SA-243 P-SU-024 SA-10 SA SU-41 MO-04 MO-05 MO-06 MO MO-07 MO TU-07 TU TU-55 TU P-SA-246 P-SU-184 P-TU-152 P-TU-174 P-TU-186 MO P-MO-187 P-SA-190 P-TU-080 P-TU-211 TU SA SA TU MO P-SU-022 TU SA P-MO-035 P-MO-278 P-SA-081 P-SU-276 SA MO TU P-SU-110 MO P-MO-167 MO P-SU-044 TU SU SU MO SU P-SU-260 P-TU-059 P-SA-224 TU-01 TU P-SA-170 WOC-C WOC-C Luco C. Ludescher M. Ludgate M. Luedtke H. Luhmann U. Lukas J. Lukauskiene R. Lüke J. Lüke M. Lumbroso B. Lumi X. Luna de Sampaio V. Luna E. Lundström M. Luo M. Luthert P. J. Lütjen-Drecoll E. Luyten G. Lyia R. Lyngholm M. Lynn W. A. M SA-38 SA SU-18 MO-81 MO P-MO-297 SU MO-82 P-SA-002 MO SU P-SU-178 P-TU-097 MO P-TU-097 P-TU-181 WOC-C P-MO-231 P-TU-262 SU SU-16 SU MO MO P-SU-009 P-SU-099 SU SU P-TU-175 SU P-SA-244 M. Dheepa P-MO-272 M. Chibisova J. SU Ma K. P-SA-095 SA Ma L.-b. MO Ma Z. P-MO-105 P-TU-264 Maalouf T. P-SU-055 Maar B. MO Macedo G. P-MO-115 Machackova M. P-MO-281 P-SU-155 Machalska M. P-TU-201 MacKeben M. P-SA-208 Mackensen F. SA-40 SA SU SU MO MO TU P-SA-241 Mackenzie G. E. WE Mackert M. MO Mackey D. MO Mackiewicz J. P-SA-168 MacLaren R. E. SA-03 SA TU-36 WE-14 WE MacRae M. P-TU-146 P-TU-150 Madrigal R. TU Mady S. P-SA-142 Maeda N. WE Maeda T. P-MO-063 Maeda-Chubachi T. SU Magalhaes Jr. O. MO Magauran D. WE Author Index

396 392 WOC 2010 Author Index Maggi R. Mahajan s. Mahatme V. Mahendra M. Mahendradas P. Maher L. Mahmood H. Mahmoud T. Maia M. Maier A.-K. Maier M. Maier P. Majdanik E. Majumdar M. Makeev O. G. Maklakova I. Makri O. Makrygiannis G. Malaravan M. Malbrán E. Malik A. Malik K. Malinouskaya I. Malinowska U. Mallipatna A. Malov I. Malyugin B. Manaysay R. Mandai M. Mandal A. K. Mandic Z. Manku K. P-MO-161 P-SA-074 P-TU-035 P-TU-042 P-TU-164 SU SU SU P-SA-005 P-SA-032 MO WE WOC-C-39 MO MO P-SU-011 SU P-SA-113 P-MO-015 P-MO-016 MO P-MO-146 P-MO-171 P-MO-205 P-MO-228 Po-MO P-SA-101 P-SA-208 P-SA-233 P-SA-263 P-TU-205 SA TU MO SU TU-19 TU Po-SU P-MO-038 P-SA-068 P-SU-061 SU P-TU-055 P-SU-181 SU P-MO-190 P-MO-214 P-MO-259 P-MO-070 TU SU P-MO-268 P-SU-195 P-TU-040 P-SU-269 P-TU-192 SU SU SU TU P-SU-062 SU-14 SU SU SU TU TU-82 TU WOC-C P-MO-081 P-TU-208 TU MO-25 WE P-SA-244 Mannan A. Mannis M. Mannsfeld A. Mannucci L. Manquez M. E. Mansberger S. L. Mansour A. Mansouri I. Manzanas L. Mao X. Marcellino G. R. Mardekian J. Marie S. Marín Lambies C. Marínez-Giralt O. Marinho A. A. P. Marinkovic M. Marin-Lambies C. Marioneaux S. J. Mariotti S. P. Marius R. Mark H. Märker D. A. Markiewicz A. Markowitz J. Marsh I. Marshall J. Martin F. Martin G. Martin K. Martin L. Martin T. P-SU-071 P-SU-085 P-TU-008 P-TU-018 P-MO-017 P-SU-021 MO TU SU SU MO MO P-MO-092 P-MO-275 P-SU-077 P-TU-189 TU P-MO-287 P-MO-195 P-MO-174 P-SA-100 P-SU-208 P-TU-210 TU MO SU P-MO-189 MO TU P-TU-107 WOC-C-38 WOC-C WOC-C WOC-C WOC-C WOC-C P-MO-096 P-MO-157 MO P-TU-092 P-TU-128 P-TU-090 P-SU-150 WE-02 MO-69 MO P-SA-161 P-TU-246 MO P-TU-144 TU SA TU P-SU-190 P-TU-188 P-MO-115 SA Martinez A. Martinez E. Martinez M. R. Martínez Serrano R. E. P-MO-183 P-MO-250 P-TU-041 P-TU-131 Martinez-Castillo S. Martinez-Castro F. Martinova L. Martins E. N. Martius P. Maruko I. Marx-Gross S. Mas A. S. Masaki T. Masayoshi K. Mashayekhi A. Mason I. P-MO-189 P-SU-024 P-SA-151 P-MO-282 P-SA-077 P-MO-165 TU P-TU-161 P-SA-047 TU P-TU-090 SU SA Masood I. MO P-MO-030 Massin P. MO SU Masuda A. P-MO-172 P-SU-121 Mata E. P-SU-083 P-SU-207 Mathenge W. SA SA SU Matsuba T. P-TU-077 Matsuda R. P-MO-064 P-SU-158 Matsumoto C. P-SA-106 P-SA-109 Matsumura N. P-SU-255 Matsunaga Y. P-SU-158 Matsuoka M. P-SA-159 Matsushita K. P-TU-069 TU Matsuura T. P-MO-138 P-SU-037 Matsuyama K. P-SA-159 Matt G. MO Matthaei M. P-TU-056 P-TU-073 WE Matu C. P-SU-005 Matveeva I. WE Maudgil A. P-TU-160 Maumenee I. H. TU-55 TU Mavija M. P-TU-230 P-TU-240 Mavija Z. P-TU-230 Max R. MO SU May F. P-SU-055 Maychuk N. SU Mayer C. P-MO-171 P-TU-120 Mayer C. F. P-TU-022 P-TU-207 Mayer E. J. P-SU-252 Mayer W. MO P-SA-051 P-SA-178 P-TU-021 WE Maynart Tavares I. P-TU-206 Mayorga Argañaraz E. MO MO MO-44 MO Mazzotta C. P-SA-071 SU McCannel C. A. MO McCannel T. MO McCluskey P. TU TU-73 TU McCluskey P. P-SA-244 McCormick S. A. P-TU-111 McCranor L. TU McDonald M. MO WE-02 WE McDonnell P. TU TU-80 McElvanney A. P-MO-295 McKeown C. MO McLauchlan R. P-MO-195 McMeel J. W. P-MO-049 McNamee P. TU-29-03

397 WOC McRae S. Md Din N. Medeiros F. A. Medina N. H. Medoruma I. Medoruma K. Megzari A. Mehat M. S. Mehdizadeh M. Mehriar M. Mehrotra A. Mehrotra S. Mehta A. Mehta K. R. Mei H. Mei L. Meier M. Meier P. Meigen T. Meindl A. Melamed S. Melicher Larson J. Melki S. A. Melkonyan H. Mellein A. C. Meller D. Melles G. R. J. Meltendorf S. Mély R. Menapace R. Mendoza C. Menghini M. Menke M. Mennel S. Menon G. Menon V. Mensink H. W. Mentkevich G. Menz D.-H. Merayo-Lloves J. Merchant A. Merle H. Mermoud A. Merriam J. SU-60 P-SU-020 P-TU-063 MO-22 SU P-SA-120 P-SA-123 P-TU-067 P-TU-067 P-MO-066 P-SA-141 P-TU-139 TU P-SU-056 MO P-SA-278 P-SU-108 P-SU-108 P-SU-195 P-TU-040 TU P-MO-261 P-SA-138 MO TU SU SU SU TU P-SU-223 WE P-SU-103 P-MO-274 P-TU-066 FR SA-17 MO WE-05 WE P-SU-038 P-SU-042 SU TU TU WE SA TU-26 TU SA-05 SA MO TU P-TU-185 SA WE P-TU-049 SU MO P-MO-220 P-MO-253 P-MO-211 MO P-TU-141 SU SU WE P-MO-102 P-SU-179 P-SU-185 TU P-SU-086 SU TU SU SA Merté R.-L. Messias A. Messinger J. D. Messmer E. M. Mestdagh P. Mester U. Metz C. Metzger L. Meyer C. Meyer C. H. Meyer K. Meyer M. Meyer M. W. Meyer T. Meyer-Rüsenberg B. Meyer- Rüsenberg H.-W. Meyer-ter-Vehn T. Michael S. Michaelis M. Michalewska Z. Michalewski J. Michalik R. Michalik-Wójcik A. Michalke B. Michelle T. Michels R. Michels S. Michelson G. Midelfart A. Midena E. Midori Yabiku M. P-TU-044 P-TU-083 P-SA-144 P-SU-251 FR SU MO TU-49 TU TU-70 TU WOC-AAD-C-24 P-SA-044 P-SA-067 P-TU-123 WE-19 WE Po-TU P-SA-239 P-TU-187 P-SU-268 SA TU MO MO Po-SU P-SA-158 P-SU-011 P-TU-227 P-TU-243 MO P-SU-220 P-SU-100 P-TU-048 P-MO-151 P-SA-182 P-SA-184 P-SA-185 P-SA-189 SU-42 MO TU-06 TU P-SU-226 P-SU-248 WOC-C-52 P-SU-013 SU MO MO TU MO P-MO-207 TU P-SU-153 MO TU SU SU TU MO P-SU-027 P-TU-177 TU SA-29 SA SU-62 MO-53 P-SU-016 MO WE P-SA-271 Mieler W. F. Mielniczuk E. Migdal C. Mihnea M. Miki A. Miki N. Milenkovic S. Milenkovic V. Miliauskaitė L. Miller J. Miller M. Miller N. Miller W. Milman T. Milojcic C. Mimura O. SA-25 SA-35 SA SU MO MO-16 MO MO WOC-C P-MO-056 MO-54 LS-17 P-TU-107 P-TU-069 TU P-TU-195 P-TU-230 P-TU-240 P-MO-157 P-SU-268 P-SA-116 MO SU-55 MO P-SU-125 TU P-TU-109 P-TU-111 P-SA-195 TU WE P-SU-121 P-SU-135 P-MO-264 TU P-TU-129 MO TU P-SU-024 Minami M. Minavi A. Minoshima S. Mintz-Hittner H. A. Miraglia O. Mira-Lorenzo X. Miranda Hernandez I. P-SA-023 Mirlay R. P-SA-016 Mironow A. MO Mirsakhanova H. P-TU-135 Mirshahi A. MO P-TU-211 TU TU Mirsoev S. Misailovic K. Misefari W. Miserocchi E. Mishev L. Mitchell P. Mito T. Mitra A. K. Mitsch C. Mittelviefhaus H. Mittica P. Mittica V. Miura H. Miura Y. Miyagawa Y. Miyahara T. P-SA-042 P-TU-071 SA SA P-TU-039 SA SU MO MO TU-35 WE WE-38 WE WE-40 P-SU-051 P-MO-011 WE P-TU-232 SU-81 P-TU-047 P-SA-137 P-SA-137 P-MO-178 P-SA-186 TU P-MO-193 P-MO-266 P-SU-053 Author Index

398 394 WOC 2010 Author Index Miyake A. Miyake K. Miyamoto C. Miyamoto N. Miyamoto T. Miyamura N. Miyata N. Miyazaki D. Mizariene V. Mizoguchi T. Mizokami J. Mladenovic J. Möbius H. Mochizuki K. Mochizuki M. Módis L. Moeller C. Mohamad C. M. Mohamed A. M. Mohamed M. Mohamed S. Mohammadi S. Mohammed I. Mohan R. R. Mohd Rawi N. A. Möhle F. Mohney B. Mojon D. Mokaddam A. Molchanyuk N. Mollayes G. Monnet D. Montemagno C. Montenarh M. Montón C. Montuoro A. Moon N. J. Moore A. T. Moorthy B. Mooy C. M. Moraes N. Morales P. H. Morawski K. Morax S. Mörchen M. Moreno L. Moreno-Nadal M. A. Morfeld P. Morgan C. Mori S. P-MO-011 SU P-MO-282 P-TU-225 P-SA-232 TU P-MO-247 P-MO-256 SU P-SU-219 P-MO-011 P-SA-279 P-SA-204 P-SA-103 P-SA-131 P-SA-154 P-SU-176 MO P-SA-107 P-SA-136 TU TU P-MO-188 P-SA-097 P-SA-229 TU-72 TU P-MO-098 P-SA-275 P-SU-050 MO P-TU-179 P-TU-182 TU P-SU-165 TU SU MO P-SA-275 P-MO-151 SU SU-23 SU-72 SU MO-66 MO MO WE-20 Po-TU P-MO-275 P-TU-166 P-MO-092 MO MO P-SU-265 P-SU-083 P-SA-164 P-MO-284 P-SA-219 WE-35 SU SA P-TU-188 SU P-SA-183 MO P-MO-083 P-MO-099 TU TU P-SA-119 P-MO-039 P-SU-071 P-MO-043 P-SA-126 Morita H. Morita I. Moriyama A. S. Moriyama M. Morkhat M. Morkhat V. Morlet N. Morris R. J. Morse L. Morsy M. Mortada H. Morton J. Mosallaei M. Mosca L. Moschos M. Moshfeghi A. Moshfeghi D. Mosqueda P. Mossböck G. Moster M. Mosuro A. Motamedi M. J. Motizuki M. Motolese E. Motolese I. Motschmann M. Mouhdi H. S. Moussa S. Moustafa M. Moutsouris K. Mrochen M. Mršić J. Mrukwa-Kominek E. Mrvos-Cobeljic D. Muacevic A. Muccioli C. Mucke E. Mucke H. Mucke P. M. Mueller A. Mueller I. TU P-SU-182 P-MO-098 P-MO-188 P-SA-229 P-SU-182 SU P-MO-053 P-TU-190 P-MO-053 P-TU-190 WE P-MO-272 SU P-SA-211 TU MO SU TU WE-28 WE WE P-SA-278 P-TU-136 P-SA-062 P-MO-035 WE TU WE WOC-C SA P-SA-135 MO WE P-SU-165 P-SU-182 P-SA-137 P-SA-137 P-SA-162 P-TU-189 P-TU-176 P-SA-230 TU SU-60 SU MO P-SU-152 SU P-MO-022 P-MO-056 P-MO-109 P-MO-162 P-TU-171 P-TU-201 WOC-C-46 WOC-C WOC-C P-SU-176 P-TU-091 P-TU-096 SU MO WE P-TU-206 P-SU-010 P-SU-018 P-SU-010 P-SU-018 P-SU-010 P-SU-018 P-SU-188 P-TU-263 SU WE WE Mueller M. Mueller S. Muhd Zafran bin Shamsudin M. Z. Muhit M. Muhović -Bejtić J. Mukherjee B. Mukherjee R. Muldoon T. Müller A. Müller A. M. Müller B.-K. Müller H. Müller M. Mulvihill A. Munana J. Munch I. C. Mundorf T. K. Mundt H. W. Munier F. Munk M. Muñoz M. F. Muñoz-Negrete F. Muqit M. Muraine M. Murakami A. Murakami Y. Murata T. Murenzi J. Murillo-Correa C. Murjaneh S. Murotani E. Murray A. Murray P. I. Murray T. G. Murta J. N. Murthy G. V. S. Murube del Castillo D. J. Mylonas G. P-SU-023 P-TU-075 P-TU-181 TU MO P-TU-105 P-SU-244 SU P-SU-189 MO P-SA-180 P-TU-216 TU SA P-SU-006 P-SU-179 MO SA MO WE WOC-C-14 WOC-C WOC-C P-TU-150 P-TU-148 SU SA P-MO-071 P-TU-059 TU TU SA SA-18 SA MO P-SA-200 SU P-SU-132 P-MO-174 P-MO-195 TU P-SA-087 P-SU-052 TU P-MO-266 P-SU-053 SU SU TU P-SU-141 P-SU-159 MO TU TU MO TU-47 TU-83 WE-30 WE SA-25 MO TU TU MO TU WE SU TU TU-79 TU MO P-TU-028

399 WOC N Nadal J. Nadarajah S. Nadras I. Nafie I. Nagai T. Nagaoka T. Nagasaka E. Nagata M. Nagel E. Nagel J. Nagel J. A. Nagori S. Nagpal P. N. Nagy A. Nagy Z. Z. Nahen K. Nahra D. Naidoo K. Naik R. K. Najm-Tehrani N. Naka M. Nakabayashi S. Nakada C. Nakagawa Y. Nakaizumi A. Nakamoto H. Nakamoto K. Nakamura H. Nakamura K. Nakamura M. Nakamura S. Nakamura Y. Nakanishi H. Nakano N. Nakao S. Nakao T. Nakata I. Nakayama M. Nakazawa M. Nan B. Naranjo-Tackman R. Nardi M. Narendran K. Narendran V. Narita A. Nasaruddin R. A. Nascimento H. Nasri A. Nasser Z. Natalia V. WOC-C-40 WOC-C WOC-C WOC-C P-TU-170 P-SU-134 P-SA-142 P-MO-213 P-MO-153 P-SU-146 SA P-TU-194 MO MO SU SU P-SU-028 TU WOC-C P-SA-006 SA SA WE-36 WE P-SU-110 SU MO P-SA-131 P-SA-154 P-MO-153 SU P-TU-231 P-MO-264 SU P-SA-115 P-MO-043 P-SA-126 P-TU-067 P-SA-037 MO P-SA-131 P-SA-154 P-TU-252 P-SA-123 P-MO-043 P-SA-097 P-SA-126 P-SA-167 P-TU-172 P-MO-043 P-SA-126 P-TU-220 P-SU-255 P-SU-262 P-SA-097 P-SA-167 P-MO-064 P-MO-193 P-SA-015 WE SA SU WOC-C WOC-C-58 WOC-C WOC-C P-TU-072 P-SA-259 P-MO-023 SU SU P-TU-175 Natarajan S. Natesh S. Nau J. Naumann G. O. H. Naumenko L. Naus N. Naval C. I. Nawrocka L. Nawrocki J. Naycheva L. Nechiporenko P. Nefedova D. Negi A. Negishi T. Neidhardt J. Neira W. Nelson S. F. Németh J. Nentwich M. M. Neophytou P. Nerad J. Nesnas K. Ness T. Netto C. Netukova M. Neubauer A. Neuburger M. Neudorfer B. Neugebauer A. Neuhann I. Neuhann T. MO WE MO P-TU-109 P-TU-111 P-TU-218 TU SU-56 TU-68 P-TU-127 P-TU-088 SU WE P-MO-162 MO TU TU TU P-SA-155 MO P-SA-203 TU SA MO P-MO-213 P-MO-254 P-SA-131 P-SA-154 P-SA-215 P-SA-088 TU MO SU-28 SU-37 TU-02 TU P-TU-091 SU SU WE P-TU-096 SU P-SU-223 P-MO-211 SU MO-50 MO SA P-SA-048 TU MO MO P-MO-210 P-MO-233 P-MO-271 P-SA-173 P-SA-202 P-SU-186 P-TU-191 P-TU-228 P-TU-237 SU TU TU P-MO-038 TU SU SA-45 SA MO P-MO-124 SU Neuhann T. F. Neutzner R. V. Newman D. Nezgoda J. Ng H. K. Ng J. Ngah N. F. Ngai J. W. S. Ngo-Tu T. Nguyen N. X. Nguyen Q. D. Nguyen T. Nicholson E. Nikolic S. Ninios K. Nischal K. K Nishi M. Nishi O. Nishida K. Nishida T. Nishiguchi K. M. Nishikawa N. Nishimura M. Nishina S. Nitta N. Nix G. Nkomazana O. Nkumbe H. Nobrega M. J. Noh Y. Nölle B. Nomoto H. Nonaka A. Noonan C. Norbert P. Noske W. Notara M. Novák J. Novak Laus K. Nowak M. Nowinska A. Ntountas Y. Nuijts R. SA-13 SA SA-26 SU-13 SU MO-37 MO TU TU-24 TU TU P-TU-174 P-MO-197 P-TU-216 P-SU-222 WE P-SA-272 P-TU-108 P-MO-142 TU-14 TU SU MO-01 MO MO MO MO TU WE-35 P-SU-036 P-SU-252 WOC-C P-SU-276 MO-05 MO MO TU-75 SU P-MO-064 P-SU-270 P-SA-282 P-SU-121 P-SU-135 P-SU-124 P-TU-200 P-TU-222 TU P-SA-044 P-SA-067 P-TU-010 SA P-TU-103 SA-37 SA SA SA MO P-TU-234 SU P-SA-020 P-MO-043 P-SU-150 P-TU-147 WE FR P-TU-025 WE MO MO SA SU SU-15 SU SU TU Author Index

400 396 WOC 2010 Author Index Nukada M. Nusanti S. Nussenblatt R. Nutheti R. Nyaga P. T. O Ober M. Oberacher-Velten I. Oberheide U. Obholzer K. O'Brien T. Obstbaum S. A. Ochiai M. Ocklenburg C. Odrobina D. Oehler S. Oelckers S. Oestreicher J. Oetoyo A. S. Ofner J. Oganesyan O. Ogata N. Ogun O. A. Ogundimu K. Ogundipe B. Ogura Y. Oh D. H. Ohashi Y. Ohba S. Ohishi M. Ohji M. Ohkubo S. Ohno K. Ohno S. Ohno-Matsui K. Ohrloff C. Ohtsuki H. Oi A. Ojima A. P-MO-043 P-SA-126 P-SU-126 TU SU-31 SU MO-46 MO MO TU-17 TU SU P-MO-079 P-MO-088 MO P-MO-210 MO-58 MO P-MO-204 P-SA-124 P-MO-144 SA TU P-SA-173 TU SA-06 SA TU-04 TU P-SU-107 TU MO TU MO SU-71 SU MO P-SU-091 TU P-SA-045 P-SA-159 WE WE SA SU P-TU-259 WE MO-01 TU P-MO-284 P-MO-296 P-MO-011 P-SU-124 P-SU-089 SU P-SU-141 P-SU-159 P-SA-097 TU-73 TU WE MO MO-24 P-MO-188 P-SA-229 P-SU-041 P-SA-222 P-MO-068 P-MO-089 P-SA-017 P-MO-165 Okada A. A. Okada E. Okajima Y. Okamoto F. Okamoto Y. Okazaki Y. O Keefe M. Oki S. Okimoto S. Oku H. Okuda T. Okunuki Y. Okuyama M. Okuyama S. Olali C. Olawoye S. Oldak M. Olędzka G. Oleksy P. Oleszczuk J. Olfa H. T. Oli Mohamed S. Olivares C. Q. Oliveira Neto H. Olivier J. Olivier M. M. G. Olsen T. Olson J. Olson J. Olson J. A. Olson R. J. Oluleye T. Olusanya B. Omae T. Omarganova I. Omran M. S. Ondas B. Ondiveeran V. R. Oner F. H. Ong L. Ono K. Onyango O. M. Oohashi H. Ooi A. Oono K. Ooto S. Ophir A. Ophthalmic PDT study group Oppermann T. Orapiriyakul L. Orgül S. Orikasa H. Orilla W. Orozco M. TU SU P-SU-219 P-MO-027 P-MO-163 P-MO-172 P-MO-235 P-MO-239 P-SA-150 P-MO-163 P-TU-220 P-TU-195 MO P-SA-004 P-SA-037 P-TU-070 P-SU-257 P-TU-068 P-SA-247 P-SU-124 P-SA-106 P-SA-109 MO WE P-SA-091 P-SU-026 P-MO-175 P-MO-267 P-TU-085 P-MO-028 P-SA-249 P-SA-272 WE MO P-TU-036 MO MO TU-10 TU SA-29 SU TU MO TU-68 TU WE SU WE P-MO-153 P-SA-160 SU P-SA-192 TU-14 TU P-MO-234 MO P-SU-052 P-MO-079 P-MO-088 P-SU-114 P-MO-258 P-SU-182 P-SA-167 P-TU-172 SA P-SA-191 P-MO-164 P-SA-117 TU-16 WE P-SU-089 P-TU-199 SU Orzekowsky- Schroeder R. Osaki M. Osaki T. Osborne N. N. Oshika T. Oshima Y. Osma I. Ossma-Gomez I. L. Oster S. Otani A. Otani F. Otani T. Othman O. Otsuji T. Otterbach F. Ouazzani Tnachri B. Owoaje E. Owoeye F. Ozaki M. Ozawa S. Ozcan S. Özkan S. B. Özlügedik S. Oztura I. Öztürk C. Ozturker C. Özyurt O. P Pačo I. Paetzold J. Pahor D. Pajaujis M. Pakalnis V. A. Pal D. Palanker D. Palis G. Palkovacs E. Pallás C. Pallerla S. Pallikaris I. G. Palomino C. Pampucha V. P-SU-031 P-SU-034 P-SU-208 P-SU-208 P-SU-208 TU P-MO-163 P-MO-172 P-MO-235 P-MO-239 P-SA-150 ES TU P-TU-014 MO-15 MO SU SU TU P-SA-167 P-TU-172 P-MO-011 P-SA-242 P-TU-233 MO P-SA-275 P-SU-020 P-TU-063 P-SA-159 P-SU-042 P-TU-189 SU WE P-SA-097 P-SA-175 P-SU-085 MO-09 MO P-MO-015 P-MO-016 P-TU-061 SA P-SU-198 SA P-TU-105 P-SA-106 MO-26 MO Po-SA P-MO-012 P-TU-058 P-MO-091 TU SU MO P-MO-145 P-MO-298 TU TU MO MO MO P-SU-142 P-TU-074 TU SU TU WE MO P-SA-098

401 WOC Pan Y. Panagakis G. Panagis L. Pande C. Pande M. Pandova M. Pang C. Pang C.-P. Panidou E. Panos L. Pantenburg S. Papanikolaou T. Paques M. Paranhos J. Paranhos Jr. A. Pardo D. Pardo-Lopez D. Paredes I. Parhovchenko E. Paridaens D. Paris V. Park C. K. Park I. K. Park K. H. Park K.-u. Park S. Park S. C. Park S.-h. Parlato Oliveira E. Parrozzani R. Parsa C. F. Partsch M. Parviz B. A. Pascu R. Pasiechnikova N. Paskaleva D. Pasquale L. R. Pastuszka M. Patel A. Patel S. Patel T. Patel V. D. Patelli F. Paterson C. A. Pathai S. Pattiata R. Patton N. Pauk M. Pauklin M. Paul A. Pauleikhoff D. Paulig S. Paulin Huerta J. M. MO SA P-SU-122 P-TU-042 SU SU P-SA-093 MO P-SA-252 P-SA-253 TU P-TU-248 P-MO-197 SU P-SA-046 P-SA-086 P-SA-102 P-MO-097 P-SU-169 P-SA-266 P-MO-081 P-TU-173 SU TU-59 SA P-MO-296 SA SA SU P-SA-211 TU SA MO P-TU-162 P-SU-112 WE WE P-TU-119 MO P-MO-048 P-SA-098 SU MO TU WE MO P-TU-046 TU WOC-C-46 WOC-C WOC-C WOC-C WOC-C MO P-MO-030 P-TU-060 TU TU TU P-SU-066 P-SU-072 P-TU-104 P-MO-174 P-MO-195 TU SA P-SU-038 P-SU-042 P-SU-189 WE TU TU-37 SA SU MO Paulsen F. SU P-SU-012 Paulsson M. P-SU-258 Paulus D. SU-30 SU Pavesio C. SA-08 SA MO Pavlin C. J. MO Pavlovskaya A. WE Peckham C. SU Pedanova E. MO Pe'er J. SA-46 SA SU-39 SU SU-67 SU MO TU Pefkianaki M. MO Peh K. K. P-SU-191 Pelayes D. SU WE-27 WE WOC-C Pellegrini G. MO-17 WE Pemp B. P-TU-232 Peña D. P-SU-086 Peñaloza-Roman I. P-SU-024 Peng J. Su Penha F. M. MO P-SU-011 Penha Morterá Rodrigues M. P-SU-084 Pepic A. P-SU-176 Pereyra-Munoz N. SU SU Perez B. MO P-TU-110 Perez L. P-SU-199 Perez V. L. SA Pèrez-Arteaga A. P-SA-009 TU Perez Fernandez C. TU Perez-Solorzano G. G. P-MO-078 Pericak D. P-MO-074 Perros P. MO-82 MO Pertile G. P-SA-170 Perulasamy N. SA-24 SA Peruzzi S. P-SA-137 Perz C. P-MO-146 P-MO-228 Pesavento R. MO Pester A. P-SU-042 Pesudovs C. WE Peters A. MO Peters N. P-TU-204 Peters S. SA MO P-TU-075 Peters T. N. TU TU Petersen H. P-MO-191 Peto T. SU TU P-SU-064 Petousis V. P-TU-114 Petrarca R. TU Petric Vickovic I. WE Petroska D. P-MO-091 P-TU-084 Petrovski B. WE Petrowitz B. P-SU-271 Petzold A. LS-04 LS Petzold G. LS-04 LS Pezzente M. SU SU Pfeifenbring S. SU Pfeiffer N. SA-23 SA-24 SA SA SU-03 SU SU-73 MO MO MO TU TU TU TU TU-44 TU WE-13 P-MO-033 P-MO-036 P-MO-039 P-MO-045 P-MO-049 P-MO-187 P-SA-111 P-SA-190 P-SU-094 P-SU-104 P-SU-194 P-SU-202 P-SU-204 P-TU-076 P-TU-080 P-TU-241 WOC-C-34 WOC-C-35 LS Pfenninger L. TU Pfirrmann K. P-SU-094 Pfister M. MO Pfrommer S. P-MO-171 P-MO-228 SA TU WE Pham D.-T. SU-14 SU TU-82 WE-10 P-SA-026 Phamonvaechavan P. P-SA-226 Pharmakakis N. P-MO-214 P-MO-190 Philip S. SU TU Philipp W. P-SA-034 Philips R. P-TU-025 Phillips T. P-SA-211 Phuljhele S. P-TU-141 Pieczara E. P-MO-162 Pieh C. SU-23 SU Pieh S. P-MO-110 SA Piekarek M. P-SU-260 Pielen A. P-MO-236 P-SA-070 P-TU-248 TU Author Index

402 398 WOC 2010 Author Index Pietras-Trzpiel M. Pietrzycka J. Pignatari A. C. Pikulski Z. Pilavas J. Pillunat L. E. Pimenidi M. Piñas Garcia P. Pinazo-Duran M. D. Pinchuk L. Piñero Llorens D. P. Pinheiro Callou C. M. Pinheiro Callou E. Pinies J. A. Pinter F. Pinto L. A. Piotrowski J. Piovella M. Piperno-Neumann S. Pircher M. Pircher M. Pisipati S. Pitz S. Pivetti P. Pizinger K. Plager D. A. Plange N. Plant G. Planyavsky M. Plaza A. B. P-MO-260 P-TU-201 P-MO-098 MO TU MO-73 WE-07 WE WE P-SA-139 LS P-SU-087 P-SU-147 P-TU-247 P-SA-119 P-MO-047 P-MO-093 P-MO-160 SU P-SA-063 P-TU-010 P-TU-013 P-TU-024 SA SU P-TU-262 P-TU-262 MO P-MO-271 WE SU TU TU TU P-MO-106 P-MO-130 P-TU-012 P-TU-026 SU MO MO TU P-MO-044 P-MO-051 MO WE-40 WE WE Po-SU P-SU-194 P-SU-202 WOC-AAD-C-27 TU P-TU-113 TU P-SU-140 TU SA SU-18 SU SU-44 TU TU P-SU-188 SA P-TU-010 P-TU-024 SA TU Pleyer U. Ploski R. Poelzl M. Pogrzebielski A. Pojda-Wilczek D. Polling J. R. Pollock A. Pollreisz A. Poloschek C. Poloski E. Polyakov V. Pomsathit J. Ponce A. Ponomareva E. Pons-Vázquez S. Ponto K. A. MO MO SU-24 SU SU SU-33 SU TU-20 TU TU-38 TU TU-47 P-SA-263 WOC-AAD-C-23 P-SA-091 TU MO P-TU-085 P-SA-153 WE TU SU P-SU-188 SA P-SA-088 P-SU-137 WE P-SU-210 TU MO P-SA-180 P-TU-216 P-SA-151 P-MO-160 P-SU-194 P-TU-080 TU P-SU-005 Ponzin D. Pop E. Popa Cherecheanu A. P-MO-048 Poposka D. TU Poposki V. TU Portero-Benito A. P-SU-086 SU SU Porz G. Posarelli C. Pöttgen J. Pournaras C. J. Power I. Po-Yen L. Pozder S. Prabowo R. Prada J. Prager S. G. Praidou A. Prajna N. V. Prakoso H. Prapatjukkit P. Pras E. Prasad S. Prata T. S. Prause J. U. Preen D. P-SU-058 SU SA SU TU-34 TU-48 TU P-SU-071 P-MO-219 P-TU-105 P-MO-132 P-MO-142 P-TU-232 MO MO P-MO-248 P-SA-012 P-SA-276 P-SU-035 TU-24 TU TU WE P-MO-186 P-SA-096 WOC-C P-SA-102 SA-46 SA SU WE Prescott G. J. Preuss M. Preussner P.-R. Price F. W. Price M. O. Priglinger Jr. S. G. Priglinger-Alge C. Prilloff S. Proença R. Prokofyeva E. Prokosch V. Promesberger J. Prünte C. Ptaszynski L. Puccioni M. Puchkov A. Puchkova I. Puech M. Pulido J. S. Puranik S. Pusey C. Pushker N. Pustolla N. Q Qerimi E. Qu C. Quaranta-Leoni F. Quek D. Quellec G. Quinn A. Quinn G. Quiroz-Mercado H. Qureshi M. B. R Rabensteiner D. F. Raber S. Rabsilber T. M. Rad F. M. Radbruch L. Radeck V. Radecka L. Radford J. Radovic N. Rahi J. Rahi J. S. TU WE SA-04 TU P-MO-137 SU-78 SU TU SU SU TU TU WE P-SA-178 P-SU-162 SU SU P-SU-122 P-MO-108 P-MO-293 P-SA-052 TU MO P-SA-164 P-SA-196 WOC-C P-TU-196 WE P-TU-173 P-TU-173 TU SU TU P-TU-141 P-SA-268 P-SU-242 P-MO-201 P-TU-159 P-SU-040 SA P-MO-084 TU TU SU WE TU-42 TU FR FR FR SU SU P-SA-010 P-TU-008 P-TU-018 P-TU-025 MO P-MO-288 P-MO-204 MO-68 P-SA-209 SU P-TU-071 WE SU-07 SU SU-73-07

403 WOC Rahman A. Rainer G. Rajan M. Rajapaksha K. Rakhmonov A. Ralfkiaer E. Rama P. Ramaesh K. Ramamurthy C. Ramamurthy D. Raman V. Ramani R. V. Ramke J. Ramos F. Ramos Lopéz M. Ramulu P. Randall A. D. Randleman J. B. Rao G. N. Rao K. Rao L. Rao N. A. Rao N. P. Rao S. K. Raoof N. Rasmussen M. L. R. Rasp M. Rathore D. S. Rattanasukon M. Rau M. Rauch N. Raum C. Raus P. P. M. Raut R. Ravech S. Raveh I. Ravilla T. Razzaq L. Read R. Realini A. Rebel C. Rebolleda G. Reed D. M. Rees G. Reese J. Regler R. Regoda V. Rehder J. R. C. L. Reichard M. Reichl S. Rein D. B. Reinecke K. P-SU-079 MO TU P-TU-062 P-TU-135 SU MO SU SA P-TU-027 SA P-MO-259 SU MO-10 P-MO-086 WE TU P-SA-033 MO P-SU-252 SU-59 SU MO-38 MO SA SU WE-25 WE MO MO SU-24 SU SU-57 TU MO TU WE-19 WE P-TU-169 SA P-TU-010 P-MO-147 P-MO-186 P-MO-122 P-MO-036 P-TU-147 P-SA-036 SU TU MO P-SA-096 P-MO-121 P-MO-087 SU P-SA-187 WE P-SA-129 P-TU-073 WE P-SU-132 WE P-SA-140 MO P-MO-204 P-MO-244 P-SA-124 P-SA-220 SU SU P-TU-048 MO P-SU-253 Reinhard T. Reinstein D. Z. Reis A. Reis R. F. Reis W. Reiter C. Reitsamer H. Rejdak R. Reka K. Remeijer L. Remky A. Remmel R. M. Remonda L. Ren R. Ren X. Renieri G. Rentz A. Repka M. X. Resende Gomes C. E. Reupsch J. Revicki D. Rezaei-Kanavi M. Reznicek L. Rheinschmitt L. Riadh M. Ricar J. Ricardo P. Ricarova R. SA-19 SA SU SU-78 TU TU-31 TU P-MO-038 P-MO-294 P-SA-059 P-SA-068 P-SA-070 P-SU-045 P-TU-043 P-TU-047 SA-04 SA TU TU-80 TU TU P-MO-111 Po-SA P-TU-036 P-SU-186 P-MO-148 SA-28 MO SA TU TU-77 TU P-MO-260 P-SU-264 P-SA-133 MO SU P-MO-075 P-SU-140 TU P-MO-114 MO P-SU-125 P-SU-004 P-TU-053 MO P-SU-202 MO P-SU-110 WE SA-47 SA SU-52 SU P-TU-165 P-SA-146 MO WE P-SU-039 P-TU-228 P-TU-237 MO MO P-MO-082 P-SA-270 P-TU-113 WE WE P-TU-113 Richard G. Richards F. Richards J. E. Richards S. Richter J. Rieck P. Riedel K. G. Riederle H. Riemann C. D. Riese J. Riha W. Ringens P. J. Rio Torres M. Rios R. Risimic D. Ristau T. Ritch R. Ritter F. Ritter H. Ritter M. Rizk H. I. R. Rizk A. Rizzo R. Rizzo S. Rizzuto P. R. Roberts P. Roberts S. Roberts T. Robinson M. Robles-Contreras A. Roca J. SU MO-61 MO TU-32 P-SA-082 P-SA-182 P-SA-184 P-SA-185 P-SA-189 P-SU-266 P-TU-056 P-TU-082 P-TU-217 WOC-C-07 WOC-C SU WE SA P-SU-094 SA WOC-C-33 P-MO-251 TU TU P-SA-044 P-SA-067 SA MO SU P-SA-023 P-SA-033 SU P-TU-230 P-TU-240 P-SA-165 P-SA-198 SA-12 SA-21 MO MO-47 MO TU TU MO P-SU-179 P-TU-028 WE SU TU MO-16 MO MO SU P-SU-231 WE MO MO TU P-SU-024 SA-41 WE-29 WE Rochtchina E. P-SU-051 Röck T. P-SA-155 Rodin S. P-MO-238 TU Rodrigues F. P-SA-090 P-SA-094 Rodrigues E. MO P-SU-011 Rodrigues E. B. MO Rodrigues F. P-SU-144 Rodriguez de la Rua E. TU Rodriguez Prats J. L. P-TU-013 SA Author Index

404 400 WOC 2010 Author Index Rodriguez-Reyes A. Rogers J. Roggia M. Rogmann J.-P. Rogowska-Godela A. Rohit S. Rohrbach J. M. Rohrschneider K. Rohrweck S. Roider J. Rojanapongpun P. Rojas-Diaz A. Rolfs A. Romac I. Romaniuk W. P-TU-110 MO P-SA-226 SU P-MO-022 TU TU P-TU-097 MO-23 MO MO P-MO-097 P-SA-243 P-SA-266 P-SU-169 SA-25 SA SU SU-45 MO MO-36 MO TU TU P-MO-151 P-MO-164 P-SA-186 P-SU-253 P-TU-196 WOC-C SA-30 SA P-SU-024 SU P-MO-112 P-MO-056 P-SA-153 P-TU-171 TU P-MO-224 P-MO-224 P-TU-166 Romano M. R. Romano V. Romanova T. Romanowska-Dixon B.MO-77 MO P-SA-183 P-MO-175 P-MO-267 P-TU-085 P-TU-092 P-TU-128 Romanowski E. G. Roman-Roman S. Romkes G. Rootman J. Rosbach J. Rose G. Rösel M. Rosen E. S. Rosen R. Rosenbaum J. T. Rosenthal J. MO SU FR TU P-TU-080 MO-34 MO SA MO MO P-SA-248 P-SA-256 MO-19 MO MO-37 MO P-SA-180 P-TU-216 P-TU-224 TU MO SA-40 SA TU P-SA-180 P-TU-224 Rosenthal P. Rosentreter A. Roskamp R. Rosman M. Rosner M. Rossetti L. Rossi T. Rossini P. Rosu L. Rotberg M. Rotchord A. Rotenstreich Y. Rothenbuehler S. Rothova A. Rothweiler F. Rottler J. Rovner B. Roy S. Rozanova Z. Rozenberg F. Rubin G. S. Rubio R. G. Rubis V. Rücker I. Rücker M. Rüdiger H. Rudnitzki F. Rudolf M. Rudolph G. Rüfer F. Ruggeri A. Ruit S. Ruiz Rodríguez Y. Ruksenas O. Rummelt C. Rüping J. Ruppenstein M. Ruschenburg H. Russ D. Rustambayova G. Ruttig A. Ryan S. J. Rybakova E. Rym K. Ryseck I. TU P-MO-274 P-SA-013 P-TU-066 P-TU-076 WE SA BS WE SU MO P-MO-232 P-SU-002 P-TU-059 MO P-MO-216 P-SA-096 SU P-TU-178 P-TU-245 WE MO TU TU-83 MO P-MO-015 P-MO-016 MO SU P-MO-238 MO MO-10 MO MO TU WOC-C MO MO SU MO SU SU MO P-SA-166 P-SA-187 P-SU-251 SU-61 SU TU P-TU-021 MO P-MO-269 SU P-TU-263 P-SA-023 SU P-SA-065 P-TU-127 P-MO-233 P-SA-188 P-SA-194 P-SA-177 P-TU-203 P-TU-244 SU TU P-MO-170 P-MO-170 P-SA-050 P-MO-180 MO TU-46 SA MO P-SA-250 P-SU-116 S Saad A. Saakyan S. V. Saatci A. O. Sabanayagam C. Sabel B. A. Saburina I. Sachdev A. Sachdev M. S. Sachs H. Sacko D. Sacu S. Sadda S. R. Sadri E. Sadun A. Saeger M. Saeki Y. Safwat E. Sagara T. Saha S. Sahel J.-A. Saif Y. S. S. Saito M. Sakai H. Sakai J.-I. Sakamoto A. Sakurai M. Sala E. Salah J. Salahim S. Salama A. Salamanca O. Salatka K. Salgado-Borges J. Salim B. Y. Salla S. Sallam A. SA P-TU-122 P-TU-125 SU P-MO-234 P-MO-169 P-SU-153 P-SU-175 SU P-SU-137 P-SU-160 P-SU-161 P-SU-162 P-SU-174 SU WE SU P-SA-261 TU TU SA MO MO P-SA-164 P-SA-207 P-SU-188 P-TU-028 SA P-SA-165 P-SA-198 P-TU-059 TU MO SA SU P-MO-011 P-MO-177 P-MO-064 MO P-MO-285 P-MO-298 P-SU-029 P-SU-030 SU-25 SU MO-75 TU TU-44 TU WE WE P-SA-097 P-SA-120 P-SA-123 P-SA-247 P-SU-135 P-SU-141 TU P-MO-082 P-SA-249 P-SA-014 P-SA-268 P-MO-006 P-SU-097 P-SA-258 P-SU-111 P-SU-144 P-SU-273 P-MO-082 P-SA-089 P-SA-250 P-MO-288 P-SA-064 P-SA-244

405 WOC Salma G. P-SA-250 Salmanova S. P-SU-131 Salom D. MO TU P-MO-097 P-SA-243 Salvi M. G. MO Samaan M. SU Samanta S. K. WE Sampaio P. C. SU Samson C. M. SU Sanchez M. J. SU Sanchez Sanchez M. T. TU Sanchez-Amaya I. D. P-MO-078 Sánchez-Mannarelli F. P-SU-086 SU Sanders R. P-MO-270 Sandhu J. P-SU-057 SU Sandkull P. MO Sänger J. MO Sano K. SA Santini R. SU Santos-Jimenez S. MO Santos-Pérez J. SU Sanz-Solana P. P-SA-119 Saornil M. A. SU-12 SU SU Sapieha M. MO Saragoussi J.-J. TU Sargan I. P-SU-002 Sargent N. WE Sarin S. P-MO-083 Saroj N. MO TU Sasai A. P-MO-014 Sasamoto Y. P-MO-179 P-SU-255 P-TU-229 TU Sashneva O. P-TU-173 Sasongko M. B. TU Sasse A. P-MO-123 Sato E. P-MO-153 P-SA-267 TU Sato G. TU Sato M. MO P-SA-215 P-TU-129 Sato T. P-MO-264 Satoh H. TU Sauder G. MO Sauerbrey M. SU Sauerwein W. MO P-TU-116 P-TU-126 Saule S. SU Saurabh K. P-MO-279 Saveleva A. SA Saw S. M. P-SU-047 WE Sawa M. SA TU P-MO-179 P-SA-163 P-TU-229 Sawada A. P-MO-060 P-SA-107 P-SA-136 Sawada M. P-SA-215 P-TU-129 Sawaguchi S. P-SA-120 P-SA-123 P-TU-067 MO TU-20 TU MO MO P-TU-141 SU TU SA P-MO-212 SU TU P-SA-164 SA P-SA-061 P-MO-164 P-TU-244 FR WE-21 WE SU P-MO-205 P-SU-276 SU P-SU-103 P-SU-256 P-TU-091 P-TU-096 SU WE SA P-TU-112 FR P-MO-008 TU TU WE-18 P-SA-022 P-SA-170 P-SU-187 TU-03 P-TU-226 P-SA-144 P-SA-155 P-SU-264 P-TU-219 P-SU-226 WOC-AAD-C-26 P-SU-272 SU MO P-SA-173 P-MO-049 TU P-SA-164 P-SA-241 WOC-C-54 P-MO-100 P-MO-101 MO-09 MO MO-69 MO FR SU-02 SU MO-14 MO TU-08 TU P-SA-106 WOC-AAD-C-25 Schielke K. C. Schiestl C. Schiffman R. M. Schilcher K. Schild A. Schill M. Schippling S. Schirra F. Schittkowski M. P. Schlanitz F. G. Schlich M. Schlichtenbrede F. Sawant S. D. Sawatzki B. Saxena R. Saxena S. Sayanagi K. Sayegh R. G. Scarpi M. Schaaf G. Schaal K. Schäfer G. F. Schaefer T. Schaeffer K. Schäffner E. Schafia A. Schalenbourg A. Schallenberg M. Schaller U. C. Schallhorn S. C. Schaperdoth- Gerlings B. Schargus M. Scharioth G. Scharrer A. Scharrer I. Schatz A. Schaudig U. Schaumberger M. Schefler A. Scheler R. Schepens C. L. Scheschy U. Scheuerle A. F. Schiabel H. Schiavi C. Schicht M. Schiefer U. Schlote H.-W. Schlott K. Schlötzer- Schrehardt U. Schmetterer L. Schmickler S. Schmid K. W. Schmid R. Schmidinger G. Schmidt C. O. Schmidt D. Schmidt J. C. Schmidt K. Schmidt M. Schmidt W. Schmidt-Erfurth U. P-SA-072 P-SA-174 P-SU-145 SU P-TU-199 TU TU TU SU P-SA-013 WOC-C SA SA Po-TU P-MO-278 P-SA-081 P-TU-006 P-TU-101 WE P-SA-196 P-TU-185 MO MO P-SU-094 SA P-MO-185 P-MO-245 P-SA-162 P-TU-196 SA SU MO-60 MO TU P-SA-065 P-SU-098 MO MO TU P-SU-042 P-SA-002 P-TU-232 SA P-MO-072 SU MO WE P-TU-239 P-SA-168 P-SU-260 P-TU-243 P-TU-254 P-MO-108 P-MO-263 P-SA-052 P-TU-213 P-TU-168 SA SA-34 SA MO MO MO MO MO MO MO-75 TU TU WE P-SA-164 P-SA-196 P-SA-200 P-SA-207 P-SU-188 Author Index

406 402 WOC 2010 Author Index Schmidt-Trucksäss A. Schmiedl J. Schmiedt K. Schmitz A. Schmitz Valckenberg S. Schmut O. Schnaidt A. G. Schneider E. Schneider M. Schneider S. Schnyder C. Scholda C. Scholl H. P. N. Scholtz S. Schönfeld C.-L. Schöpfer K. Schor P. Schorderet D. Schörkhuber M. Schossau T. Schrader S. Schrader W. F. Schraermeyer U. Schrage N. F. Schramm A. P-TU-028 P-TU-185 P-TU-232 WOC-C-15 WOC-C TU P-SA-060 P-MO-144 SA P-TU-153 P-MO-158 P-TU-183 WE P-SA-176 P-SA-197 FR FR FR P-TU-101 P-SA-081 P-SU-177 P-TU-149 P-TU-111 SU P-TU-232 SU SU MO-27 MO TU P-SU-058 P-MO-158 P-TU-204 P-TU-265 P-MO-079 P-MO-088 SU TU P-SA-086 SA P-TU-149 SU MO FR P-MO-286 SU-80 MO-28 TU-28 TU WE-26 WE-27 WE WOC-C WE-15 WE SU SU SU-62 SU MO TU-27 TU TU TU P-MO-021 P-MO-223 P-SA-061 P-TU-153 P-TU-157 P-TU-030 WOC-C-08 WOC-C WOC-C MO P-TU-123 Schramm K. Schranz E. Schriefl S. Schröder A. C. Schröder S. Schröer U. Schroeter J. Schubert C. Schuchard R. A. Schuemie M. J. Schuettauf F. Schuff A.-C. Schuknecht B. Schulte J. H. Schultheiss A. Schultheiss M. Schultz G. Schulz S. Schulze A. Schulze U. Schumacher C. Schumann R. G. Schuster R. Schütze C. Schwaiger B. Schwartz A. Schwartz G. Schwartz R. Schwartz S. Schwartzkopff J. Schwartzstein H. Schwarz A. Schwarz T. Schwechheimer H. Schweitzer D. Schwenn O. Scotland G. Scott J. A. Scott R. A. H. Seah L. L. Sebbah R. Seeliger B. Seeliger M. Seguchi J. Seibel B. S. Seifert B. U. Seiff S. Seigel G. Seiler T. P-MO-207 MO MO P-SA-196 P-TU-185 P-SA-081 P-TU-006 P-TU-007 P-TU-031 P-SA-214 P-SU-256 WOC-AAD-C-04 SA TU SU MO TU P-SU-264 P-MO-045 P-SU-027 P-TU-123 P-MO-148 P-MO-170 P-SA-025 P-SA-241 P-MO-033 P-MO-045 P-SU-012 MO P-SA-256 TU P-MO-249 P-SU-272 P-TU-114 P-SA-196 TU P-SU-111 P-TU-250 P-SA-100 P-TU-060 SA TU FR P-MO-294 P-SU-045 P-TU-043 P-TU-090 P-SU-253 SU SU-53 SU P-TU-194 P-MO-073 TU P-SU-145 MO WE P-SU-192 P-SU-245 P-TU-140 SU SU Po-SA P-TU-072 SU P-SA-147 TU-06 TU TU P-SA-111 SU SU MO MO-39 TU-39 Seiple W. Seira P. Seitz B. Sekiryu T. Sekundo W. Selma G. Semak G. Semenova E. A. Semkova I. Sen H. N. Seneadza A. Senft S. Sengupta J. Sengupta S. Seong G. J. Serbes U. Seregard S. Serova N. Serrano M. Setiobudi C. Seyam N. TU-62 TU TU-64 WE WE P-SA-180 SU SA SA-19 SA SU-68 SU SU-69 MO MO-35 TU-12 WE-03 WE-21 WE P-MO-035 P-MO-278 P-SA-066 P-SA-081 P-SU-043 P-SU-265 P-SU-276 P-TU-006 P-TU-007 P-TU-031 P-TU-031 P-TU-101 P-TU-163 P-MO-165 SA-02 SU TU Po-TU P-MO-137 P-MO-220 P-SA-043 WOC-C P-SA-270 P-SU-269 P-TU-111 P-TU-125 SU P-SA-168 P-SU-258 P-SU-260 P-TU-243 MO SA SA P-SA-080 MO P-MO-285 P-MO-298 P-SU-029 P-SU-030 P-SU-189 WE P-SU-093 P-SA-128 SU SU-75 MO-18 MO MO MO TU-40 TU WE WE P-MO-160 P-MO-159 WE-16-04

407 WOC Seyeddain O. Shaarawy T. M. Shafi F. Shah K. Shah P. Shah P. K. Shah R. Shah R. S. Shah S. Shahin M. Shahsuvaryan M. Shaikh S. Shaish A. Shalaby M. H. Shalaby O. Shami M. Shandurkov I. Shao C. Shao-Min Zhang S. Sharkawi E. Sharma H. Sharma P. Sharon D. Sharp P. F. Shaw B. E. Shaw J. Shchadnykh M. Shchypun S. Sheehan W. Sheng D. Sheng M. Sherwood M. Shetta S. Shetty B. Shetty R. Shevchyk V. Shi D. Shi W. Shi X. Shibata M. Shibata Y. Shidik A. Shields C. L. P-SA-044 P-SA-067 SA SU-06 SU SU MO TU-13 TU P-MO-252 MO P-MO-272 WOC-C SU SA SA P-TU-009 P-TU-037 WE TU TU P-TU-251 MO P-MO-216 MO P-MO-292 P-SU-214 MO SU SU SU MO P-MO-028 P-TU-212 MO P-TU-141 SU SU P-SA-096 SU TU P-MO-295 TU MO P-SA-156 P-SU-236 TU P-TU-046 P-SU-254 P-SU-088 SU SU-68 SU MO-70 MO MO SU MO P-TU-166 SU SU P-SA-168 P-SU-257 P-TU-064 P-TU-068 P-SA-229 P-TU-023 SA SA SU SU SU SU MO TU TU-32 Shields J. Shih S. Shim H. s. Shimada N. Shimajiri S. Shimizu K. Shimomura Y. Shimonura Y. Shin Y. W. Shinoda K. Shiraishi A. Shirakashi M. Shiraki K. Shoji M. Shoshani Y. Shpak A. Shrestha M. K. Shriver E. Shu V. Shushtarian S. M. Shusterov Y. Siddig M. Siddiqui A. P. Sidik M. Siebelmann S. Siesky B. Sieving P. A. Signorini S. G. Sihota R. Sikivou B. Silva E. Simader C. Simavlı H. Simmet U. Simmons P. Simões C. C. Simon M. C. Simons B. Simonyi S. TU-34 WE WOC-C P-TU-090 SA SA SU SU SU SU MO MO MO TU-22 P-TU-090 SU P-TU-079 P-MO-188 P-SA-097 P-SA-229 TU SU MO P-SA-106 P-SA-109 P-SU-089 WE SU SU P-TU-193 P-TU-184 P-SA-170 P-MO-011 P-MO-034 P-MO-042 P-TU-195 P-SA-109 P-SU-107 TU MO P-TU-263 SU MO TU P-SU-165 SU MO TU P-MO-202 WE FR P-SU-023 P-SU-031 P-SU-034 TU MO P-MO-103 SA SA WE SA-09 SA TU P-SA-164 P-SA-196 P-SA-207 P-MO-002 P-SA-233 P-MO-014 SU SU MO P-TU-094 TU SU P-MO-074 Simonyte S. Simpson E. R. S ims ek S. Simsonsen F. Singalavanija A. Singer M. Singh A. Singh A. D. Singh J. Singh K. Singh P. Sinkunaite G. Sinkunas K. Sinyavsky O. Sirtautiene R. Sisu A. Sit A. J. Sitnik H. Sivaprasad S. Sivasubramaniam S. Sivekova D. Sivkova N. Siwiec-Proscinska J. Sjahreza E. Sjo L. D. Skaat A. Skevas C. Skorpik C. Skupin A. Slade S. G. Slakter J. Sliesoraityte I. Sloper J. Smailhodzic D. Smetanina M. Smigielski J. Smiles J. Smith J. R. Smith R. E. Smretschnig E. Smuzynska M. Snead D. R. J. Sniatecki J. Soares R. Sobaci G. Socci da Costa D. P-SA-204 SU MO TU P-MO-002 P-MO-005 SU P-TU-209 MO WE-34 WE SU SA SU-43 SU MO WE TU P-SA-236 P-SA-281 SU MO TU-43 WOC-C P-SA-204 P-SU-178 WE P-SA-181 P-SU-002 WE SU-75 P-SA-083 MO P-SU-064 P-SA-048 P-SA-049 SU TU MO-28 MO SA P-TU-154 WE SU SU P-SA-185 P-TU-056 SA P-TU-152 SU-36 SU SU TU TU TU MO P-MO-221 P-SA-152 P-TU-219 MO P-SA-198 P-SA-045 MO SU SU TU TU WE-30 WE P-TU-176 P-TU-201 MO P-TU-241 P-SU-144 WE P-SU-084 Author Index

408 404 WOC 2010 Author Index Soderberg P. Sodi A. Sogawa K. Sohn Y.-h. Soleymani A. Soliman M. Soliman W. Solonina S. Solorzano A. O. Sommer A. Sommer F. Sone T. Song H. Song I. Song S. Song X. Song X.-j. Song Y. Sonia A. Sonia C. Sonia N. Sonia Z. Sonty S. Soon Phaik C. Sophian D. M. Sorenson J. Sorochynska T. A. Soroush M.-R. Soto-Pedre E. Sotozono C. Soubrane G. Sourlas V. Sousa A. K. S. Sovani I. Spada C. Spaeth G. L. Spahn K. Spaide R. F. Spaide T. C. Spalek T. Spaltmann R. Spalton D. Sparholt J. Speeg-Schatz C. Speicher L. Špička N. Spiegel D. Spierer A. Spierings E. TU WE P-MO-153 P-TU-079 P-MO-152 SU MO WE TU SA SA SU-04 SU P-SU-215 P-SU-183 SU P-SA-038 P-MO-200 P-TU-193 P-SA-216 P-SU-221 P-SU-044 SU SU P-TU-184 P-TU-193 MO P-SA-089 P-SA-249 P-SA-089 P-SA-089 P-SA-249 P-SA-250 P-SA-270 P-MO-044 P-MO-051 P-MO-054 P-SA-217 P-SU-091 MO P-TU-138 P-SU-039 MO P-SU-089 SA-33 MO-67 WE WOC-C WOC-C LS MO P-SA-102 P-SA-087 P-TU-199 P-MO-057 TU TU WE-25 WE MO SA SA SA MO P-SU-186 SU SU SU P-SA-034 P-TU-058 SA SA-28 TU MO SU MO-35 Spitzer M. S. Spivey B. E. Spoerl E. Spöler F. Sponer U. Spors F. Spreitzhofer E.-M. Springer C. Sprunger D. Sreekantam S. Sriharanathan P. Srinivasan K. Srivastava S. Stachs O. Stadler S. Stahl V. D. Stala P. Stalmans P. Stana L. Standefer J. E. Stanford M. R. Stanga P. E. Stanic R. Stankov B. Stankovič Babič G. Stanzel B. Starikova A. V. Stark W. Staurenghi G. Stavrakas P. Stefanovic I. Stefánsson E. Steffen H. Stegmann R. Stehr F. Stein J. D. Steinberg J. Steindl K. Steinert R. Steinfeld A. MO-36 MO P-MO-170 TU-46 WE-16 SA WE WE P-SA-139 MO SU P-SA-179 P-SA-207 P-SA-146 FR MO SU MO-69 P-SA-169 TU P-MO-255 MO TU MO P-SA-077 SU P-SU-007 P-SU-104 TU TU P-MO-109 TU P-SU-002 SA TU P-SA-281 P-MO-195 P-MO-174 P-SU-075 P-SA-220 P-SU-152 P-TU-167 SA SU MO-25 MO SU WOC-C MO P-TU-240 SA SU SU-53 SU-54 SU TU SU Po-SA MO MO WE-19 WE WE SU MO MO-31 WE P-TU-073 WE SA P-TU-176 MO TU P-SA-003 P-MO-288 P-SA-064 Steinhuber B. P-SA-034 Steinkogler F. J. SU Stela G. P-TU-107 Stephan H. P-TU-123 Stephanie W. P-TU-006 Stern M. SU Steuhl K.-P. FR FR SU-81 MO-41 P-SU-246 P-SU-038 P-SU-042 Steven P. MO MO P-SU-023 P-SU-031 P-SU-034 Stevens J. D. SA Stewart J. A. TU Stewart W. C. TU Stickelmann C. P-MO-206 Stieger K. MO TU Stiel S. P-MO-288 P-SA-064 Stifter E. P-TU-185 Stitt A. MO Stöcker M. P-MO-206 Stodtmeister R. P-MO-062 WE Stodulka P. TU Stoffelns B. M. P-MO-187 P-SA-190 SU Stojanovic A. TU WE Stojkovic R. P-SA-220 Stoll T. P-SU-184 Stone E. MO Stonecipher K. G. SU Stopa P. TU Stopper S. P-SA-050 Stout T. SU-25 SU TU-29 Straatsma B. R. MO TU-67 TU Strack C. MO Stratmann N. P-SA-197 Strauss O. P-MO-157 P-SU-268 Strauß R. SU Ströher E. P-SU-246 Struck H. G. WOC-C-08 WOC-C WOC-C Studeny P. SU SU TU P-SA-048 P-SA-049 Study Group Rotterdam Ocular Study Group HSV Kit MO Study Group on behalf of the DENALI TU Study Group on behalf of the LUMINATE Study Group on behalf of the MONT BLANC MO SU P-SA-212 Study Group on behalf of the RESTORE WE-38-02

409 WOC Study Group on behalf of the SECURE TU Study Group PANDA P-MO-063 Study Group The Nigeria National Blindness and Visual Impairment P-SU-064 Study Group on behalf of the EVEREST MO Stuebiger N. P-SA-254 Stulting A. MO Stulting R. D. WE Sturm T. TU Sturm V. SU Sturmbauer K. FR Su E. P-SA-180 P-TU-216 Su L. P-MO-265 Suarez E. MO-15 MO Subramani S. P-SA-199 Subramanian P. WE-04 WE Sudharshan S. MO Suelves A. P-MO-097 P-SU-169 Suelves-Cogollos A. M. P-SA-266 Sugano A. P-SU-115 Sugano Y. P-MO-165 Sugar E. A. MO Sugiura Y. P-MO-235 P-MO-239 Sugiyama K. P-SA-047 P-SU-141 P-SU-159 Sugiyama T. P-SU-257 P-TU-064 P-TU-068 Suh W. SA Suhardjo S. P-SU-091 SA Suleman H. SU TU Sulivan B. P-MO-008 Sullivan D. A. SA SU-63 SU Sullivan P. TU-28 TU WOC-C-41 WOC-C Sullivan T. WE Sulzbacher F. MO-68 MO P-SA-200 Summers A. P-TU-143 Sun C.-b. WE Sun J. P-SA-001 P-SA-007 P-SU-060 Sun L. SU Sun M. P-SA-231 Sun M.-H. P-SA-245 P-TU-134 Sunaric-Megevand G. MO Sundari S. SA Sunder-Plassmann G. WE Suntay A. T. WE Supartoto A. P-TU-124 Superti-Furga G. P-SU-188 SA Supiandi E. P-SA-118 Supramaniam G. P-MO-280 Surchev N. P-SA-076 SU Suryono A. Susanna, Jr R. Süsskind D. Sutphin J. Suwan Y. Suzuki K. Suzuki M. Suzuki S. Suzuki T. Suzuki Y. Suzuma K. Syed Osman S. I. Symes R. J. Synowiec E. Szaflik J. Szaflik J. P. Szetu J. Szulborski K. Szuminski M. Szurman P. T Tabata Y. Tabbara K. F. Tabin G. Tadayoni R. Tadic V. Tagami M. Tai E. S. Takada S. Takagi M. Takagi S. Takahashi A. Takahashi K. Takahashi M. SU TU BS BS MO TU-43 MO P-TU-119 P-MO-013 P-SA-029 P-MO-064 P-MO-193 P-SA-015 P-MO-179 P-SA-163 P-TU-235 P-TU-231 P-MO-068 P-MO-089 P-MO-193 P-MO-258 P-SA-015 P-MO-230 P-MO-247 P-MO-256 P-TU-004 P-SU-224 P-MO-295 P-SA-099 P-SA-091 P-SA-099 P-SU-026 SU TU SA SU TU TU P-SA-091 P-SA-099 P-SU-026 WE P-SA-091 SU MO-36 MO TU TU WE WE P-MO-170 P-TU-181 P-TU-181 P-TU-064 TU SA-27 TU WE SU WE P-MO-254 P-MO-169 P-SA-106 P-SA-109 P-SU-141 P-MO-225 P-MO-153 P-MO-194 P-SA-159 WE P-TU-208 Takahashi N. Takahata T. Takai S. Takamatsu M. Takeda H. Takeda N. Takemura S. Takenaka J. Taketani F. Takeuchi A. Takeuchi M. Takeuchi S. Takhchidi E. K. Takhchidi K. P. Talamo J. H. Talebnejad M. R. Talwar N. Tam P. Tam T. Y. Tamada S. Tamayo G. Tamosiunas A. Tamura H. Tan L. T. Tan D. T. H. Tan G. Tanabe F. Tanaka A. Tanaka K. Tanaka M. Tanaka T. Tanaka Y. Tanano I. Taneri S. Tang X. Tani T. Tanihara H. Taniuchi S. Tanner V. Tanyildizi Y. Tao H. Tao J. Tappeiner C. Tarassoly K. Tarif M. Tartak D. Tartak M. Taryam M. O. Tasman W. Tassignon M.-J. P-MO-064 P-SA-107 P-SA-136 P-MO-256 P-TU-064 P-SU-183 P-SU-159 TU P-SU-115 P-SA-121 P-MO-138 P-SU-037 P-MO-225 P-SA-247 P-MO-225 TU MO-26 MO P-SU-062 SU SA SU P-TU-136 WE P-SA-252 P-TU-133 P-SU-182 TU P-SA-204 P-SA-167 P-TU-172 P-SU-009 SU MO MO-64 MO TU TU P-MO-169 P-SA-106 P-SA-109 P-MO-064 P-SA-229 P-SA-017 P-SU-135 P-SU-141 P-SU-158 P-SU-124 P-MO-042 P-MO-094 SU P-MO-153 TU P-SA-038 P-MO-153 P-TU-220 SA P-TU-032 MO SU P-SA-092 SU MO MO P-SU-249 P-SA-080 P-SA-080 MO-70 MO MO MO SU MO-05 MO MO-20 Author Index

410 406 WOC 2010 Author Index Tatar O. Tatzkov R. A. Tavassol F. Tawara A. Tay W. T. Taylor D. Taylor H. R. Taylor S. Taylor S. R. J. Tech S. Tehrani N. Teimann U. Teixeira Brandt C. Tektas O. Tello C. Tembl J. Temprano J. ten Cate H. Tennant M. Teo L. Tepedino M. Teping C. Teranishi S. Terasaki H. Terubayashi A. Tervo T. Tetz M. Teus M. A. Teutloff H. Thaler S. Thaller V. Tham C. C. Y. Thangappan A. Thangkhiew L. Thanigasalam T. Thanos M. Thanos S. MO MO-55 MO TU-68 TU-76 TU WE WE P-SA-170 P-TU-125 MO SU TU WE MO-07 MO SU-65 SU MO TU WE WE TU P-SA-268 P-SA-281 P-SA-236 P-SU-009 P-TU-130 SU TU P-TU-262 P-SU-099 MO P-SU-169 SU MO SU P-SU-192 P-MO-071 TU P-MO-137 P-MO-064 P-MO-194 P-SA-175 P-SU-270 P-TU-214 P-TU-069 TU SU TU-04 TU WE P-MO-143 P-MO-117 P-SA-265 TU P-SU-264 P-SU-191 SA SA SU-08 SU MO-08 SU P-SU-173 P-TU-038 P-SU-246 SU-69 SU MO WE P-SU-103 P-SU-122 P-SU-148 P-SU-256 P-TU-118 Theelen T. Theiß B. Theodoridou A. Therese L. K. Thi Khanh Van P. Thieme H. Thiemeyer D. Thill M. Thomas S. Thomasen H. Thomson A. Thouvenin D. Thulasiraj R. D. Thumann G. Thurau S. Thygesen J. Thyzel R. Tian F. Tian L. Tian X. Tilikete C. Tillack H. Timmermann M. Ting D. Ting S. J. Ting S. W. Tinh N. X. Tint N. L. Tjia K. F. Tobin K. Tochikubo T. Toda R. Todorov V. Tojo K. Toker E. Tokoro T. Tokuhisa K. Toledo de Paula C. H. Tolic A. Tomalla M. Tomar S. Tomita G. Tomoyose E. Tong H. T. L. TU-33 TU P-TU-065 P-SA-277 MO MO P-TU-121 MO-65 MO TU-63 WOC-C-42 P-TU-076 P-TU-080 MO P-SA-185 SU FR SA P-SU-038 P-SU-042 P-SU-151 SA-47 SA-48 TU TU SA TU-37 TU P-MO-206 SA-08 TU-17 WE-09 WE P-SA-251 MO-54 MO P-SU-249 TU P-SA-040 SU P-SU-133 SA SU P-TU-089 TU WE SU SU MO TU MO WE SU P-MO-027 P-MO-068 P-MO-089 P-MO-258 P-SA-017 SU P-SU-268 P-SU-053 SU WE P-SA-229 P-MO-064 SU P-TU-071 MO TU P-TU-045 SA P-MO-225 P-SA-120 P-SA-123 P-SU-206 Tong L. SU WE Tönz M. S. P-TU-177 TU P-SU-027 Topbas S. P-MO-242 Topete-Jimenez J. P-MO-078 P-SA-127 P-TU-086 P-TU-086 Torrent Despouy J. P-SA-187 P-TU-075 SA Torres Suarez E. TU Torres V. P-TU-188 Torun Acar B. P-SA-057 P-SU-025 Toshmatov A. P-TU-135 Toshniwal N. SU SU Tossounis C. P-MO-273 Tost F. H. W. SA-29 SA SU TU-26 TU Po-MO Töteberg-Harms M. MO P-MO-041 WE Tou N. TU Touge C. P-SA-279 Toyokawa N. SA Trajanoski Z. SA Tranos P. MO Trauzettel-Klosinski S. TU WE-04 WE Traverso C. E. SA Trempe C. L. P-MO-049 Trese M. T. SU-49 SU SU-50 SU MO WE-09 WE WE Tressler C. P-SU-097 WE Treumer F. MO P-SA-186 P-SU-253 SA TU TU Trevino A. SA Trimmel J. MO-62 MO WE Troeber L. P-MO-278 P-TU-101 Tröger E. MO P-SA-152 SU Tronina S. P-SU-239 Troyanovsky R. WE Trpin S. P-MO-007 P-MO-012 Trueba Lawand A. P-SU-147 Tsai C.-C. P-SU-015 P-SU-120 Tsai H. Y. TU Tsai J. C MO-65 MO SU-05-04

411 WOC Tsai R. J.-F. Tsai R.-K. Tsai S. Tse D. Tse G. Tse J. Tseng S. C. G. Tsinopoulos I. Tsirbas A. Tsironi E. Tso M. O. M. Tsuchiya Y. Tsuiki E. Tsujikawa A. Tsujikawa M. Tsukahara Y. Tsukiyama J. Tsumura T. Tu E. Tuchen S. Tudor C. Tufail A. Tuft S. J. Tuisku I. Tulidowicz-Bielak M. Tung W. T.-H. Tuomi L. Tura A. Turan N. Turbin R. Türkeli E. Turner G. S. Tuulonen A. U Ubaida Mohien C. Ubaldi A. Udaondo P. Ude K. T. Ueki M. WE-05 WE P-TU-051 MO SU SU MO-78 MO P-SU-222 MO SA-17 SA MO TU-74 TU TU WE P-SU-100 SA SU MO MO P-MO-248 MO-43 MO MO-44 MO P-SA-215 P-MO-230 P-TU-004 P-SA-167 P-TU-172 P-MO-179 P-SA-163 P-SU-255 P-SU-262 P-TU-229 SA P-MO-213 P-MO-254 WE P-SA-020 SU WE P-SA-110 SU FR SA WE P-SU-059 WE P-SA-122 P-TU-097 P-TU-119 SA TU TU P-SU-038 P-MO-195 P-MO-174 MO-58 MO TU-52 SA P-MO-161 TU P-MO-097 P-SA-243 P-SU-169 P-SU-204 P-MO-264 P-TU-068 Uemura A. Ueno S. Ueno Y. Uetani R. Ughade S. Ughi G. Ugurbas S. H. Ugurlu N. Uhlig C. E. Ukety T. Ulbig M. Umanets N. Unal M. Ung T. Ungerechts R. Unterlauft J. Uotani R. Upadhyay M. P. Updike J. Urbancic M. Urovskaya N. Urtti A. Ushakova T. Usov V. Usui S. Usui Y. Utani A. Uthoff D. Uwaydat S. Uxó M. Uy H. V Vahdani K. Vaiceliunaite A. Vaida M. Vainchtock A. Vajaranant T. MO P-MO-194 P-SU-219 P-MO-163 P-TU-214 MO P-TU-055 SU TU-79 TU P-MO-002 P-MO-005 P-SA-059 P-TU-242 P-MO-108 P-MO-263 P-MO-293 P-SA-052 P-TU-213 SU MO P-MO-210 P-MO-233 P-MO-271 P-SA-173 P-SA-194 P-SA-202 P-TU-191 P-TU-228 P-TU-237 SU TU WE P-MO-238 WE P-SU-247 P-TU-169 MO P-SU-248 FR P-SA-060 P-MO-011 P-MO-083 P-SA-165 P-SA-198 P-MO-231 P-SA-206 P-TU-122 ES WE WE P-MO-113 P-MO-283 P-TU-069 P-SA-247 P-SU-158 P-TU-172 SU TU MO SU SU TU MO P-SA-280 P-MO-259 P-SU-191 TU SU P-SU-005 P-SU-068 P-SA-073 Vakalis A. Valdez-Gonzalez T. Valet V. Valsky V. V. Valverde-Collar C. van den Does P. van der Wees J. van Gils W. van Heyningen V. van Lookeren Campagne M. van Meurs J. van Nispen R. M. A. van Rens G. van Rij G. van Setten G. van Son M. Vanchakova N. VandenHoven C. Vani A. Vargas A. B. Vargas J. M. Varma R. Vasconcelos Santos D. V. Vashkevich G. Vasilakis P. Vasiliou T. Vasold R. Vassileva P. I. Vasu U. Vaughan J. Vazquez Membrillo M. A. Veckeneer M. A. Veerappan Rathinasabapathy S. Végh M. Vehige J. Vejarano L. F. Velikay-Parel M. Velinov O. Vemuganti G. Vengris M. Venkatapathy N. Venter J. Ventura L. Verdaguer J. MO P-SU-024 MO SU SU MO TU SU P-TU-155 MO SA-36 SU TU MO MO-10 MO MO-23 MO MO-20 MO-79 TU TU P-SU-027 P-SA-203 SU SU WE P-SA-023 MO TU-74 TU TU TU SU MO P-TU-173 P-MO-190 P-MO-214 P-SU-140 TU SU SU SU-64 SU TU-02 TU P-SA-076 P-MO-276 P-SU-274 P-TU-143 P-SU-024 SA P-MO-272 SU P-MO-014 SU SU WE P-TU-022 P-TU-083 P-TU-242 SA SU-67 SU SU P-MO-272 SU WE P-MO-100 P-MO-101 SU-20 Author Index

412 408 WOC 2010 Author Index Vergés C. Verjans G. M. G. M. Verolli K. Verstraeten T. C. Veselinovic T. Vetter J. M. SU-21 SU TU-67 TU TU TU-61 TU TU MO-21 MO P-SA-090 P-SA-094 SU P-TU-230 P-MO-137 P-SA-043 Vicente Fernandez M. D. P. P-TU-210 Vicente Rodriguez J. WOC-C Vidinov K. P-MO-156 Vidinova C. N. P-MO-156 Vieira A. C. P-SU-085 Vieira de Carvalho L. A. P-SU-180 TU Viestenz A. VIEW 2 investigators Vijayalakshmi P. Vilaplana D. Villada J. R. Villalba J. Villani G. M. Villarrubia A. Vilupuru A. Vinciguerra P. Vinekar A. Vinuesa Silva I. Virgili G. Visser N. Vit V. Vitovska O. Vlasov S. Vo T. N. U. Vogt S. Vogt U. Voigt N. Voigt U. Vokrojova M. Völcker H. E. Vold S. D. Volk G.-F. Volkovich T. WE P-MO-029 P-SA-112 P-SA-146 P-TU-057 WOC-C-50 WOC-C TU MO MO TU TU P-TU-008 TU WOC-C MO SU TU-78 TU WE P-MO-224 SU MO-04 MO P-TU-218 P-MO-160 WOC-C-10 WOC-C TU P-SA-098 P-TU-166 P-SA-125 P-SA-160 WE P-TU-145 P-SA-187 SU P-SU-162 P-SA-277 P-SA-048 P-SA-049 TU SU-56 WOC-AAD-C-09 TU P-SU-122 P-MO-176 von Hanno T. von Holstein S. L. von Jagow B. von Stebut- Borschitz E. Vorwerk C. K. Vossmerbaeumer U. Voyatzis G. Voykov B. Vrhovec L. Vucic D. Vukoja V. W Wabbels B. K. Wachtlin J. Wacker T. Wackernagel W. Wada M. Wafa A. Wafa H. Wagenbreth C. Wagenfeld L. Wagner A. Wagner C. Wagner N. Wagner P. Wagoner M. Wah W. H. Wahab T. A. Wahl J. Wakabayashi T. Wakefield D. Walch A. Waldstein S. Walker R. Wallace D. Walsh A. C. Walsh J. Walsh M. Walt J. G. Walter A. Walter H. S. MO SA P-SU-041 P-SU-202 TU-15 TU P-TU-221 P-TU-080 TU P-TU-020 P-SA-152 P-SU-264 P-TU-219 P-MO-007 P-MO-012 SU P-TU-097 SU P-TU-089 P-SU-235 SU P-TU-149 P-SU-115 MO P-SA-270 P-MO-082 P-SA-250 P-SU-174 P-TU-217 WOC-C P-SA-187 WOC-C P-SA-256 SU-79 SU P-SA-050 P-SU-235 P-MO-013 MO P-SA-259 P-TU-179 P-TU-182 SU P-MO-039 TU TU P-MO-179 TU SA-08 SA P-SU-032 P-SA-173 P-SA-207 P-SU-249 TU SU P-SA-165 P-SA-198 MO P-SA-180 P-SU-077 P-TU-216 P-TU-224 TU SA P-MO-071 P-TU-059 SA P-SU-043 P-TU-007 P-TU-031 P-SU-265 Walter P. Walter S. Wan Abdul Halim W. H. MO-27 TU P-MO-206 P-MO-288 P-SA-064 WOC-AAD-C WOC-AAD-C P-SA-146 P-TU-057 WE P-SA-275 P-TU-063 Wang C. P-TU-129 WE Wang D. P-SA-138 wang F. SU Wang F. WE Wang J. P-MO-261 P-SA-201 Wang J. J. P-SU-051 SU TU Wang J.-K. P-MO-262 Wang K. SU Wang L. P-SA-231 P-SU-133 Wang N. SU TU P-SA-092 P-SA-095 Wang N. SA TU Wang P. P-TU-137 Wang Q. P-SA-221 Wang W. P-SU-088 Wang X. P-MO-136 SU Wang Y. P-SU-238 SU SU Wang Z. Su SU SU Wangsupadilok B. P-SA-117 Waqar S. TU Waran V. P-SU-118 Waring G. MO TU TU TU WE Wariyapola D. P-MO-070 TU Wasfy T. P-SA-194 Wasielica-Poslednik J. MO Wasmuth S. MO Wassill H. P-SU-184 Watanabe H. P-MO-027 P-MO-068 P-MO-089 P-MO-258 P-SA-017 Watkins M. Watson P. G. Watson S. Webb T. Weber A. Weber B. H. F. Weber K. Weber S. SU TU SU-20 SU P-TU-049 TU TU SU P-SU-271 SU-39-04

413 WOC Wecke T. Wecker T. Wedemeyer I. Wedrich A. Weger M. Wegner A. Wegner M. Wehner W. Wei M. Wei S. Wei Y.-h. Weichselberger A. Weidemann A. Weikert M. P. Weil D. Weimer P. Weinberger D. Weindler J. Weingärnter W. E. Weinitz S. Weinreb R. N. Weirich G. Weiss C. Weiß S. Weitz R. Welch J. Welge-Lüßen U. Welkoborsky H.-J. Weller K. Welty D. Wen J. Wen-Chuan W. Weng N. Wenkstern A. Werner J. U. P-TU-221 WE P-SU-105 P-MO-274 WE-08 SU P-TU-149 P-TU-207 P-SA-135 P-SA-101 P-TU-076 P-MO-120 P-MO-125 TU P-SU-066 SU-44 SU SU P-SA-108 P-SU-117 P-SU-123 P-SU-127 P-SU-128 P-SU-129 P-SU-130 P-SU-138 P-SU-139 P-SU-143 P-SU-149 P-SU-156 P-SU-157 P-SU-163 P-SU-164 P-SU-166 P-SU-167 P-SU-168 P-SU-170 P-SU-171 P-SU-172 SU MO TU TU MO WE MO MO WE P-MO-137 TU SA MO WE-13 WE P-SA-129 P-TU-120 P-TU-116 MO P-SU-100 P-SU-220 P-TU-048 SU MO MO MO MO MO P-SA-060 MO MO P-MO-219 P-SU-261 P-SA-092 SU P-MO-191 P-TU-236 Werner L. Wesch D. Wess J. West S. Westekemper H. Wetzel B. Wheeler D. Wheeler L. While B. Whitcup S. M. White V. A. Wiafe B. Wickham L. Wickstrom K. Widayanti T. Widyawati S. Wiechens B. Wiedemann P. Wiegand M. Wieland E. Wieland R. Wienrich R. Wiermann A. Wiesen M. Wiesmann C. Wiggs J. L. Wildner G. Wilensky J. Wilhelm B. Wilhelm F. Wilhelm H. Wilke M. Wilke R. Wilkens L. SU-15 SU P-MO-151 P-TU-241 TU WE SA MO P-TU-143 MO P-TU-199 P-SU-247 MO MO MO MO MO MO MO P-MO-198 P-SU-110 P-TU-199 TU TU WE TU MO TU SU SU P-MO-155 P-SA-069 MO MO P-SU-196 P-SU-240 P-TU-223 P-TU-250 SA-36 SU-45 MO MO-29 TU-36 P-SU-204 MO P-TU-116 P-MO-029 P-SA-182 P-SA-184 P-SA-185 P-TU-219 MO MO-71 MO WE SA SU-31 SU TU P-SA-251 P-SA-073 TU WE SA SU-29 SU SU-44 MO WE MO P-SA-144 SU TU MO Wilkinson C. P. Will F. Willcox M. Wille D. Willerding G. Willert A. Williams G. J. Williams J. Williams K. A. Williamson K. Willmann G. Wilson P. Wilson S. E. Wimmer S. Windischbauer E. Winkler von Mohrenfels C. Winter K. Winter R. Winterhalter S. Wirbelauer C. Wirostko B. Wirtz C. Wiseman R. Wismann S. Wissen A. Witt M. Wittekind C. Wiyogo I. Wodong S. Wölbert M.-K. Wolf A. Wolf F. Wolf S. Wolf U. SA-41 SA TU-69 WOC-C SU SU TU P-TU-089 SA SU TU TU SA TU P-TU-155 P-SA-155 P-SU-264 WE WE WE-03 WE P-MO-148 SU P-SU-111 SA WE MO P-SU-100 P-SU-220 P-TU-048 SU P-MO-015 P-MO-016 P-SA-113 SU WE P-SA-026 P-MO-063 P-SU-097 SU WE WE P-SU-097 P-TU-186 SA SU SU TU WE MO SA MO P-SA-051 P-SA-173 P-SA-178 P-SA-188 P-SA-194 P-SA-202 P-SA-205 P-TU-017 P-TU-248 TU WE P-MO-008 WE TU-11 WE P-TU-178 P-TU-245 WOC-C-57 WOC-C WOC-C P-MO-102 Author Index

414 410 WOC 2010 Author Index Wolfensberger T. J. Wolff D. Wolff J. Wolffsohn J. Wolfram C. SU MO-29 MO MO-67 TU P-TU-050 WOC-C-56 P-TU-009 P-TU-037 SU-73 TU-52 Wolf-Schnurrbusch U. P-TU-178 P-TU-245 WE Wollensak G. Wolter-Roessler M. Wong H. S. Wong A. L. Wong A. M. F. Wong B. Wong D. Wong D. S. H. Wong H. S. Wong J. Wong P. Wong T. Y. Wong V. Wong W. L. Woo C.-m. Wormald R. Wotherspoon A. C. Wowra B. Wree A. Wrobel W. Wu L. Wu P. Wu W.-C. WuDunn D. Wulff A. J. Wutzler P. Wykes W. Wylegala E. Wyman M. SU P-SA-031 MO P-TU-029 SU P-SU-222 SU SA WOC-C-07 WOC-C WOC-C-41 WOC-C MO P-SA-073 WE MO TU WE P-MO-169 P-SA-260 P-SA-140 SU SA-21 SU-04 SU SU TU TU-30 WOC-C-10 WOC-C WOC-C SU P-TU-091 P-TU-096 SU TU SA MO-72 MO WE-29 WE MO P-MO-257 TU TU SA P-SU-151 TU SA SU MO-30 MO MO WE-05 WE WOC-C-47 WOC-C TU X Xiang N. Xiao C. Xie C. Xie G. Xie L. Xie T. Xing X. Xing Y. Xu J. Xu L. Xu X. Y Yadav N. K. Yadav P. Yadava U. Yagita K. Yaish S. B. Yakura K. Yamada K. Yamada R. Yamada Y. Yamaguchi M. Yamaguchi Y. Yamaji H. Yamakawa N. Yamamoto M. Yamamoto T. Yamamoto S. Yamashiro K. Yamashita H. Yamashita M. Yamazaki H. Yan D. B. Yan G. Yan H. Yan X. Yanagisawa M. Yanai R. Yang Q. Yang A. Yang A. h. Yang C.-H. SU SU MO-79 MO P-SU-213 P-SU-238 P-SU-088 P-SU-014 TU MO TU P-SA-038 P-MO-261 P-SA-201 P-SU-136 MO P-SA-216 P-SU-070 SU MO MO P-TU-218 P-SU-242 P-SU-173 P-MO-011 P-MO-121 P-MO-011 P-SA-279 P-SA-121 P-SA-097 P-SA-131 P-SA-154 P-TU-195 P-SA-242 P-TU-233 P-SA-020 P-SA-247 P-SU-158 P-TU-195 P-MO-060 P-MO-178 P-SA-107 P-SA-136 P-SU-115 WOC-C P-SA-097 P-SA-167 P-TU-172 P-MO-178 P-SU-115 P-SA-229 P-MO-193 P-MO-067 P-MO-074 BS P-SU-088 P-SU-014 P-SU-136 SU P-SA-216 P-SA-221 P-SU-107 WE P-SA-095 P-MO-261 P-SA-201 WE P-SU-259 Yang C.-M. Yang J.-Y. Yang M. Yang P. Yang X. Yang Y. Yang Y.-S. Yannuzzi L. Yano K. Yao K. Yaoeda K. Yarmak V. Yasuda A. Yasuda N. Yasuno Y. Yau S. K. Yee Murahashi W. Yehezkel O. Yemis ci B. Yetik H. Yeung A. M. Yiǧit U. Yilmaz O. F. Yim H. B. Ying H. Yip Y. Yiu S. C. Yoeruek E. Yogesan K. Yokochi M. Yokogawa H. Yokoi T. Yokoyama K. Yokoyama T. Yonahara M. Yong L. Yoon J. U. Yoon Y. Yoon Y.-H. Yoshida A. Yoshikawa T. Yoshimura N. Yoshino H. Yoshino M. Yoshitake S. You Q. Younesian M. Young L. Young L. B. Young M. J. Younis M. P-SU-259 MO P-SU-245 TU P-SU-266 P-SA-138 MO MO SA P-SU-089 WE P-MO-034 P-MO-042 MO MO P-SU-275 P-SU-182 P-SA-115 SA MO P-TU-133 MO TU P-MO-121 P-SA-128 P-SA-143 SA SU-41 TU P-SA-143 P-SU-198 P-TU-054 P-SA-226 P-TU-202 SA P-SA-170 SU-30 SU P-MO-149 P-SA-047 P-SU-124 P-TU-200 P-TU-222 P-MO-199 TU P-SA-123 P-TU-243 SA MO SU MO MO MO TU P-MO-153 P-SA-267 P-SA-282 P-SA-159 P-MO-043 P-SA-097 P-SA-126 P-SA-167 P-TU-172 P-MO-064 P-SA-004 P-SA-037 P-SA-097 SU SU P-MO-195 P-MO-174 TU TU-30 P-MO-092 P-MO-275 P-SU-077

415 WOC Yu A. Yu F. Yu H. Yu H. G. Yu M. Yu M. C. S. Yuan J. Yuen H. K. L. Yuen J. Yuen L. Yukawa E. Yung C. W. Yuzawa M. Z Za Z. Zabarouski I. Zaborovski I. Zagórski Z. Zaidman G. W. Zakynthinos E. Zaldivar R. Zalevsky Z. Zaliaduonyte- Peksiene D. Zaliuniene D. Zaluski S. Zandi S. Zanon-Moreno V. Zapata J. Zarbin M. Zare M. Zarei-Ghanavati M. Zarei-Ghanavati S. Zarnowski T. Zavoloka O. Zawar S. Zegans M. Zeimer R. Zeitz C. Zeitz O. Zekraoui Y. MO MO SA P-MO-243 SU P-MO-098 SU SU WE MO TU P-SU-037 TU MO P-SU-118 P-SU-269 P-TU-192 SU-37 TU-49 TU TU-67 TU SU MO MO MO-40 MO TU-61 TU TU P-MO-121 P-SA-204 P-SA-204 P-MO-133 P-TU-220 P-MO-047 P-MO-093 P-MO-160 P-SA-119 SU SA-03 SA MO-47 MO-79 SU P-SA-041 P-SA-084 P-SA-041 P-SA-084 P-SU-039 SU TU WE P-SU-095 P-SU-264 P-MO-260 MO P-SA-156 P-SU-236 P-TU-003 MO SU MO-06 MO SU-61 P-SA-182 P-SA-185 P-TU-056 P-TU-217 P-MO-066 P-SA-141 Zeng Y. Zengin M. O. Zenkel M. Zenteno Ruiz J. C. Zeschnigk M. Zetterström C. Zeyen T. Zhaboedov G. Zhang C. Zhang F. Zhang H. Zhang J. Zhang J.-d. Zhang K.-M. Zhang S. S.-M. Zhang W. Zhang X. Zhang X.-R. Zhang Z.-Y. Zhao B. Zhao F. Zhao J. Zhao J. Zhao L. Zhao S. Zhekov O. Zhen Kiat T. Zheng Y. Zhi J. Zhivov A. Zhmud T. Zhng Z. Zhou H. Zhou J. Zhou L. Zhou Y. Zhou Y.-h. Zhu J. Zhutdieva M. Ziakas N. Ziemssen F. Zierhut M. P-SA-138 P-TU-061 P-SU-080 P-SU-098 SU SU-39 SU SU TU TU-25 TU-76 TU WE-07 WE P-SA-235 MO P-SA-218 SA P-MO-265 P-SA-040 SU MO P-TU-199 MO P-SA-228 SU MO P-MO-018 P-MO-119 P-MO-119 P-SA-092 SU P-SU-088 WE SA-23 SA SU-73 TU-52 TU TU MO P-MO-018 SU SU MO P-MO-169 P-SU-136 P-SA-077 P-MO-283 MO P-SU-213 P-SU-234 P-SU-238 P-SU-060 SU P-SA-216 P-TU-102 SU P-TU-261 SU P-SA-276 P-SU-035 SA-22 SA MO SA SU MO-46 MO MO-76 MO TU-83 WE-42 P-SA-254 WOC-C WOC-AAD-C-17 Zillikens D. Zimmer-Galler I. E. Zimmerman M. B. Zimmermann A. Zimmermann C. Zin A. Zinelis K. Zivkovic M. Zlatanovic M. Zlotnik A. Zografos L. Zoric Geber M. Zorn C. Zotta P. Zrenner E. Zsolt B. Zubkova D. Zurek-Imhoff B. Zvereva A. E. Zweifel S. A. Zwiener I. MO SU P-MO-013 P-TU-099 P-SA-135 SU-61 MO-04 MO MO MO P-SU-100 P-SU-220 P-TU-048 SU P-SA-234 P-SA-237 P-MO-121 SU TU WE WE WE P-SA-263 P-TU-205 P-SA-276 P-SU-035 SA-38 SA SU-25 SU TU TU TU WE-14 WE WE-20 WE-41 P-SA-144 P-SA-152 P-SA-155 P-TU-219 WE MO P-SA-156 P-SU-236 MO P-SA-248 P-SU-181 MO SA P-SA-190 Author Index

416

417 WOC Imprint Responsible for the Content WOC 2010 Congress President Professor Gerhard K. Lang, Ulm, Germany WOC 2010 Program Director Professor Gabriele E. Lang, Ulm, Germany Content handling and adverts Professional Congress Organizer (PCO) Monika Porstmann Porstmann Kongresse GmbH Alte Jakobstr Berlin, Germany T: F: pco@woc2010.de Credits Page 34, 35: Roman Lorenz Page 39: Page 39: Eyeland Design Network Page 41: Torsten George Page 43: Herbert Spichtinger/Corbis Page 367: ICC Design Büro Roman Lorenz design alliance Munich Production and Printing MediaService GmbH Druck und Kommunikation Franz-Mehring-Platz Berlin Disclaimer The titles and contents of the presentations as well as the authors names as listed on the following pages have been printed according to the files sent by the presenters themselves. The organizer is not responsible for spelling mistakes. World Ophthalmology Congress and WOC 2010 are registered trade names of the International Council of Ophthalmology (ICO). The WOC 2010 logo design and corporate identity are protected by copyright. The rights of use lie with the German Ophthalmology Society (DOG). The use by a third party requires the express approval of the DOG. Subject to alteration without notice. Status as per April 2010 Last minute changes of the scientific program will be included in the online version at

418 414 WOC 2010 Notes

419 WOC Notes

420 416 WOC 2010 Notes

421 through innovation We see what s coming. Pfizer Ophthalmics is advancing the future of eye health. Exploring new molecular entities designed to address unmet medical needs. Investing in stem cell therapies. Developing innovative polymer-based drug delivery. Creating a diverse portfolio that delivers a promising outlook for the future of eye care. OUR VISION IS CLEAR. > Visit us at booth 12 B/ Pfizer Inc. All rights reserved. XLU01040

422 Look forward. Envision. As a committed pioneer in the field of ophthalmology, we supply innovative technologies and application-oriented solutions which enable doctors to improve the quality of life of their patients. An ophthalmic world with Carl Zeiss as your partner supporting your goals with... Sharply focused solutions for growing patient demands. Higher efficiency and faster process support. Better quality of care. Visit our booth in Hall 13 and envision new opportunities in the world to see. Get more information at our website: Carl Zeiss Meditec AG Phone: Fax: info@meditec.zeiss.com

Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS:

Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS: 0BCore Safety Profile Active substance: Betaxolol eyedrops Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS: HU/H/PSUR/0010/002 Date of FAR: 20.03.2013 4.2 Posology

More information

INDICATIONS For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye globe.

INDICATIONS For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye globe. Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM PRED FORTE Sterile Eye Suspension COMPOSITION PRED FORTE Sterile Eye Suspension contains: Prednisolone acetate 10 mg/ml Preservative:

More information

Core Safety Profile. Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% Date of FAR:

Core Safety Profile. Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% Date of FAR: Core Safety Profile Active substance: Carteolol Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% P - RMS: SK/H/PSUR/0002/002 Date of FAR: 16.03.2012 4.1 THERAPEUTIC INDICATIONS Ocular hypertension

More information

LOWPROST Eye Drops (Bimatoprost Ophthalmic Solution 0.01%)

LOWPROST Eye Drops (Bimatoprost Ophthalmic Solution 0.01%) Published on: 14 Apr 2017 LOWPROST Eye Drops (Bimatoprost Ophthalmic Solution 0.01%) For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only Composition Each ml contains: Bimatoprost...

More information

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM FML Liquifilm Sterile Eye Suspension COMPOSITION FML Liquifilm Sterile Eye Suspension contains: Fluorometholone 1,0 mg/ml Liquifilm

More information

NEW ZEALAND DATA SHEET 1. PRODUCT NAME

NEW ZEALAND DATA SHEET 1. PRODUCT NAME NEW ZEALAND DATA SHEET 1. PRODUCT NAME Flucon fluorometholone 0.1% Eye Drops Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Flucon contains 1.0 mg of fluorometholone (0.1% w/v). Excipient

More information

AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION

AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION 1 NAME OF THE MEDICINE Fluorometholone acetate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The active ingredient in

More information

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery.

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery. Page 1 of 5 SCHEDULING STATUS Schedule 3 PROPRIETARY NAME (AND DOSAGE FORM) ACULAR 0,5 % COMPOSITION ACULAR 0,5 % contains: Preservatives: Benzalkonium chloride 0,01 % m/v Disodium edetate 0,1 % m/v PHARMACOLOGICAL

More information

SCHEDULING STATUS Schedule 4. PROPRIETARY NAME (AND DOSAGE FORM) GANFORT Eye Drops

SCHEDULING STATUS Schedule 4. PROPRIETARY NAME (AND DOSAGE FORM) GANFORT Eye Drops Page 1 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME (AND DOSAGE FORM) GANFORT Eye Drops COMPOSITION Each ml contains: Bimatoprost 0,3 mg and timolol maleate equivalent to 5 mg timolol Preservative: Benzalkonium

More information

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

Who we are. We envision a world where high quality eye health and vision care is accessible to all people. Who we are The World Council of Optometry (WCO) is an international optometric association founded in 1927. The WCO represents over 200,000 optometrists in more than 60 countries, through almost 300 Country,

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT LUMIGAN 0.1 mg/ml eye drops, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of solution contains 0.1 mg bimatoprost.

More information

New Zealand Data Sheet

New Zealand Data Sheet New Zealand Data Sheet Prednisolone-AFT 1% Prednisolone acetate (Ph Eur) 1% w/v ophthalmic suspension Presentation Prednisolone-AFT 1% is a milky white suspension in an eyedropper bottle for ophthalmic

More information

INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998

INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVELTYS safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol

More information

Innovation In Ophthalmology

Innovation In Ophthalmology Innovation In Ophthalmology INVELTYS TM Approval August 2018 Disclaimers and Notices This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform

More information

Sponsor. Generic Drug Name. Trial Indications. Protocol Number. Protocol Title. Clinical Trial Phase. Study Start/End Dates. Reason for Termination

Sponsor. Generic Drug Name. Trial Indications. Protocol Number. Protocol Title. Clinical Trial Phase. Study Start/End Dates. Reason for Termination Sponsor Alcon Research, Ltd. Generic Drug Name Travoprost/timolol maleate Trial Indications Open-angle glaucoma or ocular hypertension Protocol Number C-09-007 Protocol Title An Evaluation of Patient Reported

More information

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM FML-NEO Liquifilm Ophthalmic Suspension COMPOSITION FML-NEO Liquifilm Ophthalmic Suspension contains per ml: Fluorometholone 1,0

More information

D90 (27/10/2005) Final SmPC NL/H/653/01

D90 (27/10/2005) Final SmPC NL/H/653/01 1/6 1. NAME OF THE MEDICINAL PRODUCT MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution contains 1 mg of dexamethasone phosphate as dexamethasone

More information

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery. Page 1 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME (and dosage form) ACULAR 0,4% COMPOSITION ACULAR 0,4% ophthalmic solution contains: Ketorolac tromethamine: 4 mg/ml Preservative: Benzalkonium chloride

More information

APPENDIX 1: SUMMARY OF PRODUCT CHARACTERISTICS. SPC for VEXOL Eye Drops, Suspension 1. NAME OF THE MEDICINAL PRODUCT

APPENDIX 1: SUMMARY OF PRODUCT CHARACTERISTICS. SPC for VEXOL Eye Drops, Suspension 1. NAME OF THE MEDICINAL PRODUCT APPENDIX 1: SUMMARY OF PRODUCT CHARACTERISTICS SPC for VEXOL Eye Drops, Suspension 1. NAME OF THE MEDICINAL PRODUCT VEXOL 1% (10 mg/ml) eye drops, suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

NEW ZEALAND DATA SHEET 1. PRODUCT NAME

NEW ZEALAND DATA SHEET 1. PRODUCT NAME NEW ZEALAND DATA SHEET 1. PRODUCT NAME Maxidex TM (dexamethasone) 0.1% sterile ophthalmic suspension and ointment. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Maxidex Ophthalmic Suspension contains

More information

AUSTRALIAN PRODUCT INFORMATION FML (FLUOROMETHOLONE) EYE DROPS

AUSTRALIAN PRODUCT INFORMATION FML (FLUOROMETHOLONE) EYE DROPS AUSTRALIAN PRODUCT INFORMATION FML (FLUOROMETHOLONE) EYE DROPS 1. NAME OF THE MEDICINE FML fluorometholone 1 mg/ml eye drops 2. QUALITATIVE AND QUANTITATIVE COMPOSITION FML eye drops contain fluorometholone

More information

Cardiology and Heart Diseases November 5-6, 2018 Amsterdam, Netherlands

Cardiology and Heart Diseases November 5-6, 2018 Amsterdam, Netherlands C a r d i o l o g y W o r l d 2 0 1 8 28 th World Congress on Cardiology and Heart Diseases November 5-6, 2018 Amsterdam, Netherlands Theme: A Vivid innovations in the field of Cardiology conferenceseries.com

More information

Elements for a public summary. VI.2.1 Overview of disease epidemiology

Elements for a public summary. VI.2.1 Overview of disease epidemiology VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology The term ocular hypertension usually refers to any situation in which the pressure inside the eye, called intraocular pressure,

More information

Clinical Psychology. Clinical Psychology Theme: Clutching the Characteristic in Clinical Psychology and Mental Health

Clinical Psychology. Clinical Psychology Theme: Clutching the Characteristic in Clinical Psychology and Mental Health International Conference and Expo on Clinical Psychology October 18-20, 2018 Amsterdam, Netherlands Theme: Clutching the Characteristic in Clinical Psychology and Mental Health conferenceseries.com Invitation

More information

Elements for a public summary. Overview of disease epidemiology

Elements for a public summary. Overview of disease epidemiology VI.2 VI.2.1 Elements for a public summary Overview of disease epidemiology Glaucoma is an eye disease that can result in damage to the optic nerve and loss of vision (blindness). It is the major cause

More information

TOBAFLAM Eye Drops (Loteprednol etabonate 0.5% + Tobramycin 0.3%)

TOBAFLAM Eye Drops (Loteprednol etabonate 0.5% + Tobramycin 0.3%) Published on: 23 Sep 2014 TOBAFLAM Eye Drops (Loteprednol etabonate 0.5% + Tobramycin 0.3%) Composition Loteprednol Etabonate 5 mg (0.5% w/v) Tobramycin...3 mg (0.3% w/v) Benzalkonium Chloride.. 0.01%

More information

New Zealand Data Sheet

New Zealand Data Sheet New Zealand Data Sheet 1 Prednisolone-AFT 1% Prednisolone-AFT 1.0% w/v ophthalmic suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Prednisolone acetate (Ph Eur) 1% w/v ophthalmic suspension For the

More information

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique Injection Technique Quick-Reference Guide PRECISION PROGRAM Companion booklet for the Video Guide to Injection Technique Available at www.ozurdexprecisionprogram.com Provides step-by-step directions with

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dexafree 1 mg/ml, eye drops, solution in single-dose container 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution contains 1 mg

More information

Brimonidine/timolol Version 1.2, 16Oct, Elements for a public summary. VI.2.1 Overview of disease epidemiology

Brimonidine/timolol Version 1.2, 16Oct, Elements for a public summary. VI.2.1 Overview of disease epidemiology VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology The estimated number of people with vision loss from glaucoma range from 5.2 to 6.7 million. This is approximately 10% of the

More information

APPROVED PACKAGE INSERT FOR XALATAN EYE DROPS. Each millilitre contains latanoprost 50 µg and benzalkonium chloride 0,02 % m/v as preservative.

APPROVED PACKAGE INSERT FOR XALATAN EYE DROPS. Each millilitre contains latanoprost 50 µg and benzalkonium chloride 0,02 % m/v as preservative. SCHEDULING STATUS: S4 APPROVED PACKAGE INSERT FOR XALATAN EYE DROPS PROPRIETARY NAME (and dosage form): XALATAN Eye Drops COMPOSITION: Each millilitre contains latanoprost 50 µg and benzalkonium chloride

More information

KEY MESSAGES. Details of the evidence supporting these recommendations can be found in the above CPG, available on the following websites:

KEY MESSAGES. Details of the evidence supporting these recommendations can be found in the above CPG, available on the following websites: QUICK REFERENCE FOR HEALTHCARE PROVIDERS KEY MESSAGES 1. Glaucoma is a chronic eye disease that damages the optic nerve, & can result in serious vision loss and irreversible blindness. 2. Glaucoma diagnosis

More information

Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1% (Sterile) Rx only

Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1% (Sterile) Rx only Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1% (Sterile) Rx only DESCRIPTION Prednisolone Sodium Phosphate Ophthalmic Solution, 1%, is a sterile solution for ophthalmic administration having

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET NEW ZEALAND DATA SHEET 1. PRODUCT NAME FML 0.1% w/v eye drops 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Fluorometholone 1 mg/ml (0.1% w/v) For the full list of excipients, see Section 6.1. 3. PHARMACEUTICAL

More information

For a full list of excipients, see section 6.1. A sterile, clear, bright, colourless, aqueous solution.

For a full list of excipients, see section 6.1. A sterile, clear, bright, colourless, aqueous solution. SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sofradex Ear/Eye Drops, Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each bottle contains 0.5% w/v of Framycetin Sulphate, Dexamethasone

More information

JANUARY 27-29, TH ANNUAL Retina Fellows Forum. Westin Chicago River North Chicago, IL

JANUARY 27-29, TH ANNUAL Retina Fellows Forum. Westin Chicago River North Chicago, IL 17TH ANNUAL Retina Fellows Forum JANUARY 27-29, 2017 Westin Chicago River North Chicago, IL Course Director: Course Co-Directors: and David R. Chow, MD Faculty Course Co-Director Tennessee Retina Nashville

More information

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it

More information

BRIMOPRESS-T EYE DROPS. COMPOSITION Each ml of BRIMOPRESS-T EYE DROPS contains. Brimonidine Tartarate 0.2% Timolol Maleate 0.5%

BRIMOPRESS-T EYE DROPS. COMPOSITION Each ml of BRIMOPRESS-T EYE DROPS contains. Brimonidine Tartarate 0.2% Timolol Maleate 0.5% BRIMOPRESS-T EYE DROPS COMPOSITION Each ml of BRIMOPRESS-T EYE DROPS contains Brimonidine Tartarate 0.2% Timolol Maleate 0.5% BRIMOPRESS-T ophthalmic solution is a combination of Brimonidine Tartrate,

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of solution contains 0.3

More information

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy BETAGAN Allergan Levobunolol HCl Glaucoma Therapy Action And Clinical Pharmacology: Levobunolol is a noncardioselective beta- adrenoceptor antagonist, equipotent at both beta1 and beta2 receptors. Levobunolol

More information

Medical Management of Glaucoma

Medical Management of Glaucoma Medical Management of Glaucoma Medical Management of Glaucoma Keith Barton Consultant Ophthalmologist Moorfields Eye Hospital Foundation Trust Honorary Reader Department of Epidemiology and Genetics Institute

More information

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

Who we are. We envision a world where high quality eye health and vision care is accessible to all people. Who we are The World Council of Optometry (WCO) is an international optometric association founded in 1927. The WCO represents over 200,000 optometrists in more than 60 countries, through almost 300 Country,

More information

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Read all of this leaflet carefully

More information

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Package leaflet: Information for the user PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Read all of this leaflet carefully before you start using this medicine because it contains important

More information

CORNEAL CONDITIONS CORNEAL TRANSPLANTATION

CORNEAL CONDITIONS CORNEAL TRANSPLANTATION GENERAL INFORMATION CORNEAL CONDITIONS CORNEAL TRANSPLANTATION WHAT ARE CORNEAL CONDITIONS? The cornea is the clear outer layer of the eye. Shaped like a dome, it helps to protect the eye from foreign

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS Page 1/9 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of solution contains 0.3 mg bimatoprost. One drop contains approximately

More information

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone Package leaflet: information for the user OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone Read all of this leaflet carefully before you are given this medicine because it contains

More information

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0. PRESCRIBING INFORMATION Pr MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.1% w/w Pr MAXITROL* Neomycin and Polymyxin B

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of solution contains 0.3

More information

DIABETIC RETINOPATHY

DIABETIC RETINOPATHY THE UK GUIDE DIABETIC RETINOPATHY Everything you need to know about diabetic retinopathy Jaheed Khan BSc (Hons) MBBS MD FRCOphth Fellow of the Royal College of Ophthalmologists Association for Research

More information

[TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN. TRAVOPR-v

[TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN. TRAVOPR-v [TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN TRAVOPR-v2-270214 VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Studies estimated that 3-6 million people

More information

Instil one or two drops in the conjunctival sac(s) every three to four hours as needed.

Instil one or two drops in the conjunctival sac(s) every three to four hours as needed. NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON FORTE Eye Drops 0.1% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Naphcon Forte contains naphazoline hydrochloride 1.0 mg in 1 ml (0.1%). Excipient with known

More information

Prof. Dr. Sehnaz Karadeniz

Prof. Dr. Sehnaz Karadeniz Prof. Dr. Sehnaz Karadeniz An ophthalmologist, Dr. Karadeniz has been actively involved in the field of diabetes for the past 20 years in a series of medical, scientific and social projects both at national

More information

Elements for a Public Summary. Overview of disease epidemiology

Elements for a Public Summary. Overview of disease epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Epidemiology of the disease Incidence and prevalence Increased pressure in the eye occurs in more than 100 million people, and

More information

NEW ZEALAND DATA SHEET. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 0.1 mg or 0.3 mg of bimatoprost.

NEW ZEALAND DATA SHEET. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 0.1 mg or 0.3 mg of bimatoprost. NEW ZEALAND DATA SHEET 1. PRODUCT NAME BIMATOPROST ACTAVIS, Eye drops, solution, 0.1 mg/ml and 0.3 mg/ml 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 0.1 mg or 0.3 mg of bimatoprost. Excipient

More information

NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%.

NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%. NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Naphcon-A contains naphazoline hydrochloride

More information

SPONSORSHIP. Rheumatology, Autoimmunity and Orthopedics. Warsaw, Poland. 9th European Congress on. October 16-17, 2018

SPONSORSHIP. Rheumatology, Autoimmunity and Orthopedics. Warsaw, Poland. 9th European Congress on. October 16-17, 2018 9th European Congress on October 16-17, 2018 SPONSORSHIP Rheumatology, Autoimmunity and Orthopedics http://rheumatology.conferenceseries.com/ Invitation Dear Potential Sponsor/Exhibitor, Conference Series

More information

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate Proposed PIL NL/H/0653/001/IB/024/G PACKAGE LEAFLET: INFORMATION FOR THE USER MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate Read all of this leaflet

More information

DATA SHEET. Clinical studies have shown mean intraocular pressure decreases of up to 9 mmhg.

DATA SHEET. Clinical studies have shown mean intraocular pressure decreases of up to 9 mmhg. DATA SHEET NAME OF MEDICINE LUMIGAN (bimatoprost) 0.3 mg/ml eye drops Presentation LUMIGAN (bimatoprost) eye drops are a clear, isotonic, colourless, sterile ophthalmic solution. Bimatoprost is a white

More information

JANUARY. 19TH ANNUAL Retina Fellows Forum. Westin Chicago River North, Chicago, IL

JANUARY. 19TH ANNUAL Retina Fellows Forum. Westin Chicago River North, Chicago, IL 19TH ANNUAL Retina Fellows Forum SM JANUARY -, Westin Chicago River North, Chicago, IL Course Director: Course Co-Directors: Carl C. Awh, MD and David R. Chow, MD Faculty Thomas A. Albini, MD Bascom Palmer

More information

Digestive & Metabolic Diseases

Digestive & Metabolic Diseases 4 th World Congress on Digestive & Metabolic Diseases October 29-30, 2018 San Francisco, California, USA Invitation Dear Attendees, We are glad to announce the 4 th World Congress on Digestive & Metabolic

More information

12+ Interactive Sessions. 5+ Workshops. 5+ Keynote Lectures. 10+ Exhibitors. Neurology and Neurosurgery. 50+ Plenary Lectures.

12+ Interactive Sessions. 5+ Workshops. 5+ Keynote Lectures. 10+ Exhibitors. Neurology and Neurosurgery. 50+ Plenary Lectures. 28 th Global Neurologists Annual Meeting on conferenceseries.com Neurology and Neurosurgery November 01-03, 2018 Brussels, Belgium Dear Attendees, Invitation We are glad to announce the 28 th Global Neurologists

More information

This indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye.

This indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye. Page 1 of 5 SCHEDULING STATUS Schedule 0 PROPRIETARY NAME AND DOSAGE FORM REFRESH LIQUIGEL COMPOSITION REFRESH LIQUIGEL lubricant eye drops contain carboxymethylcellulose sodium 10 mg/ml. Preservative:

More information

AUSTRALIAN PRODUCT INFORMATION ACULAR (ketorolac trometamol) Eye Drops

AUSTRALIAN PRODUCT INFORMATION ACULAR (ketorolac trometamol) Eye Drops AUSTRALIAN PRODUCT INFORMATION ACULAR (ketorolac trometamol) Eye Drops 1 NAME OF THE MEDICINE Ketorolac trometamol 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACULAR contains ketorolac trometamol 5 mg/ml.

More information

Chemical Names: Prednisolone acetate: 11ß,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate.

Chemical Names: Prednisolone acetate: 11ß,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate. PRED-G (gentamicin and prednisolone acetate ophthalmic suspension, USP) 0.3%/1% sterile DESCRIPTION PRED-G sterile ophthalmic suspension is a topical anti-inflammatory/anti-infective combination product

More information

Department of Ophthalmology

Department of Ophthalmology Department of Ophthalmology Period : 02/July/18 to 30/August/18 Semester : 7 th Semester Lecture Lesson Plan Sr. Date Topic Lesson plan Name of Faculty No. 1 02.07.18 Lens- Lens-Anatomy, Classification

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2. QUALITATIVE AND QUANTITATIVE COMPOSITION NEW ZEALAND DATA SHEET 1. PRODUCT NAME ISOPTO CARPINE pilocarpine hydrochloride eye drops 1% ISOPTO CARPINE pilocarpine hydrochloride eye drops 2% ISOPTO CARPINE pilocarpine hydrochloride eye drops 4%

More information

12+ Interactive Sessions. 5+ Workshops. 5+ Keynote Lectures. 20+ Exhibitors. Control and Prevention of HIV/AIDS, STDs & STIs. 50+ Plenary Lectures

12+ Interactive Sessions. 5+ Workshops. 5+ Keynote Lectures. 20+ Exhibitors. Control and Prevention of HIV/AIDS, STDs & STIs. 50+ Plenary Lectures 6 th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs conferenceseries.com October 29-30, 2018 Valencia, Spain Dear Attendees, Invitation We are glad to announce the 6 th World Congress

More information

23rd Annual World Dental Summit

23rd Annual World Dental Summit 23rd Annual World Dental Summit March 11-13, 2019 https://worlddental.conferenceseries.com/ Invitation Dear Attendees, Conference Series LLC Ltd hosting and welcomes you at 23rd Annual World Dental Summit

More information

Summary of the risk management plan (RMP) for Izba (travoprost)

Summary of the risk management plan (RMP) for Izba (travoprost) EMA/14138/2014 Summary of the risk management plan (RMP) for Izba (travoprost) This is a summary of the risk management plan (RMP) for Izba, which details the measures to be taken in order to ensure that

More information

PRODUCT MONOGRAPH. (Fluorometholone 0.1% Ophthalmic Suspension), USP. Corticosteroid

PRODUCT MONOGRAPH. (Fluorometholone 0.1% Ophthalmic Suspension), USP. Corticosteroid PRODUCT MONOGRAPH Pr Sandoz Fluorometholone (Fluorometholone 0.1% Ophthalmic Suspension), USP Corticosteroid Sandoz Canada Inc., Date of Revision: June 21, 2012 145 Jules-Léger Boucherville, QC, Canada

More information

East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults

East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults Introduction Glaucoma is a group of eye diseases causing optic nerve damage. In most cases

More information

Glaucoma What You Should Know

Glaucoma What You Should Know Glaucoma What You Should Know U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute The National Eye Institute (NEI) conducts and supports research that leads

More information

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost Package leaflet: Information for the user Xalatan 50 micrograms/ml Eye drops, solution Latanoprost Read all of this leaflet carefully before you start using this medicine because it contains important

More information

PRED-G (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% sterile

PRED-G (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% sterile PRED-G (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% sterile PRED-G sterile ophthalmic ointment is a topical anti-inflammatory/anti-infective combination product for ophthalmic

More information

PHARMACOLOGY Class: Ketorolac trometamol is a member of the pyrrolo-pyrolle group of non-steroidal antiinflammatory

PHARMACOLOGY Class: Ketorolac trometamol is a member of the pyrrolo-pyrolle group of non-steroidal antiinflammatory ACULAR Eye Drops NAME OF THE DRUG Non-proprietary name: ketorolac trometamol. Chemical Structure: Chemical Name: ( )-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol

More information

TREATMENT TRACKER Indication LUMIGAN (bimatoprost ophthalmic solution) 0.01% is used for the reduction of high eye pressure, also called intraocular pressure (IOP), in people with open-angle glaucoma or

More information

AAO ASCME Summit Learn and Engage with Colleagues. September 10-11, 2016 at Delhi, India

AAO ASCME Summit Learn and Engage with Colleagues. September 10-11, 2016 at Delhi, India Learn and Engage with Colleagues September 10-11, 2016 at Delhi, India AAO ASCME Summit 2016 Date and Venue: September 10 th 11 th, 2016 at Delhi, India. Total No. Of Delegates: At Delhi: 219 AAO ASCME

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PRED FORTE Sterile Eye Suspension, prednisolone acetate 10 mg/ml sterile eye suspension

More information

AAO ASCME Summit Learn and Engage with Colleagues. September 13 14, 2016 at Kolkata, India

AAO ASCME Summit Learn and Engage with Colleagues. September 13 14, 2016 at Kolkata, India Learn and Engage with Colleagues September 13 14, 2016 at Kolkata, India AAO ASCME Summit 2016 Date and Venue: September 13 th 14 th, 2016 at Kolkata, India. Total No. Of Delegates: At Kolkata: 431 AAO

More information

What you can expect with OZURDEX

What you can expect with OZURDEX Important Information About Macular Edema Following Branch or Central Retinal Vein Occlusion (RVO) and Treatment For patients with RVO What you can expect with OZURDEX Approved Use OZURDEX (dexamethasone

More information

Autoimmunity. Autoimmunity Brochure. International Conference on. Autoimmunity Manchester, UK October 13-14, 2016

Autoimmunity. Autoimmunity Brochure. International Conference on. Autoimmunity Manchester, UK October 13-14, 2016 International Conference on Autoimmunity Manchester, UK October 13-14, 2016 Brochure Conference Secretariat 2360 Corporate Circle, Suite 400, Henderson, NV 89074-7722, USA Ph: +1-888-843-8169, Fax: +1-650-618-1417,

More information

Optometric Glaucoma Foundation

Optometric Glaucoma Foundation Optometric Glaucoma Foundation In partnership with the 2nd Annual Educators Program September 8, 2018 489 Minor Hall School of Optometry University of California, Berkeley Berkeley, CA Optometric Glaucoma

More information

Advances in gastric cancer

Advances in gastric cancer ESMO Asia 2016 Industry Satellite Symposium 16 19 December 2016, Singapore Advances in gastric cancer Chair: Ian Chau With Mitsuru Sasako, Kei Muro and Yung-Jue Bang Saturday 17th December, 12:45-14:15

More information

VI.2.2 Summary of treatment benefits

VI.2.2 Summary of treatment benefits EU-Risk Management Plan for Bimatoprost V01 aetiology), both OAG and ACG can be secondary conditions. Secondary glaucoma refers to any case in which another disorder (e.g. injury, inflammation, vascular

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 Proprietary name, Strength and Pharmaceutical Form LUMIGAN 0,03 % Eye Drops (each ml contains bimatoprost 0,3 mg) Read all of this leaflet

More information

Dermatopathology and Skin Diagnosis

Dermatopathology and Skin Diagnosis International Conference and Expo on Dermatopathology and Skin Diagnosis August 31-September 01, dermatology-skin.pathologyconferences.com Invitation Dear Attendees, We are glad to announce the Dermatopathology

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Contents METHODS... 2 Inclusion and exclusion criteria... 2 Supplementary table S1... 2 Assessment of abnormal ocular signs and symptoms... 3 Supplementary table S2... 3 Ocular

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Xatabloc 50 micrograms/ml + 5 mg/ml eye drops, solution. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution contains latanoprost

More information

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v. PRESCRIBING INFORMATION WITH CONSUMER INFORMATION Pr MYDRIACYL tropicamide ophthalmic solution, USP 0.5% and 1% w/v Anticholinergic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga, ON L5N 8C7 www.alcon.ca

More information

nepafenac 1mg/mL eye drops, suspension (Nevanac ) SMC No. (813/12) Alcon Laboratories (UK) Ltd

nepafenac 1mg/mL eye drops, suspension (Nevanac ) SMC No. (813/12) Alcon Laboratories (UK) Ltd nepafenac 1mg/mL eye drops, suspension (Nevanac ) SMC No. (813/12) Alcon Laboratories (UK) Ltd 05 October 2012 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product

More information

NEW ZEALAND DATA SHEET 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

NEW ZEALAND DATA SHEET 2 QUALITATIVE AND QUANTITATIVE COMPOSITION NEW ZEALAND DATA SHEET 1 PRODUCT NAME SOFRADEX, Ear/Eye Drops 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of drops contains framycetin sulfate 5mg, gramicidin 0.05mg and dexamethasone 0.5mg. For

More information

PROPOSED PACKAGE INSERT FOR XALACOM EYE DROPS

PROPOSED PACKAGE INSERT FOR XALACOM EYE DROPS PROPOSED PACKAGE INSERT FOR XALACOM EYE DROPS SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): XALACOM Eye Drops COMPOSITION: Each millilitre contains latanoprost 50 µg and timolol maleate equivalent

More information

YOUR VYZULTA TREATMENT GUIDE. Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information.

YOUR VYZULTA TREATMENT GUIDE. Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information. YOUR VYZULTA TREATMENT GUIDE Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information. INDICATION VYZULTA TM (latanoprostene bunod ophthalmic

More information

sodium [2-(2,6-dichloroanilino)phenyl] acetate, a phenylacetic acid derivative CH 2 COONa

sodium [2-(2,6-dichloroanilino)phenyl] acetate, a phenylacetic acid derivative CH 2 COONa PRODUCT INFORMATION VOLTAREN * OPHTHA Eye Drop (diclofenac sodium) NAME OF THE MEDICINE Active ingredient: Chemical name: Molecular formula: C 14 H 10 Cl 2 NNaO 2 CAS number: 15307-79-6 Molecular weight:

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zaditen 0.25 mg/ml, eye drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains 0.345 mg ketotifen fumarate corresponding

More information

PRODUCT INFORMATION. PREDNEFRIN FORTE Eye Drops NAME OF THE MEDICINE

PRODUCT INFORMATION. PREDNEFRIN FORTE Eye Drops NAME OF THE MEDICINE PRODUCT INFORMATION PREDNEFRIN FORTE Eye Drops NAME OF THE MEDICINE AUSTRALIAN APPROVED NAME The active constituents of PREDNEFRIN FORTE eye drops are prednisolone acetate and phenylephrine hydrochloride.

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 PATIENT INFORMATION LEAFLET Please read this leaflet carefully before using COMBIGAN. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor

More information